Citrus Sinensis ID: 021299

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310----
Protein Sequence
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHcccccccccEEEEEEEEcccccEEEEEEEEccccccccccHHHHHHHHHHHccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEcccccccccccccccccccEEEEEccccHHcccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccHHcccccccHHHHHHHHHcccccccccccHHHHHccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccEEEccEEEEEEEEccccccEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHcccccccEccEEEEEEccccEEEEEEcccEEHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRlgkqkegvnfTALREIKLLKelksphiielidafphkgnlhLVFEFMETDLETVIRntniflspaDIKSYMQMTLKGLAFCHKKwvlhrdmkpnnlligshgqlkladfglarifgspdrrftHQVFARWYrapellfgakqygagVDVWAAGCIFAELlnrrpflqgssdIDQLGKIFAAfgtatpsqwpdlaylpdyveyqyvaapplrslfpsasDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Flexible Loop (DISEMBL)
maevdlskkvadrylkrevlgegtygvvykaidtktgqtvaikkirlgkqkegvnfTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Low Complexity Region (SEG)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Disordered region (IsUnstruct)
**********ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLY***
Disordered Region (DISOPRED)
*************YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSS*
Disordered Region (DISEMBL)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Disordered Region (DISPRO)
*****LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSY*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLYSSN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	314	2.2.26 [Sep-21-2011]
P29620	424	Cyclin-dependent kinase D	yes	no	0.910	0.674	0.877	1e-149
A2Y4B6	424	Cyclin-dependent kinase D	N/A	no	0.910	0.674	0.877	1e-149
Q9LMT0	391	Cyclin-dependent kinase D	yes	no	0.920	0.739	0.840	1e-143
Q9C9U2	398	Cyclin-dependent kinase D	no	no	0.920	0.726	0.816	1e-141
Q9C9M7	348	Cyclin-dependent kinase D	no	no	0.907	0.818	0.807	1e-140
P50613	346	Cyclin-dependent kinase 7	yes	no	0.910	0.826	0.588	3e-98
Q03147	346	Cyclin-dependent kinase 7	yes	no	0.910	0.826	0.577	8e-97
P20911	352	Cyclin-dependent kinase 7	N/A	no	0.920	0.821	0.583	1e-96
P51952	329	Cyclin-dependent kinase 7	yes	no	0.901	0.860	0.576	2e-95
P51953	344	Cyclin-dependent kinase 7	N/A	no	0.907	0.828	0.564	1e-91

>sp|P29620|CDKD1_ORYSJ Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. japonica GN=CDKD-1 PE=1 SV=1

 Score =  528 bits (1360), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/286 (87%), Positives = 267/286 (93%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+VADRYLKREVLGEGTYGVV+KA+DTKTG TVAIKKIRLGK KEGVNFTALREIKLLKE
Sbjct: 13  KRVADRYLKREVLGEGTYGVVFKAVDTKTGNTVAIKKIRLGKYKEGVNFTALREIKLLKE 72

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK  +IIELIDAFP+KGNLHLVFEFMETDLE VIR+ NI LSPAD KSY+QM LKGLAFC
Sbjct: 73  LKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMMLKGLAFC 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HKKWVLHRDMKPNNLLIG+ GQLKLADFGLARIFGSP+R FTHQVFARWYRAPELLFG K
Sbjct: 133 HKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAPELLFGTK 192

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYG+ VD+WAAGCIFAELL RRPFLQGSSDIDQLGKIFAAFGT   SQWPD+ YLPDYVE
Sbjct: 193 QYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMVYLPDYVE 252

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YQ+V+APPLRSLFP ASDDALDLLS+MFTYDPKARITAQQALEHR+
Sbjct: 253 YQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRY 298

CDK-activating kinase that may control G1/S phase progression. May control the rate of cell differentiation to accomplish proper development of organs, or in response to a changing environment. Forms a complex with cyclin CYCH1-1 that phosphorylates CDKA-1 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.
Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|A2Y4B6|CDKD1_ORYSI Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. indica GN=CDKD-1 PE=2 SV=1

 Score =  526 bits (1355), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/286 (87%), Positives = 266/286 (93%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+VADRYLKREVLGEGTYGVV+KA DTKTG TVAIKKIRLGK KEGVNFTALREIKLLKE
Sbjct: 13  KRVADRYLKREVLGEGTYGVVFKADDTKTGNTVAIKKIRLGKYKEGVNFTALREIKLLKE 72

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK  +IIELIDAFP+KGNLHLVFEFMETDLE VIR+ NI LSPAD KSY+QM LKGLAFC
Sbjct: 73  LKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMMLKGLAFC 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HKKWVLHRDMKPNNLLIG+ GQLKLADFGLARIFGSP+R FTHQVFARWYRAPELLFG K
Sbjct: 133 HKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAPELLFGTK 192

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYG+ VD+WAAGCIFAELL RRPFLQGSSDIDQLGKIFAAFGT   SQWPD+ YLPDYVE
Sbjct: 193 QYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMVYLPDYVE 252

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YQ+V+APPLRSLFP ASDDALDLLS+MFTYDPKARITAQQALEHR+
Sbjct: 253 YQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRY 298

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9LMT0|CDKD3_ARATH Cyclin-dependent kinase D-3 OS=Arabidopsis thaliana GN=CDKD-3 PE=1 SV=1

 Score =  508 bits (1309), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 243/289 (84%), Positives = 260/289 (89%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           KKVADRYLK+EVLG+GTYGVV+KA DTKT QTVAIKKIRLGKQ+EGVN TALREIK+LKE
Sbjct: 6   KKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREIKMLKE 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK PHII LIDAFPHK NLHLVFEFMETDLE VIR++NIFLSPADIKSY+ MT KGLA+C
Sbjct: 66  LKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFKGLAYC 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H KWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSP+R+FTHQVFARWYRAPELLFGAK
Sbjct: 126 HDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPELLFGAK 185

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYGA VDVWA  CIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPDL  LPDYVE
Sbjct: 186 QYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKLPDYVE 245

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YQ+V AP LRSLFP+ SDDALDLLSKMFTYDPKARI+ +QALEHR+  S
Sbjct: 246 YQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTS 294

May form a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9C9U2|CDKD1_ARATH Cyclin-dependent kinase D-1 OS=Arabidopsis thaliana GN=CDKD-1 PE=1 SV=1

 Score =  500 bits (1287), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 236/289 (81%), Positives = 258/289 (89%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           KKVADRYLKREVLG+GTYGVV+KA DTK G+TVAIKKIRLGK+KEGVN TALREIKLLKE
Sbjct: 5   KKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIKLLKE 64

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK PHIIELIDAFPHK NLH+VFEFMETDLE VIR+ N++LSP D+KSY+QM LKGL +C
Sbjct: 65  LKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKGLEYC 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H KWVLHRDMKPNNLLIG +GQLKLADFGLARIFGSP R+FTHQVFARWYRAPELLFGAK
Sbjct: 125 HGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELLFGAK 184

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QY   VDVWAAGCIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPD+  LPDYVE
Sbjct: 185 QYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLPDYVE 244

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YQ+V AP LRSL P+ S+DALDLLSKMFTYDPK+RI+ QQAL+HR+  S
Sbjct: 245 YQFVPAPSLRSLLPTVSEDALDLLSKMFTYDPKSRISIQQALKHRYFTS 293

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9C9M7|CDKD2_ARATH Cyclin-dependent kinase D-2 OS=Arabidopsis thaliana GN=CDKD-2 PE=1 SV=1

 Score =  498 bits (1281), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 230/285 (80%), Positives = 257/285 (90%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           DRYL+R++LGEGTYGVVYKA DTKTG+TVA+KKIRLG QKEGVNFTALREIKLLKEL  P
Sbjct: 11  DRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALREIKLLKELNHP 70

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           HI+ELIDAFPH G+LHLVFE+M+TDLE VIR+ NIFLSP DIKSYM MTLKGLA+CHKKW
Sbjct: 71  HIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTLKGLAYCHKKW 130

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRDMKPNNLLIG +G LKLADFGLAR+FGSP+RRFTHQVFA WYRAPELLFG++QYGA
Sbjct: 131 VLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPELLFGSRQYGA 190

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           GVDVWAAGCIFAELL RRPFL GS++IDQLGKIF AFGT  PSQW D+ YLPDY+E+ Y 
Sbjct: 191 GVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIYLPDYMEFSYT 250

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
            APPLR++FP ASDDALDLL+KMF YDP+ RIT QQAL+HR+  S
Sbjct: 251 PAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSS 295

Forms a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P50613|CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens GN=CDK7 PE=1 SV=1

 Score =  358 bits (919), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 170/289 (58%), Positives = 215/289 (74%), Gaps = 3/289 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ ++
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q03147|CDK7_MOUSE Cyclin-dependent kinase 7 OS=Mus musculus GN=Cdk7 PE=1 SV=2

 Score =  353 bits (907), Expect = 8e-97,   Method: Compositional matrix adjust.
 Identities = 167/289 (57%), Positives = 214/289 (74%), Gaps = 3/289 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YV ++     PL+ +F +A DD L+L+  +F ++P  R TA QAL+ ++
Sbjct: 246 YVTFKSFPGVPLQHIFIAAGDDLLELIQGLFLFNPCTRTTASQALKTKY 294

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P20911|CDK7_XENLA Cyclin-dependent kinase 7 OS=Xenopus laevis GN=cdk7 PE=1 SV=1

 Score =  353 bits (905), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 171/293 (58%), Positives = 216/293 (73%), Gaps = 4/293 (1%)

Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALR 60
           VD+  + A +Y K + LGEG +  VYKA D  T + VAIKKI+LG + E   G+N TALR
Sbjct: 9   VDVRSR-AKQYEKLDFLGEGQFATVYKARDKNTDRIVAIKKIKLGHRAEANDGINRTALR 67

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++T++ L+PA IKSYM MT
Sbjct: 68  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDTSLVLTPAHIKSYMLMT 127

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           L+GL + H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYR+P
Sbjct: 128 LQGLEYLHHLWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRIYTHQVVTRWYRSP 187

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWP ++
Sbjct: 188 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPGMS 247

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            LPDYV ++     PL  +F +A DD L+LL  +FT++P AR TA QAL  R+
Sbjct: 248 SLPDYVAFKSFPGTPLHLIFIAAGDDLLELLQGLFTFNPCARCTASQALRKRY 300

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts (By similarity). Involved in negative regulation of the meiotic maturation of Xenopus oocytes.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51952|CDK7_RAT Cyclin-dependent kinase 7 (Fragment) OS=Rattus norvegicus GN=Cdk7 PE=2 SV=2

 Score =  348 bits (894), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 165/286 (57%), Positives = 212/286 (74%), Gaps = 3/286 (1%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
           A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct: 1   ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct: 61  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct: 121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct: 181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  ++
Sbjct: 241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKY 286

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51953|CDK7_CARAU Cyclin-dependent kinase 7 OS=Carassius auratus GN=cdk7 PE=2 SV=1

 Score =  336 bits (862), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 163/289 (56%), Positives = 209/289 (72%), Gaps = 4/289 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A  Y K + LGEG +  VYKA D  T   VAIKKI++G +   K+G+N TALREIKL
Sbjct: 6   KSRAKLYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ L+  FMETDLE +I++T++ L+PA+IK+Y+ M+L+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLLC-FMETDLEVIIKDTSLVLTPANIKAYILMSLQGL 124

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 125 EYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPELLF 184

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA G I AELL R PFL G SD+DQL  IF A GT T   WP ++ LPD
Sbjct: 185 GARMYGVGVDMWAVGSILAELLLRVPFLAGDSDLDQLTGIFEALGTPTEETWPGMSNLPD 244

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YV ++     PL  +F +A DD L+LL  +FT++P  R TA QAL+ R+
Sbjct: 245 YVSFKLFPGTPLEHIFSAAGDDLLELLKGLFTFNPCTRTTASQALKMRY 293

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts.

Carassius auratus (taxid: 7957)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	314
356531164	411	PREDICTED: cyclin-dependent kinase D-1-l	0.942	0.720	0.895	1e-156
449439111	418	PREDICTED: cyclin-dependent kinase D-1-l	0.942	0.708	0.895	1e-156
356524652	413	PREDICTED: LOW QUALITY PROTEIN: cyclin-d	0.942	0.716	0.885	1e-155
356520635	411	PREDICTED: LOW QUALITY PROTEIN: cyclin-d	0.942	0.720	0.891	1e-155
15419985	412	CDK-activating kinase [Medicago sativa s	0.933	0.711	0.883	1e-153
356513008	412	PREDICTED: cyclin-dependent kinase D-1-l	0.942	0.718	0.871	1e-152
255583528	399	cak1, putative [Ricinus communis] gi|223	0.942	0.741	0.881	1e-151
225456067	422	PREDICTED: cyclin-dependent kinase D-1 [	0.942	0.701	0.875	1e-151
156104834	411	CDK activating kinase [Nicotiana tabacum	0.939	0.717	0.869	1e-150
224118722	416	predicted protein [Populus trichocarpa]	0.942	0.711	0.861	1e-148

>gi|356531164|ref|XP_003534148.1| PREDICTED: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  555 bits (1431), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 265/296 (89%), Positives = 278/296 (93%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MAE+DLSKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MAELDLSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LSP DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSPGDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAICHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARVFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT + SQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSASQWPDMI 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           +LPDYVEYQ+V APPLRSLFP ASDDALDLLSKMFTYDPKARI+ QQALEHR+  S
Sbjct: 241 FLPDYVEYQHVPAPPLRSLFPMASDDALDLLSKMFTYDPKARISVQQALEHRYFSS 296

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439111|ref|XP_004137331.1| PREDICTED: cyclin-dependent kinase D-1-like [Cucumis sativus] gi|449497514|ref|XP_004160424.1| PREDICTED: cyclin-dependent kinase D-1-like [Cucumis sativus]

 Score =  555 bits (1430), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 265/296 (89%), Positives = 278/296 (93%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA++D SKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MADLDPSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK  +IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY+QMT
Sbjct: 61  EIKLLKELKDSNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLARIFGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG+ VDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT TPSQWPD+ 
Sbjct: 181 ELLFGTKQYGSAVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPTPSQWPDML 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YLPDYVE+QYV APPLRSLFP ASDD LDLLSKMF YDPK+RIT QQALEHR+  S
Sbjct: 241 YLPDYVEFQYVPAPPLRSLFPMASDDTLDLLSKMFAYDPKSRITIQQALEHRYFTS 296

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524652|ref|XP_003530942.1| PREDICTED: LOW QUALITY PROTEIN: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 262/296 (88%), Positives = 279/296 (94%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+++D SKKVADRYLKREVLGEGTYGVVYKAIDT TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSDMDPSKKVADRYLKREVLGEGTYGVVYKAIDTHTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+I+ELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP+D KSY+QMT
Sbjct: 61  EIKLLKELKDPNIVELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPSDTKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARMFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYG GVDVWAAGCIFAELL RRPFLQG+SDIDQLGKIF+AFGT T SQWPD+ 
Sbjct: 181 ELLFGAKQYGPGVDVWAAGCIFAELLLRRPFLQGTSDIDQLGKIFSAFGTPTASQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YLPDYVEYQYV APPLRSLFP  +DDALDLLSKMFTYDPKARI+ QQALEHR+  S
Sbjct: 241 YLPDYVEYQYVPAPPLRSLFPMVTDDALDLLSKMFTYDPKARISVQQALEHRYFSS 296

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520635|ref|XP_003528966.1| PREDICTED: LOW QUALITY PROTEIN: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  553 bits (1424), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 264/296 (89%), Positives = 277/296 (93%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MAE+DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MAELDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LSP+DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSPSDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAICHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARVFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT + SQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSASQWPDMI 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           +LPDYVEYQ+V APPLRSLFP ASDDALDLL KMFTYDPKARI+  QALEHR+  S
Sbjct: 241 FLPDYVEYQHVPAPPLRSLFPMASDDALDLLXKMFTYDPKARISVPQALEHRYFSS 296

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15419985|gb|AAK97227.1|AF302013_1 CDK-activating kinase [Medicago sativa subsp. x varia]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 259/293 (88%), Positives = 274/293 (93%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M E+D SKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIR+GKQKEGVNFTALR
Sbjct: 1   MTELDPSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRIGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELID FPHKGNLHLVFEFMETDLE VIR+ NIFL+P DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDCFPHKGNLHLVFEFMETDLEAVIRDRNIFLAPGDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKW+LHRDMKPNNLLIG +GQLKLADFGLARIFGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAHCHKKWILHRDMKPNNLLIGPNGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT +PSQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSPSQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YLPDYVEYQ+V APPLRSLFP A+DDALDLLSKMFTYDPK RI+ QQALEHR+
Sbjct: 241 YLPDYVEYQFVPAPPLRSLFPMATDDALDLLSKMFTYDPKDRISVQQALEHRY 293

Source: Medicago sativa subsp. x varia

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513008|ref|XP_003525206.1| PREDICTED: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  544 bits (1401), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 258/296 (87%), Positives = 274/296 (92%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M ++D SKKVADRYLKREVLGEGTYGVVYKAIDT TGQTVAIKKIRLGK+KEGVNFTALR
Sbjct: 1   MTDMDHSKKVADRYLKREVLGEGTYGVVYKAIDTHTGQTVAIKKIRLGKRKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+I+ELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP D KSY+QMT
Sbjct: 61  EIKLLKELKDPNIVELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPGDTKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARMFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYG GVDVWAAGCIFAELL RRPFLQG+SDIDQLGKIF+AFG  T  QWPD+ 
Sbjct: 181 ELLFGAKQYGPGVDVWAAGCIFAELLLRRPFLQGTSDIDQLGKIFSAFGIPTAPQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YLPDYVEYQYV APPLRSLFP A+DDALDLLSKMFTYDPK RI+  QALEHR+  S
Sbjct: 241 YLPDYVEYQYVLAPPLRSLFPMATDDALDLLSKMFTYDPKTRISVHQALEHRYFSS 296

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583528|ref|XP_002532521.1| cak1, putative [Ricinus communis] gi|223527752|gb|EEF29855.1| cak1, putative [Ricinus communis]

 Score =  541 bits (1394), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 261/296 (88%), Positives = 271/296 (91%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+E D  KKVADRYLKRE+LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSENDGEKKVADRYLKREILGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKE+K P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY QMT
Sbjct: 61  EIKLLKEIKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYFQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLI  +GQLKLADFGLARIFGSPDR+FTHQVFARWYRAP
Sbjct: 121 LKGLAVCHKKWVLHRDMKPNNLLIAPNGQLKLADFGLARIFGSPDRKFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYGAGVDVWAA CIFAELL RRPFLQGSSDIDQLGKIF AFGT +PSQWPDL 
Sbjct: 181 ELLFGTKQYGAGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFQAFGTPSPSQWPDLV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           YLPDYVEYQ V A P R LFP ASDDALDLL KMFTYDPKARITA+QALEHR+  S
Sbjct: 241 YLPDYVEYQSVPAQPWRKLFPMASDDALDLLIKMFTYDPKARITAEQALEHRYFSS 296

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456067|ref|XP_002280613.1| PREDICTED: cyclin-dependent kinase D-1 [Vitis vinifera] gi|297734275|emb|CBI15522.3| unnamed protein product [Vitis vinifera]

 Score =  539 bits (1388), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 261/298 (87%), Positives = 272/298 (91%), Gaps = 2/298 (0%)

Query: 1   MAEVD--LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           M+EV    SKKVADRYLKREVLGEGTYGVV KAIDTKTGQ VAIKKIRLGK KEGVNFTA
Sbjct: 1   MSEVPNVFSKKVADRYLKREVLGEGTYGVVSKAIDTKTGQIVAIKKIRLGKHKEGVNFTA 60

Query: 59  LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LREIKLLKELK PHIIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LS ADIKS++Q
Sbjct: 61  LREIKLLKELKDPHIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSLADIKSFLQ 120

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           MTLKGLAFCHKKWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSPDR+FTHQVFARWYR
Sbjct: 121 MTLKGLAFCHKKWVLHRDMKPNNLLIGDKGQLKLADFGLARIFGSPDRKFTHQVFARWYR 180

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APELLFG+KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT  P+QWPD
Sbjct: 181 APELLFGSKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKPAQWPD 240

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           + YLPDYVEYQ+V APPLRSLFP ASDDALDLLSKMFTYDPK RI+ QQALEHR+  S
Sbjct: 241 MVYLPDYVEYQFVPAPPLRSLFPMASDDALDLLSKMFTYDPKTRISVQQALEHRYFTS 298

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|156104834|dbj|BAF75824.1| CDK activating kinase [Nicotiana tabacum]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 259/298 (86%), Positives = 277/298 (92%), Gaps = 3/298 (1%)

Query: 1   MAEVD--LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           M EVD  L+KKVADRYLKREVLGEGTYGVV+KAIDTK+GQTVAIKKIRLGKQKEGVNFTA
Sbjct: 1   MTEVDNLLTKKVADRYLKREVLGEGTYGVVFKAIDTKSGQTVAIKKIRLGKQKEGVNFTA 60

Query: 59  LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LREIKLLKELK PH+IELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY+Q
Sbjct: 61  LREIKLLKELKDPHVIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYIQ 120

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           MTLKGLAFCHKK+VLHRDMKPNNLLIG  GQLKLADFGLAR+FGSPD RFTHQVFARWYR
Sbjct: 121 MTLKGLAFCHKKYVLHRDMKPNNLLIGPKGQLKLADFGLARLFGSPD-RFTHQVFARWYR 179

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APELLFGAKQYG GVDVWAA CIFAELL RRPFLQG+SDIDQLGKIFAAFGT  PSQW D
Sbjct: 180 APELLFGAKQYGPGVDVWAAACIFAELLLRRPFLQGNSDIDQLGKIFAAFGTPKPSQWAD 239

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           + YLPDYVEYQYV   PL++LFP+A++DALDLLSKMF+YDPKARI+AQQALEHR+  S
Sbjct: 240 MVYLPDYVEYQYVPGQPLKTLFPTATEDALDLLSKMFSYDPKARISAQQALEHRYFSS 297

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118722|ref|XP_002317890.1| predicted protein [Populus trichocarpa] gi|222858563|gb|EEE96110.1| predicted protein [Populus trichocarpa]

 Score =  531 bits (1367), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 255/296 (86%), Positives = 267/296 (90%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+E D+ KKVADRYLKRE+LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSENDVEKKVADRYLKREILGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP DIKSY QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDPNIFLSPGDIKSYFQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGL  CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLARIFGSP R+FTHQVFARWYRAP
Sbjct: 121 LKGLLVCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYGAGVDVWAAGCI AELLNRRPFLQG SDIDQLGKIF   GT TPSQWPDL 
Sbjct: 181 ELLFGAKQYGAGVDVWAAGCILAELLNRRPFLQGDSDIDQLGKIFQKLGTPTPSQWPDLE 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           +LPD+VEY    A P R L P+ASDDALDLLSK+FTYDPK RIT QQALEHR+  S
Sbjct: 241 WLPDFVEYSSQTAQPWRKLCPTASDDALDLLSKLFTYDPKTRITVQQALEHRYFTS 296

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	314
TAIR|locus:2194045	391	CDKD1;3 "cyclin-dependent kina	0.920	0.739	0.840	2.5e-129
TAIR|locus:2027819	398	CDKD1;1 "cyclin-dependent kina	0.920	0.726	0.816	2e-127
TAIR|locus:2033349	348	CAK4 "CDK-activating kinase 4"	0.907	0.818	0.807	2.6e-127
UNIPROTKB|P50613	346	CDK7 "Cyclin-dependent kinase	0.910	0.826	0.588	8.3e-90
UNIPROTKB|C9K505	346	CDK7 "Uncharacterized protein"	0.920	0.835	0.576	4.6e-89
UNIPROTKB|Q08DX5	346	CDK7 "Cyclin-dependent kinase	0.920	0.835	0.576	5.9e-89
MGI|MGI:102956	346	Cdk7 "cyclin-dependent kinase	0.920	0.835	0.573	9.6e-89
ZFIN|ZDB-GENE-010320-2	345	cdk7 "cyclin-dependent kinase	0.910	0.828	0.581	2.5e-88
RGD|621124	329	Cdk7 "cyclin-dependent kinase	0.901	0.860	0.576	4.7e-87
UNIPROTKB|P51952	329	Cdk7 "Cyclin-dependent kinase	0.901	0.860	0.576	4.7e-87

TAIR|locus:2194045 CDKD1;3 "cyclin-dependent kinase D1;3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1269 (451.8 bits), Expect = 2.5e-129, P = 2.5e-129
 Identities = 243/289 (84%), Positives = 260/289 (89%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             KKVADRYLK+EVLG+GTYGVV+KA DTKT QTVAIKKIRLGKQ+EGVN TALREIK+LKE
Sbjct:     6 KKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREIKMLKE 65

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             LK PHII LIDAFPHK NLHLVFEFMETDLE VIR++NIFLSPADIKSY+ MT KGLA+C
Sbjct:    66 LKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFKGLAYC 125

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H KWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSP+R+FTHQVFARWYRAPELLFGAK
Sbjct:   126 HDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPELLFGAK 185

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
             QYGA VDVWA  CIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPDL  LPDYVE
Sbjct:   186 QYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKLPDYVE 245

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
             YQ+V AP LRSLFP+ SDDALDLLSKMFTYDPKARI+ +QALEHR+  S
Sbjct:   246 YQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTS 294

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000280 "nuclear division" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

TAIR|locus:2027819 CDKD1;1 "cyclin-dependent kinase D1;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
 Identities = 236/289 (81%), Positives = 258/289 (89%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             KKVADRYLKREVLG+GTYGVV+KA DTK G+TVAIKKIRLGK+KEGVN TALREIKLLKE
Sbjct:     5 KKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIKLLKE 64

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             LK PHIIELIDAFPHK NLH+VFEFMETDLE VIR+ N++LSP D+KSY+QM LKGL +C
Sbjct:    65 LKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKGLEYC 124

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H KWVLHRDMKPNNLLIG +GQLKLADFGLARIFGSP R+FTHQVFARWYRAPELLFGAK
Sbjct:   125 HGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELLFGAK 184

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
             QY   VDVWAAGCIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPD+  LPDYVE
Sbjct:   185 QYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLPDYVE 244

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
             YQ+V AP LRSL P+ S+DALDLLSKMFTYDPK+RI+ QQAL+HR+  S
Sbjct:   245 YQFVPAPSLRSLLPTVSEDALDLLSKMFTYDPKSRISIQQALKHRYFTS 293

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030154 "cell differentiation" evidence=TAS

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

TAIR|locus:2033349 CAK4 "CDK-activating kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
 Identities = 230/285 (80%), Positives = 257/285 (90%)

Query:    12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             DRYL+R++LGEGTYGVVYKA DTKTG+TVA+KKIRLG QKEGVNFTALREIKLLKEL  P
Sbjct:    11 DRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALREIKLLKELNHP 70

Query:    72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
             HI+ELIDAFPH G+LHLVFE+M+TDLE VIR+ NIFLSP DIKSYM MTLKGLA+CHKKW
Sbjct:    71 HIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTLKGLAYCHKKW 130

Query:   132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
             VLHRDMKPNNLLIG +G LKLADFGLAR+FGSP+RRFTHQVFA WYRAPELLFG++QYGA
Sbjct:   131 VLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPELLFGSRQYGA 190

Query:   192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
             GVDVWAAGCIFAELL RRPFL GS++IDQLGKIF AFGT  PSQW D+ YLPDY+E+ Y 
Sbjct:   191 GVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIYLPDYMEFSYT 250

Query:   252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
              APPLR++FP ASDDALDLL+KMF YDP+ RIT QQAL+HR+  S
Sbjct:   251 PAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSS 295

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

UNIPROTKB|P50613 CDK7 "Cyclin-dependent kinase 7" [Homo sapiens (taxid:9606)]

 Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
 Identities = 170/289 (58%), Positives = 215/289 (74%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
             K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct:     6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query:    65 LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct:    66 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query:   125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
              + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct:   126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query:   185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct:   186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query:   245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ ++
Sbjct:   246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

GO:0005524 "ATP binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0003713 "transcription coactivator activity" evidence=NAS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=NAS

GO:0050681 "androgen receptor binding" evidence=NAS

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IDA;TAS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0008022 "protein C-terminus binding" evidence=IPI

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IDA

GO:0030521 "androgen receptor signaling pathway" evidence=NAS

GO:0005675 "holo TFIIH complex" evidence=IDA

GO:0008094 "DNA-dependent ATPase activity" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006281 "DNA repair" evidence=TAS

GO:0006283 "transcription-coupled nucleotide-excision repair" evidence=TAS

GO:0006289 "nucleotide-excision repair" evidence=TAS

GO:0006360 "transcription from RNA polymerase I promoter" evidence=TAS

GO:0006361 "transcription initiation from RNA polymerase I promoter" evidence=TAS

GO:0006362 "transcription elongation from RNA polymerase I promoter" evidence=TAS

GO:0006363 "termination of RNA polymerase I transcription" evidence=TAS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=TAS

GO:0006368 "transcription elongation from RNA polymerase II promoter" evidence=TAS

GO:0006370 "7-methylguanosine mRNA capping" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016032 "viral reproduction" evidence=TAS

GO:0050434 "positive regulation of viral transcription" evidence=TAS

GO:0000080 "G1 phase of mitotic cell cycle" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0000718 "nucleotide-excision repair, DNA damage removal" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

UNIPROTKB|C9K505 CDK7 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 889 (318.0 bits), Expect = 4.6e-89, P = 4.6e-89
 Identities = 169/293 (57%), Positives = 218/293 (74%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              LPD+V ++     PL+ +F +A DD LDL+  +F ++P  RITA QAL+ ++
Sbjct:   242 SLPDFVTFKSFPGIPLQHIFIAAGDDLLDLIQGLFLFNPCTRITATQALKTKY 294

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q08DX5 CDK7 "Cyclin-dependent kinase 7" [Bos taurus (taxid:9913)]

 Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
 Identities = 169/293 (57%), Positives = 217/293 (74%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPSRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              LPD+V ++     PL+ +F +A DD LDL+  +F ++P  RITA QAL+ ++
Sbjct:   242 SLPDFVTFKSFPGIPLQHIFIAAGDDLLDLIQGLFLFNPCTRITATQALKTKY 294

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0008094 "DNA-dependent ATPase activity" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005675 "holo TFIIH complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:102956 Cdk7 "cyclin-dependent kinase 7" [Mus musculus (taxid:10090)]

 Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
 Identities = 168/293 (57%), Positives = 217/293 (74%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              LPDYV ++     PL+ +F +A DD L+L+  +F ++P  R TA QAL+ ++
Sbjct:   242 SLPDYVTFKSFPGVPLQHIFIAAGDDLLELIQGLFLFNPCTRTTASQALKTKY 294

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005829 "cytosol" evidence=ISO

GO:0005856 "cytoskeleton" evidence=ISO

GO:0006281 "DNA repair" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;ISS;IDA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007049 "cell cycle" evidence=ISS

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0016020 "membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032403 "protein complex binding" evidence=ISO

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0051301 "cell division" evidence=IEA

ZFIN|ZDB-GENE-010320-2 cdk7 "cyclin-dependent kinase 7" [Danio rerio (taxid:7955)]

 Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
 Identities = 168/289 (58%), Positives = 215/289 (74%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
             K  A RY K + LGEG +  VYKA D  T   VAIKKI++G +   K+G+N TALREIKL
Sbjct:     6 KSRAKRYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREIKL 65

Query:    65 LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             L+EL  P+II L+DAF HK N+ LVF++METDLE +I++T++ L+PA+IK+Y+ MTL+GL
Sbjct:    66 LQELSHPNIIGLLDAFGHKSNISLVFDYMETDLEVIIKDTSLVLTPANIKAYILMTLQGL 125

Query:   125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
              + H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct:   126 EYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPELLF 185

Query:   185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             GA+ YG GVD+WA GCI AELL R PFL G SD+DQL KIF A GT T   WP ++ LPD
Sbjct:   186 GARMYGVGVDMWAVGCILAELLLRVPFLAGDSDLDQLTKIFEALGTPTDEIWPGMSSLPD 245

Query:   245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             YV ++     PL  +F +A DD L+LL  +FTY+P +R TA QAL+ ++
Sbjct:   246 YVSFKPFPGTPLEHIFSAAGDDLLELLRGLFTYNPCSRTTAMQALKMKY 294

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

RGD|621124 Cdk7 "cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
 Identities = 165/286 (57%), Positives = 212/286 (74%)

Query:    11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
             A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct:     1 ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct:    61 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct:   121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
              YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct:   181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  ++
Sbjct:   241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKY 286

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=TAS

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO;ISS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005856 "cytoskeleton" evidence=IDA

GO:0006281 "DNA repair" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO;ISS

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007126 "meiosis" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO;ISS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO;ISS

GO:0016020 "membrane" evidence=IDA

GO:0016301 "kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=ISO

GO:0032403 "protein complex binding" evidence=IDA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|P51952 Cdk7 "Cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
 Identities = 165/286 (57%), Positives = 212/286 (74%)

Query:    11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
             A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct:     1 ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct:    61 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct:   121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
              YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct:   181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  ++
Sbjct:   241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKY 286

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A2Y4B6	CDKD1_ORYSI	2, ., 7, ., 1, 1, ., 2, 3	0.8776	0.9108	0.6745	N/A	no
P50613	CDK7_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.5882	0.9108	0.8265	yes	no
P29620	CDKD1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.8776	0.9108	0.6745	yes	no
P20911	CDK7_XENLA	2, ., 7, ., 1, 1, ., 2, 3	0.5836	0.9203	0.8210	N/A	no
Q9LMT0	CDKD3_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.8408	0.9203	0.7391	yes	no
Q12126	CRK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.4897	0.9203	0.8626	yes	no
P51952	CDK7_RAT	2, ., 7, ., 1, 1, ., 2, 3	0.5769	0.9012	0.8601	yes	no
P51953	CDK7_CARAU	2, ., 7, ., 1, 1, ., 2, 3	0.5640	0.9076	0.8284	N/A	no
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.4722	0.9108	0.9930	yes	no
Q03147	CDK7_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.5778	0.9108	0.8265	yes	no
Q9C9M7	CDKD2_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.8070	0.9076	0.8189	no	no
P54685	CDK7_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5328	0.9076	0.7916	yes	no
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.4720	0.9044	0.9861	yes	no
P06242	KIN28_YEAST	2, ., 7, ., 1, 1, ., 2, 3	0.4744	0.9171	0.9411	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.991
3rd Layer	2.7.11.23	0.991
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	314
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	0.0
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-150
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-134
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-128
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-120
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-119
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-109
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-108
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-107
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-105
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-103
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-101
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-101
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-98
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-97
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-96
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-96
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-95
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-94
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-94
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-93
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-92
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-92
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-87
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-87
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-85
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-85
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-83
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-78
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-75
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-74
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-74
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-74
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-73
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-71
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-70
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-69
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-69
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-69
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-68
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-67
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-65
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-61
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-61
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-60
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-59
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-59
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-58
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-53
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-52
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-51
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-50
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-50
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-50
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-50
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-47
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-44
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-44
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-42
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-41
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-39
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-34
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-33
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-32
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-31
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-30
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-30
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-28
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-27
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-26
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-26
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-25
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-25
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-25
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-25
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-24
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-23
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-22
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-21
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-21
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-18
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-17
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	0.003
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.004

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  529 bits (1366), Expect = 0.0
 Identities = 190/287 (66%), Positives = 227/287 (79%), Gaps = 3/287 (1%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELK 69
           RY K + LGEGTY VVYKA D +TG+ VAIKKI+LG++KE   G+NFTALREIKLL+ELK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+II L+D F HK N++LVFEFMETDLE VI++ +I L+PADIKSYM MTL+GL + H 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            W+LHRD+KPNNLLI S G LKLADFGLAR FGSP+R+ THQV  RWYRAPELLFGA+ Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G GVD+W+ GCIFAELL R PFL G SDIDQLGKIF A GT T   WP +  LPDYVE++
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                PL+ +FP+ASDDALDLL ++ T +P  RITA+QALEH +  +
Sbjct: 241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  421 bits (1084), Expect = e-150
 Identities = 145/281 (51%), Positives = 186/281 (66%), Gaps = 1/281 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E LGEGTYGVVYKA D KTG+ VA+KKIRL  ++EG+  TALREI LLKELK P+I
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L+D    +  L+LVFE+ + DL+  +      LSP  IKS M   L+GLA+CH   +L
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP N+LI   G LKLADFGLAR FG P R +TH+V   WYRAPE+L G+K Y   V
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV 180

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQYVA 252
           D+W+ GCIFAE++  +P   G S+IDQL KIF   GT T   WP +  LPDY   +    
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              L  + P    + +DLLSKM  Y+P  RI+A++AL+H +
Sbjct: 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  383 bits (985), Expect = e-134
 Identities = 165/282 (58%), Positives = 195/282 (69%), Gaps = 2/282 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K   +GEGTYGVVYKA D  TG+ VAIKKI+L  + EG+  TALREIKLLKEL  P+I
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           I+L+D F HKG+L+LVFEFM+TDL  +I++    L  + IKSY+   L+GLAFCH   +L
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP NLLI + G LKLADFGLAR FGSP R +TH V  RWYRAPELL G K Y   V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--VEYQYV 251
           D+W+ GCIFAELL+RRP   G S+IDQL KIF   GT  P  WP    L       +   
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           A  PL  LFP+AS  ALDLLS+M  YDP  RITA+QAL H +
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  366 bits (942), Expect = e-128
 Identities = 137/284 (48%), Positives = 189/284 (66%), Gaps = 3/284 (1%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     +GEG +G+V+KA D +TG+TVA+KK+ L + + G+   ALREIK L+  + P+
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +++L+D FPH     LV E+M +DL  V+R+    L  A +KSYM+M LKG+A+ H   +
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FTHQVFARWYRAPELLFGAKQYGA 191
           +HRD+KP NLLI + G LK+ADFGLAR+F   + R ++HQV  RWYRAPELL+GA++Y  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           GVD+WA GCIFAELLN  P   G +DI+QL  +F   GT     WP L  LPDY +  + 
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240

Query: 252 AAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            + P  L  +FP AS +ALDLL  +  YDP  R++A +AL H +
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  346 bits (890), Expect = e-120
 Identities = 129/286 (45%), Positives = 183/286 (63%), Gaps = 6/286 (2%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K   +GEGTYG VYKA + KTG+ VA+KKIR+  +KEG   TA+REIKLL++L+ P+I
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 74  IELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L +      KG++++VFE+M+ DL  ++ +  +  + + IK YM+  L+GL + H   
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           +LHRD+K +N+LI + G LKLADFGLAR +       +T++V   WYR PELL GA +YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCI AEL   +P  QGS++++QL KIF   G+ T   WP ++ LP +   + 
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240

Query: 251 VAAPP--LRSLFPSASD-DALDLLSKMFTYDPKARITAQQALEHRF 293
                  LR  F    D  ALDLL K+ T DPK RI+A QAL+H +
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  345 bits (886), Expect = e-119
 Identities = 148/282 (52%), Positives = 189/282 (67%), Gaps = 2/282 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E +GEGTYGVVYKA D  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P+I
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L+D    +  L+LVFEF++ DL+  + ++    L P  IKSY+   L+G+A+CH   V
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI   G LKLADFGLAR FG P R +TH+V   WYRAPE+L G++QY   
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTP 180

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYV 251
           VD+W+ GCIFAE++NRRP   G S+IDQL +IF   GT     WP +  LPDY   +   
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           A   L  + P+  +D LDLLSKM  YDP  RI+A+ AL+H +
Sbjct: 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  318 bits (818), Expect = e-109
 Identities = 138/281 (49%), Positives = 183/281 (65%), Gaps = 3/281 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E +GEGTYGVVYK  + KTGQ VA+KKIRL  ++EGV  TA+REI LLKEL+ P+I
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L D    +  L+L+FEF+  DL+  + +     ++    +KSY+   L+G+ FCH + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G+ +Y  
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQY 250
            VD+W+ G IFAE+  ++P   G S+IDQL +IF   GT T   WP +  LPDY   +  
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                LRS   +  +D LDLL KM  YDP  RI+A++AL H
Sbjct: 242 WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  315 bits (808), Expect = e-108
 Identities = 141/280 (50%), Positives = 180/280 (64%), Gaps = 2/280 (0%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P+I++
Sbjct: 4   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L+D    +  L+LVFEF+  DL+  +  + +  +    IKSY+   L+GLAFCH   VLH
Sbjct: 64  LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y   VD
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 183

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQYVAA 253
           +W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  LPDY   +   A 
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                + P   +D  DLLS+M  YDP  RI+A+ AL H F
Sbjct: 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  314 bits (806), Expect = e-107
 Identities = 126/285 (44%), Positives = 180/285 (63%), Gaps = 24/285 (8%)

Query: 22  EGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL----- 76
           EGTYGVVY+A D KTG+ VA+KK+++ K+KEG   T+LREI +L +L+ P+I+ +     
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 77  ---IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
              +D       +++V E++E DL++++         +++K  M   L G+A  H  W+L
Sbjct: 75  GSNLD------KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K +NLL+ + G LK+ DFGLAR +GSP + +T  V   WYRAPELL GAK+Y   +
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP-----DYVEY 248
           D+W+ GCIFAELL ++P   G S+IDQL KIF   GT T   WP  + LP      + +Y
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248

Query: 249 QYVAAPPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEH 291
            Y     LR  FP  S SD+  DLL+++ TYDP  RI+A+ AL+H
Sbjct: 249 PYN---QLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  307 bits (788), Expect = e-105
 Identities = 142/293 (48%), Positives = 190/293 (64%), Gaps = 5/293 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D+Y K E +GEGTYGVVYKA D  T +T+A+KKIRL ++ EGV  TA+REI LLKE++  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHKK 130
           +I+ L D    +  L+LVFE+++ DL+  + ++  F  +P  IK+Y+   L+G+A+CH  
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+KP NLLI      LKLADFGLAR FG P R FTH+V   WYRAPE+L G++ Y
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE++N++P   G S+ID+L KIF   GT     WP +  LPDY    
Sbjct: 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS-A 240

Query: 250 YVAAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV 300
           +   PP  L ++ P+     +DLLSKM   DP  RITA+ ALEH + K     
Sbjct: 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  302 bits (775), Expect = e-103
 Identities = 135/283 (47%), Positives = 179/283 (63%), Gaps = 2/283 (0%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFE+ + DL+    + N  + P  +KS+M   LKGLAFCH   V
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLADFGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 193 VDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T   WP ++ LPDY  Y  Y
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H +
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  300 bits (770), Expect = e-101
 Identities = 130/304 (42%), Positives = 178/304 (58%), Gaps = 23/304 (7%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             Y     LGEGT+G VYKA   KTG+ VA+KKI +  +K+G   TALREIK+LK+LK P
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67

Query: 72  HIIELID-AFPH-------KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LID A          +G++++V  +M+ DL  ++ N ++ L+ + IK YM   L+G
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEG 127

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQV 172
           + + H+  +LHRD+K  N+LI + G LK+ADFGLAR +           G   R++T+ V
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
             RWYR PELL G ++Y   VD+W  GC+FAE+  RRP LQG SDIDQL  IF   GT T
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 233 PSQWPDLAYLPDYVEYQYVAA---PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
              WP    LP   E  +        L   F     + LDLLSK+ + DP  R+TA  AL
Sbjct: 248 EETWPGWRSLPGC-EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306

Query: 290 EHRF 293
           EH +
Sbjct: 307 EHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  299 bits (768), Expect = e-101
 Identities = 127/318 (39%), Positives = 185/318 (58%), Gaps = 28/318 (8%)

Query: 7   SKKVADRYL-KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------------G 53
           S  +++RY+ K   LGEGTYG V KA DT TG+ VAIKK+++ +               G
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 54  VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADI 113
           ++FT LRE+K++ E+K  +I+ L+D +     ++LV + M +DL+ V+ +  I L+ + +
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQV 121

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG----------- 162
           K  +   L GL   HK + +HRD+ P N+ I S G  K+ADFGLAR +G           
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 163 ---SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID 219
                    T +V   WYRAPELL GA++Y   VD+W+ GCIFAELL  +P   G ++ID
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP 279
           QLG+IF   GT     WP    LP Y E+       L+++FP+ASDDA+DLL  +   +P
Sbjct: 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301

Query: 280 KARITAQQALEHRFAKSF 297
             RI+A++AL+H + KS 
Sbjct: 302 LERISAKEALKHEYFKSD 319

Length = 335

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  293 bits (753), Expect = 1e-98
 Identities = 121/306 (39%), Positives = 166/306 (54%), Gaps = 32/306 (10%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR-------LGKQKEGVNFTALREIKLL 65
           RY   + +G G YGVV  A+D +TG+ VAIKKI          K+        LREIKLL
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-------ILREIKLL 53

Query: 66  KELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           + L+  +II L+D            +++V E METDL  VI+ +   L+   I+ ++   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQYFLYQI 112

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWY 177
           L+GL + H   V+HRD+KP+N+L+ S+  LK+ DFGLAR     +      T  V  RWY
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPELL  + +Y   +D+W+ GCIFAELL R+P   G   IDQL  I    GT +     
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE--- 229

Query: 238 DLAYLPD-----YVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           DL ++       Y++        PL  LFP AS +A+DLL KM  +DPK RITA +AL H
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 292 RFAKSF 297
            +    
Sbjct: 290 PYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  287 bits (736), Expect = 2e-97
 Identities = 108/281 (38%), Positives = 150/281 (53%), Gaps = 29/281 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   E LGEG++G VY A D KTG+ VAIK I+  K K+      LREIK+LK+LK P+I
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE-RILREIKILKKLKHPNI 59

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L D F  +  L+LV E+ E  DL  +++     LS  + + Y++  L  L + H K +
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           +HRD+KP N+L+   G +KLADFGLAR     ++  T  V    Y APE+L G K YG  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLG-KGYGKA 176

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           VD+W+ G I  ELL  +P   G    DQL ++F   G   P   P               
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP-------------- 219

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      S +A DL+ K+   DP+ R+TA++AL+H F
Sbjct: 220 -------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  287 bits (737), Expect = 1e-96
 Identities = 120/286 (41%), Positives = 175/286 (61%), Gaps = 4/286 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K   +GEGTYG+VY+A DT +G+ VA+KK+R+  +++G+  ++LREI LL  L+ P+I
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 74  IELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +EL +     H  ++ LV E+ E DL +++ N     S + +K  M   L+GL + H+ +
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           ++HRD+K +NLL+   G LK+ADFGLAR +G P +  T +V   WYRAPELL G   Y  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+WA GCI AELL  +P L G S+I+QL  I    GT   S WP  + LP   ++   
Sbjct: 189 AIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLP 248

Query: 252 AAP--PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
             P   L+  FP  S+  L LL+ +  YDPK R TA++ALE  + K
Sbjct: 249 KQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  284 bits (729), Expect = 5e-96
 Identities = 126/281 (44%), Positives = 174/281 (61%), Gaps = 4/281 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + + E LGEGTY  VYK  +  TG+ VA+K+I L  + EG   TA+REI L+KELK  +I
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETV--IRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L D    +  L LVFE+M+ DL+           L P  +KS+    LKG+AFCH+  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR FG P   F+++V   WYRAP++L G++ Y  
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQY 250
            +D+W+ GCI AE++  RP   G+++ DQL KIF   GT T S WP ++ LP+Y   +  
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                L+ LFP A    +DLL ++   +P+ RI+A  AL+H
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  281 bits (722), Expect = 9e-95
 Identities = 121/286 (42%), Positives = 170/286 (59%), Gaps = 18/286 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-----EGVNFTALREIKLLKELKS-P 71
           + LG+GT+G VY A + +TG+ VAIKK+   K+K     E +N   LRE+K L++L   P
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMN---LREVKSLRKLNEHP 58

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L + F     L+ VFE+ME +L  ++++      S + I+S +   L+GLA  HK 
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
              HRD+KP NLL+     +K+ADFGLAR I   P   +T  V  RWYRAPE+L  +  Y
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSY 176

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
            + VD+WA GCI AEL   RP   GSS+IDQL KI +  GT T   WP+   L   + ++
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236

Query: 250 --YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
               A   L  L P+AS +A+DL+  M  +DPK R TA QAL+H +
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  281 bits (721), Expect = 1e-94
 Identities = 121/283 (42%), Positives = 168/283 (59%), Gaps = 12/283 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIEL 76
           +GEG YG VYKA D  TG+ VA+KK+R+   +EG+  + LREI LLK+L+S   P+I+ L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 77  ID--AFPHKGN---LHLVFEFMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +D    P       L LVFE ++ DL T +       L P  IK  M+  L+G+ F H  
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH 126

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+ S GQ+K+ADFGLARI+   +   T  V   WYRAPE+L  +  Y 
Sbjct: 127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVVTLWYRAPEVLLQS-SYA 184

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCIFAEL  RRP  +G+S+ DQL KIF   G  +  +WP    LP    +  
Sbjct: 185 TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPS 243

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 +S  P   ++ LDLL KM T++P  RI+A +AL+H +
Sbjct: 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  280 bits (717), Expect = 5e-94
 Identities = 121/288 (42%), Positives = 176/288 (61%), Gaps = 6/288 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            + Y K + LGEG+Y  VYK     TGQ VA+K+IRL + +EG  FTA+RE  LLK+LK 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L LVFE+++TDL+  + +    LS  +++ ++   L+GLA+CH++
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y 
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             +D+W  GCIF E+   RP   GS+D+ DQL KIF   GT T   WP ++  P++  Y 
Sbjct: 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242

Query: 250 YVAAPP--LRSLFPSASD--DALDLLSKMFTYDPKARITAQQALEHRF 293
           +   PP  L +  P         +L  K   Y+PK RI+A +A++H +
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  276 bits (708), Expect = 5e-93
 Identities = 98/277 (35%), Positives = 139/277 (50%), Gaps = 23/277 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G++G VYKA    TG+ VA+K ++   +K   + TA REI++L+ L  P+I+ LI
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           DAF  K +L+LV E+ E  DL   +       S  + K      L+GL + H   ++HRD
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLHSNGIIHRD 123

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP N+L+  +G +K+ADFGLA+         T  V   WY APE+L G   YG  VDVW
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183

Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + G I  ELL  +P   G + +DQL  I    G       P                   
Sbjct: 184 SLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW----------------- 226

Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                S S++A DL+ K    DP  R TA++ L+H +
Sbjct: 227 ----SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Length = 260

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  277 bits (709), Expect = 1e-92
 Identities = 131/293 (44%), Positives = 176/293 (60%), Gaps = 11/293 (3%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KS 70
           D Y K E +GEGTYG VYKA D  TG+ VA+KK RL   +EG+  TALREI LL+ L +S
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 71  PHIIELIDAF-----PHKGNLHLVFEFMETDLETVI----RNTNIFLSPADIKSYMQMTL 121
            +I+ L+D         K +L+LVFE++++DL+  +    R     L    IKS+M   L
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           KG+A CHK  V+HRD+KP NLL+    G LK+AD GL R F  P + +TH++   WYRAP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E+L G+  Y   VD+W+ GCIFAE+  ++P   G S++ QL  IF   GT T   WP ++
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            L D+ E+       L    P  S + LDLL KM  YDP  RI+A+ AL H +
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  274 bits (704), Expect = 5e-92
 Identities = 117/287 (40%), Positives = 159/287 (55%), Gaps = 5/287 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    V+GEG YGVV K  +  TG+ VAIKK +  +  E V  TALRE+K+L++L+  
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L +AF  KG L+LVFE++E  L  ++  +   L P  ++SY+   L+ +A+CH   
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++HRD+KP N+L+   G LKL DFG AR +   P    T  V  RWYRAPELL G   YG
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VDVWA GCI AELL+  P   G SDIDQL  I    G   PS     +  P +    +
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240

Query: 251 VAAP---PLRSLFPSASDD-ALDLLSKMFTYDPKARITAQQALEHRF 293
                   L   +P      ALD L      DPK R+T  + L+H +
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  263 bits (675), Expect = 2e-87
 Identities = 123/298 (41%), Positives = 170/298 (57%), Gaps = 16/298 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K   +G+GT+G V+KA   KT Q VA+KK+ +  +KEG   TALREIK+L+ LK  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 72  HIIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LI+     A P+   KG+ +LVFEF E DL  ++ N N+  + ++IK  M+M L G
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RFTHQVFARWYRA 179
           L + H+  +LHRDMK  N+LI   G LKLADFGLAR F         R+T++V   WYR 
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP +
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 240 AYLPDYVEYQYVA----APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             L  + + +           R         ALDL+ K+   DP  RI A  AL H F
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  263 bits (674), Expect = 3e-87
 Identities = 127/301 (42%), Positives = 182/301 (60%), Gaps = 17/301 (5%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+  D++     +GEGTYG VYKA D  TG+ VA+KK+RL  +KEG   TA+REIK+L++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 68  LKSPHIIEL----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           L   +I+ L          +D    KG  +LVFE+M+ DL  ++ +  +  S   IKS+M
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FTHQVFARW 176
           +  L+GL +CHKK  LHRD+K +N+L+ + GQ+KLADFGLAR++ S + R +T++V   W
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YR PELL G ++YG  +DVW+ GCI  EL  ++P  Q + ++ QL  I    G+  P+ W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Query: 237 PDLAYLPDY----VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR 292
           PD+  LP +     + QY     LR  F      ALDLL  M T DP  R TA++AL   
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRR--LREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 293 F 293
           +
Sbjct: 301 W 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  259 bits (663), Expect = 2e-85
 Identities = 116/307 (37%), Positives = 165/307 (53%), Gaps = 34/307 (11%)

Query: 21  GEGTYGVVYKAI--DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
           G GTYG VYKA   + K G+  AIKK +  K Q  G++ +A REI LL+ELK  +++ L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 78  DAFPHKGN--LHLVFEFMETDLETVI----RNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + F    +  ++L+F++ E DL  +I    +   + + P+ +KS +   L G+ + H  W
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128

Query: 132 VLHRDMKPNNLLIGS----HGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLF 184
           VLHRD+KP N+L+       G +K+ D GLAR+F +P +        V   WYRAPELL 
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAFGTATPSQ 235
           GA+ Y   +D+WA GCIFAELL   P  +G             DQL +IF   GT T   
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKD 248

Query: 236 WPDLAYLPDY---VEYQYVAAPPLRSL------FPSASDDALDLLSKMFTYDPKARITAQ 286
           WPD+  +P+Y   ++       P  SL               DLL K+  YDP  RITA+
Sbjct: 249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308

Query: 287 QALEHRF 293
           +ALEH +
Sbjct: 309 EALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  259 bits (663), Expect = 4e-85
 Identities = 122/316 (38%), Positives = 174/316 (55%), Gaps = 43/316 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-------- 59
           K +  +Y   + LG+G YG+V+KAID +T + VA+KKI          F A         
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQR 52

Query: 60  --REIKLLKELKS-PHIIELIDAFPHKGN--LHLVFEFMETDLETVIRNTNIFLSPADIK 114
             REI  L+EL   P+I++L++    + +  ++LVFE+METDL  VIR  NI L     +
Sbjct: 53  TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR-ANI-LEDVHKR 110

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------GSPDRR 167
             M   LK L + H   V+HRD+KP+N+L+ S  ++KLADFGLAR          +P   
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV-- 168

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            T  V  RWYRAPE+L G+ +Y  GVD+W+ GCI  E+L  +P   G+S ++QL KI   
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Query: 228 FGTATPSQWPDLAYL-PDYVEYQYVAAP-----PLRSLFPSASDDALDLLSKMFTYDPKA 281
            G  +     D+  +   +      + P     PL  L P ASDDALDLL K+  ++P  
Sbjct: 229 IGPPSAE---DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285

Query: 282 RITAQQALEHRFAKSF 297
           R+TA++ALEH +   F
Sbjct: 286 RLTAEEALEHPYVAQF 301

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  251 bits (643), Expect = 7e-83
 Identities = 121/287 (42%), Positives = 164/287 (57%), Gaps = 7/287 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y K   +GEG+YGVV+K  + +TGQ VAIKK    +    +   ALREI++LK+LK P
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++ LI+ F  K  LHLVFE+ + T L  + +N    +    IK  +  TL+ + FCHK 
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
             +HRD+KP N+LI   GQ+KL DFG ARI   P   +T  V  RWYRAPELL G  QYG
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VDVWA GC+FAELL  +P   G SD+DQL  I    G   P +   +     + +   
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQFFKGLS 238

Query: 251 VAAP----PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +  P    PL S FP+ S  AL  L      DP  R++ ++ LEH +
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  242 bits (619), Expect = 1e-78
 Identities = 115/311 (36%), Positives = 166/311 (53%), Gaps = 34/311 (10%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-------LRE 61
            V  RY   E +G G YGVV  AIDT++G+ VAIKKI          F         LRE
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRE 54

Query: 62  IKLLKELKSPHIIELIDAFPHKGNL----HLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           +K+L+  K  +II + D     G      ++V + ME+DL  +I  ++  L+   I+ ++
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYFL 113

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD---RRFTHQVF 173
              L+GL + H   V+HRD+KP+NLL+    +L++ DFG+AR +  SP       T  V 
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            RWYRAPELL    +Y   +D+W+ GCIFAE+L RR    G + + QL  I +  G  +P
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG--SP 231

Query: 234 SQ------WPDLAYLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           S+        D      Y++        P   +FP AS +ALDLLS+M  +DP+ RIT +
Sbjct: 232 SEEVLNRIGSDRVR--KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289

Query: 287 QALEHRFAKSF 297
           QAL+H F   +
Sbjct: 290 QALQHPFLAQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  232 bits (593), Expect = 3e-75
 Identities = 127/288 (44%), Positives = 169/288 (58%), Gaps = 6/288 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A  YL  E LGEG+Y  VYK I    GQ VA+K I + K +EGV FTA+RE  LLK LK 
Sbjct: 4   ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIREASLLKGLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L  VFE+M TDL   +      L P +++ +M   L+GLA+ H +
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +LHRD+KP NLLI   G+LKLADFGLAR    P + ++ +V   WYR P++L GA  Y 
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDY-VEY 248
           + +D+W AGCIF E+L  +P   G SD+ +QL KI+   G  T   WP ++ LP+Y  E+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242

Query: 249 QYVAAPP-LRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                P  LR ++   S    A DL S+M    PK RI+AQ AL H +
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  230 bits (587), Expect = 2e-74
 Identities = 116/285 (40%), Positives = 172/285 (60%), Gaps = 5/285 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  V+K     T   VA+K+IRL + +EG   TA+RE+ LLK LK  
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKNLKHA 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    +  L LVFE++++DL+  + N    +S  ++K +M   L+GL++CHK+ 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +LHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y  
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY--- 248
            +D+W  GCI  E+   RP   GS+  ++L  IF   GT T   WP +    ++  Y   
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           QY A  PL +  P    D +DLLS +  Y+ K+RI+A+ AL H +
Sbjct: 244 QYRAQ-PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  229 bits (584), Expect = 8e-74
 Identities = 111/284 (39%), Positives = 171/284 (60%), Gaps = 3/284 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GL +CH++ 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+  Y  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244

Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              A  L +  P    D  +LLSK+  ++ + RI+A++A++H +
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  229 bits (587), Expect = 9e-74
 Identities = 117/298 (39%), Positives = 165/298 (55%), Gaps = 20/298 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A    TG  VAIKKI    + +      LREIK+L+  K
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFK 61

Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II ++D     +F    ++++V E METDL  +I+  +  LS   I+ ++   L+GL
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGL 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRF-THQVFARWYRAPE 181
            + H   VLHRD+KP+NLL+ ++  LK+ DFGLARI         F T  V  RWYRAPE
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  +K Y   +D+W+ GCI AE+L+ RP   G   + QL  I    G  TPSQ  DL  
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG--TPSQ-EDLNC 236

Query: 242 LP-----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +      +Y++   +    P   LFP+A   ALDLL KM T++P  RIT ++AL H +
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  228 bits (582), Expect = 2e-73
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 3/288 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K E LGEGTY  V+K     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D      +L LVFE+++ DL+  + +    +S  ++K ++   L+GLA+CH++ 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+ + RP   GS+  D+L  IF   GT T   WP ++   ++  Y + 
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244

Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                PL +  P    + ++LL+K   Y+ K RI+A++A++H + +S 
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  222 bits (568), Expect = 2e-71
 Identities = 113/291 (38%), Positives = 160/291 (54%), Gaps = 15/291 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    ++GEG+YG+V K    +TGQ VAIKK    +  + V   A+REI++LK+L+  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++ LI+ F  K  L+LVFEF++ T L+ + +  N  L  + ++ Y+   L+G+ FCH  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+   G +KL DFG AR   +P   +T  V  RWYRAPELL G  +YG
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP------SQWPDLA--YL 242
             VD+WA GC+  E+L   P   G SDIDQL  I    G   P       + P  A   L
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P+  E       PL   FP  S   LDL  +    DP  R ++ Q L H F
Sbjct: 240 PEVKE-----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  221 bits (566), Expect = 1e-70
 Identities = 111/297 (37%), Positives = 164/297 (55%), Gaps = 19/297 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKE 67
           V  +Y+  + +G G YG+V  A +++T + VAIKKI      +        LREIKLL+ 
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRH 60

Query: 68  LKSPHIIELIDAF--PHKGN---LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           L   ++I + D    PH+     +++V+E M+TDL  +IR++   LS    + ++   L+
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLR 119

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   VLHRD+KP+NLL+ ++  LK+ DFGLAR         T  V  RWYRAPEL
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L    +Y   +DVW+ GCIFAELL R+P   G   + QL  I    G+ +     DL ++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE---DLGFI 236

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +    +Y+ + P         LFP A+  A+DLL KM  +DP  RIT ++AL H +
Sbjct: 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  219 bits (559), Expect = 1e-69
 Identities = 115/294 (39%), Positives = 160/294 (54%), Gaps = 27/294 (9%)

Query: 20  LGEGTYGVVYKA--IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           LG+G YG+V  A   +T   +TVAIKKI     K+ +   ALRE+KLL+  +   +I  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 77  ID---AFPHKGN-LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            D    FP   N L+L  E ME DL  +IR +   L+ A  +S++   L GL + H   V
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANV 126

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR----IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           LHRD+KP NLL+ +  +LK+ DFGLAR      G      T  V  RWYRAPE++   + 
Sbjct: 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT---------ATPSQWPDL 239
           Y   +DVW+ GCI AELL R+P  +G   +DQL +I    GT          +P     +
Sbjct: 187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             LP+  +       P  S+FP+A+  ALDLL K+  +DP  RI+ ++ALEH +
Sbjct: 247 RSLPNIPKK------PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  217 bits (553), Expect = 3e-69
 Identities = 113/283 (39%), Positives = 163/283 (57%), Gaps = 12/283 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIEL 76
           +G G YG VYKA D  +G  VA+K +R+   ++G+  + +RE+ LLK L++   P+I+ L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 77  IDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +D         +  + LVFE ++ DL T +        PA+ IK  M+  L+GL F H  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y 
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVLLQST-YA 185

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP    +  
Sbjct: 186 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG-AFSP 244

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
               P++S+ P   +    LL +M T++P  RI+A +AL+H F
Sbjct: 245 RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  215 bits (550), Expect = 7e-69
 Identities = 115/287 (40%), Positives = 152/287 (52%), Gaps = 25/287 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKELKS-PHII 74
           +GEGT+  V KA   KTG+  AIK +   K+     E VN   LREI+ L+ L   P+I+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVN--NLREIQALRRLSPHPNIL 61

Query: 75  ELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            LI+       G L LVFE M+ +L  +I+     L    +KSYM   LK L   H+  +
Sbjct: 62  RLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
            HRD+KP N+LI     LKLADFG  R I+  P   +T  +  RWYRAPE L     YG 
Sbjct: 122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGP 178

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+WA GC+F E+L+  P   G++++DQ+ KI    GT        L          Y 
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---LKKFRKSRHMNY- 234

Query: 252 AAPP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             P      LR L P+AS + LDLL K+  YDP  RITA+QAL H +
Sbjct: 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  214 bits (547), Expect = 3e-68
 Identities = 118/288 (40%), Positives = 167/288 (57%), Gaps = 6/288 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           AD Y K E LGEG+Y  VYK      G+ VA+K IRL +++EG  FTA+RE  LLK LK 
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L LVFE++ TDL   +      L P ++K ++   L+GL++ H++
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++LHRD+KP NLLI   G+LKLADFGLAR    P   ++++V   WYR P++L G+ +Y 
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             +D+W  GCIF E++       G  DI DQL +IF   GT     WP +  LP +   +
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242

Query: 250 YV--AAPPLRSLFPSAS--DDALDLLSKMFTYDPKARITAQQALEHRF 293
           +   +   LR  +   S  + A DL SK+    PK R++AQ AL H +
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  211 bits (538), Expect = 5e-67
 Identities = 112/285 (39%), Positives = 159/285 (55%), Gaps = 13/285 (4%)

Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +       +    IK  M   L+GL F H 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQS-SY 186

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 245

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
             +A P+        +   DLL K  T++P  RI+A  AL H + 
Sbjct: 246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  208 bits (532), Expect = 2e-65
 Identities = 108/307 (35%), Positives = 154/307 (50%), Gaps = 17/307 (5%)

Query: 4   VDLSKK---VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
            +L+K    V DRY     +G G YG V  A DTKTG+ VAIKK+    Q         R
Sbjct: 4   QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63

Query: 61  EIKLLKELKSPHIIELIDAF-PHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIK 114
           E++LLK +   ++I L+D F P         ++LV   M  DL  +++     LS   I+
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQ 121

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA 174
             +   L+GL + H   ++HRD+KP+N+ +    +LK+ DFGLAR     D   T  V  
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT 178

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++     Y   VD+W+ GCI AELL  +    GS  IDQL +I    GT    
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238

Query: 235 --QWPDLAYLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             Q        +Y++    +     + +F  A+  A+DLL KM   DP  RITA +AL H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298

Query: 292 RFAKSFN 298
            +   ++
Sbjct: 299 PYLAEYH 305

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  198 bits (506), Expect = 1e-61
 Identities = 120/304 (39%), Positives = 168/304 (55%), Gaps = 21/304 (6%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY  +EV+G+G+YGVV  AIDT TG+ VAIKKI    +        LREIKLL+ L+ P 
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 73  IIEL--IDAFPHK---GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           I+E+  I   P +    ++++VFE ME+DL  VI+  N  L+P   + ++   L+ L + 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYI 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRF-THQVFARWYRAPELL- 183
           H   V HRD+KP N+L  +  +LK+ DFGLAR+    +P   F T  V  RWYRAPEL  
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 184 -FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL--- 239
            F +K Y   +D+W+ GCIFAE+L  +P   G + + QL  I    GT +P     +   
Sbjct: 180 SFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 240 ---AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
               YL    + Q V   P    FP+A   AL LL ++  +DPK R TA++AL   + K 
Sbjct: 239 KARRYLSSMRKKQPV---PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295

Query: 297 FNGV 300
              V
Sbjct: 296 LAKV 299

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  195 bits (497), Expect = 6e-61
 Identities = 106/278 (38%), Positives = 152/278 (54%), Gaps = 6/278 (2%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+GEG YGVV K    +T + VAIKK +  ++ E V  T LRE+K+L+ LK  +I+EL +
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           AF  +G L+LVFE++E ++  ++      + P  ++SY+   +K + +CHK  ++HRD+K
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGS-PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           P NLLI  +  LKL DFG AR      +  +T  V  RWYR+PELL GA  YG  VD+W+
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWS 186

Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--VEYQYVAAPP 255
            GCI  EL + +P   G S+IDQL  I    G     Q       P +  + +  V  P 
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246

Query: 256 L--RSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              R      S   LDL+  +   +P  R   +Q L H
Sbjct: 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  195 bits (497), Expect = 3e-60
 Identities = 108/301 (35%), Positives = 156/301 (51%), Gaps = 21/301 (6%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ +RY   + +G G YG V  AID +TG+ VAIKK+    Q E     A RE+ LLK +
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           +  ++I L+D F    +        LV  +M+TDL+ ++ +    LS   ++  +   L 
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLC 128

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G   P     +  L
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF---VQKL 242

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
            D     Y+ + P        +LFP AS  A+DLL KM   D   R+TA +ALEH +  S
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 297 F 297
           F
Sbjct: 303 F 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  193 bits (493), Expect = 8e-60
 Identities = 106/297 (35%), Positives = 161/297 (54%), Gaps = 17/297 (5%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + +RY+  + +G G +G+V  A D  TGQ VAIKKI        +     RE+KLLK L+
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 70  SPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             +II L D F  P + +++ V E + TDL  ++ +    L    I+ ++   L+GL + 
Sbjct: 68  HENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYV 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   V+HRD+KP+N+LI  +  LK+ DFGLARI    D + T  V  R+YRAPE++   +
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQ 181

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT------ATPSQWPDLAY 241
           +Y   VD+W+AGCIFAE+L  +P   G   ++Q   I    GT       T      L +
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
           +    + + V   P    F +A   A+DLL KM  +DP+ RI+A +AL H +   ++
Sbjct: 242 VQSLPKREPV---PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  189 bits (482), Expect = 2e-59
 Identities = 72/188 (38%), Positives = 108/188 (57%), Gaps = 3/188 (1%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LGEG +G VY A D KTG+ VAIK I+       +    LREI++LK+L  P+I++L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59

Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F  + +L+LV E+ E   L+ +++     LS  +I   +   L+GL + H   ++HRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 139 PNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           P N+L+ S +G++KLADFGL+++  S        V    Y APE+L G   Y    D+W+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 198 AGCIFAEL 205
            G I  EL
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  192 bits (489), Expect = 5e-59
 Identities = 114/301 (37%), Positives = 162/301 (53%), Gaps = 20/301 (6%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V DRY   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK +
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L      +LV  FM TDL  ++++    LS   I+  +   LK
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQMLK 129

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEV 186

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AE+L  +P  +G   +DQL +I     T TPS+   +  L
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV--TGTPSK-EFVQKL 243

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                  YV   P       RSL P+A+  A+++L KM   D ++RITA +AL H + + 
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Query: 297 F 297
           F
Sbjct: 304 F 304

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  190 bits (484), Expect = 6e-58
 Identities = 100/290 (34%), Positives = 151/290 (52%), Gaps = 23/290 (7%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +GVV+   D + G+ VA+KK+    Q         RE+K+L   K  +++  +D 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 80  F--PHKGNLHLVF---EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
              PH      ++   E M++DL  +I  +   LS   +K ++   L+GL + H   +LH
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILH 126

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+KP NLL+ S+  LK+ DFGLAR+   PD  +  T +V  ++YRAPE+L G++ Y + 
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA 185

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD-----LAYLPDYVE 247
           VD+W+ GCIFAELL RR   Q  S I QL  I    GT +            A++     
Sbjct: 186 VDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI----- 240

Query: 248 YQYVAAPPLRS----LFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +    PP       L   A+ +A+ LL +M  +DP  RI+A  AL H +
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  187 bits (476), Expect = 5e-57
 Identities = 102/308 (33%), Positives = 163/308 (52%), Gaps = 30/308 (9%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY+    LG G+ G+V+ A+D+   + VA+KKI L    + V   ALREIK+++ L   +
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVK-HALREIKIIRRLDHDN 63

Query: 73  IIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           I+++ +     G+              +++V E+METDL  V+      LS    + +M 
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP--LSEEHARLFMY 121

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ------ 171
             L+GL + H   VLHRD+KP N+ I +    LK+ DFGLARI    D  ++H+      
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEG 178

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +P   G+ +++Q+  I  +    
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 232 TPSQWPD-LAYLPDYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
                 + L  +P +V         PLR L P  + +ALD L ++ T++P  R+TA++AL
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 290 EHRFAKSF 297
            H +   +
Sbjct: 299 MHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  182 bits (465), Expect = 2e-56
 Identities = 87/291 (29%), Positives = 143/291 (49%), Gaps = 42/291 (14%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSP 71
            + + E+LG G++G VY A+D  TG+ +A+K + L    E     AL REI++L  L+ P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHP 59

Query: 72  HIIELIDAF--PHKGNLHLVFEFM-ETDLETVIRNTNIF--LSPADIKSYMQMTLKGLAF 126
           +I+    +     K  L++  E++    L ++++    F  L    I+ Y +  L+GLA+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAY 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVF--ARWYRAPELL 183
            H   ++HRD+K  N+L+ S G +KLADFG A+  G  +    T  V     W  APE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM-APEVI 175

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G ++YG   D+W+ GC   E+   + P+ +  + +  L KI        P        +
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPP-------EI 225

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P+++                 S++A D L K    DPK R TA + L+H F
Sbjct: 226 PEHL-----------------SEEAKDFLRKCLRRDPKKRPTADELLQHPF 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  174 bits (444), Expect = 3e-53
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y   + +G+G++G VY       G+   +K+I L    E     AL E+K+LK+L  P+
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYM-QMTLKGLAFC 127
           II+  ++F  KG L +V E+ +  DL   I+             I  +  Q+ L  L + 
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL-ALKYL 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPE 181
           H + +LHRD+KP N+ + S+G +KL DFG++++  S          A+      +Y +PE
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS------TVDLAKTVVGTPYYLSPE 173

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           L    K Y    D+W+ GC+  EL   + PF +G + ++   KI                
Sbjct: 174 LCQN-KPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI---------------- 215

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                ++ QY   PP+ S +   S +  +L+S +   DP+ R +  Q L+
Sbjct: 216 -----LKGQY---PPIPSQY---SSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  173 bits (441), Expect = 9e-52
 Identities = 111/309 (35%), Positives = 156/309 (50%), Gaps = 38/309 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT----ALREIKLL 65
           V  RY   + +G G  G+V  A DT TGQ VAIKK+     +   N T    A RE+ L+
Sbjct: 14  VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL----SRPFQNVTHAKRAYRELVLM 69

Query: 66  KELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYM-- 117
           K +   +II L++ F P K      +++LV E M+ +L  VI    + L   +  SY+  
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLD-HERMSYLLY 125

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           QM L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+Y
Sbjct: 126 QM-LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYY 183

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPE++ G   Y   VD+W+ GCI  E++       G+  IDQ  KI    GT +     
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 238 DLAY-LPDYVE----YQYVAAPPL--RSLFPSASDD--------ALDLLSKMFTYDPKAR 282
            L   + +YVE    Y   +   L    LFP  S+         A DLLSKM   DP+ R
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 283 ITAQQALEH 291
           I+   AL+H
Sbjct: 303 ISVDDALQH 311

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  172 bits (437), Expect = 2e-51
 Identities = 104/297 (35%), Positives = 148/297 (49%), Gaps = 20/297 (6%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 69  KSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 131

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 188

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        L  +
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL---LKKI 245

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                  Y+ +          ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  170 bits (432), Expect = 4e-51
 Identities = 90/299 (30%), Positives = 139/299 (46%), Gaps = 62/299 (20%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   E +GEG  G VYKA D  TG+ VAIKK+RL KQ + +      EI ++K+ K P+I
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN---EILIMKDCKHPNI 77

Query: 74  IELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           ++  D++     L +V E+M+    TD   +I    + ++   I    +  L+GL + H 
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTD---IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + V+HRD+K +N+L+   G +KLADFG A        +    V   ++ APE++   K Y
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E+       +G                            P Y+   
Sbjct: 194 GPKVDIWSLGIMCIEM------AEGE---------------------------PPYLRE- 219

Query: 250 YVAAPPLRSLF-------P------SASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
               PPLR+LF       P        S +  D L+K    DP+ R +A++ L+H F K
Sbjct: 220 ----PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  168 bits (427), Expect = 1e-50
 Identities = 88/282 (31%), Positives = 141/282 (50%), Gaps = 32/282 (11%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +   E +G+G +G VYKA   +TG+ VAIK I+L  +++      + EI++LK+ K P+I
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPNI 59

Query: 74  IELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++   ++  K  L +V EF     L+ ++++TN  L+ + I    +  LKGL + H   +
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           +HRD+K  N+L+ S G++KL DFGL+    S  +     V   ++ APE++ G K Y   
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVING-KPYDYK 177

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
            D+W+ G    EL   +P         +L  + A F  AT                    
Sbjct: 178 ADIWSLGITAIELAEGKP------PYSELPPMKALFKIAT------------------NG 213

Query: 253 APPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P LR+  P   SD+  D L K    +P+ R TA+Q L+H F
Sbjct: 214 PPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  169 bits (430), Expect = 2e-50
 Identities = 98/294 (33%), Positives = 152/294 (51%), Gaps = 14/294 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DT+  Q VA+KK+    Q         RE++LLK +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    ++      +LV   M  DL  +++     LS   ++  +   L+
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIYQLLR 129

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAPEI 186

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA-- 240
           +     Y   VD+W+ GCI AELL  +    G+  IDQL +I    GT +P     ++  
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246

Query: 241 YLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +   Y++   ++    L+ +F  A+  A+DLL KM   D   RI+A +AL H +
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  168 bits (426), Expect = 5e-50
 Identities = 110/309 (35%), Positives = 158/309 (51%), Gaps = 42/309 (13%)

Query: 20  LGEGTYGVVYKA--IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA   D K  +  A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L  + +KS +   L G+ + 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAP 180
           H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +        V   WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ-GSSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF+  G  
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 232 TPSQWPDLAYLPDYVEYQ-------YVAAPPLRSLFP---SASDDALDLLSKMFTYDPKA 281
               W D+  +P+Y   Q       Y  +  ++ +             LL K+ T DP  
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTK 304

Query: 282 RITAQQALE 290
           RIT++QAL+
Sbjct: 305 RITSEQALQ 313

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  169 bits (429), Expect = 7e-50
 Identities = 89/300 (29%), Positives = 133/300 (44%), Gaps = 38/300 (12%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-TALREIKLLKELKSP- 71
           Y     LGEG++G VY A D K    VA+K +    + +       LREI++L  L  P 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRN--TNIFLSPADIKSYMQMTLKGLAFCH 128
           +I++L D F  +G+L+LV E+++   LE +++       LS ++    +   L  L + H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 129 KKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFA------RWYRAPE 181
            K ++HRD+KP N+L+   G  +KL DFGLA++   P    +             Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 182 LLFG--AKQYGAGVDVWAAGCIFAELLN-RRPF--LQGSSDIDQLGKIFAAFGTATPSQW 236
           +L G       +  D+W+ G    ELL    PF   + SS   Q  KI     T      
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT------ 232

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                         +A+P   S     S  A DLL K+   DPK R+++   L H     
Sbjct: 233 ------------PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280

Length = 384

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  167 bits (424), Expect = 8e-50
 Identities = 109/309 (35%), Positives = 155/309 (50%), Gaps = 42/309 (13%)

Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA   D K  +  A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L    +KS +   L G+ + 
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAP 180
           H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +        V   WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ-GSSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF   G  
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 232 TPSQWPDLAYLP-------DYVEYQYVAAPPLRSLFP---SASDDALDLLSKMFTYDPKA 281
               W D+  +P       D+    Y     ++ +          A  LL K+ T DP  
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 282 RITAQQALE 290
           RIT++QA++
Sbjct: 305 RITSEQAMQ 313

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 1e-47
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 38/284 (13%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            Y   +++G G +GVVYK ++ +TG  VAIK+I L K KE    + ++EI LLK LK P+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I++ I +     +L+++ E+ E   L  +I+    F   + +  Y+   L+GLA+ H++ 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAYLHEQG 119

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K  N+L    G +KLADFG+A       +     V   ++ APE++       +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-----EMS 174

Query: 192 GV----DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           G     D+W+ GC   ELL   P      D++ +  +F       P        LP    
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHP-------PLP---- 220

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                           S +  D L + F  DP  R TA+Q L+H
Sbjct: 221 -------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  155 bits (392), Expect = 1e-44
 Identities = 103/309 (33%), Positives = 154/309 (49%), Gaps = 25/309 (8%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 14  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 73

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 130

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR     +   T  V  R+YR
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 189

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  EL+      QG+  IDQ  K+    GT +      
Sbjct: 190 APEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 239 LA-----YLPDYVEYQYVAAPPLRS--LFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  ++   L    +FPS S+        A DLLSKM   DP  RI+
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 285 AQQALEHRF 293
             +AL H +
Sbjct: 309 VDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  157 bits (397), Expect = 2e-44
 Identities = 100/308 (32%), Positives = 163/308 (52%), Gaps = 24/308 (7%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M + D+++     Y    ++G G++GVVY+AI   T + VAIKK+    Q +       R
Sbjct: 55  MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------R 108

Query: 61  EIKLLKELKSPHIIELIDAF------PHKGN--LHLVFEFMETDLETVIR---NTNIFLS 109
           E+ ++K L   +II L D +       ++ N  L++V EF+   +   ++     N  L 
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRF 168
              +K Y     + LA+ H K++ HRD+KP NLLI  +   LKL DFG A+   +  R  
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           ++ + +R+YRAPEL+ GA  Y   +D+W+ GCI AE++   P   G S +DQL +I    
Sbjct: 229 SY-ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287

Query: 229 GTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSAS-DDALDLLSKMFTYDPKARITA 285
           GT T  Q  ++   P+Y + ++  V    L+ +FP  + DDA++ +S+   Y+P  R+  
Sbjct: 288 GTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345

Query: 286 QQALEHRF 293
            +AL   F
Sbjct: 346 IEALADPF 353

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  148 bits (374), Expect = 6e-42
 Identities = 103/309 (33%), Positives = 154/309 (49%), Gaps = 25/309 (8%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 285 AQQALEHRF 293
             +AL+H +
Sbjct: 305 VDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  142 bits (360), Expect = 9e-41
 Identities = 82/289 (28%), Positives = 134/289 (46%), Gaps = 40/289 (13%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           VLG+G+ GVVYK     TG+  A+KKI +   +E      LRE+K L+  +SP++++   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-QLLRELKTLRSCESPYVVKCYG 66

Query: 79  AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRD 136
           AF  +G + +V E+M+   L  +++          +    +  LKGL + H K+ ++HRD
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKI-PEPVLAYIARQILKGLDYLHTKRHIIHRD 125

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPELLFGAKQYGA 191
           +KP+NLLI S G++K+ADFG++++  +     T      +     Y +PE + G + Y  
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTFVGTVTYMSPERIQG-ESYSY 179

Query: 192 GVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             D+W+ G    E    + PFL                    P   P    L   +    
Sbjct: 180 AADIWSLGLTLLECALGKFPFL--------------------PPGQPSFFELMQAI--CD 217

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
              P L +     S +  D +S     DPK R +A + L+H F K  + 
Sbjct: 218 GPPPSLPA--EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  142 bits (359), Expect = 1e-39
 Identities = 101/310 (32%), Positives = 151/310 (48%), Gaps = 27/310 (8%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310

Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 8e-37
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 41/282 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIELI 77
           LG+G++G V       TG+  A+K ++  K  +++ V  T L E  +L  +  P I++L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT-LTERNILSRINHPFIVKLH 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVLHR 135
            AF  +  L+LV E+    +L + +     F S    + Y  ++ L  L + H   +++R
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF-SEERARFYAAEIVL-ALEYLHSLGIIYR 117

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+ + G +KL DFGLA+   S   R         Y APE+L G K YG  VD 
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDW 176

Query: 196 WAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           W+ G +  E+L  + PF       +   +I+                 P+++        
Sbjct: 177 WSLGVLLYEMLTGKPPF-----YAEDRKEIYEKILKDPL-------RFPEFL-------- 216

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRF 293
                    S +A DL+S +   DP  R+ +  A E   H F
Sbjct: 217 ---------SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  131 bits (331), Expect = 2e-36
 Identities = 87/303 (28%), Positives = 135/303 (44%), Gaps = 68/303 (22%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP 81
           G YG V+ A    TG   AIK I +    ++      L E  +L + +SP++++L  +F 
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 82  HKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWVLHRDMKP 139
            K NL+LV E++   DL +++ N        D+ + Y+   +  L + H   ++HRD+KP
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSL--DEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 140 NNLLIGSHGQLKLADFGLA-------------------RIFGSPDRRFTHQVFARWYRAP 180
           +N+LI S+G LKL DFGL+                   RI G+PD           Y AP
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD-----------YIAP 170

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++ G + +   VD W+ GCI  E L   P   G +  +    I          +WP+  
Sbjct: 171 EVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI-----LNGKIEWPE-- 222

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRFAKSF 297
                                  SD+A+DL+SK+   DP+ R+ A+   E   H F   F
Sbjct: 223 -------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF---F 260

Query: 298 NGV 300
            G+
Sbjct: 261 KGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  131 bits (331), Expect = 2e-36
 Identities = 94/311 (30%), Positives = 155/311 (49%), Gaps = 69/311 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL---------GKQKEGVNFTALR-EI 62
           +++K E++G+GTYG VY A++  TG+ +A+K++ L          +QK+ V   ALR EI
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK--ALRSEI 59

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD----LETV--------IRNTNIFLSP 110
           + LK+L   +I++           +L FE  E      LE V        +R    F   
Sbjct: 60  ETLKDLDHLNIVQ-----------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EE 107

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR----IFGSPDR 166
             ++ + +  L+GLA+ H K +LHRD+K +NLL+ + G  K++DFG+++    I+ + D+
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN-DQ 166

Query: 167 RFTHQVFARWYRAPELLFGAKQ-YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI 224
             + Q    W  APE++    Q Y A VD+W+ GC+  E+   RRP+    SD + +  +
Sbjct: 167 NMSMQGSVFWM-APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW----SDEEAIAAM 221

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARI 283
           F      +                    APP+   +  + S  ALD L+  FT +P  R 
Sbjct: 222 FKLGNKRS--------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Query: 284 TAQQALEHRFA 294
           TA++ L+H F 
Sbjct: 262 TARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  127 bits (321), Expect = 6e-35
 Identities = 81/294 (27%), Positives = 134/294 (45%), Gaps = 42/294 (14%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           R+ +   +G GT+G VY A++  TG+ +A+K+IR+             E+K+L+ LK P+
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           +++      H+  +++   FME      LE ++ +  I L    I+ Y    L+GLA+ H
Sbjct: 61  LVKYYGVEVHREKVYI---FMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLH 116

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPELL 183
              ++HRD+KP N+ +  +G +KL DFG A    +       +          Y APE++
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM-GEEVQSLAGTPAYMAPEVI 175

Query: 184 FGAKQ--YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            G K   +G   D+W+ GC+  E+   +RP+    S++D   +I    G       PD  
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDNEFQIMFHVGAGHKPPIPDSL 231

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            L                     S +  D L +    DPK R TA + L+H F 
Sbjct: 232 QL---------------------SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  126 bits (318), Expect = 1e-34
 Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 69/296 (23%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LGEG+YG VYKAI  +TGQ VAIK + +    E      ++EI +LK+  SP+I++  
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 78  DAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            ++    +L +V E+      +D+   ++ TN  L+  +I + +  TLKGL + H    +
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDI---MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLA-----------RIFGSPDRRFTHQVFARWYRAPEL 182
           HRD+K  N+L+   GQ KLADFG++            + G+P           ++ APE+
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP-----------FWMAPEV 170

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA-----AFGTATPSQWP 237
           +     Y    D+W+ G    E+   +P     SDI  +  IF          + P +W 
Sbjct: 171 IQEIG-YNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPTLSDPEKW- 225

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                                     S +  D + K    DP+ R +A Q L+H F
Sbjct: 226 --------------------------SPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  124 bits (314), Expect = 1e-33
 Identities = 86/305 (28%), Positives = 131/305 (42%), Gaps = 61/305 (20%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELK-SPHI 73
           +++GEG++  V  A + +T +  AIK   K +L K+K+ V +    E ++L  L   P I
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKY-VKIEKEVLTRLNGHPGI 64

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+L   F  + NL+ V E+    +L   IR     L     + Y    L  L + H K +
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGI 123

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--------------------RRFTHQV 172
           +HRD+KP N+L+     +K+ DFG A++                         RRF   V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
               Y +PELL   K  G   D+WA GCI  ++L  +P  +GS++     KI        
Sbjct: 184 GTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL----- 237

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-- 290
                         EY +   PP    FP    DA DL+ K+   DP+ R+   +  +  
Sbjct: 238 --------------EYSF---PP---NFP---PDAKDLIEKLLVLDPQDRLGVNEGYDEL 274

Query: 291 --HRF 293
             H F
Sbjct: 275 KAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  123 bits (312), Expect = 1e-33
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 43/289 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G++G V K      G+ +  K+I  G   E      + E+ +L+ELK P+I+   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 78  DAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK 130
           D    + N  L++V E+ E  DL  +I+         +     +   Q+ L  L  CH +
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL-ALYECHNR 124

Query: 131 W-----VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLF 184
                 VLHRD+KP N+ + ++  +KL DFGLA+I G  D  F    V   +Y +PE L 
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPYYMSPEQLN 183

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
               Y    D+W+ GC+  EL    P     + +    KI          + P       
Sbjct: 184 HMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----KEGKFRRIP------- 231

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              Y+Y             S +  +++  M   DP  R + ++ L+   
Sbjct: 232 ---YRY-------------SSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  121 bits (306), Expect = 7e-33
 Identities = 79/291 (27%), Positives = 140/291 (48%), Gaps = 44/291 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL---GKQKEGVNFTALREIKLLKELK 69
           R+ K E+LG G++G VY+ ++   G   A+K++ L   G+  +       +EI LL +L+
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P+I++ +     + NL++  E +    L  +++    F  P  I+ Y +  L GL + H
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-IRLYTRQILLGLEYLH 119

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPEL 182
            +  +HRD+K  N+L+ ++G +KLADFG+A       ++     FA+      ++ APE+
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEV 172

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     YG   D+W+ GC   E+   +P     S ++ +  +F    +       +L  +
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKP---PWSQLEGVAAVFKIGRS------KELPPI 223

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           PD++                 SD+A D + K    DP  R TA + LEH F
Sbjct: 224 PDHL-----------------SDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 1e-32
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 34/284 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA   +TG   A K I++  ++E  +F  + EI +L E K P+I+ L +A
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF--MVEIDILSECKHPNIVGLYEA 70

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + ++  L ++ EF +   L++++      L+   I+   +  L+ L F H   V+HRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL----FGAKQYGAGVD 194
             N+L+   G +KLADFG++    S  ++    +   ++ APE++    F    Y    D
Sbjct: 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKAD 190

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           +W+ G    EL    P                          P     P  V  + + + 
Sbjct: 191 IWSLGITLIELAQMEP--------------------------PHHELNPMRVLLKILKSE 224

Query: 255 PLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           P     PS  S    D L      DP  R TA + L+H F    
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  120 bits (303), Expect = 2e-32
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-----GKQKEGVNFTALREIKLLKELKSPHII 74
           +G+G + VVYKAI    G+ VA+KK+++      K ++      L+EI LLK+L  P++I
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ----DCLKEIDLLKQLDHPNVI 65

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHK 129
           + + +F     L++V E  +  DL  +I++      +       K ++Q+    L   H 
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC-SALEHMHS 124

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K ++HRD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-Y 183

Query: 190 GAGVDVWAAGCIFAELLN-RRPF 211
               D+W+ GC+  E+   + PF
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  119 bits (299), Expect = 5e-32
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +     +G+G++GVV+K +     +  A+K+I L K        A+ E ++L +L S +I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTLKGLAFCHKK 130
           I   ++F  KG L++V E+ E  DL  +++       P D   + ++Q+ L GLA  H K
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLHSK 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPELLF 184
            +LHRD+K  NL + ++  +K+ D G+A++         +  FA       +Y +PEL  
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS------DNTNFANTIVGTPYYLSPELC- 173

Query: 185 GAKQYGAGVDVWAAGCIFAEL-LNRRPF 211
             K Y    DVWA G +  E    + PF
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 6e-32
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 54/291 (18%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           G +G VY A    TG   AIK ++   +  + +  N  A R I ++ + +SP++ +L  +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYYS 65

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F  K  L+LV E++   D  ++I+     L     K Y+   + G+   H++ ++HRD+K
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 139 PNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           P NLLI   G LKL DFGL+R         G+PD           Y APE + G      
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----------YLAPETILGVGDDKM 173

Query: 192 GVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             D W+ GC+  E L    PF   + D      +F     +    WP+            
Sbjct: 174 S-DWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNI-LSRRINWPEEV---------- 216

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRFAKSFN 298
                        S +A+DL++++   DP  R+ A    E   H F KS N
Sbjct: 217 ---------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-31
 Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 57/300 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + +   E +G+G++G VYKAID +T Q VAIK I L + ++ +     +EI+ L + +SP
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDL-------ETVIRNTNIFLSPADIKSYMQMT 120
           +I +   +F     L ++ E+       DL       ET I         A I   ++  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI---------AFI---LREV 107

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRA 179
           L GL + H++  +HRD+K  N+L+   G +KLADFG++ ++  +  +R T  V   ++ A
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMA 166

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++  +  Y    D+W+ G    EL    P L   SD+  +  +F              
Sbjct: 167 PEVIKQSG-YDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFL------------- 209

Query: 240 AYLPDYVEYQYVAAPPL--RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
             +P          PP    + F   S    D +S     DPK R +A++ L+H+F K  
Sbjct: 210 --IPK-------NNPPSLEGNKF---SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  118 bits (297), Expect = 3e-31
 Identities = 85/286 (29%), Positives = 140/286 (48%), Gaps = 35/286 (12%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY AID  TGQ VAIK++ L +Q  KE +    + EI +++E K 
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI----INEILVMRENKH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 192

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  I A  GT      P+L   P+     
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGT------PELQN-PE----- 239

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ L+H F K
Sbjct: 240 -----KLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (292), Expect = 1e-30
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPH 72
           + LGEG +G VYK        K    VA+K ++    ++ +  F  LRE +++++L  P+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++L+     +  L++V E+ME  DL + +R     LS +D+ S+     +G+ +   K 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAKQ 188
            +HRD+   N L+G +  +K++DFGL+R     D  +  +   +  RW  APE L    +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWM-APESLK-EGK 179

Query: 189 YGAGVDVWAAGCIFAELLNR 208
           + +  DVW+ G +  E+   
Sbjct: 180 FTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  115 bits (290), Expect = 2e-30
 Identities = 80/299 (26%), Positives = 143/299 (47%), Gaps = 51/299 (17%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL------GKQKEGVNFTAL-REIKLL 65
           +++K  ++G G++G VY  ++  +G+ +A+K++ L       K ++     AL REI LL
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           KEL+  +I++ + +     +L++  E++       + N         ++++++  LKGL 
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFARWYR 178
           + H + ++HRD+K  N+L+ + G +K++DFG+++          +   R + Q    W  
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM- 179

Query: 179 APELLFGAKQ--YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE++   KQ  Y    D+W+ GC+  E+L  + PF     D  QL  IF     A+P  
Sbjct: 180 APEVV---KQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKIGENASPE- 231

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                                    PS  S +A+D L K F  D   R TA + L+H F
Sbjct: 232 ------------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  114 bits (288), Expect = 3e-30
 Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 13/232 (5%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL----GKQKEGVNFTALREIKLLKELK 69
           +LK + LG G +   Y+A D KTG  +A+K++        ++E V     +EI+L+  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            PHII ++ A     + +L  E+M    +  ++     F     I  Y +  L+GL++ H
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLH 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRR---FTHQVFAR-WYRAPELL 183
           +  ++HRD+K  NLLI S GQ L++ADFG A    +       F  Q+     + APE+L
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA-AFGTATPS 234
            G +QYG   DVW+ GC+  E+   +P        + L  IF  A  T  PS
Sbjct: 181 RG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  114 bits (287), Expect = 5e-30
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 43/294 (14%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
                LG G  GVV K +   TG+ +A+K IRL    E +    LRE+ +L +  SP+I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIV 62

Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHKKW-V 132
               AF + G++ +  E+M+      I        P  I   + +  LKGL + H+K  +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +HRD+KP+N+L+ S GQ+KL DFG++ ++  S  + F   V    Y APE + G   Y  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQGND-YSV 178

Query: 192 GVDVWAAGCIFAEL-LNRRPFLQ----GSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             D+W+ G    EL   R P+           + L  I                      
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------------------- 216

Query: 247 EYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
               V  PP R   PS   S D  D ++     DP+ R + ++ LEH F K + 
Sbjct: 217 ----VNEPPPR--LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 7e-30
 Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 47/291 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G+G YG V+ A    TG+ VA+K  K  L  +   V    L E  +L   KS  +++L+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTTTKSEWLVKLL 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            AF     L+L  E++   D  T++ N  + LS    + YM    + +   H+   +HRD
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 137 MKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +KP N LI + G +KL DFGL++        + GSPD           Y APE+L G K 
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----------YMAPEVLRG-KG 174

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y   VD W+ GC+  E L   P   GS+  +    +           W +    P Y + 
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKETLQRPVYDDP 225

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRFAKSFN 298
           ++           + SD+A DL++K+   DP  R  + +    H F K  +
Sbjct: 226 RF-----------NLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  114 bits (286), Expect = 8e-30
 Identities = 93/287 (32%), Positives = 147/287 (51%), Gaps = 37/287 (12%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G V+ AID  TGQ VAIK+I L KQ  KE +    + EI ++KELK+
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI----INEILVMKELKN 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D+F     L +V E++    L  V+  T   +  A I +  +  L+ L F H 
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
             V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++   K 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV-TRKA 191

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           YG  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+ +  
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGT------PELQN-PEKL-- 241

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
               +P  R           D L++    D + R +A++ L+H F K
Sbjct: 242 ----SPIFR-----------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  112 bits (283), Expect = 2e-29
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPH 72
           + LGEG +G VYK             VA+K ++    ++ +  F  LRE +++++L  P+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKK 130
           I++L+     +  L +V E+M   DL   +R      LS +D+ S+     +G+ +   K
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
             +HRD+   N L+G +  +K++DFGL+R     D  +  +   +  RW  APE L    
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWM-APESLK-EG 179

Query: 188 QYGAGVDVWAAGCIFAELLNR 208
           ++ +  DVW+ G +  E+   
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  111 bits (279), Expect = 5e-29
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 36/275 (13%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSP 71
           +    V+G+G +G V       T +  A+K +   K  +K  V    L E ++L+EL  P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVLNERRILQELNHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  +F  + N++LV + +   DL   +     F S   +K ++   +  L + H K
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF-SEEQVKFWICEIVLALEYLHSK 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP+N+L+   G + + DF +A    +PD   T       Y APE+L     Y 
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVLCRQG-YS 177

Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W+ G    E L  +RP+   S  I     I A   TA                  
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ--IRAKQETADV---------------- 219

Query: 250 YVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI 283
                    L+P+  S +A+D ++K+   DP+ R+
Sbjct: 220 ---------LYPATWSTEAIDAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  110 bits (276), Expect = 3e-28
 Identities = 82/286 (28%), Positives = 142/286 (49%), Gaps = 35/286 (12%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 193

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 240

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ L+H+F K
Sbjct: 241 -----KLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 4e-28
 Identities = 89/290 (30%), Positives = 135/290 (46%), Gaps = 38/290 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKS 70
           + Y   + +G GTYG VYKA D  TG+ VAIK I+L   + G +F  ++ EI +LKE + 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL---EPGDDFEIIQQEISMLKECRH 59

Query: 71  PHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           P+I+    ++  +  L +V E+       D+  V R     LS   I    + TLKGLA+
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAY 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFG 185
            H+   +HRD+K  N+L+   G +KLADFG+ A++  +  +R +      W  APE+   
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM-APEVAAV 175

Query: 186 AKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            ++  Y    D+WA G    EL   +P +    D+  +  +F                L 
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPM---FDLHPMRALF----------------LI 216

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
               +     PP        S    D + K  T DPK R TA + L+H F
Sbjct: 217 SKSNFP----PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  108 bits (273), Expect = 5e-28
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 17/193 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           + LGEG +G VYK         T   VA+K ++ G  ++E   F  L E  ++K+L  P+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF--LEEASIMKKLSHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+        L++V E+M   DL   +R     L+  D+        KG+ +   K 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQ----VFARWYRAPELLFGA 186
            +HRD+   N L+  +  +K++DFGL+R I+     R        +  +W  APE L   
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI--KWM-APESLKDG 179

Query: 187 KQYGAGVDVWAAG 199
           K + +  DVW+ G
Sbjct: 180 K-FTSKSDVWSFG 191

Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  108 bits (271), Expect = 1e-27
 Identities = 82/290 (28%), Positives = 139/290 (47%), Gaps = 44/290 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A D  TG+ VA+KK+ L KQ+         E+ ++++ + P
Sbjct: 22  DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHP 76

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +I+E+  ++     L +V EF+E    TD+ T  R     ++   I +     LK L+F 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFL 131

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS--PDRRFTHQVFARWYRAPELLFG 185
           H + V+HRD+K +++L+ S G++KL+DFG         P R+    V   ++ APE++  
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEVI-S 188

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              YG  VD+W+ G +  E+++  P       +  + +I             D   LP  
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDN--LPPK 234

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           ++  +  +P LRS            L +M   DP  R TA + L H F  
Sbjct: 235 LKNLHKVSPRLRS-----------FLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  108 bits (270), Expect = 2e-27
 Identities = 70/202 (34%), Positives = 113/202 (55%), Gaps = 12/202 (5%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY AID  TGQ VAIK++ L +Q  KE +    + EI +++E K+
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI----INEILVMRENKN 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHS 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
             V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++   K 
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV-TRKA 191

Query: 189 YGAGVDVWAAGCIFAELLNRRP 210
           YG  VD+W+ G +  E++   P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  107 bits (270), Expect = 2e-27
 Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 14/202 (6%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +T + VAIKK+   GKQ        ++E++ L++L+ P+ IE
Sbjct: 21  REI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 76  LIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
               +  +    LV E+     +D+  V +     L   +I +     L+GLA+ H    
Sbjct: 80  YKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYLHSHER 136

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYG 190
           +HRD+K  N+L+   G +KLADFG A +  SP   F   V   ++ APE++      QY 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLV-SPANSF---VGTPYWMAPEVILAMDEGQYD 192

Query: 191 AGVDVWAAGCIFAELLNRRPFL 212
             VDVW+ G    EL  R+P L
Sbjct: 193 GKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 86/325 (26%), Positives = 137/325 (42%), Gaps = 70/325 (21%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKEL 68
           D +   +V+G G +G V+   D  TGQ  A+K +R   + K+ +  +  A R+I  L + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LADA 58

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAF 126
            SP I++L  +F  + +L+LV E+M   DL  ++   ++F  P +  + Y+   +  L  
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--PEETARFYIAELVLALDS 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-------------QVF 173
            HK   +HRD+KP+N+LI + G +KLADFGL +       R  +              V 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 174 ARW----------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSS 216
            R                 Y APE+L G   YG   D W+ G I  E+L    PF   + 
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT 276
                 KI           W +    P                    S +A+DL+ ++  
Sbjct: 236 QETYN-KI---------INWKESLRFPPDPPV---------------SPEAIDLICRLLC 270

Query: 277 YDPKARIT-AQQALEHRFAKSFNGV 300
            DP+ R+   ++   H F   F G+
Sbjct: 271 -DPEDRLGSFEEIKSHPF---FKGI 291

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  106 bits (266), Expect = 6e-27
 Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 42/295 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y   EV+G G   VVY AI     + VAIK+I L K +  V+    +E++ + +   P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIR--NTNIFLSPADIKSYMQMTLKGLAFCH 128
           ++++   +F     L LV  ++    L  +++       L  A I + ++  LKGL + H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDR----RFTHQVFARWYRAPELL 183
               +HRD+K  N+L+G  G +K+ADFG+ A +    DR    R T  V    + APE++
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPEVM 178

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y    D+W+ G    EL                     A G A  S++P +  L 
Sbjct: 179 EQVHGYDFKADIWSFGITAIEL---------------------ATGAAPYSKYPPMKVLM 217

Query: 244 DYVEYQYVAAPPLRSLFPSASDDAL-----DLLSKMFTYDPKARITAQQALEHRF 293
             ++      PP  SL   A           ++S     DP  R TA++ L+H+F
Sbjct: 218 LTLQ----NDPP--SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  105 bits (263), Expect = 8e-27
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 6/203 (2%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K  V+G G +G+V+        + V IK+I + +  +     A  E ++LK L  P+
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           IIE  + F     L +V E+    T  E + +  N  L    I  +    L  L   H K
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            +LHRD+K  N+L+  H   +K+ DFG+++I  S  + +T  V    Y +PEL  G K Y
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEG-KPY 178

Query: 190 GAGVDVWAAGCIFAELLN-RRPF 211
               D+WA GC+  EL + +R F
Sbjct: 179 NQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 9e-27
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 33/295 (11%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---S 70
           Y + E++G G YG VY+     TG+ VA+K I L    + V+    RE+ LL +L+    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQP 61

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I +   ++     L ++ E+ E   + T+++   I  +   I   ++  L  L + HK
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI--AEKYISVIIREVLVALKYIHK 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K  N+L+ + G +KL DFG+A +      + +  V   ++ APE++   K Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
               D+W+ G    E+    P     SD+D   +       + P +  D  Y        
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY---SDVDAF-RAMMLIPKSKPPRLEDNGYSKL----- 230

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
                 LR    +  D+           +PK R++A++ L+ ++ K+ +   V +
Sbjct: 231 ------LREFVAACLDE-----------EPKERLSAEELLKSKWIKAHSKTPVSI 268

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-26
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 20/199 (10%)

Query: 18  EVLGEGTYGVVYKA-IDTKTGQT--VAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHI 73
           + LGEG +G VYK  +  K G+T  VA+K ++    +E   +F  L+E +++K+L  P++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF--LKEARVMKKLGHPNV 58

Query: 74  IELIDAFPHKGNLHLVFEFME-TDLETVIRNTNI--------FLSPADIKSYMQMTLKGL 124
           + L+     +  L+LV E+ME  DL   +R +           LS  D+ S+     KG+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQ--VFARWYRAPE 181
            +   K  +HRD+   N L+G    +K++DFGL+R ++     R      +  RW  APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APE 177

Query: 182 LLFGAKQYGAGVDVWAAGC 200
            L     + +  DVW+ G 
Sbjct: 178 SLKD-GIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  105 bits (263), Expect = 1e-26
 Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 38/278 (13%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G+YG VYK       Q  A+K++ LG   +     A+ EI++L  +  P+II   +A
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIF--LSPADI--KSYMQMTLKGLAFCHKKWVLH 134
           F     L +V E+    DL   I        L P     + ++Q+ L+GL   H++ +LH
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL-LRGLQALHEQKILH 126

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-QVFARWYRAPELLFGAKQYGAGV 193
           RD+K  N+L+ ++  +K+ D G++++           Q+    Y APE+  G + Y    
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKK---NMAKTQIGTPHYMAPEVWKG-RPYSYKS 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GC+  E+                    A F  A P +   +  L    + Q    
Sbjct: 183 DIWSLGCLLYEM--------------------ATF--APPFEARSMQDL--RYKVQRGKY 218

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           PP+  ++   S D  + +  M    PK R    + L  
Sbjct: 219 PPIPPIY---SQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  105 bits (263), Expect = 1e-26
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIR-----LGKQKEGVNFTALREIKLLKELKSPHII 74
           LG G +G V         +T A+K ++        Q+E +      E ++L+E   P I+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI----FSEKEILEECNHPFIV 56

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L   F  K  ++++ E+    +L T++R+  +F      + Y+   +    + H + ++
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIACVVLAFEYLHNRGII 115

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT-----HQVFARWYRAPELLFGAKQ 188
           +RD+KP NLL+ S+G +KL DFG A+   S  + +T            Y APE++   K 
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE------YVAPEIILN-KG 168

Query: 189 YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL 221
           Y   VD W+ G +  ELL  R PF  G  D D +
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF--GEDDEDPM 200

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  104 bits (261), Expect = 2e-26
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 7/207 (3%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y    V+GEG++G         + Q  A+K+IRL K    V   + +E  LL ++K P+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPN 59

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           I+   ++F   G+L++V E+ +  DL   I+     L P D  ++ ++QM L G+   H+
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL-GVQHIHE 118

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K VLHRD+K  N+ +  +G++KL DFG AR+  SP       V   +Y  PE ++    Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMPY 177

Query: 190 GAGVDVWAAGCIFAELLN-RRPFLQGS 215
               D+W+ GCI  EL   + PF   S
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  106 bits (265), Expect = 3e-26
 Identities = 85/281 (30%), Positives = 127/281 (45%), Gaps = 39/281 (13%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G  G VYK I   TG+  A+K I  G  ++ V     REI++L+++  P++++  D 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F H G + ++ EFM+   LE        FL  AD+    +  L G+A+ H++ ++HRD+K
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFL--ADVA---RQILSGIAYLHRRHIVHRDIK 195

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE-----LLFGAKQYGAGV 193
           P+NLLI S   +K+ADFG++RI           V    Y +PE     L  GA    AG 
Sbjct: 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG- 254

Query: 194 DVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D+W+ G    E  L R PF  G                       D A L   +      
Sbjct: 255 DIWSLGVSILEFYLGRFPFGVGRQG--------------------DWASLMCAICMSQPP 294

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             P      +AS +    +S     +P  R +A Q L+H F
Sbjct: 295 EAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (257), Expect = 1e-25
 Identities = 83/296 (28%), Positives = 125/296 (42%), Gaps = 50/296 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI------RLGKQKEGVNFTALREIKLLKELKSPHI 73
           LGEG  G V K     TG   A+K I       L KQ        LRE+++ K  KSP+I
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ-------ILRELEINKSCKSPYI 61

Query: 74  IELIDAF--PHKGNLHLVFEFMET-DLETV---IRNTNIFLSPADIKSYMQMTLKGLAFC 127
           ++   AF      ++ +  E+ E   L+++   ++     +    +    +  LKGL++ 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG-SPDRRFTHQVFARWYRAPELLFGA 186
           H + ++HRD+KP+N+L+   GQ+KL DFG++     S    FT   F   Y APE + G 
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---YMAPERIQG- 177

Query: 187 KQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           K Y    DVW+ G    E+  NR PF         LG I                   + 
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPP--EGEPPLGPI-------------------EL 216

Query: 246 VEYQYVAAPPLRSLFPSA----SDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           + Y      P     P      S++  D + +    DP  R T    LEH + K+ 
Sbjct: 217 LSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  103 bits (257), Expect = 2e-25
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 7/196 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A ++ T + VA+KK+   GKQ        ++E+K L++LK P+ IE   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   GQ+KLADFG A    SP   F   V   ++ APE++      QY   VDVW
Sbjct: 149 AGNILLTEPGQVKLADFGSASK-SSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVW 204

Query: 197 AAGCIFAELLNRRPFL 212
           + G    EL  R+P L
Sbjct: 205 SLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 2e-25
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 45/287 (15%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ----KEGVNFTALR-EIKLLKELKSPHII 74
           LG+G +G VY   D  TG+ +A+K++         K+ VN  AL  EI+LLK L+   I+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN--ALECEIQLLKNLQHERIV 67

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +          L +  E+M    ++  ++     L+    + Y +  L+G+ + H   ++
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLA------RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HRD+K  N+L  S G +KL DFG +         G+  +  T      ++ +PE++ G +
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG---TPYWMSPEVISG-E 182

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG   DVW+ GC   E+L  +P                         W +  +      
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKP------------------------PWAE--FEAMAAI 216

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
           ++    P    L    S DA + L + F  + K R +A++ L H F 
Sbjct: 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  103 bits (257), Expect = 2e-25
 Identities = 77/235 (32%), Positives = 117/235 (49%), Gaps = 11/235 (4%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +T + VAIKK+   GKQ        ++E+K L+ +K P+ IE
Sbjct: 31  REI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGV 193
           D+K  N+L+   GQ+KLADFG A I  SP   F   V   ++ APE++      QY   V
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASI-ASPANSF---VGTPYWMAPEVILAMDEGQYDGKV 205

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG-TATPSQWPDLAYLPDYVE 247
           DVW+ G    EL  R+P L   + +  L  I      T   ++W D  Y  ++V+
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD--YFRNFVD 258

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  102 bits (255), Expect = 2e-25
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 37/287 (12%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +E+LG G  G VYKA    T + +A+K I L    E +    + E+++L +  SP+II  
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGF 64

Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHKKWVLHR 135
             AF  +  + +  EFM+     V R       P  +   + +  +KGL +     +LHR
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVYRKI-----PEHVLGRIAVAVVKGLTYLWSLKILHR 119

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N+L+ + GQ+KL DFG++  +  S  + +   V    Y APE + G +QYG   D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISG-EQYGIHSD 175

Query: 195 VWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G  F EL L R P+ Q          I    G+  P Q   L  + D         
Sbjct: 176 VWSLGISFMELALGRFPYPQ----------IQKNQGSLMPLQL--LQCIVD-------ED 216

Query: 254 PPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
           PP+    P    S+  +  +++     PK R   +  ++H F   +N
Sbjct: 217 PPV---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-25
 Identities = 73/217 (33%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKEL 68
              +   EV+GEGTYG VYKA   KTGQ VAIK   I   +++E        E  +L++ 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-----IKEEYNILRKY 59

Query: 69  KS-PHIIELIDAF---PHKGN---LHLVFEFME----TDLETVIRNTNIFLSPADIKSYM 117
            + P+I     AF      GN   L LV E       TDL   +R     L    I   +
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           + TL+GLA+ H+  V+HRD+K  N+L+  + ++KL DFG++    S   R    +   ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 178 RAPELLFGAKQ----YGAGVDVWAAGCIFAELLNRRP 210
            APE++   +Q    Y A  DVW+ G    EL + +P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  101 bits (254), Expect = 3e-25
 Identities = 83/304 (27%), Positives = 131/304 (43%), Gaps = 50/304 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D     + LG+G YG VYK +   TG T+A+K+IRL   +   N   + E+ +L +  SP
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET---------DLETVIRNTNIFLSPADIKSYMQMTLK 122
           +I++   AF  +G +++  E+M+           + T     ++      I   +   LK
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL---RRITYAVVKGLK 116

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPE 181
            L   H   ++HRD+KP N+L+  +GQ+KL DFG++  +  S  +     +  + Y APE
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAPE 171

Query: 182 LL-----FGAKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
            +          Y    DVW+ G    E+ L R P+   +        IFA         
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQ-------- 218

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L   V+      PP  +L    SDDA D ++K     P  R T  Q LEH +  
Sbjct: 219 ------LSAIVD----GDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266

Query: 296 SFNG 299
            +  
Sbjct: 267 KYKN 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  101 bits (252), Expect = 4e-25
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 32/284 (11%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y+K + +GEG++G        + G+   IK+I + K        + +E+ +L  +K P+
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           I++  ++F   GNL++V ++ E  DL   I      L P D  +  ++Q+ L  L   H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL-ALKHVHD 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + +LHRD+K  N+ +   G +KL DFG+AR+  S        +   +Y +PE+    + Y
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-ENRPY 178

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
               D+WA GC+  E+   +   +  +  + + KI               +Y P    Y 
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG------------SYPPVSSHYS 226

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           Y               D  +L+S++F  +P+ R +    LE  F
Sbjct: 227 Y---------------DLRNLVSQLFKRNPRDRPSVNSILEKNF 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 99.6 bits (248), Expect = 1e-24
 Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 45/294 (15%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI------RLGKQKEGVNFTALRE-IKLLK 66
           + K EVLG+G YG VY  + T  GQ +A+K++       L  +KE   +  L+E + LLK
Sbjct: 2   WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKE---YEKLQEEVDLLK 57

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            LK  +I++ +        + +  EF+    + +++        P     Y +  L G+A
Sbjct: 58  SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV-FCKYTKQILDGVA 116

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRA 179
           + H   V+HRD+K NN+++  +G +KL DFG AR         TH    +      ++ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++     YG   D+W+ GC   E+   +P L   + +D+L  +F              
Sbjct: 177 PEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYIGAHRGL------ 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                         P L   F   S  A+D ++   T D   R +A Q L H F
Sbjct: 227 -------------MPRLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 8/199 (4%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+
Sbjct: 21  REI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGV 193
           D+K  N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   V
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKV 195

Query: 194 DVWAAGCIFAELLNRRPFL 212
           DVW+ G    EL  R+P L
Sbjct: 196 DVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 99.0 bits (246), Expect = 4e-24
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 38/289 (13%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++  + EI++L     P+I++L+ A
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--MVEIEILATCNHPYIVKLLGA 77

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F   G L ++ EF     ++ ++   +  L+   I+   +  L+ L + H   ++HRD+K
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGV 193
             N+L+   G +KLADFG+ A+   +  RR +  +   ++ APE++         Y    
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-IGTPYWMAPEVVMCETMKDTPYDYKA 196

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYV 251
           D+W+ G    E+    P     + +  L KI  +     + PS+W               
Sbjct: 197 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW--------------- 241

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV 300
                       S +  D L       P+ R +A Q LEH F  S    
Sbjct: 242 ------------SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.9 bits (244), Expect = 5e-24
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 34/282 (12%)

Query: 13  RYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            Y+   VLG+G +G   +Y+   T+    V  K++ L +  E     AL EI +L  L+ 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 71  PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+II   + F     L +  E+    T  + ++R          +  Y+   +  +++ H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  +LHRD+K  N+ +   G +KL DFG+++I GS        V   +Y +PEL  G  +
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VK 177

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y    D+WA GC+  ELL  +     ++ ++ + KI     T   S +            
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY------------ 225

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          S + + L+  +   DP+ R TA + L+
Sbjct: 226 ---------------SSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.4 bits (246), Expect = 7e-24
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 35/211 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLL 65
           D +   + LG G++G V       +G+  A+K       ++L KQ E V      E ++L
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHVL----NEKRIL 55

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKG 123
           + ++ P ++ L  +F    NL+LV E++   +L + +R +  F  P   + Y  Q+ L  
Sbjct: 56  QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-VARFYAAQVVL-A 113

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFAR 175
           L + H   +++RD+KP NLL+ S G +K+ DFG A+        + G+P+          
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE---------- 163

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            Y APE++   K YG  VD WA G +  E+L
Sbjct: 164 -YLAPEIILS-KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 97.9 bits (244), Expect = 8e-24
 Identities = 84/279 (30%), Positives = 124/279 (44%), Gaps = 32/279 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G  G V K     TG  +A K + +G  K  V    LRE++++ E +SP+I+    A
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDM 137
           F ++ N+ +  EFM+   L+ + +     +    +       ++GL + +    ++HRD+
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130

Query: 138 KPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           KP+N+L+ S GQ+KL DFG++  +  S    F   V    Y +PE + G K Y    DVW
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQGGK-YTVKSDVW 186

Query: 197 AAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           + G    EL L + PF   + D D         G   P    DL         Q V  PP
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDD---------GQDDPMGILDLL-------QQIVQEPP 230

Query: 256 LR---SLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            R   S FP    D  D +      DP  R T QQ    
Sbjct: 231 PRLPSSDFPE---DLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 95.3 bits (237), Expect = 7e-23
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 42/291 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           LG+G +G V       TG+  A KK+   RL K+++G    AL E K+L+++ S  I+ L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQM-ALNEKKILEKVSSRFIVSL 58

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLH 134
             AF  K +L LV   M   DL+  I N        A    Y    + GL   H++ +++
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFGAKQYGAGV 193
           RD+KP N+L+  HG ++++D GLA        +          Y APE+L G + Y   V
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQG-EVYDFSV 175

Query: 194 DVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D +A GC   E++  R PF Q    +++              +      L   VEY    
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEK--------------EELKRRTLEMAVEYPDKF 221

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
           +P  +           DL   +   DP+ R+     +A +  EH   K  N
Sbjct: 222 SPEAK-----------DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 96.0 bits (239), Expect = 8e-23
 Identities = 86/305 (28%), Positives = 138/305 (45%), Gaps = 35/305 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV K +   +G  +A K I L + K  +    +RE+K+L E  SP
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P +I   + +  L+GL +  +
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PENILGKISIAVLRGLTYLRE 117

Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 173

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLP-- 243
            Y    D+W+ G    E+   R +     D  +L  +F               ++  P  
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR-YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 244 -----------DYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALE 290
                      DY+    V  PP +   PS   SD+  D + K    +PK R   ++  +
Sbjct: 233 SPRPMAIFELLDYI----VNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286

Query: 291 HRFAK 295
           H F K
Sbjct: 287 HPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 36/281 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 70

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+   I+   + TL+ L + H+  ++HRD+K
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF----GAKQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 131 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 190

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 191 VWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 234

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      S +  D L K    +  AR T  Q L+H F
Sbjct: 235 -----------SSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 75/288 (26%), Positives = 141/288 (48%), Gaps = 44/288 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 24  ENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQ 78

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ +  R     L+   I +  +  L+ L + 
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYL 133

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGS-PDRRFTHQVFARWYRAPELLFG 185
           H + V+HRD+K +++L+   G++KL+DFG  A+I    P R+    V   ++ APE++  
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVI-S 190

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              YG  VD+W+ G +  E+++  P                 + + +P Q   +  L D 
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEP----------------PYFSDSPVQ--AMKRLRD- 231

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 + PP        S    D L +M T +P+ R TAQ+ L+H F
Sbjct: 232 ------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 94/329 (28%), Positives = 149/329 (45%), Gaps = 41/329 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 121

Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 177

Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIF--------AAFGTAT---PSQ 235
            Y    D+W+ G    E+ + R P      D  +L  +F        A   T+    P  
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPI--PPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235

Query: 236 WPDLAYLPD---------YVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARIT 284
            P  +Y PD          ++Y  V  PP +   PS     +  D ++K    +P  R  
Sbjct: 236 RPLSSYGPDSRPPMAIFELLDY-IVNEPPPK--LPSGVFGAEFQDFVNKCLIKNPAERAD 292

Query: 285 AQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
            +Q + H F K        VDF  +L S+
Sbjct: 293 LKQLMVHAFIK--RSEAEEVDFAGWLCST 319

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 93.6 bits (232), Expect = 5e-22
 Identities = 75/288 (26%), Positives = 137/288 (47%), Gaps = 40/288 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A +  TG+ VA+KK+ L KQ+         E+ ++++    
Sbjct: 25  DSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHE 79

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++++ +++     L +V EF+E    TD+ T  R     ++   I +     L+ L++ 
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYL 134

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+ S G++KL+DFG          +    V   ++ APE++    
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRL 193

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG  VD+W+ G +  E+++  P       +  + +I                 LP  V+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--------------LPPRVK 239

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
             +  +  LR          LDL   M   +P  R TAQ+ L+H F K
Sbjct: 240 DSHKVSSVLRGF--------LDL---MLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 93.2 bits (231), Expect = 7e-22
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 40/286 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 77

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+ +++     L +V EF+E    TD+ T  R     ++   I +     LK L+  
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVL 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+    
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRL 191

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG  VD+W+ G +  E+++  P       +  +  I                 LP  ++
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPKLK 237

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +  +P L+             L ++   DP  R TA + L+H F
Sbjct: 238 NLHKVSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 6/191 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A      + VA+KK+++ +  +       ++EI LLK+L  P++I+ +D
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 79  AFPHKGNLHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I   +     +    +  Y       +   H + V+H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188

Query: 195 VWAAGCIFAEL 205
           +W+ GC+  E+
Sbjct: 189 IWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 91.3 bits (226), Expect = 2e-21
 Identities = 80/278 (28%), Positives = 135/278 (48%), Gaps = 31/278 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G GTYG VYKA +  TG+  AIK I+L   + G +F  ++ EI ++K+ K  +I+    
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           ++  +  L +  EF        I +    LS + I    + TL+GL + H K  +HRD+K
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133

Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDV 195
             N+L+  +G +KLADFG+ A+I  +  +R +  +   ++ APE+    ++  Y    D+
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAPEVAAVERKGGYNQLCDI 192

Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           WA G    EL   +P +    D+  +  +F    T +  Q P L    D +++       
Sbjct: 193 WAVGITAIELAELQPPM---FDLHPMRALF--LMTKSNFQPPKLK---DKMKW------- 237

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                   S+     +    T +PK R TA++ L+H F
Sbjct: 238 --------SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 90.8 bits (225), Expect = 2e-21
 Identities = 71/290 (24%), Positives = 131/290 (45%), Gaps = 40/290 (13%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKT--GQTVAI-KKIRLGKQKEGVNFTALREIKLLKELK 69
           RY+ ++ LG+G++G VY   D K    + + + K+I +G+        A +E +LL +L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFLSPADIKSYMQMTLKGL 124
            P I++   +F  +    ++ E+ E  DL+  +                + ++Q+ L G+
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL-GV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELL 183
            + H++ +LHRD+K  N+ +  +  LK+ DFG++R + GS D   T      +Y +PE L
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTF-TGTPYYMSPEAL 177

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
              + Y +  D+W+ GCI  E+       +G + +  + +I       TPS       LP
Sbjct: 178 -KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---PTPS-------LP 226

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +    Q  +                 ++  M   DP  R +A + L + F
Sbjct: 227 ETYSRQLNS-----------------IMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 90.4 bits (224), Expect = 3e-21
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 5/203 (2%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY   + +GEG++G +Y A      +   IK+I L K        + +E+ LL ++K P+
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           I+    +F   G L +V E+ +  DL   I R   +  S   I S+      GL   H +
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 131 WVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            +LHRD+K  N+ +  +G + KL DFG+AR            V   +Y +PE+    + Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-QNRPY 179

Query: 190 GAGVDVWAAGCIFAELLN-RRPF 211
               D+W+ GC+  EL   + PF
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.9 bits (225), Expect = 3e-21
 Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T Q VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +     F     I + ++  LKGL + H +  +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F                +P          
Sbjct: 183 DIWSLGITAIELAKGEP---PNSDMHPMRVLF---------------LIPKN------NP 218

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P L   F   S    + +      DP  R TA++ L+H+F
Sbjct: 219 PTLTGEF---SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 4e-21
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 23/208 (11%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +R VLG+GTYG+VY A D  T   +AIK+I     +         EI L   LK  +I++
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL--HEEIALHSYLKHRNIVQ 69

Query: 76  LIDAFPHKGNLHLVFEFMET----DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHK 129
            + +    G   +   FME      L  ++R+    +  +   I  Y +  L+GL + H 
Sbjct: 70  YLGSDSENGFFKI---FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 130 KWVLHRDMKPNNLLIGSH-GQLKLADFG----LARIFGSP-DRRFTHQVFARWYRAPELL 183
             ++HRD+K +N+L+ ++ G +K++DFG    LA I  +P    FT  +    Y APE++
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTL---QYMAPEVI 181

Query: 184 -FGAKQYGAGVDVWAAGCIFAELLNRRP 210
             G + YGA  D+W+ GC   E+   +P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.5 bits (224), Expect = 5e-21
 Identities = 74/282 (26%), Positives = 132/282 (46%), Gaps = 34/282 (12%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G VYK ID +T + VAIK I L + ++ +     +EI +L +  SP+I
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYI 64

Query: 74  IELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
                ++     L ++ E++   + L+ +       L    I + ++  LKGL + H + 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSER 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
            +HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y  
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDF 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
             D+W+ G    EL    P    +SD+  +  +F     + P+           +E QY 
Sbjct: 181 KADIWSLGITAIELAKGEP---PNSDLHPMRVLFLIPKNSPPT-----------LEGQY- 225

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            + P +           + +      DP+ R TA++ L+H+F
Sbjct: 226 -SKPFK-----------EFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 90.1 bits (223), Expect = 5e-21
 Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 44/290 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALR-EIKLLKELKSPHII 74
           ++LG+G +G VY   D  TG+ +A K+++   +    +   +AL  EI+LLK L+   I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 75  ELIDAFPHKG--NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +       +    L +  E+M              L+ +  + Y +  L+G+++ H   +
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFGA 186
           +HRD+K  N+L  S G +KL DFG ++      + G+  R  T      ++ +PE++ G 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYWMSPEVISG- 183

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + YG   DVW+ GC   E+L  +P     ++ + +  IF                     
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKP---PWAEYEAMAAIFK-------------------- 220

Query: 247 EYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
               +A  P     PS  S+ A D L  +F  + + R +A++ L H FA+
Sbjct: 221 ----IATQPTNPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 7e-21
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 33/206 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +G GT+G V+   D  +    A+K       IRL KQ++ V+     E ++LKE+  P I
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-KQEQHVH----NEKRVLKEVSHPFI 63

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L      +  L+++ E++   +L + +RN+  F S +    Y    +  L + H K +
Sbjct: 64  IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF-SNSTGLFYASEIVCALEYLHSKEI 122

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELLF 184
           ++RD+KP N+L+   G +KL DFG A+        + G+P+           Y APE++ 
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-----------YLAPEVI- 170

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
            +K +   VD WA G +  E+L   P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 72/289 (24%), Positives = 130/289 (44%), Gaps = 44/289 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALR-EIKLLKELKSPHII 74
           ++LG+G +G VY   D  TG+ +A+K+++   +    +    AL  EI+LLK L    I+
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 75  ELIDAF--PHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +       P +  L +  E M    ++  +++    L+    + Y +  L+G+++ H   
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSNM 126

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFG 185
           ++HRD+K  N+L  S G +KL DFG ++      + G+  +  T      ++ +PE++ G
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPYWMSPEVISG 183

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            + YG   D+W+ GC   E+L  +P     ++ + +  IF      T    P        
Sbjct: 184 -EGYGRKADIWSVGCTVVEMLTEKP---PWAEFEAMAAIFKIATQPTNPVLP-------- 231

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
                          P  SD   D L ++F  + K R +A + L H F 
Sbjct: 232 ---------------PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 64/195 (32%), Positives = 104/195 (53%), Gaps = 8/195 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G GTYG VYKA +  TG+  A+K I+L   + G +F+ ++ EI ++KE K  +I+    
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL---EPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           ++  +  L +  E+        I +    LS   I    + TL+GLA+ H K  +HRD+K
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133

Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDV 195
             N+L+  +G +KLADFG+ A+I  +  +R +  +   ++ APE+    K   Y    D+
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSF-IGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 196 WAAGCIFAELLNRRP 210
           WA G    EL   +P
Sbjct: 193 WAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G  GVV K     +G  +A K I L + K  +    +RE+++L E  SP+I+    A
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHKK-WVLHRD 136
           F   G + +  E M+   L+ V++       P +I   + +  L+GLA+  +K  ++HRD
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLREKHQIMHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G   Y    D+
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT-HYSVQSDI 185

Query: 196 WAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFA 226
           W+ G    EL + R P      D  +L  IF 
Sbjct: 186 WSMGLSLVELAIGRYPI--PPPDAKELEAIFG 215

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P     S++  +  +F       P+           +E  Y  +
Sbjct: 183 DIWSLGITAIELAKGEP---PHSELHPMKVLFLIPKNNPPT-----------LEGNY--S 226

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            PL+           + +      +P  R TA++ L+H+F
Sbjct: 227 KPLK-----------EFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.0 bits (218), Expect = 3e-20
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 70

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130

Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 187

Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 7e-20
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 16/214 (7%)

Query: 12  DRYLKR-EVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            R+LK  + LGEG +G V       +   TG+ VA+K +     +E       REI++L+
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFEREIEILR 61

Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   +I++   +   P   +L L+ E++ +  L   ++     ++   +  +     KG
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K++DFGLA++       +      +    WY A
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFL 212
           PE L  +K   A  DVW+ G    EL     P  
Sbjct: 181 PECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (214), Expect = 9e-20
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 42/287 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRL--GKQKEGVNFTALR-EIKLLKELKSPHII 74
           ++LG G +G VY   D  TG+ +A+K++      Q+      AL  EI+LLK L+   I+
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 75  ELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +       P +  L +  E+M              L+    + Y +  L+G+++ H   +
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFGA 186
           +HRD+K  N+L  S G +KL DFG ++      + G+  +  T      ++ +PE++ G 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMSPEVISG- 183

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + YG   DVW+  C   E+L  +P     ++ + +  IF      T    PD        
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKP---PWAEYEAMAAIFKIATQPTKPMLPD-------- 232

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                            SD   D L ++F  + K R TA+  L H F
Sbjct: 233 ---------------GVSDACRDFLKQIF-VEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.4 bits (214), Expect = 1e-19
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKI-------RLGKQKEGVNFTAL-REIKLLKE- 67
           E LG G +G VYK      GQ  +A+K+I          K++   +   +  E+ ++KE 
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLK 122
           L+ P+I+     F     L++V + +E         ++      F        ++QM L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124

Query: 123 GLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            L + HK K ++HRD+ PNN+++G   ++ + DFGLA+    P+ + T  V    Y  PE
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTILYSCPE 183

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           ++   + YG   DVWA GCI  ++   +P
Sbjct: 184 IVKN-EPYGEKADVWAFGCILYQMCTLQP 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 6/191 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A     G  VA+KK+++    +       ++EI LLK+L  P++I+   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 79  AFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I++       +    +  Y       L   H + V+H
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188

Query: 195 VWAAGCIFAEL 205
           +W+ GC+  E+
Sbjct: 189 IWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 89/313 (28%), Positives = 136/313 (43%), Gaps = 64/313 (20%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIR-----LGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           G YG VY     +T Q  A+KKI      L  Q + V     R+I    E  +P ++ + 
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV--FVERDILTFAE--NPFVVSMF 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWVLHR 135
            +F  K +L +V E++E  D  T+++N      P D+ + Y   T+  L + H   ++HR
Sbjct: 68  CSFETKRHLCMVMEYVEGGDCATLLKNIGAL--PVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLARI-------------FGSPDRRFT-HQVFAR-WYRAP 180
           D+KP+NLLI S G +KL DFGL++I                  R F   QV     Y AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++   + YG  VD WA G I  E L       G +  +  G++      +   +WP+  
Sbjct: 186 EVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-----SDDIEWPEGD 239

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRFAKSF 297
                       A P          DA DL+S++   +P  R+    A +  +HRF    
Sbjct: 240 -----------EALP---------ADAQDLISRLLRQNPLERLGTGGAFEVKQHRF---- 275

Query: 298 NGVFVFVDFCSYL 310
              F+ +D+   L
Sbjct: 276 ---FLGLDWNGLL 285

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 84.8 bits (210), Expect = 9e-19
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 17  REVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK----QKEGVNFTALREIKLLKELK 69
            +VLG+G YG V+   K     TG+  A+K ++       QK+  +  A R I  L+ +K
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVK 58

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKS-YMQMTLKGLAFC 127
            P I++LI AF   G L+L+ E++   +L   +    IF+   D    Y+      L   
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME--DTACFYLSEISLALEHL 116

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
           H++ +++RD+KP N+L+ + G +KL DFGL +     G+    F   +    Y APE+L 
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI---EYMAPEILM 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
            +  +G  VD W+ G +  ++L   P
Sbjct: 174 RSG-HGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 53/293 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-------S 70
           E LG G YGVV K     TG  +A+K+IR       VN    +  +LL +L         
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQK--RLLMDLDISMRSVDC 59

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNT---NIFLSPADIKSYMQMTL-KGLAF 126
           P+ +    A   +G++ +  E M+T L+   +      + + P DI   + +++ K L +
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI-PEDILGKIAVSIVKALEY 118

Query: 127 CHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLF 184
            H K  V+HRD+KP+N+LI  +GQ+KL DFG++  +  S  +  T     + Y APE + 
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERIN 176

Query: 185 G---AKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
                K Y    DVW+ G    EL   R P+    +   QL                   
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK------------------ 218

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                   Q V  P  +      S +  D ++K    + K R    + L+H F
Sbjct: 219 --------QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.5 bits (206), Expect = 1e-18
 Identities = 67/198 (33%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           LG+G +G V       TG+  A KK+   RL K+K G    AL E ++L+++ SP I+ L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-KKKSGEKM-ALLEKEILEKVNSPFIVNL 58

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             AF  K +L LV   M   DL+  I N     L    +  Y      G+   H   +++
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RDMKP N+L+   G  +L+D GLA +     +  T +     Y APE+L   + Y   VD
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILK-EEPYSYPVD 176

Query: 195 VWAAGC-IFAELLNRRPF 211
            +A GC I+  +  R PF
Sbjct: 177 WFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSP 71
            E LG G++G V  A    TG+  AIK     +I   KQ + V     +E  +L EL  P
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV----AQEKSILMELSHP 78

Query: 72  HIIELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHK 129
            I+ ++ +F  +  ++ + EF +  +L T +R    F  P D+ K Y    +    + H 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF--PNDVAKFYHAELVLAFEYLHS 136

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K +++RD+KP NLL+ + G +K+ DFG A+    PDR FT       Y APE++  +K +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEYLAPEVI-QSKGH 192

Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD W  G +  E +   P
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 77/274 (28%), Positives = 111/274 (40%), Gaps = 45/274 (16%)

Query: 36  TGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHIIELID---AFPHKGNLHLVFE 91
           TG  VAIK +R    +E        RE  L   L  P+I+ L+D   A P  G L  VFE
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP--GLLFAVFE 59

Query: 92  FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-- 148
           ++    L  V+      L   +    M   L  LA  H + ++HRD+KP N+++   G  
Sbjct: 60  YVPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 149 -QLKLADFGLARI---FGSPDR----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGC 200
              K+ DFG+  +       D     R T  +    Y APE L G +      D++A G 
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGL 177

Query: 201 IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF 260
           IF E L  +  +QG+S  + L +  +          P    LP      ++A  PL    
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLS----------PVDVSLP-----PWIAGHPLG--- 219

Query: 261 PSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
                    +L K    DP+ R  +  AL  RF 
Sbjct: 220 --------QVLRKALNKDPRQRAASAPALAERFR 245

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 3e-18
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 14/204 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V +      G+    VAIK ++ G   K+ ++F  L E  ++ +   P+I
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF--LTEASIMGQFDHPNI 67

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ E+ME   L+  +R  +   +   +   ++    G+ +  +   
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAKQY 189
           +HRD+   N+L+ S+   K++DFGL+R     +  +T +   +  RW  APE +   +++
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEAI-AYRKF 185

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+++   RP+
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 84/315 (26%), Positives = 126/315 (40%), Gaps = 72/315 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKEL 68
             +  + ++G G +G V    +  TG   A+K ++   L  Q+    F   R+I  L   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI--LSIS 58

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            SP I +L  AF  K NL+LV E+    DL +++            + Y+   +  +   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFG-LARI-----------FGSPDRRFTHQVFAR 175
           H+   +HRD+KP N+LI   G +KLADFG  AR+            G+PD          
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD---------- 168

Query: 176 WYRAPELL-----FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFG 229
            Y APE+L      G   YG   D W+ G I  E++  R PF +G+S       I     
Sbjct: 169 -YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-AKTYNNI----- 221

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSL-FPS---ASDDALDLLSKMFTYDPKARITA 285
                           + +Q       R L FP     S D LDL+  +     K R+  
Sbjct: 222 ----------------MNFQ-------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGY 257

Query: 286 QQALEHRFAKSFNGV 300
           +    H F   F+ +
Sbjct: 258 EGLCCHPF---FSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 37/286 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELKSPHIIELID 78
           +G GT G VYK    KTG  +A+K++R    KE  N   L ++  +LK    P+I++   
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHKKW-VLHRD 136
            F    ++ +  E M T L+ +++     + P DI   M +  +K L +  +K  V+HRD
Sbjct: 82  YFITDSDVFICMELMSTCLDKLLKRIQGPI-PEDILGKMTVAIVKALHYLKEKHGVIHRD 140

Query: 137 MKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL---FGAKQYGAG 192
           +KP+N+L+ + G +KL DFG++ R+  S  +  T       Y APE +       +Y   
Sbjct: 141 VKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIR 198

Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            DVW+ G    EL   + P+    ++ + L KI                 L +       
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-----------------LQE------- 234

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
             PP        S D    +    T D + R   ++ L+H F + +
Sbjct: 235 -EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.3 bits (201), Expect = 9e-18
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 31/221 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-------KSPH 72
           +G G +G V K +   +G  +A+K+IR              + +LL +L         P+
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS-------TVDEKEQKRLLMDLDVVMRSSDCPY 64

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETV------IRNTNIFLSPADIKSYMQM-TLKGLA 125
           I++   A   +G+  +  E M+  L+        +  + I   P +I   + + T+K L 
Sbjct: 65  IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALN 121

Query: 126 FCHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL 183
           +  ++  ++HRD+KP+N+L+  +G +KL DFG++ ++  S  +  T     R Y APE +
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERI 179

Query: 184 --FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQL 221
                  Y    DVW+ G    E+   + P+ + +S  DQL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 79.6 bits (196), Expect = 2e-17
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 6/196 (3%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y    V+G+G+YG V        G+   IKK+ L          A +E +LL +LK P+I
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 74  IELIDAFP-HKGNLHLVFEFMET-DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           +   +++    G L++V  F E  DL   ++     L P +  ++ ++Q+ +  L + H+
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM-ALQYLHE 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K +LHRD+K  N+ +     +K+ D G+AR+  +     +  +   +Y +PE LF  K Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPY 179

Query: 190 GAGVDVWAAGCIFAEL 205
               DVWA GC   E+
Sbjct: 180 NYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 58/296 (19%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK  K  +  + + V  T +    L    + P +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F  K +L  V E++   DL   I+++  F   A  + Y    + GL F HKK +++R
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF-DEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+L+   G +K+ADFG+ +             G+PD           Y APE+L 
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD-----------YIAPEILK 169

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           G K Y   VD W+ G +  E+L  + PF     D D+L   F +     P       + P
Sbjct: 170 GQK-YNESVDWWSFGVLLYEMLIGQSPF--HGEDEDEL---FDSILNDRP-------HFP 216

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALEHRFAKSFN 298
            ++                 S +A D LSK+F  DP  R+       +H F +  +
Sbjct: 217 RWI-----------------SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 42/296 (14%)

Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSP 71
           +VLG G YG V+   K     TG+  A+K ++   L ++ + V  T      L    +SP
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF  +  LHL+ +++   ++ T +   + F S  +++ Y    +  L   HK 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF-SEDEVRFYSGEIILALEHLHKL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+K  N+L+ S G + L DFGL++ F S ++  T+       Y APE++ G   +
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 190 GAGVDVWAAGCIFAELLN-RRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           G  VD W+ G +  ELL    PF L+G  +              T S+          V 
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERN--------------TQSE----------VS 220

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
            + +   P          +A DLL K+   DPK R+      A +  EH F K  +
Sbjct: 221 RRILKCDP--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 53/296 (17%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L  V E+    +L   +    +F S    + Y    +  L + H   V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRF--THQVFARWYRAPELLFGAKQY 189
           RD+K  NL++   G +K+ DFGL +     G+  + F  T +     Y APE+L     Y
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----YLAPEVL-EDNDY 172

Query: 190 GAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           G  VD W  G +  E++  R PF   + D ++L                          +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL--------------------------F 204

Query: 249 QYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
           + +    +R  FP   S +A  LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 205 ELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 78.9 bits (194), Expect = 7e-17
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 59

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S  +++ Y    + GL   H ++V
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF-SEKEMRFYATEIILGLEHMHNRFV 118

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 193 VDVWAAGCIFAELL-NRRPFLQ 213
            D ++ GC+  +LL    PF Q
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 28/217 (12%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L  + K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++++ GL F H++ +++R
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-GLFFLHRRGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+           R F G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
             + YG  VD WA G +  E+L  +P   G  D D+L
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 51/302 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E    G  G  +  ID KT + V IK      Q+ G       E  +L+ +  P II+L 
Sbjct: 98  ETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGG----TATEAHILRAINHPSIIQLK 149

Query: 78  DAFPHKGNLHLVFEFMETDLETVI---RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             F +     L+    +TDL   +   RN  I     DI +  +  L+ + + H+  ++H
Sbjct: 150 GTFTYNKFTCLILPRYKTDLYCYLAAKRNIAI----CDILAIERSVLRAIQYLHENRIIH 205

Query: 135 RDMKPNNLLIGSHGQLKLADFGLA---------RIFGSPDRRFTHQVFARWYRAPELLFG 185
           RD+K  N+ I   G + L DFG A         + +G      T+        APELL  
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN--------APELL-A 256

Query: 186 AKQYGAGVDVWAAGCIFAEL------LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
              YG  VD+W+AG +  E+      L  +  L G  D D+  K+        P+++P  
Sbjct: 257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316

Query: 240 AYLPDYVEYQYVAA-------PPLRSLFPSASDDALD---LLSKMFTYDPKARITAQQAL 289
           A     ++  Y+         P  R L+ +  +  +D   L+ KM  +D   R +A+  L
Sbjct: 317 A--QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374

Query: 290 EH 291
           + 
Sbjct: 375 DF 376

Length = 391

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 42/289 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +VLG+G++G V  A     G+  A+K ++  +    + V  T + +  L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVL 133
           L   F  K +L  V EF+   DL   I++   F L  A    Y    + GL F H K ++
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQFLHSKGII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +RD+K +N+++   G +K+ADFG+ +  +FG  D R +       Y APE+L G K Y  
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQGLK-YTF 175

Query: 192 GVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
            VD W+ G +  E+L  + PF     D D+L   F +    TP       + P ++    
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF--HGDDEDEL---FESIRVDTP-------HYPRWI---- 219

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-HRFAKSFN 298
                        + ++ D+L K+F  DP  R+     +  H F K+ N
Sbjct: 220 -------------TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+G++G V+ A    T Q  AIK ++  +    + V  T + +  L    + P +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  K NL  V E++   DL   I++ + F  P     Y    + GL F H K +++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA-TFYAAEIICGLQFLHSKGIVY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ + G +K+ADFG+ +             G+PD           Y APE+L
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
            G K Y   VD W+ G +  E+L  + PF
Sbjct: 169 LGQK-YNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 63/257 (24%), Positives = 102/257 (39%), Gaps = 22/257 (8%)

Query: 51  KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSP 110
           K G   T L E  LL+ +  P +I + D         +V     +DL T +   +  L  
Sbjct: 97  KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI 156

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
                  +  L+GL + H + ++HRD+K  N+ I    Q+ + D G A+ F      F  
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG 215

Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL----------NRRPFLQGSSDIDQ 220
                   APE+L   K Y +  D+W+AG +  E+L             P     S    
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 221 LGKIFAAFGTATPSQW---PDLAYLPDYVEYQYVAAPPLRSLFPSAS-----DDALDLLS 272
           L KI +      P ++   P    +  ++EY  +   P  + +P         D   L+ 
Sbjct: 275 LLKIISTLKV-HPEEFPRDPGSRLVRGFIEYASLERQP-YTRYPCFQRVNLPIDGEFLVH 332

Query: 273 KMFTYDPKARITAQQAL 289
           KM T+D   R +A++ L
Sbjct: 333 KMLTFDAAMRPSAEEIL 349

Length = 357

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 30/202 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-----KQKEGVNFTALREIKLLKELKSPH 72
           E +G+G +G VYK +  K    VA+K  R       K+K    F  L+E ++LK+   P+
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRK----F--LQEAEILKQYDHPN 53

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK---GLAFCH 128
           I++LI     K  +++V E +    L T +R     L+   +K  +QM+L    G+ +  
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLE 110

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL 183
            K  +HRD+   N L+G +  LK++DFG++R     I+   D     Q+  +W  APE L
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL--KQIPIKW-TAPEAL 167

Query: 184 -FGAKQYGAGVDVWAAGCIFAE 204
            +G  +Y +  DVW+ G +  E
Sbjct: 168 NYG--RYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 5e-16
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA--MALNEKQILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y      GL   H++ ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  +G ++++D GLA      +     +V    Y APE++   ++Y    
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVV-KNERYTFSP 182

Query: 194 DVWAAGCIFAELLN-RRPFLQ 213
           D W  GC+  E++  + PF Q
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 20  LGEGTYGVVYKA---IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G+V+        K    VAIK IR G   E  +F  + E +++ +L  P +++L
Sbjct: 12  IGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEE-DF--IEEAQVMMKLSHPKLVQL 64

Query: 77  IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWV 132
                 +  + LVFEFME   L   +R      S    ++ + M L   +G+A+     V
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSNV 121

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV---FARWYRAPELLFGAKQY 189
           +HRD+   N L+G +  +K++DFG+ R     D ++T      F   + +PE +F   +Y
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPE-VFSFSKY 178

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+ +  + P+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE---IKLLKELKSPH 72
           ++G G +G VY      TG+  A+K   K R+ K K+G    AL E   + L+     P 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETL-ALNERIMLSLVSTGDCPF 58

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ +  AF     L  + + M   DL   +    +F S A+++ Y    + GL   H ++
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEAEMRFYAAEIILGLEHMHNRF 117

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDS 175

Query: 192 GVDVWAAGCIFAELLN-RRPFLQ 213
             D ++ GC+  +LL    PF Q
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 76/290 (26%), Positives = 116/290 (40%), Gaps = 42/290 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           E +G+GTYG V+K ++ K G   A+K +        ++     E  +LK L   P++++ 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 77  IDAFPHKG-----NLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              +  K       L LV E       TDL          +    I   +   L GL   
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H    +HRD+K NN+L+ + G +KL DFG++    S   R    V   ++ APE++   +
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200

Query: 188 Q----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           Q    Y A  DVW+ G    EL +  P L     +  L KI        P   P   + P
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI--------PRNPPPTLHQP 252

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +                   S++  D + K  T D + R T    L+H F
Sbjct: 253 EL-----------------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 34/234 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G V+     +T +    K I     KE      + E+ +++ELK  +I+  ID 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 80  FPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHK---- 129
           F +K N  L+++ EF +  DL   I+         +  + + +T   L  LA+CH     
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 130 ---KWVLHRDMKPNNLLIGSH----GQL-------------KLADFGLARIFGSPDRRFT 169
              + VLHRD+KP N+ + +     G++             K+ DFGL++  G       
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI--ESMA 198

Query: 170 HQ-VFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
           H  V   +Y +PELL    K Y    D+WA GCI  EL + +     +++  QL
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           RYLK+  VLGEG +G V    Y   +  TG+ VA+K +   K++ G   T+   +EI +L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL---KRECGQQNTSGWKKEINIL 60

Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           K L   +I++       +G   L L+ E++    L   +    + L  A +  + Q   +
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICE 118

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------W 176
           G+A+ H +  +HRD+   N+L+ +   +K+ DFGLA+    P+    ++V         W
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFW 176

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
           Y A E L   K   A  DVW+ G    ELL  
Sbjct: 177 Y-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTA-LREIKLLKELKS 70
           K +VLG G +G VYK +    G+     VAIK +R  ++         L E  ++  +  
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDH 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           PH++ L+        + L+ + M    L   +RN    +    + ++     KG+++  +
Sbjct: 69  PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGA 186
           K ++HRD+   N+L+ +   +K+ DFGLA++    ++ +     +V  +W  A E +   
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILHR 186

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
             Y    DVW+ G    EL+    +P+
Sbjct: 187 I-YTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I +             Y      GL   H++ ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSP 182

Query: 194 DVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D WA GC+  E++  + PF Q    I +                 ++  L   V+ +Y  
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRKKKIKR----------------EEVERLVKEVQEEYSE 226

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                      S DA  L   +   DPK R+      A++  EH   K  N
Sbjct: 227 ---------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 66/302 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKEL--KSPHII 74
           VLG+G++G V  A    T +  A+K ++     Q + V  T + E ++L  L  K P + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVL-ALAGKHPFLT 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L   F  K  L  V E++   DL   I+ +  F  P       ++ L GL F H++ ++
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-GLQFLHERGII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPEL 182
           +RD+K +N+L+ S G +K+ADFG+             F G+PD           Y APE+
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-----------YIAPEI 167

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD WA G +  E+L  + PF     + D   ++F +              
Sbjct: 168 LSYQP-YGPAVDWWALGVLLYEMLAGQSPF-----EGDDEDELFQSI------------- 208

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKS 296
           L D V Y        R L    S +A  +L    T +P+ R+       Q    H F + 
Sbjct: 209 LEDEVRYP-------RWL----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Query: 297 FN 298
            +
Sbjct: 258 ID 259

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 67/232 (28%), Positives = 99/232 (42%), Gaps = 38/232 (16%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
            L  K  D +   +V+G G +G V       + Q  A+K   K  + K+ +   F   R+
Sbjct: 37  KLRMKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQM 119
           I  +    S  I++L  AF     L++V E+M   DL  ++ N +I   P    + Y   
Sbjct: 96  I--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKWARFYTAE 150

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF---------GLAR---IFGSPDRR 167
            +  L   H    +HRD+KP+N+L+   G LKLADF         G+ R     G+PD  
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD-- 208

Query: 168 FTHQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGS 215
                    Y +PE+L    G   YG   D W+ G    E+L    PF   S
Sbjct: 209 ---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 40/292 (13%)

Query: 20  LGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           L  G+ G V+  + TK G    + V +K +  GK          REI +LK +    II 
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPG-------REIDILKTISHRAIIN 150

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
           LI A+  K  + +V    + DL T +  +   L      +  +  L+ LA+ H + ++HR
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGRGIIHR 209

Query: 136 DMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARW-----YRAPELLFGAKQY 189
           D+K  N+ +       L DFG A ++   PD   T Q +  W       +PELL     Y
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPD---TPQCYG-WSGTLETNSPELL-ALDPY 264

Query: 190 GAGVDVWAAGCIFAELL-NRRPFL--QGSSDIDQLGKIFAAFGTATPSQWP---DLAYLP 243
            A  D+W+AG +  E+          Q  S   QL  I        P ++P         
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGSTNLCK 323

Query: 244 DYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
            + +Y  V  PP      +R        D   L++KM T+D + R +AQ  L
Sbjct: 324 HFKQYAIVLRPPYTIPPVIRKYGMHM--DVEYLIAKMLTFDQEFRPSAQDIL 373

Length = 392

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 80/286 (27%), Positives = 117/286 (40%), Gaps = 49/286 (17%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIELI 77
           +G+G++G V +     T +  A+K IR      +  V  T L E  +L ++  P I+ L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT-LAERTVLAQVNCPFIVPLK 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            +F     L+LV  F+   +L   ++    F   +  + Y    L  L   HK  V++RD
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRF-DLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP N+L+   G + L DFGL ++    D +         Y APELL G   Y   VD W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWW 177

Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-----YQYV 251
             G +  E+L   P                                P Y E     Y+ +
Sbjct: 178 TLGVLLYEMLTGLP--------------------------------PFYDENVNEMYRKI 205

Query: 252 AAPPLRSLFPSASD-DALDLLSKMFTYDPKARI---TAQQALEHRF 293
              PLR  FP   D DA DLL  + + DP  R+    AQ+   H F
Sbjct: 206 LQEPLR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 17/221 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           E +G+GTYG VYK  + K G   A+K +        V+     E  +L+ L + P++++ 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 77  IDAFPHK-----GNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              F        G L LV E       T+L   +      L  A I   +   L GL   
Sbjct: 85  YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   ++HRD+K NN+L+ + G +KL DFG++    S   R    V   ++ APE++   +
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204

Query: 188 Q----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
           Q    Y A  DVW+ G    EL +  P L     +  L KI
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L    K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F H K +++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-GLFFLHSKGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
             + YG  VD WA G +  E+L  +   +G  D D+L
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.4 bits (180), Expect = 6e-15
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LKR   LGEG +G V    Y      TG+ VA+K ++       +     +EI++L+ 
Sbjct: 4   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRN 62

Query: 68  LKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTLKG 123
           L   +I++        G   + L+ EF+ +    E + RN N       +K  +Q+  KG
Sbjct: 63  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC-KG 121

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFARWY 177
           + +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +    +T +      VF  WY
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF--WY 179

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K Y A  DVW+ G    ELL
Sbjct: 180 -APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 7e-15
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A K++   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNSQFVVN 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y    L GL   H++  +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  +G ++++D GLA      +     +V    Y APE+L   ++Y    
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVL-NNQRYTLSP 182

Query: 194 DVWAAGCIFAELLN-RRPF 211
           D W  GC+  E++  + PF
Sbjct: 183 DYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 6/215 (2%)

Query: 17  REVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
            +VLG+G++G V+   K      GQ  A+K ++    K         E  +L E+  P I
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   +
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGI 119

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +   
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQS 178

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            D W+ G +  E+L      QG    + +  I  A
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 46/231 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGV-NFTALREIKLLKELKSPHII 74
           +V+G G +G V       TG   A+KK+R  +  +KE V +  A R+I  L E  +P ++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVV 64

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  +F  +  L+L+ E++   D+ T++   + F +  + + Y+  T+  +   HK   +
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF-TEEETRFYIAETILAIDSIHKLGYI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV--------------------- 172
           HRD+KP+NLL+ + G +KL+DFGL        R   +++                     
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183

Query: 173 -FARW----------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               W                Y APE +F    Y    D W+ G I  E+L
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIE 75
           EV+G GTYG VYK    KTGQ  AIK + + + +E        EI +LK+  S H  I  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLEINMLKKY-SHHRNIAT 77

Query: 76  LIDAF------PHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYM-QMTLKGL 124
              AF       H   L LV EF      TDL   ++NT       D  +Y+ +  L+GL
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL---VKNTKGNALKEDWIAYICREILRGL 134

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELL 183
           A  H   V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR T  +   ++ APE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 193

Query: 184 FGAKQ----YGAGVDVWAAGCIFAELLNRRPFL 212
              +     Y    D+W+ G    E+    P L
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 70

Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 191 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 15/194 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E+LG+G +G V+K    K    VA+K  +    +E +    L E ++LK+   P+I++LI
Sbjct: 1   ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLI 58

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  +++V E +   D  + +R     L    +  +      G+A+   K  +HRD
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 137 MKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL-FGAKQYG 190
           +   N L+G +  LK++DFG++R     I+ S   +   Q+  +W  APE L +G  +Y 
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK---QIPIKW-TAPEALNYG--RYS 172

Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 173 SESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 59/237 (24%), Positives = 115/237 (48%), Gaps = 16/237 (6%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           K++V+G G +G V++ I    G+    VAIK ++ G  +K+  +F  L E  ++ +    
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF--LSEASIMGQFSHH 66

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +II L           ++ E+ME   L+  +R+ +   S   +   ++    G+ +    
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGA 186
             +HRD+   N+L+ S+ + K++DFGL+R+    P+  +T    ++  RW  APE +   
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEAI-AY 184

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +++ +  DVW+ G +  E+++   RP+   S+  + +  I   F    P   P   Y
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFRLPAPMDCPSAVY 240

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV+     +    VAIK I  G   E  +F  + E K++ +L  P +++L   
Sbjct: 12  LGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEE-DF--IEEAKVMMKLSHPKLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  L++V EFME   L   +R     LS   + S  Q   +G+ +  +   +HRD+ 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+ S G +K++DFG+ R     D  +T    A++   +  PE +F   +Y +  DV
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPE-VFNFSKYSSKSDV 184

Query: 196 WAAGCIFAELLN--RRPF 211
           W+ G +  E+    + PF
Sbjct: 185 WSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 35/273 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G++G V  A     G   A+K   K  + K+KE  +  A R + LLK LK P ++
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+ V +++   +L   ++    FL P   + Y       + + H   ++
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFYAAEVASAIGYLHSLNII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ S G + L DFGL +    P+   +       Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-RKEPYDRTV 177

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D W  G +  E+L   P    S D+ Q+                          Y  +  
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY-SRDVSQM--------------------------YDNILH 210

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
            PL+ L    +  A DLL  +   D + R+ A+
Sbjct: 211 KPLQ-LPGGKTVAACDLLVGLLHKDQRRRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 19/200 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++GEG +G V +     TGQ VA+K I+     +      L E  ++ +L   +++ L+
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLL 65

Query: 78  DAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWVL 133
               H G L++V E M + +L   +R     L    +   +Q +L   +G+ +   K ++
Sbjct: 66  GVILHNG-LYIVMELMSKGNLVNFLRTRGRALVS--VIQLLQFSLDVAEGMEYLESKKLV 122

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+   N+L+   G  K++DFGLAR+          ++  +W  APE L   K++ +  
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKW-TAPEAL-KHKKFSSKS 178

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  E+ +  R P+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQK--EGVNFTALREIKLLKELKSPHII 74
           LG+G +G V       TG+  A KK+   RL K+K  EG    A+ E ++L ++ S  I+
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEG----AMVEKRILAKVHSRFIV 56

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLAFCHK 129
            L  AF  K +L LV   M   DL   I N +     F  P     Y    + GL   H+
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRAC-FYTAQIISGLEHLHQ 115

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + +++RD+KP N+L+ + G ++++D GLA        +         + APELL G ++Y
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 190 GAGVDVWAAGCIFAELLNRR-PF 211
              VD +A G    E++  R PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 30/218 (13%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK  K  +  Q + V  T + +  L    K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +  Y      GL F H K +++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHSKGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR--IF---------GSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ + G +K+ADFG+ +  IF         G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQ-YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
            A Q YG  VD WA G +  E+L  +P   G  D D+L
Sbjct: 174 -AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 4e-14
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKS-PHIIE 75
           E++G GTYG VYK    KTGQ  AIK + + G ++E +     +EI +LK+     +I  
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK----QEINMLKKYSHHRNIAT 67

Query: 76  LIDAFPHKG------NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFC 127
              AF  K        L LV EF     +  +I+NT       +  +Y+ +  L+GL+  
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR T  +   ++ APE++   
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACD 186

Query: 187 KQ----YGAGVDVWAAGCIFAELLNRRPFL 212
           +     Y    D+W+ G    E+    P L
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELK 69
           E LGEG +G VYK       +  +  +VAIK ++     K ++   F   +E +L+ +L+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFR--QEAELMSDLQ 66

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNI--------------FLSPADI 113
            P+I+ L+     +    ++FE++   DL E ++RN+                 L  +D 
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQV 172
                    G+ +      +HRD+   N L+G    +K++DFGL+R   S D  R   + 
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 173 F--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
               RW     +L+G  ++    D+W+ G +  E+
Sbjct: 187 LLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIE 75
           +VLG+G++G V  A    T +  AIK ++     Q + V+ T   +  L    K P +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  K  L  V E++   DL   I+ +  F  P       ++TL  L F H+  V++
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHGVIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ + G  KLADFG+ +             G+PD           Y APE+L
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID 219
               +YG  VD WA G +  E++  +P  +  ++ D
Sbjct: 169 -QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 74/259 (28%), Positives = 111/259 (42%), Gaps = 51/259 (19%)

Query: 12  DRYLKREVLGEGTYGVVY------------KAIDTKTGQ--TVAIKKIRLGKQKEGVNFT 57
            +   +E LGEG +G V+            +      GQ   VA+K +R    K   N  
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-D 63

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKS- 115
            L+EIK++  LK+P+II L+        L ++ E+ME  DL       N FLS  +I+S 
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-------NQFLSQREIEST 116

Query: 116 ----------------YMQMTL-KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
                           YM + +  G+ +      +HRD+   N L+G+H  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 159 RIFGSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAE---LLNRRPF- 211
           R   S D  R     V   RW     +L G  ++    DVWA G    E   L   +P+ 
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYS 234

Query: 212 -LQGSSDIDQLGKIFAAFG 229
            L     I+  G+ F   G
Sbjct: 235 LLSDEQVIENTGEFFRNQG 253

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKELKSPHII 74
            LGEG +G V KA   +         + +   KE  + + LR    E  LLK++  PH+I
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIR----------------NTNIFLSP------- 110
           +L  A    G L L+ E+ +   L + +R                N++   +P       
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---RR 167
            D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     D   +R
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              ++  +W  A E LF    Y    DVW+ G +  E++
Sbjct: 187 SKGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 7e-14
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 11/190 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV+     +    VAIK IR G   E  +F  + E K++ +L  P++++L   
Sbjct: 12  LGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSED-DF--IEEAKVMMKLSHPNLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + +V E+M    L   +R     L    +        + + +      +HRD+ 
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G    +K++DFGLAR     D ++T     ++   +  PE+   ++ + +  DV
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDV 184

Query: 196 WAAGCIFAEL 205
           W+ G +  E+
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 51/299 (17%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG G YG V+   K      G+  A+K ++    + K K   +    R++ L    + P
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV-LEAVRRCP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF     LHL+ +++   +L T +     F + ++++ Y+   +  L   H+ 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF-TESEVRVYIAEIVLALDHLHQL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S G + L DFGL++ F + +    +       Y APE++ G    
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 189 YGAGVDVWAAGCIFAELLN-RRPF-LQG----SSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +   VD W+ G +  ELL    PF + G     S+I +  +I                  
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILK---------------- 226

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRFAKSFN 298
                    + PP        S +A D + K+   DPK R+    A +   H F +  +
Sbjct: 227 ---------SKPPFPKTM---SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++    +   +F   REI++LK
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILK 60

Query: 67  ELKSPHIIELIDAFPHKG--------NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM 117
            L+  +I++      +KG        NL LV E++    L   ++     L    +  Y 
Sbjct: 61  SLQHDNIVK------YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------ 171
               KG+ +   K  +HRD+   N+L+ S  ++K+ DFGL ++       +  +      
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           +F  WY APE L  +K +    DVW+ G +  EL
Sbjct: 175 IF--WY-APESLTESK-FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 70.3 bits (172), Expect = 9e-14
 Identities = 73/269 (27%), Positives = 113/269 (42%), Gaps = 42/269 (15%)

Query: 12  DRYLKREVLGEGTYGVVYK--------------AIDTKTGQT--VAIKKIRLGKQKEGVN 55
            R   +E LGEG +G V+               ++D    Q   VA+K +R    K   N
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL----------ETVIRNT 104
              L+EIK++  LK P+II L+        L ++ E+ME  DL          E   +  
Sbjct: 65  -DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 105 NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
            + +S + +         G+ +      +HRD+   N L+G +  +K+ADFG++R   S 
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 165 D--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---RRPFLQGSSD- 217
           D  R     V   RW     +L G  ++    DVWA G    E+L     +P+ Q S + 
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241

Query: 218 -IDQLGKIFAAFGTAT----PSQWPDLAY 241
            I+  G+ F   G       P+  PD  Y
Sbjct: 242 VIENTGEFFRDQGRQVYLPKPALCPDSLY 270

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
            VLG+G++G V  A   ++G+  A+K ++  +  Q + V  T   +  L      P + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F     L  V EF+   DL   I+ +  F   A  + Y       L F H K +++
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEITSALMFLHDKGIIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IF---------GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+   G  KLADFG+ +  IF         G+PD           Y APE+L
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELL 206
                YG  VD WA G +  E+L
Sbjct: 169 -QEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLK 66
           A+ Y   +V+G G +G V + +  K+ Q V     + K  + K+ +   F   R+I    
Sbjct: 42  AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
              SP +++L  AF     L++V E+M   DL  ++ N ++    A  K Y    +  L 
Sbjct: 101 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALD 156

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA------------RIFGSPDRRFTHQVF 173
             H   ++HRD+KP+N+L+  HG LKLADFG                 G+PD        
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD-------- 208

Query: 174 ARWYRAPELLF---GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGS 215
              Y +PE+L    G   YG   D W+ G  +F  L+   PF   S
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 31/225 (13%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQ---TVAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+ +      G+    VAIK +      +E + F  L E  ++KE 
Sbjct: 10  LIRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF--LNEASVMKEF 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNT------NIFLSPADIKSYMQMTL 121
              H++ L+          +V E M + DL++ +R+       N  L P  ++ ++QM  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 122 ---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS----PDRRFTHQVF 173
               G+A+   K  +HRD+   N ++     +K+ DFG+ R I+ +       +    V 
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 185

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSS 216
            RW  APE L     +    DVW+ G +  E+  L  +P+ QG S
Sbjct: 186 -RWM-APESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPY-QGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 3/148 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKS 70
           D +   +V+G G +G V       TG   A+K +R     E      +R E  +L E   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
             ++++  +F  K NL+L+ EF+   D+ T++   +  LS    + Y+  T+  +   H+
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQ 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL 157
              +HRD+KP+NLL+ + G +KL+DFGL
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 61/233 (26%), Positives = 115/233 (49%), Gaps = 19/233 (8%)

Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           L+ EV LG+G +G V+      T + VAIK ++ G          L+E +++K+L+   +
Sbjct: 8   LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKL 63

Query: 74  IELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++L  A   +  +++V E+M     L+ +      +L    +         G+A+  +  
Sbjct: 64  VQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAK 187
            +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G  
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG-- 178

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 230

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E        E K++ +L    +++L   
Sbjct: 12  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMKLSHEKLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  +++V E+M    L   +R       P+ +    +   +G+A+   K  +HRD+ 
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPELLFGAKQYGAGVD 194
             N L+   G +K++DFGL+R     D  +T  V +    RW   PE+L  +K + +  D
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRW-SPPEVLLYSK-FSSKSD 183

Query: 195 VWAAGCIFAEL--LNRRPF 211
           VWA G +  E+  L + P+
Sbjct: 184 VWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 45/142 (31%), Positives = 77/142 (54%), Gaps = 3/142 (2%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIEL 76
           +V+G G +G V       TG   A+K +R     E      +R E  +L E  S  ++++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
             +F  K NL+L+ EF+   D+ T++   +  L+  + + Y+  T+  +   H+   +HR
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGL 157
           D+KP+NLL+ S G +KL+DFGL
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 8/192 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKE---LKSPHII 74
           +G+GT+G VY+     T +  A+K +  +    K+ V  T + E  +L      +SP I+
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHT-IGERNILVRTLLDESPFIV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F    +L+LV ++M   +L   ++    F S    K Y+   +  L   HK  ++
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF-SEDRAKFYIAELVLALEHLHKYDIV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ + G + L DFGL++   + ++          Y APE+L   K Y   V
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 194 DVWAAGCIFAEL 205
           D W+ G +  E+
Sbjct: 179 DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 7/148 (4%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G +G V       TG+  A+K   K  + K+ +  +  A R++  L E  SP ++
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAESDSPWVV 64

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+L+ EF+   DL T++   + F S    + YM   +  +   HK   +
Sbjct: 65  SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF-SEDVTRFYMAECVLAIEAVHKLGFI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF 161
           HRD+KP+N+LI   G +KL+DFGL+  F
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.5 bits (165), Expect = 5e-13
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHI 73
           L+R+ LG G +G V++ +  K    VAIK +   K  + +      +E++ LK L+  H+
Sbjct: 10  LERK-LGSGYFGEVWEGL-WKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL--------KGLA 125
           I L         ++++ E ME        +   FL   + +     +L        +G+A
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKG------SLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI----FGSPDRRFTHQVFARWYRAPE 181
           +  ++  +HRD+   N+L+G     K+ADFGLAR+              ++  +W  APE
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS---DKKIPYKW-TAPE 174

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNR 208
                  +    DVW+ G +  E+   
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G+G++G V  A     G+  A+K   K  + K+KE  +  A R + LLK +K P ++ 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L+ V +++   +L   ++    F  P   + Y       L + H   +++
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIASALGYLHSLNIIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAG 192
           RD+KP N+L+ S G + L DFGL +     +   T   F     Y APE+L   + Y   
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRT 176

Query: 193 VDVWAAGCIFAELLNRRP 210
           VD W  G +  E+L   P
Sbjct: 177 VDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.0 bits (163), Expect = 7e-13
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 13/194 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                K  +++V E ++  D  T +R     L   ++   ++    G+ +   K  +HRD
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 137 MKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL-FGAKQYG 190
           +   N L+     LK++DFG++R     ++ S       Q+  +W  APE L +G  +Y 
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG--MKQIPVKW-TAPEALNYG--RYS 174

Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 7/197 (3%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G++G V  A      +  A+K   K  + K+KE  +  + R + LLK +K P ++
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   ++
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASALGYLHSLNIV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ S G + L DFGL +     +   +       Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-KQPYDRTV 177

Query: 194 DVWAAGCIFAELLNRRP 210
           D W  G +  E+L   P
Sbjct: 178 DWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 65/302 (21%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF     L  V E+    +L   +    +F +    + Y    +  L + H + V++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRDVVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLA----------RIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K  NL++   G +K+ DFGL           + F G+P+           Y APE+L
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----------YLAPEVL 167

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD W  G +  E++  R PF   + D ++L                     
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------- 203

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKS 296
                ++ +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHRF  S
Sbjct: 204 -----FELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256

Query: 297 FN 298
            N
Sbjct: 257 IN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 9e-13
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +V+G+G++G V  A     G+  A+K    KI L + KE  +  A R + LLK +K P +
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNV-LLKNVKHPFL 58

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L  +F     L+ V +F+   +L   ++    F  P   + Y       L + H   +
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR-ARFYAAEIASALGYLHSINI 117

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ-YGA 191
           ++RD+KP N+L+ S G + L DFGL +   +     T       Y APE++   KQ Y  
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQPYDN 175

Query: 192 GVDVWAAGCIFAELLNRRP 210
            VD W  G +  E+L   P
Sbjct: 176 TVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKI--RLGKQKEGVNFTALREIKL-LKEL 68
           K ++LG G +G V+K I    G +    VAIK I  R G+Q     F  + +  L +  L
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ----TFQEITDHMLAMGSL 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              +I+ L+   P   +L LV +      L   +R     L P  + ++     KG+ + 
Sbjct: 67  DHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAPELLF 184
            +  ++HR++   N+L+ S   +++ADFG+A +    D+++    H+   +W     +LF
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLN 207
           G  +Y    DVW+ G    E+++
Sbjct: 186 G--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)

Query: 15  LKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           LKRE LGEG +G V     Y     +    VA+K ++        +F   RE +LL  L+
Sbjct: 9   LKRE-LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQ 65

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR------------NTNIFLSPADIKSY 116
             HI++          L +VFE+M+  DL   +R            N    L+ + +   
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA 174
            Q    G+ +   +  +HRD+   N L+G +  +K+ DFG++R   S D  R   H +  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 175 -RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSD 217
            RW     +++  +++    DVW+ G +  E+    ++P+ Q S++
Sbjct: 186 IRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 52/282 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+G G+Y  V      KT +  A+K ++    KE VN     +I  ++  K  H+ E   
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVK----KELVNDD--EDIDWVQTEK--HVFEQAS 53

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK---------------G 123
             P    LH  F+  E+ L  VI     +++  D+  +MQ   K                
Sbjct: 54  NHPFLVGLHSCFQ-TESRLFFVIE----YVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H++ +++RD+K +N+L+ S G +KL D+G+ +    P    +       Y APE+L
Sbjct: 109 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            G + YG  VD WA G +  E++  R PF + GSSD               P Q  +   
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD--------------NPDQNTE--- 210

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
             DY+ +Q +    +R +  S S  A  +L      DPK R+
Sbjct: 211 --DYL-FQVILEKQIR-IPRSLSVKAASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 28/262 (10%)

Query: 20  LGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+ I       +    VAIK +      +E + F  L E  ++KE    H+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEFNCHHV 71

Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT---LKG 123
           + L+          ++ E M   DL++ +R+       N   +P  +K  +QM      G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYRAP 180
           +A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   RW    
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P   PD
Sbjct: 192 SLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEGGLLDKPDNCPD 248

Query: 239 LAYLPDYVEYQYVAAPPLRSLF 260
           + +    + +QY   P +R  F
Sbjct: 249 MLFELMRMCWQY--NPKMRPSF 268

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G V +    +  K    VAIK ++ G  +K+  +F  L E  ++ +   P+I
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSEASIMGQFDHPNI 67

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ EFME   L++ +R  +   +   +   ++    G+ +  +   
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFARWYRAPELLFGA 186
           +HRD+   N+L+ S+   K++DFGL+R     + D  +T     ++  RW  APE +   
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEAI-AY 185

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++ +  DVW+ G +  E+++   RP+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--EAMALNEKRILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y      GL    ++ ++
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFARWYRAPELLFGAKQYGAG 192
           +RD+KP N+L+   G ++++D GLA     P+      +V    Y APE++   K Y   
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRVGTVGYMAPEVINNEK-YTFS 181

Query: 193 VDVWAAGCIFAELLN-RRPF 211
            D W  GC+  E++  + PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 53/227 (23%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+G G+Y  V      KT +  A+K I+    KE VN     +I  ++  K  H+ E   
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK----KELVNDD--EDIDWVQTEK--HVFETAS 53

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK---------------G 123
             P    LH  F+  E+ L  VI     F+S  D+  +MQ   K                
Sbjct: 54  NHPFLVGLHSCFQ-TESRLFFVIE----FVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQV 172
           L F H++ +++RD+K +N+L+ + G +KL D+G+ +             G+P+       
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN------- 161

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPF-LQGSSD 217
               Y APE+L G + YG  VD WA G +  E++  R PF + G SD
Sbjct: 162 ----YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGK-QKEGVNFTALREIKLLKEL-KS 70
           + LGEG +G V KA    +D      TVA+K ++    +K+  +   + E++++K + K 
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL--VSEMEMMKMIGKH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEF---------------METDLETVI-RNTNIFLSPADIK 114
            +II L+     +G L++V E+                         R     L+  D+ 
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S+     +G+ F   K  +HRD+   N+L+     +K+ADFGLAR     D  R+ T+  
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 196 LPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 14/162 (8%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKS 70
           ++K + +G G +G V       T    A+K +R   +  + +  +  A R+I  L E  +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADN 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCH 128
             +++L  +F  K NL+ V +++   D+ +++    IF    D+ + Y+      +   H
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIF--EEDLARFYIAELTCAIESVH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
           K   +HRD+KP+N+LI   G +KL DFGL   F     R+TH
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 39/143 (27%), Positives = 76/143 (53%), Gaps = 9/143 (6%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL----LKELKSPHIIELID 78
           G +G VY        +  A+K +   K+ + +N   + +++     L   KSP I+ L  
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVV---KKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           +     N++LV E++   D+++++     F     +K   ++ L  L + H+  ++HRD+
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL-ALDYLHRHGIIHRDL 130

Query: 138 KPNNLLIGSHGQLKLADFGLARI 160
           KP+N+LI + G +KL DFGL+++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 50/295 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  +G+  A+K  K  +   K+ V  T L E ++LK  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT-LTESRVLKNTRHPFLTS 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F  K  L  V E++   +L   +    +F S    + Y    +  L + H   +++
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVF-SEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAG 192
           RD+K  NL++   G +K+ DFGL +  G  D   T + F     Y APE+L     YG  
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAA-TMKTFCGTPEYLAPEVL-EDNDYGRA 175

Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VD W  G +  E++  R PF     +     K+F            +L  + D       
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF------------ELILMEDIK----- 213

Query: 252 AAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFNGV 300
                   FP + S DA  LLS +   DP  R+      A++ + H F   F GV
Sbjct: 214 --------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF---FTGV 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS----PHII 74
           VLG G +G V  A   KTG+  AIK ++ G         +L   K + E  +    P ++
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L   F  + ++  V E+    DL   I +T++F  P     Y    + GL + H+  ++
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPR-AVFYAACVVLGLQYLHENKIV 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARI---FGSPDRRF--THQVFARWYRAPELLFGAKQ 188
           +RD+K +NLL+ + G +K+ADFGL +    FG     F  T +     + APE+L     
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE-----FLAPEVLTE-TS 177

Query: 189 YGAGVDVWAAGC-IFAELLNRRPF 211
           Y   VD W  G  I+  L+   PF
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 46/256 (17%)

Query: 13  RYLKREVLGEGTYGVVYKA--------------IDTKTGQT--VAIKKIRLGKQKEGVNF 56
             L +E LGEG +G V+                 + + G+   VA+K +R    K   N 
Sbjct: 6   HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN- 64

Query: 57  TALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET----------DLETVIRNTNI 106
             L+E+K+L  LK P+II L+     +  L ++ E+ME            L+    N N 
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 107 FLSPA------DIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL 157
            + PA         S + + L+   G+ +      +HRD+   N L+G +  +K+ADFG+
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 158 ARIFGSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELL---NRRPF 211
           +R   + D  R     V   RW     +L G  ++    DVWA G    E+L     +P+
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 212 LQGSSD--IDQLGKIF 225
            + + +  I+  G+ F
Sbjct: 243 GELTDEQVIENAGEFF 258

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 35/221 (15%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 37  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 96  IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 151

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA------------RIFGSPDRRF 168
           +  L   H    +HRD+KP+N+L+   G LKLADFG                 G+PD   
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--- 208

Query: 169 THQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELL 206
                   Y +PE+L    G   YG   D W+ G    E+L
Sbjct: 209 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 43/297 (14%)

Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK-SP 71
           +VLG G YG V+   K     +G+  A+K ++     QK         E ++L+ ++ SP
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF     LHL+ +++   +L T +     F    +++ Y    +  L   HK 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-KEQEVQIYSGEIVLALEHLHKL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S+G + L DFGL++ F   +    +       Y AP+++ G    
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 189 YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +   VD W+ G +  ELL    PF        Q                       +   
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ----------------------AEISR 222

Query: 248 YQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
               + PP    +P   S  A D++ ++   DPK R+      A +  +H F +  N
Sbjct: 223 RILKSEPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.2 bits (156), Expect = 7e-12
 Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 7/190 (3%)

Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V K +    K+ +TVA+K ++       +    LRE  ++++L +P+I+ +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
                  +  LV E  E          N  ++  +I   +     G+ +  +   +HRD+
Sbjct: 63  -GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N+L+ +    K++DFGL++  G+ +  +  +   +W   + APE +   K + +  D
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSD 180

Query: 195 VWAAGCIFAE 204
           VW+ G +  E
Sbjct: 181 VWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     L+ V  + +   S   +   +Q+  KG+ +  
Sbjct: 69  PHLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 126

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 185

Query: 186 AKQYGAGVDVWAAGCIFAELL 206
            +++    DVW+ G    EL+
Sbjct: 186 -RKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 31/231 (13%)

Query: 9   KVADRYLKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LKRE LGEG +G V     Y    TK    VA+K ++        +F   RE +
Sbjct: 3   KRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--REAE 59

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFLSPADIKSYMQ 118
           LL  L+  HI++          L +VFE+M+  DL   +R    +  I +     ++  +
Sbjct: 60  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 119 MTLK-----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           + L            G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 166 RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQ 213
           R   H +   RW     +++  +++    DVW+ G I  E+    ++P+ Q
Sbjct: 180 RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQ 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 26/271 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      K  Q  A+K ++  L    E +++    +    +   +P ++ L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F     L LV E++              L     + Y       L F H++ +++RD
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ + G +KL D+G+ +    P    +       Y APE+L G ++YG  VD W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWW 180

Query: 197 AAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           A G +  E++  R PF     DI               +  PD+    DY+ +Q +   P
Sbjct: 181 ALGVLMFEMMAGRSPF-----DI--------------ITDNPDMN-TEDYL-FQVILEKP 219

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           +R +    S  A  +L      DPK R+  Q
Sbjct: 220 IR-IPRFLSVKASHVLKGFLNKDPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 20  LGEGTYGVVYKAI-DTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V K +   +  Q  VAIK ++   +K  V    +RE +++ +L +P+I+ +I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L LV E      L   +      ++ +++   M     G+ +   K  +HRD
Sbjct: 62  -GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +  +   +W   + APE +   K + +  
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRS 179

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G    E  +  ++P+
Sbjct: 180 DVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 24/238 (10%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           L R+ LG G +G V++ +   T   VA+K ++ G      +F  L E +++K+L+ P +I
Sbjct: 10  LLRK-LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPK-DF--LAEAQIMKKLRHPKLI 64

Query: 75  ELIDAFPHKGNLHLVFEFM--ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +L      +  +++V E M   + LE +       L    +         G+A+   +  
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL----FG 185
           +HRD+   N+L+G +   K+ADFGLAR+       +  +  A++   + APE      F 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFS 182

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            K      DVW+ G +  E++   R P+  G ++ + L ++   +    P   P   Y
Sbjct: 183 IKS-----DVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYRMPCPPGCPKELY 234

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 16/199 (8%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIKLLKELKSPH-- 72
            LG G +G V +A      ++ A+ K+ +   K   + +     + E+K++  L   H  
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL-GNHEN 100

Query: 73  IIELIDAFPHKGNLHLVFEF-METDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           I+ L+ A    G + ++ E+    DL   + R    FL+  D+ S+     KG+AF   K
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 131 WVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
             +HRD+   N+L+ +HG++ K+ DFGLAR   + D  +  +  AR    + APE +F  
Sbjct: 161 NCIHRDLAARNVLL-THGKIVKICDFGLARDIMN-DSNYVVKGNARLPVKWMAPESIFNC 218

Query: 187 KQYGAGVDVWAAGCIFAEL 205
             Y    DVW+ G +  E+
Sbjct: 219 -VYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 18  EVLGEGTYGVVYKA--IDT-KTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
            V+G+G +G VY    ID+       A+K + R+   +E   F  L+E  ++K+   P++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF--LKEGIIMKDFSHPNV 58

Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+    P +G+  +V  +M+  DL   IR+     +  D+  +     KG+ +   K 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      + S       ++  +W  A E L   
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM-ALESL-QT 176

Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ +V LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 8   LRLDVKLGQGCFGEVW--MGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDK 62

Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L  A   +  +++V EFM     L+ +      +L    +         G+A+  + 
Sbjct: 63  LVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 178

Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
            ++    DVW+ G +  EL+ +
Sbjct: 179 -RFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +G V+          VAIK ++ G          L E  L+K+L+ P ++ L 
Sbjct: 12  KKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLVRL- 66

Query: 78  DAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   +  ++++ E+ME    ++ +     I L+   +        +G+AF  +K  +HR
Sbjct: 67  YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA- 191
           D++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A  YG  
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----AINYGTF 180

Query: 192 --GVDVWAAGCIFAELLN--RRPF 211
               DVW+ G +  E++   R P+
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK I    G+     VAIK +R     +  N   L E  ++  + SP
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSP 69

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++  L+        + LV + M    L   +R     +   D+ ++     KG+++  + 
Sbjct: 70  YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAK 187
            ++HRD+   N+L+ S   +K+ DFGLAR+    +  +     +V  +W     +L   +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--HR 186

Query: 188 QYGAGVDVWAAGCIFAELL 206
           ++    DVW+ G    EL+
Sbjct: 187 RFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.8 bits (150), Expect = 4e-11
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 15/204 (7%)

Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E  ++ +   P+II
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF--LSEASIMGQFDHPNII 68

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V E+ME   L+  +R  +   +   +   ++    G+ +      +
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQY 189
           HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAI-AYRKF 186

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+++   RP+
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 16/171 (9%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK---QKEGVNFTALREIKLLKELKS 70
           ++K + LG G +G V  A    T    A+K +R      + +  +  A R+I  L E  +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADN 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCH 128
             ++ L  +F  K NL+ V +++   D+ +++    IF  P D+ + Y+      +   H
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIF--PEDLARFYIAELTCAVESVH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           K   +HRD+KP+N+LI   G +KL DFGL   F     R+TH   +++Y++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD--SKYYQS 162

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+GEG +G V +A+  K G     AIK ++    + +  +F    E+ L K    P+II
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66

Query: 75  ELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYMQ 118
            L+ A  ++G L++  E+               +ETD      + T   L+   +  +  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
               G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW  
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
              L +    Y    DVW+ G +  E+++
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 49/172 (28%), Positives = 90/172 (52%), Gaps = 20/172 (11%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK----LLKELK 69
           ++K + LG G +G V  A    T    A+K +R   +K+ +N   +  +K    +L E  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR---KKDVLNRNQVAHVKAERDILAEAD 59

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSY--MQMTLKGLAF 126
           +  +++L  +F  K NL+ V +++   D+ +++    +F  P  +  +   ++TL  +  
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF--PEVLARFYIAELTL-AIES 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            HK   +HRD+KP+N+LI   G +KL DFGL   F     R+TH   +++Y+
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF-----RWTHN--SKYYQ 161

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+II
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------------LSPADIKSYMQ 118
            L+ A  H+G L+L  E+    +L   +R + +                LS   +  +  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
              +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
              L +    Y    DVW+ G +  E+++
Sbjct: 180 IESLNYSV--YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.4 bits (149), Expect = 8e-11
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 20  LGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +G+G +G V++A     +  +    VA+K ++     + +     RE  L+ E   P+I+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDHPNIV 71

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF----------------LSPADIKSYM 117
           +L+        + L+FE+M   DL   +R+ +                  L+P  +    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 118 QMTLK-----GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           Q+ +      G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D     + 
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 173 FA---RWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            A   RW   PE +F  + Y    DVWA G +  E+
Sbjct: 192 DAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 38/204 (18%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL--- 76
           LG G +G V+      T + VA+K ++ G       F  L+E +++K+L+   +++L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPE-AF--LQEAQIMKKLRHDKLVQLYAV 69

Query: 77  ---------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
                    +  +  KG+L    +F+++     +R   +    A I         G+A+ 
Sbjct: 70  CSEEEPIYIVTEYMSKGSL---LDFLKSGEGKKLRLPQLVDMAAQIAE-------GMAYL 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLF 184
             +  +HRD+   N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE   
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPE--- 174

Query: 185 GAKQYGA---GVDVWAAGCIFAEL 205
            A  YG      DVW+ G +  E+
Sbjct: 175 -AANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 15/189 (7%)

Query: 20  LGEGTYGVVYKAI-DTKTGQ--TVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPHII 74
           LG G +G V K +   K+G+   VA+K +   KQ+         LRE  ++ +L  P I+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL---KQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 75  ELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            LI     +  L LV E      L   ++        +D+K        G+A+   K  +
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHFV 117

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYG 190
           HRD+   N+L+ +  Q K++DFG++R  G+    +      RW   + APE +   K + 
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FS 176

Query: 191 AGVDVWAAG 199
           +  DVW+ G
Sbjct: 177 SKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 17/196 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG G +G V+    T  G T VA+K ++ G        + L E +++K+L+   +++L  
Sbjct: 14  LGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQLY- 67

Query: 79  AFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   +  +++V E+M     L+ +       L   ++         G+A+  +   +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAKQYGAG 192
           ++  N+L+G     K+ADFGLAR+    D  +T +  A++   + APE  L+G  ++   
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG--RFTIK 183

Query: 193 VDVWAAGCIFAELLNR 208
            DVW+ G +  EL+ +
Sbjct: 184 SDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 20  LGEGTYGVVYK--AID---TKTG-QTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           LG G +G VY+  A D     +G   VA+K +R G   +E   F  L+E  L+     P+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF--LKEAHLMSNFNHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPA-DIKSYMQMTL---KGLA 125
           I++L+         +++ E ME  DL + +R+  +  F  P   +K  + + L   KG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPD---RRFTHQVFARWY 177
           +  +   +HRD+   N L+   G      +K+ DFGLAR     D   +     +  RW 
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L   K +    DVW+ G +  E+L
Sbjct: 181 -APESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 14/193 (7%)

Query: 20  LGEGTYG-VVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           LG G++G V+      +    VAIK   K ++ KQK+  +     E K+L  +  P  + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH--VFSERKILNYINHPFCVN 95

Query: 76  LIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKS-YMQMTLKGLAFCHKKWVL 133
           L  +F  +  L+LV EF +  +  T +R    F  P D+   Y    +    +     ++
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF--PNDVGCFYAAQIVLIFEYLQSLNIV 153

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP NLL+   G +K+ DFG A++    D R         Y APE+L     +G   
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG-HGKAA 209

Query: 194 DVWAAGCIFAELL 206
           D W  G    E+L
Sbjct: 210 DWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 36/205 (17%)

Query: 26  GVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHIIELIDAFPHKG 84
            +V+ A    T   VA+KKI L    +  +   L +EI   ++L+ P+I+  + +F    
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72

Query: 85  NLHLVFEFME----TDL----------ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            L++V   M      DL          E  I               ++  L  L + H K
Sbjct: 73  ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFI------------LKDVLNALDYIHSK 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT-------HQVFARWYRAPELL 183
             +HR +K +++L+   G++ L+    +       +R           V    + +PE+L
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 184 FGAKQ-YGAGVDVWAAGCIFAELLN 207
               Q Y    D+++ G    EL N
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELAN 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 23/203 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+ A   K  + VA+K ++ G          L E  ++K L+   +++L  A
Sbjct: 14  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKL-HA 68

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              K  ++++ EFM    L   +++   +    P  I    Q+  +G+AF  ++  +HRD
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA-EGMAFIEQRNYIHRD 127

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           ++  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE    A  +G+  
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE----AINFGSFT 181

Query: 194 ---DVWAAGCIFAELLN--RRPF 211
              DVW+ G +  E++   R P+
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 64/297 (21%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVL 133
           L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +K V+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSEKNVV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPEL 182
           +RD+K  NL++   G +K+ DFGL +             G+P+           Y APE+
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YLAPEV 167

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD W  G +  E++  R PF     +     K+F                
Sbjct: 168 L-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF---------------- 205

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRF 293
             + +  + +  P  R+L P A      LLS +   DPK R+      A++ ++H+F
Sbjct: 206 --ELILMEEIRFP--RTLSPEAK----SLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + K +VLG G +G VYK +    G+     VAIK++R     +  N   L E  ++  + 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVD 67

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +PH+  L+        + L+ + M     L+ V  + +   S   +   +Q+  KG+ + 
Sbjct: 68  NPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA-KGMNYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLF 184
            ++ ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +     +V  +W     +L 
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL- 184

Query: 185 GAKQYGAGVDVWAAGCIFAELL 206
             + Y    DVW+ G    EL+
Sbjct: 185 -HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V         +  A+K   K  + K+ E   F   R++  L    +  I 
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + NL+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +PE
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-----------YISPE 173

Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 21/198 (10%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
                +G+G +G V        GQ VA+K ++         F  L E  ++  L+ P+++
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKCLK-DDSTAAQAF--LAEASVMTTLRHPNLV 63

Query: 75  ELIDAFPHKGNLHLVFEFMETD-----LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           +L+        L++V E+M        L +  R        A    +     +G+ +  +
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL---AQQLGFALDVCEGMEYLEE 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV--FARWYRAPELLFGAK 187
           K  +HRD+   N+L+      K++DFGLA+     +             + APE L   K
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REK 174

Query: 188 QYGAGVDVWAAGCIFAEL 205
           ++    DVW+ G +  E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 16/220 (7%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +K+ A +Y    VLG G  G V  A     G+  A+K + +    E     A  E+  L 
Sbjct: 27  AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL 86

Query: 67  ELKSPHIIELIDAFPHKGN--------LHLVFEFMET-DLETVIRN---TNIFLSPADIK 114
                 I++  + F  K          + LV ++    DL   I++   TN      +  
Sbjct: 87  NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF- 173
                 L  +   H K ++HRD+K  N+L+ S+G +KL DFG ++++ +       + F 
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPF 211
              +Y APE ++  K Y    D+++ G +  ELL  +RPF
Sbjct: 207 GTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       TGQ  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + NL+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFG-LARI-----------FGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG   R+            G+PD           Y +PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD-----------YISPE 173

Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKI 224
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 30/233 (12%)

Query: 9   KVADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +
Sbjct: 3   KRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAE 59

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNI---FLSPADIKSYMQM 119
           LL  L+  HI+           L +VFE+M   DL   +R+       L+  +  +  Q+
Sbjct: 60  LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 120 TL-----------KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR 167
           TL            G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
              +     RW     +L+  +++    D+W+ G +  E+    ++P+ Q S+
Sbjct: 180 VGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 81

Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------METDLETVIRNTNIFLSPADIK 114
           +II L+ A    G L+++ E+                 ME   + + R  +  ++  D+ 
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQMTFKDLV 140

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S      +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+  
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 201 LPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 48/215 (22%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 18  EVLGEGTYGVVYKA----IDTKTGQTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPH 72
           E LGE  +G +YK           Q VAIK ++ +   ++   F   +E  L+ EL  P+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ--QEASLMAELHHPN 68

Query: 73  IIELIDAFPHKGNLHLVFEFM-ETDLET--VIRNTN-----------IFLSPADIKSYMQ 118
           I+ L+     +  + ++FE++ + DL    ++R+ +              S  D   ++ 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 119 MTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF- 173
           + ++   G+ +    + +H+D+   N+LIG    +K++D GL+R I+ +   R   +   
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             RW     +++G  ++ +  D+W+ G +  E+ +
Sbjct: 189 PIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 3/156 (1%)

Query: 51  KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSP 110
           K G   +++ E +LL+ L  P ++ L+D     G   LV     +DL T +      L  
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGL 259

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFT 169
           A + +  +  L  + + H + ++HRD+K  N+L+     + L DFG A    GS    F 
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 170 HQVFARW-YRAPELLFGAKQYGAGVDVWAAGCIFAE 204
           + +       APE+L G   Y   VD+W+AG +  E
Sbjct: 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKA----IDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G V  A    +D +       VA+K ++    ++ ++   + E+++
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 76

Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   +R                    
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 197 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 77/320 (24%), Positives = 116/320 (36%), Gaps = 79/320 (24%)

Query: 17  REVLGEGTYGVVY-------KAIDTKTGQT---------VAIKKIRLGKQKEGVN-FTAL 59
            E LGEG +G V+       +    K             VA+K +R          F  L
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF--L 67

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLS--------- 109
           +E+K+L  L  P+I  L+        L ++ E+ME  DL       N FL          
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-------NQFLQKHVAETSGL 120

Query: 110 PADIKSYMQMTLK--------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF 161
             + KS    TL         G+ +      +HRD+   N L+G +  +K+ADFG++R  
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 162 GSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---RRPFLQGS 215
            S D  R         RW  A E +   K +    DVWA G    E+L     +P+   +
Sbjct: 181 YSSDYYRVQGRAPLPIRWM-AWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 216 SD--IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSK 273
               I+  G  F                  D     Y+  PP          D  +L+ +
Sbjct: 239 DQQVIENAGHFFR-----------------DDGRQIYLPRPPN------CPKDIYELMLE 275

Query: 274 MFTYDPKARITAQQALEHRF 293
            +  D + R T ++   H F
Sbjct: 276 CWRRDEEDRPTFREI--HLF 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 15  LKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIKLL 65
           LKRE LGEG +G V+             + VA+K +     KE  +  A     RE +LL
Sbjct: 9   LKRE-LGEGAFGKVFLGECYHLEPENDKELVAVKTL-----KETASNDARKDFEREAELL 62

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR----NTNIFLSPAD------IK 114
              +  +I++            +VFE+ME  DL   +R    +     SP        + 
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 115 SYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFT 169
             +Q+ ++   G+ +   +  +HRD+   N L+G    +K+ DFG++R   + D  R   
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 170 HQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGS 215
           H +   RW     +++   ++    DVW+ G +  E+    ++P+   S
Sbjct: 183 HTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 21/232 (9%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+      + + VA+K ++ G          L E  L+K L+   ++ L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYAV 69

Query: 80  FPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              +  ++++ E+M      D         + L P  I    Q+  +G+A+  +K  +HR
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA-EGMAYIERKNYIHR 127

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGA 191
           D++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG+  +  
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGS--FTI 183

Query: 192 GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             DVW+ G +  E++   + P+  G S+ D +  +   +        PD  Y
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGYRMPRMENCPDELY 234

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R +  L       I 
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWV 132
            L  AF  +  L+LV ++ +  DL T++      L P D+ + Y+   +  +   H+   
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLAIHSIHQLHY 123

Query: 133 LHRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAP 180
           +HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +P
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD-----------YISP 172

Query: 181 ELLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKI 224
           E+L     G  +YG   D W+ G C++  L    PF    S ++  GKI
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKI 220

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 26/223 (11%)

Query: 18  EVLGEGTYGVVYKAI-DTKTGQT--VAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHI 73
           + LG+G++GVV +    T  G+   VA+K ++  K  + + +F  L+E  ++  L   ++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF--LKEAAIMHSLDHENL 58

Query: 74  IEL---IDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           I L   +   P    L +V E     + L+ + ++       + +  Y      G+ +  
Sbjct: 59  IRLYGVVLTHP----LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV-----FARWYRAPELL 183
            K  +HRD+   N+L+ S  ++K+ DFGL R     +  +  +      FA W  APE L
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WC-APESL 172

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
              + +    DVW  G    E+      P+  G S    L KI
Sbjct: 173 -RTRTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 54/241 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           RY    ++G+G  G VY A D    + VA+KKIR    +   +    LRE K+  +L  P
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLK----- 122
            I+ +         ++    ++E   L++++++             K+ +   L      
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 123 --GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA---------------------- 158
              + + H K VLHRD+KP+N+L+G  G++ + D+G A                      
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 159 -------RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRP 210
                  +I G+PD           Y APE L G        D++A G I  ++L    P
Sbjct: 183 SSMTIPGKIVGTPD-----------YMAPERLLGVPA-SESTDIYALGVILYQMLTLSFP 230

Query: 211 F 211
           +
Sbjct: 231 Y 231

Length = 932

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 64/290 (22%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G VY+ +          VA+K  +          F  L+E  ++++   PHI
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF--LQEAYIMRQFDHPHI 69

Query: 74  IELIDA-----------FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++LI                 G L     +++ +  +        L  A +  Y      
Sbjct: 70  VKLIGVITENPVWIVMELAPLGELR---SYLQVNKYS--------LDLASLILYSYQLST 118

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA---RWYRA 179
            LA+   K  +HRD+   N+L+ S   +KL DFGL+R     +  +         +W  A
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWM-A 176

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           PE +   +++ +  DVW  G    E+L    +PF QG  + D +G+I        P   P
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPF-QGVKNNDVIGRIENGERLPMPPNCP 234

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                           P L S           L++K + YDP  R    +
Sbjct: 235 ----------------PTLYS-----------LMTKCWAYDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 25/223 (11%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+    D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 10  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 67  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSD 217
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+
Sbjct: 187 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSN 227

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.1 bits (133), Expect = 8e-09
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)

Query: 12  DRYLKREVLGEGTYGVVYKAI--DTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           DR    ++L EGT+G ++  I  D K G  + V +K ++    +  V    L+E  LL  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL-LQESCLLYG 64

Query: 68  LKSPHI-------IELID------AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK 114
           L   +I       IE  +       + + GNL L   F+         N    LS   + 
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL---FL-QQCRLGEANNPQALSTQQLV 120

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IF-------GSPDR 166
                   G+++ HK+ V+H+D+   N +I    Q+K+ D  L+R +F       G  + 
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDID 219
           R       +W  A E L   K+Y +  DVW+ G +  EL  L + P++    +ID
Sbjct: 181 RPV-----KWM-ALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV----EID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 20  LGEGTYGVVYKA----ID---TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID        TVA+K ++     + ++   + E++++K + K  
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHK 78

Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------METDLETVIRNTNIFLSPADIK 114
           +II L+ A    G L+++ E+                 M+   +T  +     L+  D+ 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC-KLPEEQLTFKDLV 137

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S      +G+ +   +  +HRD+   N+L+     +K+ADFGLAR   + D  ++ T+  
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 198 LPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD 165
            L+  D+  Y     KG+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+  PD
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 234

Query: 166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 235 YVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 34/178 (19%)

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFG 185
           H + ++HRD+K  N+ +   G +KL DFG ++ +           F    +Y APE L+ 
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWE 244

Query: 186 AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            K+Y    D+W+ G I  ELL   RPF +G S  + + ++   +G   P           
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVL--YGKYDP----------- 290

Query: 245 YVEYQYVAAPPLRSLFPSASDDALD-LLSKMFTYDPKARITAQQALEHRFAKSFNGVF 301
                          FP      +  LL  + + +P  R T QQ L   F K    +F
Sbjct: 291 ---------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLF 333

Length = 478

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)

Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +LG+G +G V +A    +  + Q VA+K ++            LRE   +KE   P++I+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 76  LIDAFPH---KGNL---HLVFEFME-TDLETVIRNTNIFLSPADIK-----SYMQMTLKG 123
           LI        KG L    ++  FM+  DL T +  + I   P  +       +M     G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---RRFTHQVFARWYRAP 180
           + +   K  +HRD+   N ++  +  + +ADFGL++   S D   +    ++  +W    
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNR 208
            L      Y    DVWA G    E++ R
Sbjct: 186 SL--ADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 8/109 (7%)

Query: 105 NIFLSP---ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-I 160
           +++ SP    D+  Y     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I
Sbjct: 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 161 FGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +  PD  R+ + ++  +W  APE +F  K Y    DVW+ G +  E+ +
Sbjct: 225 YKDPDYVRKGSARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 5/102 (4%)

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD 165
            L+  D+ SY     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+  PD
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228

Query: 166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
             R+   ++  +W  APE +F  K Y    DVW+ G +  E+
Sbjct: 229 YVRKGDARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 40/230 (17%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           ++LG+G  G V+      TG+  A+K   K  + K+ +       +EI  L  L  P + 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLP 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVI--RNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
            L  +F  +  L LV ++    +L  ++  +      S    + Y    L  L + H   
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCL-SEEVARFYAAEVLLALEYLHLLG 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGL-------------ARIFGSPDRRFTHQVFARW-- 176
           +++RD+KP N+L+   G + L+DF L             A   GS            +  
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 177 --------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
                         Y APE++ G   +G+ VD W  G +  E+L    PF
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 17/188 (9%)

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-V 172
           ++ M+  L  + + H K ++HRD+K  N+ +   G++ L DFG A  F      F +  V
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR--PFLQGSSDI-DQLGKIFAAFG 229
                 +PE+L G   Y    D+W+ G I  ++L+    P   G      QL KI  +  
Sbjct: 330 GTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL- 387

Query: 230 TATPSQWPD-----LAYLPDYVEYQYV--AAPPL-RSLFPSASDDALDLLSKMFTYDPKA 281
           +    ++PD       Y+ D  E  +   + PPL R+L   A  D    L KM T+D   
Sbjct: 388 SVCDEEFPDPPCKLFDYI-DSAEIDHAGHSVPPLIRNLGLPA--DFEYPLVKMLTFDWHL 444

Query: 282 RITAQQAL 289
           R  A + L
Sbjct: 445 RPGAAELL 452

Length = 501

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 18  EVLGEGTYGVVYKA--IDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           E LGE  +G VYK     T  G   Q VAIK ++  K +  +      E  +   L+ P+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 73  IIELIDAFPHKGNLHLVF---------EFM----------ETDLETVIRNTNIFLSPADI 113
           I+ L+     +  L ++F         EF+           TD +  +++T   L PAD 
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST---LEPADF 126

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQ 171
              +     G+ F     V+H+D+   N+L+     +K++D GL R   + D  +   + 
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 172 VFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +   RW     +++G  ++    D+W+ G +  E+ +
Sbjct: 187 LLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPH 72
           ++LGEG +G V +     D  +   VA+K ++L      E   F  L E   +K+   P+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF--LSEAACMKDFDHPN 62

Query: 73  IIELIDAFPHKGNLH------LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK--- 122
           +++LI       +L       ++  FM+  DL + +  + +   P  +   +Q  LK   
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP--LQTLLKFMV 120

Query: 123 ----GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTH--QVFAR 175
               G+ +   +  +HRD+   N ++     + +ADFGL++   S D  R     ++  +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
           W  A E L   + Y +  DVWA G    E+  R
Sbjct: 181 WI-AIESL-ADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKA----IDTKTGQ---TVAIKKIR-LGKQKEGVNFTALREIK 63
           DR +  + LGEG +G V +A    ID        TVA+K ++     K+  +  +  E++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS--EME 69

Query: 64  LLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET----------------DLETVIRNTNI 106
           L+K + K  +II L+     +G L+++ E+                       + +    
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD- 165
            LS  D+ S      +G+ +   +  +HRD+   N+L+     +K+ADFGLAR     D 
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189

Query: 166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            ++ ++      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 190 YKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 22/46 (47%), Positives = 30/46 (65%)

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
           IK  M+  L GL   H+  ++HRD+KP NLL+   GQ+K+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 35/216 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT--VAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + LGEG +G V +    +      VA+K  KI +  + E  +F  L E   +KE   P++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF--LSEAVCMKEFDHPNV 62

Query: 74  IELI---------DAFP---------HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
           + LI         + +P           G+LH    F+   L + + +   +L    +  
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLH---SFL---LYSRLGDCPQYLPTQMLVK 116

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF-- 173
           +M     G+ +   K  +HRD+   N ++  +  + +ADFGL++   + D     ++   
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
             +W     L    + Y    DVW+ G    E+  R
Sbjct: 177 PVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 25/242 (10%)

Query: 20  LGEGTYGVVYKA-IDTKTGQT-VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G V          +  V +K++R      E + F  L+E++  +EL  P++++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLF--LQEVQPYRELNHPNVLQC 60

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM----TLKGLAFCHKKW 131
           +          LV EF    DL+  +R+    ++    K  +Q        GL + H+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL------ 182
            +H D+   N  + +   +K+ D+GLA      D   T   H V  RW  APEL      
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQ 179

Query: 183 -LFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L    Q     ++W+ G    EL     +P+    SD   L ++        P    DL
Sbjct: 180 DLLPKDQTKKS-NIWSLGVTMWELFTAADQPYPD-LSDEQVLKQVVREQDIKLPKPQLDL 237

Query: 240 AY 241
            Y
Sbjct: 238 KY 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 13/130 (10%)

Query: 92  FMETDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL 150
           +++ D+ + I     + L   D+ S+     KG++F   K  +HRD+   N+L+ +HG++
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL-THGRI 252

Query: 151 -KLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            K+ DFGLAR   + D  +  +  AR    + APE +F    Y    DVW+ G +  E+ 
Sbjct: 253 TKICDFGLARDIRN-DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEI- 309

Query: 207 NRRPFLQGSS 216
               F  GSS
Sbjct: 310 ----FSLGSS 315

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V   +    G  VA+K I+     +   F A  E  ++ +L+  ++++L+
Sbjct: 12  QTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQA--FLA--EASVMTQLRHSNLVQLL 65

Query: 78  DAF-PHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKWVLH 134
                 KG L++V E+M +  L   +R+    +   D      + + + + +      +H
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+   N+L+      K++DFGL +   S     T ++  +W  APE L   K++    D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL-REKKFSTKSD 181

Query: 195 VWAAGCIFAEL--LNRRPF 211
           VW+ G +  E+    R P+
Sbjct: 182 VWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 9/169 (5%)

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDR 166
           L+  D+ S+     +G+ F   K  +HRD+   N+L+     +K+ DFGLAR I    + 
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 167 RFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLG 222
                 F   +W  APE +F    Y    DVW+ G +  E+  L   P+     D     
Sbjct: 294 VSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
           KI + +  A P       Y  D +   + + P  R  F   SD    LL
Sbjct: 352 KIKSGYRMAKPDHATQEVY--DIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 22/195 (11%)

Query: 26  GVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH 82
           GV+ K +   DT+T QT  +K +R   +         RE   +     P+++ L      
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSSEYS-------RERLTIIPHCVPNMVCLHKYIVS 56

Query: 83  KGNLHLVFEFME--TDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDMKP 139
           + ++ LV +  E       + +  NI   P + +K +    +  L   H++ ++ RD+ P
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNI---PEECVKRWAAEMVVALDALHREGIVCRDLNP 113

Query: 140 NNLLIGSHGQLKLADFG-LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAA 198
           NN+L+   G ++L  F   + +  S D     +     Y APE + G  +     D W+ 
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDSCDG----EAVENMYCAPE-VGGISEETEACDWWSL 168

Query: 199 GCIFAELLNRRPFLQ 213
           G I  ELL  +  ++
Sbjct: 169 GAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 76/342 (22%), Positives = 143/342 (41%), Gaps = 75/342 (21%)

Query: 3   EVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREI 62
           ++D+S +   R+    +LGEGT+G V +A D K  +  A+K +R           A  EI
Sbjct: 123 DIDVSTQ---RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR---NVPKYTRDAKIEI 176

Query: 63  KLLKELKSPHIIELIDAFP----------HKGNLHLVF-EFMETDLETVIRNTNIFLSPA 111
           + +++++     +  D FP            G++ +V  ++    L+ ++++      P 
Sbjct: 177 QFMEKVRQA---DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH-----GPF 228

Query: 112 DIKSYMQMTLK---GLAFCHKKW-VLHRDMKPNNLLIGSHG----------------QLK 151
             +   Q+  +    L + H +  ++H D+KP N+L+ +                  +++
Sbjct: 229 SHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288

Query: 152 LADFGLARIFGSPDRRF--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR 209
           + D G     G  D R   T  V  R YR+PE++ G   +    D+W+ GCI  EL   +
Sbjct: 289 ICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGK 342

Query: 210 PFLQGSSDIDQLGKIFAAFGTATPSQWP-------------DLAYLPDYVEYQYVA---- 252
                  +++ L  +    G   PS+W                  L    + +++A    
Sbjct: 343 LLYDTHDNLEHLHLMEKTLGR-LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401

Query: 253 APPLRSLFPSASDDAL-DLLSKMFTYDPKARITAQQALEHRF 293
           A P+R +     DD L DL+  +  YD + R+ A+Q   H +
Sbjct: 402 ARPVREVI---RDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 36/115 (31%), Positives = 53/115 (46%), Gaps = 6/115 (5%)

Query: 95  TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD 154
           T  +T+I N +  LS  D+  +      G+ F   K  +HRD+   N+LI     +K+ D
Sbjct: 224 TRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 155 FGLAR-IFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           FGLAR I    +       F   +W  APE +F    Y    DVW+ G +  E+ 
Sbjct: 283 FGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 10/110 (9%)

Query: 110 PADIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR 166
           P D+   ++ + +   G+ F   K  +HRD+   N+L+      K+ DFGLAR   + D 
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN-DS 266

Query: 167 RFTHQVFARW---YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPF 211
            +  +  AR    + APE +F    Y    DVW+ G +  E+  L + P+
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 20  LGEGTYG-VVYKAIDTKTGQT-VAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G V+   I T TG   V +K+++     KE   F  L++    + L+ P+I++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEF--LQQGDPYRILQHPNILQC 60

Query: 77  I----DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK---GLAFCH 128
           +    +A P+     LVFE+ E  DL++ +         + +    +M  +   G+   H
Sbjct: 61  LGQCVEAIPYL----LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH--QVFARWYRAPEL---- 182
           K   LH D+   N  + S   +K+ D+G+       D   T   +     + APEL    
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 183 ---LFGAKQYGAGVDVWAAGCIFAELL 206
              L  A+Q     +VWA G    EL 
Sbjct: 177 HGGLITAEQTKPS-NVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 19/162 (11%)

Query: 19  VLGEGTYGVVYKAI-----DTKTGQTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPH 72
            LG G +G VY+ +            VA+K +     +++  +F  L E  ++ +    +
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF--LMEALIMSKFNHQN 70

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTL---KGLA 125
           I+ LI     +    ++ E M   DL++ +   R      S   +K  +       KG  
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLAR-IFGS 163
           +  +   +HRD+   N L+   G     K+ADFG+AR I+ +
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 24/55 (43%), Positives = 27/55 (49%), Gaps = 13/55 (23%)

Query: 158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAG-CIFAELLNRRPF 211
            RI G+PD           Y APELL G K +G  VD WA G C+F  L    PF
Sbjct: 538 ERILGTPD-----------YLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPF 580

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 45/208 (21%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 19  VLGEGTYGVVY----KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
            LG G +G V+    K I+ + G+T+ + K     + E +     RE+ + ++L   +++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 75  ELI----DAFPHKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTL----- 121
            L+    +A PH    +++ E+ +  DL+  +R T   +  L P  + +  ++ L     
Sbjct: 72  RLLGLCREAEPH----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRA 179
            G+        +HRD+   N L+ S  ++K++   L++   + +           RW  A
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-A 186

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PE +     +    DVW+ G +  E+  
Sbjct: 187 PEAVQ-EDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 37.9 bits (89), Expect = 0.004
 Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 104 TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFG 162
               LS A++K  ++  ++ L   HK  ++H D+K  N+L   +  ++ L D+GL +I G
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161

Query: 163 SP---DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
           +P   D   T   F     +PE + G   Y    D WA G +  ELL  + PF
Sbjct: 162 TPSCYDG--TLDYF-----SPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	314
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK10345	210	hypothetical protein; Provisional	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG1243	690	consensus Protein kinase [General function predict	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG3087	229	consensus Serine/threonine protein kinase [General	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
COG4248	637	Uncharacterized protein with protein kinase and he	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.14
PRK09902	216	hypothetical protein; Provisional	98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.97
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.61
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.53
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.13
KOG2270	520	consensus Serine/threonine protein kinase involved	98.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.93
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.88
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.87
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.72
PRK05231	319	homoserine kinase; Provisional	97.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.72
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.57
PLN02236	344	choline kinase	97.39
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.34
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.32
PRK12396	409	5-methylribose kinase; Reviewed	97.31
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.28
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.27
PLN02756	418	S-methyl-5-thioribose kinase	97.2
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.06
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.03
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.98
PTZ00384	383	choline kinase; Provisional	96.91
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.88
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.7
PRK10593	297	hypothetical protein; Provisional	96.64
PTZ00296	442	choline kinase; Provisional	96.55
COG2334	331	Putative homoserine kinase type II (protein kinase	96.37
PRK06148	1013	hypothetical protein; Provisional	96.23
PRK11768	325	serine/threonine protein kinase; Provisional	95.93
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.79
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.48

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-59  Score=374.93  Aligned_cols=287  Identities=73%  Similarity=1.187  Sum_probs=278.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|...++||+|.||.||+|++..+|+.||||+++........+....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            68999999999999999999999999999999999988887778888899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++.+|...++.+...++...+..++.++++|++|||++.|.||||||.|++++.+|.+||+|||+++.++++.......
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~  161 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ  161 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988888888


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      +.|.||.|||++++...|+...|+||.|||+.||+.+.+.|.+.++.+++..++..++++.+++||++..+++.....+.
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..++....++.+++++.+|+++||..||.+|+++.|+|+|+||++..
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            99999999999999999999999999999999999999999999754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-58  Score=376.11  Aligned_cols=289  Identities=40%  Similarity=0.675  Sum_probs=259.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +.|+.+..+|+|++|+||+|+++.+|+.||||++.-+..++...+-.++|+++|++++|+|+|.++.+|...+..++|||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            67999999999999999999999999999999998887777777777899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ||+-++++.+......++...+..++.|++.|+.|+|+++++||||||+||+++.+|.+||||||+|+....+...++..
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY  161 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY  161 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence            99999999999988889999999999999999999999999999999999999999999999999999987788899999


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc---chhhh
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP---DYVEY  248 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  248 (314)
                      +.|.||.|||++.++.+|....|||++||++.||++|.+.|++..+.+++..+....+...|....=....+   ...--
T Consensus       162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP  241 (396)
T KOG0593|consen  162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP  241 (396)
T ss_pred             hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence            999999999999999999999999999999999999999999999999999999999888776543221111   11111


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ......+++..++.++.-+.+|+++||..||++|++.+|+|.||||..+-++
T Consensus       242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            2223344566678899999999999999999999999999999999877543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-56  Score=391.70  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=230.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+|...++||+|+|.+||.+++..+|+.||+|++.+... ......+..+|+++.+.++|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            379999999999999999999999999999999987653 3334456779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |.|.. +|..+.+ +++.++|..|+.++.||+.||.|||+++|+|||||..|+|++++..|||+|||+|+....+.....
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            99995 5555555 777899999999999999999999999999999999999999999999999999999988878888


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..+|||-|+|||++.. ...+..+||||+||+||.|+.|++||......+++.++.......+.                
T Consensus       177 TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----------------  239 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----------------  239 (592)
T ss_pred             eecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----------------
Confidence            8999999999999986 66799999999999999999999999999999999998766433322                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                  .++.++.+||.++|+.||.+|||+++||.|+||+
T Consensus       240 ------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  240 ------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             ------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                        4699999999999999999999999999999993

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-57  Score=379.88  Aligned_cols=267  Identities=30%  Similarity=0.477  Sum_probs=230.4

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-----cchhhHHHHHHHhhcCCCCeeeeecee
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-----VNFTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      .++.+.+.|.+.+.||+|+||.|-+|..+.+|+.||+|.+.+......     ......+|+++|+.++||+|+++.++|
T Consensus       166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            567789999999999999999999999999999999999987653331     222345899999999999999999999


Q ss_pred             ccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcEEEeecc
Q 021299           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFG  156 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~df~  156 (314)
                      +.....|+||||++| +|.+.+-..+ .+.+.....++.|++.|+.|||++||+||||||+|||++.+   .-+||+|||
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999985 8888887554 58899999999999999999999999999999999999776   579999999


Q ss_pred             ceeeeCCCCCcccccccCccccCcccccCc--cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH-HHHHHHHhhCCCCC
Q 021299          157 LARIFGSPDRRFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATP  233 (314)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~  233 (314)
                      +|+..+.. ..-...+|||.|.|||++.+.  ..+..+.|+|||||+||-+++|.+||....... ...++.++.....|
T Consensus       325 lAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  325 LAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            99988743 344567899999999999752  234568999999999999999999998766555 77777777666666


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..|.                        .+++++.+||.+||..||++|||++|+|+||||+...
T Consensus       404 ~~w~------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  404 LQWD------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhh------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            5554                        4699999999999999999999999999999999654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-56  Score=384.70  Aligned_cols=289  Identities=40%  Similarity=0.679  Sum_probs=255.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCC-e
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG-N   85 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~   85 (314)
                      ..+.++|.+++.||.|.||.||+|+.+.+|+.||||.++.....-+. .--.+|+..|++++ ||||+++.+++.++. .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            35689999999999999999999999999999999999876543211 12237999999998 999999999987777 9


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .|+|||||+.+|.++++.++..+++..++.|+.||++||+|+|++|++|||+||+|||+..+..+||+|||+|+... ..
T Consensus        85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-SK  163 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc-cC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998763 34


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .-++..+.|.||.|||++.....|+.+.|+|++|||++|+.+-++.|++.++.+++.++....|++....|+....+...
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            45567788999999999988889999999999999999999999999999999999999999999999888875433333


Q ss_pred             h--hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 V--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      -  .+.+....++....+++++++.+||.+||.+||++||||.|+|+||||+--.
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            2  3333445556777788999999999999999999999999999999998543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-55  Score=369.27  Aligned_cols=259  Identities=29%  Similarity=0.472  Sum_probs=221.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-eEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~   90 (314)
                      ++.+.++.||+|+.|+||+++|+.+++.+|+|++.. ..++...+.+.+|+++++..+||+||.+++.|..++ .++|+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            577889999999999999999999999999999943 344556667889999999999999999999998888 499999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+| +|...+.. .+.+++.....++.++++||.|||. ++|+||||||+|||++..|.|||||||-+...-..  ..
T Consensus       158 EYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a  234 (364)
T KOG0581|consen  158 EYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA  234 (364)
T ss_pred             hhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence            99997 55555544 4679999999999999999999995 99999999999999999999999999999876333  55


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-----CcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-----SDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      ...+||..|||||.+.+ ..|+.++||||||+.++|+.+|..|+...     ...+.+..+..    .++..+|..    
T Consensus       235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~----~ppP~lP~~----  305 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD----EPPPRLPEG----  305 (364)
T ss_pred             ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc----CCCCCCCcc----
Confidence            67889999999999988 78999999999999999999999999775     34444444433    333333321    


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                        ..|+++++||..||++||++|||+.|+++|||+++..+..
T Consensus       306 ------------------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  306 ------------------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ------------------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                              2599999999999999999999999999999999886543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-54  Score=356.26  Aligned_cols=287  Identities=43%  Similarity=0.787  Sum_probs=260.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--CCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~i   88 (314)
                      .++|..+..|++|+||.||+|+++.+++.||+|+++.........-...+|+.++.+++|||||.+-.+...  -+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            588999999999999999999999999999999999887666655566799999999999999999987754  347999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||||+.+|.+.+...+.++...++..++.|+++|++|||++.|+||||||+|++++..|.+||+|||+|+..+++-...
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            99999999999999988899999999999999999999999999999999999999999999999999999999888888


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+-|.||.|||++.+...|+.+.|+||+|||+.+|+++.+.|.+....+++..++...+.+....||....++.....
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            88899999999999999899999999999999999999999999999999999999999999999999999888876433


Q ss_pred             --ccccCCCCCccCCC--CCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          249 --QYVAAPPLRSLFPS--ASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       249 --~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                        .......+...++.  +++...+|+..+|..||.+|.|++|.|.|+||...
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence              33333334444443  55999999999999999999999999999999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-54  Score=370.85  Aligned_cols=284  Identities=45%  Similarity=0.805  Sum_probs=253.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   88 (314)
                      .+.|..+++||+|.||.||++++..+|+.||+|+++.+...+....-..+|+.+|++++||||+++.+...+.  +.+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            5789999999999999999999999999999999998876666665667999999999999999999977554  79999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||||+-+|..++......+++.++..++.||+.||+|||++|+.|||||.+|||+|.+|.+||+|||+|.+...... .
T Consensus       196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~  275 (560)
T KOG0600|consen  196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP  275 (560)
T ss_pred             EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999997755443 3


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+-|.||.|||++.+...|+.+.|+||.||||.||++|++.|.+..+.+++..|++.-+++....|+ ...++....
T Consensus       276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~  354 (560)
T KOG0600|consen  276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATI  354 (560)
T ss_pred             cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccc
Confidence            6677889999999999998899999999999999999999999999999999999999999999999998 445553332


Q ss_pred             hccc--cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          248 YQYV--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       248 ~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      +...  ....+...+..+++...+|+..||..||++|.||.++|+|+||.
T Consensus       355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            2222  22334455778899999999999999999999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-53  Score=354.33  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=229.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|+++++||+|+||+|+.++++.+++.||+|++++...-.. .......|..++.+++||+|++++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            6899999999999999999999999999999999988764443 233556899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      +||+.| .|..-++ +.+.++++.++-++..|+.||.|||++||+||||||+|||++.+|.++|+|||+|+..-......
T Consensus       104 ld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             EeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence            999997 5555554 44569999999999999999999999999999999999999999999999999999766666666


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+||+.|+|||++.+ ..++.++|.||||+++|+|++|.+||.+.+.......+...-....+.              
T Consensus       183 ~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~--------------  247 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG--------------  247 (357)
T ss_pred             ccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc--------------
Confidence            66789999999999988 689999999999999999999999999999999999887763222221              


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~ell~h~~~~~~~  298 (314)
                                   .++.+++++++++|..||++|.    ++++|-+||||..++
T Consensus       248 -------------~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  248 -------------YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             -------------cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence                         2599999999999999999996    689999999999985

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-52  Score=347.37  Aligned_cols=290  Identities=48%  Similarity=0.813  Sum_probs=263.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC-eeeeeceeccCC-----
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKG-----   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~-----   84 (314)
                      ...|..++.||+|++|+||+|+.+.+|+.||+|+++.....+.......+|+.+++.++|+| |+.+.+++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            56789999999999999999999999999999999988776666667779999999999999 999999987666     


Q ss_pred             -eEEEEEecccccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           85 -NLHLVFEFMETDLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        85 -~~~iv~e~~~g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                       ..++||||++-+|..++....   ..++...+..+++||+.||+|||+++|+||||||.||+++++|.+||+|||+|..
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence             889999999999999998766   4688899999999999999999999999999999999999999999999999998


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ..-+.......++|.+|.|||++.+...|+...||||+|||++||+++.+.|.+..+.+++..++...+++....||...
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            87777788899999999999999998889999999999999999999999999999999999999999999999999888


Q ss_pred             cccchh-hhcccc-CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          241 YLPDYV-EYQYVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       241 ~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .++... .+.... ...+....+..++...+++.+||+.+|.+|.|++.+|+||||+.....
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            777665 333333 445666667777899999999999999999999999999999988543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-53  Score=352.30  Aligned_cols=300  Identities=37%  Similarity=0.631  Sum_probs=257.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-----CC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-----KG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   84 (314)
                      +...|..++.||.|++|.|+.+.++.+|+.||+|++...........+..+|++.+++++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4567777899999999999999999999999999997555555555566799999999999999999998744     34


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .+|+|+|+|+.+|...++... .++++.+..++.|++.||+|+|+-|++|+||||.|++++.+..+||+|||+|+.....
T Consensus       100 DvYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             eeEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence            689999999888888877654 4999999999999999999999999999999999999999999999999999987542


Q ss_pred             --CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC--
Q 021299          165 --DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA--  240 (314)
Q Consensus       165 --~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  240 (314)
                        ...-+..+.|.||.|||++.....|+.+.||||.||||.||++|++.|++.+...++..+....+++.++.+....  
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~  258 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE  258 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence              2223456779999999999888899999999999999999999999999999999999999999999877665544  


Q ss_pred             -cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceeecccceec
Q 021299          241 -YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYL  310 (314)
Q Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~  310 (314)
                       -..-..........++...++++++.+.+|+.+||..||.+|+|++|+|+|||+..+-+--..+..|+.+
T Consensus       259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~  329 (359)
T KOG0660|consen  259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIF  329 (359)
T ss_pred             HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence             2222233445556667778899999999999999999999999999999999999998777766555543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-51  Score=354.72  Aligned_cols=282  Identities=40%  Similarity=0.765  Sum_probs=238.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||.|++|+||++.++.++..+++|.+...... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            5799999999999999999999999999999998754322 223356689999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++|+|.+.+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~  163 (288)
T cd07871          84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE  163 (288)
T ss_pred             CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence            99999999888776678999999999999999999999999999999999999999999999999998654444344455


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+......|+..............
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (288)
T cd07871         164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP  243 (288)
T ss_pred             eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence            67889999999877667899999999999999999999999999999999999888888888777765433322221111


Q ss_pred             --cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          252 --AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       252 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                        ...+.....+.+++++.+||.+||+.||.+|||++|+++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              1111222345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-52  Score=361.93  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=225.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhh-HHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ..+|+..+.||+|+|++|++|.++.+++.||||++.+.-...+...+. ..|-..|..| .||+|++++..|+++...|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            578999999999999999999999999999999987653222222222 2577778888 79999999999999999999


Q ss_pred             EEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      |+||++ |+|++++.+. +.+++..++.++.+|+.||+|||++||+||||||+|||++.+++++|+|||.++.+..... 
T Consensus       152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999998 6999999876 4699999999999999999999999999999999999999999999999999988743211 


Q ss_pred             ----------cc--cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          167 ----------RF--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       167 ----------~~--~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                                ..  ...+||-.|.|||+|.. ...+..+|+|+|||++|+|+.|.+||.+.++.-+..+++......+  
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp--  307 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP--  307 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence                      11  44689999999999977 7789999999999999999999999999999999999988743333  


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                                ++.++.+.+||+++|..||++|+++.||.+||||.+++
T Consensus       308 --------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  308 --------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             --------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                                      35689999999999999999999999999999999884

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=356.73  Aligned_cols=259  Identities=33%  Similarity=0.488  Sum_probs=227.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhcC-CCCeeeeeceeccCC
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   84 (314)
                      ...+.|.+.+.||+|+||+|+++.+..+|..+|+|.+......   ......+.+|+.+++.++ ||||+++.+++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4578999999999999999999999999999999977665221   123445558999999999 999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFG  162 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~  162 (314)
                      .+++||||+.| +|.+++.+ .+++.+..++.+++|++.|++|||++||+||||||+||+++.+ +++||+|||++....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999986 99999998 6789999999999999999999999999999999999999999 999999999999875


Q ss_pred             CCCCcccccccCccccCcccccCcc-CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..........|++.|+|||++.+.. +...++||||+|++||.|++|..||...+.......+..+...     +|    
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~-----~p----  243 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK-----IP----  243 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc-----CC----
Confidence            4556667788999999999998866 5579999999999999999999999998777777775544211     11    


Q ss_pred             ccchhhhccccCCCCCccCCCC-CHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                         ..+ ++++++|+.+||..||.+|+++.++++||||+.
T Consensus       244 -------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  244 -------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                               224 899999999999999999999999999999997

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.7e-50  Score=348.30  Aligned_cols=288  Identities=40%  Similarity=0.702  Sum_probs=229.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||+|++|+||++.++.+++.+++|++....... ....+.+|+.+++.++||||+++.+++.+....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            378999999999999999999999999999999987654322 2235568999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||+++++.+.+....+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+............
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            99999999998877777999999999999999999999999999999999999999999999999999765444334445


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc-HHHHHHHHHhhCCCCCCCCCCcCcccchhhh-
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-  248 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  248 (314)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|..||....+ ......+....+......|+.....+..... 
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            66788999999987656688999999999999999999999987544 3445555555555444444433221111000 


Q ss_pred             -ccccCCCCCccC--CCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          249 -QYVAAPPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       249 -~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                       ...........+  ...++.+.+|+.+||+.||.+|||++|+++||||+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence             000000000111  124678999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-52  Score=336.63  Aligned_cols=248  Identities=28%  Similarity=0.489  Sum_probs=218.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeec-eeccCC-eEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID-AFPHKG-NLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~-~~~i   88 (314)
                      ..+|+++++||.|+||+||++.+..+|..+|.|.+.....+.........|+.+|++++||||+++++ .+.+++ ..+|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            46799999999999999999999999999999999877777667777889999999999999999998 554444 4899


Q ss_pred             EEeccc-ccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCceEEecCCcEEEeeccceee
Q 021299           89 VFEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHK--KW--VLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~--~~--i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      |||+|. |+|..+++.   .+..+++..+|.++.|++.||.++|+  ..  +.|+||||.||+++.+|.|||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999998 688888863   45679999999999999999999999  44  99999999999999999999999999999


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      +.+........+|||.|||||.+.+ ..|+.+||||||||++|||...++||.+.+-.+....+.++..++.|.      
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------  250 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------  250 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence            8877777778899999999999988 789999999999999999999999999997777777776663222221      


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA  285 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  285 (314)
                                          ...|..+..||..|+..||++||+.
T Consensus       251 --------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 --------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             --------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence                                2358899999999999999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=341.13  Aligned_cols=261  Identities=32%  Similarity=0.501  Sum_probs=227.5

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|...+.||+|+|++||+|+++.++..||||.+...............|+++|+.++||||+.++++.+..+++|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            46789999999999999999999999999999999988765555555667899999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC------CcEEEeeccceeeeC
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH------GQLKLADFGLARIFG  162 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~------~~~~l~df~~~~~~~  162 (314)
                      ||||. |+|.++++..+ .+++..++.++.||+.|+++||+++|+||||||.|||++..      -.+||+|||+|+...
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999 58888888765 59999999999999999999999999999999999999875      358999999999875


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                       +........|+|.|||||++.. ..|+.|+|+||+|+++|+|++|.+||......+.+..+.+.....+.         
T Consensus       167 -~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~---------  235 (429)
T KOG0595|consen  167 -PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV---------  235 (429)
T ss_pred             -chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc---------
Confidence             4555567789999999999976 68999999999999999999999999999999988866554222111         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                      ....+++...+|+...|+.+|..|.+..+-..|+++..-.
T Consensus       236 ----------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  236 ----------------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ----------------hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                            1123477788999999999999999999999999987654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9e-52  Score=327.50  Aligned_cols=262  Identities=32%  Similarity=0.474  Sum_probs=236.0

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      -+.++|.+.+.||+|.|+.|+++.+..+|+.+++|.+...........++.+|+++.+.++||||+.+.+.+.+.+..|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            45799999999999999999999999999999999998877777677788899999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccceeeeCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSP  164 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~~~~~~~~  164 (314)
                      |||++.| +|...+-.+ -..++..+...++||+.+|.|+|.+||+|+|+||.|+++-.   .--+||+|||.+...+ .
T Consensus        88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~  165 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D  165 (355)
T ss_pred             EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence            9999997 676666544 34789999999999999999999999999999999999943   2369999999999887 6


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....+..|+|.|+|||++.. .+++..+|||+.||+||-|+.|.+||-+.+......++.++-...++..|+       
T Consensus       166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~-------  237 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD-------  237 (355)
T ss_pred             ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC-------
Confidence            666677889999999999988 789999999999999999999999999999999999998886666665554       


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                       .+++++++||++||..||.+|+|+.|.|+|||+..-
T Consensus       238 -----------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  238 -----------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             -----------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                             569999999999999999999999999999999864

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-49  Score=345.97  Aligned_cols=288  Identities=39%  Similarity=0.756  Sum_probs=241.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||+|++|.||++.++.++..+++|.+....... ....+.+|+++++.++||||+++++++..++..+++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            68999999999999999999999999999999997654322 23356689999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |+++++.+.+...+..+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  164 (309)
T cd07872          85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE  164 (309)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence            99999999988777778999999999999999999999999999999999999999999999999997654444333445


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+....+....+......|+..............
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07872         165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP  244 (309)
T ss_pred             cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence            67888999999877667899999999999999999999999999988888888888877777666654333222211111


Q ss_pred             --cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          252 --AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       252 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                        .........+.+++++.+||.+||+.||.+|||++|+++||||+.+..+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence              1111122335679999999999999999999999999999999987644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.2e-51  Score=355.39  Aligned_cols=256  Identities=32%  Similarity=0.513  Sum_probs=233.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||+|+||+||+++++.+.+.||+|.+.+....+...+.+.+|+++++.++||||+.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            68999999999999999999999999999999999887776666678899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |+.|+|..++...+ .++++.+..++.+++.||.|||+++|.|+|+||.||++..+|.+|+||||+++.++.........
T Consensus        82 ~a~g~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   82 YAVGDLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhhhHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence            99998888887654 59999999999999999999999999999999999999999999999999999998888777888


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .|||.|||||++.+ .+++..+|+|||||++||++.|++||-..........+...     +..||              
T Consensus       161 kGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----~v~~p--------------  220 (808)
T KOG0597|consen  161 KGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----PVKPP--------------  220 (808)
T ss_pred             cCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----CCCCc--------------
Confidence            89999999999986 88999999999999999999999999888777777766543     22222              


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                               ..++..+.+|+..+|.+||.+|.+..+++.|||.++-
T Consensus       221 ---------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  221 ---------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ---------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                     1469999999999999999999999999999998864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-49  Score=341.97  Aligned_cols=282  Identities=37%  Similarity=0.639  Sum_probs=224.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|+||+++++.++..+++|++............+.+|+.+++.++||||+++.+++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999998765444444566789999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Ccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTH  170 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~  170 (314)
                      |++++++..+......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+....... .....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE  160 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence            99998888777666679999999999999999999999999999999999999999999999999998653322 22234


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc-
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ-  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  249 (314)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+....+..+...+......+...... 
T Consensus       161 ~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         161 YVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             cccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            567889999999876 557899999999999999999999999887776666655544433322211100000000000 


Q ss_pred             ---cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 ---YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                         .............++.++.+||.+||+.||++|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               000000111223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9e-49  Score=340.89  Aligned_cols=290  Identities=38%  Similarity=0.724  Sum_probs=238.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||.|++|.||++.+..+++.+++|.+....... ....+.+|+++++.++||||+++++++...+..+++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            368999999999999999999999999999999987554322 2235568999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||+++++...+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            99999999999877777999999999999999999999999999999999999999999999999999765443333344


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+....+....+......|+.............
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY  243 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence            55688899999987756678999999999999999999999999888888887777777666665554322211111111


Q ss_pred             --ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          251 --VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       251 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                        ............+++.+.+||.+||+.||.+|||++|+++||||+...++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence              111112233456789999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-50  Score=334.47  Aligned_cols=280  Identities=37%  Similarity=0.659  Sum_probs=240.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-----eE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   86 (314)
                      =.|...+++|.|+||.||.+....+++.+|||+...+..-.      ..|+++++.++||||+++.-+|....     ..
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            36888999999999999999999999999999987654322      17999999999999999998874322     34


Q ss_pred             EEEEecccccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeC
Q 021299           87 HLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~  162 (314)
                      .+||||++-+|.+.++.   .+..++.-.+.-+..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            58999999999999874   35568889999999999999999999999999999999999987 899999999999885


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ....+ .+...+..|.|||++.+...|+.+-||||.||++.||+.|++.|++.+..+++..+.+.+|.++.+++..+...
T Consensus       178 ~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            54444 66777889999999999999999999999999999999999999999999999999999999998887765444


Q ss_pred             cchhhhccccCCCCCc-cCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      -....+......+... .....++++.+|+.++|.-+|++|.++.|++.||||....
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            3333333333333323 5567899999999999999999999999999999999764

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-48  Score=337.20  Aligned_cols=280  Identities=40%  Similarity=0.736  Sum_probs=226.7

Q ss_pred             hhccceeeeCccccceEEEEEECC-CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc---CCCCeeeeeceec-----c
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP-----H   82 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~   82 (314)
                      ++|++.+.||+|++|+||+|.+.. ++..+++|.+..............+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 467899999876654443333455676666655   6999999999874     3


Q ss_pred             CCeEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           83 KGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ....+++||++++++.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            4568999999999999988754 345899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+....+...+..++....
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            433 23344567889999999876 5688999999999999999999999999999999999888877666666654432


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .... .+......++....+.+++.+.+|+.+||+.||++|||+.|+|+||||
T Consensus       239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccch-hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            2211 111222223334445678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=322.14  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=224.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||.|+||+|.+++++.+|.-||+|.+.+...-.- ......+|.++|+.+.||+++.+++.+.+.++.|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            5789999999999999999999999999999999976542111 112334799999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||.+| .+.+++++ .+++++..++-++.||+.||+|||+++|++|||||+|||++.+|.+||+|||+|+....   ..
T Consensus       123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---RT  198 (355)
T ss_pred             EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---cE
Confidence            999997 56666654 44699999999999999999999999999999999999999999999999999997633   24


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+|||.|+|||++.+ ..++.++|-|+||+++|||+.|.+||-..++..+...+..+.-..++               
T Consensus       199 ~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~---------------  262 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS---------------  262 (355)
T ss_pred             EEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc---------------
Confidence            56789999999999988 88999999999999999999999999999999999999887443332               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC-----CCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR-----ITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-----ps~~ell~h~~~~~~~  298 (314)
                                   .+++++++|+.++|+.|-++|     ....+|..||||++++
T Consensus       263 -------------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  263 -------------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             -------------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence                         359999999999999999999     3567899999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=347.69  Aligned_cols=257  Identities=30%  Similarity=0.503  Sum_probs=226.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ...|.....||+|+.|.||.+....+++.||+|.+.......  ...+.+|+.+++..+|+|||.+++.|...+..|+||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            478899999999999999999999999999999998765432  335679999999999999999999998889999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+.+....  +++.+++.+++.++.||+|||.+||+|+|||.+||++..+|.+||+|||+|...........
T Consensus       350 Eym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             eecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            99997 5555555444  99999999999999999999999999999999999999999999999999998877777888


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      .-+|||+|||||+... ..|+.+.||||||++++||+-|.+||-..++...+..+... ++...                
T Consensus       428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l----------------  489 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL----------------  489 (550)
T ss_pred             cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc----------------
Confidence            8999999999999977 78999999999999999999999999988887777776543 22111                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                              .....+|+++++|+.+||+.||++|+++.|||+||||+.-
T Consensus       490 --------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  490 --------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             --------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                    1234679999999999999999999999999999999643

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-48  Score=336.36  Aligned_cols=282  Identities=47%  Similarity=0.806  Sum_probs=228.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||.|++|.||++.+..+|+.+++|.+............+.+|+++++.++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58999999999999999999999999999999976554444444566899999999999999999999999999999999


Q ss_pred             ccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccc
Q 021299           93 METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        93 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      +++++.+.+....+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...+..........
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            99999998887677799999999999999999999999999999999999999999999999999986654433334456


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      +++.|+|||.+.+...++.++|+||||+++|+|++|..| |...+.......+....+......++..............
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY  240 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence            678899999987756678999999999999999998866 5666666666666666555544444332222221111110


Q ss_pred             cC-CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          252 AA-PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       252 ~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .. ....+..+.+++++.+||.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00 00122334678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.1e-48  Score=333.35  Aligned_cols=282  Identities=49%  Similarity=0.856  Sum_probs=232.0

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58899999999999999999999999999999976554444445667899999999999999999999999999999999


Q ss_pred             ccccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 METDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +.+++.+.+....  ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...+........
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            9999988886543  56899999999999999999999999999999999999999999999999999876544444444


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh-c
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  249 (314)
                      ..+++.|+|||.+.+...++.++|+||||+++++|++|.+||................+......|+........... .
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP  240 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence            566888999999876566789999999999999999999999988877777777776665555555443333222111 1


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .............+++++.++|.+||+.||++|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            111111222344579999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-48  Score=339.90  Aligned_cols=261  Identities=30%  Similarity=0.463  Sum_probs=221.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-chhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.++++||+|+||.||+|+.+.+|+.||+|++++....... ......|-.+|...++|.||+++..|++..+.|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            47899999999999999999999999999999999987643322 22445688888888999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC-----
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-----  163 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~-----  163 (314)
                      |||++| ++.+++...+ .+++..++.++.+++.|+..||+.|++|+||||+|+||+..|.+||+|||+|.-...     
T Consensus       220 MEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             EEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            999996 7888887655 699999999999999999999999999999999999999999999999999943211     


Q ss_pred             -----------------CCCc-------------------------ccccccCccccCcccccCccCCCCcchHhhHHHH
Q 021299          164 -----------------PDRR-------------------------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCI  201 (314)
Q Consensus       164 -----------------~~~~-------------------------~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~l  201 (314)
                                       ....                         ....+|||-|+|||++.+ ..++..+|.||||||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCI  377 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHH
Confidence                             0000                         013478899999999988 669999999999999


Q ss_pred             HHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC
Q 021299          202 FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA  281 (314)
Q Consensus       202 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  281 (314)
                      +|||+.|.+||.+.++.++...+..-.....   +                     +....+++++++||.+||+ ||++
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---f---------------------P~~~~~s~eA~DLI~rll~-d~~~  432 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLK---F---------------------PEEVDLSDEAKDLITRLLC-DPEN  432 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---C---------------------CCcCcccHHHHHHHHHHhc-CHHH
Confidence            9999999999999999999999876532211   1                     1112458999999999999 9999


Q ss_pred             CCC---HHHHhcCccccccC
Q 021299          282 RIT---AQQALEHRFAKSFN  298 (314)
Q Consensus       282 Rps---~~ell~h~~~~~~~  298 (314)
                      |..   ++||..||||+.++
T Consensus       433 RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  433 RLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             hcCcccHHHHhcCCccccCC
Confidence            986   89999999999884

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-48  Score=343.79  Aligned_cols=287  Identities=38%  Similarity=0.628  Sum_probs=224.9

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----CeEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----GNLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   87 (314)
                      +|++.+.||+|++|.||++.++.+|..|++|.+............+.+|+++++.++||||+++.+++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            68999999999999999999999999999999875433333334567899999999999999999987432     3589


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      ++|||++++|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            999999999988886544 589999999999999999999999999999999999999999999999999975432211 


Q ss_pred             --cccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          167 --RFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       167 --~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                        ......+++.|+|||.+.+. ..++.++||||||+++|+|++|.+||...........+....+...+..+.......
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence              12345688999999988642 467899999999999999999999998887777666666655544433222111100


Q ss_pred             c---hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          244 D---YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       244 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .   ..........+.....+.+++.+.+++.+||+.||++|||++|+++||||+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            0   00111111222333345678999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=330.69  Aligned_cols=270  Identities=27%  Similarity=0.339  Sum_probs=226.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.|++...||.|..++||+|+....++.|+||++........ ...+.+|++.++.++||||++.+..|..+...|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            4789999999999999999999999999999999998877665 457789999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ++|. |++++.+... ...+++..+..+.+++++||.|||++|.+|||||+.|||++.+|.|+|+|||.+..+.......
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            9998 5888888764 4469999999999999999999999999999999999999999999999999987664433222


Q ss_pred             ----cccccCccccCccccc-CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          169 ----THQVFARWYRAPELLF-GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       169 ----~~~~~~~~y~sPE~~~-~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                          ....|+++|+|||++. .-..|+.|+||||+|++..||.+|..||..-.+...+-.-.++......     ....+
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-----t~~~~  258 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-----TSGLD  258 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-----cccCC
Confidence                3458999999999954 3355899999999999999999999999988777766554443221111     00000


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..             -....+..++++|..||+.||++|||++++|+|+||++...
T Consensus       259 ~d-------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  259 KD-------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hH-------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            00             01234678999999999999999999999999999998753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=296.98  Aligned_cols=286  Identities=47%  Similarity=0.823  Sum_probs=264.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..|...+.||+|.+|+|++++.+.+++.|++|..+.+..++.......+|+-+++.++|.||+++++....++...+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            46788899999999999999999999999999999999888888889999999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      +|..+|..+..+-++.++.+.++.++.|+++|+.++|++++.|+|+||.|.+++.+|.+|+.|||+++.++-+-......
T Consensus        82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998888888888


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      +.|.||.+|.++++..-|+..-|+||-||++.++. .|.+.|++.+..+++.+++...+....++||....+++...+..
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            99999999999999888999999999999999997 67799999999999999999999999999999988887754433


Q ss_pred             ccC-CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          251 VAA-PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      -.. ....++.+.++..-++|++++|.-+|.+|+++++.++||||...
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            322 22345567788889999999999999999999999999999854

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=331.10  Aligned_cols=261  Identities=31%  Similarity=0.492  Sum_probs=214.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC--eEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--NLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~i   88 (314)
                      ..+|...+.||+|+||+||++.+..+|..+|+|.........  ...+.+|++++..++|||||++.+......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            356889999999999999999999999999999998763222  334679999999999999999999743333  6899


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCC---
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGS---  163 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~---  163 (314)
                      +|||+.| +|.+++...++.++++.++.+.+||+.||+|||++|++|+||||+|||++. ++.+||+|||.+.....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999985 888888877668999999999999999999999999999999999999999 79999999999987653   


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .........||+.|+|||++..+.....++|||||||++.+|+||.+||... ........+...  . .          
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~--~-~----------  240 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE--D-S----------  240 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc--C-C----------
Confidence            1222345789999999999985333446999999999999999999999874 333322222211  1 1          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                   .+.+...+++++++++.+||..||.+|||++++|+|||.++...
T Consensus       241 -------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  241 -------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                         11233457999999999999999999999999999999987544

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-47  Score=330.01  Aligned_cols=279  Identities=40%  Similarity=0.750  Sum_probs=224.7

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc---CCCCeeeeeceecc-----CC
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFPH-----KG   84 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~   84 (314)
                      +|++.+.||+|++|+||++.++.+|+.+++|.+..............+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58999999999999999999999999999999876544333333445666666655   79999999998753     34


Q ss_pred             eEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++++|++++++.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            689999999999988887643 4589999999999999999999999999999999999999999999999999976532


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+....+......|+......
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             c-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            2 22234467888999999876 568999999999999999999999999988888888888776665555555332211


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      . ..+............+.++..+.++|.+||+.||++|||+.|++.||||
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 R-GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             c-cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1 1111222233334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-49  Score=317.62  Aligned_cols=264  Identities=30%  Similarity=0.503  Sum_probs=231.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc--hh----hHHHHHHHhhc-CCCCeeeeecee
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FT----ALREIKLLKEL-KSPHIIELIDAF   80 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~--~~----~~~e~~~l~~l-~~~~i~~~~~~~   80 (314)
                      +.+.+.|...+.||.|..++|-++.++.+|+.+++|++..........  .+    -.+|+.+|+++ .||+|.++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            456788999999999999999999999999999999997765433221  11    22689999998 599999999999


Q ss_pred             ccCCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           81 PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        81 ~~~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      +.+.+.++|+|.|+ |.|.+++.+.- .+++...+.|++|++.|++|||.++|+|+||||+||+++++.+++|+|||+++
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            99999999999998 78999887654 59999999999999999999999999999999999999999999999999999


Q ss_pred             eeCCCCCcccccccCccccCcccccCc-----cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~-----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      .. .+.......+|||.|+|||.++..     ..|+...|+|++|+|||.|+.|.+||=.....-.+..++++......+
T Consensus       172 ~l-~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  172 QL-EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             cc-CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence            87 345566778999999999998642     347899999999999999999999998877778888888887777777


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      .|.+                        +++..++||.+||+.||++|.|++|+|.||||+++
T Consensus       251 eWad------------------------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  251 EWAD------------------------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             chhh------------------------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            7664                        49999999999999999999999999999999766

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-48  Score=345.37  Aligned_cols=264  Identities=28%  Similarity=0.451  Sum_probs=233.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecC-CcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      -.+=|++.+-||.|+.|.|-+|++..+|+..|||.+.+. .........+..|+-+++.+.||||+.++++|++..+.|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            356789999999999999999999999999999999877 3334444567799999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |.||+.| .|.+++..++ ++++..++.++.||+.|+.|+|..+|+|+||||+|++++..+++||+|||.|... .+...
T Consensus        90 vlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gkl  167 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGKL  167 (786)
T ss_pred             EEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCCcc
Confidence            9999985 8888888665 5899999999999999999999999999999999999999999999999999875 34445


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+|.|-|.+||++.+..+.+.++||||.|||||.|++|..||.+.+.-..+..+.++....+               
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP---------------  232 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP---------------  232 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC---------------
Confidence            56678999999999999977789999999999999999999999998888888888776643322               


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceee
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVF  303 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~  303 (314)
                                   ..+++++++||.+||+.||.+|+|.+||++|||+.+..+..+.
T Consensus       233 -------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  233 -------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             -------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                         3579999999999999999999999999999999998765543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.2e-47  Score=339.03  Aligned_cols=285  Identities=33%  Similarity=0.512  Sum_probs=222.0

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      .+.++|++.+.||+|+||.||++.+..+|..+++|.+............+.+|+.+++.++||||+++++++...     
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            567999999999999999999999999999999999976544444445667899999999999999999988543     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...+++|||+++++...+..   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence             35799999999998887643   37899999999999999999999999999999999999999999999999997543


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC--
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA--  240 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  240 (314)
                      .. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+....+......+....  
T Consensus       175 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         175 TN-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             cC-ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            22 22234567888999999976 668899999999999999999999999888777666665554433321111000  


Q ss_pred             ------------cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          241 ------------YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       241 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  .............+.........++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                        0000000000001111112223578899999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.4e-48  Score=352.23  Aligned_cols=282  Identities=33%  Similarity=0.562  Sum_probs=220.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   82 (314)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....      ...+|+.+++.++||||+++.+++..        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4679999999999999999999999999999998854321      23479999999999999999887632        


Q ss_pred             CCeEEEEEecccccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccce
Q 021299           83 KGNLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLA  158 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~  158 (314)
                      ....+++|||+++++...+..   ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            225679999999988777653   455799999999999999999999999999999999999998765 7999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ....... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+....+.+..+....+......+..
T Consensus       219 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        219 KNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             hhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            8653322 223456788999999987756789999999999999999999999999988888888887766554332221


Q ss_pred             cCcccchhhhccccCCCCC-ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          239 LAYLPDYVEYQYVAAPPLR-SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ....-....+.......+. .+....++++.+||.+||+.||.+|||+.|++.||||+.+.+
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            1000000000001111111 122346889999999999999999999999999999987754

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.8e-47  Score=330.96  Aligned_cols=286  Identities=66%  Similarity=1.125  Sum_probs=240.3

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +|.+.+.||+|++|.||++.+..+|+.+++|.+......   ......+.+|+++++.++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999989999999999876543   22333456899999999999999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||+.|+|.+++......+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            99997799998876655799999999999999999999999999999999999999999999999999987755444444


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+...++.++|+||||+++++|++|.+||......+....+....+......++............
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            45667889999998765678999999999999999999999999888888888877776666665565544444333333


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .....+........+.++.++|.+||..||++|||++|++.||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            3333444445567789999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-47  Score=329.90  Aligned_cols=288  Identities=41%  Similarity=0.759  Sum_probs=235.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   88 (314)
                      .++|++.+.||.|++|.||++.++.+|+.|++|.+..............+|+++++.++|+|++++.+++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4789999999999999999999999999999999976554443333456899999999999999999988654  56899


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||||+++++.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  165 (309)
T cd07845          86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM  165 (309)
T ss_pred             EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence            99999999998888766779999999999999999999999999999999999999999999999999998765443333


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+....+....+......++.....+.....
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07845         166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF  245 (309)
T ss_pred             CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence            44455778999999877567899999999999999999999999999999988888887776666555544333322111


Q ss_pred             cc--ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QY--VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..  .............++++.++|.+||+.||++|||+++++.||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            11  111111222334688999999999999999999999999999998553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=332.37  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=215.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|+||++.++.+|+.+++|.+...... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4799999999999999999999999999999999754322 122335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+.| +|.+++...+ .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            99985 7888776544 6899999999999999999999999999999999999999999999999999765322   22


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....                    
T Consensus       157 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------------------  215 (291)
T cd05612         157 TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--------------------  215 (291)
T ss_pred             cccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------------------
Confidence            3467889999999876 5678999999999999999999999988877666666544311                    


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                              .+...+++.+.+||.+||+.||.+||+     ++++++||||+.++
T Consensus       216 --------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         216 --------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             --------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence                    011235889999999999999999995     99999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-48  Score=331.25  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=220.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC------------cchhhHHHHHHHhhcCCCCeeeee
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------------VNFTALREIKLLKELKSPHIIELI   77 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~   77 (314)
                      ..++|++.+.||+|.+|.|-+|++..+++.||+|++.+......            ...+..+|+.+++++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            46899999999999999999999999999999999977643211            113566899999999999999999


Q ss_pred             ceec--cCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           78 DAFP--HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        78 ~~~~--~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      .+..  ..+.+|+|+|||..+-..+.-..+.-+++.+++.++++++.||+|||.+||+||||||+|+|++.+|.|||+||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence            9985  45689999999996655555444434899999999999999999999999999999999999999999999999


Q ss_pred             cceeeeCC-----CCCcccccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHh
Q 021299          156 GLARIFGS-----PDRRFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       156 ~~~~~~~~-----~~~~~~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~  227 (314)
                      |.+.....     .........|||+|+|||...++   ...+.+.|||||||+||-|+.|+.||.+....++...+...
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND  334 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence            99987621     22223346899999999998762   34578999999999999999999999999999998888654


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      -...+.                          .+.+.+.+++||.+||++||++|+++.+|..|||...-
T Consensus       335 pL~fP~--------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  335 PLEFPE--------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cccCCC--------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            222211                          23468899999999999999999999999999999866

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-47  Score=333.62  Aligned_cols=263  Identities=35%  Similarity=0.563  Sum_probs=235.7

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcC-CCCeeeeeceeccCC
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   84 (314)
                      ...+.+.|.+.+.||.|.||.||++.++.+|+.+|+|.+.+...... ......+|+++++++. ||||+.+.+.|++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            45677899999999999999999999999999999999988765433 3346679999999998 999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC----CcEEEeecccee
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLAR  159 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~df~~~~  159 (314)
                      .+++|||++.| .|.+.+...  .+++..+..++.|++.++.|||+.|++|+||||+|+++...    +.++++|||++.
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999995 899988877  39999999999999999999999999999999999999543    479999999999


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .... .......+||+.|+|||++.. ..++...||||+|+++|.|++|.+||...........+..+........|+  
T Consensus       188 ~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~--  263 (382)
T KOG0032|consen  188 FIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD--  263 (382)
T ss_pred             EccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc--
Confidence            8866 666778899999999999976 789999999999999999999999999999888888887776655555554  


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                            .++..+.++|++||..||.+|+|+.++|+|||++..
T Consensus       264 ----------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  264 ----------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ----------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                                  569999999999999999999999999999999976

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-47  Score=336.86  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=209.8

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      +.||+|+||.||++.++.+|+.+++|++...... ........+|+++++.++||||+++.+++..++..++||||+.| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999764321 22223456899999999999999999999999999999999986 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCc
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  175 (314)
                      +|...+.. .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|++
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            66666654 44689999999999999999999999999999999999999999999999999875433333334456899


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (314)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                          
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------------------------  212 (323)
T cd05571         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------------------------  212 (323)
T ss_pred             cccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------------------------
Confidence            9999999876 6689999999999999999999999987766555544432210                          


Q ss_pred             CCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       256 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                        .+...+++++.+||.+||..||++||     ++.++++||||++++
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence              11234689999999999999999999     899999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-48  Score=336.65  Aligned_cols=258  Identities=28%  Similarity=0.474  Sum_probs=238.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe-EEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN-LHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv   89 (314)
                      .++|..++++|.|+||.+++++++..++.+++|.+..............+|+.+++++.||||+.+.+.|.+++. .+|+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            478999999999999999999999999999999999988888777788899999999999999999999988887 9999


Q ss_pred             Eecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |+||+| ++.+.+.+++ ..++++.+..|+.|++.|+.|||+++|.|+|||+.|||++.++.|+|+|||+++.++.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            999996 8888887665 67999999999999999999999999999999999999999999999999999999887777


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+||+.|++||.+.+ .+|+.++|||||||++|+|++-+++|.+.+-.....++......+.+.             
T Consensus       163 a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~-------------  228 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS-------------  228 (426)
T ss_pred             hheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc-------------
Confidence            788999999999999987 899999999999999999999999999999999999998876444443             


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                    ..+.+++.||..||..+|..||++.++|.+|.++-
T Consensus       229 --------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  229 --------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             --------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                          34999999999999999999999999999998873

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.5e-47  Score=326.37  Aligned_cols=282  Identities=50%  Similarity=0.872  Sum_probs=231.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++++.||.|++|.||++.++.+|+.+++|.+............+.+|++++++++||||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48899999999999999999999999999999876654444445677899999999999999999999999999999999


Q ss_pred             ccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           93 METDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        93 ~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      +.+++...+... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+...+.........
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence            998988888654 4568999999999999999999999999999999999999999999999999987664443333444


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh-hhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  250 (314)
                      .+++.|+|||.+.+...++.++|+||||+++|+|++|..||..........++....+......++.....+... .+..
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK  240 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence            567889999998775667899999999999999999999999888888888877776665554444322221111 1111


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ..........+.+++++.++|.+||+.||++|||+++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            11122223345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.7e-47  Score=336.14  Aligned_cols=285  Identities=32%  Similarity=0.514  Sum_probs=224.3

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      .+.++|.+.+.||+|+||.||++.+..+++.+++|.+..............+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            457999999999999999999999999999999999876544444444566899999999999999999987533     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...+++|||+++++...+..   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...+
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             35799999999998887753   48899999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....+...++.+......
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            32 22234567889999999876 66889999999999999999999999988877777777666655443322211100


Q ss_pred             c--------------chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 P--------------DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .              ..........+.........+.++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence            0              0000000001111112233567899999999999999999999999999998664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-46  Score=336.34  Aligned_cols=286  Identities=32%  Similarity=0.513  Sum_probs=225.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      .+.++|.+.+.||+|++|.||.+.+..+++.+++|++............+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            357899999999999999999999999999999999976544444445667899999999999999999887433     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...|+||||+++++...+..   .+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||++...+
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             35799999999998887753   37889999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+....+...+..++.....
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            32 22234567889999999977 66899999999999999999999999998888888887776665443322211110


Q ss_pred             cc--------------hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PD--------------YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..              .........+.........+..+.+||.+||+.||.+|||+.|+|+||||+.+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence            00              0000000011111112234678999999999999999999999999999987644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-47  Score=334.84  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=215.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.+.+.||+|++|.||++.++.+|+.+++|.+..... .......+.+|+.+++.++||||+++++++.+++..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            5889999999999999999999999999999999976532 122234566899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|.+.+... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......   
T Consensus        97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---  172 (329)
T ss_pred             EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence            999985 777777654 468999999999999999999999999999999999999999999999999998653322   


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....     .+            
T Consensus       173 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----~~------------  234 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL-----KF------------  234 (329)
T ss_pred             ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc-----CC------------
Confidence            23468889999999876 5678999999999999999999999988776666555543211     01            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCcccccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSF  297 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~  297 (314)
                                 ...+++.+.+||.+||+.||.+||+     ++++++||||++.
T Consensus       235 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        235 -----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             -----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                       1235889999999999999999997     7999999999874

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-46  Score=322.94  Aligned_cols=283  Identities=41%  Similarity=0.711  Sum_probs=225.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++.++.+|+.+++|.+............+.+|+.+++.++|+|++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999999899999999987654444444456789999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |+++++++.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY  160 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence            99998777776666679999999999999999999999999999999999999999999999999998765443333344


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC---CcCcccchhhh
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP---DLAYLPDYVEY  248 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  248 (314)
                      .++..|+|||.+.+...++.++|+||||+++++|++|..||......+....+....+...+....   ...........
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07847         161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP  240 (286)
T ss_pred             ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence            567889999998775667899999999999999999999998887777666655544433221100   00000000000


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ......+.....+.++..+.+|+.+||+.||++||++.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0011111122345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-46  Score=326.74  Aligned_cols=284  Identities=44%  Similarity=0.829  Sum_probs=235.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   88 (314)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.++...........+.+|+.+++.++||||+++.+++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999998999999999987655443334556899999999999999999988766  89999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ++||++++|.+.+......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99999999999887766679999999999999999999999999999999999999999999999999998775543444


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....+++.|+|||.+.+...++.++|+||||+++++|++|.+||...........+....+...+..|+.....+.....
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            45567888999999877566789999999999999999999999998888888888877776666655544333322211


Q ss_pred             ccc--cCCCCCccCCC--CCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYV--AAPPLRSLFPS--ASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~--~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ...  .........+.  +++.+.++|++||+.||++|||++|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            111  11111222233  48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-46  Score=325.32  Aligned_cols=261  Identities=25%  Similarity=0.361  Sum_probs=214.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .|+..+.||+|+||.||++.+..+|+.+++|.+....... .....+.+|+++++.++|++++++.+++.+++..++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3788999999999999999999999999999987654322 222345689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |+.| +|...+... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            9985 676666543 346899999999999999999999999999999999999999999999999999875322 2233


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+........                 
T Consensus       160 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  221 (285)
T cd05631         160 GRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-----------------  221 (285)
T ss_pred             CCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------------
Confidence            4568899999999976 6789999999999999999999999987655433333322211111                 


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccCc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFNG  299 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~~  299 (314)
                             ......+++++.+|+.+||+.||.+||+     ++++++||||+.++.
T Consensus       222 -------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         222 -------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             -------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                   1122346899999999999999999997     899999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-47  Score=340.11  Aligned_cols=285  Identities=34%  Similarity=0.561  Sum_probs=226.1

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-----eEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   87 (314)
                      +|.+.+.||+|++|.||++.+..+|+.||+|.+............+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999999999999998654333333345678999999999999999999987766     789


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-C
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-R  166 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~  166 (314)
                      +|+||+.+++...+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus        81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            99999999988887654 368999999999999999999999999999999999999999999999999998653322 1


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc-h
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD-Y  245 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (314)
                      ......+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+......+........ .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  239 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH  239 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence            223345788899999998756689999999999999999999999999988888888877766554433221100000 0


Q ss_pred             hhhccccCCC---CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ........+.   ........++++.+||.+||+.||++|||++|+++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            0000000000   1122345688999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-47  Score=336.98  Aligned_cols=286  Identities=34%  Similarity=0.583  Sum_probs=226.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      ++.++|.+.+.||.|+||+||++.+..++..||+|.+............+.+|+++++.++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            467899999999999999999999999999999999876543333334566899999999999999999987433     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...+++++++++++...+...  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence             357899999988888777543  49999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   .....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+...+..+......
T Consensus       170 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            32   234567889999999877567899999999999999999999999988888877777766555443322211111


Q ss_pred             cchh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ....   .........+.......++.+.+||.+||+.||.+|||+.|+++||||..+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            0000   00000111122233456788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-46  Score=325.85  Aligned_cols=284  Identities=45%  Similarity=0.789  Sum_probs=230.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCe-----
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGN-----   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----   85 (314)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            5799999999999999999999999999999998776544444456778999999995 6999999998866554     


Q ss_pred             EEEEEecccccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceee
Q 021299           86 LHLVFEFMETDLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~  160 (314)
                      .|++|||+++++.+++...    ...+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999998888653    235899999999999999999999999999999999999998 88999999999986


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ............+++.|+|||.+.+...++.++|+||||+++|+|++|..||...........+...........++...
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            54433333444567889999998765667999999999999999999999999888888887777766655555554433


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      ....................+.+++++.++|.+||..||.+||+++|++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            3333222222222222333456799999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-46  Score=323.12  Aligned_cols=283  Identities=48%  Similarity=0.887  Sum_probs=235.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||+|++|.||++.+..+|..+++|.+............+.+|+.++++++|+|++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            58999999999999999999998999999999987654444445677899999999999999999999999999999999


Q ss_pred             ccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-ccccc
Q 021299           93 METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQ  171 (314)
Q Consensus        93 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~  171 (314)
                      ++++|.+.+......+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence            97799998887767799999999999999999999999999999999999999999999999999987644321 23345


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc-
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY-  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  250 (314)
                      .++..|+|||.+.+...++.++|+||||+++++|++|.+||....+......+....+...+..|+............. 
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP  240 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence            6788899999987756679999999999999999999999988888888888877777666655554333322211111 


Q ss_pred             -ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       251 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                       ..........+..+.++.++|.+||..+|++||+++++++||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             111112334456789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-47  Score=337.86  Aligned_cols=260  Identities=30%  Similarity=0.480  Sum_probs=218.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||+|++|+||+|.+..+|+.||+|++....... .....+.+|++++..++|+||+++++++.++++.++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997654322 23345668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC----
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~----  165 (314)
                      ||+.| +|.+.+... +.+++..++.++.||+.||++||++|++|+||||+||+++.++.++|+|||.+.......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99975 888887765 569999999999999999999999999999999999999999999999999997654333    


Q ss_pred             -------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH
Q 021299          166 -------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (314)
Q Consensus       166 -------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~  220 (314)
                                               .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                     22334568899999999977 5789999999999999999999999998887666


Q ss_pred             HHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-HHHHhcCccccccC
Q 021299          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRFAKSFN  298 (314)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~h~~~~~~~  298 (314)
                      ...+........   .+                     ....+++++.+||.+||. ||.+||+ ++++++||||+++.
T Consensus       239 ~~~i~~~~~~~~---~p---------------------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         239 YNKIINWKESLR---FP---------------------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHhccCCccc---CC---------------------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            666544211111   00                     011258999999999997 9999999 99999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=339.87  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=224.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|+++++||.|.||+|+++..+.+++.||||++++...-.. .....+.|.+++...+ ||.++.++..|+...+.|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            4789999999999999999999999999999999998764333 3334557888887775 9999999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||||+.|+.... ....+.+++..++-++..|+.||.|||++||+|||||.+||++|.+|.+||+|||+|+..-......
T Consensus       447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T  525 (694)
T KOG0694|consen  447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT  525 (694)
T ss_pred             EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence            999999755222 2334569999999999999999999999999999999999999999999999999998765455566


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....|||.|+|||++.+ ..|+.+.|.|+|||+||+|+.|..||.+.+..+....+......     +            
T Consensus       526 sTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-----y------------  587 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-----Y------------  587 (694)
T ss_pred             ccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----C------------
Confidence            77889999999999988 78999999999999999999999999999999999888654211     1            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                                 +..++.++.++++++|..+|++|...     ++|..||||+.++
T Consensus       588 -----------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  588 -----------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             -----------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence                       12469999999999999999999976     7799999999985

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.7e-46  Score=323.36  Aligned_cols=289  Identities=48%  Similarity=0.842  Sum_probs=235.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||.|++|+||++.++.+|+.+++|.+............+.+|+++++.++|+||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999987654444444566789999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |+++++.+.+.... ..+++..++.++.||+.||++||++|++|+||+|+||+++. ++.++|+|||.+...+.......
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            99999888876543 34688899999999999999999999999999999999985 45799999999976544433334


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+......|.....++......
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            45667889999998775668899999999999999999999999888888888877776666655555443333321111


Q ss_pred             cc-cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          250 YV-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       250 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .. .........+.+++++.+++.+||+.+|++||++.++++||||..+.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence            11 1111222345678999999999999999999999999999999987653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.9e-47  Score=338.18  Aligned_cols=284  Identities=33%  Similarity=0.554  Sum_probs=230.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-C-----CCeeeeeceec
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-S-----PHIIELIDAFP   81 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~   81 (314)
                      +-|.-+|.+.++||+|+||.|.+|.+..+++.||||+++....-   ......|+.+|..++ |     -|+|++.++|.
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f---~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF---LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH---HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            33445999999999999999999999999999999999865432   224457999999997 3     58999999999


Q ss_pred             cCCeEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC--cEEEeeccce
Q 021299           82 HKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLA  158 (314)
Q Consensus        82 ~~~~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~~~l~df~~~  158 (314)
                      ..++.|+|+|.++-+|.++++.. -.+++...++.++.||+.||..||+.||+|+||||+|||+...+  .+||+|||.+
T Consensus       259 fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  259 FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999999999999999865 34699999999999999999999999999999999999997654  7999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      +.....-   ...+-+..|.|||++.+ .+|+.+-||||||||+.||++|.+.|.+.++.++++.|++.++.+++.-+..
T Consensus       339 c~~~q~v---ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQRV---YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCcc---eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9764322   25566788999999998 8899999999999999999999999999999999999999998766543331


Q ss_pred             cCcccchhhh------------------------------ccccCC----CCCccCC-CCCHHHHHHHhhhcccCCCCCC
Q 021299          239 LAYLPDYVEY------------------------------QYVAAP----PLRSLFP-SASDDALDLLSKMFTYDPKARI  283 (314)
Q Consensus       239 ~~~~~~~~~~------------------------------~~~~~~----~~~~~~~-~~~~~~~~li~~~l~~dp~~Rp  283 (314)
                      ........+.                              .....+    .+..... .....+.+++++||++||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence            1111000000                              000011    1112222 3456689999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 021299          284 TAQQALEHRFAKSFN  298 (314)
Q Consensus       284 s~~ell~h~~~~~~~  298 (314)
                      |+.|+|+||||..-.
T Consensus       495 tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTS  509 (586)
T ss_pred             CHHHHhcCccccccc
Confidence            999999999999543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-46  Score=332.78  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=215.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC-cEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|.+.+.||+|++|.||+|.+..++ ..+++|.+...... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            578999999999999999999866554 68999998754322 2223356689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......   
T Consensus       109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence            9999975 777777654 46899999999999999999999999999999999999999999999999999875432   


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......                 
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----------------  246 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-----------------  246 (340)
T ss_pred             cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence            234568889999999876 56789999999999999999999999988777666665443211                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                 ....+++.+.++|++||+.||.+|+     +++++++||||++++
T Consensus       247 -----------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        247 -----------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             -----------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                       1123588999999999999999995     899999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=331.86  Aligned_cols=261  Identities=28%  Similarity=0.408  Sum_probs=217.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997653221 22335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+++... +.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.....   ...
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            99985 777777644 4689999999999999999999999999999999999999999999999999976533   234


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+.............            
T Consensus       157 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------------  223 (333)
T cd05600         157 SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD------------  223 (333)
T ss_pred             CcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC------------
Confidence            4568899999999977 578999999999999999999999998887766665554321111100000            


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                              .....+++++.+||.+||..+|++||+++++++||||+..
T Consensus       224 --------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         224 --------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             --------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence                    0012468999999999999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-46  Score=335.26  Aligned_cols=278  Identities=25%  Similarity=0.340  Sum_probs=215.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+++.||+|++|.||++.+..+++.+|+|....        ....+|++++++++||||+++++++..+...++++|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            679999999999999999999999999999997532        234589999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC-CCcccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-DRRFTH  170 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~  170 (314)
                      ++.+++...+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ......
T Consensus       164 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        164 RYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence            99999988887654 5899999999999999999999999999999999999999999999999999653222 223334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC-------cHHHHHHHHHhhCCCCCCCCCCcCc--
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-------DIDQLGKIFAAFGTATPSQWPDLAY--  241 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~--  241 (314)
                      ..||+.|+|||++.+ ..++.++||||||+++|+|++|..||-...       .......+....+..+. .++....  
T Consensus       243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~-~~~~~~~~~  320 (391)
T PHA03212        243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN-EFPIDAQAN  320 (391)
T ss_pred             ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh-hcCcchhHH
Confidence            578999999999876 668999999999999999999997664322       23445555555444322 2221100  


Q ss_pred             ccchh-hhcc--ccCC---CCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          242 LPDYV-EYQY--VAAP---PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       242 ~~~~~-~~~~--~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ..... ....  ...+   +.......++.++.+||.+||+.||.+|||++|+|+||||+.+...
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            00000 0000  0000   0001112357789999999999999999999999999999987543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-46  Score=321.31  Aligned_cols=283  Identities=41%  Similarity=0.772  Sum_probs=224.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||+|++|.||++.++.+++.|++|.+....... ....+.+|+++++.++|+||+++++++.+++..++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            378999999999999999999998899999999987654322 2234568999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||++++|.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            99999999988876667899999999999999999999999999999999999999999999999998754333333333


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..++..|+|||.+.+...++.++|+||+|+++|+|++|..||.... ..+....+....+...+..++............
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            4467789999998765667899999999999999999999997665 445555555555555454444333222111111


Q ss_pred             c--ccCCCCCccCCCCC--HHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 Y--VAAPPLRSLFPSAS--DDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~--~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .  .....+......++  ..+.+++.+||+.+|++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1  11111222223344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-46  Score=329.26  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=209.4

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      +.||+|+||.||++.+..+|..|++|.+...... ......+.+|+++++.++||||+++.+.+..++..++||||++| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999765321 12223456799999999999999999999999999999999986 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCc
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  175 (314)
                      +|...+.. .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|++
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            66665554 34689999999999999999999999999999999999999999999999999875433333334456889


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (314)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                          
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--------------------------  212 (323)
T cd05595         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------------------------  212 (323)
T ss_pred             CcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------------------
Confidence            9999999876 5679999999999999999999999988776665555432211                          


Q ss_pred             CCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       256 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                        .....+++++.++|.+||..||.+||     ++.++++||||.+..
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence              01124689999999999999999998     899999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-46  Score=319.42  Aligned_cols=281  Identities=53%  Similarity=0.920  Sum_probs=230.8

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      |++.+.||.|++|.||++.++.+|..+++|++............+.+|++.++.++|+|++++++++.+++..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67899999999999999999999999999999876544444456778999999999999999999999999999999999


Q ss_pred             cccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccc
Q 021299           94 ETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        94 ~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      ++++.+++.... ..+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  160 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV  160 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence            989988887654 4689999999999999999999999999999999999999999999999999976544333333445


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh-hccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  251 (314)
                      +++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+.......+...........|+.....+.... +...
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW  240 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence            678899999887755678999999999999999999999998888777777777665555544443332222211 1111


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .........+.+++.+.++|.+||+.||++|||++|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2222333455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-46  Score=326.82  Aligned_cols=295  Identities=42%  Similarity=0.763  Sum_probs=243.2

Q ss_pred             cHHHHhhccc-eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC------------cchhhHHHHHHHhhcCCCCe
Q 021299            7 SKKVADRYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------------VNFTALREIKLLKELKSPHI   73 (314)
Q Consensus         7 ~~~~~~~y~~-~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i   73 (314)
                      ...+.++|.. .+.||+|++|+||++.+..+++.+++|++........            ....+.+|+++++.++|+||
T Consensus         3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   82 (335)
T PTZ00024          3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI   82 (335)
T ss_pred             ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence            4567889975 4779999999999999999999999999876533221            11235689999999999999


Q ss_pred             eeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEe
Q 021299           74 IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLA  153 (314)
Q Consensus        74 ~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~  153 (314)
                      +++.+++..++..+++||++.|++.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999999999999998888654 358999999999999999999999999999999999999999999999


Q ss_pred             eccceeeeCC--------------CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH
Q 021299          154 DFGLARIFGS--------------PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID  219 (314)
Q Consensus       154 df~~~~~~~~--------------~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~  219 (314)
                      |||.+.....              .........+++.|+|||.+.+...++.++|+||||+++++|++|.+||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999976641              11122233457789999998775667999999999999999999999999999888


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ....+....+......|+.....+....................++++.++|.+||+.+|++||+++|++.||||+....
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            88888888777777667665544444433333444444455667899999999999999999999999999999998876


Q ss_pred             cee
Q 021299          300 VFV  302 (314)
Q Consensus       300 ~~~  302 (314)
                      ...
T Consensus       322 ~~~  324 (335)
T PTZ00024        322 PCD  324 (335)
T ss_pred             CCC
Confidence            543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-46  Score=327.11  Aligned_cols=249  Identities=28%  Similarity=0.406  Sum_probs=208.1

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||+|+||+||++.+..+++.+++|.+..... .......+..|+.+++.++||||+++.+++...+..++||||++| +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999999999999999875432 222233556899999999999999999999999999999999986 77


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccc
Q 021299           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (314)
Q Consensus        98 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  177 (314)
                      .+.+... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|++.|
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            7777654 468999999999999999999999999999999999999999999999999997643333333445689999


Q ss_pred             cCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCC
Q 021299          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (314)
Q Consensus       178 ~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (314)
                      +|||.+.+ ..++.++||||||+++|+|++|..||...+.......+....     .                       
T Consensus       160 ~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-----~-----------------------  210 (312)
T cd05585         160 LAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-----L-----------------------  210 (312)
T ss_pred             CCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----C-----------------------
Confidence            99999876 668999999999999999999999998877665555443210     0                       


Q ss_pred             ccCCCCCHHHHHHHhhhcccCCCCCC---CHHHHhcCccccccC
Q 021299          258 SLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRFAKSFN  298 (314)
Q Consensus       258 ~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~~  298 (314)
                      .....+++++.++|.+||+.||.+||   ++.+++.||||+..+
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            11234688999999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-46  Score=332.40  Aligned_cols=260  Identities=25%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++++.||+|++|+||++.++.+++.||+|++...... ......+..|+.+++.++|++|+++++.+++....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999999764322 222234567999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC---
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---  166 (314)
                      ||++| +|.+.+... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........   
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99986 777777654 4699999999999999999999999999999999999999999999999999875422110   


Q ss_pred             --------------------------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC
Q 021299          167 --------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG  214 (314)
Q Consensus       167 --------------------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~  214 (314)
                                                      ......||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            0123468999999999876 5688999999999999999999999988


Q ss_pred             CCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCC---CCCCHHHHhcC
Q 021299          215 SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPK---ARITAQQALEH  291 (314)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rps~~ell~h  291 (314)
                      ....+....+.......   ..+.                     ...+++++.++|.+|+. +|.   .||+++||++|
T Consensus       239 ~~~~~~~~~i~~~~~~~---~~p~---------------------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYKKVMNWKETL---IFPP---------------------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHHHHHcCcCcc---cCCC---------------------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            87777666654321110   0000                     11358899999999776 444   46899999999


Q ss_pred             ccccccC
Q 021299          292 RFAKSFN  298 (314)
Q Consensus       292 ~~~~~~~  298 (314)
                      |||+.++
T Consensus       294 p~f~~~~  300 (363)
T cd05628         294 PFFEGVD  300 (363)
T ss_pred             CCCCCCC
Confidence            9999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-46  Score=333.62  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=213.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||+||++++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999999999999999999764322 122234567999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC---
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---  166 (314)
                      ||+.| +|.+.+... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........   
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99985 677776654 4699999999999999999999999999999999999999999999999999875422110   


Q ss_pred             -----------------------------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc
Q 021299          167 -----------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF  211 (314)
Q Consensus       167 -----------------------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p  211 (314)
                                                         ......||+.|+|||++.. ..++.++|||||||++|+|++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCC
Confidence                                               0112358999999999876 6689999999999999999999999


Q ss_pred             cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHH
Q 021299          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQA  288 (314)
Q Consensus       212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~el  288 (314)
                      |...........+.......   ..+.                     ...+++++.+||.+||. +|.+|++   ++++
T Consensus       239 f~~~~~~~~~~~i~~~~~~~---~~~~---------------------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l  293 (364)
T cd05599         239 FCSDNPQETYRKIINWKETL---QFPD---------------------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI  293 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCcc---CCCC---------------------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence            98887666655554321100   0010                     11458999999999997 9999998   9999


Q ss_pred             hcCccccccC
Q 021299          289 LEHRFAKSFN  298 (314)
Q Consensus       289 l~h~~~~~~~  298 (314)
                      +.||||+..+
T Consensus       294 l~h~~~~~~~  303 (364)
T cd05599         294 KSHPFFKGVD  303 (364)
T ss_pred             hcCCCcCCCC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-46  Score=327.11  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHH---hhcCCCCeeeeeceeccCCeEEEE
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLL---KELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      |++++.||+|++|.||++.+..+|+.|++|.+...... ......+..|.+++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999764321 12223344555544   566899999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|...+..  +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..........
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999986 66665543  359999999999999999999999999999999999999999999999999987543333333


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+......                  
T Consensus       159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------------  219 (324)
T cd05589         159 STFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR------------------  219 (324)
T ss_pred             cccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence            44568899999999876 66789999999999999999999999888776666555432111                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                ....+++.+.++|.+||+.||++||     ++.++++||||+.+.
T Consensus       220 ----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         220 ----------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             ----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                      1124588999999999999999999     799999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.4e-46  Score=331.30  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=218.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||+|++|+||++.++.+|+.+++|.+..... .......+.+|+.+++.++|++|+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999986543 2223334568899999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~  168 (314)
                      ||++| +|.+++......+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99975 88888877666799999999999999999999999999999999999999999999999999987643322 22


Q ss_pred             cccccCccccCcccccC-----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          169 THQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      ....+++.|+|||.+..     ...++.++||||||+++|+|++|..||...........+......   ..++      
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~------  231 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---LKFP------  231 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---cCCC------
Confidence            33468899999999863     345789999999999999999999999887776666655432110   0111      


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                     ..+.+++++.+||.+||+ +|.+||++++++.||||+.++
T Consensus       232 ---------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         232 ---------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             ---------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence                           012468999999999998 999999999999999999764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-46  Score=328.29  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      +.||+|+||.||++.+..+|..+|+|++...... ......+.+|+++++.++||||+++.+.+...+..++||||++| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999999999999999999765322 22234566899999999999999999999999999999999986 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCc
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  175 (314)
                      +|...+.. .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|++
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            66666654 34689999999999999999999999999999999999999999999999999875433333334456889


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (314)
                      .|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+....     .                     
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-----~---------------------  212 (328)
T cd05593         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-----I---------------------  212 (328)
T ss_pred             CccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-----c---------------------
Confidence            9999999876 567999999999999999999999998766555544432210     0                     


Q ss_pred             CCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       256 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                        .+...+++++.++|.+||..||++|+     +++++++||||...+
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         213 --KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             --cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence              11234689999999999999999997     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-45  Score=330.06  Aligned_cols=261  Identities=26%  Similarity=0.331  Sum_probs=215.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|++|.||++.++.+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            578999999999999999999999999999999997543222 2223456899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||++| +|.+.+...  .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........ .
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            999985 777776543  488999999999999999999999999999999999999999999999999987643322 2


Q ss_pred             ccccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....|++.|+|||.+.+.   ..++.++|+||||+++|+|++|..||...........+......   ..++.      
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~------  270 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS---LTFPD------  270 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---CCCCC------
Confidence            2345689999999998652   24789999999999999999999999988776666665432111   11111      


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~  297 (314)
                                     ...++.++.+||++||+.+|.+  |++++++++||||+..
T Consensus       271 ---------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         271 ---------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             ---------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                           1235899999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.5e-46  Score=325.90  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|++|+||++.++.+++.|++|.+..... .......+..|..+++.+ +||||+++++++...+..++||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999976432 122233455777888766 699999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence             676666544 469999999999999999999999999999999999999999999999999987643333333445689


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                        
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------------------  214 (320)
T cd05590         160 PDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------------------  214 (320)
T ss_pred             ccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------------------------
Confidence            99999999876 66789999999999999999999999988777766665432110                        


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH------HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~h~~~~~~~  298 (314)
                          ....+++++.++|.+||+.||.+||++      +++++||||+.+.
T Consensus       215 ----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         215 ----YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             ----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence                112358899999999999999999998      9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-45  Score=318.75  Aligned_cols=281  Identities=44%  Similarity=0.830  Sum_probs=228.9

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||.|++|.||++.+..+|..+++|.+...... .....+.+|+++++.++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            589999999999999999999999999999999765432 2234566899999999999999999999999999999999


Q ss_pred             ccccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 METDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ++|++.+.+....  ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            9999988887544  56899999999999999999999999999999999999999999999999999765443333344


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh-hc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  249 (314)
                      ..++..|+|||.+.+...++.++|+||||+++|+|++|..||......+...++...........+........... ..
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            55678899999987756678999999999999999999999999888888888777766555554443332221110 00


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ...........+.+++.+.++|.+||+.||++||+++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000111122334568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=321.86  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=212.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcE-EEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-eEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~-~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~i   88 (314)
                      .+...+.+.||+|+||+||++.+.  |.. +++|.+............+.+|+.++.+++||||+++++++.+.. ..++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            455566777999999999999766  555 999999877655554668889999999999999999999998877 7999


Q ss_pred             EEeccc-ccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCceEEecCC-cEEEeeccceeeeCCC
Q 021299           89 VFEFME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSP  164 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~  164 (314)
                      ||||++ |+|..++.. ....++...+..++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999998 578888877 4778999999999999999999999999 99999999999999997 9999999999877544


Q ss_pred             CCcccccccCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          165 DRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      ........||+.|||||++.+ ...++.++||||+|+++|+|+||..||...........+........           
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-----------  266 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-----------  266 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence            334444789999999999985 26799999999999999999999999999888555555543322111           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                                     +....++.+..|+.+||..||.+||+..+++
T Consensus       267 ---------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  267 ---------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             ---------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence                           1123588999999999999999999998875

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-46  Score=319.44  Aligned_cols=259  Identities=34%  Similarity=0.528  Sum_probs=215.4

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      |++.+.||+|++|+||++.+..+++.+|+|.+..............+|+..+++++||||+++.+++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999987655544444456999999999999999999999999999999999


Q ss_pred             cc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccc
Q 021299           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        94 ~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      ++ +|.+++. ..+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            98 8888887 344589999999999999999999999999999999999999999999999999987544455556677


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
                      +++.|+|||.+......+.++|+||||+++++|++|..||...........+..............              
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  225 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ--------------  225 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS--------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc--------------
Confidence            889999999987347789999999999999999999999988743333333322211111110000              


Q ss_pred             CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       253 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             ....+.++.++|.+||+.||++||+++++++||||
T Consensus       226 -------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 -------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                   01113789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8e-46  Score=325.56  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=212.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCC-CCeeeeeceeccCCeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +|++.+.||+|++|.||+|.++.+++.||+|++...... ......+..|.+++..+.| ++|+.+.+++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999764321 2223345678888988876 46888999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|...+... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99985 777776554 4589999999999999999999999999999999999999999999999999875433333334


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.....                    
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------------------  218 (324)
T cd05587         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------------------  218 (324)
T ss_pred             eecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            4568899999999976 6678999999999999999999999988777666665543211                    


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                              .....+++++.+++.+||..||.+|++.     +++++||||+..+
T Consensus       219 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         219 --------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                    1112458899999999999999999986     8999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.8e-45  Score=324.26  Aligned_cols=285  Identities=25%  Similarity=0.388  Sum_probs=216.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+..+|..+++|.+..... ......+.+|+++++.++||||+++++++..++..+++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            4799999999999999999999999999999999876432 223346778999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++| +|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......  ..
T Consensus        83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  159 (331)
T cd06649          83 EHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (331)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence            99986 7777776543 589999999999999999999986 6999999999999999999999999998755322  22


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc----
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD----  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  244 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....................    
T Consensus       160 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34568889999999876 5689999999999999999999999987665444332211110000000000000000    


Q ss_pred             ---------------hhhhccccCCCCCcc-CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 ---------------YVEYQYVAAPPLRSL-FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 ---------------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                     ............+.. ...+++++.+||.+||+.||++|||++++++||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  310 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence                           000000000000000 12468899999999999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-45  Score=316.36  Aligned_cols=254  Identities=25%  Similarity=0.354  Sum_probs=207.1

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||+|+||+||++.++.+|+.+++|.+........ ....+..|+++++.++|++|+++.+++......+++|||++| +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999999999999999876533221 223456799999999999999999999999999999999985 77


Q ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           98 ETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        98 ~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                      ...+..   ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+..............++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            666543   34568999999999999999999999999999999999999999999999999998765444444455788


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+........                      
T Consensus       161 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------  217 (280)
T cd05608         161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----------------------  217 (280)
T ss_pred             cCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC----------------------
Confidence            89999999977 5678999999999999999999999977554333222222211111                      


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                        ......+++.+.+++.+||+.||++||     +++++++||||+.++
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         218 --VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             --CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence              011234689999999999999999999     889999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.4e-46  Score=324.71  Aligned_cols=250  Identities=27%  Similarity=0.367  Sum_probs=208.6

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||.||+|.++.+++.+++|.+...... ......+..|.+++..+ +||+|+++++++..++..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999764322 22223455788888766 799999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..............|+
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence             777666544 458999999999999999999999999999999999999999999999999997643333334455688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+......                        
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~------------------------  214 (321)
T cd05591         160 PDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL------------------------  214 (321)
T ss_pred             ccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------------
Confidence            99999999876 66899999999999999999999999988877766665432110                        


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCC-------CHHHHhcCcccccc
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-------TAQQALEHRFAKSF  297 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~ell~h~~~~~~  297 (314)
                          ....+++++.+++.+||+.||++||       +++++++||||..+
T Consensus       215 ----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         215 ----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                0113588999999999999999999       99999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-45  Score=318.34  Aligned_cols=285  Identities=42%  Similarity=0.726  Sum_probs=224.6

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   83 (314)
                      ..++|.+.+.||+|++|.||++.+..+++.+++|.+..............+|++++++++||||+++++++...      
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            45789999999999999999999999999999999876554443344556899999999999999999987543      


Q ss_pred             --CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           84 --GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        84 --~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                        ...+++|||+++++.+.+......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              346999999999999988877667999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCC----cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          162 GSPDR----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       162 ~~~~~----~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      .....    ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||...+.......+....+..++..++
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            33221    11233567789999998775567899999999999999999999999888777777776666655555554


Q ss_pred             CcCcccchhhhccccCC--CCCc--cCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          238 DLAYLPDYVEYQYVAAP--PLRS--LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .................  ....  .....+..+.++|.+||..||.+|||++++++||||
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            43222211111000000  0000  001136778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=317.20  Aligned_cols=258  Identities=28%  Similarity=0.499  Sum_probs=231.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCC-cccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++..+|.+.+.||+|.+|.|-++.....|..||||.++++. .+++....+.+|++++..++||||++++.+|++.+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            357789999999999999999999988999999999998875 4445556788999999999999999999999999999


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .|||||.. |.|.+++.+++ .+++..++.+++||++|+.|+|+++++|+|||.+||+++.|+++||.|||++-... +.
T Consensus       129 vivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~-~~  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-DK  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-cc
Confidence            99999998 58999998765 59999999999999999999999999999999999999999999999999997663 33


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ......+|+|.|.+||++.+..+-.+..|.||||++||.|+.|..||.+.+....+.++..+....++            
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~------------  274 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE------------  274 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC------------
Confidence            44456789999999999999777789999999999999999999999999999999998877443332            


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                       -+..+.-||+.||..+|++|.|+++|.+|=|++=
T Consensus       275 -----------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  275 -----------------TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             -----------------CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence                             2777999999999999999999999999999873

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=327.93  Aligned_cols=262  Identities=28%  Similarity=0.415  Sum_probs=224.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ...|+..+.||.|+||.||+|.+..+++.||+|++........ ...+.+|+.++..++++||.+.++.|..+...+++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3578889999999999999999999999999999988765443 346778999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |||.|+...-+.+.+..+++..+..++++++.|+.|||..+.+|+|||+.||++..+|.|+|+|||.+............
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99997555555555555689999999999999999999999999999999999999999999999999988776666688


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .+|||.|||||++.+ ..|+.++||||||++.++|++|.+|+....+...+..+    ....|..+              
T Consensus       171 fvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~~PP~L--------------  231 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKSAPPRL--------------  231 (467)
T ss_pred             ccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCCCCCcc--------------
Confidence            899999999999985 78999999999999999999999999887773332222    11112111              


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                               ....++.+++||..||+.||+.||+|.++|+|+|++.-.+..
T Consensus       232 ---------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s  273 (467)
T KOG0201|consen  232 ---------DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTS  273 (467)
T ss_pred             ---------ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCch
Confidence                     124689999999999999999999999999999999855433

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-45  Score=330.33  Aligned_cols=260  Identities=26%  Similarity=0.356  Sum_probs=209.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .|.+++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            589999999999999999999999999999999765322 2223356689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-----
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-----  165 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-----  165 (314)
                      |++| +|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9985 777777654 358999999999999999999999999999999999999999999999999875321100     


Q ss_pred             ------------------------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHH
Q 021299          166 ------------------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFA  203 (314)
Q Consensus       166 ------------------------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~  203 (314)
                                                                .......||+.|+|||.+.+ ..++.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHH
Confidence                                                      00112468899999999876 56789999999999999


Q ss_pred             HHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcc--cCCCC
Q 021299          204 ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT--YDPKA  281 (314)
Q Consensus       204 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~--~dp~~  281 (314)
                      +|++|..||...........+.......   ..+                     ....+++++.+||.+|+.  .+|.+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~---------------------~~~~~s~~~~dli~~ll~~~~~~~~  295 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTL---HIP---------------------PQVKLSPEAVDLITKLCCSAEERLG  295 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHcccccc---CCC---------------------CCCCCCHHHHHHHHHHccCcccccC
Confidence            9999999998877665555443221110   011                     012468999999999665  45555


Q ss_pred             CCCHHHHhcCccccccC
Q 021299          282 RITAQQALEHRFAKSFN  298 (314)
Q Consensus       282 Rps~~ell~h~~~~~~~  298 (314)
                      |+++++++.||||+.+.
T Consensus       296 R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         296 RNGADDIKAHPFFSEVD  312 (381)
T ss_pred             CCCHHHHhcCcccCCCC
Confidence            99999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=311.81  Aligned_cols=261  Identities=26%  Similarity=0.349  Sum_probs=222.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+.|++++.||.|.-|+||+++.+.++..+|+|++.+..... ....+...|.++|+.++||.++.+++.|+.+...|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            368899999999999999999999999999999998876543 2333455799999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC----
Q 021299           90 FEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS----  163 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~----  163 (314)
                      ||||.| +|..+.+++ ++.+++..++-++..++.||+|||..||++|||||+||||-++|.+.|+||.++.....    
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence            999996 788777765 55799999999999999999999999999999999999999999999999988732200    


Q ss_pred             -----------------------------C-C----------------------CcccccccCccccCcccccCccCCCC
Q 021299          164 -----------------------------P-D----------------------RRFTHQVFARWYRAPELLFGAKQYGA  191 (314)
Q Consensus       164 -----------------------------~-~----------------------~~~~~~~~~~~y~sPE~~~~~~~~~~  191 (314)
                                                   . .                      ......+||-.|+|||++.+ ..-+.
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgs  314 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGS  314 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCc
Confidence                                         0 0                      11123456777999999998 44689


Q ss_pred             cchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHH
Q 021299          192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL  271 (314)
Q Consensus       192 ~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  271 (314)
                      +.|.|+||+++|||+.|..||++.+..+++..+.......+..                          +.++..+++||
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--------------------------~~vs~~akDLI  368 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--------------------------PEVSSAAKDLI  368 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------------------------CcchhHHHHHH
Confidence            9999999999999999999999999999999887653322221                          24688999999


Q ss_pred             hhhcccCCCCCCC----HHHHhcCccccccC
Q 021299          272 SKMFTYDPKARIT----AQQALEHRFAKSFN  298 (314)
Q Consensus       272 ~~~l~~dp~~Rps----~~ell~h~~~~~~~  298 (314)
                      +++|.+||.+|..    ++||.+||||++++
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcCccccCCC
Confidence            9999999999999    99999999999985

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-45  Score=322.88  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=207.8

Q ss_pred             eeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcc--cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           17 REVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++.||+|+||.||++++.   .+++.+++|.+......  ......+.+|+.+++.++||||+++++.+..++..|++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   46789999999764321  1222345679999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |+.| +|.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            9986 676666544 46889999999999999999999999999999999999999999999999998754333333344


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....                     
T Consensus       160 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------------------  217 (323)
T cd05584         160 FCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------------------  217 (323)
T ss_pred             cCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            568899999999876 5678999999999999999999999988777666655543211                     


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCcccccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~  297 (314)
                             ...+.+++.+.++|.+||..||++||     +++++++||||+..
T Consensus       218 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         218 -------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                   11224588999999999999999999     89999999999865

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3e-45  Score=321.03  Aligned_cols=274  Identities=38%  Similarity=0.674  Sum_probs=206.9

Q ss_pred             eeeeCccccceEEEEEEC--CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--cCCeEEEEEec
Q 021299           17 REVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGNLHLVFEF   92 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~   92 (314)
                      ...||+|+||+||+|.++  .++..+++|.+.....    .....+|++++++++||||+++.+.+.  .+...+++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999865  3668899999864432    234568999999999999999999874  45678999999


Q ss_pred             ccccHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE----ecCCcEEEeeccceee
Q 021299           93 METDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARI  160 (314)
Q Consensus        93 ~~g~l~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~df~~~~~  160 (314)
                      +++++.+.+...        ...+++..++.++.||+.||.|||++|++|+||||+||++    +.++.+||+|||.+..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            999988887532        2258999999999999999999999999999999999999    3557899999999986


Q ss_pred             eCCCC---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---------HHHHHHHHHhh
Q 021299          161 FGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAF  228 (314)
Q Consensus       161 ~~~~~---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---------~~~~~~~~~~~  228 (314)
                      .....   .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.....         ......+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54322   1223456788999999998766789999999999999999999999965442         34455555555


Q ss_pred             CCCCCCCCCCcCcccchhhhccc-------cC---CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYV-------AA---PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      +......|+..............       ..   ..........++++.+||++||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            55444444432222111100000       00   00001112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6e-46  Score=326.50  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=207.5

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      +.||+|+||.||++.+..+|..+++|.+...... ........+|+++++.++||||+++.+.+..++..++||||++| 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999764322 12223456789999999999999999999999999999999986 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                      +|...+.. ...+++..+..++.||+.||.|||+ +|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            66555544 4468999999999999999999997 799999999999999999999999999987643333333445688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-------------------------  213 (325)
T cd05594         160 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------------------  213 (325)
T ss_pred             cccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence            99999999876 5679999999999999999999999987766555444322110                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                         .+...+++++.+||.+||+.||++|+     ++.++++||||.+..
T Consensus       214 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         214 ---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence               01124588999999999999999997     899999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-45  Score=315.43  Aligned_cols=281  Identities=59%  Similarity=0.957  Sum_probs=233.1

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      |.+.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++|++|+++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999889999999998776555444556778999999999999999999999999999999999


Q ss_pred             cccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        94 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      ++++.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            99999998877677999999999999999999999999999999999999999999999999999877554433344567


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch--hhhccc
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--VEYQYV  251 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  251 (314)
                      +..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+....+....+...+..++........  ......
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK  240 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence            788999999877557899999999999999999999999998888887777766666555555443321111  111111


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .........+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1112223345678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.5e-45  Score=326.11  Aligned_cols=258  Identities=27%  Similarity=0.412  Sum_probs=206.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|..++.||+|++|+||++.+..+|+.|++|.+..... ......+.+|+++++.++|+||+++++++..++..+++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            5788999999999999999999999999999999865432 223345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+.| +|..     ....++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus       152 e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        152 EFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             ecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            99997 4432     22356788889999999999999999999999999999999999999999999987644333334


Q ss_pred             ccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ...|+..|+|||.+..    ....+.++||||||+++|+|++|..||......+....+........             
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  293 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-------------  293 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-------------
Confidence            4578899999998743    23446799999999999999999999974433222222211111111             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                 ......++.++.+||.+||..||++||++.|+++||||.+-.
T Consensus       294 -----------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        294 -----------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                       111234688999999999999999999999999999999753

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.7e-45  Score=327.21  Aligned_cols=261  Identities=26%  Similarity=0.349  Sum_probs=214.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            58999999999999999999999999999999998753322 12223456899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||++| +|.+++...  .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus       122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            999985 788877644  488999999999999999999999999999999999999999999999999987643222 2


Q ss_pred             ccccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....|++.|+|||.+.+.   ..++.++|+||||+++|+|++|..||...........+.......   .++.      
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~p~------  270 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL---NFPE------  270 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc---CCCC------
Confidence            2355689999999998653   237899999999999999999999998887776666655432111   1111      


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~  297 (314)
                                     ...++..+.+++.+||+.++.+  |++++|+++||||+..
T Consensus       271 ---------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 ---------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ---------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                           1235889999999999865544  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-45  Score=322.24  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=205.7

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||.||++.++.+|+.+++|.+...... .........|..++... +||+|+++++++.+.+..|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999765321 12223345677777654 899999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..............|+
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence             777776654 468999999999999999999999999999999999999999999999999987543333333455689


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....     .                   
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-----~-------------------  214 (316)
T cd05620         160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-----H-------------------  214 (316)
T ss_pred             cCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C-------------------
Confidence            99999999976 6689999999999999999999999988776655554432210     0                   


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH-HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~h~~~~~~~  298 (314)
                          ....++.++.+||.+||+.||++||++ +++++||||+.++
T Consensus       215 ----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         215 ----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                112358899999999999999999998 5899999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.7e-45  Score=316.56  Aligned_cols=283  Identities=37%  Similarity=0.674  Sum_probs=223.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++||||+++++++...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            57999999999999999999998899999999987655444344456789999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++++++..+......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            99987766665555568999999999999999999999999999999999999999999999999998764444433445


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc---hhhh
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD---YVEY  248 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  248 (314)
                      .++..|+|||.+.+...++.++|+||||+++++|++|.+||......+....+....+...............   ....
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07846         161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP  240 (286)
T ss_pred             cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence            6788899999987656678899999999999999999999988777776666665544322111000000000   0000


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ............++++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0000111122245678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-45  Score=324.95  Aligned_cols=260  Identities=27%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             hccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcc--cCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNL   86 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   86 (314)
                      +|++.+.||+|++|+||++++.   .++..+++|++......  ......+..|+.+++.+. |++|+++.+++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999764   46789999999754321  122234567999999994 89999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++|||+.| +|.+.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            999999986 777777654 358999999999999999999999999999999999999999999999999997643322


Q ss_pred             -CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       166 -~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .......|++.|+|||.+.+...++.++||||||+++|+|++|..||...........+........+           
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----------  228 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-----------  228 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-----------
Confidence             22224468899999999977556789999999999999999999999654322222222211111111           


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~  297 (314)
                                   .....+++.+.+++.+||..||++||     +++++++||||+..
T Consensus       229 -------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         229 -------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                         11234688999999999999999999     88999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.6e-45  Score=318.74  Aligned_cols=284  Identities=45%  Similarity=0.775  Sum_probs=231.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   82 (314)
                      .++|.+.+.||+|++|.||++.++.+++.+++|.+..............+|+++++.++|+||+++++++.+        
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            689999999999999999999999999999999987655444333456689999999999999999987633        


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ....++++||+.+++...+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            23579999999999988888766679999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCc-----------ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCC
Q 021299          163 SPDRR-----------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       163 ~~~~~-----------~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      .....           .....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...........+....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            32211           1223457789999998765668899999999999999999999999888888888877776666


Q ss_pred             CCCCCCCcCcccchhh--hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          232 TPSQWPDLAYLPDYVE--YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .+..++.....+....  ...............+++.+.++|.+||..||.+|||+.+++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            6666665544443321  11111122222344567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-44  Score=313.17  Aligned_cols=282  Identities=43%  Similarity=0.750  Sum_probs=219.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++.+..+|..+++|.+...... .....+.+|+.+++.++|+||+++.+++..++..++++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            6899999999999999999999999999999998765432 233355689999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |+.+++.+.+......+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  163 (291)
T cd07870          84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE  163 (291)
T ss_pred             cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence            99999998887666678889999999999999999999999999999999999999999999999987654433333444


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc-HHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .+++.|+|||.+.+...++.++|+||||+++++|++|..||..... .+...++....+......++.....+.......
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (291)
T cd07870         164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF  243 (291)
T ss_pred             cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence            5688899999987655678899999999999999999999976543 344444444444333333322221111111000


Q ss_pred             cc--CCCCCccCC--CCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VA--APPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~--~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ..  .........  ..++.+.+++.+||..||++|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00  000111111  236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-44  Score=314.81  Aligned_cols=287  Identities=43%  Similarity=0.770  Sum_probs=233.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC---
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   84 (314)
                      ....++|++.+.||+|++|.||++.++.+|+.+++|.+............+.+|++++++++|||++++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            44678999999999999999999999999999999999766544444445668999999999999999999886544   


Q ss_pred             -------eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           85 -------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        85 -------~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                             ..++++||+++++...+......+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                   7899999999999888887666799999999999999999999999999999999999999999999999999


Q ss_pred             eeeeCCCCC-cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          158 ARIFGSPDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      +........ ......++..|+|||.+.+....+.++|+||||+++++|++|.+||...+..+....+....+...+..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            986543321 1223345677999998876556789999999999999999999999988888888888877776666666


Q ss_pred             CCcCcccchhhhccc--cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          237 PDLAYLPDYVEYQYV--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      +.....+........  ...........++..+.+++.+||..||++||++++++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            554333222111110  1111222334568999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-45  Score=322.44  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=208.1

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++.++.++..+++|.+...... .........|.++++.+ +||||+++++++...+..++||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999865322 22223455788888877 699999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..............++
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence             676666544 469999999999999999999999999999999999999999999999999987543333333345688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-------------------------  213 (318)
T cd05570         160 PDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-------------------------  213 (318)
T ss_pred             ccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            89999999976 6789999999999999999999999988776665555432210                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                         .....+++++.+||++||..||.+||++     .++++||||+..+
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence               0112458899999999999999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=330.88  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=209.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+++.||+|+||+||++.+..+|+.|++|++..... .......+.+|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999875432 1222234567999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC---
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---  166 (314)
                      ||++| +|.+.+... +.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........   
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99975 787777654 4689999999999999999999999999999999999999999999999999863211000   


Q ss_pred             --------------------------------------------cccccccCccccCcccccCccCCCCcchHhhHHHHH
Q 021299          167 --------------------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF  202 (314)
Q Consensus       167 --------------------------------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll  202 (314)
                                                                  ......|++.|+|||.+.+ ..++.++|+|||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhh
Confidence                                                        0012458899999999876 6689999999999999


Q ss_pred             HHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC
Q 021299          203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       203 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      |+|++|.+||......+....+......   ..++.                     ...++.++.+||.+||. +|.+|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~---------------------~~~~s~~~~dli~~lL~-~~~~r  293 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRET---LYFPD---------------------DIHLSVEAEDLIRRLIT-NAENR  293 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCc---cCCCC---------------------CCCCCHHHHHHHHHHhc-CHhhc
Confidence            9999999999887766665554432110   01110                     12358899999999998 66665


Q ss_pred             ---CCHHHHhcCccccccC
Q 021299          283 ---ITAQQALEHRFAKSFN  298 (314)
Q Consensus       283 ---ps~~ell~h~~~~~~~  298 (314)
                         +++.+++.||||+..+
T Consensus       294 ~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         294 LGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             CCCCCHHHHhcCCCcCCCC
Confidence               5999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-45  Score=321.68  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=213.0

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +|.+.+.||+|+||.||++.+..+++.+++|.+....... ........|..++..+ .|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999998653222 1222345677777777 4799999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|...+... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99985 777776554 3589999999999999999999999999999999999999999999999999976543333444


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                   
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-------------------  219 (323)
T cd05616         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------------  219 (323)
T ss_pred             cCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence            5668899999999976 66899999999999999999999999988777666665443111                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                               ....++.++.+++.+||+.||++|++.     .++++||||+.++
T Consensus       220 ---------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         220 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             ---------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                     112458899999999999999999984     8999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.6e-46  Score=331.54  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=211.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+|++++.||+|++|+||++++..+++.+|+|.+...... ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3699999999999999999999999999999998654321 122335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC----
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~----  165 (314)
                      ||++| +|.+++... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99985 787777654 468999999999999999999999999999999999999999999999999975321000    


Q ss_pred             ---------------------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH
Q 021299          166 ---------------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (314)
Q Consensus       166 ---------------------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll  206 (314)
                                                             .......|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence                                                   00112468899999999976 66799999999999999999


Q ss_pred             hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC---
Q 021299          207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---  283 (314)
Q Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---  283 (314)
                      +|..||......+....+.......   ..                     +....+++++.++|.+|+ .+|.+|+   
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~---~~---------------------~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTL---HI---------------------PSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCccc---cC---------------------CCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            9999998877666555443211100   00                     011246889999999976 5999999   


Q ss_pred             CHHHHhcCccccccC
Q 021299          284 TAQQALEHRFAKSFN  298 (314)
Q Consensus       284 s~~ell~h~~~~~~~  298 (314)
                      ++.++++||||+.++
T Consensus       294 t~~ell~h~~~~~~~  308 (376)
T cd05598         294 GADEIKAHPFFKGID  308 (376)
T ss_pred             CHHHHhCCCCcCCCC
Confidence            999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-45  Score=330.24  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=210.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +|++++.||+|+||+||++++..+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            689999999999999999999999999999998754321 1222356689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-----
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-----  165 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-----  165 (314)
                      |++| +|.+.+... +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9985 777777654 468999999999999999999999999999999999999999999999999875321000     


Q ss_pred             ------------------------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHH
Q 021299          166 ------------------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFA  203 (314)
Q Consensus       166 ------------------------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~  203 (314)
                                                                .......||+.|+|||++.+ ..++.++|+|||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHH
Confidence                                                      00112368899999999876 56889999999999999


Q ss_pred             HHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC
Q 021299          204 ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI  283 (314)
Q Consensus       204 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  283 (314)
                      +|++|.+||...++.+....+........   .+                     ....+++++.++|.+|+ .+|.+|+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p---------------------~~~~~s~~~~~li~~l~-~~p~~R~  294 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLH---IP---------------------PQAKLSPEASDLIIKLC-RGPEDRL  294 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcC---CC---------------------CcccCCHHHHHHHHHHc-cCHhHcC
Confidence            99999999988776665555443211110   00                     11246899999999986 5999999


Q ss_pred             C---HHHHhcCccccccC
Q 021299          284 T---AQQALEHRFAKSFN  298 (314)
Q Consensus       284 s---~~ell~h~~~~~~~  298 (314)
                      +   ++++++||||+.++
T Consensus       295 ~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         295 GKNGADEIKAHPFFKTID  312 (382)
T ss_pred             CCCCHHHHhcCCCcCCcC
Confidence            7   99999999998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.8e-45  Score=322.64  Aligned_cols=295  Identities=37%  Similarity=0.631  Sum_probs=234.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec----cCCe
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP----HKGN   85 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~   85 (314)
                      +.++|.+.+.||+|++|.||++.++.+|..|++|.+............+.+|+.+++.++||||+++.+++.    ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            458999999999999999999999999999999998765443344455668999999999999999999874    3457


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .++|+||++|++.+.+... +.+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          83 VYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            8999999999888877654 459999999999999999999999999999999999999999999999999997654322


Q ss_pred             Cc----ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RR----FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~----~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..    .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+..++..+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            11    12346788899999987655689999999999999999999999998888877777777666554443332211


Q ss_pred             ccc---hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceeecc
Q 021299          242 LPD---YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVD  305 (314)
Q Consensus       242 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~~  305 (314)
                      ...   ................+.+++++.++|++||+.+|++||++++++.||||+++........
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence            100   0011111111122234567999999999999999999999999999999998876665544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-45  Score=320.22  Aligned_cols=251  Identities=28%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhh-cCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||.||+|.+..+++.||+|.+....... ........|..++.. .+||||+++++++..++..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998653221 222233456666654 4799999999999999999999999985


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence             676666544 469999999999999999999999999999999999999999999999999998654333344455689


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------------------  213 (316)
T cd05592         160 PDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-------------------------  213 (316)
T ss_pred             ccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            99999999876 5689999999999999999999999988777666655432210                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH-HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~ell~h~~~~~~~  298 (314)
                         .....++.++.+++.+||+.||++||++ .+++.||||+..+
T Consensus       214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         214 ---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence               0112358899999999999999999986 5888999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-45  Score=322.65  Aligned_cols=290  Identities=37%  Similarity=0.646  Sum_probs=230.1

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----C
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   84 (314)
                      +.++|.+.+.||.|++|+||++.+..++..+++|.+............+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            56789999999999999999999999999999999876433333334566899999999999999999987543     3


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..++++||+++++.+.+... +.+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            58999999999998887654 46999999999999999999999999999999999999999999999999999865433


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ........++..|+|||.+.....++.++|+||||+++|+|++|.+||...+.......+....+...+..+........
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            22233445678899999887645688999999999999999999999988877777777766666555444321111110


Q ss_pred             hh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 YV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 ~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ..   ..............+.+++++.++|.+||+.+|++|||++++++||||+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            00   000111112223345689999999999999999999999999999999987644

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-46  Score=324.75  Aligned_cols=252  Identities=26%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             eeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           17 REVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      ++.||+|++|.||++++.   .+|+.+++|++..............+|++++++++||||+++++++..++..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            367999999999999763   57889999999865443333345567999999999999999999999999999999999


Q ss_pred             cc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccc
Q 021299           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        94 ~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      .| +|.+.+... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          81 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            85 777777543 4689999999999999999999999999999999999999999999999999976544333334556


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
                      |++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....     .                 
T Consensus       160 g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----~-----------------  216 (318)
T cd05582         160 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----G-----------------  216 (318)
T ss_pred             CChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----C-----------------
Confidence            8899999999876 5678999999999999999999999988777666655543211     0                 


Q ss_pred             CCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          253 APPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       253 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                            ....+++.+.+||++||+.||++||+     +++++.||||+.+.
T Consensus       217 ------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         217 ------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             ------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence                  11245889999999999999999999     78899999998763

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-46  Score=293.78  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=228.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.+.+.||.|-||.||+++.+.++-.+++|++.++... ......+.+|+++...++||||++++++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            58899999999999999999999999999999999877533 23444566899999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      +||.. |.+...++.. .+.+++..++.++.|++.|+.|+|.++++||||||+|++++..+.+||+|||-+...  +...
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--p~~k  178 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSNK  178 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--CCCC
Confidence            99998 6888888754 556999999999999999999999999999999999999999999999999999765  3556


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+||.-|.|||...+ ...+...|+|++|++.|+++.|.+||......++.+++.+..-..+               
T Consensus       179 R~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p---------------  242 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP---------------  242 (281)
T ss_pred             ceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC---------------
Confidence            677889999999998877 6779999999999999999999999999998899888876532222               


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                   ..++..+.++|.+||..+|.+|.+..|++.|||+.+.
T Consensus       243 -------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 -------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                         2569999999999999999999999999999999865

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-45  Score=320.39  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=214.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||+||++.+..+++.||+|++...... ......+.+|..+++.++|+||+++++++.++++.++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999999753221 122234567899999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~  168 (314)
                      ||+.| +|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99975 88888876666799999999999999999999999999999999999999999999999999876543322 22


Q ss_pred             cccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....|++.|+|||.+..    ...++.++|+||||+++|+|++|..||......+....+.......   .         
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---~---------  228 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF---Q---------  228 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc---c---------
Confidence            23468899999999863    2456889999999999999999999998877666655554321100   0         


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~~  298 (314)
                                 +......+++.+.++|++||+.++.+  |++++++++||||...+
T Consensus       229 -----------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         229 -----------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             -----------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                       11112346899999999999765544  88999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=312.90  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=213.2

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .|++.+.||+|++|+||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++.+.+..++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999999999999999997654322 222345679999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |+.| +|.+.+... ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence            9985 777666543 3468999999999999999999999999999999999999999999999999997653222 223


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.........                
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  222 (285)
T cd05605         160 GRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE----------------  222 (285)
T ss_pred             cccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc----------------
Confidence            4467889999999876 56789999999999999999999999876654444443332211111                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                              .....+++.+.+||.+||..||.+||     +++++++||||...+
T Consensus       223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         223 --------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             --------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence                    11234688999999999999999999     999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-45  Score=314.06  Aligned_cols=283  Identities=41%  Similarity=0.703  Sum_probs=226.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++|+||+++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999999999999999997765555555677899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTH  170 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~  170 (314)
                      |+++++...+......+++..+..++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            999988877766666799999999999999999999999999999999999999999999999999877644432 3334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+...+.................
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            56678899999998754789999999999999999999999988777766666665555444332222111110000000


Q ss_pred             --c-cCCCCC-ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 --V-AAPPLR-SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 --~-~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                        . ...... .....+++++.+||++||..+|++||++++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              0 000000 1122348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-45  Score=323.66  Aligned_cols=287  Identities=34%  Similarity=0.544  Sum_probs=223.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      .+.++|++.+.||+|++|.||++.+..+|+.+++|.+............+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            568999999999999999999999999999999999865443333344566899999999999999999987543     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...++||||+.+++...+...   ++...+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             357999999999988887643   8899999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+....+...+.........
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TSF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCC-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            332 2233456788999999876 66899999999999999999999999988877777777665554432211110000


Q ss_pred             cch--------------hhhccccCCC-CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          243 PDY--------------VEYQYVAAPP-LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       243 ~~~--------------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...              ........+. ........++.+.++|.+||+.||++|||+.|+|.||||+.|...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            000              0000000000 000122357789999999999999999999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-45  Score=323.75  Aligned_cols=275  Identities=24%  Similarity=0.333  Sum_probs=209.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..|++++.||+|++|.||++.+..++..+++|.....        ....|+.+++.++|+||+++++++...+..++|+|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            5699999999999999999999999999999975322        22468999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++.|++.+++......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..... .......
T Consensus       138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~  216 (357)
T PHA03209        138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLGL  216 (357)
T ss_pred             ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-Ccccccc
Confidence            999999999987777899999999999999999999999999999999999999999999999999975422 2223345


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCc---------HHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSD---------IDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .|++.|+|||.+.+ ..++.++|+||||+++|+|+++. ++|.....         ...+..+....+.. +..++....
T Consensus       217 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~  294 (357)
T PHA03209        217 AGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH-PEEFPRDPG  294 (357)
T ss_pred             cccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC-hhhcCCCCc
Confidence            68899999999877 56899999999999999999865 44443221         12222233332222 222221110


Q ss_pred             ccc---hhhhccccCCCCC----ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          242 LPD---YVEYQYVAAPPLR----SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       242 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ...   ..........+..    .....++..+.+||.+||+.||++|||++|+|+||||+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000   0000000000000    0012467788899999999999999999999999999864

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-45  Score=323.04  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=205.5

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHH-HHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|++|+||++.++.+|+.+++|.+....... .....+..|.. +++.++||||+++++.+.+.+..++||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999997643221 12223334444 56788999999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence             67666654 4468999999999999999999999999999999999999999999999999987543333333445688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------------  213 (323)
T cd05575         160 PEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-------------------------  213 (323)
T ss_pred             hhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            99999999876 6688999999999999999999999988776665555443210                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~~~~~  298 (314)
                         ...+.+++.+.++|.+||+.||.+||++    .++++||||..+.
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         214 ---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence               1123458899999999999999999998    6999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-45  Score=312.92  Aligned_cols=281  Identities=51%  Similarity=0.890  Sum_probs=234.3

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      |+..+.||+|.+|.||++....+++.+++|.+............+..|+.+++.++|+|++++++++.+.+..++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67789999999999999999999999999999876544444456678999999999999999999999999999999999


Q ss_pred             cccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        94 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      +++|.+.+......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            99999999877557999999999999999999999999999999999999999999999999999876544433444556


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc-hhhhcccc
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD-YVEYQYVA  252 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  252 (314)
                      +..|+|||.+.+...++.++|+||||++++++++|.+||...........+....+...+..|+....... ...+....
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP  240 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence            77899999987755789999999999999999999999999888888888888777666665554433321 11111111


Q ss_pred             CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       253 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ........+.++..+.++|.+||+.||++||++++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            122223345568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-45  Score=321.00  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|++|.||++.++.+++.||+|.+....... .....+..|..+++.+ +||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999998653322 2223456788888888 699999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence             776666544 469999999999999999999999999999999999999999999999999987533333333445688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH--------HHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--------DQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||......        .........   .               
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~---------------  220 (329)
T cd05588         160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---K---------------  220 (329)
T ss_pred             ccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---C---------------
Confidence            99999999876 66789999999999999999999999642211        111111100   0               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC------HHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~h~~~~~~~  298 (314)
                               .......++.++.++|.+||..||.+|++      ++++++||||..+.
T Consensus       221 ---------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         221 ---------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                     01112346889999999999999999997      78999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-44  Score=305.76  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=215.9

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.++|||++++++++.+.+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            48889999999999999999999999999999976554444455677899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 MET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +.| +|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            975 888888764 457899999999999999999999999999999999999999999999999999876544433344


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...........+......                    
T Consensus       161 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  219 (256)
T cd08529         161 IVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--------------------  219 (256)
T ss_pred             cccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            567888999999876 56789999999999999999999999887755555444332111                    


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             +....+++++.+++.+||+.+|++||++.++++|||+
T Consensus       220 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         220 -------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                   1112458899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.4e-44  Score=304.84  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=212.3

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-CCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   91 (314)
                      +|++.+.||.|++|.||++.++.+++.+++|.+............+.+|++++++++|+|++++.+.+.. +...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999999999999999997655444444566789999999999999999998764 456899999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      +++| ++.+.+... ...+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            9985 788777653 44689999999999999999999999999999999999999999999999999987654444444


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+......                   
T Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------------------  220 (257)
T cd08223         161 TLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-------------------  220 (257)
T ss_pred             cccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-------------------
Confidence            4567888999999876 66789999999999999999999999876655544443332110                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                              .....+++++.+++.+||+.||++||++.++++||||
T Consensus       221 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         221 --------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             --------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    0112458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.7e-45  Score=318.41  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=206.0

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhh-cCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++.++.+++.||+|.+...... .........|..+++. ++||||+++++++.+.+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999765321 1222334467777765 4899999999999999999999999985


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence             777776643 458999999999999999999999999999999999999999999999999987643333333455688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+....+......     .                  
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-----~------------------  215 (316)
T cd05619         160 PDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC-----Y------------------  215 (316)
T ss_pred             ccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----C------------------
Confidence            99999999876 56899999999999999999999999887766655554322100     0                  


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCHH-HHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~h~~~~~~~  298 (314)
                           ...++.++.++|.+||+.||++||++. +++.||||+.++
T Consensus       216 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         216 -----PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             -----CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                 113588899999999999999999996 899999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.3e-45  Score=324.68  Aligned_cols=261  Identities=26%  Similarity=0.344  Sum_probs=213.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||.||++.++.+++.+++|.+...... ......+.+|..+++.++||||+++++.+.+++..++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            58999999999999999999999999999999998753321 22223456889999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||++| +|.+++...  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........ .
T Consensus       122 ~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         122 MEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence            999985 777777544  488999999999999999999999999999999999999999999999999987643322 2


Q ss_pred             ccccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....||+.|+|||.+...   ..++.++|+||||+++|+|++|..||...+.......+.......   .++.      
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~------  270 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---TFPD------  270 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc---cCCC------
Confidence            2345689999999998653   237899999999999999999999999887776666654321111   1110      


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~  297 (314)
                                     ...++.++.++|.+||..++.+  |++++++++||||++.
T Consensus       271 ---------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         271 ---------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             ---------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence                           1246999999999999854443  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7e-45  Score=320.05  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=201.8

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++.++.+++.+++|.+....... .....+..|+.++..+ +||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998654322 2223455788887776 799999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence             676665543 469999999999999999999999999999999999999999999999999987543333333445688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc--------HHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--------IDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....        ..........   .               
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---~---------------  220 (329)
T cd05618         160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---K---------------  220 (329)
T ss_pred             ccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---C---------------
Confidence            99999999976 6678999999999999999999999953211        1111111100   0               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC------HHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~h~~~~~~~  298 (314)
                               ...+...++..+.++|++||..||.+||+      .+++++||||+.++
T Consensus       221 ---------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         221 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                     01122356889999999999999999998      58999999998763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=319.67  Aligned_cols=261  Identities=28%  Similarity=0.460  Sum_probs=238.1

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .|.+=|.+.+-||+|-|..|-++++-.+|+.||+|++.+...+......+++|++.++..+|||||+++.+...+...|+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            35677999999999999999999999999999999999998888777788999999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE-ecCCcEEEeeccceeeeCCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~-~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      |.|.-+| +|.+++.+....++++.+.+++.||+.|+.|+|+..++|+||||+||++ .+-|-|||+|||++-.+ .+..
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf-~PG~  173 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF-QPGK  173 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-CCcc
Confidence            9999985 9999999888889999999999999999999999999999999999866 56799999999999766 3444


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+|+..|.|||++.++.+..++.||||||||||-|++|++||...++.+++..++.+-.+.               
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv---------------  238 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV---------------  238 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC---------------
Confidence            55667889999999999998888999999999999999999999999999999999988763322               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   +..++.+.++||..||..||.+|.+.++|..|+|++.++
T Consensus       239 -------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  239 -------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             -------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence                         235799999999999999999999999999999999986

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-45  Score=320.09  Aligned_cols=287  Identities=41%  Similarity=0.671  Sum_probs=235.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-----eEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   87 (314)
                      +|++.+.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++.+++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            689999999999999999999888999999999765443444456778999999999999999999987664     789


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--  165 (314)
                      ++|+|+++++.+.+.... .+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            999999998888876544 79999999999999999999999999999999999999999999999999998765443  


Q ss_pred             -CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       166 -~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .......+++.|+|||.+.+...++.++|+||||+++++|++|.+||......+....+....+...+..+........
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence             1233456788899999998744789999999999999999999999999998888888888776666554432111111


Q ss_pred             h---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 Y---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 ~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .   ...............+.+++.+.++|.+||+.+|++||++++++.||||+++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            1   1111112222333455679999999999999999999999999999999988644

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-44  Score=311.78  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=215.9

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..+.|++++.||.|++|.||++.+..++..+++|.+....  ......+.+|+.+++.++|+|++++.+.+..++..++|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            3578999999999999999999999999999999987542  22234566899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| ++...+.+....+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            999997 5555565556679999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....+++.|+|||.+.+    ...++.++|+||||+++|+|++|.+||...........+...   ..+ ..        
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-~~--------  235 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP-TL--------  235 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCc-cC--------
Confidence            44567888999998853    244688999999999999999999999776655444443221   110 00        


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                   .....++.++.++|.+||+.+|++||+++++++||||+.+...
T Consensus       236 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         236 -------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             -------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                         0112457889999999999999999999999999999987543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.1e-46  Score=304.02  Aligned_cols=288  Identities=42%  Similarity=0.732  Sum_probs=241.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-CC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   84 (314)
                      -...|++++.||+|.+|.||+|..+.++.    .+|+|+++........-....+|+..++.++|+|++.+..++.+ +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35789999999999999999996555433    68999998876655566677799999999999999999998866 88


Q ss_pred             eEEEEEecccccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC----CcEEEeecc
Q 021299           85 NLHLVFEFMETDLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFG  156 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~df~  156 (314)
                      .+++++||.+-+|.+.++..    ...++...+..|+.||+.|+.|||++.+.||||||.||+|..+    |+|||+|+|
T Consensus       102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            99999999999999999632    3579999999999999999999999999999999999999877    899999999


Q ss_pred             ceeeeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC---------cHHHHHHH
Q 021299          157 LARIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---------DIDQLGKI  224 (314)
Q Consensus       157 ~~~~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---------~~~~~~~~  224 (314)
                      +++.+..+-.   .....+.|.||.|||++.+...|+.+.|+|+.|||+.||++..+.|.+.+         ..+.+.++
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            9987754321   22345679999999999998999999999999999999999999996533         56788899


Q ss_pred             HHhhCCCCCCCCCCcCcccchhhhcccc----CCC--CCcc---CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          225 FAAFGTATPSQWPDLAYLPDYVEYQYVA----APP--LRSL---FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      +...+.+....||+....+.....-...    ..+  +..+   ...-++...+|+.+||+-||-+|+|+++.++|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            9999999999999988888774322211    111  1111   122356699999999999999999999999999999


Q ss_pred             cc
Q 021299          296 SF  297 (314)
Q Consensus       296 ~~  297 (314)
                      ..
T Consensus       342 ~d  343 (438)
T KOG0666|consen  342 ED  343 (438)
T ss_pred             cC
Confidence            77

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.9e-45  Score=325.72  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=212.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++++.||+|++|+||++.++.+++.+++|.+..... .......+..|..++..++|++|+++++.+++.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999975432 2223345667999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC----
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~----  165 (314)
                      ||++| +|.+.+.+. +.+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99986 777777654 458999999999999999999999999999999999999999999999999986432110    


Q ss_pred             -------------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC
Q 021299          166 -------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG  214 (314)
Q Consensus       166 -------------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~  214 (314)
                                                     .......||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCC
Confidence                                           00113468899999999876 6688999999999999999999999988


Q ss_pred             CCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcC
Q 021299          215 SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEH  291 (314)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h  291 (314)
                      .........+.......   ..+.                     ...+++++.+||.+|+ .||.+|++   ++++++|
T Consensus       239 ~~~~~~~~~i~~~~~~~---~~p~---------------------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKVMNWKETL---VFPP---------------------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHHHcCCCce---ecCC---------------------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            87776665554321000   0100                     1135889999999987 49999984   8999999


Q ss_pred             ccccccC
Q 021299          292 RFAKSFN  298 (314)
Q Consensus       292 ~~~~~~~  298 (314)
                      |||++++
T Consensus       294 p~f~~~~  300 (360)
T cd05627         294 PFFEGVD  300 (360)
T ss_pred             CCCCCCC
Confidence            9999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=310.50  Aligned_cols=281  Identities=46%  Similarity=0.820  Sum_probs=230.9

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEEEEe
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHLVFE   91 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e   91 (314)
                      |.+.+.||+|++|.||++.+..+|+.+++|.+............+.+|+++++.++|+|++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6789999999999999999999999999999987653333444667899999999999999999999877  89999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTH  170 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~  170 (314)
                      |+++++.+.+......+++..++.++.||+.|+++||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN  160 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence            999999988887766799999999999999999999999999999999999999999999999999987644321 1233


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.+...++.++|+||||+++++|++|..||...........+....+...+..++.............
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP  240 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence            45577899999887656678999999999999999999999999888888888877766666666665444322111111


Q ss_pred             c--cCCCCCccCCC-CCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 V--AAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~--~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .  ....+...... .++.+.+++.+||+.+|++||+++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            1  01111122233 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.5e-44  Score=305.54  Aligned_cols=254  Identities=26%  Similarity=0.484  Sum_probs=215.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||+|++|.+|.+.+..+|+.+++|.+............+.+|+.+++.++|+||+++.+++.+.+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            58999999999999999999999999999999876544333444677899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 MET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +.| ++.+.+... ...+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            975 888887654 345889999999999999999999999999999999999999999999999999876544333334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+......                    
T Consensus       161 ~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------------------  219 (256)
T cd08218         161 CIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--------------------  219 (256)
T ss_pred             ccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--------------------
Confidence            567788999999876 56789999999999999999999999877766665555432111                    


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             ......+.++.++|.+||+.+|++||++.++++||||
T Consensus       220 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 -------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   0112458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=311.81  Aligned_cols=263  Identities=28%  Similarity=0.404  Sum_probs=217.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||.|++|.||++.+..++..+++|.+......  ....+..|+.+++.++|+||+++++.+..+...+++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            47899999999999999999999888999999998754322  2235668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+.+......+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99986 77777776666799999999999999999999999999999999999999999999999998876544433334


Q ss_pred             ccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ...+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...........+.....   + ..         
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-~~---------  228 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP---P-TL---------  228 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC---C-Cc---------
Confidence            4567888999998752    24567899999999999999999999987765554444322110   0 00         


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                  .....++.++.++|.+||+.+|++||+++++++||||.+..+-
T Consensus       229 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         229 ------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             ------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence                        0112458899999999999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-44  Score=333.28  Aligned_cols=278  Identities=23%  Similarity=0.378  Sum_probs=211.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC------CCeeeeeceeccC-
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS------PHIIELIDAFPHK-   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-   83 (314)
                      .++|++.+.||+|+||+||++.+..+++.||+|+++....   .......|+++++.+.|      .+++.+.+++..+ 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            5789999999999999999999999999999999964321   11233456666666644      5688888888654 


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCC--------------
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHG--------------  148 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~--------------  148 (314)
                      ++.++||++++++|.+.+... +.+++..+..++.||+.||.|||+ .||+|+||||+||+++.++              
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            578999999999999988765 469999999999999999999998 5999999999999998765              


Q ss_pred             --cEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHH
Q 021299          149 --QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       149 --~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~  226 (314)
                        .+||+|||.+....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+..
T Consensus       284 ~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        284 PCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              49999999886432   22334578999999999977 6789999999999999999999999999888888777766


Q ss_pred             hhCCCCCCCCCCcCcccchhhh-----------------ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          227 AFGTATPSQWPDLAYLPDYVEY-----------------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      ..+..+. .|............                 ..........  ...++.+.+||.+||+.||.+|||++|+|
T Consensus       360 ~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        360 TLGRLPS-EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE--VIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HcCCCCH-HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhh--hhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            6554432 12111000000000                 0000000000  01256788999999999999999999999


Q ss_pred             cCccccccCc
Q 021299          290 EHRFAKSFNG  299 (314)
Q Consensus       290 ~h~~~~~~~~  299 (314)
                      +||||+++..
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999998643

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-44  Score=317.48  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=211.8

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +|...+.||+|++|+||+|.++.+|+.||+|++...... ......+..|..+++.+. |++|+++.+++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478899999999999999999999999999999764322 222234557888888876 577888999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|...+... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99985 777766544 4599999999999999999999999999999999999999999999999999876433333334


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......                   
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-------------------  219 (323)
T cd05615         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-------------------  219 (323)
T ss_pred             CccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence            4568899999999876 66889999999999999999999999888776666665543111                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                               ....++.++.+++.+||+.+|.+|++     .+++++||||+.++
T Consensus       220 ---------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         220 ---------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ---------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                     11235889999999999999999997     47899999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-44  Score=310.38  Aligned_cols=278  Identities=39%  Similarity=0.645  Sum_probs=217.3

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccC--CeEEEEE
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK--GNLHLVF   90 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~iv~   90 (314)
                      |++.+.||+|++|.||++.+..++..+++|.+........ .....+|+..++++. |+|++++++++.++  +..++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            7889999999999999999999999999999876433222 223457888888885 99999999999877  8899999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||++|++.+.+......+++..++.++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+........ ...
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~  157 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTE  157 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCC
Confidence            99999999998877667999999999999999999999999999999999999999 9999999999976533222 223


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc-hhhhc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD-YVEYQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  249 (314)
                      ..+++.|+|||.+.....++.++|+||||+++|+|++|.+||...+..+....+....+...+........... .....
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            45678899999876556678999999999999999999999998887777766665544333211000000000 00000


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .............++.++.++|.+||..+|++||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000111122234568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-44  Score=313.33  Aligned_cols=274  Identities=38%  Similarity=0.684  Sum_probs=206.4

Q ss_pred             eeeeCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee--ccCCeEEEEEec
Q 021299           17 REVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF--PHKGNLHLVFEF   92 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~iv~e~   92 (314)
                      ...||+|+||+||+|.++.  ++..+++|.+.....    ...+.+|+++++.++||||+++.+++  ..+...++++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            3579999999999998654  567899998864422    23566899999999999999999987  345678999999


Q ss_pred             ccccHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE----ecCCcEEEeeccceee
Q 021299           93 METDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARI  160 (314)
Q Consensus        93 ~~g~l~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~df~~~~~  160 (314)
                      +++++.+.+...        ...+++..++.++.||+.||.|||++|++|+||||+||++    +.++.++|+|||++..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            999988887532        2358899999999999999999999999999999999999    4567899999999986


Q ss_pred             eCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---------HHHHHHHHHhh
Q 021299          161 FGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAF  228 (314)
Q Consensus       161 ~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---------~~~~~~~~~~~  228 (314)
                      ......   ......+++.|+|||.+.+...++.++||||||+++|+|++|.+||.....         ......+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543221   223346788899999987756789999999999999999999999975432         23444555555


Q ss_pred             CCCCCCCCCCcCcccchhhhcccc----C--C----CCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVA----A--P----PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~----~--~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      +......|+.....+.........    .  .    .........+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            555554444332222111111000    0  0    0011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=319.64  Aligned_cols=287  Identities=38%  Similarity=0.669  Sum_probs=224.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----C
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   84 (314)
                      ++++|.+.+.||+|++|.||++.+..+|+.|++|.+...... .....+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            568999999999999999999999999999999998643222 2233566899999999999999999876433     3


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..++++|++++++...+...  .+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999999988877543  4899999999999999999999999999999999999999999999999999765432


Q ss_pred             CC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..   ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+.......+....+...++.+.....
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            21   112346788899999876656689999999999999999999999988777777766666655544433321111


Q ss_pred             ccchhh---hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVE---YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ......   .......+.....+.+++++.+++.+||+.||++|||+.|+++||||+.+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000000   0000111111223456889999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-44  Score=316.75  Aligned_cols=284  Identities=25%  Similarity=0.389  Sum_probs=214.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++.++|+||+++++++.+++..+++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            5899999999999999999999999999999998876432 223345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||+.| +|.+++... +.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......  ..
T Consensus        83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  159 (333)
T cd06650          83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (333)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence            99985 787777654 3589999999999999999999985 7999999999999999999999999998654222  12


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC-cccc---
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA-YLPD---  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---  244 (314)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+ .......+....... ....   
T Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF-GCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             ccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh-cCcccCCccccccCcccCCccch
Confidence            33467888999999876 56889999999999999999999999776543332221 110111000000000 0000   


Q ss_pred             -----------h---hhhccccCCCCCcc-CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 -----------Y---VEYQYVAAPPLRSL-FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 -----------~---~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                 .   ...........+.. ....+.++.+||.+||+.||++|||++|++.||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  308 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE  308 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence                       0   00000000000111 12357899999999999999999999999999999976543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.9e-45  Score=320.18  Aligned_cols=250  Identities=26%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHH-HHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++.++.+|+.+++|++...... ......+..|.. +++.++||||+++++.+..++..++||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999999999999999764321 122223344444 56778999999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence             66666554 4469999999999999999999999999999999999999999999999999987543333333455688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-------------------------  213 (325)
T cd05604         160 PEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-------------------------  213 (325)
T ss_pred             hhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-------------------------
Confidence            99999999876 6678999999999999999999999988776665555433210                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCcccccc
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFAKSF  297 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~~~~  297 (314)
                         ...+..+..+.++|++||..||.+||++    .++++||||+..
T Consensus       214 ---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             ---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence               0112458899999999999999999987    589999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-45  Score=322.11  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc---CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL---KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      ||+|+||+||+++++.+|+.+|+|.+....... ........|..++...   .||+|+++.+.+......++||||+.|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999986543211 1122333566666555   699999999999999999999999985


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+.. .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence             67666654 4468999999999999999999999999999999999999999999999999987543333333455688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+......     ++                 
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~~-----------------  217 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-----FP-----------------  217 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-----CC-----------------
Confidence            99999999876566899999999999999999999999887766655554322110     00                 


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCC----CHHHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARI----TAQQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~ell~h~~~~~~~  298 (314)
                           ...+++++.++|.+||..||.+||    +++++++||||....
T Consensus       218 -----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         218 -----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             -----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                 013588999999999999999998    799999999998653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-44  Score=303.09  Aligned_cols=255  Identities=26%  Similarity=0.462  Sum_probs=210.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC---cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +.|.+.+.||+|++|.||.+.+..++..+++|.+........   ....+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999988999999999876543222   12356689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ++|+++| ++.+.+... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999986 777776654 45899999999999999999999999999999999999999999999999999765332211


Q ss_pred             c---cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 F---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~---~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .   ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+............   ..           
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~-----------  225 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP---TN-----------  225 (263)
T ss_pred             cccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC---CC-----------
Confidence            1   23456778999999977 558899999999999999999999998766555444332211   11           


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                  ......+++.+.++|.+||..+|.+|||+.++++||||
T Consensus       226 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         226 ------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                        11123468899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-43  Score=300.26  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=218.7

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|+..+.||.|++|.||.+++..++..+++|.+............+.+|++++++++|+||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58999999999999999999999999999999977655555555677999999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 MET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ++| +|.+.+... ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            985 888888765 456899999999999999999999999999999999999999999999999999876444433445


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|.|||.+.+ ..++.++|+||||+++++|++|..||......+....+.......                   
T Consensus       161 ~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------------------  220 (256)
T cd08221         161 VVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-------------------  220 (256)
T ss_pred             cCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            567889999999876 557899999999999999999999998877777666654321111                   


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                              ....++.++.+++.+||..+|++||+++++++|||+
T Consensus       221 --------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         221 --------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                    113458899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-44  Score=315.03  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=203.5

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|++|+||++.+..+++.+++|.+....... .....+.+|..++..+ .||+|++++++++..+..++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998653322 2223456788888888 599999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence             676666544 459999999999999999999999999999999999999999999999999997543333333456689


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC------cHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||....      ...........   . +.              
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~-~~--------------  220 (327)
T cd05617         160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---K-PI--------------  220 (327)
T ss_pred             cccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---C-CC--------------
Confidence            99999999876 667999999999999999999999995422      11112221111   0 00              


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC------HHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~h~~~~~~~  298 (314)
                               .....++..+.+++.+||..||.+|++      .+++++||||+.++
T Consensus       221 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         221 ---------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             ---------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                     112346889999999999999999998      57999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.8e-44  Score=306.63  Aligned_cols=260  Identities=27%  Similarity=0.393  Sum_probs=213.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +.|++.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+++++.++|+|++++++++...+..++++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            458899999999999999999999999999999864432  223356689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |++| ++...+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9986 565666555667999999999999999999999999999999999999999999999999998765433333344


Q ss_pred             cccCccccCccccc----CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          171 QVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       171 ~~~~~~y~sPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ..+++.|+|||.+.    ....++.++|+||+|+++|+|++|.+||...........+.........             
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  229 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-------------  229 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-------------
Confidence            56788899999874    2345678999999999999999999999877665555554332111100             


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  ....++.++.++|.+||..||++||+++++++||||+...
T Consensus       230 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         230 ------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence                        1123588999999999999999999999999999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-44  Score=305.69  Aligned_cols=259  Identities=29%  Similarity=0.427  Sum_probs=216.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||.|++|.||++.+..+++.+++|.+..... ......+.+|+++++.++|+|++++.+++.++...++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            579999999999999999999999999999999875532 2223356689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ++.| +|.+.+...  .+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            9986 777777654  6899999999999999999999999999999999999999999999999999887654444445


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...    .+...+             
T Consensus       158 ~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~-------------  219 (274)
T cd06609         158 FVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN----NPPSLE-------------  219 (274)
T ss_pred             ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc----CCCCCc-------------
Confidence            667888999999877 45899999999999999999999999876654443333222    111110             


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                               ...+++++.+++.+||..||++|||++++++||||+.....
T Consensus       220 ---------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         220 ---------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             ---------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence                     01158889999999999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.7e-44  Score=315.99  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=215.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||+||+++++.+++.+++|.+...... ......+.+|..++..++|++|+++.+.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            5799999999999999999999999999999998653221 122234567888999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cc
Q 021299           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~  168 (314)
                      ||+. |+|.+++......+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            9997 588888877666799999999999999999999999999999999999999999999999999875433222 22


Q ss_pred             cccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....|++.|+|||.+..    ...++.++|+||||+++|+|++|..||...+..+....+.......   .+        
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~--------  229 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---QF--------  229 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---cC--------
Confidence            23568999999999863    3457899999999999999999999998887777666654321110   01        


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~~  298 (314)
                                  +.....+++++.+|+++||+.++.+  |++++++++||||++++
T Consensus       230 ------------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         230 ------------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             ------------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                        1112346899999999999765554  78999999999999763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.1e-44  Score=305.80  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||+|+||+||++..+.+|+.+++|.+........ .......|+++++.++||||+++.+.++.+.+.+++|||+.| +|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999975433221 222345699999999999999999999999999999999985 77


Q ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCcc
Q 021299           98 ETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW  176 (314)
Q Consensus        98 ~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  176 (314)
                      ...+... ...+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+...... .......+++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCC
Confidence            7776543 345899999999999999999999999999999999999999999999999999765432 22234567888


Q ss_pred             ccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCC
Q 021299          177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL  256 (314)
Q Consensus       177 y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (314)
                      |+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.........                       
T Consensus       160 y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------  215 (277)
T cd05607         160 YMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-----------------------  215 (277)
T ss_pred             ccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-----------------------
Confidence            999999877 55899999999999999999999999765433222222221111000                       


Q ss_pred             CccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCccccccC
Q 021299          257 RSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFAKSFN  298 (314)
Q Consensus       257 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~~~~~  298 (314)
                      ......+++++.+|+.+||+.||.+||++    ++++.||||+.++
T Consensus       216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            00012468899999999999999999999    6788999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-44  Score=329.51  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=216.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   84 (314)
                      ...++|.+.+.||+|+||+||++.+..+|+.||+|.+............+.+|+..+..++|++++++...+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3458999999999999999999999999999999999876554444445668999999999999999988763221    


Q ss_pred             ----eEEEEEeccc-ccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecc
Q 021299           85 ----NLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        85 ----~~~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                          ..++||||+. |+|.+.+...   ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                3689999998 4888887643   3468999999999999999999999999999999999999999999999999


Q ss_pred             ceeeeCCC--CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          157 LARIFGSP--DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       157 ~~~~~~~~--~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ++......  ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....     
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-----  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-----  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence            99765332  122234568899999999976 6689999999999999999999999988766555554433211     


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                            .+..+.+++++.+++.+||+.||.+||++.++++|||++.+.
T Consensus       263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                  111235689999999999999999999999999999988754

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-44  Score=323.41  Aligned_cols=276  Identities=22%  Similarity=0.292  Sum_probs=210.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ...|.+.+.||+|++|.||++.+..++..|++|....        ....+|++++++++|+||+++++++..++..+++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            4579999999999999999999999999999996422        23458999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--cc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RF  168 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~  168 (314)
                      +++.++|..++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......  ..
T Consensus       240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            9999999999887766799999999999999999999999999999999999999999999999999976533211  12


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCc------HHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSD------IDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....|++.|+|||.+.+ ..++.++|||||||++|+|++|..+ |.....      ...+.+++....... ..++....
T Consensus       320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~~  397 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHAG  397 (461)
T ss_pred             cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCcc
Confidence            23468999999999977 6689999999999999999988743 433211      223333333222111 11111100


Q ss_pred             ---ccchhhh-----ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          242 ---LPDYVEY-----QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       242 ---~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                         .......     ...........+..++..+.+||++||+.||.+|||++|+|+||||++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence               0000000     000000001112246778999999999999999999999999999974

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.9e-44  Score=315.68  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=214.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||+|+||+||+++++.+++.+|+|.+...... ......+.+|..++..++|++|+++.+++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999998753221 122234557889999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-c
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-F  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  168 (314)
                      ||+.| +|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......... .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99975 888888776667999999999999999999999999999999999999999999999999999766433221 2


Q ss_pred             cccccCccccCcccccCc----cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....|++.|+|||.+.+.    ..++.++|+||||+++|+|++|..||...+..+....+.......   .         
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~---------  228 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF---Q---------  228 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc---c---------
Confidence            234688999999988642    346889999999999999999999998877666665554321110   0         


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~  297 (314)
                                 ++.....+++++.++|.+||+.++++  |+++++++.||||+..
T Consensus       229 -----------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         229 -----------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             -----------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                       11112346899999999999976655  5789999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-44  Score=317.03  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHH-HHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREI-KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|++|.||++.+..+|+.+++|.+...... ......+..|. .+++.++||||+++.+.+.+.+..++||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999754321 11222333444 467888999999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence             66666654 4468999999999999999999999999999999999999999999999999987543333333445688


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....     .                    
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----~--------------------  213 (321)
T cd05603         160 PEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-----L--------------------  213 (321)
T ss_pred             cccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----C--------------------
Confidence            99999999876 668899999999999999999999998877655555443220     0                    


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCccccccC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFAKSFN  298 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~~~~~  298 (314)
                         ...+..+.++.++|.+||+.||.+||++    .++++|+||..++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         214 ---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence               1122458899999999999999999976    4999999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-44  Score=316.81  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHH-HHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREI-KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++++..+++.+++|++...... ......+..|. .+++.++|+||+++++++...+..++||||+.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999764321 11122333333 456778999999999999999999999999986


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                       +|...+.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence             67666654 4458899999999999999999999999999999999999999999999999987543333334455689


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      +.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------------------  213 (325)
T cd05602         160 PEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-------------------------  213 (325)
T ss_pred             ccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-------------------------
Confidence            99999999876 6788999999999999999999999988776666555433210                         


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCHH----HHhcCcccccc
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQ----QALEHRFAKSF  297 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----ell~h~~~~~~  297 (314)
                         ...+.++..+.++|.+||+.||.+||++.    ++++|+||..+
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         214 ---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence               11234689999999999999999999876    89999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-44  Score=320.48  Aligned_cols=280  Identities=26%  Similarity=0.333  Sum_probs=215.2

Q ss_pred             HHHhhccceeeeCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .+..+|.+++.||+|++|.||++....  ++..+++|.+....       ...+|+++++.++||||+++++++......
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            346789999999999999999997543  45789999875431       234799999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +++||++.+++..++. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       162 ~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9999999999999884 445699999999999999999999999999999999999999999999999999976543222


Q ss_pred             --cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC---cHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          167 --RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       167 --~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                        ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....   ....+..+....+..+.. ++....
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~-~~~~~~  318 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE-FPQNGS  318 (392)
T ss_pred             cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc-cCCccc
Confidence              2234568899999999876 668899999999999999999999996644   344455555544433222 221111


Q ss_pred             cc---chhhhccccCCC--CCcc--CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          242 LP---DYVEYQYVAAPP--LRSL--FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~---~~~~~~~~~~~~--~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..   ....+.....++  .+..  ....+.++.++|.+||+.||++|||+.|+|.||||++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            00   000111111110  0000  123577899999999999999999999999999998754

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=311.10  Aligned_cols=282  Identities=40%  Similarity=0.746  Sum_probs=215.4

Q ss_pred             hccceeeeCccccceEEEEEECC--CCcEEEEEEeecCC-cccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   87 (314)
                      +|.+.+.||+|++|.||++.++.  ++..|++|.+.... ..........+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58899999999999999999988  78999999998754 1222234556899999999999999999999877  7899


Q ss_pred             EEEecccccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec----CCcEEEeecccee
Q 021299           88 LVFEFMETDLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLAR  159 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~----~~~~~l~df~~~~  159 (314)
                      +|||++++++.+.+...    ...+++..++.++.|++.||.|||+++++|+||+|+||+++.    ++.++|+|||.+.
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            99999999888877532    236899999999999999999999999999999999999999    8999999999998


Q ss_pred             eeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH---------HHHHHHHh
Q 021299          160 IFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID---------QLGKIFAA  227 (314)
Q Consensus       160 ~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~---------~~~~~~~~  227 (314)
                      .......   ......+++.|+|||.+.+...++.++|+||||+++++|++|.+||.......         ....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV  240 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence            6543322   22334567889999988775678999999999999999999999997655432         33444444


Q ss_pred             hCCCCCCCCCCcCcccchhhhccc-cCCCCC--------ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYV-AAPPLR--------SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .+...+..++.....+........ ......        ......+..+.+++.+||+.||.+|||+.|++.||||
T Consensus       241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            443333322222111111110000 000000        0012568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-43  Score=306.20  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=209.3

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .|++.+.||+|+||.||++.+..+++.+++|.+........ ....+.+|+.+++.++|++++++.+.+..++..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999876543222 12345579999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |+.| +|.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK  159 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence            9985 777776543 3458999999999999999999999999999999999999999999999999987653222 223


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.................. ..                
T Consensus       160 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~----------------  221 (285)
T cd05630         160 GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQ----------------  221 (285)
T ss_pred             CCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hh----------------
Confidence            4468889999999876 66899999999999999999999999765432211111111000 00                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                             ......+++++.+|+.+||+.||++|||     ++|+++||||+.+.
T Consensus       222 -------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         222 -------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             -------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence                   0112345889999999999999999999     99999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-44  Score=318.28  Aligned_cols=289  Identities=36%  Similarity=0.598  Sum_probs=228.5

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ...++.++|.+.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+.|+|++++.+++...+.
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            34567899999999999999999999999999999999987543333333456689999999999999999998765544


Q ss_pred             ------EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           86 ------LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        86 ------~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                            .++++|+++++|.+.+...  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        89 ~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          89 LEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccccEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                  8999999998998888753  58999999999999999999999999999999999999999999999999997


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .....   .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+...+..+...
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            65332   233456788999999876557789999999999999999999999988887777777665443332222211


Q ss_pred             Ccccchhhh----ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          240 AYLPDYVEY----QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       240 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ... ....+    .......+......+++.+.++|.+||+.||.+|||+.+|+.||||+++...
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         244 SSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             cch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            100 00000    0011111222234568999999999999999999999999999999988654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-43  Score=302.19  Aligned_cols=257  Identities=28%  Similarity=0.396  Sum_probs=209.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||+|++|.||++.+..+++.+++|.+......  ....+.+|+.+++.++||||+++++.+...+..++++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999998765322  2234568999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+++ +|.+++... +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99986 777766544 4689999999999999999999999999999999999999999999999999977654433344


Q ss_pred             ccccCccccCccccc--CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          170 HQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~--~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ...+++.|+|||.+.  ....++.++|+||||+++|+|++|..||....+..........  ...+....          
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~----------  232 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPPKLK----------  232 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCCccc----------
Confidence            557888999999874  2345788999999999999999999998765544433332211  11111000          


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                                 ....++..+.++|.+||..+|++||++++++.|||
T Consensus       233 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         233 -----------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                       01135788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6e-44  Score=315.40  Aligned_cols=290  Identities=40%  Similarity=0.695  Sum_probs=228.0

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc--C
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH--K   83 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~   83 (314)
                      ...+.++|++.+.||+|++|.||++.+..+|+.+++|++............+.+|+.+++.+ +|+||+++++++..  .
T Consensus         2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            45688999999999999999999999988899999999865432222333556899999999 99999999998754  3


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ...++||||++++|...+...  .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            468999999999998888765  588899999999999999999999999999999999999999999999999976533


Q ss_pred             CCC-----cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          164 PDR-----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       164 ~~~-----~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ...     ......++..|+|||.+.+...++.++|+||||+++|+|++|..||..........++....+......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221     222345788899999887656788999999999999999999999998888877777766654433222111


Q ss_pred             cCcccc---hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          239 LAYLPD---YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ......   ................+.++.++.++|.+||+.||++|||+.++++|||++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            100000   000111111222333455799999999999999999999999999999999884

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-43  Score=301.08  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=211.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++....++..+++|.+.....    ...+.+|+++++.++|+|++++.+.+......++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            689999999999999999999988899999999875432    4467789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +++| +|.+.+......+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            9996 787777766777999999999999999999999999999999999999999999999999999876443333334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...........+..    .....+              
T Consensus       159 ~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~--------------  219 (256)
T cd06612         159 VIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPPPTL--------------  219 (256)
T ss_pred             ccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CCCCCC--------------
Confidence            557788999999876 5678999999999999999999999976554433222111    000000              


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             .....++.++.++|.+||+.||++|||+.|++.||||
T Consensus       220 -------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         220 -------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                   0112357899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-43  Score=301.32  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=214.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||.|++|+||++....++..+++|.+....... ....+.+|+..++.++|+|++++++.+...+..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            57999999999999999999988889999999987554333 34567789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-
Q 021299           92 FMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (314)
Q Consensus        92 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  167 (314)
                      ++.| ++.+.+...  ...+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9986 777777653  246899999999999999999999999999999999999999999999999998765433222 


Q ss_pred             ---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                         .....++..|+|||.+.....++.++|+||||+++++|++|..||..........+.....    +..++..     
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~-----  230 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND----PPSLETG-----  230 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC----CCCcCCc-----
Confidence               2334578889999998775578999999999999999999999998766555444433321    1111100     


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                   ..+..+++.+.+++.+||..||++||++++++.||||
T Consensus       231 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 -------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                         0123568999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-43  Score=307.23  Aligned_cols=264  Identities=30%  Similarity=0.481  Sum_probs=216.3

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...++|++.+.||+|++|.||++.+..+++.+++|.+......  ....+.+|+.+++.++|+||+++++++..++..++
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            3468999999999999999999999899999999998754332  23456689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||++| ++.+.+.+.  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        94 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             eecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            9999986 777776543  4789999999999999999999999999999999999999999999999999876444333


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... +.. +              
T Consensus       172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~-~--------------  234 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP-E--------------  234 (297)
T ss_pred             cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC-C--------------
Confidence            344567888999999876 66789999999999999999999999765543322211110 000 0              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                               ......+++.+.+|+.+||..+|++||++++++.||||+.......
T Consensus       235 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         235 ---------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             ---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence                     0112245888999999999999999999999999999997765554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=300.06  Aligned_cols=257  Identities=32%  Similarity=0.422  Sum_probs=212.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+......  ....+.+|+++++.++||||+++++++...+..+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            6899999999999999999999888999999999765433  33567789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |++| ++...+......+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            9996 677766665567999999999999999999999999999999999999999999999999998765443323344


Q ss_pred             cccCccccCcccccCc--cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          171 QVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ..++..|+|||.+.+.  ..++.++|+||||+++++|++|.+||...........+.....  .+...            
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~------------  226 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF--PPPKL------------  226 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCccc------------
Confidence            5677889999998652  2678899999999999999999999987765555444322210  00000            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                               .....++.++.+++.+||..+|++|||+.+++.|+|
T Consensus       227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         227 ---------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                     001234778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.6e-43  Score=303.34  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=214.7

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .|+..+.||+|+||+||.+.+..+++.+++|.+........ ....+.+|+++++.++|++++++.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999876533222 22345679999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |+.| ++...+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            9986 676666543 346999999999999999999999999999999999999999999999999999765322 2223


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.........                
T Consensus       160 ~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~----------------  222 (285)
T cd05632         160 GRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE----------------  222 (285)
T ss_pred             CCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----------------
Confidence            4568899999999876 56889999999999999999999999877655544444332211111                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccCcc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFNGV  300 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~~~  300 (314)
                              .....+++++.+|+.+||+.||.+||+     +.+++.|+||+.+...
T Consensus       223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         223 --------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             --------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                    112345889999999999999999999     8899999999988543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.6e-43  Score=304.24  Aligned_cols=260  Identities=32%  Similarity=0.510  Sum_probs=215.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .+|++.+.||.|++|+||++.+..+|+.+++|.+.....  .....+.+|+.+++.++|+|++++++++..+...++++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            579999999999999999999999999999999875432  223456789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |+.| +|...+...  .+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            9986 666655433  4899999999999999999999999999999999999999999999999998765443333334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... .. ...                
T Consensus       175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~-~~~----------------  235 (296)
T cd06655         175 MVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-PEL----------------  235 (296)
T ss_pred             cCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC-ccc----------------
Confidence            567888999999876 56789999999999999999999999887765554433221 00 000                


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                             .....+++.+.++|.+||..||++||++.+++.||||+......
T Consensus       236 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~  279 (296)
T cd06655         236 -------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS  279 (296)
T ss_pred             -------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence                   01124688999999999999999999999999999999766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-43  Score=313.73  Aligned_cols=285  Identities=34%  Similarity=0.634  Sum_probs=218.9

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   83 (314)
                      +.++|.+.+.||.|++|.||++.++.+|+.+++|.+.....  .....+.+|+++++.++||||+++++++...      
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            46899999999999999999999999999999999876543  2334566899999999999999999876543      


Q ss_pred             --------CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEee
Q 021299           84 --------GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLAD  154 (314)
Q Consensus        84 --------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~d  154 (314)
                              ...++++||+++++.+.+...  .+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeecccccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    357899999999888777543  5899999999999999999999999999999999999974 55789999


Q ss_pred             ccceeeeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCC
Q 021299          155 FGLARIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       155 f~~~~~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      ||.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||....+.+............
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999976532211   11223567789999987665678899999999999999999999998887777666655543322


Q ss_pred             CCCCCCCcCcccch-hh-hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          232 TPSQWPDLAYLPDY-VE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       232 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .+............ .. .......+.....+.++.++.+||.+||+.||.+|||+.+++.||||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            22111111000000 00 001111122223456789999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=302.58  Aligned_cols=278  Identities=43%  Similarity=0.790  Sum_probs=220.3

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc---CCCCeeeeeceeccCCe-----
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFPHKGN-----   85 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   85 (314)
                      |++.+.||.|++|.||++.++.+++.+++|.+............+.+|+.+++++   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6789999999999999999988899999999976554433333455677766665   59999999999877665     


Q ss_pred             EEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .+++||++++++.+.+.... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            99999999999888876643 36899999999999999999999999999999999999999999999999999876433


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||......+...++...........++.......
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             c-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2 2223346778999999876 5688999999999999999999999999888888888877655444333332211111


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                       ...............+.+++.+.++|.+||+.||++||++++++.||||
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 -SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             1111111112223334567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.6e-43  Score=303.74  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=208.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHH-HhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||.||++.++.+|+.||+|.+........ ...+..|... ++..+|||++++++++..++..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            479999999999999999999999999999999876543222 2234445554 66678999999999999999999999


Q ss_pred             ecccccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||++|++.+.+..   ....+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            9999988877754   345689999999999999999999997 99999999999999999999999999987653221 


Q ss_pred             cccccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 RFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ......++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||.... ..+..........    ...+     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~-----  229 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS----PQLP-----  229 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC----CCCC-----
Confidence            12224567789999988642   346889999999999999999999996532 3333333322111    1000     


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                       ...++.++.++|.+||..+|++||+++++++||||+.......
T Consensus       230 -----------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  272 (283)
T cd06617         230 -----------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT  272 (283)
T ss_pred             -----------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccH
Confidence                             0135889999999999999999999999999999998875533

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-43  Score=301.42  Aligned_cols=260  Identities=28%  Similarity=0.364  Sum_probs=208.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ..-.++|++.+.||+|++|.||++.+..+++.+++|++......  ....+.+|+.+++.++||||+++.+++...+..+
T Consensus         5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            34568899999999999999999999999999999998754322  2235668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +++||+++ +|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999986 676666543 4689999999999999999999999999999999999999999999999999987644333


Q ss_pred             cccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ......+++.|+|||.+..  ...++.++|+||+|+++|+|++|..||....+......+.....  .+..+        
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--------  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF--QPPKL--------  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC--CCCCC--------
Confidence            3334567888999998753  24467899999999999999999999865543332222111100  00000        


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                                   .....++..+.++|++||+.||++|||++++++|+|
T Consensus       232 -------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         232 -------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                         011245889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.1e-43  Score=310.63  Aligned_cols=285  Identities=20%  Similarity=0.205  Sum_probs=208.9

Q ss_pred             ceeeeCcc--ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           16 KREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        16 ~~~~lg~g--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      ++++||+|  ++++||++.++.+|+.|++|.+............+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  6789999999999999999999766544433445667999999999999999999999999999999999


Q ss_pred             cc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-----
Q 021299           94 ET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----  166 (314)
Q Consensus        94 ~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-----  166 (314)
                      ++ ++.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++||+.+........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            85 777777543 34589999999999999999999999999999999999999999999999986543211110     


Q ss_pred             --cccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCC-------CCCC
Q 021299          167 --RFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT-------PSQW  236 (314)
Q Consensus       167 --~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~  236 (314)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||....................       ++..
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence              11123456679999998653 3578999999999999999999999986554443333222110000       0000


Q ss_pred             C-------CcCcccchhh----hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          237 P-------DLAYLPDYVE----YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       237 ~-------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .       ..........    ...............+++++.+|+.+||+.||++|||++|+++||||+.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~  316 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  316 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence            0       0000000000    00000011112233568899999999999999999999999999999987543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-43  Score=324.20  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=212.8

Q ss_pred             hhccceeeeCccccceEEEEEECCC-CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ..|.+.+.||.|++|.||.+.+..+ +..+++|.+.....  .....+..|+.+++.++||||+++++++..++..|+||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4499999999999999999998877 77888887654322  12234557999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||+.| +|.+.+..   ...++++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99985 88777643   345689999999999999999999999999999999999999999999999999987643221


Q ss_pred             --cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 --RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 --~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                        ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+.......             
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------------  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-------------  290 (478)
T ss_pred             cccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence              2234468999999999876 668999999999999999999999998877666555544321111             


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                    ....+++++.++|.+||..||++||++++++.|+|++...
T Consensus       291 --------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        291 --------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             --------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence                          1124588999999999999999999999999999998653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-43  Score=313.01  Aligned_cols=285  Identities=36%  Similarity=0.615  Sum_probs=222.8

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   83 (314)
                      +.++|.+.+.||+|++|.||+|.+..+|+.+++|.+............+.+|+.+++.++|+||+++.+++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            46899999999999999999999988999999999876543333344567899999999999999999988544      


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..+++++|++.+++....   +..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            346899999988776654   23589999999999999999999999999999999999999999999999999875422


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                         ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+...+..++......
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence               22334567889999998765668899999999999999999999999887777777766655433332222111100


Q ss_pred             chh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          244 DYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       244 ~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...   .........+....+.+++.+.+||.+||+.||.+||++++++.||||+.+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            000   000011111222234678899999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-43  Score=336.43  Aligned_cols=269  Identities=26%  Similarity=0.405  Sum_probs=217.5

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--   81 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--   81 (314)
                      ++-++...++|.+++.||.|+||+||++.+..++..+++|.+............+..|+.+++.++||||++++++|.  
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            344566678999999999999999999999999999999999876554444556778999999999999999999874  


Q ss_pred             cCCeEEEEEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCceEEecC---
Q 021299           82 HKGNLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKK-------WVLHRDMKPNNLLIGSH---  147 (314)
Q Consensus        82 ~~~~~~iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~i~H~di~~~nil~~~~---  147 (314)
                      ....+|+||||+++ +|...+...   .+.+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            44678999999985 888887642   35699999999999999999999984       49999999999999642   


Q ss_pred             --------------CcEEEeeccceeeeCCCCCcccccccCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhCCCcc
Q 021299          148 --------------GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFL  212 (314)
Q Consensus       148 --------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf  212 (314)
                                    +.++|+|||++....... ......+++.|+|||++.+ ...++.++|||||||+||+|++|..||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                          348999999997654322 2344578999999999864 245789999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                      ........+.......   +...                        ....+.++.+||..||..+|.+||++.|+|.||
T Consensus       244 ~~~~~~~qli~~lk~~---p~lp------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        244 HKANNFSQLISELKRG---PDLP------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             CcCCcHHHHHHHHhcC---CCCC------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            7665554443332211   1000                        123488999999999999999999999999999


Q ss_pred             cccccCcc
Q 021299          293 FAKSFNGV  300 (314)
Q Consensus       293 ~~~~~~~~  300 (314)
                      |++.+...
T Consensus       297 ~ik~i~~p  304 (1021)
T PTZ00266        297 IIKNVGPP  304 (1021)
T ss_pred             HHhhcCCC
Confidence            99877543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.7e-43  Score=303.24  Aligned_cols=259  Identities=30%  Similarity=0.510  Sum_probs=213.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ..+|++.+.||+|++|.||++.+..++..+++|.+......  ....+.+|+.+++.+.|+|++++.+.+..+...++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            47999999999999999999999999999999998764432  2345668999999999999999999999899999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+.| +|.+++...  .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            99985 787777543  478999999999999999999999999999999999999999999999999876543333333


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||............... .  .+ .              
T Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~--~~-~--------------  235 (296)
T cd06654         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G--TP-E--------------  235 (296)
T ss_pred             cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-C--CC-C--------------
Confidence            4567888999998876 56789999999999999999999999776654433222111 0  00 0              


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                             ......+++.+.++|.+||..||++||++++++.||||.....
T Consensus       236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         236 -------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             -------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                   0112246888999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.9e-43  Score=301.60  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+..... ......+.+|++++++++||||+++++++...+..++++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            478899999999999999999999999999999875432 2233457789999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++++.+...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            9997544433    24788999999999999999999999999999999999999999999999999765332  22345


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH---HHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ---LGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........   ............+...            
T Consensus       154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------  220 (279)
T cd06619         154 VGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------------  220 (279)
T ss_pred             CCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------------
Confidence            67888999999876 5689999999999999999999999865332111   0111111111111100            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                .....++++.++|.+||+.+|++||++++++.||||+..+....
T Consensus       221 ----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         221 ----------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             ----------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence                      01235889999999999999999999999999999998765544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-43  Score=298.65  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=211.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--cCCeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~   90 (314)
                      +|.+.+.||.|++|.||++.+..++..+++|.+............+.+|+++++.++|+|++++++++.  .....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999999999999999998766544444455678999999999999999999764  445789999


Q ss_pred             ecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           91 EFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCH-----KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        91 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ||+++ +|.+.+...   ...+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99985 788777653   457899999999999999999999     899999999999999999999999999999876


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ...........+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...........+....    .        
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~--------  227 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK----F--------  227 (265)
T ss_pred             cCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC----C--------
Confidence            554432344567888999999876 557899999999999999999999998876444433332211    1        


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                     .......+..+.+++.+||..+|++||++++|++|||+
T Consensus       228 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 ---------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                           11122458899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.8e-43  Score=299.81  Aligned_cols=256  Identities=27%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH------   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------   82 (314)
                      ..+.|.+.+.||+|++|.||++.+..+++.+++|.+.....   ....+..|+.+++.+ +|+|++++.+++..      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            46889999999999999999999999999999999875432   223566889999988 69999999998854      


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ....+++|||+++ +|.+.+... ...+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            3468999999985 787777654 34689999999999999999999999999999999999999999999999999986


Q ss_pred             eCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      ............+++.|+|||.+.+    ...++.++|+||+|+++|+|++|..||...............    ...  
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----~~~--  234 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PAP--  234 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC----CCC--
Confidence            5443333445567888999999863    235788999999999999999999999765544333322110    000  


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                          ......++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       235 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 --------------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             --------------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                00112457899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.5e-43  Score=307.46  Aligned_cols=288  Identities=35%  Similarity=0.590  Sum_probs=225.2

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-CCeEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGNLH   87 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   87 (314)
                      .+.++|.+.+.||.|++|.||++.+..+++.+++|++............+.+|+++++.++|||++++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            36789999999999999999999999999999999987544333344566789999999999999999998855 56789


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      +++|++++++...+...  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....   .
T Consensus        87 lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          87 FVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEeehhccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            99999988888777643  478888999999999999999999999999999999999999999999999875422   1


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc---c
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP---D  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  244 (314)
                      .....+++.|+|||.+.+...++.++|+||||+++++|++|.+||...........+....+..+...........   .
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            2234567789999988665678999999999999999999999998877766666555554443322211110000   0


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                      ..........+.....+.+++.+.++|++||+.+|++||++++++.||||..+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            001111111122233356789999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-43  Score=299.23  Aligned_cols=253  Identities=25%  Similarity=0.499  Sum_probs=207.3

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-------cchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-------VNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      +|++.+.||+|++|.||+|.+..++..+++|.+........       ....+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            58899999999999999999988899999999876543222       11245579999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .++++||++| +|.+++... +.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999986 777777654 46889999999999999999999999999999999999999999999999998766421


Q ss_pred             CC------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          165 DR------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       165 ~~------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ..      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  229 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---------  229 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---------
Confidence            11      1112346778999999876 5678899999999999999999999987655444433322110         


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                        ......++..+.++|.+||+.||.+||++.++++||||
T Consensus       230 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 ------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              01112458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-43  Score=306.68  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=215.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||+|++|+||++.+..+++.+++|.+....... .....+.+|+++++.++|+||+++++.+.++...+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998654332 23335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--  166 (314)
                      ||+.| +|.+.+... +..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99986 888877654 35689999999999999999999999999999999999999999999999999865422111  


Q ss_pred             ---------------------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH
Q 021299          167 ---------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID  219 (314)
Q Consensus       167 ---------------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~  219 (314)
                                                 ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                       1112356778999999876 567899999999999999999999998877666


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC----HHHHhcCcccc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT----AQQALEHRFAK  295 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~ell~h~~~~  295 (314)
                      ....+.....     .++.                     ...+++++.++|.+||..||++||+    +++++.||||+
T Consensus       240 ~~~~~~~~~~-----~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         240 TFSNILKKEV-----TFPG---------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             HHHHHhcCCc-----cCCC---------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            5554432111     0110                     1125899999999999999999999    99999999999


Q ss_pred             ccC
Q 021299          296 SFN  298 (314)
Q Consensus       296 ~~~  298 (314)
                      +.+
T Consensus       294 ~~~  296 (316)
T cd05574         294 GVN  296 (316)
T ss_pred             cCC
Confidence            874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-43  Score=311.94  Aligned_cols=288  Identities=35%  Similarity=0.563  Sum_probs=226.0

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      ++.++|.+.+.||+|++|.||++.+..+|+.|++|++............+.+|+.++++++|+||+++.+++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            456999999999999999999999999999999999876433333334566899999999999999999987432     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...+++++++++++.+.+...  .+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             357889999988888777643  48999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+...+..++.....
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2   2234467888999998876556789999999999999999999999888877777777666555444333322211


Q ss_pred             cchh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                      ....   .................++++.++|.+||+.||.+||++.+++.||||+++....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            1000   0011111112222335688999999999999999999999999999999876443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=301.29  Aligned_cols=279  Identities=42%  Similarity=0.699  Sum_probs=224.9

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEec
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      |.+.+.||+|++|+||+|....+++.+++|.+....... ......+|+..++.++ |+|++++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            678899999999999999998889999999987543321 2223446889999999 99999999999999999999999


Q ss_pred             ccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           93 METDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        93 ~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++|++.+.+.... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~  158 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDY  158 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCC
Confidence            9889998887654 568999999999999999999999999999999999999999999999999998664322 22345


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc--
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ--  249 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  249 (314)
                      .++..|+|||.+.....++.++|+||||+++++|++|.+||......+....+....+......|+............  
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            677889999998765678999999999999999999999999998888888777776666554444322211111111  


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ...........+..+..+.++|.+||+.||++||+++|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111111222233457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-43  Score=302.56  Aligned_cols=262  Identities=28%  Similarity=0.438  Sum_probs=211.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|++|.||++.+..+|..+++|.+.... .......+.+|+.++++++|+||+++++.+..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            57999999999999999999999899999999986542 22223466789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           92 FMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        92 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |++| ++..++...  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+......  .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence            9997 676666543  2368999999999999999999997 59999999999999999999999999998765322  2


Q ss_pred             ccccccCccccCcccccCcc-----CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          168 FTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~-----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .....+++.|+|||.+.+..     .++.++|+||||+++|+|++|..||...........+....... +.        
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~--------  228 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-PP--------  228 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-CC--------
Confidence            22345677899999986522     35789999999999999999999997655444333332221111 11        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                     ...+.+++++.++|.+||+.+|++||++++++.||||......
T Consensus       229 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         229 ---------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ---------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                           1122468999999999999999999999999999999877543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-43  Score=312.12  Aligned_cols=286  Identities=38%  Similarity=0.613  Sum_probs=222.1

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   84 (314)
                      .+.++|++.+.||+|++|.||++.+..+|..|++|.+............+.+|+++++.++|+||+++.+++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3578999999999999999999999999999999998654333333345668999999999999999999886543    


Q ss_pred             --eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        85 --~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                        .+++|+|++++++...+..  ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              4689999998888877764  358999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   .....+++.|+|||.+.+...++.++|+||||++++++++|..||...........+..................
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            22   233456788999999876456789999999999999999999999887776666666554333221111111000


Q ss_pred             cch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...   ..........+....+.+++++.++|.+||..||++|||+.+++.||||+.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            000   000000111122334567889999999999999999999999999999998854

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-43  Score=299.51  Aligned_cols=257  Identities=30%  Similarity=0.413  Sum_probs=209.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH------   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------   82 (314)
                      ..++|++.+.||+|++|.||++.++.+++.+++|.+.....   ....+.+|+.+++.+ .|+||+++++++..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            35899999999999999999999988899999999875543   234567899999998 69999999999854      


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      ....+++|||+++ +|.+.+...   +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            3458999999996 777666542   457899999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ..............+++.|+|||.+..    ...++.++|+||||+++++|++|..||...........+....    ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP----PP  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC----CC
Confidence            776444444445667888999998753    2346789999999999999999999998665555444432211    11


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .+.                     .....++++.+||.+||..||++|||+.+++.|||+
T Consensus       237 ~~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLK---------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCC---------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            110                     011357899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-43  Score=302.94  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=214.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|++++++++||||+++++++.+++..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987543222 22345668999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++ ++|.+.+... +.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            9996 5888887665 46899999999999999999999999999999999999999999999999999765433   23


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+.....                    
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  215 (290)
T cd05580         157 TLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV--------------------  215 (290)
T ss_pred             CCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--------------------
Confidence            3457888999998866 5678999999999999999999999987775555554432210                    


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                              .....+++.+.++|.+||+.||.+|+     +++|++.||||+...
T Consensus       216 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         216 --------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             --------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                    01123488999999999999999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-42  Score=294.72  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=213.1

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||+|++|.||++.+..+++.+++|.+............+.+|+++++.++|||++++++.+..++..++|||+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            58999999999999999999999999999999987654444455677899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeCCCCCccc
Q 021299           93 MET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        93 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ++| +|.+.+... ...+++..+..++.+++.++++||++|++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            986 888888764 3458999999999999999999999999999999999999865 468999999998764332 222


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+......                   
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  219 (256)
T cd08220         160 TVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-------------------  219 (256)
T ss_pred             ccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-------------------
Confidence            3457788999999876 56789999999999999999999999877666555554332111                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                              +....+++.+.+++.+||..+|++|||+.|++.||||
T Consensus       220 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 --------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                    1112458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=308.98  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=210.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..++.++.||+|.||.||++.++.+ ..+++|.+.......   ..+.+|++++++++|++|+++++++..++.+|||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            4567889999999999999987643 489999997654332   356799999999999999999999998889999999


Q ss_pred             ccc-ccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-c
Q 021299           92 FME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-F  168 (314)
Q Consensus        92 ~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  168 (314)
                      |+. |+|+++++. .+..++..+...++.||++|++||++++++||||-..||||+++..+||+|||+++..+.+... .
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            998 899999997 5677999999999999999999999999999999999999999999999999999965443322 2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .+...+.-|.|||.+.- ..++.+|||||+|++|+||+| |+.|++.....+.+..+.++..-+.|.             
T Consensus       362 ~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~-------------  427 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE-------------  427 (468)
T ss_pred             CCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC-------------
Confidence            22223455999999977 678999999999999999985 568989999999999988875544443             


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                                    .+|+++.+++..||..+|++|||.+.+.
T Consensus       428 --------------~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  428 --------------GCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             --------------CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                          4689999999999999999999998654

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-42  Score=295.35  Aligned_cols=254  Identities=29%  Similarity=0.504  Sum_probs=217.2

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||.|++|.||++.+..++..+++|.+............+.+|+++++.++|+|++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            58899999999999999999998999999999987665545555677899999999999999999999888999999999


Q ss_pred             ccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           93 MET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        93 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ++| +|.+.+...   ...+++..+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            986 888888765   3679999999999999999999999999999999999999999999999999998765544333


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.............    ..             
T Consensus       161 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~-------------  222 (258)
T cd08215         161 KTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PP-------------  222 (258)
T ss_pred             cceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----CC-------------
Confidence            44567888999998866 5678999999999999999999999987775555554432211    11             


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                ....++..+.+++.+||..+|++||+++++++||||
T Consensus       223 ----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         223 ----------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                      112458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7e-43  Score=307.93  Aligned_cols=287  Identities=39%  Similarity=0.626  Sum_probs=225.4

Q ss_pred             hccceeeeCccccceEEEEEECCC--CcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceec----cCCe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKT--GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP----HKGN   85 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----~~~~   85 (314)
                      +|++.+.||+|++|.||++.+..+  +..+++|.+............+.+|+++++++ .||||+++++...    ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588999999999999999999887  88999999875433333344566899999999 5999999998642    2346


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .++++++++++|...+... ..+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            7899999999998888654 458999999999999999999999999999999999999999999999999997653321


Q ss_pred             C----cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 R----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~----~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .    ......+++.|+|||.+.+...++.++|+||||+++++|++|.+||...+.......+....+......+.....
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence            1    112346788899999887656689999999999999999999999999888888888887766544332222111


Q ss_pred             ccc---hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          242 LPD---YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       242 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...   ...........+....+..+..+.+++.+||+.||.+|||+.+++.|||++++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence            100   00111111222333345578999999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-43  Score=301.42  Aligned_cols=261  Identities=29%  Similarity=0.484  Sum_probs=211.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|+..+.||.|++|.||++.++.+++.+++|.+...... .....+.+|++.++.++||||+++.+.+..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            4788999999999999999999999999999998765433 334456789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      +++| +|.+++......+++..+..++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence            9994 8888887665679999999999999999999999 99999999999999999999999999998655322211  


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||.... .........+..........+.          
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  226 (265)
T cd06605         158 TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS----------  226 (265)
T ss_pred             cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh----------
Confidence            2567778999999877 578899999999999999999999986542 1111111111111111111110          


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  ..+++++.++|.+||..||++|||+.+++.||||+.+.
T Consensus       227 ------------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         227 ------------GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------------hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                        01588999999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-42  Score=295.48  Aligned_cols=254  Identities=28%  Similarity=0.494  Sum_probs=212.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||.|++|.||++.++.+|..+++|.+............+.+|+++++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58899999999999999999999999999999977544333444667899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCCCccc
Q 021299           93 MET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        93 ~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~  169 (314)
                      +.+ +|.+.+.... ..+++..+..++.|++.|+.+||+++++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            975 8888776543 3579999999999999999999999999999999999998886 579999999987654443334


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.................                    
T Consensus       161 ~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------  219 (257)
T cd08225         161 TCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF--------------------  219 (257)
T ss_pred             ccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC--------------------
Confidence            4567888999998866 5688999999999999999999999987665554444332110                    


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             ....+.++.++.++|.+||..+|++|||+.+++.||||
T Consensus       220 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 -------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                   11123458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=291.96  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=212.8

Q ss_pred             HHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc----C
Q 021299           10 VADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH----K   83 (314)
Q Consensus        10 ~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~   83 (314)
                      |.++|.+- ++||-|-.|.|-.+.++.+++++|+|++.-..       +..+|++..... .|||||.++++|++    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            56778654 67899999999999999999999999986432       444777766555 59999999999854    3


Q ss_pred             CeEEEEEecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcEEEeeccce
Q 021299           84 GNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLA  158 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~df~~~  158 (314)
                      ....+|||.++| .|.+.++.++ +.+++..+.+|+.||..|+.|||+.+|+||||||+|+|+...   ..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            456789999986 8999998764 579999999999999999999999999999999999999654   47999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC----cHHHHHHHHHhhCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS----DIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~  234 (314)
                      +.-.... .......||+|.|||++-. ..+....|+|||||++|-|++|.+||=.+.    ......++..+...++.+
T Consensus       212 K~t~~~~-~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  212 KETQEPG-DLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccCCCc-cccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            8764433 3345667899999999866 679999999999999999999999994433    455666666665555555


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .|.                        .+|+.++++|+++|..+|++|.|+++++.|||+++..
T Consensus       290 EWs------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  290 EWS------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hHh------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            554                        4699999999999999999999999999999999765

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-42  Score=303.09  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=216.1

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ....++|.+.+.||+|++|+||++.+..+|+.+++|.+....... .....+.+|+.+++.++|||++++.+++...+..
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            344578999999999999999999998899999999986543222 2223566899999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|+||+.|++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            999999999998888766667999999999999999999999999999999999999999999999999998765332  


Q ss_pred             cccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                        ....+++.|+|||.+.+  ...++.++|+||||+++|+|++|..||...+.......+....    +...+       
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~-------  235 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLS-------  235 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC----CCCCC-------
Confidence              23456778999998742  3457889999999999999999999998776655544432210    00000       


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                     ....+..+.++|.+||..+|++||++.+++.||||..-.
T Consensus       236 ---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         236 ---------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             ---------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                           012477899999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-42  Score=303.49  Aligned_cols=279  Identities=26%  Similarity=0.406  Sum_probs=210.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++.+..++..+++|.+..... ......+.+|++++++++||||+++++.+..++..++++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            479999999999999999999999999999999865432 2223356689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |++| +|.+++... +.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  156 (308)
T cd06615          80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  156 (308)
T ss_pred             ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence            9986 777777654 568999999999999999999997 59999999999999999999999999988654222  223


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC------------
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP------------  237 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------  237 (314)
                      ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..... ...............            
T Consensus       157 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         157 SFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCcc
Confidence            4567888999999866 56789999999999999999999999766533322 222111111100000            


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ................++.. -...++.++.+++.+||..+|++||++++++.||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            00000000000000000100 011368899999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-42  Score=294.93  Aligned_cols=251  Identities=29%  Similarity=0.461  Sum_probs=210.2

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||.|++|.||++.+..++..+++|.+....... ....+.+|+.+++.++|+|++++.+.+..++..++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            5889999999999999999999999999999987543322 234566899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 MET-DLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +++ ++.+.+.. ....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            985 78887765 3456899999999999999999999999999999999999999999999999999876544433444


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......                   
T Consensus       160 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  219 (255)
T cd08219         160 YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-------------------  219 (255)
T ss_pred             ccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence            567888999999876 568999999999999999999999998776655554443321111                   


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                              ....++..+.++|.+||+.||++||++.++++.-
T Consensus       220 --------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         220 --------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             --------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                    1123578899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.7e-43  Score=301.98  Aligned_cols=258  Identities=27%  Similarity=0.428  Sum_probs=211.6

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +.+.|...+.||+|++|.||++.+..++..+++|.+....... ....+.+|+.+++.++|+||+++++.+..+...++|
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            4578999999999999999999998889999999987543322 234567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      +||++| ++.+.+..  +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          81 MEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            999986 67666643  358999999999999999999999999999999999999999999999999997654333233


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...    .+               
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~~---------------  218 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN----SP---------------  218 (277)
T ss_pred             hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----CC---------------
Confidence            33457788999999876 56789999999999999999999998765544333221111    00               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              ......++.++.++|.+||+.+|++||++.+++.||||..+.
T Consensus       219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         219 --------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             --------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                    011123578899999999999999999999999999998654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.6e-43  Score=297.24  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=209.8

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+....... .....+.+|++++++++||||+++++.+.++...++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999899999999998654322 334567789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |+.| +|...+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            9986 677666554 579999999999999999999999999999999999999999999999999997654332 2234


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.. ..++.++|+||||+++|+|++|..||...... ....+...... ..                 
T Consensus       159 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~-----------------  218 (258)
T cd05578         159 TSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-AD-----------------  218 (258)
T ss_pred             cCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-cc-----------------
Confidence            557778999999876 55899999999999999999999999876642 11111111111 00                 


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH--HHHhcCccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA--QQALEHRFA  294 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~ell~h~~~  294 (314)
                            ......++..+.++|.+||+.||.+||+.  .|+++||||
T Consensus       219 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         219 ------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                  11122457899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-43  Score=302.59  Aligned_cols=262  Identities=24%  Similarity=0.420  Sum_probs=214.4

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ....+.|.....||+|++|.||++.+..++..+++|.+.....  .....+.+|+..++.++|+|++++++.+...+..+
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            3456778888899999999999999988999999999865332  22335668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|||++| ++.+.+..  +.+++..+..++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        96 lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658          96 VVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             EEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            99999987 56565543  3489999999999999999999999999999999999999999999999999875533333


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.......    .+         
T Consensus       174 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~---------  239 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----VK---------  239 (292)
T ss_pred             cCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc----cc---------
Confidence            3334567888999998866 567899999999999999999999998776655544433221111    10         


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                  ....++..+.+++.+||..||.+|||++++++||||.....
T Consensus       240 ------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         240 ------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             ------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence                        01235889999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-42  Score=295.03  Aligned_cols=257  Identities=29%  Similarity=0.498  Sum_probs=214.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.+.+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+..+..++|+|++++.+++...+..++++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4689999999999999999999999999999998765433 334567789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |++| +|.+.+... ..+++..++.++.|++.|+.+||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            9995 777777654 568999999999999999999999 9999999999999999999999999999987654444333


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---HHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....   ......+.    ......           
T Consensus       159 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~-----------  222 (264)
T cd06623         159 TFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPPS-----------  222 (264)
T ss_pred             ceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCCC-----------
Confidence            4567788999999876 5788999999999999999999999977752   22222221    111111           


Q ss_pred             hhccccCCCCCccCCC-CCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  .... ++..+.++|.+||..+|++||++.++++|||++..+
T Consensus       223 ------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         223 ------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                        1122 588999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-42  Score=306.97  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=196.6

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc-C
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~   83 (314)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|.+..... ......+.+|+.+++.+ +||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            479999999999999999999742     3456899999864322 22234577899999999 89999999998765 4


Q ss_pred             CeEEEEEecccc-cHHHHHHhCC---------------------------------------------------------
Q 021299           84 GNLHLVFEFMET-DLETVIRNTN---------------------------------------------------------  105 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~---------------------------------------------------------  105 (314)
                      +..+++|||++| +|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            468999999985 8887776421                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--CcccccccCccccC
Q 021299          106 ----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRA  179 (314)
Q Consensus       106 ----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~s  179 (314)
                          ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......  .......+++.|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                237788889999999999999999999999999999999999999999999997643221  11222345677999


Q ss_pred             cccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCc
Q 021299          180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS  258 (314)
Q Consensus       180 PE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (314)
                      ||.+.+ ..++.++||||||+++|+|++ |..||...............   ....                       .
T Consensus       245 PE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~-----------------------~  297 (338)
T cd05102         245 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTRM-----------------------R  297 (338)
T ss_pred             cHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---CCCC-----------------------C
Confidence            999876 668999999999999999997 99999876543333222211   0000                       0


Q ss_pred             cCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          259 LFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       259 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-42  Score=295.55  Aligned_cols=258  Identities=29%  Similarity=0.503  Sum_probs=207.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +|+..+.||+|++|.||.+.+..+++.+++|.+........    ....+.+|++.+++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48889999999999999999999999999999875442221    23456689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDR  166 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~  166 (314)
                      ++||+.| +|.+.+... +++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999996 677766543 4689999999999999999999999999999999999998776 699999999976643311


Q ss_pred             c----ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 R----FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~----~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .    .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+.........         
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  229 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---------  229 (268)
T ss_pred             cCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---------
Confidence            1    122356778999999876 56789999999999999999999999765443333322221111111         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                    ......+++++.+++.+||+.+|++||++.+++.||||+
T Consensus       230 --------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         230 --------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                          111234688999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-42  Score=298.74  Aligned_cols=258  Identities=29%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccC-----
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-----   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----   83 (314)
                      ..++|.+.+.||+|++|.||++.+..+++.+++|.+.....   ....+.+|+.+++.+ +|||++++++++...     
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            46899999999999999999999999999999999865321   223455788899988 799999999987543     


Q ss_pred             CeEEEEEecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           84 GNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      +..++++||++| +|.+.+..   ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            468999999986 77776643   34568999999999999999999999999999999999999999999999999987


Q ss_pred             eeCCCCCcccccccCccccCcccccCcc----CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAK----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      .............++..|+|||.+....    .++.++|+||||+++|+|++|.+||...........+...    .+..
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~----~~~~  252 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN----PPPT  252 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC----CCCC
Confidence            6544333334456788899999885432    3689999999999999999999999877665554443221    1100


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      +                     ......+..+.++|.+||+.+|++||++.+++.||||+
T Consensus       253 ~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 L---------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C---------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            0                     00123477899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-42  Score=297.88  Aligned_cols=256  Identities=29%  Similarity=0.394  Sum_probs=206.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceec------c
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP------H   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------~   82 (314)
                      -.+.|++.+.||.|++|.||++.+..+++.+++|.+.....   ....+..|+.+++++ +|+|++++++++.      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            35899999999999999999999999999999999865432   223556788888888 6999999999874      3


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ....+++|||+++ +|.+.+... ...+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            4678999999986 777777653 34588899999999999999999999999999999999999999999999999875


Q ss_pred             eCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      ............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||....+......+...    .+.  
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~----~~~--  244 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PPP--  244 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC----CCC--
Confidence            5433333344567888999998753    245788999999999999999999999765544333322111    000  


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                          ......++.++.+||.+||+.||.+||++.|+++||||
T Consensus       245 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 --------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                00112458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=297.17  Aligned_cols=257  Identities=25%  Similarity=0.455  Sum_probs=210.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC---CCCeeeeeceeccCCeEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .|++.+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.+++.+.   |||++++++++..+...+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            588899999999999999999999999999998754322 22335667888888886   99999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|.+++...  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999986 677666543  68999999999999999999999999999999999999999999999999998775544334


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+..    ..+..++           
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----~~~~~~~-----------  223 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----SKPPRLE-----------  223 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----CCCCCCC-----------
Confidence            4456788899999987656678999999999999999999999976654333221110    0111110           


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                 ...++.++.+++.+||+.||++||++.+++.||||+...
T Consensus       224 -----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         224 -----------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -----------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                       012578999999999999999999999999999998765

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.8e-42  Score=296.96  Aligned_cols=261  Identities=27%  Similarity=0.455  Sum_probs=214.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .-..+|...+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.++|+|++++++++...+..++
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            334577778999999999999999988999999998864322  223356789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ++||+.| +|.+.+..  +.+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999976 77777766  45899999999999999999999999999999999999999999999999988655433333


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.....    ...           
T Consensus       172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~----~~~-----------  235 (285)
T cd06648         172 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP----PKL-----------  235 (285)
T ss_pred             cccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC----CCC-----------
Confidence            334567888999999866 5678999999999999999999999987766655554433211    000           


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                .....+++.+.+++.+||+.+|++||++.++++||||++..+
T Consensus       236 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         236 ----------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ----------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                      001235889999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-42  Score=297.34  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ...|+..+.||.|++|.||.+.+..++..+++|.+...... .....+.+|+.+++++.|+||+++++.+.++...++||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788999999999999999999989999999998754322 22345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+.+..  +.+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            99986 77776654  3588999999999999999999999999999999999999999999999999976644333333


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....+......+...    .+                
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~~----------------  218 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN----NP----------------  218 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC----CC----------------
Confidence            4457778999999876 56799999999999999999999999776554433322111    01                


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                             ......++..+.+++.+||+.+|++||++++++.||||.....
T Consensus       219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         219 -------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             -------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                   1112235788999999999999999999999999999986643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.6e-42  Score=292.30  Aligned_cols=257  Identities=28%  Similarity=0.482  Sum_probs=209.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||+|++|.||++.+..++..+++|.+............+..|+++++.++|+||+++++.....+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            68999999999999999999988999999999987655433445677899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc--
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT--  169 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~--  169 (314)
                      +.+ +|.+.+... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...........  
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            986 677666543 4588999999999999999999999999999999999999999999999999987644332221  


Q ss_pred             --ccccCccccCcccccCcc--CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          170 --HQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       170 --~~~~~~~y~sPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                        ...+++.|+|||.+.+..  ..+.++|+||+|++++++++|..||...+...........   ......+.       
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~-------  229 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD-------  229 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc-------
Confidence              245677899999987632  2789999999999999999999999765433322211111   11111111       


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                    ...+++.+.++|.+||+.+|.+||++++++.|||+
T Consensus       230 --------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         230 --------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             --------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                          12358889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=311.09  Aligned_cols=253  Identities=30%  Similarity=0.452  Sum_probs=218.3

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccccc
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD   96 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~   96 (314)
                      .++||+|.||+||-++++.+|+.||+|++.+............+|+.+|+.+.||+|+.+-..|+..+.+++|||.+.|+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999999999999999999988766555567779999999999999999999999999999999999999


Q ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeeccceeeeCCCCCcccccc
Q 021299           97 LETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        97 l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      .++++... .+.+++..-..++.||+.||.|||.+||+|+||||+||++....   .+||||||++++.++... ....+
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-RrsVV  727 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRSVV  727 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhhhc
Confidence            99998754 67899999999999999999999999999999999999997653   699999999999876543 45678


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
                      |||.|+|||++.. +.|+...|+||.|||+|--+.|..||...++..  .++....--.++..|                
T Consensus       728 GTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp~PW----------------  788 (888)
T KOG4236|consen  728 GTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPPNPW----------------  788 (888)
T ss_pred             CCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCCCch----------------
Confidence            9999999999987 778999999999999999999999996544322  222111111223333                


Q ss_pred             CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       253 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                              ..+++++++||..+|+...++|.|.+..|.|||++..
T Consensus       789 --------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  789 --------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             --------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                    3569999999999999999999999999999999976

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.5e-42  Score=293.28  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=205.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +|++.+.||.|++|+||++.. .+|..+++|.+........    ....+.+|++++++++|+||+++.+++.+++..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            589999999999999999975 4788999999876533221    12346689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC---
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP---  164 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~---  164 (314)
                      ++||+.| +|.+.+.+. ..+++..+..++.|++.|+++||+.+++|+||+|+||+++.++.++|+|||.+......   
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999986 777776544 45889999999999999999999999999999999999999999999999998754221   


Q ss_pred             ---CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 ---DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ---~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                         ........++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+......           
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-----------  226 (265)
T ss_pred             ccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-----------
Confidence               111223457888999999876 56789999999999999999999999776544433322211000           


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                    .......++.++.++|.+||+.+|++||++.+++.||||
T Consensus       227 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 --------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          111223468999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.4e-42  Score=296.57  Aligned_cols=258  Identities=27%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeecee-----cc
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAF-----PH   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-----~~   82 (314)
                      ...++|.+.+.||+|++|.||++.+..+++.+++|.+.....   ....+..|+.+++.+ +|+||+++++++     ..
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            356899999999999999999999999999999998764321   123456788999998 699999999987     34


Q ss_pred             CCeEEEEEecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           83 KGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      ++..+++|||++| +|.+.+..   ....+++..++.++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5678999999986 77776642   3456899999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ..............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...............    .+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~----~~~  247 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN----PPP  247 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc----CCC
Confidence            876443333344568889999998853    234688999999999999999999999766543333221110    000


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ..                     ......+..+.++|.+||+.||++|||+.|+++|+||
T Consensus       248 ~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TL---------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cc---------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            00                     0011247789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=316.54  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=222.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+-|.|+..||.|+||.||++..+.++-..|.|++.....  .....++-|+.+|..++||+|+++++.|-.++..+++.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse--EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE--EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch--hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4678999999999999999999888888889998875543  33346778999999999999999999888889999999


Q ss_pred             ecccccHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMETDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||+|+-.+.+ ...+..+.+.++..++.|++.||.|||+++|+|+|||..||++..+|.++|.|||.+...........
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99998655554 56677899999999999999999999999999999999999999999999999999987655555566


Q ss_pred             ccccCccccCccccc----CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          170 HQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ..+|||+|||||+..    .+.+|..++||||||+.|.+|.-+.+|....++-..+-.+..-   .+|..+.        
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLlq--------  257 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLLQ--------  257 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcccC--------
Confidence            789999999999874    3578999999999999999999999999888877766665443   2222111        


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                    +...+..+.+++.+||.+||+.||+++++++|||+++.+
T Consensus       258 --------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  258 --------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             --------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                          123488999999999999999999999999999999775

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-42  Score=291.31  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=209.3

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +|+..+.||+|++|.||++....++..+++|.+......   ......+.+|+.+++.++|+|++++.+++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            588899999999999999999888999999998764422   22334567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      +||++| +|.+++... +.+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            999986 777777654 458999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....++..|++||.+.....++.++|+||||+++|+|++|..||...............   ..                
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~----------------  219 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS---KE----------------  219 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc---cc----------------
Confidence            34557888999999866344889999999999999999999999776644433332211   00                


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             .......+++.+.+++.+||+.+|++||++++++.|||+
T Consensus       220 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 -------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   011123468899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.5e-42  Score=299.25  Aligned_cols=262  Identities=30%  Similarity=0.498  Sum_probs=215.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.++|||++++.+++...+..++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            5899999999999999999999888899999999864322  22345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+.| ++.+++.+.  .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            99985 777777654  378899999999999999999999999999999999999999999999999876644443334


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...+++.|++||.+.. ..++.++|+||||+++|++++|..||...+.......+... +  .+ .              
T Consensus       174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~--~~-~--------------  234 (293)
T cd06647         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G--TP-E--------------  234 (293)
T ss_pred             cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-C--CC-C--------------
Confidence            4567888999999876 56789999999999999999999999876554333222110 0  00 0              


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                             ......++..+.++|.+||..+|++||++.+++.||||+..+.+..
T Consensus       235 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         235 -------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence                   0111235788999999999999999999999999999998775543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.9e-42  Score=299.57  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=219.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      +...+.|...+.||+|++|+||++.+..+|..+++|.+....... .....+.+|+++++.++|+|++++.+++.+....
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            344677888899999999999999999999999999997654322 2223566899999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +++|||+.|++.+.+......+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        97 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633          97 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99999999999998887777799999999999999999999999999999999999999999999999998864322   


Q ss_pred             cccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+........            
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  240 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL------------  240 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Confidence             123457788999999842  24578899999999999999999999987776666555433211100            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                    ....++..+.+|+.+||+.+|.+||++.+++.||||+......+
T Consensus       241 --------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         241 --------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             --------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence                          01234778999999999999999999999999999998765444

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.7e-42  Score=292.08  Aligned_cols=255  Identities=26%  Similarity=0.481  Sum_probs=204.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc---chhhHHHHHHHhhcCCCCeeeeeceecc--CCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV---NFTALREIKLLKELKSPHIIELIDAFPH--KGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   86 (314)
                      ..|.+.+.||+|++|.||++.+..++..+++|.+.........   ...+.+|+.+++.++||||+++.+++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688999999999999999999999999999998765432221   2345679999999999999999998754  4678


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC-
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-  164 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~-  164 (314)
                      ++++|+++| +|.+.+.... .+++...+.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            899999986 7777776543 5889999999999999999999999999999999999999999999999998754321 


Q ss_pred             --CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 --DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 --~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                        ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+...   ....        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~~~--------  228 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PTNP--------  228 (266)
T ss_pred             ccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CCCC--------
Confidence              111223456788999999876 66789999999999999999999999876554444332211   1111        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                     .....+++.+.+++ +||..+|++||+++|+++||||+
T Consensus       229 ---------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         229 ---------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                           11124578899999 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.6e-42  Score=297.20  Aligned_cols=263  Identities=31%  Similarity=0.477  Sum_probs=219.4

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .+...+.|++...||+|++|.||++.+..++..+++|.+.....   ....+.+|++.++.++|+|++++++.+..+...
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            44567889999999999999999999988899999999976544   334566899999999999999999999999999


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++||++ ++|.+.+......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999 58888887765579999999999999999999999999999999999999999999999999887654433


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....    ....        
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~--------  237 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI----PPLK--------  237 (286)
T ss_pred             hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----CCCc--------
Confidence            33334456778999998876 5678999999999999999999999987766655444332110    0000        


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ....++.++.++|.+||+.+|.+||++.++++||||+...
T Consensus       238 -------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         238 -------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             -------------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                         0123578899999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.2e-42  Score=298.02  Aligned_cols=260  Identities=28%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||+|++|.||++.+..+++.|++|.+....... .....+.+|+++++.++||||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47899999999999999999999999999999987654321 22235568999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC----
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~----  165 (314)
                      ||++| +|.+.+... +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99986 777777654 468999999999999999999999999999999999999999999999999886321000    


Q ss_pred             -----------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          166 -----------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       166 -----------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                                 .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+....+............+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  237 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-  237 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-
Confidence                       00112345677999999876 56799999999999999999999999877665555544332111000 


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcCccccccC
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRFAKSFN  298 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~  298 (314)
                                              ....+++++.++|.+||..||++||+   +.++++||||...+
T Consensus       238 ------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         238 ------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                                    01235889999999999999999998   79999999997764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-42  Score=297.20  Aligned_cols=266  Identities=21%  Similarity=0.341  Sum_probs=209.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|...+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.++.++. |+||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            5677889999999999999999999999999998755433 23345668999999996 999999999998888999999


Q ss_pred             ecccccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           91 EFMETDLETVIR----NTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        91 e~~~g~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |++++++.+...    .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            999976655432    2345699999999999999999999975 99999999999999999999999999986543221


Q ss_pred             CcccccccCccccCcccccCc--cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 RRFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                       ......+++.|+|||.+.+.  ..++.++|+||||+++|+|++|..||....  .....+........+. .+      
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~-~~------  232 (288)
T cd06616         163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI-LS------  232 (288)
T ss_pred             -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc-CC------
Confidence             22233577889999998764  368899999999999999999999997654  1222222211111111 00      


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                   ......+++++.+||.+||+.||++|||+++++.||||+....+-
T Consensus       233 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~  277 (288)
T cd06616         233 -------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN  277 (288)
T ss_pred             -------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence                         011124688999999999999999999999999999998865443

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=288.10  Aligned_cols=253  Identities=32%  Similarity=0.523  Sum_probs=214.0

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||+|++|.||++.+..+++.+++|.+............+.+|++++++++|+|++++++++.+.+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58899999999999999999998999999999987755434445677999999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++| +|.+.+... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            986 777766654 569999999999999999999999999999999999999999999999999998775544433445


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .++..|+|||.+.+ ..++.++|+||||+++++|++|..||...............   .                    
T Consensus       160 ~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~--------------------  215 (254)
T cd06627         160 VGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---D--------------------  215 (254)
T ss_pred             ccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---C--------------------
Confidence            67888999999876 44789999999999999999999999766544444333211   0                    


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                          .......+++.+.+++.+||..+|++||++++++.||||
T Consensus       216 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                011123568899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-41  Score=293.05  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=211.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+-|++.+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.+++.++||||+++++++..+...++||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            45688999999999999999999889999999988654322 22345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| ++..++..  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          82 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            99986 67766653  3589999999999999999999999999999999999999999999999999876544332333


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...    .+.               
T Consensus       160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~---------------  219 (277)
T cd06641         160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN----NPP---------------  219 (277)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC----CCC---------------
Confidence            4467788999998876 56788999999999999999999999776654444433211    111               


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              .....++.++.+++.+||+.+|++||++.+++.||||....
T Consensus       220 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         220 --------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             --------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                    11224588999999999999999999999999999998653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-41  Score=292.09  Aligned_cols=259  Identities=28%  Similarity=0.481  Sum_probs=207.0

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc--------chhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV--------NFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      +|.+.+.||+|++|.||++.+..+|+.+++|.+.........        ...+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588999999999999999999889999999998653221111        124557999999999999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++|+||+.| +|.+.+... +.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            99999999985 777777655 4689999999999999999999999999999999999999999999999999976532


Q ss_pred             CCC--cccccccCccccCcccccCcc-CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          164 PDR--RFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       164 ~~~--~~~~~~~~~~y~sPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ...  ......++..|+|||.+.... .++.++|+||||++++++++|..||...+...........   ......+   
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~---  234 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK---RSAPPIP---  234 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc---ccCCcCC---
Confidence            211  122335677899999987643 4789999999999999999999999765544433332111   1111110   


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                      ....+.++.++.++|.+||..+|++||+++++++|||+
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         235 ----------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                            11223568999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.6e-42  Score=290.76  Aligned_cols=250  Identities=25%  Similarity=0.442  Sum_probs=206.0

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.++||||+++++.+.+++..++++||++| +|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999999999999999765432 22334677899999999999999999999999999999999985 78


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccc
Q 021299           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (314)
Q Consensus        98 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  177 (314)
                      .+.+... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... ......+++.|
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            7777654 358999999999999999999999999999999999999999999999999998764432 22334577889


Q ss_pred             cCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC--cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC
Q 021299          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS--DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (314)
Q Consensus       178 ~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (314)
                      ++||.+.+ ..++.++|+||+|+++|+|++|..||....  .......+.....   ..                     
T Consensus       159 ~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~---------------------  213 (262)
T cd05572         159 VAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG---KL---------------------  213 (262)
T ss_pred             cChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC---CC---------------------
Confidence            99998866 567899999999999999999999997766  3333333321100   00                     


Q ss_pred             CCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          256 LRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       256 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                        ......++++.++|.+||+.+|++||+     ++|+++||||++++
T Consensus       214 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         214 --EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             --CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence              111234789999999999999999999     99999999999764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-45  Score=297.08  Aligned_cols=262  Identities=26%  Similarity=0.422  Sum_probs=227.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      =.+-|.+++.||+|++|.||++.++.+|..+++|.......    ..++.+|+.++++++.+++|++++.|-.+...|||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            34678999999999999999999999999999999876543    33667999999999999999999998888899999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||||+ |+..+.++.+++.+++..+..+++.-+.||.|||...=+|+|||..||+++.+|..||.|||.+-....-....
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            99999 79999999999999999999999999999999999999999999999999999999999999997776656666


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+|||.|+|||++.. -.|+.++||||||+...+|..|++|+....+-..+..    +.+.+|..+..          
T Consensus       187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----IPT~PPPTF~K----------  251 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----IPTKPPPTFKK----------  251 (502)
T ss_pred             CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEe----ccCCCCCCCCC----------
Confidence            77899999999999976 6689999999999999999999999987765544332    23333333221          


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                 ....++++.++|++||-+.|++|.|+.++++|||+++-.+..
T Consensus       252 -----------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  252 -----------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             -----------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence                       112488999999999999999999999999999999876543

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.6e-42  Score=293.84  Aligned_cols=253  Identities=29%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||+|++|+||++.+..+|+.+++|.+........ ....+..|+++++.++|||++++.+.+...+..++||||++| +|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999999999999999999976543222 223456799999999999999999999999999999999985 78


Q ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCcc
Q 021299           98 ETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW  176 (314)
Q Consensus        98 ~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  176 (314)
                      .+.+.... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+..... ........++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCC
Confidence            77776543 3689999999999999999999999999999999999999999999999998875532 222233456778


Q ss_pred             ccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCC
Q 021299          177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL  256 (314)
Q Consensus       177 y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (314)
                      |+|||.+.+ ..++.++|+||||+++++|++|..||...........+........                        
T Consensus       160 y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------  214 (277)
T cd05577         160 YMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA------------------------  214 (277)
T ss_pred             cCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc------------------------
Confidence            999999876 4588999999999999999999999977654322222222111100                        


Q ss_pred             CccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          257 RSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       257 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                      ....+..++.+.++|.+||+.||++||     ++.+++.||||..++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            011234588999999999999999999     899999999998775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-42  Score=318.69  Aligned_cols=294  Identities=20%  Similarity=0.270  Sum_probs=207.4

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCc-EEEEEEee--------------cC-CcccCcchhhHHHHHHHhh
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQ-TVAIKKIR--------------LG-KQKEGVNFTALREIKLLKE   67 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~-~~~iK~~~--------------~~-~~~~~~~~~~~~e~~~l~~   67 (314)
                      +.-.+.+.++|++++.||+|+||+||++..+.... ..+.|.+.              .. .........+.+|+.++++
T Consensus       140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~  219 (501)
T PHA03210        140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR  219 (501)
T ss_pred             cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence            34456778999999999999999999987544322 22222110              00 0111122345689999999


Q ss_pred             cCCCCeeeeeceeccCCeEEEEEecccccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTN----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        68 l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      ++|+||+++++++...+..|++++++.+++..++....    .......+..++.||+.||.|||++||+|+||||+||+
T Consensus       220 l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL  299 (501)
T PHA03210        220 LNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF  299 (501)
T ss_pred             CCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            99999999999999999999999999999888875432    22446678889999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCC-cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCC-ccCCC--CcHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP-FLQGS--SDID  219 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~-pf~~~--~~~~  219 (314)
                      ++.++.++|+|||++........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|.. |+...  .+..
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987644322 2234578999999999877 568999999999999999999874 44432  2333


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCc-ccchhhhccc--cCCCCCcc--CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAY-LPDYVEYQYV--AAPPLRSL--FPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      ....+...... ....+++... ..........  ....+...  ...++..+.++|.+||+.||.+|||+.|+|.||||
T Consensus       379 ~~~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        379 QLLKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            44444433322 1122222100 0000000000  00000000  12357788999999999999999999999999999


Q ss_pred             cccCc
Q 021299          295 KSFNG  299 (314)
Q Consensus       295 ~~~~~  299 (314)
                      +....
T Consensus       458 ~~~~~  462 (501)
T PHA03210        458 SAEEE  462 (501)
T ss_pred             hcCCc
Confidence            87653

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-41  Score=291.35  Aligned_cols=251  Identities=17%  Similarity=0.221  Sum_probs=203.0

Q ss_pred             HhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||.||++.++   ..+..+++|.+...... .....+.+|+..++.++||||+++++++..++..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            468999999999999999999765   34568999998764322 22345678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||++| +|.+++......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++++|||.+........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            99999986 67767766566799999999999999999999999999999999999999999999999998764322111


Q ss_pred             -cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 -RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 -~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       ......++..|+|||.+.+ ..++.++||||||+++|++++ |..||......+....+.......             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  228 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-------------  228 (266)
T ss_pred             hcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-------------
Confidence             1112234567999998876 678999999999999999875 999998877766655553321111             


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                    ....++..+.+++.+||+.+|++||++++|++
T Consensus       229 --------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         229 --------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             --------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                          11245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-41  Score=291.95  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=196.8

Q ss_pred             eeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc-hhhHHHHHHH---hhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLL---KELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      .||+|++|.||++.+..++..+++|.+.......... ....++..++   ....|++++.+.+++..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997654332221 1223343333   33478999999999988899999999998


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      | +|...+... +.+++..+..++.|++.||.+||+++++|+||||+||+++.++.++|+|||++......  ......+
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence            6 666666543 46999999999999999999999999999999999999999999999999998755332  2233467


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      ++.|+|||.+..+..++.++|+||+|+++|+|++|..||......... .+....... .                    
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~-~--------------------  215 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTV-N--------------------  215 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcC-C--------------------
Confidence            889999998865466789999999999999999999999754322211 111110000 0                    


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                         ......+++++.++|.+||..||.+||     +++++++||||+.++
T Consensus       216 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         216 ---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             ---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence               011234688999999999999999999     699999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-44  Score=284.16  Aligned_cols=288  Identities=41%  Similarity=0.725  Sum_probs=242.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   82 (314)
                      .+.|..+..||+|.||.||+|+.+.+|+.|++|+.......+.......+|+.++..+.|+|++.++..+..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            467888899999999999999999999999999877655555444566789999999999999999987732        


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ...+|+||.+|..+|..++......++...+..++.+++.||.|+|.+.|.|+|+|+.|++++.+|.++|.|||+++.+.
T Consensus        96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs  175 (376)
T KOG0669|consen   96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS  175 (376)
T ss_pred             cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence            23589999999999999999888889999999999999999999999999999999999999999999999999996553


Q ss_pred             CC----CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          163 SP----DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       163 ~~----~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ..    ...+...+.|.+|.+||.+.+...++++-|+|.-||++.+|+++.+.+..+....++..+...-++..++.||.
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~  255 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN  255 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence            22    12233345589999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cCcccchhhhcccc-----CCCCCccCC--CCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          239 LAYLPDYVEYQYVA-----APPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ...++-........     ...+++...  .-.+++.+|+.++|..||.+|+++.+++.|.||.+-.
T Consensus       256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            77766554331111     111111111  1266899999999999999999999999999997653

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-41  Score=288.92  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      .......||+|++|.||++.+..++..+++|.+......  ....+.+|+.+++.++|+||+++++++..++..++++||
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            334556899999999999999888999999988654322  233566899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCCCCCcc
Q 021299           93 MET-DLETVIRNTNIFL--SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      +.| +|.+.+......+  ++..+..++.||+.|+++||++|++|+||+|+||+++. ++.++|+|||.+..........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            985 8888887654445  88889999999999999999999999999999999976 6799999999997654333333


Q ss_pred             cccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.................                  
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  228 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------------------  228 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc------------------
Confidence            344578889999998653 3478899999999999999999999875443222111110000                  


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                             ........+++++.+++.+||+.+|.+|||+.|++.||||
T Consensus       229 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                   0011123468899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.8e-41  Score=285.78  Aligned_cols=255  Identities=29%  Similarity=0.533  Sum_probs=211.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~   90 (314)
                      +|.+.+.||+|++|.||++.+..++..+++|.+............+.+|+..+++++|+||+++.+.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58889999999999999999998999999999987665444455677899999999999999999999887  8899999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--c
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--R  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~  167 (314)
                      |++++ +|.+++.... .+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99964 7877776654 799999999999999999999999999999999999999999999999999987755432  1


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||........  .+........               
T Consensus       160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~---------------  221 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGSSGE---------------  221 (260)
T ss_pred             ccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccccCC---------------
Confidence            344567788999998876 5589999999999999999999999987662221  1111100001               


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                              .......+++.+.++|.+||+.+|++||++.+++.||||
T Consensus       222 --------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         222 --------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                    111223458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=289.98  Aligned_cols=252  Identities=29%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHH-HHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      ++.||+|++|.||+|.+..+|+.+++|.+........ ....+..|.. .....+|+|++++++++..++..++++||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            3679999999999999988999999999875432211 1112233433 3445589999999999999999999999998


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      | +|.+++... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....    .....+
T Consensus        81 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCC
Confidence            6 777766544 4689999999999999999999999999999999999999999999999998875432    223456


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      ++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.........                    
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------  214 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE--------------------  214 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC--------------------
Confidence            778999999877 44789999999999999999999999887766655554332111100                    


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcCccccccC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRFAKSFN  298 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~  298 (314)
                          .....+++++.+++.+||+.+|++||+   ++|+++||||++++
T Consensus       215 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         215 ----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                111246899999999999999999995   57999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.6e-41  Score=288.10  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             HHhhccceeee--CccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhh-cCCCCeeeeeceeccCCeE
Q 021299           10 VADRYLKREVL--GEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        10 ~~~~y~~~~~l--g~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~   86 (314)
                      ..+.|.+.+.+  |+|++|.||++.++.++..+++|.+........       |...... .+|+|++++++.+...+..
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            45778887777  999999999999999999999999875432211       2222221 2799999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSP  164 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~  164 (314)
                      ++||||++| +|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999975 8888887654 799999999999999999999999999999999999999998 9999999999765432


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH-HHHHHHhhCCCCCCCCCCcCccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                          ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ........ ....          
T Consensus       164 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~----------  227 (267)
T PHA03390        164 ----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL----------  227 (267)
T ss_pred             ----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC----------
Confidence                22356788999999976 5678999999999999999999999975543321 12221111 1110          


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-HHHHhcCccccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRFAKS  296 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~h~~~~~  296 (314)
                                    ...+.+++.+.++|.+||+.+|.+||+ .+++|+||||+.
T Consensus       228 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        228 --------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          112346999999999999999999996 599999999973

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-41  Score=291.67  Aligned_cols=267  Identities=25%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--CCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   89 (314)
                      ++|...+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+++++.++||||+++++++.+  .+..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            5789999999999999999999999999999998755332 233457789999999999999999998744  4478999


Q ss_pred             Eecccc-cHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           90 FEFMET-DLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        90 ~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |||++| +|.+.+.   .....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999986 7766654   234568999999999999999999999999999999999999999999999999986543221


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc--HHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--IDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....  .... ..............+..    
T Consensus       160 --~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----  231 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPELKDE----  231 (287)
T ss_pred             --cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchhhccC----
Confidence              123446778999998866 6678999999999999999999999976532  1111 11111111111111000    


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                   .......++.+.++|.+||..+|++|||+.|+++||||++...+
T Consensus       232 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         232 -------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             -------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence                         00001246789999999999999999999999999999877654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.5e-41  Score=284.91  Aligned_cols=252  Identities=33%  Similarity=0.518  Sum_probs=210.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|.+.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|++.++.++|++++++.+.+..+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            48899999999999999999988999999999976543  2334667899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++| +|.+.+......+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            995 78777776656799999999999999999999999999999999999999999999999999987654332 3445


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+...........    .....+.             
T Consensus       158 ~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~-------------  219 (253)
T cd05122         158 VGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----GPPGLRN-------------  219 (253)
T ss_pred             ecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----CCCCcCc-------------
Confidence            67788999999876 55789999999999999999999999876554444433221    1111100             


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                              ...++..+.++|.+||+.||++|||+.++++|||
T Consensus       220 --------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         220 --------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                    0113788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-41  Score=289.58  Aligned_cols=252  Identities=26%  Similarity=0.458  Sum_probs=203.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+..... .......+.+|+++++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            589999999999999999999999999999998875432 2223335668999999999999999999999899999999


Q ss_pred             ecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||+++ +|.+.+..   ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99995 77766643   334589999999999999999999999999999999999999999999999999987654333


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc--HHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--IDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.....  ......+... .  .+.. +       
T Consensus       162 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~-~-------  229 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-D--YPPL-P-------  229 (267)
T ss_pred             HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-C--CCCC-C-------
Confidence            3334567888999999876 5578999999999999999999999865432  2222222111 0  0100 0       


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     ....+..+.+++.+||+.+|++||+++++++
T Consensus       230 ---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         230 ---------------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ---------------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                           1134788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-42  Score=302.83  Aligned_cols=261  Identities=26%  Similarity=0.381  Sum_probs=212.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +.+|+++++||.|+.+.||++.. .+...|++|+......+......+.+|+..|.+++ |..|+++++|-..+++.|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            46899999999999999999974 34467888888777777777778889999999995 89999999999899999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc--
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--  167 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--  167 (314)
                      ||+-+.+|...+.+....++.-.++.+..|++.|+.++|+.||+|.||||.|+++- .|++||+|||+|.....+..+  
T Consensus       439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccccee
Confidence            99999999999998877677668899999999999999999999999999999884 579999999999887655443  


Q ss_pred             ccccccCccccCcccccCc----------cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          168 FTHQVFARWYRAPELLFGA----------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~----------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ....+||+-|||||.+...          -..++++||||||||||+|+.|++||..-....  +++...........+|
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--AKLHAITDPNHEIEFP  595 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--HHHHhhcCCCcccccc
Confidence            3456899999999998531          124789999999999999999999997543222  2222221111111222


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      +.                    ..  ..++.++++.||..||.+||++.++|+|||++-+
T Consensus       596 ~~--------------------~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  596 DI--------------------PE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CC--------------------CC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            21                    11  3349999999999999999999999999999874

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-41  Score=287.82  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=212.0

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +|++.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.++|+||+++.+++.+....++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58899999999999999999999999999999987654444445667899999999999999999999999999999999


Q ss_pred             ccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           93 MET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        93 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ++| +|...+...   ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~  158 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA  158 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence            976 787777542   346899999999999999999999999999999999999999999999999999776443  22


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+......                  
T Consensus       159 ~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  219 (256)
T cd08530         159 KTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP------------------  219 (256)
T ss_pred             ccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC------------------
Confidence            33457788999999876 66788999999999999999999999877665544443221111                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                               ......+.++.+++.+||..+|++||++.+++.||++
T Consensus       220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         220 ---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                     1112458889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-41  Score=295.31  Aligned_cols=256  Identities=25%  Similarity=0.455  Sum_probs=210.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..|.....||+|++|.||++.+..++..+++|.+......  ....+.+|+.+++.++|||++++++++..++..++++|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            4456677899999999999999889999999998654322  23456689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |++| ++...+..  ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            9986 66665543  34899999999999999999999999999999999999999999999999998755443333344


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+....+...    ....+              
T Consensus       177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~--------------  237 (297)
T cd06659         177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKL--------------  237 (297)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CCCCc--------------
Confidence            567888999999876 56789999999999999999999999877665555443211    01000              


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                             .....+++.+.++|.+||+.+|.+||++++++.||||.+-
T Consensus       238 -------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         238 -------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             -------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence                   1122458889999999999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.9e-41  Score=286.06  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=203.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|++|.||++..+ .+..+++|.+......   ...+.+|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            67999999999999999999765 4568999987644322   3466789999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-cc
Q 021299           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FT  169 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  169 (314)
                      |++ |+|.+.+....+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            998 5888888766667899999999999999999999999999999999999999999999999998765332221 12


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||......+....+........                
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------  222 (256)
T cd05114         160 GAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------------  222 (256)
T ss_pred             CCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----------------
Confidence            2234567999999866 568899999999999999999 8999988777766666544321111                


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 ....+.++.+++.+||..+|++||+++++++
T Consensus       223 -----------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         223 -----------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       1124778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-41  Score=291.98  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=204.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC-----cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|++|.||++.+...+     ..+++|.+..... ......+.+|++.++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468999999999999999999876554     6799998864432 2223356789999999999999999999998899


Q ss_pred             EEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc
Q 021299           86 LHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~  149 (314)
                      .+++|||+++ +|.+++....               ..+++..+..++.|++.||++||++|++|+||||+||+++.++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence            9999999985 8888876532               45888999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHH
Q 021299          150 LKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       150 ~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~  226 (314)
                      ++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999997653322  11223445678999998876 567999999999999999997 9999987776665554433


Q ss_pred             hhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ....                           .....+++++.+|+.+||+.||.+||++.+|+++
T Consensus       242 ~~~~---------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         242 RQLL---------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCcC---------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2111                           1123468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-41  Score=293.74  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             HhhccceeeeCccccceEEEEEECC----------------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK----------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   74 (314)
                      .++|++.+.||+|+||.||+|.+..                ++..+++|.+..... ......+.+|+++++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCee
Confidence            5789999999999999999997532                334799999875432 22334577899999999999999


Q ss_pred             eeeceeccCCeEEEEEecccc-cHHHHHHhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 021299           75 ELIDAFPHKGNLHLVFEFMET-DLETVIRNTN------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHR  135 (314)
Q Consensus        75 ~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~  135 (314)
                      ++++++.+.+..+++|||+.+ +|.+++....                  ..+++..++.++.||+.||.|||++|++|+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999998999999999975 8888775421                  246778899999999999999999999999


Q ss_pred             CCCCCceEEecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh--CCCc
Q 021299          136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPF  211 (314)
Q Consensus       136 di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~p  211 (314)
                      ||||+||+++.++.++|+|||.+........  ......++..|+|||.+.. ..++.++|+||||+++|+|++  +..|
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999976533221  1122344677999999876 568999999999999999986  4577


Q ss_pred             cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      |......+................                    .....+.+++.+.+|+.+||+.||.+|||+.+|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQV--------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccc--------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            876665555444333221111000                    0011234588999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-41  Score=292.22  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=207.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+..+|..+++|.+..... ......+.+|+++++.++||||+++++++...+..++++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            4789999999999999999999998999999999875432 333456778999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++| +|...+.. .+.+++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~  159 (284)
T cd06620          83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IA  159 (284)
T ss_pred             ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--cc
Confidence            99996 66665554 4468999999999999999999997 69999999999999999999999999988654222  12


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH----H---HHHHHHhhCCCCCCCCCCcCc
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID----Q---LGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.......    .   ............+...+    
T Consensus       160 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  234 (284)
T cd06620         160 DTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP----  234 (284)
T ss_pred             CccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC----
Confidence            23467888999999876 578899999999999999999999997654421    0   00111111111111000    


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                        ...++.++.+|+.+||+.||++|||++|++.|+||.+
T Consensus       235 ------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         235 ------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             ------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                              0125788999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-41  Score=292.97  Aligned_cols=253  Identities=31%  Similarity=0.488  Sum_probs=212.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ++|.+.+.||+|++|.||++.+..+|+.+++|++...... ......+.+|..+++.+. |+||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4799999999999999999999999999999998764322 222345668899999998 99999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC---
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---  165 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~---  165 (314)
                      ||++. ++|.+.+...+ .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99995 58888887654 69999999999999999999999999999999999999999999999999997654332   


Q ss_pred             -----------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhh
Q 021299          166 -----------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (314)
Q Consensus       166 -----------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~  228 (314)
                                       .......++..|+|||.+.. ..++.++|+||||++++++++|..||...........+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                             11223346778999998876 558899999999999999999999998887655555543221


Q ss_pred             CCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCccc
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFA  294 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~  294 (314)
                      .                            .....+++.+.++|.+||+.+|++||++    ++++.||||
T Consensus       239 ~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 Y----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             C----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1                            1112458899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.2e-41  Score=286.76  Aligned_cols=255  Identities=26%  Similarity=0.487  Sum_probs=204.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC---cchhhHHHHHHHhhcCCCCeeeeeceecc--CCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKELKSPHIIELIDAFPH--KGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   86 (314)
                      .+|++.+.||+|++|.||.+.+..+|..+++|.+........   ....+.+|+++++.+.||||+++.+++.+  ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            478999999999999999999999999999999865432221   12345679999999999999999998865  3568


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++|||++| +|.+++... +.+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            899999985 787777654 358899999999999999999999999999999999999999999999999987543211


Q ss_pred             ---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                         .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..............   .....        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~--------  228 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP--------  228 (265)
T ss_pred             ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC--------
Confidence               11223457788999999876 5678999999999999999999999977654544433221   11100        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                     .....++..+.+++.+|+. +|.+||++++++.|||+.
T Consensus       229 ---------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         229 ---------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                           1122457889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.9e-41  Score=285.04  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=203.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||.+.... +..+++|.+.....   ....+.+|+.+++.++||||+++++++.+....+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3679999999999999999997653 45699998864432   2245778999999999999999999998888999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-c
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-F  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~  168 (314)
                      ||+.+ +|.+.+......+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99985 788888765557899999999999999999999999999999999999999999999999998765332211 1


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........               
T Consensus       159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------  222 (256)
T cd05113         159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------------  222 (256)
T ss_pred             CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---------------
Confidence            22334567999999876 568899999999999999998 8999987776655555433311111               


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  ....++.+.+++.+||..+|++||++.+++++
T Consensus       223 ------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         223 ------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                        11247899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=274.25  Aligned_cols=255  Identities=26%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-----CCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-----KGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   85 (314)
                      .+||++.+.||+|+|+-||+++...++..||+|++.-+.  .......++|++..++++|||+++++++...     ...
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            479999999999999999999988999999999998765  2334467799999999999999999998633     335


Q ss_pred             EEEEEeccc-ccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeecccee
Q 021299           86 LHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .|++++|+. |++.+.+...   +..+++.++..|+.+|++||.+||...  ++|+||||+||++..++.++|.|||.++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            899999987 7899888643   347999999999999999999999998  9999999999999999999999999997


Q ss_pred             eeCCCCCcc---------cccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhh
Q 021299          160 IFGSPDRRF---------THQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (314)
Q Consensus       160 ~~~~~~~~~---------~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~  228 (314)
                      ...-.-...         .....|..|.|||++.-  ....+.++|||||||+||+||.|..||.....  ...++.   
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSla---  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLA---  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEE---
Confidence            653211111         12344677999998853  23468999999999999999999999964221  000000   


Q ss_pred             CCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                         ..........+-...+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       253 -------------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 -------------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             -------------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                               00000000111122369999999999999999999999999864

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.5e-41  Score=293.15  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=215.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ...|...+.||+|++|.||++.+..++..+++|.+....... .....+.+|+++++.++|+|++++++++.++...+++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            466899999999999999999998899999999987553322 2233566899999999999999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||+.|++.+.+......+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......    .
T Consensus       104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~  179 (317)
T cd06635         104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----N  179 (317)
T ss_pred             EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----c
Confidence            999999998888776677999999999999999999999999999999999999999999999999988654321    2


Q ss_pred             ccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          170 HQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ...+++.|+|||.+..  ...++.++|+||+|+++|+|++|..||...........+.........              
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  245 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------------  245 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--------------
Confidence            3457788999998742  245788999999999999999999998776655555544332111100              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                  ....++.+.+++.+||+.+|.+||++.++++|+|+.....
T Consensus       246 ------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         246 ------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                        1134788999999999999999999999999999976554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.1e-41  Score=294.38  Aligned_cols=263  Identities=26%  Similarity=0.421  Sum_probs=215.5

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      +++.-.+.|...+.||+|++|.||+++++.++..+++|.+...... ......+.+|+++++.++|+|++++.+++....
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634           9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             hcCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            3444567899999999999999999999999999999998754222 222335668999999999999999999999999


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..++|+||+.|++.+.+......+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+......
T Consensus        89 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            99999999999998888766667899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 DRRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                          ....+++.|+|||.+.+  ....+.++|+||||+++|+|++|..||...+.......+.....   +.        
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~--------  233 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---PA--------  233 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC---CC--------
Confidence                23456778999998752  24578899999999999999999999876554444433322111   00        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                     ......+..+.+||.+||..+|.+||++++++.|||+....
T Consensus       234 ---------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         234 ---------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ---------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                           00123588899999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.8e-41  Score=291.60  Aligned_cols=258  Identities=24%  Similarity=0.421  Sum_probs=210.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..|.....||+|++|.||++..+.+|..+++|++....  ......+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            34445578999999999999999999999999885432  2233456689999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |+++ ++.+.+..  ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657          98 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            9987 56555433  34899999999999999999999999999999999999999999999999998765433333334


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.....    ..+              
T Consensus       176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~--------------  236 (292)
T cd06657         176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----PKL--------------  236 (292)
T ss_pred             cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC----ccc--------------
Confidence            567888999998865 5678999999999999999999999987766655544433211    110              


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                             .....+++.+.+++.+||+.+|.+||++++++.||||.....
T Consensus       237 -------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         237 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                   011245888999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-41  Score=301.28  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             HhhccceeeeCccccceEEEEEE-----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||.||++.+     ..++..+++|.+..... ......+.+|+++++.+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            46899999999999999999964     34566899999865432 22234566899999999 8999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC----------------------------------------------------------
Q 021299           85 NLHLVFEFMET-DLETVIRNTN----------------------------------------------------------  105 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~----------------------------------------------------------  105 (314)
                      ..++||||++| +|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999984 8888876432                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc--
Q 021299          106 ----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--  167 (314)
Q Consensus       106 ----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--  167 (314)
                                      ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........  
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                            24778889999999999999999999999999999999999999999999999865432211  


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................   ..           
T Consensus       273 ~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~-----------  337 (375)
T cd05104         273 KGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---ML-----------  337 (375)
T ss_pred             cCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc---CC-----------
Confidence            112234566999999876 668999999999999999997 88898765544333333221100   00           


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus       338 ------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         338 ------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                        011247889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=284.50  Aligned_cols=269  Identities=27%  Similarity=0.408  Sum_probs=216.4

Q ss_pred             cccccHHHHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeecee
Q 021299            3 EVDLSKKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAF   80 (314)
Q Consensus         3 ~~~~~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~   80 (314)
                      +-.++..+.+-|++. +.||+|+++.|-.+....+|..||+|++.+...  ..+....+|++++.+.+ |+||++++++|
T Consensus        68 ~ss~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   68 TSSLSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             cccccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            445666677888764 578999999999999999999999999988743  34556779999999985 99999999999


Q ss_pred             ccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeecc
Q 021299           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFG  156 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~  156 (314)
                      +++..+|+|||.+.| .+++-++++. .+++..+..+..+|+.||.+||.+||+|+|+||+||+....+   -||||||.
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999986 7777777655 499999999999999999999999999999999999996654   48999998


Q ss_pred             ceeeeCCCC-------CcccccccCccccCccccc----CccCCCCcchHhhHHHHHHHHHhCCCccCCCC---------
Q 021299          157 LARIFGSPD-------RRFTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---------  216 (314)
Q Consensus       157 ~~~~~~~~~-------~~~~~~~~~~~y~sPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---------  216 (314)
                      +..-.....       .....++|+..|||||+..    ....|..+.|.||||+|+|-|+.|.+||.+.=         
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            774332111       1122345666799999863    23468999999999999999999999995532         


Q ss_pred             ------cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          217 ------DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       217 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                            ......++..+....+..+|                        ..+|.++.++|+.+|..|+.+|.++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGkYeFPdkdW------------------------ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYEFPDKDW------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCCcCChhhh------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  12233344444444444444                        357999999999999999999999999999


Q ss_pred             CccccccC
Q 021299          291 HRFAKSFN  298 (314)
Q Consensus       291 h~~~~~~~  298 (314)
                      |||++..-
T Consensus       361 hPw~~~~~  368 (463)
T KOG0607|consen  361 HPWVQRCA  368 (463)
T ss_pred             Cccccccc
Confidence            99998763

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.2e-41  Score=285.18  Aligned_cols=244  Identities=23%  Similarity=0.343  Sum_probs=196.1

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-c
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-D   96 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~   96 (314)
                      +.||+|++|.||++.+..+++.+++|.+.... .......+.+|+++++.++||||+++++++......++||||+.| +
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            46999999999999998899999999876432 222334677899999999999999999999999999999999985 8


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc--cccccC
Q 021299           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF--THQVFA  174 (314)
Q Consensus        97 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~  174 (314)
                      |.+.+......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..........  .....+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            888887666678999999999999999999999999999999999999999999999999987543211111  111223


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......    .                  
T Consensus       160 ~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~----~------------------  216 (252)
T cd05084         160 VKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL----P------------------  216 (252)
T ss_pred             eeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----C------------------
Confidence            45999999876 567899999999999999997 88888766554443333221110    0                  


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                           .....+..+.+++.+||+.+|++|||+.++++
T Consensus       217 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         217 -----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 11235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.9e-41  Score=285.34  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=203.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ..+|.+.+.||+|++|.||++.++.+++.+++|.+.....   ....+.+|++.++.++|+|++++++++..++..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            4578999999999999999999999999999999864322   2345678999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++ ++|.+.+... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9997 4888887654 3458999999999999999999999999999999999999999999999999997654322111


Q ss_pred             -cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       169 -~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......                
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  224 (263)
T cd05052         162 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM----------------  224 (263)
T ss_pred             cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence             11223456999998866 667899999999999999998 88999876655544444322111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 .....++.++.+++.+||+.||++||++.++++
T Consensus       225 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         225 -----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                       111345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.7e-41  Score=287.89  Aligned_cols=251  Identities=32%  Similarity=0.538  Sum_probs=206.4

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l   97 (314)
                      ||.|++|.||++.+..+|+.+++|.+...... ......+.+|+++++.++|+|++++++.+......++++|++.| +|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999998765432 22334566899999999999999999999999999999999986 77


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--------ccc
Q 021299           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--------RFT  169 (314)
Q Consensus        98 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~  169 (314)
                      .+.+...+ .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            77776544 689999999999999999999999999999999999999999999999999875433211        223


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...++..|++||.+.. ...+.++|+||||++++++++|..||...........+.....     .++.           
T Consensus       160 ~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~-----------  222 (265)
T cd05579         160 RIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-----EWPE-----------  222 (265)
T ss_pred             CcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----CCCc-----------
Confidence            3456778999999876 4478999999999999999999999987776655544433110     1110           


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH---HHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA---QQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~h~~~~~~~  298 (314)
                                ...+++.+.+++.+||+.+|.+|||+   .++++||||++++
T Consensus       223 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         223 ----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             ----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                      01248899999999999999999999   9999999999763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-41  Score=285.86  Aligned_cols=252  Identities=19%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||+||+|..+..   ...+++|.+..... ......+..|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            36899999999999999999987654   35799998865432 222345668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++||++.| +|.+++....+.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            99999985 88888877666799999999999999999999999999999999999999999999999999987642221


Q ss_pred             c--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          167 R--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       167 ~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........           
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  229 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-----------  229 (266)
T ss_pred             ceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence            1  112234567999998876 567899999999999999997 9999977665555544433211111           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                      ....++.+.+++.+||+.+|++||++++++++
T Consensus       230 ----------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         230 ----------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                            12358899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-41  Score=287.76  Aligned_cols=252  Identities=27%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             eeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc-hhhHHH---HHHHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALRE---IKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      .||+|++|.||++.+..+++.|++|.+.......... ....++   .+.++...||+|+.+.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999987654332211 112233   334445579999999999999999999999998


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      | +|...+. ..+.+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+......  ......+
T Consensus        81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (278)
T ss_pred             CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence            6 5655554 4456999999999999999999999999999999999999999999999999998755322  2233467


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      +..|+|||.+.++..++.++|+||+|+++|+|++|..||............ ...... ..                   
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~-~~-------------------  216 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTM-AV-------------------  216 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhcc-CC-------------------
Confidence            888999999876556889999999999999999999999765322211111 100000 00                   


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                          .....++.++.+++.+||..+|++||     ++.++++||||+..+
T Consensus       217 ----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         217 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence                11223588999999999999999999     999999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-43  Score=306.12  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=225.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ..|.-++.||+|+||.||.+++..+.+.||||++..+.. ....+..+.+|++.|+++.|||.+.+.++|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            567888999999999999999999999999999987754 3456678889999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |||-|+-.+++.-.++++-+..+..|..+.+.||+|||+++.+|+|||..||++++.|.|||+|||.+....+.    ..
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----ns  181 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NS  181 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----hc
Confidence            99999988888877778999999999999999999999999999999999999999999999999999776432    45


Q ss_pred             cccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          171 QVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      .+|||+|||||++..  .+.|+-+.||||||++..+|...++|.-+.+.-..+.-+.+...+...               
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---------------  246 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---------------  246 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---------------
Confidence            789999999999752  467899999999999999999999888777777776666654322211               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                 .+..+..+.+|+..||++-|..|||.+++|.|+|..--.
T Consensus       247 -----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  247 -----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             -----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                       123488999999999999999999999999999987543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=283.42  Aligned_cols=252  Identities=29%  Similarity=0.495  Sum_probs=204.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|.||++....+|+.+++|.+....... .....+.+|++++++++|++++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999987543322 22446678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||++| +|..++..   ....+++..+..++.+++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99985 88777753   244689999999999999999999999999999999999999999999999999876644333


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH--HHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--DQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......  .....+...    .....+       
T Consensus       162 ~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~-------  229 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----DYPPLP-------  229 (267)
T ss_pred             ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----CCCCCC-------
Confidence            3344567888999998876 56789999999999999999999998654321  111111111    000000       


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     ...++..+.++|.+||..+|++|||+.+|++
T Consensus       230 ---------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ---------------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                           1145789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-41  Score=300.35  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|.+.+.||+|+||.||++.+...     +..|++|.+...... .....+.+|+++++.+ +|+||+++++++...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            57899999999999999999986443     357999999754322 2233566899999999 8999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC----------------------------------------------------------
Q 021299           85 NLHLVFEFMET-DLETVIRNTN----------------------------------------------------------  105 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~----------------------------------------------------------  105 (314)
                      ..+++|||+.+ +|.+.+....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999984 8887775321                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc--ccccc
Q 021299          106 -----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--FTHQV  172 (314)
Q Consensus       106 -----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~  172 (314)
                                 .++++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........  .....
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                       24788889999999999999999999999999999999999999999999999765332211  11223


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      +++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....   ....               
T Consensus       276 ~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---~~~~---------------  336 (374)
T cd05106         276 LPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---QMSR---------------  336 (374)
T ss_pred             CccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc---CccC---------------
Confidence            4567999999876 668999999999999999997 9999977655443333332210   0000               


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                              ...+++++.+++.+||+.||.+|||+.++++
T Consensus       337 --------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         337 --------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    1134889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-41  Score=286.53  Aligned_cols=249  Identities=21%  Similarity=0.350  Sum_probs=206.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||.|++|.||++.++. +..+++|.+......  ....+..|+.+++.++|+||+++++++......+++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            4689999999999999999999877 789999998754331  2335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||+++ +|.+.+... ...+++..+..++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            99985 888888764 4568999999999999999999999999999999999999999999999999997664433333


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+......                 
T Consensus       162 ~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  223 (261)
T cd05148         162 SDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-----------------  223 (261)
T ss_pred             cCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------------
Confidence            33445667999998876 568899999999999999998 88999877766655554432111                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                +.....++++.+++.+||+.||++|||+.++++
T Consensus       224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      111345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-41  Score=291.26  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=210.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|++|.||++.+..+++.+++|.+....... ....+..|+.++... .|+||+++++++.+....+++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            478999999999999999999999889999999997543222 223445566655555 599999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++++++.+.+......+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~  171 (296)
T cd06618          93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-K  171 (296)
T ss_pred             eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-c
Confidence            9999988888887766689999999999999999999997 5999999999999999999999999999876533222 2


Q ss_pred             cccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCc-HHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+....+.....    ..++.      
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~------  241 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PSLPP------  241 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CCCCC------
Confidence            233466779999998653   2468899999999999999999999965332 233333222110    00100      


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                     ...++.++.+|+.+||..||.+||++++++.||||+.......
T Consensus       242 ---------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         242 ---------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             ---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence                           0135789999999999999999999999999999998765443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-41  Score=283.67  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=203.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .+|++.+.||+|++|.||++.++ ++..+++|.+.....   ....+.+|+++++.++|+||+++++++...+..+++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            46899999999999999999875 456899999864332   22356789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-cc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  169 (314)
                      +++| +|.+.+......+++..+..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            9975 788888766667899999999999999999999999999999999999999999999999998765432211 11


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.......                 
T Consensus       160 ~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  221 (256)
T cd05059         160 GTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-----------------  221 (256)
T ss_pred             CCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-----------------
Confidence            2223456999998876 567899999999999999998 789998777666655543321111                 


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                .....+.++.+++.+||..+|++|||+.++++.
T Consensus       222 ----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         222 ----------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                      112358899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-40  Score=288.01  Aligned_cols=259  Identities=20%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|++|.||++..+.     .+..+++|.+...... .....+.+|+..++.++|+||+++++++.....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5899999999999999999997542     3457999987643321 122345689999999999999999999988899


Q ss_pred             EEEEEeccc-ccHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           86 LHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      .+++|||+. |+|.+++....         ...+...+..++.|++.||.|||+++++|+||||+||+++.++.++|+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence            999999998 58888886432         23466788999999999999999999999999999999999999999999


Q ss_pred             cceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCC
Q 021299          156 GLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      |.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--  240 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL--  240 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            998754322211  112234567999999876 567899999999999999998 67899877766655444322100  


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc------CccccccC
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE------HRFAKSFN  298 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~------h~~~~~~~  298 (314)
                                               ......++.+.+++.+||+.||++|||+.++++      ||||+.++
T Consensus       241 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         241 -------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence                                     011234789999999999999999999999987      99998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.1e-41  Score=288.09  Aligned_cols=251  Identities=22%  Similarity=0.360  Sum_probs=204.2

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|.+.+.||+|++|.||++....     ++..+++|.+...... .....+.+|+++++.+.|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4679999999999999999997643     3578999998654332 123467789999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           86 LHLVFEFMET-DLETVIRNTN-------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                      .+++|||++| +|.+++...+             ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            9999999985 8888876432             3478889999999999999999999999999999999999999999


Q ss_pred             EeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhh
Q 021299          152 LADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF  228 (314)
Q Consensus       152 l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~  228 (314)
                      |+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            99999997643222  11223345677999999876 668999999999999999998 999998777666555544321


Q ss_pred             CCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ....                           ...++..+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         242 LLQR---------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCC---------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1111                           1245889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.4e-41  Score=285.34  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=204.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc---ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +|.+.+.||+|++|.||++.+...+..+++|.++....   .......+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            68999999999999999999888777777776654322   222223455788999999999999999999988999999


Q ss_pred             Eecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           90 FEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +||+.+ ++.+.+..   ....+++..+..++.|++.|+.+||++|++|+||+|+||+++. +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999986 77766643   3456999999999999999999999999999999999999974 579999999998764444


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...........+....    .            
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----~------------  222 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP----T------------  222 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC----C------------
Confidence            44444567788999998865 567889999999999999999999997766555444433211    0            


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                 ......++.++.++|.+||+.+|++||+++++++||||
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 -----------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -----------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                       01122458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.6e-41  Score=285.92  Aligned_cols=254  Identities=24%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|.+.+.||.|++|.||++.+..++..+++|.+...... ......+.+|+++++.+.|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5799999999999999999999889999999988754322 222345668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      |+++| +|.+.+..   ....+++..++.++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99986 78777653   344689999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......  ...............          
T Consensus       162 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~----------  228 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDYPPL----------  228 (267)
T ss_pred             ccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhcCCCCCC----------
Confidence            3334567888999999876 567899999999999999999999986543221  111111111000000          


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  .....++.+.+++.+||..||++|||+++|++
T Consensus       229 ------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         229 ------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                        01235889999999999999999999997763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-41  Score=288.38  Aligned_cols=247  Identities=26%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             cceeeeCccccceEEEEEEC----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDT----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.+.||.|+||.||+|...    ..+..|++|.+... ........+.+|++.++.++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999887    34568999999543 22223567789999999999999999999999888899999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--C
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R  166 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~  166 (314)
                      ||+. |+|.+.+... ...+++..+..++.||+.||.|||+++++|++|+++||+++.++.+||+|||.+.......  .
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9998 6899999877 6679999999999999999999999999999999999999999999999999998762221  1


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ..........|+|||.+.. ..++.++||||||+++|++++ |..||......+....+........             
T Consensus       161 ~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------  226 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI-------------  226 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS-------------
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccee-------------
Confidence            2223345667999999877 457999999999999999999 6799988877666666644322111             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                    ...++..+.++|.+||..||.+|||+.++++
T Consensus       227 --------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  227 --------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                          1245889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=282.83  Aligned_cols=245  Identities=28%  Similarity=0.429  Sum_probs=205.4

Q ss_pred             eeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           18 EVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      +.||+|++|.||++.+...   +..+++|.+....... ....+.+|++.++.++|+|++++++++......+++|||+.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4689999999999998865   8899999997665433 34566789999999999999999999999999999999996


Q ss_pred             -ccHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           95 -TDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        95 -g~l~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                       |+|.+.+...        ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence             5888888776        4679999999999999999999999999999999999999999999999999998764432


Q ss_pred             --CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 --~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                        .......+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+......            
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------  226 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL------------  226 (262)
T ss_pred             ccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence              22334456778999998877 478999999999999999998 58999888766665555432111            


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                     .....+++++.+++.+||+.+|++|||++|++++
T Consensus       227 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         227 ---------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ---------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                           1122458899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=284.94  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=223.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|..+++||+|.||.|.+++.+.+|+.||+|++++...-.. ....-..|-++|+..+||.+..+.-.|+.+.+.|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            5789999999999999999999999999999999987642211 112234688899999999999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||.+|+-+-+-.++...++++.++-+...|+.||.|||+++|+++|||.+|.+++.+|.+||+|||+|+.--.......
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k  326 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK  326 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence            99999754444444555699999999999999999999999999999999999999999999999999987666666777


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..+|||.|+|||++.. ..|..+.|.|.+||+||+|++|+.||-+.+.......+...-..                   
T Consensus       327 TFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k-------------------  386 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK-------------------  386 (516)
T ss_pred             cccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc-------------------
Confidence            7899999999999977 77899999999999999999999999988887777766544221                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                               ++..++++++.|+..+|.+||.+|..     +.||.+|+||.+++
T Consensus       387 ---------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  387 ---------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             ---------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence                     12356999999999999999999974     78999999999885

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-40  Score=286.75  Aligned_cols=241  Identities=18%  Similarity=0.178  Sum_probs=195.6

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-chhhHHHHHHHhhcCCCCeeeeeceecc----CCeEEEEEec
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELIDAFPH----KGNLHLVFEF   92 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~iv~e~   92 (314)
                      ..|++|+++.||++..  +|+.|++|.+......... ...+.+|++++++++||||+++++++.+    ....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999976  5889999999765432221 2456689999999999999999998865    4578999999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ++| +|.+.+... +.+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~  179 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK  179 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence            996 677777654 4689999999999999999999984 99999999999999999999999999987553322   23


Q ss_pred             cccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          171 QVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..++..|+|||.+.+. ..++.++||||||+++|+|++|..||......+....+.......   ..             
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---~~-------------  243 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL---KL-------------  243 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---CC-------------
Confidence            4577889999998652 467999999999999999999999999877666555543321111   01             


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                ....++++.+|+.+||+.||++|||++++++
T Consensus       244 ----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        244 ----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                      1135889999999999999999999999985

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5e-41  Score=295.65  Aligned_cols=282  Identities=20%  Similarity=0.226  Sum_probs=205.7

Q ss_pred             eeeCcc--ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      ..||.|  ++|+||++.+..+|+.|++|.+............+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  899999999999999999999876544333345667899999999999999999999999999999999985


Q ss_pred             -cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc------
Q 021299           96 -DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR------  167 (314)
Q Consensus        96 -~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~------  167 (314)
                       ++.+.+... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++++||+.+.........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence             787777654 335899999999999999999999999999999999999999999999999765332111110      


Q ss_pred             -ccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 -FTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 -~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       .....++..|+|||.+.+. ..++.++|+||||+++++|++|.+||................... +............
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  242 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS-PLDITTFPCEESR  242 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC-Cccccccchhhhh
Confidence             0111234569999998663 346899999999999999999999998776555444333221100 0000000000000


Q ss_pred             h-----hh---------c-----ccc-CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          246 V-----EY---------Q-----YVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       246 ~-----~~---------~-----~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .     ..         .     ... .....+.....++.+.+|+++||+.||++|||++|+++||||+...++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            0     00         0     000 000011123467889999999999999999999999999999988765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-40  Score=290.12  Aligned_cols=272  Identities=20%  Similarity=0.221  Sum_probs=200.7

Q ss_pred             ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cHHHHHH
Q 021299           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR  102 (314)
Q Consensus        24 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~  102 (314)
                      +.+.||.++...+++.+++|++............+.+|+++++.++|+||+++++++.+++..+++|||+++ ++.+.+.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            445566666677899999999987644444445677999999999999999999999999999999999985 7777776


Q ss_pred             hC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-------cccccccC
Q 021299          103 NT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-------RFTHQVFA  174 (314)
Q Consensus       103 ~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~  174 (314)
                      .. ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+||+.+........       ......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence            53 34689999999999999999999999999999999999999999999999998875532211       11223456


Q ss_pred             ccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch--------
Q 021299          175 RWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--------  245 (314)
Q Consensus       175 ~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  245 (314)
                      ..|+|||.+... ..++.++|+||+|+++++|++|..||..........+.....   .+..+.........        
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT---VPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CccccccCchhhhcCCcCcccc
Confidence            679999998653 347889999999999999999999998766544433222111   11111000000000        


Q ss_pred             -hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 -VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                       .................++.++.+|+.+||+.||++|||++++|+||||+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence             00000001111122234567899999999999999999999999999999775

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=273.43  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=217.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++..+++.||+|+.|+|++++.+.+|...|+|.+++....+ ..+++...+.++... ++|+||+++++|-.+..+++.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            355678899999999999999999999999999998775444 334555666665554 489999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||.|.-....++....+++++..+-.+..-+++||.||-. +|++|+|+||+||++++.|++||||||++-.+-. ....
T Consensus       170 MelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-SkAh  248 (391)
T KOG0983|consen  170 MELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-SKAH  248 (391)
T ss_pred             HHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec-cccc
Confidence            9999988888888888889999999999999999999986 5999999999999999999999999999987643 3333


Q ss_pred             cccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          169 THQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ....|-+.|||||.+..  ...|...+||||||+.+++|.||+.||... .+.+.+..+...    .|..++.       
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~----ePP~L~~-------  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE----EPPLLPG-------  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc----CCCCCCc-------
Confidence            45567788999999864  245789999999999999999999999874 455666555442    1122221       


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                    ..+.|+.+.+++..||++|+.+||.-.++|+|||+......
T Consensus       318 --------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  318 --------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             --------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence                          12369999999999999999999999999999999877543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=285.24  Aligned_cols=253  Identities=21%  Similarity=0.333  Sum_probs=200.5

Q ss_pred             HHhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      ..++|++.+.||+|++|.||.+.+..     ++..+++|.+..... ......+.+|+.+++.++|+||+++++++..+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            57899999999999999999997642     356799998754322 122335678999999999999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEee
Q 021299           85 NLHLVFEFMET-DLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d  154 (314)
                      ..+++|||+++ +|.+++....         ...+...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            99999999985 8888876532         2356788899999999999999999999999999999999999999999


Q ss_pred             ccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCC
Q 021299          155 FGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       155 f~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      ||.+.........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+...... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-  240 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-  240 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            9998754322111  112334667999999876 668999999999999999998 67898876665555443322110 


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                .....+++.+.+++.+||+.||++|||+.|++++
T Consensus       241 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      0112357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=321.85  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=224.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.++++||.|+||.|.+++++.+++.||+|.+.+-.... ....-|++|-.++..-+.+=|+.++-.|+++++.|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            489999999999999999999999999999999997743322 2223456777788877889999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |+|++| +|+.++.+.. .+++..++.+...|+.||..||+.|+|||||||+|||++.+|.++|.|||.|-.+..++. .
T Consensus       154 MdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             EecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            999985 8888888777 899999999999999999999999999999999999999999999999999998875543 4


Q ss_pred             ccccccCccccCcccccC---c-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          168 FTHQVFARWYRAPELLFG---A-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~---~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      ....+|||-|+|||++..   + ..|++.+|.|||||++|+|+.|..||=+..-.+++..|+..-..   ..+|+     
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~---l~FP~-----  304 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES---LSFPD-----  304 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh---cCCCc-----
Confidence            556789999999999853   2 56899999999999999999999999999999999988776211   11111     


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~  298 (314)
                                      ...+|+++++||+++++ +|+.|..   ++++-.||||.+++
T Consensus       305 ----------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  305 ----------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ----------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence                            12379999999999998 4778888   99999999999874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-40  Score=290.97  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcE----EEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ..+|++.+.||+|+||.||++.+..++..    +++|.+..... ......+.+|+.+++.++||||+++++++..+ ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46799999999999999999987666553    89998864322 22334667899999999999999999988664 46


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++++++. |++.+.+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            78999987 58989888776678999999999999999999999999999999999999999999999999998764332


Q ss_pred             Ccc--cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 RRF--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~~~--~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ...  .....+..|++||.+.+ ..++.++||||||+++|+|++ |..||......+... +..... ..          
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~-~~----------  230 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGE-RL----------  230 (316)
T ss_pred             cceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCC-CC----------
Confidence            221  12223567999999876 668999999999999999997 899997765444332 222110 00          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                     +..+..+..+.+++.+||..+|++||++.+++.+
T Consensus       231 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           0112347789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-40  Score=285.82  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|.+.+.||+|++|+||++...     .++..+++|.+....  ......+.+|+++++.++||||+++.+++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            468999999999999999999752     345578999886432  2223356789999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           86 LHLVFEFMET-DLETVIRNTN------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      .+++|||+++ +|.+++....            ..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            9999999984 8888876432            24899999999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhC
Q 021299          153 ADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (314)
Q Consensus       153 ~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~  229 (314)
                      +|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+.....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999975533221  1122334667999998876 668999999999999999998 8899987776665555433211


Q ss_pred             CCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .    .                       .....+.++.+|+.+||+.||.+|||+.+++.
T Consensus       241 ~----~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 L----Q-----------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             C----C-----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0    0                       11235789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.5e-40  Score=280.98  Aligned_cols=248  Identities=20%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++... ++..+++|.+.....   ....+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            578999999999999999999864 557899998764322   2346678999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  167 (314)
                      |++. |+|.+.+... ...+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9997 4888887653 456889999999999999999999999999999999999999999999999999876432211 


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......                
T Consensus       161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  223 (261)
T cd05072         161 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------------  223 (261)
T ss_pred             cCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            122334567999998876 567889999999999999998 89999877666655554332111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 +....++.++.+++.+||..+|++||+++++++
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 -----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       111245889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-40  Score=284.87  Aligned_cols=253  Identities=19%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             HHhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      -.++|.+.+.||+|++|.||++.+..     ++..+++|.+...... .....+.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            35889999999999999999999876     6678999987644322 22335678999999999999999999998888


Q ss_pred             eEEEEEecccc-cHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEee
Q 021299           85 NLHLVFEFMET-DLETVIRNTN------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLAD  154 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~d  154 (314)
                      ..+++|||+.| +|.+++...+      ..+++..+..++.||+.|++|||+++++|+||+|+||+++.++   .++|+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            89999999975 8888886543      2588999999999999999999999999999999999998765   599999


Q ss_pred             ccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCC
Q 021299          155 FGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       155 f~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      ||.+.........  ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.....  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--  239 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR--  239 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            9999765322111  112223456999999876 568999999999999999996 8899987666554433322100  


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                        ..                       ....++..+.+++.+||..+|++||++.++++|
T Consensus       240 --~~-----------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 --LD-----------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CC-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              00                       112458899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-40  Score=279.06  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+. ++..+++|.+......   ...+.+|+.+++.++|++++++++++.. ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            578999999999999999999765 5567999998754332   2457789999999999999999998754 5678999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      ||+.+ +|.+.+... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99985 888888654 34589999999999999999999999999999999999999999999999999987543221 1


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+....+......                
T Consensus       160 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------  222 (260)
T cd05070         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----------------  222 (260)
T ss_pred             ccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            122334567999998866 567899999999999999999 88999877666655554322111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                                 +.....+..+.+|+.+||..+|++|||+++++
T Consensus       223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         223 -----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             -----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                       11224588999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=304.76  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=216.1

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      .-+||+|.+|+||-+++..+..++|||.+.-..  .+...-..+|+...++++|.|||++.+.+.+++++-|.||.++| 
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            347999999999999999999999999986432  22233556899999999999999999999999999999999986 


Q ss_pred             cHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCCCCCcccccc
Q 021299           96 DLETVIRNTNIFL--SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        96 ~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      +|.+++...=+++  ++..+..+..||+.||.|||++.|+|+|||-+||+|+. .|.+||+|||.++..-.-........
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            7777777777777  88899999999999999999999999999999999975 68999999999988766666667788


Q ss_pred             cCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          173 FARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      ||..|||||++.. ...|..++|||||||++.+|.||++||-........--.+..+..-                    
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvH--------------------  797 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVH--------------------  797 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecC--------------------
Confidence            9999999999964 3458999999999999999999999997766555433222222111                    


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                           ++++..++++++.+|.+|+.+||.+||++.++|.+||++.-+++
T Consensus       798 -----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  798 -----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             -----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence                 12234579999999999999999999999999999999977443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=300.93  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=210.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++..+...||+|+||+||++++-   ..||||.+............|.+|+.+++.-+|.||+-+.+++-..+. .||+
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            577889999999999999999763   369999999888777766788899999999999999999999977777 9999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc--
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~--  167 (314)
                      .+|+| +|...++-..-.+.....+.|++||++|+.|||.++|+|+|||..|||+.++++|||+|||++.........  
T Consensus       467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence            99999 888888877777999999999999999999999999999999999999999999999999999865443222  


Q ss_pred             ccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ..-..|...|+|||++..  +.+++.++||||+|+++|||++|..||........+..+-++...+..            
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~------------  614 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL------------  614 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc------------
Confidence            223456677999999853  457899999999999999999999999955555544443333222221            


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 .......+.++++|+..||..++++||...+||.
T Consensus       615 -----------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 -----------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -----------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                       1222345779999999999999999999999886

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-40  Score=278.72  Aligned_cols=248  Identities=22%  Similarity=0.362  Sum_probs=202.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+. +++.+++|.+.....   ....+.+|++++++++|+||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            478999999999999999999864 456899999865432   2345678999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-
Q 021299           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-  167 (314)
                      |++. ++|.+.+.... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9995 58888886543 46899999999999999999999999999999999999999999999999999876432211 


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......+..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+.......               
T Consensus       161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------  224 (261)
T cd05068         161 REGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---------------  224 (261)
T ss_pred             cCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence            111222356999998866 668999999999999999999 899998877666555543321110               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  .....+..+.+++.+||+.+|++||++.++++
T Consensus       225 ------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         225 ------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                        11235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-42  Score=303.61  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=215.4

Q ss_pred             hhc-cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC--cchhhHHHHHHHhhcCCCCeeeeeceeccCCe--E
Q 021299           12 DRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--VNFTALREIKLLKELKSPHIIELIDAFPHKGN--L   86 (314)
Q Consensus        12 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~   86 (314)
                      ++| +....||+|+|.+||+|.|..+|..||--.++.......  ...++..|+++|+.|+|+||++++++|.+...  +
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            455 556789999999999999999998888766555443333  33678899999999999999999999976554  7


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecC-CcEEEeeccceeeeC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSH-GQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~-~~~~l~df~~~~~~~  162 (314)
                      -+|+|.+. |+|..++++.+ .++...+..|++||+.||.|||++.  |+|||||-+||||+.+ |.|||+|+|+|+...
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            78999998 68888887665 4889999999999999999999985  9999999999999876 899999999999874


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCcc-CCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL-QGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..  .....+|||.|||||.+..  .|+...||||||++|+||+|+..|+ ...++.++++++..+..+......     
T Consensus       198 ~s--~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV-----  268 (632)
T KOG0584|consen  198 KS--HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV-----  268 (632)
T ss_pred             cc--ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc-----
Confidence            43  3445899999999998864  7899999999999999999999888 457788888888777544333322     


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                           -.+++++||.+||.. .+.|||+.|+|.||||..-.+
T Consensus       269 ---------------------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  269 ---------------------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             ---------------------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence                                 278999999999999 999999999999999998644

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-40  Score=291.96  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceec-cC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP-HK   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-~~   83 (314)
                      .++|++.+.||+|+||.||+|.+..     +++.|++|.+...... .....+.+|+.+++++ +|+||+++++++. .+
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4799999999999999999996433     3578999998643321 2223456899999999 7999999999775 44


Q ss_pred             CeEEEEEecccc-cHHHHHHhCC---------------------------------------------------------
Q 021299           84 GNLHLVFEFMET-DLETVIRNTN---------------------------------------------------------  105 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~---------------------------------------------------------  105 (314)
                      ...++++||++| +|.+.+....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            578899999985 7877775421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--cccccccCccccCc
Q 021299          106 ---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAP  180 (314)
Q Consensus       106 ---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sP  180 (314)
                         ..+++..+..++.||+.||+|||++|++|+||||.||+++.++.++|+|||++........  ......++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2578899999999999999999999999999999999999999999999999976532211  12223446679999


Q ss_pred             ccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCcc
Q 021299          181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL  259 (314)
Q Consensus       181 E~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (314)
                      |.+.+ ..++.++||||||+++|+|++ |..||......+...........   .                       ..
T Consensus       245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~-----------------------~~  297 (337)
T cd05054         245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---M-----------------------RA  297 (337)
T ss_pred             HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---C-----------------------CC
Confidence            99877 678999999999999999997 99999775544433332221000   0                       01


Q ss_pred             CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          260 FPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       260 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ....++++.+++.+||+.+|++||+++|+++|
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            12357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.1e-40  Score=278.97  Aligned_cols=248  Identities=22%  Similarity=0.371  Sum_probs=202.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|++|.||+|.. .+++.+++|.+......   ...+.+|+.++++++|+|++++++++. .+..+++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            468999999999999999999985 45678999998754332   235678999999999999999999874 4568999


Q ss_pred             Eeccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      ||++. |+|.+.+... +..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99997 4888887654 45689999999999999999999999999999999999999999999999999976542221 


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ......++..|+|||.+.. ..++.++|+||||+++|++++ |.+||......+....+........             
T Consensus       159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-------------  224 (260)
T ss_pred             cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-------------
Confidence            1223345667999998876 567899999999999999998 9999988776666555533221111             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                    ....+.++.+++.+||..+|++||+++++++
T Consensus       225 --------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         225 --------------PDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             --------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                          1234789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.8e-40  Score=287.75  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=197.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcE--EEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||.||+|.++.++..  +++|.+.... .......+.+|+.++.++ +|+||+++++++..++..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            36899999999999999999998877764  4666654322 122234566899999999 8999999999999999999


Q ss_pred             EEEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           88 LVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                      +++||++ |+|.+++....               ..+++..+..++.|++.|++|||++|++|+||||+||+++.++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence            9999998 48888886432               2578999999999999999999999999999999999999999999


Q ss_pred             EeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCC
Q 021299          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT  230 (314)
Q Consensus       152 l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  230 (314)
                      |+|||++...... .......++..|+|||.+.+ ..++.++||||||+++++|++ |..||......+....+....  
T Consensus       165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  240 (303)
T cd05088         165 IADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  240 (303)
T ss_pred             eCccccCcccchh-hhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence            9999998632111 11111223556999998866 567899999999999999998 999997766555444332110  


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                        ..                       .....+++++.+|+.+||+.+|++||++++++.+
T Consensus       241 --~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RL-----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cC-----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              00                       0012357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-41  Score=299.15  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=229.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.|.+.+.||+|.|++|.++.+..+|..||+|.+.+...+.....+..+|+++++.++||||++++.+.+.+...|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            46799999999999999999999999999999999998887777677889999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+.| .+.+++.+.+ .+.+..+..++.|+++|++|||+++|+|+|||++||+++.+.++||+|||++..+. ......
T Consensus       135 eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lq  212 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQ  212 (596)
T ss_pred             EeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-cccccc
Confidence            99985 7888887665 46779999999999999999999999999999999999999999999999999885 555667


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...|++.|.|||++.+..+..++.|+||||+++|.|+.|..||.+..-.+...+...+....                  
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI------------------  274 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI------------------  274 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc------------------
Confidence            78899999999999997778999999999999999999999999876665555543331111                  


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                .-.++.+..+||+++|-.+|++|++++++.+|.|.+-..+.
T Consensus       275 ----------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  275 ----------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ----------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                      11358889999999999999999999999999999876544

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=278.64  Aligned_cols=245  Identities=29%  Similarity=0.472  Sum_probs=205.4

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc-ccH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l   97 (314)
                      ||.|++|.||.+.+..+++.+++|.+........ ....+..|+.+++.++|+|++++++.++.++..+++||++. ++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999877643322 33456689999999999999999999999999999999995 588


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccc
Q 021299           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (314)
Q Consensus        98 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  177 (314)
                      .+.+.... .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+..............++..|
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            88876554 58999999999999999999999999999999999999999999999999998765443334455677789


Q ss_pred             cCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCC
Q 021299          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (314)
Q Consensus       178 ~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (314)
                      +|||...+ ...+.++|+||||+++|++++|..||...+.......+...     ..                       
T Consensus       160 ~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~-----------------------  210 (250)
T cd05123         160 LAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----PL-----------------------  210 (250)
T ss_pred             cChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----CC-----------------------
Confidence            99998876 55788999999999999999999999877664444444321     00                       


Q ss_pred             ccCCCCCHHHHHHHhhhcccCCCCCCCH---HHHhcCccc
Q 021299          258 SLFPSASDDALDLLSKMFTYDPKARITA---QQALEHRFA  294 (314)
Q Consensus       258 ~~~~~~~~~~~~li~~~l~~dp~~Rps~---~ell~h~~~  294 (314)
                      +....++..+.+++++||+.||++||++   +++++||||
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            1122348899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-39  Score=278.31  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+..+ ..+++|.+.....   ....+.+|++++++++|+||+++++.+.+ ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            47899999999999999999987655 4699999875332   22356789999999999999999998754 5679999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||+++ ++.+++... ...+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            99985 888888754 3458999999999999999999999999999999999999999999999999997664332211


Q ss_pred             -cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       169 -~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       ....++..|+|||...+ ..++.++|+||||+++|+|++ |..||...........+......                
T Consensus       160 ~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------  222 (262)
T cd05071         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------  222 (262)
T ss_pred             ccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------------
Confidence             23345667999998865 567999999999999999999 78899877666555443322100                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 .....++..+.+++.+||..||++||+++++++
T Consensus       223 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                       011245889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-41  Score=317.73  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=207.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   82 (314)
                      ...+|+.++.||+|+||.||+|+.+-+|..||||++.... ......++.+|+..+.+++||||++++..|.+       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4578899999999999999999999999999999998876 55566678899999999999999999988732       


Q ss_pred             --------------------------------------------------------------------------------
Q 021299           83 --------------------------------------------------------------------------------   82 (314)
Q Consensus        83 --------------------------------------------------------------------------------   82 (314)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEecccccHHHHHHhCCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 021299           83 ------------------------K--------GNLHLVFEFMETDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHK  129 (314)
Q Consensus        83 ------------------------~--------~~~~iv~e~~~g~l~~~~~~~~~~l-~~~~~~~i~~~i~~~l~~Lh~  129 (314)
                                              +        ...||.||||+.+++..+-..+... ....+|.++++|+.||+|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1258899999987777776665544 467899999999999999999


Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceeee------------------CCCCCcccccccCccccCcccccCcc--CC
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF------------------GSPDRRFTHQVFARWYRAPELLFGAK--QY  189 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~~------------------~~~~~~~~~~~~~~~y~sPE~~~~~~--~~  189 (314)
                      .|++||||||.|||+++++.|||+|||+++..                  +......+..+||..|+|||++.+..  .|
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            99999999999999999999999999999872                  11122345668899999999997755  69


Q ss_pred             CCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHH
Q 021299          190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALD  269 (314)
Q Consensus       190 ~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (314)
                      +.|.|+||||++|+||+.-  .-...+....+..+..+..+.+                        ..++.+--+.-..
T Consensus       796 n~KiDmYSLGIVlFEM~yP--F~TsMERa~iL~~LR~g~iP~~------------------------~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP--FGTSMERASILTNLRKGSIPEP------------------------ADFFDPEHPEEAS  849 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc--CCchHHHHHHHHhcccCCCCCC------------------------cccccccchHHHH
Confidence            9999999999999999943  2233444444444442211111                        1111222456789


Q ss_pred             HHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          270 LLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       270 li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      +|+.||+.||++||||.|+|.+.||-
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999998

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-40  Score=279.81  Aligned_cols=242  Identities=22%  Similarity=0.366  Sum_probs=194.4

Q ss_pred             eeCccccceEEEEEE--CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           19 VLGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      .||+|++|.||++.+  ..++..+++|.+............+.+|+.+++.+.|+||++++++++ ....+++|||+++ 
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964  456789999998765544444556778999999999999999999875 4567899999995 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc---cccc
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQV  172 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~  172 (314)
                      +|.+.+... ..+++..+..++.|++.|+++||++|++|+||||.||+++.++.++|+|||.+..........   ....
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            677777644 468999999999999999999999999999999999999999999999999997664332211   1222


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      ++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...........+.....    .                 
T Consensus       160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~----~-----------------  217 (257)
T cd05116         160 WPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER----M-----------------  217 (257)
T ss_pred             CCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----C-----------------
Confidence            3467999998865 567899999999999999997 9999988766655555432211    0                 


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                            +....+++++.++|.+||+.||++||++.+|..
T Consensus       218 ------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 ------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                  112246899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-40  Score=285.91  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=197.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCc--EEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ++|++.+.||+|++|.||++..+.++.  .+++|.+...... .....+.+|++++.++ +||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            579999999999999999998877665  4677777532221 1223566899999999 79999999999999999999


Q ss_pred             EEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           89 VFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      ++||++ |+|.+.+....               ..+++..++.++.|++.||++||++|++|+||||+||+++.++.++|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999998 58888886532               35888999999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCC
Q 021299          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       153 ~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      +|||++....... .......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...... 
T Consensus       161 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~-  237 (297)
T cd05089         161 ADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM-  237 (297)
T ss_pred             CCcCCCcccccee-ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence            9999986422111 1111222456999998866 567899999999999999997 99999877665555443222111 


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                .....+++++.+|+.+||+.+|.+||+++++++.
T Consensus       238 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 --------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      0112458899999999999999999999999755

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=277.81  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=204.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|++|.||++..+ ++..+++|.+.....   ....+.+|+.+++.++|+|++++++++......+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            3589999999999999999999865 457899999875432   234577899999999999999999999888899999


Q ss_pred             Eecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||++.+ +|.+.+.... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999985 8888887653 46899999999999999999999999999999999999999999999999999766432111


Q ss_pred             -ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 -FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 -~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       ......+..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+........             
T Consensus       160 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  225 (261)
T cd05034         160 AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-------------  225 (261)
T ss_pred             hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence             112223456999998876 668899999999999999998 9999988776666665544321111             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                    ....+.++.+++.+||+.+|.+||+++++++
T Consensus       226 --------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         226 --------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             --------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                          1234788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-40  Score=280.72  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=198.0

Q ss_pred             ccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC------
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   84 (314)
                      |.+.+.||+|+||.||.+....+   +..+++|.+............+.+|+..++.++|+||+++++++....      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999987653   478999998765443333346678999999999999999999775444      


Q ss_pred             eEEEEEecccc-cHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           85 NLHLVFEFMET-DLETVIRNT-----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      ..++++||+.+ +|...+...     ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            37999999985 777776432     235899999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCCcc--cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          159 RIFGSPDRRF--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       159 ~~~~~~~~~~--~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      ..........  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  234 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-----  234 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            8654322111  11223567999998865 668999999999999999998 88999877666555444332111     


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                            .....+++++.+++.+||..||++|||+.+++++
T Consensus       235 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 ----------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  1122458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-40  Score=313.45  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=200.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|++|.||+|.+..+|+.|++|++....... .....+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997543222 22345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           91 EFMET-DLETVIRNT----------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        91 e~~~g-~l~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      ||++| +|.+.+...          ....+...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            99986 787777532          1235667788999999999999999999999999999999999999999999997


Q ss_pred             eeCCCC------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHH
Q 021299          160 IFGSPD------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL  221 (314)
Q Consensus       160 ~~~~~~------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~  221 (314)
                      ......                  .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            652111                  01112468999999999876 66799999999999999999999999764432221


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ...    ....+...                     .-...+++.+.+++.+||..||++||+..+.+.+
T Consensus       241 ~~~----~i~~P~~~---------------------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        241 YRD----VILSPIEV---------------------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhh----hccChhhc---------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            110    00001000                     0012568899999999999999999887665533

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.9e-40  Score=280.59  Aligned_cols=251  Identities=21%  Similarity=0.335  Sum_probs=203.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|++|.||++.+..++.   .+++|.+...... .....+.+|+.++++++||||+++.+++..++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            4689999999999999999998765443   7999988654322 22345678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|||++| +|.+++....+.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            99999985 88888877666789999999999999999999999999999999999999999999999999976543221


Q ss_pred             cc---cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 RF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~~---~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+......  +         
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--~---------  229 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL--P---------  229 (267)
T ss_pred             eeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--C---------
Confidence            11   11222456999999876 568999999999999999886 99999877666555554332110  0         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                      ....+++.+.+++.+||+.+|++||++.++++
T Consensus       230 ----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 ----------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                            01235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-40  Score=281.30  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|++|.||++.++..     +..+++|.+...... .....+.+|+.+++.++|+||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            57999999999999999999987643     378999998644321 222356689999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           86 LHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      .+++|||++ |+|.+.+....         ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence            999999997 58888876432         24678899999999999999999999999999999999999999999999


Q ss_pred             cceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCC
Q 021299          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      |.+........  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+....    
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----  238 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG----  238 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC----
Confidence            99875433221  1122345677999998866 568999999999999999998 889998776665554443111    


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ..                       ......+.++.+++.+||+.+|++|||+.++++
T Consensus       239 ~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HL-----------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC-----------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00                       011234889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.5e-40  Score=281.08  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=199.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|++|+||++.+..+|.    .|++|.+..... ......+.+|+.+++.+.|+||+++.+++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            5789999999999999999998777666    478998864432 2223456689999999999999999998865 456


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++++++ |++.+.+....+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            78999998 58888887766679999999999999999999999999999999999999999999999999998764322


Q ss_pred             Cc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 RR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.......           
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------  231 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP-----------  231 (279)
T ss_pred             ceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-----------
Confidence            21  112233567999999876 568899999999999999998 889987765554444332211100           


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                      .....+.++.+++.+||..||++||++.++++
T Consensus       232 ----------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 ----------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            11235788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=277.47  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=204.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhcCCCCeeeeeceecc--CCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   86 (314)
                      .+|.+.+.||+|++|.||++.+..++..+++|.+......   ......+.+|+++++.++|+||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999999999999999988643221   2223356689999999999999999998855  3568


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++|+++| +|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            899999986 7777776544 48899999999999999999999999999999999999999999999999997653211


Q ss_pred             ---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                         .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.............   ......        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~--------  228 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTKP--------  228 (264)
T ss_pred             ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCCC--------
Confidence               11123457788999999876 557899999999999999999999998765544433322   111111        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                     .....+++++.++|.+||. +|.+||++.++++|||.
T Consensus       229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                           1223568999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=308.17  Aligned_cols=250  Identities=27%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeece-ec---cC---
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDA-FP---HK---   83 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~---~~---   83 (314)
                      .++++.++|.+|+|+.||+|.+...|..||+|++...  ++.......+|+.+++.|+ |+|||.+++. ..   .+   
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4678999999999999999999888899999999876  4445556779999999997 9999999993 21   11   


Q ss_pred             CeEEEEEeccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeecccee
Q 021299           84 GNLHLVFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        84 ~~~~iv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      -.+.++||||. |+|.+++..+ ...+++..+.+|+.|+++|+++||...  |+|||||.+|||++.+|..||||||.++
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            25789999999 5999999754 334999999999999999999999987  9999999999999999999999999997


Q ss_pred             eeCCCCCc---------ccccccCccccCccccc--CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhh
Q 021299          160 IFGSPDRR---------FTHQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (314)
Q Consensus       160 ~~~~~~~~---------~~~~~~~~~y~sPE~~~--~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~  228 (314)
                      -.......         ......|+.|.|||.+.  ++...++|+|||+|||+||.|+....||.......++.-    .
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng----~  270 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG----N  270 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec----c
Confidence            54322211         11235688999999863  456789999999999999999999999987643332211    1


Q ss_pred             CCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                      ...++                          .+..+..+.+||+.||+.||++||++.|++++-+
T Consensus       271 Y~~P~--------------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  271 YSFPP--------------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ccCCC--------------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            11111                          1345899999999999999999999999886543

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-39  Score=279.93  Aligned_cols=250  Identities=21%  Similarity=0.290  Sum_probs=196.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|++|+||++.+..++.    .+++|.+..... .....++..++..++++.||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            4789999999999999999999877776    366676643211 1222345577888899999999999998754 456


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++|++. |+|.+.+....+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            78899987 69999988777779999999999999999999999999999999999999999999999999998653322


Q ss_pred             C--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+...  ...+  .      
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~~--~------  232 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG--ERLA--Q------  232 (279)
T ss_pred             cccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--CcCC--C------
Confidence            1  2223345667999999876 568999999999999999998 99999876654433332211  0000  0      


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ....+..+.+++.+|+..||++|||+.|+++
T Consensus       233 -----------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         233 -----------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             1124678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.2e-40  Score=282.03  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             hhccceeeeCccccceEEEEEEC----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDT----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ++|++.+.||+|+||+||++...    .++..+++|.+...... .....+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            67899999999999999999742    35578999998754322 22235668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcE
Q 021299           88 LVFEFMET-DLETVIRNTN----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~  150 (314)
                      ++|||+++ +|.+++....                ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            99999985 8888775321                247888899999999999999999999999999999999999999


Q ss_pred             EEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +|+|||++.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999997653322  11222334567999998876 567999999999999999998 88899776554444433221


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ..    .                       +....+++.+.+++.+||+.||.+||++.+|+++
T Consensus       243 ~~----~-----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         243 QL----L-----------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             Cc----C-----------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            10    0                       1112458899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.1e-40  Score=283.79  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=202.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|++|.||++.+...     ...+++|.+...... .....+.+|+.+++.+ +|+||+++++++..++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            57899999999999999999987643     367999988754322 2223566899999999 7999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC
Q 021299           85 NLHLVFEFMET-DLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~  148 (314)
                      ..+++|||+.+ +|..++...               ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence            99999999975 888887532               34688999999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHH
Q 021299          149 QLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIF  225 (314)
Q Consensus       149 ~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~  225 (314)
                      .++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+.
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999765432211  112233566999998866 667899999999999999997 889998776655555443


Q ss_pred             HhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ......                           .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       249 ~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         249 EGYRME---------------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             cCCcCC---------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            221110                           112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.4e-40  Score=282.65  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             hccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCccc--CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKE--GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   86 (314)
                      .|++.+.||.|++|.||++.+.   .+|..+++|.+.......  .....+.+|+++++.+ +|++|+++.+.++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   368899999987543221  2223456799999999 589999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++||++| +|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            999999996 787777654 458899999999999999999999999999999999999999999999999987653322


Q ss_pred             -CcccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 -RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 -~~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                       .......++..|+|||.+... ..++.++|+||||+++|+|++|..||...........+........+          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  229 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------  229 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC----------
Confidence             112234577889999998653 34678999999999999999999999754433333333222111111          


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                    .....+++.+.+++.+||+.||++||     ++++++.||||+.++
T Consensus       230 --------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         230 --------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             --------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                          01123588999999999999999997     899999999999886

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.7e-40  Score=285.52  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=199.9

Q ss_pred             HhhccceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|.+.+.||+|+||.||.+++..       ++..+++|.+..... ......+.+|+.+++.+ +|+||+++++++..
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            5899999999999999999997643       234699999875432 22234566899999999 79999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ++..+++|||+++ +|.+++....               ..+++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence            9999999999985 8888887542               24788999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+.........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            999999999998755322111  111223467999998876 567899999999999999998 7888877655444443


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +....    ..                       .....++.++.+|+.+||..+|++|||+.+++++
T Consensus       255 ~~~~~----~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         255 LKEGH----RM-----------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHcCC----CC-----------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            32211    00                       1112458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=275.88  Aligned_cols=244  Identities=21%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||.|++|.||++...  |+.+++|.+.....   ....+.+|+.+++.++|+||+++++++.+....+++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            468999999999999999999754  78999999975533   3346778999999999999999999998889999999


Q ss_pred             ecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |++++ +|.+++.... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99985 8888887554 3689999999999999999999999999999999999999999999999999976532221  


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                       ....+..|+|||.+.. ..++.++|+||||+++++|++ |..||......+....+......                 
T Consensus       158 -~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  218 (256)
T cd05039         158 -SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-----------------  218 (256)
T ss_pred             -cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence             2234556999998876 567889999999999999997 99999877655544433322110                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                ......++.+.++|.+||..+|++||++++++.
T Consensus       219 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         219 ----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                      011245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=276.30  Aligned_cols=243  Identities=24%  Similarity=0.377  Sum_probs=197.4

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-c
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-D   96 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~   96 (314)
                      +.||.|++|.||++.+.. ++.+++|.+...... .....+.+|+++++.++|+||+++++++......++++|++.| +
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            478999999999999877 899999988765433 2334677899999999999999999999999999999999975 7


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc--cccccC
Q 021299           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF--THQVFA  174 (314)
Q Consensus        97 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~  174 (314)
                      +.+++......++...+..++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+..........  .....+
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            888887666678999999999999999999999999999999999999999999999999997653221111  112224


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.......                      
T Consensus       159 ~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~----------------------  215 (251)
T cd05041         159 IKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP----------------------  215 (251)
T ss_pred             eccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC----------------------
Confidence            56999998866 568999999999999999998 788887766555444432221100                      


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                           ....++.++.+++.+||..+|.+||++.|+++
T Consensus       216 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         216 -----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                 11235789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-39  Score=277.76  Aligned_cols=251  Identities=21%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|+..+.||+|++|.||++....++.   .+++|.+...... .....+.+|++++++++|+|++++.+++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            4688999999999999999999876554   7899988654321 12335668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|||+++ +|.+.+....+.+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            99999986 78788776666799999999999999999999999999999999999999999999999999976533221


Q ss_pred             ccc---ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 RFT---HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~~~---~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ...   ....+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...........+......  +.        
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~--~~--------  231 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL--PA--------  231 (268)
T ss_pred             cceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC--CC--------
Confidence            111   1122456999998876 567899999999999999997 99999877766665555432111  10        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ....+.++.+++.+||..+|++||+..++++
T Consensus       232 -----------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         232 -----------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             1135788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.1e-39  Score=275.27  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=202.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .+|++.+.||+|++|.||++.+. ++..+++|.+......   ...+.+|++++++++||+++++++++......++++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            57899999999999999999875 4678999988644332   2356789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc-cc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  169 (314)
                      |+.| +|.+.+....+.++++.++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9985 777777766667899999999999999999999999999999999999999999999999999765432211 12


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........                
T Consensus       160 ~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------  222 (256)
T cd05112         160 GTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------------  222 (256)
T ss_pred             CCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC----------------
Confidence            2334567999998876 568899999999999999998 8999987766555555432211000                


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                 ....++.+.+|+.+||..+|++||++.+++++
T Consensus       223 -----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         223 -----------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                       11247899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-39  Score=279.30  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=196.2

Q ss_pred             ccceeeeCccccceEEEEEECCCCc--EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc------CCe
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------KGN   85 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   85 (314)
                      +.+.+.||+|++|.||++....++.  .+++|.+............+..|+++++.++|+||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3577899999999999998877665  68999887654444444566789999999999999999987532      125


Q ss_pred             EEEEEeccc-ccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           86 LHLVFEFME-TDLETVIRN-----TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .++++||+. |+|.+.+..     ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            689999998 477776642     22358899999999999999999999999999999999999999999999999998


Q ss_pred             eeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          160 IFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       160 ~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      ........  .....+++.|++||.+.+ ..++.++|+||||+++|+|++ |..||...........+......      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL------  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            65432211  112234567999999876 568999999999999999998 78999876665544443322110      


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                           .....++..+.++|.+||+.||++|||+.+++++
T Consensus       234 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 ---------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                 0112457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=284.53  Aligned_cols=287  Identities=28%  Similarity=0.487  Sum_probs=224.2

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC--C----Ceeeeec
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--P----HIIELID   78 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~----~i~~~~~   78 (314)
                      ..++.+.++|.+++.+|+|.||.|..+.+..++..+|+|+++.-.....   ..+-|+++++++.+  |    -++++.+
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYre---Aa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYRE---AALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhh---HHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            4577889999999999999999999999999999999999975443222   33468889999842  2    3677788


Q ss_pred             eeccCCeEEEEEecccccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-----------
Q 021299           79 AFPHKGNLHLVFEFMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-----------  146 (314)
Q Consensus        79 ~~~~~~~~~iv~e~~~g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----------  146 (314)
                      +|+-.++.+||+|.++-++.+.+.+ ...+++...++.++.|++.++++||+.+++|-||||+||++..           
T Consensus       159 wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  159 WFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            8999999999999999999999986 4668999999999999999999999999999999999999842           


Q ss_pred             ---------CCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc
Q 021299          147 ---------HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (314)
Q Consensus       147 ---------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~  217 (314)
                               +..++|+|||.|+......   ...+.|.-|.|||++.+ ..++..+||||+||||+|+.+|...|...+.
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                     2248999999998754433   44566777999999988 8899999999999999999999999999999


Q ss_pred             HHHHHHHHHhhCCCCCCCCCCc-------------Ccccchh--hhccccCCCCCccCCCC---CHHHHHHHhhhcccCC
Q 021299          218 IDQLGKIFAAFGTATPSQWPDL-------------AYLPDYV--EYQYVAAPPLRSLFPSA---SDDALDLLSKMFTYDP  279 (314)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp  279 (314)
                      .+.++.|....++.+..-....             .......  ..-...+.++.......   ..++.+|+++||..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            9988777666664332211111             0000000  11111122222222222   3348899999999999


Q ss_pred             CCCCCHHHHhcCccccccC
Q 021299          280 KARITAQQALEHRFAKSFN  298 (314)
Q Consensus       280 ~~Rps~~ell~h~~~~~~~  298 (314)
                      .+|+|+.|+|.||||+...
T Consensus       395 ~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccHHHHhcCHHhhcCC
Confidence            9999999999999998654

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.3e-40  Score=281.97  Aligned_cols=251  Identities=21%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             hhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .+|.+.+.||+|++|.||++.+..     .+..+++|.+...... .....+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            568999999999999999998654     3568999998754322 2233566899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcE
Q 021299           87 HLVFEFMET-DLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~  150 (314)
                      ++++||+.+ ++..++...               ...+++..+..++.|++.||.+||++|++|+||||+||+++.++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence            999999985 777776422               2347888899999999999999999999999999999999999999


Q ss_pred             EEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +|+|||++........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+...
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999876532221  1123345678999999876 557899999999999999998 78898877766665555433


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ....                           ....++.++.+++.+||+.+|++||++++|+..
T Consensus       243 ~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         243 QVLP---------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CcCC---------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            2111                           122458899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=275.93  Aligned_cols=242  Identities=21%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             eeeCccccceEEEEEECCCC---cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      +.||+|++|.||+|.....+   ..+++|.+...... .....+.+|+++++.++|+|++++++++. ....+++|||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            47999999999999765544   78999998765443 23345678999999999999999999875 456799999998


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc---
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---  170 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~---  170 (314)
                      + +|.+.+.... .+++..+..++.|++.|+++||+.+++|+||+|+||+++.++.++|+|||.+............   
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            5 8888887554 6899999999999999999999999999999999999999999999999999866443322111   


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+....+......                   
T Consensus       158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  217 (257)
T cd05060         158 GRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-------------------  217 (257)
T ss_pred             ccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------------
Confidence            122456999998866 568999999999999999997 99999877665554444322110                   


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                              .....++..+.++|.+||..+|++||++.+++.
T Consensus       218 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         218 --------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                    111245789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.8e-39  Score=274.54  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|.+.+.||+|++|.||++.+..+ ..+++|.+.....   ....+.+|+++++.++|++++++++++.. +..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence            47899999999999999999987554 4689998764332   23456789999999999999999998754 5678999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      ||+.+ +|.+++... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99985 888888754 34588999999999999999999999999999999999999999999999999976533221 1


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||...+ ..++.++|+||||+++|+|++ |..||......+....+......                
T Consensus       160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM----------------  222 (260)
T ss_pred             cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            122345567999998866 568899999999999999999 88999877666555444332110                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 ......+..+.+++.+||..||++||+++++++
T Consensus       223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       011245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-39  Score=281.44  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ..+|.+.+.||+|++|.||++.+..     ++..+++|.+.....  .....+.+|++.+++++|+||+++.+++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            3579999999999999999997543     345688888754332  122356689999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc
Q 021299           86 LHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~  149 (314)
                      .++||||++| +|.+++....               +.+++..++.++.||+.|+++||++|++|+||||+||+++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            9999999975 8888876432               34889999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHH
Q 021299          150 LKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       150 ~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~  226 (314)
                      ++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence            99999999976533221  1223445678999998876 668899999999999999998 9999977766655444322


Q ss_pred             hhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ....    .                       .....+..+.+++.+||+.||++||++.++++
T Consensus       241 ~~~~----~-----------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         241 GRVL----E-----------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCC----C-----------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2110    0                       01234788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-39  Score=279.56  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ..+|...+.||+|++|.||++...     .++..+++|.+....  ......+.+|++.++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            468899999999999999999642     345678888876432  2223456789999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcE
Q 021299           86 LHLVFEFMET-DLETVIRNTN--------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~  150 (314)
                      .+++|||+.+ +|.+++....              ..+++..+..++.|++.|++|||++|++|+||+|+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            9999999985 8888876543              247889999999999999999999999999999999999999999


Q ss_pred             EEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+....+...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            9999999976532221  1122234567999998876 568999999999999999998 88999776666555444322


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ....                           ....+++.+.+++.+||+.||++||++++|++
T Consensus       241 ~~~~---------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         241 RELE---------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ccCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1110                           11245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.6e-39  Score=280.63  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=203.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC----------------cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG----------------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~----------------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   74 (314)
                      .++|++++.||+|+||.||++.+...+                ..+++|.+...... .....+.+|+++++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999999866533                45799988755332 2234566899999999999999


Q ss_pred             eeeceeccCCeEEEEEecccc-cHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           75 ELIDAFPHKGNLHLVFEFMET-DLETVIRNTN----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        75 ~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      ++++++..++..++++|++.+ +|..++....          ..+++..++.++.|++.||++||++|++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            999999998999999999985 7887776543          25899999999999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh--CCCccCCCCcHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDID  219 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~  219 (314)
                      ++.++.++|+|||.+.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++  +..||......+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            9999999999999987653322  11223445677999998876 568999999999999999998  668887766666


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ........+.......                    .......++.++.+++.+||+.||++|||+.+|++
T Consensus       242 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDGRQI--------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccccccc--------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5555443321111000                    00112245789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-39  Score=280.82  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             HHHhhccceeeeCccccceEEEEEE-----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      ...++|.+.+.||+|++|.||++.+     ...+..+++|.+..... ......+.+|+++++++ +|+||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            3468999999999999999999975     23455799998865432 22234567899999999 79999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .+..+++|||+. |+|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999998 58888887543 3489999999999999999999999999999999999999999999999999975


Q ss_pred             eCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          161 FGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       161 ~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ......  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||................   ...   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~---  263 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---YRM---  263 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---CcC---
Confidence            533221  1112334677999998876 567899999999999999998 899987766555443333211   000   


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                          ......++++.+++.+||..+|++|||+.|++.
T Consensus       264 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 --------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                011234789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.1e-39  Score=277.38  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=202.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .+.|++.+.||+|++|.||++..+.+++   .+++|.+.... .......+..|+.+++.++||||+++.+++.++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            3568999999999999999999877664   59999986532 2223346778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|||++| +|.+++....+.+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999986 78778776666789999999999999999999999999999999999999999999999999875432211


Q ss_pred             c--ccccc---cCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          167 R--FTHQV---FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       167 ~--~~~~~---~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .  .....   .+..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+.......         
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------  231 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP---------  231 (269)
T ss_pred             ccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC---------
Confidence            1  11111   1346999999866 567899999999999999886 999998776665555443221100         


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                        ....++..+.+++.+||..+|++||++++++.
T Consensus       232 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         232 ------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              01245788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-39  Score=273.27  Aligned_cols=243  Identities=21%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~iv   89 (314)
                      .++|.+.+.||+|++|.||++...  |..+++|.+....    ....+.+|+.+++.++|++++++++++ ..++..+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            368999999999999999999654  7789999885432    233567899999999999999999865 556678999


Q ss_pred             Eecccc-cHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      +||+++ +|.+++..... .+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999985 88888876543 48899999999999999999999999999999999999999999999999987653322  


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.....    .            
T Consensus       157 -~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~------------  218 (256)
T cd05082         157 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----M------------  218 (256)
T ss_pred             -CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----C------------
Confidence             22233456999998866 567899999999999999997 8999877655554444432211    0            


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 ...+.+++.+.+++.+||+.+|++|||+.++++
T Consensus       219 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         219 -----------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       112345889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-39  Score=274.58  Aligned_cols=242  Identities=21%  Similarity=0.344  Sum_probs=192.5

Q ss_pred             eeCccccceEEEEEEC--CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           19 VLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      .||+|++|.||++...  ..+..+++|.+..... ......+.+|+.++++++|+||++++++++ ....++||||++| 
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            3899999999999765  3455799998865432 223345678999999999999999999875 4578999999985 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc---cccc
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQV  172 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~  172 (314)
                      +|.+.+......+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+..........   ....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            7888887666679999999999999999999999999999999999999999999999999997553332211   1122


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      ++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+.....    ..                
T Consensus       160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~----------------  218 (257)
T cd05115         160 WPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR----LD----------------  218 (257)
T ss_pred             CCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----CC----------------
Confidence            2467999998876 567899999999999999996 9999987766655544433211    11                


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                             .....++++.++|.+||..+|++||+..+|.+
T Consensus       219 -------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         219 -------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   11245889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.2e-39  Score=273.43  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             ccceeeeCccccceEEEEEECCCC----cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +++.+.||.|++|.||++.+...+    ..+++|.+....... ....+.+|++.++.++|+||+++++.+.+.+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            457889999999999999988766    889999986543221 334667899999999999999999999998999999


Q ss_pred             Eecccc-cHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||+++| ++.+.+...... +++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999985 888888765544 899999999999999999999999999999999999999999999999999876443221


Q ss_pred             cc-ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FT-HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~-~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .. ...+++.|+|||.+.+ ..++.++|+||||+++++|++ |.+||...........+.......              
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  224 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP--------------  224 (258)
T ss_pred             ccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--------------
Confidence            11 2235678999998855 668999999999999999998 788888766666555543321110              


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                   .....+.++.+++.+||..||++|||+.|+++
T Consensus       225 -------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      225 -------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                         11235889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=279.99  Aligned_cols=258  Identities=25%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCC--------------CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeee
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT--------------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL   76 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~--------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   76 (314)
                      .++|++.+.||+|++|.||++.+..+              ...+++|.+..... ......+.+|+++++.++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            46899999999999999999976532              23589999875422 2223356789999999999999999


Q ss_pred             eceeccCCeEEEEEecccc-cHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE
Q 021299           77 IDAFPHKGNLHLVFEFMET-DLETVIRNTN-----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI  144 (314)
Q Consensus        77 ~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~  144 (314)
                      ++++...+..+++|||+.| +|.+.+....           ..+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            9999999999999999985 7877775431           236788899999999999999999999999999999999


Q ss_pred             ecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh--CCCccCCCCcHHH
Q 021299          145 GSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQ  220 (314)
Q Consensus       145 ~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~~  220 (314)
                      +.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++|+||||+++++|++  +..||........
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            9999999999999875432211  1122334667999998876 568999999999999999988  5678877766665


Q ss_pred             HHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ...............                    .....+..++.+.+|+.+||+.||++|||+++|++
T Consensus       242 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQI--------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccc--------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            554433221110000                    00112235789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-39  Score=272.61  Aligned_cols=243  Identities=23%  Similarity=0.387  Sum_probs=196.2

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-c
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-D   96 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~   96 (314)
                      +.||+|++|.||++... ++..+++|.+...... .....+.+|+++++.++||||+++.+++...+..+++|||++| +
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46899999999999854 6789999988654322 2223566899999999999999999999999999999999985 8


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc-cccccCc
Q 021299           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-THQVFAR  175 (314)
Q Consensus        97 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~  175 (314)
                      |.+++......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.......... ....++.
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            888887666678999999999999999999999999999999999999999999999999987543221111 1123345


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      .|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+......                        
T Consensus       159 ~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------  213 (250)
T cd05085         159 KWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM------------------------  213 (250)
T ss_pred             cccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC------------------------
Confidence            6999999866 568899999999999999998 88999877666555444322110                        


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                         .....++..+.+++.+||..+|++||++.++++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         214 ---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               111245889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-39  Score=289.61  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||.||++.+...     +..|++|.+..... ......+.+|+++++++. ||||+++++++.+.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            46888999999999999999986432     34699999865432 222345778999999996 999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC----------------------------------------------------------
Q 021299           85 NLHLVFEFMET-DLETVIRNTN----------------------------------------------------------  105 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~----------------------------------------------------------  105 (314)
                      ..++||||+.| +|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999984 8877765321                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC
Q 021299          106 -------------------------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (314)
Q Consensus       106 -------------------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~  148 (314)
                                                           ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence                                                 2377788899999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHH
Q 021299          149 QLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIF  225 (314)
Q Consensus       149 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~  225 (314)
                      .++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.............
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            999999999976533221  1222345677999999876 667999999999999999997 888887654333322221


Q ss_pred             HhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ...   ...                       .....++.++.+++.+||+.||++||++.+|.+
T Consensus       354 ~~~---~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 KSG---YRM-----------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hcC---CCC-----------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            110   000                       011245889999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.3e-39  Score=281.68  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             HhhccceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|.+.+.||+|++|.||++.+..       ....+++|.+...... .....+.+|+++++.+ .||||+++++++..
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            4799999999999999999997532       3457899987654322 2233566899999999 59999999999998


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ++..+++|||+.+ +|.+++....               ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence            8999999999985 8888886532               34788899999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999765322111  111223456999999876 668899999999999999998 8889987766555554


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      +......                           .....++.++.+++.+||..+|++|||+.++++
T Consensus       249 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         249 LREGHRM---------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4322100                           011245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.9e-39  Score=279.66  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=197.0

Q ss_pred             hccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +|++.+.||+|+||.||++.+..     ....+++|.+...... .....+.+|+.+++.++||||+++++.+..++..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47889999999999999998653     2246888877644322 12235668999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           88 LVFEFMET-DLETVIRNT-----------------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      +++||+.+ +|.+++...                       ...+++..++.++.|++.||.+||+++++|+||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            99999984 787776532                       124788999999999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ  220 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~  220 (314)
                      ++.++.++|+|||.+........  ......++..|+|||.+.+ ..++.++||||||+++++|++ |..||....+...
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999975432221  1122334567999998866 668899999999999999998 9999987766655


Q ss_pred             HHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ...........                           ....++.++.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRME---------------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhCCCCCC---------------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            54433221110                           11235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-39  Score=277.20  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             Hhhc-cceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--C
Q 021299           11 ADRY-LKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--K   83 (314)
Q Consensus        11 ~~~y-~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   83 (314)
                      .+|| ++.+.||+|++|+||++.    ...++..+++|.+..... ......+.+|+++++.++||||+++.+++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4677 999999999999998864    334677899999875432 1233456789999999999999999998754  4


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ...+++|||+.+ +|.+.+...  .+++..++.++.|++.|+.+||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            468999999985 777777654  48999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCCc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          163 SPDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       163 ~~~~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .....   .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.......  ..+.....    ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~----~~~~~~  231 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQ----GQMTVV  231 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccc----cccchh
Confidence            32211   112234566999998876 567899999999999999999998886543211  11111000    000000


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                          ......  ......+.....+.++.+++.+||..+|++|||++++++
T Consensus       232 ----~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 ----RLIELL--ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ----hhhhhh--hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                000000  000011123456899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-39  Score=276.05  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|.+.+.||+|++|+||++..+.+|.    .+++|.+..... ......+.+|+.+++.++|+|++++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4789999999999999999998776654    588888765533 2223456689999999999999999998876 788


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++||+. |+|.+.+......+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999997 58888888776679999999999999999999999999999999999999999999999999997654322


Q ss_pred             Ccc--cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 RRF--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~~~--~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ...  ....++..|+|||.+.. ..++.++|+||||++++++++ |..||......+....+........          
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  232 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ----------  232 (279)
T ss_pred             cceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC----------
Confidence            111  11223456999998865 667899999999999999998 9999988766555544432211100          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ....+..+.+++.+||..||.+||++.++++
T Consensus       233 -----------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         233 -----------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                             1124778999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=286.56  Aligned_cols=264  Identities=27%  Similarity=0.373  Sum_probs=219.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+.|+..++||.|+||.||-++.+.+|+.||.|++.+.... .....-..+|-.++..++.+.||.+--.|+..+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            57789999999999999999999999999999998766432 22333456899999999999999999999999999999


Q ss_pred             EecccccHHHHH-HhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMETDLETVI-RNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g~l~~~~-~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      +..|+|+-+.+- .+. .+.+++..+.-++.+|+.||.+||..+|++||+||+|||+|+.|.++|+|+|+|..+......
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            999997444333 332 357999999999999999999999999999999999999999999999999999987544433


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                       .+.+||..|||||++.+ ..|+...|.|||||++|+|+.|..||..........++-+...+.+. .+           
T Consensus       344 -~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~-ey-----------  409 (591)
T KOG0986|consen  344 -RGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE-EY-----------  409 (591)
T ss_pred             -ccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-hc-----------
Confidence             34489999999999988 45999999999999999999999999876655555444433322221 11           


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccCcc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFNGV  300 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~~~  300 (314)
                                  ....|+++++|.+.+|++||.+|..     +.++.+||||+.++=+
T Consensus       410 ------------~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  410 ------------SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             ------------ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence                        2346999999999999999999976     4689999999998733

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.1e-39  Score=278.41  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             HhhccceeeeCccccceEEEEEECC----------------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK----------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   74 (314)
                      .++|++.+.||+|++|.||++.+..                ++..+++|.+..... ......+.+|+++++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence            5789999999999999999985432                344689998865422 22234567899999999999999


Q ss_pred             eeeceeccCCeEEEEEecccc-cHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           75 ELIDAFPHKGNLHLVFEFMET-DLETVIRNTN----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        75 ~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      ++++++..++..+++|||+.+ +|.+++....          ..+++..+..++.|++.|+++||++|++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            999999999999999999985 8888876532          23677889999999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh--CCCccCCCCcHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDID  219 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~--g~~pf~~~~~~~  219 (314)
                      ++.++.++|+|||.+........  ......++..|++||...+ ..++.++|+||||+++|+|++  |..||......+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999875532221  1122233567999998766 568999999999999999998  668887766555


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ........+......                    ...+....+++.+.+|+.+||+.||++||++.+|++
T Consensus       242 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQ--------------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhcccc--------------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            544332221110000                    000111245789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-39  Score=279.78  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=201.3

Q ss_pred             HHhhccceeeeCccccceEEEEEEC-------CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceec
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP   81 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   81 (314)
                      ..++|.+.+.||+|++|.||.+++.       ..+..+++|.+..... ......+.+|+.+++.+ +||||+++++++.
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            3689999999999999999999742       2345789998864322 22234567899999999 7999999999999


Q ss_pred             cCCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe
Q 021299           82 HKGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (314)
Q Consensus        82 ~~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~  145 (314)
                      .....+++|||+.+ +|.+++....               ..++...+..++.||+.||.|||++|++|+||||+||+++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            99999999999985 8888886532               2477888999999999999999999999999999999999


Q ss_pred             cCCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHH
Q 021299          146 SHGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (314)
Q Consensus       146 ~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~  222 (314)
                      .++.++|+|||.+.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+...
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            9999999999999866432221  112234567999999876 568899999999999999998 778887776555554


Q ss_pred             HHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .+......                           .....++.++.+|+.+||..+|++|||+.++++.
T Consensus       251 ~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         251 LLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            44222100                           0012458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-39  Score=277.83  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|++|.||++.+..     ++..+++|.+..... ......+.+|+.++++++|||++++.+++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4789999999999999999998743     567899998864332 2223456789999999999999999999999899


Q ss_pred             EEEEEecccc-cHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           86 LHLVFEFMET-DLETVIRNTN---------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      .++++||+++ +|.+++....                     ..+++..++.++.|++.||.+||+++++|+||+|+||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            9999999985 8888886432                     24778889999999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ  220 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~  220 (314)
                      ++.++.++|+|||.+........  .......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999876432211  1222334566999998866 568999999999999999997 7788876665555


Q ss_pred             HHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ...+......                           .....++.++.+|+.+||+.||.+|||++|++.
T Consensus       242 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         242 IYYVRDGNVL---------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4443221100                           011235789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.9e-39  Score=273.70  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=200.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|.+.+.||+|++|.||++.+...   ...+++|....... ......+.+|+++++.+.||||+++++++.+ ...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            46799999999999999999986543   34688998865432 2233466789999999999999999998865 4568


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++|||+. |+|.+++......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            9999998 488888876665689999999999999999999999999999999999999999999999999976533321


Q ss_pred             c-ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 R-FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~-~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      . .....++..|+|||.+.. ..++.++|+||||++++++++ |..||......+....+......              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--------------  227 (270)
T cd05056         163 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--------------  227 (270)
T ss_pred             eecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------------
Confidence            1 112223456999998865 567899999999999999986 99999887766655544322111              


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                   .....+++++.++|.+|+..+|++|||+.+++..
T Consensus       228 -------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 -------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         1123458899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-39  Score=278.03  Aligned_cols=261  Identities=24%  Similarity=0.396  Sum_probs=203.2

Q ss_pred             hccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcc--cCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   86 (314)
                      +|.+.+.||+|++|.||++.+.   .++..+++|.+......  ......+.+|++++.++ +|++|+++.+.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999754   35678999998754321  12223456899999999 599999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++||||+.| +|.+.+... ..+++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999986 777776544 458899999999999999999999999999999999999999999999999987653322


Q ss_pred             C-cccccccCccccCcccccCcc-CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 R-RFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 ~-~~~~~~~~~~y~sPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . ......++..|++||.+.+.. ..+.++|+||||+++++|++|..||...........+........           
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  228 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-----------  228 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-----------
Confidence            1 122235678899999986532 368899999999999999999999965432222222211111100           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~  298 (314)
                                   ......++..+.+++.+||+.||++|||   +.++++||||+.++
T Consensus       229 -------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         229 -------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             -------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence                         0112245888999999999999999998   56789999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.9e-39  Score=284.05  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=194.8

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc-C
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~   83 (314)
                      .++|++.+.||+|+||.||+|.+.     .+++.|++|.++..... .....+.+|+.++.++ +|+||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            479999999999999999999743     45678999998754322 2233566899999999 68999999997754 4


Q ss_pred             CeEEEEEecccc-cHHHHHHhCC---------------------------------------------------------
Q 021299           84 GNLHLVFEFMET-DLETVIRNTN---------------------------------------------------------  105 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~---------------------------------------------------------  105 (314)
                      ...+++|||++| +|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567899999985 8887775421                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--cccccccC
Q 021299          106 ---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFA  174 (314)
Q Consensus       106 ---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~  174 (314)
                               ..+++..+..++.|++.||+|||++|++|+||||.||+++.++.++|+|||.+........  ......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                     2367788889999999999999999999999999999999999999999999876432211  11223345


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++ |..||................   .....                 
T Consensus       245 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~-----------------  303 (343)
T cd05103         245 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---TRMRA-----------------  303 (343)
T ss_pred             cceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc---CCCCC-----------------
Confidence            67999999876 567899999999999999996 888987654433222221110   00000                 


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                            ....++++.+++.+||+.||.+|||+.+|++|
T Consensus       304 ------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         304 ------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  11247789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.2e-39  Score=273.16  Aligned_cols=239  Identities=20%  Similarity=0.286  Sum_probs=186.6

Q ss_pred             eeeCccccceEEEEEECCC------------CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           18 EVLGEGTYGVVYKAIDTKT------------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      +.||.|++|.||++.....            ...+++|.+....  ......+.+++.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4689999999999974321            2358888876532  2233356688999999999999999999988888


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc-------EEEeeccc
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-------LKLADFGL  157 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-------~~l~df~~  157 (314)
                      .+++|||+++ ++..++......+++..+..++.||+.||+|||++|++|+||+|+||+++.++.       ++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            9999999996 566666555667999999999999999999999999999999999999987664       89999998


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      +......    ....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+.. .....   ..    
T Consensus       159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---~~----  226 (262)
T cd05077         159 PITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---QC----  226 (262)
T ss_pred             CccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---Cc----
Confidence            8654321    23456778999998875567899999999999999997 577887665433321 11111   00    


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                           ......++++.+||.+||+.||++||+..+|+++
T Consensus       227 ---------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 ---------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ---------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                 0011236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.1e-39  Score=281.96  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=199.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-------CcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      ..+|++.+.||+|+||.||++.+...       +..+++|.+...... .....+.+|+++++++ +|+||+++++++..
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            46899999999999999999975432       236899987643222 2234567899999999 79999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ++..++++||+++ +|.+++....               ..++...+..++.|++.||++||++|++|+||+|+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            9999999999985 8888886532               24778888999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999765432211  112233456999999876 667899999999999999998 7889987665555444


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                      +......                           ......+.++.+++.+||..+|++||++.+++++-
T Consensus       249 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         249 LKEGHRM---------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            4321110                           01124578999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-38  Score=272.36  Aligned_cols=251  Identities=27%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             hccceeeeCccccceEEEEEECC-CCcEEEEEEeecCCccc--------CcchhhHHHHHHHhh-cCCCCeeeeeceecc
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKE--------GVNFTALREIKLLKE-LKSPHIIELIDAFPH   82 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~--------~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   82 (314)
                      .|++.+.||+|++|.||++.+.. .++.+++|.+.......        .....+.+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999887 67899999886543211        112234567777764 789999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           83 KGNLHLVFEFMET-DLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      ++..+++|||+.| ++.+.+.   .....+++..++.++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999986 7777664   344568999999999999999999996 7899999999999999999999999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|.+||...........+........+    
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  234 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP----  234 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC----
Confidence            98764433 3345567888999999976 56799999999999999999999999877666655554432211110    


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                            ....++++.++|.+||+.||++||++.|+.++
T Consensus       235 ----------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         235 ----------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ----------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                  11347899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-38  Score=270.56  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=197.9

Q ss_pred             eeeCccccceEEEEEECC-CCc--EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           18 EVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~-~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      +.||+|++|.||++.+.. ++.  .+++|.+...... .....+.+|++.+++++|+||+++++.+.. ...++++|+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998765 333  6899998776554 334467789999999999999999999887 88999999997


Q ss_pred             -ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc---cc
Q 021299           95 -TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FT  169 (314)
Q Consensus        95 -g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~  169 (314)
                       |+|.+.+.... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence             58888887655 56899999999999999999999999999999999999999999999999999876432211   11


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...++..|+|||.+.+ ..++.++|+||||+++++|++ |..||......+....+....     ..+            
T Consensus       159 ~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~------------  220 (257)
T cd05040         159 HLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERL------------  220 (257)
T ss_pred             CCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CcC------------
Confidence            2345667999998866 567899999999999999998 999998776666555543211     000            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                               ......+..+.+++.+||+.+|++||++.++++
T Consensus       221 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                     011234789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-39  Score=276.47  Aligned_cols=266  Identities=21%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             hhccceeeeCccccceEEEEEE----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--Ce
Q 021299           12 DRYLKREVLGEGTYGVVYKAID----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   85 (314)
                      .-|++++.||+|++|.||+++.    ..++..+++|.+..... ......+.+|+++++.+.|||++++.+++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            3468999999999999999974    45678999999865432 22334677899999999999999999988664  57


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .+++|||++| +|.+++......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            8999999975 888888766556899999999999999999999999999999999999999999999999999765432


Q ss_pred             CCc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 DRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ~~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ...   .....++..|+|||.+.+ ..++.++|+||||+++|+|+++..|+.....  ....   ..+..... ..    
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~---~~~~~~~~-~~----  231 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLK---MIGPTHGQ-MT----  231 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhhh---hccccccc-cc----
Confidence            211   122345667999998866 5678999999999999999998765433211  0000   00000000 00    


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .......  .......+....++..+.+|+.+||+.+|++||++++++++
T Consensus       232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         232 VTRLVRV--LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHH--HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0000000  00000111234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=274.60  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=199.1

Q ss_pred             HhhccceeeeCccccceEEEEEECC----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc-CCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   85 (314)
                      .++|++.+.||+|++|.||++.+..    ++..+++|.+.... .......+.+|+.+++.++|+|++++++++.. +..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            5899999999999999999998776    25788888876432 22223456689999999999999999997644 567


Q ss_pred             EEEEEeccc-ccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           86 LHLVFEFME-TDLETVIRNTN-------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      .++++++++ |+|..++....       ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            899999998 58888775432       4589999999999999999999999999999999999999999999999999


Q ss_pred             eeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          158 ARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ++........  .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||......+....+......    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----  238 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL----  238 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC----
Confidence            9754322211  112234566999998876 568999999999999999998 99999877665554443322110    


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .                       ....+++++.+++.+||..||++|||+.++++
T Consensus       239 ~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 A-----------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C-----------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                       01235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-38  Score=269.50  Aligned_cols=242  Identities=24%  Similarity=0.403  Sum_probs=196.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||.+.  .+++.+++|.+....    ....+.+|+.+++.++|||++++.+++..+ ..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            3789999999999999999985  567889999986432    223567899999999999999999988654 468999


Q ss_pred             ecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||+.| +|.+.+.... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---V  154 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---C
Confidence            99985 8888887543 35899999999999999999999999999999999999999999999999998764321   1


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+....+.......                
T Consensus       155 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  217 (254)
T cd05083         155 DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME----------------  217 (254)
T ss_pred             CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC----------------
Confidence            22233566999998865 567899999999999999997 899998776655544433221100                


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 ....++.++.+++.+||..+|++||+++++++
T Consensus       218 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         218 -----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       01245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-38  Score=273.52  Aligned_cols=265  Identities=21%  Similarity=0.339  Sum_probs=195.1

Q ss_pred             hhccceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--cCCe
Q 021299           12 DRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~   85 (314)
                      ++|++.+.||+|++|.||++.    +..++..+++|.+.....  .....+.+|+++++.++||||+++.+++.  +...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            578999999999999999997    345688999999865432  22335668999999999999999998753  3457


Q ss_pred             EEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .++++||++ |+|.+++......+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            899999997 5898888776667999999999999999999999999999999999999999999999999999865332


Q ss_pred             CCcc---cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 DRRF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ~~~~---~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....   ....++..|+|||.+.+ ..++.++|+||||+++++|++|..++...... .... ..   .......    .
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~-~~---~~~~~~~----~  231 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM-MG---NDKQGQM----I  231 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh-cc---ccccccc----c
Confidence            2111   11123445999999866 56789999999999999999988765433211 1000 00   0000000    0


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .....+  ........+....++.++.+|+.+||..+|++|||+.+++.
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         232 VYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hHHHHH--HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000000  00000011122456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-38  Score=269.62  Aligned_cols=248  Identities=20%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|++|.||++.+. .+..+++|.+.....   ....+.+|+++++.++|+||+++.+.+.. ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            3689999999999999999999754 456799998764322   23456789999999999999999999877 778999


Q ss_pred             Eeccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      |||++ |++.+++... ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99997 5898888764 44578889999999999999999999999999999999999999999999999976533211 


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ......++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+......               
T Consensus       159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------------  222 (260)
T ss_pred             cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---------------
Confidence            1122334566999999876 567889999999999999998 89999877666555544322111               


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  +.....+.++.+++.+||+.+|++||++.++++
T Consensus       223 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                        011245889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=290.25  Aligned_cols=241  Identities=24%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +....++.||+|+.|.||+++  ..++.||||+.+-..         ..+++.|++|+|+||+.+.++|....-+|||||
T Consensus       124 e~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGR--LHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             HHhhhhhhhccCcccceeeee--ccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            445668899999999999995  457899999975221         268999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||. |-|...++ .+..+.......|..+|+.|+.|||.+.|+|+|||.-||||..+..|||+|||.++..... .....
T Consensus       193 fCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  193 FCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             ccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            998 56666555 4456899999999999999999999999999999999999999999999999999876433 55567


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..||..|||||++.. .+.+.|.||||+||+||+|+||..|+++.+..-+    +-+.+.....                
T Consensus       271 FaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGsNsL~----------------  329 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGSNSLH----------------  329 (904)
T ss_pred             hhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccCCccc----------------
Confidence            789999999999988 7889999999999999999999999976542221    1111111110                


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                            -+....+++-++-||++||...|+.||+..++|.|-
T Consensus       330 ------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  330 ------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             ------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence                  011235688899999999999999999999999883

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=273.68  Aligned_cols=238  Identities=19%  Similarity=0.254  Sum_probs=185.8

Q ss_pred             eeCccccceEEEEEECC------------------------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee
Q 021299           19 VLGEGTYGVVYKAIDTK------------------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~------------------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   74 (314)
                      .||+|+||.||++....                        ....+++|.+.....  .....+.+++.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            69999999999986422                        123588888764322  2234566889999999999999


Q ss_pred             eeeceeccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-----
Q 021299           75 ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----  148 (314)
Q Consensus        75 ~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-----  148 (314)
                      ++++++.++...++||||++| +|...+....+.+++..+..++.|++.||+|||++|++|+||||+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999996 66666666566789999999999999999999999999999999999997654     


Q ss_pred             --cEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHH
Q 021299          149 --QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIF  225 (314)
Q Consensus       149 --~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~  225 (314)
                        .++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||......+.... .
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~  234 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-Y  234 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-H
Confidence              3899999987543221    12345677999999876566899999999999999985 78899977655443222 1


Q ss_pred             HhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .... .                           .....++.+.++|.+||+.+|++|||+++++++
T Consensus       235 ~~~~-~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EKKH-R---------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             Hhcc-C---------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1100 0                           011235689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=275.41  Aligned_cols=267  Identities=13%  Similarity=0.158  Sum_probs=195.8

Q ss_pred             CccccccHHHHhhccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcc---------hhhHHHHHHHhhc
Q 021299            1 MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVN---------FTALREIKLLKEL   68 (314)
Q Consensus         1 ~~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l   68 (314)
                      |...-+.+...++|.+.+.||+|+||+||++.+..+   +..+++|............         .....++..+..+
T Consensus         1 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~   80 (294)
T PHA02882          1 MEGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI   80 (294)
T ss_pred             CCCeeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC
Confidence            667777888889999999999999999999998776   5667777644332211110         0111334455667


Q ss_pred             CCCCeeeeeceeccCC----eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE
Q 021299           69 KSPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI  144 (314)
Q Consensus        69 ~~~~i~~~~~~~~~~~----~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~  144 (314)
                      .|++++.+++......    ..+++++++..++.+.+... ...++..+..++.|++.||+|||+++++|+||||+||++
T Consensus        81 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill  159 (294)
T PHA02882         81 DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV  159 (294)
T ss_pred             CCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            8999999998653322    45788888887777666543 236788899999999999999999999999999999999


Q ss_pred             ecCCcEEEeeccceeeeCCCC-------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc
Q 021299          145 GSHGQLKLADFGLARIFGSPD-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (314)
Q Consensus       145 ~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~  217 (314)
                      +.++.++|+|||++.......       .......||+.|+|||.+.+ ..++.++||||||+++++|++|..||.....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999998663221       11122468999999998876 6689999999999999999999999987643


Q ss_pred             -HHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          218 -IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                       ..........+.......                     ....+..+.++.+++..|+..+|++||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHEG---------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             chHHHHHhHHHHHHHhhhh---------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             222221111100000000                     0011245789999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-38  Score=276.54  Aligned_cols=251  Identities=21%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|+..+.||+|++|.||++.+..+|.    .+++|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            4788999999999999999999877775    468887754322 22223566899999999999999999988654 46


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++++++ |++.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            78999998 58888888766678999999999999999999999999999999999999999999999999998654322


Q ss_pred             C--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  ......++..|++||.+.+ ..++.++||||||+++|+|++ |..||...........+... .. .+         
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-~~---------  231 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ER-LP---------  231 (303)
T ss_pred             cccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CC-CC---------
Confidence            2  1122334567999998866 668999999999999999997 88898765543333222211 00 00         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                      ..+..+..+.+++.+|+..+|++||+++++++.
T Consensus       232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 ----------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            012347789999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-38  Score=283.63  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=199.9

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   84 (314)
                      .++|.+.+.||+|+||.||++.+.     .++..|++|++....... ....+.+|++++..+. ||||+++++++..++
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-EKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            478899999999999999999853     345689999997543222 2335678999999997 999999999999999


Q ss_pred             eEEEEEeccc-ccHHHHHHhCC----------------------------------------------------------
Q 021299           85 NLHLVFEFME-TDLETVIRNTN----------------------------------------------------------  105 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~~----------------------------------------------------------  105 (314)
                      ..++|+||+. |+|.+++...+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999998 48888875431                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299          106 ---------------------------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus       106 ---------------------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                                                             ..+++..+..++.|++.||+|||+.+++|+||||+||+++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE  274 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence                                                   13566778899999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            99999999999976432211  1122345677999999876 567899999999999999998 8889876655444433


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ....-.  .+                        .....++.++.+|+.+||..+|++||++.+|+..
T Consensus       354 ~~~~~~--~~------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIKRGY--RM------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHcCC--CC------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            322100  00                        0112458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=288.15  Aligned_cols=243  Identities=26%  Similarity=0.429  Sum_probs=200.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ..++|.....+|.|+|+.|-.+.+..+++.+++|.+........      +|+.++... +|||+++..+.+.++.+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~------~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQ------DEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccc------cccchhhhhcCCCcceeecceecCCceeee
Confidence            56889999999999999999999999999999999987632222      455444444 79999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE-ecCCcEEEeeccceeeeCCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~-~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      |||.+.| .+++.+....  .....+..|+.+|+.|+.|||.+|++||||||+|||+ +..+.++|+|||.+......  
T Consensus       394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999997 4555554443  2237788999999999999999999999999999999 58889999999999876443  


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       ......|..|.|||++.. ..++.++|+||||++||+|++|..||...... ++..++..+    .             
T Consensus       470 -~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~-------------  530 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----K-------------  530 (612)
T ss_pred             -hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----c-------------
Confidence             334456777999999985 77999999999999999999999999776555 333332111    1             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                   +...+|+++++||++||+.||.+|+++.+++.||||
T Consensus       531 -------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 -------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                         113579999999999999999999999999999999

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-38  Score=269.38  Aligned_cols=245  Identities=22%  Similarity=0.319  Sum_probs=189.2

Q ss_pred             eeeCccccceEEEEEECC---CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec-cCCeEEEEEecc
Q 021299           18 EVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLVFEFM   93 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~   93 (314)
                      +.||+|++|.||++....   .+..+++|.+..... ......+.+|+.+++.++|||++++++++. .++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998543   345799998753221 122335668999999999999999999764 566788999999


Q ss_pred             c-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC----cc
Q 021299           94 E-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RF  168 (314)
Q Consensus        94 ~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~----~~  168 (314)
                      . |+|.+++.......++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+........    ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            8 588888876655677888899999999999999999999999999999999999999999999875432211    11


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++| .+||......+....+......                 
T Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  221 (262)
T cd05058         160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-----------------  221 (262)
T ss_pred             ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence            23344667999998876 5688999999999999999995 5777766555544443222100                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                .....+++.+.+++.+||..+|++||++.+++..
T Consensus       222 ----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         222 ----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                      0012347889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-38  Score=271.38  Aligned_cols=243  Identities=26%  Similarity=0.382  Sum_probs=190.0

Q ss_pred             eeeCccccceEEEEEECCCCc--EEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEEeccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      +.||+|++|.||++.++.++.  .+++|.+..... ......+.+|++++.++ .||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            468999999999999887775  457777763321 12223566899999999 79999999999999999999999998


Q ss_pred             -ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           95 -TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        95 -g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                       |+|.+++....               ..+++..+..++.|++.|+++||++|++|+||||+||+++.++.++|+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence             58888886432               24789999999999999999999999999999999999999999999999998


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ...... ........+..|+|||.+.. ..++.++|+||||+++++|++ |..||......+....+....    ..   
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----~~---  230 (270)
T cd05047         160 RGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----RL---  230 (270)
T ss_pred             cccchh-hhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----CC---
Confidence            532111 11111223556999998865 668899999999999999996 999997765554444332110    00   


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                          .....++.++.+++.+||..+|.+|||+.+++.
T Consensus       231 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 --------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                011235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-39  Score=273.59  Aligned_cols=239  Identities=16%  Similarity=0.243  Sum_probs=188.8

Q ss_pred             eeeCccccceEEEEEECCCCc-------EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQ-------TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~-------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +.||+|+||.||++.+...+.       .+++|.+....  ......+.+|+.+++.++|||++++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999998765443       47888775432  122335668999999999999999999998888999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc--------EEEeeccceeee
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--------LKLADFGLARIF  161 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--------~~l~df~~~~~~  161 (314)
                      ||+++ +|.+++...+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.        ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            99985 788888776667899999999999999999999999999999999999987764        699999988654


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ...    ....++..|+|||.+.+...++.++|+||||+++|+|++|. +||...+........ .. .    .      
T Consensus       159 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~-~----~------  222 (258)
T cd05078         159 LPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED-R----H------  222 (258)
T ss_pred             CCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc-c----c------
Confidence            321    22456777999999976556789999999999999999995 666655544332221 11 0    0      


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                       ......+.++.+|+.+||+.||++|||++++++.
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         223 -----------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                             0112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-38  Score=269.33  Aligned_cols=236  Identities=19%  Similarity=0.259  Sum_probs=186.9

Q ss_pred             eeeCccccceEEEEEECCCC----------cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           18 EVLGEGTYGVVYKAIDTKTG----------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +.||+|++|.||++.+..++          ..+++|.+......   ...+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999987766          35777776544322   4567789999999999999999998877 7789


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-------cEEEeecccee
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-------QLKLADFGLAR  159 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-------~~~l~df~~~~  159 (314)
                      ++|||+.+ +|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|||.+.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999985 77777766555789999999999999999999999999999999999999887       79999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ....    .....++..|+|||.+.+. ..++.++|+||||+++++|++ |..||..............    ...  . 
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~~--~-  225 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QHR--L-  225 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CCC--C-
Confidence            6543    2233455679999998774 468999999999999999998 4677766543322221110    000  0 


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                            .......+.+++.+||..+|++|||+.++++
T Consensus       226 ----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 ----------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ----------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                  0011378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=279.16  Aligned_cols=264  Identities=25%  Similarity=0.407  Sum_probs=200.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-eE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~   86 (314)
                      ....+.|.....||+|+||.||++.-. +|..+|||.+.......  ..++.+|+.++.+++|||+++++|||.+.+ ..
T Consensus        71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   71 RKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            344688999999999999999999754 44899999776654432  446889999999999999999999998888 59


Q ss_pred             EEEEeccc-ccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           87 HLVFEFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKW---VLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~---i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      .+|+||+. |+|.+.+..... .++|....+|+.++|+||+|||...   |+|+|||++|||+|++..+||+|||+|...
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            99999998 799999887766 8999999999999999999999853   999999999999999999999999999654


Q ss_pred             CCCCCccccc-ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC---cHHHHHHHHHhhCCCCCCCCC
Q 021299          162 GSPDRRFTHQ-VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       162 ~~~~~~~~~~-~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      .......... .||..|++||.... ...+.++||||+|++|+|+++|+.+.....   ......-............+ 
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei-  305 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI-  305 (361)
T ss_pred             CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe-
Confidence            3312221222 78999999999977 678999999999999999999997776532   11111111111111111111 


Q ss_pred             CcCcccchhhhccccCCCCC-ccCC--CCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLR-SLFP--SASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                    ..+.+. ..+.  ..-..+..+..+|++.+|.+||+..||+.
T Consensus       306 --------------iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 --------------VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             --------------eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                          111111 0000  01223678889999999999999999753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-38  Score=269.92  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=189.8

Q ss_pred             eeeCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||.||++....  ....+++|.+.... .......+.+|+..++.++|+||+++++.+......+++|||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            368999999999996432  34568888765432 222234566899999999999999999999999999999999985


Q ss_pred             -cHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--Ccc
Q 021299           96 -DLETVIRNTNI----FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRF  168 (314)
Q Consensus        96 -~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~  168 (314)
                       +|.+.+.....    ..++..+..++.||+.|++|||++|++|+||||+||+++.++.++|+|||.+.......  ...
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence             88888765432    34677889999999999999999999999999999999999999999999986532221  111


Q ss_pred             cccccCccccCcccccC------ccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          169 THQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~------~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....+++.|+|||.+..      ...++.++|+||||+++|+|++ |..||......+.............+.       
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-------  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-------
Confidence            22344567999998743      2356889999999999999998 778998777666555544332211111       


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     ......+++.+.+++..|+ .||++|||+++|++
T Consensus       233 ---------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 ---------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                           1112346888999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.8e-38  Score=270.47  Aligned_cols=252  Identities=19%  Similarity=0.312  Sum_probs=201.0

Q ss_pred             hhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ++|++.+.||.|+||.||+++.+.     +.+.+++|.+..... ......+.+|+++++.++|+|++++++++.+....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            789999999999999999998654     345788888754322 22334677899999999999999999999998999


Q ss_pred             EEEEeccc-ccHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           87 HLVFEFME-TDLETVIRNTN--------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      +++|||++ |+|.+.+....        ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++++|||.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999998 58888876543        1589999999999999999999999999999999999999999999999999


Q ss_pred             eeeeCCC-CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          158 ARIFGSP-DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      +...... ........++..|+|||.+.+ ..++.++|+||||+++|++++ |..||..................     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-----  237 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----  237 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-----
Confidence            8644222 112223345667999998866 457889999999999999998 77898766555544443322110     


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +                     .....++..+.+++.+||+.+|++||++.|++..
T Consensus       238 ~---------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 L---------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C---------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            0                     0112458899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=286.51  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=208.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCc---E-EEEEEeecCC-cccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQ---T-VAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~---~-~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +-.+.+.||+|+||.||++..+..+.   . ||+|...... .......++++|+++++.++||||++++|+...+..++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44566899999999999998665432   3 8899887632 44455567889999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +|||+|.| +|.+++++..+.++......++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++........
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence            99999985 99999998887899999999999999999999999999999999999999999999999999875432222


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHH-hhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA-AFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (314)
                      .....--+..|+|||.+.. ..++.++||||+||++||+++ |..|+.+....+....+.. +.....+.          
T Consensus       318 ~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~----------  386 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS----------  386 (474)
T ss_pred             ccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC----------
Confidence            2212334567999999988 589999999999999999986 7889999999999888844 32222222          


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                                       ..+.++..++.+|+..+|++||+..++.
T Consensus       387 -----------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  387 -----------------KTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             -----------------CCHHHHHHHHHHhccCChhhccCHHHHH
Confidence                             3488899999999999999999998865

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-38  Score=270.85  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=192.8

Q ss_pred             eeeCccccceEEEEEECCCC------cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           18 EVLGEGTYGVVYKAIDTKTG------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +.||+|++|.||++.++..+      ..+++|.+..... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999876433      6799998764322 2233466789999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-----cEEEeecccee
Q 021299           92 FMET-DLETVIRNT------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----QLKLADFGLAR  159 (314)
Q Consensus        92 ~~~g-~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-----~~~l~df~~~~  159 (314)
                      |++| +|.+.+...      ...+++..+..++.|++.|++|||+++++|+||+|+||+++.++     .++|+|||.+.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9985 888888642      23478899999999999999999999999999999999999887     89999999987


Q ss_pred             eeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          160 IFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       160 ~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      .......  ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....    .   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~---  231 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----R---  231 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----c---
Confidence            5432211  1122334567999999876 567999999999999999998 999998766555444332110    0   


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                          ......++..+.++|.+||..+|.+||++.++++
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 --------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                0111245889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.4e-38  Score=267.88  Aligned_cols=249  Identities=20%  Similarity=0.264  Sum_probs=189.5

Q ss_pred             eeeCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc-
Q 021299           18 EVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-   94 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-   94 (314)
                      +.||+|+||.||++....  ++..+++|.+...... .....+.+|+.+++.++||||+++++++.+....++||||++ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            468999999999997543  4567999988655432 222356789999999999999999999998889999999998 


Q ss_pred             ccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--cc
Q 021299           95 TDLETVIRNTN----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RF  168 (314)
Q Consensus        95 g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~~  168 (314)
                      |+|.+++....    ...++..+..++.|++.|++|||++|++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            58888876432    2456778889999999999999999999999999999999999999999999865432211  11


Q ss_pred             cccccCccccCcccccCc------cCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          169 THQVFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~------~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....++..|+|||.+.+.      ..++.++|+||||+++|+|++ |..||......+.............+.       
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  232 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK-------  232 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC-------
Confidence            233456779999988542      135789999999999999996 999998766555433322211110100       


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     .......++.+.+++.+|+ .+|++|||+++|+.
T Consensus       233 ---------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         233 ---------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ---------------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                           1111235788999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-38  Score=271.52  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=198.5

Q ss_pred             hhccceeeeCccccceEEEEEECC----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--CCe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   85 (314)
                      +.|++.+.||+|++|.||++....    ++..+++|.+...... .....+.+|+++++.+.|+||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            578899999999999999998543    4789999999765443 234467789999999999999999998866  557


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .+++|||+++ ++.+.+......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            8999999975 888888776667999999999999999999999999999999999999999999999999999876432


Q ss_pred             CCcc---cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH-----------HHHHHHhhCC
Q 021299          165 DRRF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-----------LGKIFAAFGT  230 (314)
Q Consensus       165 ~~~~---~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~-----------~~~~~~~~~~  230 (314)
                      ....   ....++..|++||.+.+ ..++.++|+||||+++++|++|..|+........           ...+......
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211   12233456999998866 5678999999999999999999988755322110           0001000000


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                             ....+.....+.++.+++.+||..+|++|||+.|+++
T Consensus       242 -----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 -----------------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -----------------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                   0001112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-38  Score=267.59  Aligned_cols=228  Identities=23%  Similarity=0.315  Sum_probs=183.6

Q ss_pred             cccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cHHHHH
Q 021299           23 GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVI  101 (314)
Q Consensus        23 g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~  101 (314)
                      |.+|.||++.++.+++.+++|.+.....       ..++...+....|||++++++++.+....+++|||++| +|.+.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            7899999999999999999999976432       12344445556799999999999999999999999985 788877


Q ss_pred             HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcc
Q 021299          102 RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE  181 (314)
Q Consensus       102 ~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE  181 (314)
                      .... .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++++|||.+.......   ....++..|+|||
T Consensus        77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE  152 (237)
T cd05576          77 SKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPE  152 (237)
T ss_pred             HHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCc
Confidence            6543 58999999999999999999999999999999999999999999999999876543321   2234466799999


Q ss_pred             cccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCC
Q 021299          182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (314)
Q Consensus       182 ~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (314)
                      .+.. ..++.++|+||+|+++|+|++|..|+.......         .....                       .....
T Consensus       153 ~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~-----------------------~~~~~  199 (237)
T cd05576         153 VGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTT-----------------------LNIPE  199 (237)
T ss_pred             ccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccc-----------------------cCCcc
Confidence            8865 567899999999999999999998764321100         00000                       01123


Q ss_pred             CCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccc
Q 021299          262 SASDDALDLLSKMFTYDPKARITA-----QQALEHRFA  294 (314)
Q Consensus       262 ~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~  294 (314)
                      .+++.+.++|.+||+.||++||++     ++++.||||
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            468899999999999999999996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=265.64  Aligned_cols=279  Identities=34%  Similarity=0.524  Sum_probs=230.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   84 (314)
                      -.||.-++.+|.|+. .|..+.+.-.+.++++|+...........++..+|...+..+.|+||+.+..+|.-..      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            478999999999999 8889999999999999999877666666677889999999999999999999884333      


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .+|+|||++..++...++.   .++-+.+..++.|++.|+.|||+.||+||||||+||+++.++.+||.|||++...+..
T Consensus        95 e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   95 EVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence            5799999999999888873   2677889999999999999999999999999999999999999999999999876544


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC----
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA----  240 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  240 (314)
                       ...+..+.+..|.|||++.+ ..+....||||+||++.+|++|...|++.+..+...++.+..++..+..+.+..    
T Consensus       172 -~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             -cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence             45566778899999999988 458999999999999999999999999999999999999988887766443211    


Q ss_pred             ----------cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          241 ----------YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       241 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                .......+.-...+......+.-+..+++++.+||-.||++|.|+.++|+|||++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                      1111111111111111111233466799999999999999999999999999999

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.2e-38  Score=298.32  Aligned_cols=148  Identities=24%  Similarity=0.468  Sum_probs=130.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.+.+.||.|+||+||++.+..+++.||+|++...... ......+..|+.+++.++|+||+++++.+....+.|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999999754322 12223556789999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      |||+.| +|..++... +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999975 787777654 458999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.5e-38  Score=267.95  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             ccceeeeCccccceEEEEEECC---CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC------
Q 021299           14 YLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   84 (314)
                      |.+.+.||+|++|.||++.+..   ++..+++|.+............+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998543   5688999999766544444456778999999999999999999874432      


Q ss_pred             eEEEEEeccc-ccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           85 NLHLVFEFME-TDLETVIRNT-----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      ..+++++|+. |++..++...     ...++...+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            2468889987 5776665432     124788999999999999999999999999999999999999999999999998


Q ss_pred             eeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          159 RIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       159 ~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      ........  ......+++.|++||.+.. ..++.++|+||||+++|+|++ |.+||......+....+.......    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----  235 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK----  235 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC----
Confidence            76533221  1112234567999998866 567889999999999999998 889987766554444333211000    


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                             .....++.+.+++.+||..+|++||++.+++.+
T Consensus       236 -----------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 -----------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   012357899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=272.30  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=221.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchh-hHHHHHHHhhcC-CCCeeeeeceeccCCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~-~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+|..+.+||.|+||.|-++..+.+.+.||||+++++..-.....+ -+.|-++|.... -|.+++++..|+.-+..|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            5788999999999999999999999999999999887644333222 235667776553 58899999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|.--+++ -+.+.+..|.-++..|+.||-+||++||+++|||.+||+++.+|.+||+|||.++..-......
T Consensus       429 MEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT  507 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT  507 (683)
T ss_pred             EEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence            999996 66555554 4468999999999999999999999999999999999999999999999999998765556666


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....|||-|+|||++.= .+|+...|.||+||+||+|+.|++||.+.+..+....+....-+                  
T Consensus       508 kTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs------------------  568 (683)
T KOG0696|consen  508 KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS------------------  568 (683)
T ss_pred             eeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc------------------
Confidence            67789999999998855 78999999999999999999999999999999999998876432                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                                +..++|.++.+++...|.+.|.+|..+     .+|-+||||+.++
T Consensus       569 ----------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  569 ----------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             ----------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence                      234579999999999999999999876     6799999999874

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=310.65  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=213.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      =+|.....||.|.||.||.+....+|+..|+|.+..............+|..++..++|||+++++++=......+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            46777789999999999999999999999999998876665555566799999999999999999999888888999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC----Cc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----RR  167 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~----~~  167 (314)
                      ||.|+.+..+.+.++..++-....+-.|++.|++|||++||+|+||||.||+++.+|.+|++|||.|.......    ..
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99975444444455456777778888999999999999999999999999999999999999999998774432    12


Q ss_pred             ccccccCccccCcccccCcc--CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FTHQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      -.+..||+.|||||++.+..  .-..++|||||||++.||+||+.||...+....+--.+..                  
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------------ 1456 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------------ 1456 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------------
Confidence            23567999999999997633  3467999999999999999999999876665544332221                  


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                              +..++++..++++.+++|..||+.||.+|+++.|+++|-|=+.
T Consensus      1457 --------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1457 --------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             --------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                    1122233457999999999999999999999999999988653

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=297.24  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=212.3

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCc-----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      |+..=.+.-+..+.||+|+||.||.+.......     .|++|.+..... .+...+|.+|+.+++.++|||||++++++
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            444445677889999999999999998665332     489998876543 34455788999999999999999999999


Q ss_pred             ccCCeEEEEEeccc-ccHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEe
Q 021299           81 PHKGNLHLVFEFME-TDLETVIRNT------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLA  153 (314)
Q Consensus        81 ~~~~~~~iv~e~~~-g~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~  153 (314)
                      -+....+|++|||. |+|++++++.      ...++......++.||++|+.||++++++|+||...|+|++....|||+
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence            88999999999998 5999999987      5679999999999999999999999999999999999999999999999


Q ss_pred             eccceeeeCCC-CCcccc-cccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCC
Q 021299          154 DFGLARIFGSP-DRRFTH-QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT  230 (314)
Q Consensus       154 df~~~~~~~~~-~~~~~~-~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  230 (314)
                      |||+|+..-.. ...... ..-+..|||||.+.. ..++.|+||||+||++||+++ |..||...+..+.......+-.-
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99999844222 111111 233456999999987 789999999999999999996 45899999988888755544222


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .+|                           ..+++.+.+++.+||..+|++||+...|++
T Consensus       924 ~~P---------------------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPP---------------------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCC---------------------------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            222                           245888999999999999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=274.23  Aligned_cols=268  Identities=27%  Similarity=0.439  Sum_probs=214.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc-----hhhHHHHHHHhhcCCCCeeeeecee-cc
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-----FTALREIKLLKELKSPHIIELIDAF-PH   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~-~~   82 (314)
                      .+.++|-.+..||.|+|+.||++.+......+|+|+-.....+.+..     +...+|.++.+.++||.||+++++| .+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            57899999999999999999999998888889999876665443322     3455799999999999999999998 46


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--WVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      ...+|.|.|||+|+-+++..+..+.+++..++.|+.||+.||.||...  .|+|.||||.||++..   .|.+||+|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            678999999999966666666666799999999999999999999976  5999999999999843   47899999999


Q ss_pred             eeeeCCCCCcc-------cccccCccccCcccccCc---cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHh
Q 021299          158 ARIFGSPDRRF-------THQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       158 ~~~~~~~~~~~-------~~~~~~~~y~sPE~~~~~---~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +++++.+....       ....||.||++||++.-+   ...+.+.||||.|||+|+++.|..||..+.....+-+.--.
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            99986654432       234679999999998643   34588999999999999999999999887654433221111


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      +.. ....+|                 +    .+.+++++..+|++||.--.+.|.+..++..||+|.-..
T Consensus       700 lkA-tEVqFP-----------------~----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  700 LKA-TEVQFP-----------------P----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             hcc-eeccCC-----------------C----CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            000 001111                 1    245799999999999999999999999999999997643

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-36  Score=260.60  Aligned_cols=248  Identities=20%  Similarity=0.233  Sum_probs=187.4

Q ss_pred             eeCccccceEEEEEECCC--CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-
Q 021299           19 VLGEGTYGVVYKAIDTKT--GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      .||+|+||.||++.....  ...+++|.+..... ......+.+|+..++.++||||+++++.+......+++|||+.+ 
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999974332  23566777654332 22334677899999999999999999999999999999999985 


Q ss_pred             cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--Ccccc
Q 021299           96 DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH  170 (314)
Q Consensus        96 ~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~  170 (314)
                      +|.+.+...   ....+...+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||.+.......  .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            888888653   2346677888999999999999999999999999999999999999999999875432111  12233


Q ss_pred             cccCccccCcccccC------ccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          171 QVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~------~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      ..++..|+|||.+..      ...++.++|+||||+++|+|++ |..||......+....+........+.         
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------  231 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK---------  231 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC---------
Confidence            456778999998743      1235789999999999999996 467887766665555543321111100         


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                   +......++.+.+++..|+ .+|++||++++|++
T Consensus       232 -------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 -------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                         1112245788999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.8e-38  Score=287.97  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=207.5

Q ss_pred             hhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .+-...+.||+|+||+||+++--.     ....||||.++.. ...+.+.+|.+|++.+..++|||||+++|++.+++..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            455678899999999999996332     2357999999754 3344667899999999999999999999999999999


Q ss_pred             EEEEeccc-ccHHHHHHhCCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           87 HLVFEFME-TDLETVIRNTNI-------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      ++|||||. |+|.+++....+             +++..+...|+.||+.|+.||-++.++|+||-..|.||.++..|||
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence            99999998 899999975322             3788899999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCC-CC-cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhC
Q 021299          153 ADFGLARIFGSP-DR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (314)
Q Consensus       153 ~df~~~~~~~~~-~~-~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~  229 (314)
                      +|||+++..-.. .. ......-+.+|||||.+.- ..++.+|||||+||+|||+++ |..|+-.....+.++.+..+..
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            999999865221 11 1112334677999999876 678999999999999999984 5689999999998888877643


Q ss_pred             CCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH
Q 021299          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (314)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  288 (314)
                      -..                           ....+.++.+|+..||...|.+||+.+||
T Consensus       724 L~~---------------------------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  724 LSC---------------------------PENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             ccC---------------------------CCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            222                           23568999999999999999999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.4e-36  Score=253.57  Aligned_cols=242  Identities=40%  Similarity=0.614  Sum_probs=198.8

Q ss_pred             ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc-cHHHHHH
Q 021299           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR  102 (314)
Q Consensus        24 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~  102 (314)
                      ++|.||++.+..+|+.+++|.+........ ...+.+|++.++.++|++++++.+.+......++++|++++ +|.+.+.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            578999999988899999999976544322 45677899999999999999999999888999999999997 8888876


Q ss_pred             hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCccc
Q 021299          103 NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL  182 (314)
Q Consensus       103 ~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~  182 (314)
                      .... ++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus        80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       80 KRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             hccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            5543 8999999999999999999999999999999999999999999999999998764432 3344567778999999


Q ss_pred             ccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCC
Q 021299          183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (314)
Q Consensus       183 ~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (314)
                      +.+ ..++.++|+||||++++++++|..||... ........+.........                         ...
T Consensus       158 ~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~  211 (244)
T smart00220      158 LLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-------------------------PEW  211 (244)
T ss_pred             Hcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------ccc
Confidence            875 56788999999999999999999999773 333333332221111100                         001


Q ss_pred             CCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          262 SASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       262 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                      .++.++.+++.+||..+|++||++.++++||||
T Consensus       212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             cCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            157899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=264.57  Aligned_cols=290  Identities=29%  Similarity=0.478  Sum_probs=220.0

Q ss_pred             ccccHHHH-hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-----C---CCee
Q 021299            4 VDLSKKVA-DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----S---PHII   74 (314)
Q Consensus         4 ~~~~~~~~-~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~   74 (314)
                      |-+++.+. +||.+.+.||.|-|+|||++.+..+.+.||+|+.+...   .-......|+++|++++     +   .+||
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            55677787 99999999999999999999999999999999987532   12224558999999884     2   4799


Q ss_pred             eeecee----ccCCeEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecC-
Q 021299           75 ELIDAF----PHKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSH-  147 (314)
Q Consensus        75 ~~~~~~----~~~~~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~-  147 (314)
                      ++++.|    .++.++++|+|+.+.+|+.++... ...++...+.+|++||+.||.|||. .||+|-||||+|||+..+ 
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            999998    455699999999999999999754 5679999999999999999999997 599999999999999600 


Q ss_pred             --------------------------------------------------------------------------------
Q 021299          148 --------------------------------------------------------------------------------  147 (314)
Q Consensus       148 --------------------------------------------------------------------------------  147 (314)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 021299          148 --------------------------------------------------------------------------------  147 (314)
Q Consensus       148 --------------------------------------------------------------------------------  147 (314)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             -----CcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC------CC
Q 021299          148 -----GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG------SS  216 (314)
Q Consensus       148 -----~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~------~~  216 (314)
                           -++||.|||.|+...   ......+-|..|.|||++.+ ..|+..+||||++|++|||+||...|..      ..
T Consensus       386 ~~~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             CCccceeEEEeeccchhhhh---hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence                 013444444443321   11223344556999999998 7899999999999999999999988855      45


Q ss_pred             cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC--CCCcc------------CCCCCHHHHHHHhhhcccCCCCC
Q 021299          217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP--PLRSL------------FPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      +.+.++.|+...+..+..-.-.-.....+++.......  .++.+            ...-..++.+++.-||+.+|++|
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence            88899999988887765543332222222222111110  01111            11224568899999999999999


Q ss_pred             CCHHHHhcCccccccCcc
Q 021299          283 ITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       283 ps~~ell~h~~~~~~~~~  300 (314)
                      |||.++|+|||++.+.+.
T Consensus       542 ~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  542 PTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             ccHHHHhcCccccCCCCC
Confidence            999999999999988765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.4e-38  Score=274.62  Aligned_cols=287  Identities=31%  Similarity=0.510  Sum_probs=230.0

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC------CCeeeee
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS------PHIIELI   77 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~   77 (314)
                      |.+++.|-++|.+....|+|-|++|.+|.+..-|..||||+++.....   ...-..|+++|+.|+.      -|.+.++
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            668888999999999999999999999999999999999999865432   1233479999999963      4888899


Q ss_pred             ceeccCCeEEEEEecccccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEee
Q 021299           78 DAFPHKGNLHLVFEFMETDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLAD  154 (314)
Q Consensus        78 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~d  154 (314)
                      ..|...++.|+|||.+.-+|.+.++.-+  ..+....++.++.|++.||.+|-..|++|.||||+||||+++ ..+||||
T Consensus       501 r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             HHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence            9999999999999999999999998654  457889999999999999999999999999999999999886 5799999


Q ss_pred             ccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       155 f~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ||.|...+....  .....+..|.|||++.+ .+|...-|+||.||+||+|.||+..|++......+.-.+..-+..+-.
T Consensus       581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  581 FGSASFASENEI--TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             Cccccccccccc--cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            999987654332  23344566999999988 889999999999999999999999999999999998888776665544


Q ss_pred             CCCCcCcccchhhhc----ccc------------CCCCCc----------------cCCCCCHHHHHHHhhhcccCCCCC
Q 021299          235 QWPDLAYLPDYVEYQ----YVA------------APPLRS----------------LFPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~----~~~------------~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      -+....+.++.+...    +..            .....+                --+.+-..+++|+.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            333222222221110    000            000111                011123458899999999999999


Q ss_pred             CCHHHHhcCccccc
Q 021299          283 ITAQQALEHRFAKS  296 (314)
Q Consensus       283 ps~~ell~h~~~~~  296 (314)
                      .|+.|+|.||||+.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999973

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=280.43  Aligned_cols=259  Identities=29%  Similarity=0.397  Sum_probs=219.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeecee-----ccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAF-----PHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~-----~~~~   84 (314)
                      .+-|++.+.||.|.+|.||+++.+.+|+..++|+......   ...++..|.++++.. .|||++.++++|     ..++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            5789999999999999999999999999999999976544   334666788888888 589999999987     3566


Q ss_pred             eEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           85 NLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ..|+|||||+| +.-++++.. +..+.++.+..|++.++.|+.|||.+.++|+|||-.||+++.++.|||+|||.+...+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            89999999995 666777644 5679999999999999999999999999999999999999999999999999999888


Q ss_pred             CCCCcccccccCccccCcccccCcc----CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAK----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      .-.......+|||.|||||++....    .+...+|+||||++..+|..|.+|+.+..+...+..+-.    .+|..+..
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR----NPPPkLkr  250 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPPPKLKR  250 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC----CCCccccc
Confidence            7777788899999999999986533    357889999999999999999999988777666554422    12222211


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                           +...+.++.++|..||.+|-.+||+..++|.|||+...
T Consensus       251 ---------------------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  251 ---------------------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ---------------------hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                 12348899999999999999999999999999999844

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=260.08  Aligned_cols=297  Identities=35%  Similarity=0.622  Sum_probs=235.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-----eEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NLH   87 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   87 (314)
                      +....+.||-|+||.||.+.+-.+|+++++|++..-...-...+...+|+.++..++|.|++...+..+...     ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445678899999999999999999999999999765555445556778999999999999999988875443     356


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      +++|.+..+|...+.+- ..++.+.+.-+..||++||+|||+-||.|+||||.|.+++.|..+||||||+++....+.. 
T Consensus       134 V~TELmQSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  134 VLTELMQSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            78888888887777644 3689999999999999999999999999999999999999999999999999987654433 


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .-...+.|.+|.+||++.+...|+.+.||||.|||+.|++..+..|....+.+.+..+....++++.+.+..-...-..-
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            33345668889999999998999999999999999999999999999999999999999999988776544211111110


Q ss_pred             hhccc-cCCCCCccC-----CCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceeecccceecc
Q 021299          247 EYQYV-AAPPLRSLF-----PSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSYLY  311 (314)
Q Consensus       247 ~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~  311 (314)
                      ..... ..+.++..+     .....+...++.++|..||++|.+.++.+.|+++....=.+-++ -|+.|+
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sC-mC~~~~  362 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSC-MCSCCY  362 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeee-eEeeec
Confidence            00111 111111111     12356788999999999999999999999999998776555555 344444

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=280.20  Aligned_cols=270  Identities=26%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------Ce
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------GN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   85 (314)
                      .-|...+.||+|+||.||+++++.+|..+|+|.+.... .........+|++++++++|+|||+.+++=++.      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            44567789999999999999999999999999998754 222333455899999999999999999985433      35


Q ss_pred             EEEEEecccc-cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec--CC--cEEEeeccce
Q 021299           86 LHLVFEFMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HG--QLKLADFGLA  158 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~--~~~l~df~~~  158 (314)
                      ..++||||.| +|...+.+-  ..++++.....+..++..||.|||++||+||||||.||++-.  +|  ..||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            6899999985 777777642  346999999999999999999999999999999999999843  33  5899999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      +..+.+ ....+..||+.|++||.+..+++++...|.||+||++|+++||..||...........+.-...+..+....-
T Consensus       172 rel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  172 RELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             ccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            987544 4777889999999999998668899999999999999999999999976554432222222222333333221


Q ss_pred             cC--cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC
Q 021299          239 LA--YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT  284 (314)
Q Consensus       239 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  284 (314)
                      ..  ..+.........+. -.+..+.+-..+...+..+|..+|++|..
T Consensus       251 ~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence            11  11111111111111 11222233445668889999999999983

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=257.33  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=207.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+..+-++.||.|+||+|++..++.+|+..|+|.++..... .....+..|.....+- ++|+||++++..-.++..|+.
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            35566788999999999999999999999999999876542 2233444555544444 689999999999899999999


Q ss_pred             EecccccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           90 FEFMETDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        90 ~e~~~g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ||.|+-++..+.+.    ....+++..+-.+..-.+.||.||-. .+|+|||+||+||+++..|.+||||||.+-... +
T Consensus       142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-~  220 (361)
T KOG1006|consen  142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-D  220 (361)
T ss_pred             HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH-H
Confidence            99999876655532    24458999888888888999999986 589999999999999999999999999996542 2


Q ss_pred             CCcccccccCccccCcccccCccC-CCCcchHhhHHHHHHHHHhCCCccCC-CCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQ-YGAGVDVWAAGCIFAELLNRRPFLQG-SSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~-~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      +.......|-..|+|||.+..... +..+||+||||++|||+.||..|+.. .+..+++..+..+-.+........    
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~----  296 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC----  296 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc----
Confidence            222334456667999999976444 89999999999999999999988854 445555555554422222111110    


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                        -+.+..+..+|..||.+|-+.||.-.+++++||++...
T Consensus       297 ------------------~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  297 ------------------VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             ------------------cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence                              14688999999999999999999999999999998663

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=273.19  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=221.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCC-cccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..+.+++.-||-|+||.|-++..+.....+|+|++++.. -+.........|-+++...+.|.|++++..|.++.++|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            356678889999999999999877666568999887643 2222233566899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||.|-| .+.+.+..+ +.+++..++-++..++.|+.|||++||+++||||+|.+++.+|-+||.|||+|+..+... ..
T Consensus       499 mEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-KT  576 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-KT  576 (732)
T ss_pred             HHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-ce
Confidence            999975 777776654 469999999999999999999999999999999999999999999999999999886544 34


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+|||.|.|||++.. .....+.|.|+||+++|+|++|.+||.+.++..++..+.+++...                 
T Consensus       577 wTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-----------------  638 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----------------  638 (732)
T ss_pred             eeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------------
Confidence            56689999999999876 556899999999999999999999999999999999998874322                 


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                               .++..++..+.+||++++.-+|.+|..     +.+|-.|.||.+++
T Consensus       639 ---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  639 ---------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             ---------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence                     112356889999999999999999987     79999999999985

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.9e-36  Score=280.56  Aligned_cols=276  Identities=20%  Similarity=0.272  Sum_probs=177.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCC----CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeece------e
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA------F   80 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~   80 (314)
                      .++|.+.+.||+|+||.||++.+..+    +..+++|.+......     +.... ..++...+.++..+...      .
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~-e~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMN-ERVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHH-HHHHhhchhhHHHHHHhhhccccc
Confidence            57899999999999999999999888    899999987532211     11101 11122122222222211      2


Q ss_pred             ccCCeEEEEEecccc-cHHHHHHhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 021299           81 PHKGNLHLVFEFMET-DLETVIRNTNIF-------------------LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPN  140 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~-------------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~  140 (314)
                      ......++++||+++ +|.+.+......                   .....+..++.||+.||.|||+++|+|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            455678999999985 777777643211                   123446789999999999999999999999999


Q ss_pred             ceEEec-CCcEEEeeccceeeeCCC-CCcccccccCccccCcccccCcc---------------------CCCCcchHhh
Q 021299          141 NLLIGS-HGQLKLADFGLARIFGSP-DRRFTHQVFARWYRAPELLFGAK---------------------QYGAGVDVWA  197 (314)
Q Consensus       141 nil~~~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~y~sPE~~~~~~---------------------~~~~~~Di~s  197 (314)
                      ||+++. ++.+||+|||++...... ........+++.|+|||.+....                     .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 579999999999765322 22233456788999999763211                     1335679999


Q ss_pred             HHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhccc
Q 021299          198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTY  277 (314)
Q Consensus       198 lG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  277 (314)
                      |||++|+|+++..++.  ................ ...|...  ......  .. ....-...........+||.+||+.
T Consensus       365 lGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~-~~~~~~~--~~~~~~--~~-~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        365 AGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD-LVAWRKL--VEPRAS--PD-LRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc-HHHHHHh--hccccc--hh-hhhhhhhccccchHHHHHHHHHccC
Confidence            9999999998665432  2222222222221110 0000000  000000  00 0000011122355677999999999


Q ss_pred             CCCCCCCHHHHhcCccccccCcc
Q 021299          278 DPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       278 dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ||++|||++|+|+||||+.....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999976543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-37  Score=243.90  Aligned_cols=279  Identities=30%  Similarity=0.568  Sum_probs=216.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceec--cCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFP--HKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~   87 (314)
                      .++|++++.+|.|-++.|+.+....+++.+++|.+++-.     ..++.+|+.+++.+. +|||+++.+...  .+....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            588999999999999999999988899999999997543     346779999999997 999999999874  455778


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPD  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~~~~  165 (314)
                      ++||+++. +...+..    .++...++.++.+++.||.|+|++||.|+|+||-|++++.. .+++|+|+|+|.+.... 
T Consensus       112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  186 (338)
T ss_pred             hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-
Confidence            99999996 4444433    37788899999999999999999999999999999999875 57999999999876433 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc--c
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--L  242 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  242 (314)
                      ....-.+.+..|..||++..-..+....|+|||||++..|+..+ +.|.+.+..+++-++....++.....+-.-..  +
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            33334456777999999988778999999999999999998887 55577888888888877766543221110000  0


Q ss_pred             cc--------hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          243 PD--------YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       243 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      +.        ..........+ ...-.-+++++.+|+.++|.-|..+|+|+.|.+.||||..+.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~-~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFIN-SENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ChhHhhHhhccccccHHHhCC-ccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            00        00000000000 00112257999999999999999999999999999999877544

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-36  Score=266.07  Aligned_cols=260  Identities=26%  Similarity=0.387  Sum_probs=207.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .-|..++.||-|+||.|.++....+...||+|.+++...... ......-|-.+|...+++-||+++-.|++.+..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457889999999999999999988989999999976542211 1112335778899999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC------
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS------  163 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~------  163 (314)
                      +|++| ++.+++.+.+ -+++..++.++..++.|+++.|..|++|+||||+|||||.+|.+||+|||+|+-+..      
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99986 8888877665 589999999999999999999999999999999999999999999999999954310      


Q ss_pred             ---C-----C----------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh
Q 021299          164 ---P-----D----------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN  207 (314)
Q Consensus       164 ---~-----~----------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~  207 (314)
                         .     .                            ...-..+||+-|+|||++.. ..++..+|.||.|||||+|+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhh
Confidence               0     0                            00013478888999999977 568999999999999999999


Q ss_pred             CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---
Q 021299          208 RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---  284 (314)
Q Consensus       208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---  284 (314)
                      |++||-+..+.++-.++..         |...-               --+.-..++.+..+||.++++ ++++|..   
T Consensus       867 g~~pf~~~tp~~tq~kv~n---------w~~~l---------------~~~~~~~ls~e~~~li~kLc~-sad~RLGkng  921 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVIN---------WRNFL---------------HIPYQGNLSKEALDLIQKLCC-SADSRLGKNG  921 (1034)
T ss_pred             CCCCccCCCCCcceeeeee---------hhhcc---------------ccccccccCHHHHHHHHHHhc-Chhhhhcccc
Confidence            9999988877666544321         11100               001113569999999998766 4667765   


Q ss_pred             HHHHhcCccccccC
Q 021299          285 AQQALEHRFAKSFN  298 (314)
Q Consensus       285 ~~ell~h~~~~~~~  298 (314)
                      ++||..||||+.++
T Consensus       922 ~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  922 ADQVKAHPFFKGID  935 (1034)
T ss_pred             hhhhhcCccccccc
Confidence            67899999999885

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=273.56  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=216.4

Q ss_pred             hccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..+|.++||.|.||.||+++-+..|+   .||||.++..-. +..+.+|..|+.++-+++||||+.+.++....+.+.||
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            34789999999999999999887765   599999976543 34456888999999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      .|||+ |.|..+++...+.+..-+..-+++.|+.|+.||-++|++||||-..||||+.+...|++|||+++...++....
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            99998 79999999999999999999999999999999999999999999999999999999999999999875544222


Q ss_pred             ccccc---CccccCcccccCccCCCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVF---ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~---~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....|   +.+|.|||.+.- ..++.+||+||+|++|||.| .|..|+=.....+.+..+.+++.-++|-+         
T Consensus       789 ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD---------  858 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD---------  858 (996)
T ss_pred             ccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC---------
Confidence            22222   467999999866 77899999999999999987 67778877788888888888876666543         


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                        ++..+.+|+..||++|-.+||...||+.
T Consensus       859 ------------------CP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  859 ------------------CPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------------------CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                              4889999999999999999999999875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=262.25  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             hhccceeeeCccccceEEEEEECC--CCc--EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTK--TGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~--~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +..+..+.||+|.||.||.+....  .|+  -||+|.-+.+.... ...+|..|+.+++.++||||++++|++.+ ...|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            344667889999999999997543  233  58899887765443 46789999999999999999999999855 4579


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||||.++ |.|..+++..+..++......++.||..||+|||+.+++||||-..||+|....-|||+|||+++.+..+..
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999 899999999988999999999999999999999999999999999999999999999999999998754332


Q ss_pred             ccccccc--CccccCcccccCccCCCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          167 RFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       167 ~~~~~~~--~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                       +....|  +.-|+|||.+.- ..++.++|||.+||++||++ .|..||.+....+.+..+..+...+            
T Consensus       547 -YkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------------  612 (974)
T KOG4257|consen  547 -YKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------------  612 (974)
T ss_pred             -hhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------------
Confidence             222222  344999998854 67899999999999999985 7889998877777766665443222            


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                                     .++.+++.+..|+.+||..||.+||+..++.
T Consensus       613 ---------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ---------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ---------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                           2346789999999999999999999988764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=245.98  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=211.9

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchh-hHHHHHHHhhc-CCCCeeeeeceeccCCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~-~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ++|.++++||.|++..|.+++.+.+.+.||+|++++...+.+..-. ...|-.+.... +||.++-++.+|+.+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            6899999999999999999999999999999999876544332211 22455555555 689999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      .||++| +|.--++..+ .++++.++.+...|.-||.|||++||+++|||.+|++++..|.+||+|+|.++..-.+....
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t  408 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT  408 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence            999996 5554444333 59999999999999999999999999999999999999999999999999998876777777


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC-------CCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-------SSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ....|||-|.|||++.+ ..|....|.|+||++|++||.|..||.-       .+.++.+.+++-...-           
T Consensus       409 stfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-----------  476 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-----------  476 (593)
T ss_pred             ccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----------
Confidence            78899999999999988 7789999999999999999999999932       2233333333222111           


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC------HHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~ell~h~~~~~~~  298 (314)
                                      .++..+|-.+..+++..|.+||.+|..      ..++.+|+||+.++
T Consensus       477 ----------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  477 ----------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ----------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence                            122345778889999999999999975      47899999999774

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=261.13  Aligned_cols=243  Identities=24%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      +.+....||.|.+|.||.+.++...-.+++|.++-+..   ...+|.+|+.+++.+.|||+|++.++|..+..+|||+||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            44667899999999999999999989999999875433   234788999999999999999999999999999999999


Q ss_pred             cc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           93 ME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        93 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |. |+|++++.+.+ ..++.....+++.||..|+.||..++++|+||-..|.||.++..||+.|||+++.+..+.  +..
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTA  422 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTA  422 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--eec
Confidence            87 89999998654 457777889999999999999999999999999999999999999999999999885443  223


Q ss_pred             ccc---CccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          171 QVF---ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       171 ~~~---~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ..|   ..-|.|||.+.= ..++.++|||++||+||++.| |..|+++.+-...+..+..++.-..|             
T Consensus       423 HAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P-------------  488 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP-------------  488 (1157)
T ss_pred             ccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC-------------
Confidence            333   445999998854 568999999999999999985 55899988877777766555433333             


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  288 (314)
                                    .++++.+.+|++.||++.|..||+.+|+
T Consensus       489 --------------eGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  489 --------------EGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             --------------CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                          3568999999999999999999999886

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=258.89  Aligned_cols=260  Identities=23%  Similarity=0.295  Sum_probs=213.0

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +.-.+.-.+++.||+|.||.|.+++-. .+..||+|.++...... ....+.+|+++|.+++||||+.++++|..++.++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            334567789999999999999999743 36899999998765433 3567889999999999999999999999999999


Q ss_pred             EEEeccc-ccHHHHHHhCCCCC-CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC--C
Q 021299           88 LVFEFME-TDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG--S  163 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l-~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~--~  163 (314)
                      +++||++ |+|.+++.+...+. .......++.||++|++||.+.+++|+||.+.|+|++.++.+||+|||.++-.-  +
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999998 79999998764433 556677899999999999999999999999999999999999999999998542  2


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH--hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ........+.+.+|+|+|.+.. ..++.++|+|++|+++||++  +...||....+.+.....-..+.......+..   
T Consensus       692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~---  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS---  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc---
Confidence            2333334455778999999877 67899999999999999986  55689988888777777655554444333221   


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       .++-++..+.+++.+||..|-.+||+.+++-.
T Consensus       768 -----------------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  768 -----------------RPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -----------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                             12346889999999999999999999999843

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-34  Score=259.39  Aligned_cols=270  Identities=24%  Similarity=0.338  Sum_probs=182.4

Q ss_pred             HhhccceeeeCccccceEEEEEEC----------------CCCcEEEEEEeecCCcccC------------cchhhHHHH
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT----------------KTGQTVAIKKIRLGKQKEG------------VNFTALREI   62 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~----------------~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~   62 (314)
                      .++|.+.++||+|+||+||++...                ..+..|++|.+........            .......|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            578999999999999999998642                2346799999865432110            111223466


Q ss_pred             HHHhhcCCCCe-----eeeeceecc--------CCeEEEEEecccc-cHHHHHHhCC-----------------------
Q 021299           63 KLLKELKSPHI-----IELIDAFPH--------KGNLHLVFEFMET-DLETVIRNTN-----------------------  105 (314)
Q Consensus        63 ~~l~~l~~~~i-----~~~~~~~~~--------~~~~~iv~e~~~g-~l~~~~~~~~-----------------------  105 (314)
                      .++..++|.++     +.+++++..        .+..++|+||+++ +|.+.+....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     556666532        3568999999985 7777765321                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cccccccCccccCccccc
Q 021299          106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLF  184 (314)
Q Consensus       106 ~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~sPE~~~  184 (314)
                      ..+++..+..++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            1245677889999999999999999999999999999999999999999999976533211 111223478899999875


Q ss_pred             CccC---------------------CCCcchHhhHHHHHHHHHhCCC-ccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          185 GAKQ---------------------YGAGVDVWAAGCIFAELLNRRP-FLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       185 ~~~~---------------------~~~~~Di~slG~ll~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ....                     ...+.|+||+||++++|+++.. ||..............    .....|...   
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~~---  456 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRMY---  456 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHhh---
Confidence            4211                     1234799999999999999874 6643221111000000    000000000   


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCC---CCCCCHHHHhcCcccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP---KARITAQQALEHRFAK  295 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~ell~h~~~~  295 (314)
                             ... ...-..++.+++..++|+.+||..+|   .+|+|++|+|+||||.
T Consensus       457 -------~~~-~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        457 -------KGQ-KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             -------ccc-CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence                   000 00011244569999999999999866   6899999999999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=258.26  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=216.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-Cc--EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-GQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++.+..+.||+|+||.|+++.++.. |+  .||+|.++...... ....|.+|+.++..|+|+|+++++++..+ ....
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            46778889999999999999987763 33  69999998876654 56688999999999999999999998866 6678


Q ss_pred             EEEeccc-ccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           88 LVFEFME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +|||.+. |+|++.+.+ ....+.......++.||+.|+.||.+++++|+||-..|+++-....|||+|||+.+..+...
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999 689999987 46678888999999999999999999999999999999999888899999999999887766


Q ss_pred             Cccccc---ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RRFTHQ---VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~~~~~---~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..+...   .-...|+|||.+.. ..++.++|+|++||++|||+++ ..||.+.....++..+-.+..-..         
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---------  336 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---------  336 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---------
Confidence            554322   22456999999987 7889999999999999999965 589999998888887753322211         


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                        .+.+++.+.+++..||...|.+|||...|.+.-++...
T Consensus       337 ------------------Pk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  337 ------------------PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             ------------------CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence                              23458999999999999999999999999876665543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.4e-34  Score=282.19  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=186.5

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +.+.+...+.||+|++|.||+|.+..+|..|++|.+.....      ....|++.+++++||||+++++++.+.+..++|
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            45678888999999999999999988999999998864321      112568899999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH---KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh---~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |||++| +|.+.+..    +++..+..++.|++.|++|||   +.+++|+||||+||+++.++..++. ++.......  
T Consensus       762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            999985 78877753    789999999999999999999   6699999999999999988887775 554432211  


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhC-CCCCCCCCCcCccc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFG-TATPSQWPDLAYLP  243 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~  243 (314)
                        .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ....+...... ......+-+     
T Consensus       835 --~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  906 (968)
T PLN00113        835 --DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID-----  906 (968)
T ss_pred             --CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC-----
Confidence              122357788999999876 66899999999999999999999998542211 11111111100 000000000     


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                            ..... ..........++.+++.+||+.||++||+++|+++.
T Consensus       907 ------~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 ------PSIRG-DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ------ccccC-CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                  00000 000001113357899999999999999999999865

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.4e-34  Score=245.86  Aligned_cols=283  Identities=31%  Similarity=0.508  Sum_probs=216.8

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECC---CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccC
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK   83 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   83 (314)
                      .++.+.|..+..||+|.|++||++.+..   .+..+++|.+.......    .+..|+++|..+. +.||+++.+++..+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~----ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS----RILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch----HHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3567899999999999999999998777   67789999997665433    4668999999995 89999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeee
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIF  161 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~  161 (314)
                      +.+.+|+||++. ...++...    ++...+..++..++.||+++|++||+|+||||.||+.+.. ++-.|+|||++...
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            999999999996 55555553    6789999999999999999999999999999999999865 68999999999621


Q ss_pred             CC----------------C----------------------------CCcccccccCccccCcccccCccCCCCcchHhh
Q 021299          162 GS----------------P----------------------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA  197 (314)
Q Consensus       162 ~~----------------~----------------------------~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~s  197 (314)
                      ..                +                            ........||++|.|||++.....-+.+.||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            00                0                            000112357888999999988777799999999


Q ss_pred             HHHHHHHHHhCCCcc-CCCCcHHHHHHHHHhhCCCCCCCCCCc---------Ccccch----hhhccc---c----C---
Q 021299          198 AGCIFAELLNRRPFL-QGSSDIDQLGKIFAAFGTATPSQWPDL---------AYLPDY----VEYQYV---A----A---  253 (314)
Q Consensus       198 lG~ll~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~----~~~~~~---~----~---  253 (314)
                      .|+|++.++++..|| ...++.+.+.++.-.++...-......         ...+..    ..+...   .    .   
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999998665 667777777776666554432221100         000000    000000   0    0   


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..........+..+.+|+.+||+.||.+|.|+++.|.||||....
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            112223345677899999999999999999999999999999664

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=267.69  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=194.4

Q ss_pred             ccceeeeCccccce-EEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEe
Q 021299           14 YLKREVLGEGTYGV-VYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        14 y~~~~~lg~g~~g~-vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      |.-.+.+|.|+.|+ ||++.  ..|+.||+|.+-....     ....+|+..++.-+ ||||+++++.-.+..+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~~-----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEFF-----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHhH-----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            44556789999876 48884  4578999999864432     23458999999884 9999999999889999999999


Q ss_pred             cccccHHHHHHhCCC--C-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---C--CcEEEeeccceeeeCC
Q 021299           92 FMETDLETVIRNTNI--F-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---H--GQLKLADFGLARIFGS  163 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~--~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~--~~~~l~df~~~~~~~~  163 (314)
                      .|..+|.+++.....  . ......+.+..|++.||+|||+.+|+||||||.||||..   +  .+++|+|||+|+....
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            999999999987411  1 111446889999999999999999999999999999976   2  3799999999998755


Q ss_pred             CCCc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          164 PDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       164 ~~~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      ....   .....||..|+|||.+.. ...+.+.|||||||++|+.++| .+||...-.-+  +.+..+  ......+   
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~--~~~L~~L---  735 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTG--NYTLVHL---  735 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcC--ccceeee---
Confidence            4332   345678899999999987 4557799999999999999887 69997643221  112111  1111111   


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                          .+....++.+||.+|+..||..||+|.+||.||+|=...++..
T Consensus       736 --------------------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~  778 (903)
T KOG1027|consen  736 --------------------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS  778 (903)
T ss_pred             --------------------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence                                0111228999999999999999999999999999976655543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.3e-32  Score=220.83  Aligned_cols=213  Identities=39%  Similarity=0.649  Sum_probs=185.3

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc-ccHH
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLE   98 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~   98 (314)
                      ||+|++|.||++....+++.+++|.+....... ....+.+|++.++.++|++++++++++......++++|+++ +++.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999988889999999998664432 23467789999999999999999999998899999999999 5888


Q ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCCCCCcccccccCccc
Q 021299           99 TVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (314)
Q Consensus        99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  177 (314)
                      +.+......++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+..............+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            887765456899999999999999999999999999999999999999 8999999999998765443223345567779


Q ss_pred             cCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCC
Q 021299          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (314)
Q Consensus       178 ~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (314)
                      ++||.+......+.++|+|++|++++++                                                    
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------------  187 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------------  187 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------------
Confidence            9999987743778999999999999999                                                    


Q ss_pred             ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       258 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                             ..+.+++.+|++.+|++||+++++++|+
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   2588999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=215.88  Aligned_cols=214  Identities=27%  Similarity=0.435  Sum_probs=175.8

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +....+..||.|++|.|-+.++..+|...|+|.+..... .+...+...|+.+..+. .+|+++.+++.+-..+.++|.|
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            445567889999999999999999999999999977654 23334455677766655 5899999999988999999999


Q ss_pred             ecccccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      |.+.-++..+..   ..++.+++..+-+++..++.||.|||++ .++|||+||+|||++.+|+||+||||.+-..... .
T Consensus       125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-i  203 (282)
T KOG0984|consen  125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-I  203 (282)
T ss_pred             HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh-h
Confidence            999987766654   4677899999999999999999999985 8999999999999999999999999999876332 2


Q ss_pred             cccccccCccccCcccccC---ccCCCCcchHhhHHHHHHHHHhCCCccCC-CCcHHHHHHHHHh
Q 021299          167 RFTHQVFARWYRAPELLFG---AKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDIDQLGKIFAA  227 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~---~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~~~~~  227 (314)
                      ..+...|-..|+|||.+..   +..|+.++||||||+.+.||.++..|+.. ..+.+++.+++..
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            2223456666999999854   34689999999999999999999988854 5667777766543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-34  Score=249.15  Aligned_cols=198  Identities=30%  Similarity=0.402  Sum_probs=172.8

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcch------hhHHHHHHHhhcC---CCCeeeeeceecc
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF------TALREIKLLKELK---SPHIIELIDAFPH   82 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~------~~~~e~~~l~~l~---~~~i~~~~~~~~~   82 (314)
                      .+|+.++.||+|+||.|++|.++.+...|++|-+.+.+.-.+.+.      ..--|+++|.+++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            358999999999999999999999999999999987754333221      2235999999997   9999999999999


Q ss_pred             CCeEEEEEeccc-c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           83 KGNLHLVFEFME-T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        83 ~~~~~iv~e~~~-g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ++++|++||..+ | +|.+++.... .+++..+..|++|++.|++|||+.||+|||||-+||.++.+|-+||+|||.+..
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            999999999987 5 8888887554 599999999999999999999999999999999999999999999999999976


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCcc
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL  212 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf  212 (314)
                      ..+  .......||..|.|||++.+..+....-|||+||++||.++....||
T Consensus       720 ~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  720 TKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            532  23345678999999999999888899999999999999998877765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=255.21  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=221.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|..+..+|+|.+|.||+++++.+++..++|+++......  ..-+.+|+-+++..+||||+.+++.|......++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            588999999999999999999999999999999998765433  234558999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |||+|+.++.+-.-.+++++.++...++..+++++|||+.|=+|||||-.||+++..|.+|+.|||.+...+.--.+...
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            99998666666666778999999999999999999999999999999999999999999999999999877666666778


Q ss_pred             cccCccccCccccc--CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          171 QVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       171 ~~~~~~y~sPE~~~--~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      .+||+.|+|||+-.  ....|+..+|+|++|+...++-..++|-....+...+..+..-  ...|..+.+-         
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS--~~qpp~lkDk---------  240 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS--GFQPPTLKDK---------  240 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--CCCCCcccCC---------
Confidence            89999999999853  3356899999999999999999888877666666555544322  1112222111         


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                  ...++.+.+|++.+|.++|.+||+++.+|.|||...--+
T Consensus       241 ------------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~  279 (829)
T KOG0576|consen  241 ------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLS  279 (829)
T ss_pred             ------------ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchh
Confidence                        123889999999999999999999999999999987543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-32  Score=249.27  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=207.9

Q ss_pred             hccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +.+..++||+|+||+||++.+-..|+    +|++|++.... ......++.+|+-++..++|||++++++++..+. ..+
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34567899999999999999877765    57777775443 3334567889999999999999999999986665 789


Q ss_pred             EEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |+++++ |+|+++++..+..+-......|..||++|+.|||.++++||||-..||||..-..+||+|||+++....+...
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            999999 6999999998888999999999999999999999999999999999999999999999999999988766665


Q ss_pred             cccccc--CccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~--~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....|  .+-|+|-|.+.. ..++.++||||+||.+||+|| |..|+.+....++...+..+..-..            
T Consensus       855 y~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsq------------  921 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQ------------  921 (1177)
T ss_pred             ccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCC------------
Confidence            555544  344899888866 788999999999999999985 6688888887777766655433211            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     .+..+-++..++.+||..|+..||+++++.+
T Consensus       922 ---------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  922 ---------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                           2356889999999999999999999998753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=224.16  Aligned_cols=260  Identities=27%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeec-eeccCCeEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELID-AFPHKGNLH   87 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~~~~~~   87 (314)
                      +.|+|.|.+.||+|.||.+-+++|+.+..++++|.+.....   ...++.+|..---.+. |.||+..++ .|+..+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            57999999999999999999999999999999999976543   2346677777666664 899998777 578889999


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC--CcEEEeeccceeeeCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSP  164 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~~~l~df~~~~~~~~~  164 (314)
                      +++||++ |+|.+.+...+  +-+.....++.|+++|+.|||+++++|||||.+||||-..  .++||||||.....+.-
T Consensus        99 F~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999 79999887755  8899999999999999999999999999999999999533  48999999999765432


Q ss_pred             CCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH-HHHHHHhhCCCCCCCCCCc
Q 021299          165 DRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (314)
                      -..   ......|.+||....    .....+.+|+|.||+++|.+++|.+||......+. ..+..+-            
T Consensus       177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w------------  241 (378)
T KOG1345|consen  177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW------------  241 (378)
T ss_pred             ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH------------
Confidence            211   112333899997642    22347889999999999999999999964221111 1111111            


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC---CCHHHHhcCccccccC
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR---ITAQQALEHRFAKSFN  298 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~h~~~~~~~  298 (314)
                               .....+..+..+..+++.+..++++-|..+|.+|   .+++......|..+.-
T Consensus       242 ---------~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  242 ---------LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             ---------hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence                     1112223344456679999999999999999999   7777777788877653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-31  Score=249.54  Aligned_cols=248  Identities=27%  Similarity=0.411  Sum_probs=198.9

Q ss_pred             hccceeeeCccccceEEEEEECC---C----CcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCC
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTK---T----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~---~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   84 (314)
                      +..+.+.||+|+||.|+++.-..   .    ...||+|.++..... .....+..|+++++.+. |+||+.+.+.+...+
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            33566799999999999996331   1    347999988766554 45567789999999994 999999999998889


Q ss_pred             eEEEEEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC
Q 021299           85 NLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~  148 (314)
                      ..+++.||+. |+|+.++...+               ..++......++.||+.|++||++.+++||||-..||++..+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence            9999999998 79999998776               3488899999999999999999999999999999999999999


Q ss_pred             cEEEeeccceeeeCCCCCcc-cccc--cCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCC-cHHHHHH
Q 021299          149 QLKLADFGLARIFGSPDRRF-THQV--FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSS-DIDQLGK  223 (314)
Q Consensus       149 ~~~l~df~~~~~~~~~~~~~-~~~~--~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~-~~~~~~~  223 (314)
                      .+||+|||+++.......-. ....  -+..|+|||.+.. ..++.++||||+|++|||+++. ..|+.+.. ..+....
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            99999999998643322111 1122  2444999999988 8899999999999999999865 58887755 4444443


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      +..+..-..|                           ..+++++.++++.||..+|++||+..++.
T Consensus       535 l~~G~r~~~P---------------------------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  535 LKEGNRMEQP---------------------------EHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HhcCCCCCCC---------------------------CCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            4443222222                           24589999999999999999999998875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=228.05  Aligned_cols=189  Identities=26%  Similarity=0.376  Sum_probs=154.0

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHH--HHHHHhhcCCCCeeeeeceeccC---
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR--EIKLLKELKSPHIIELIDAFPHK---   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~--e~~~l~~l~~~~i~~~~~~~~~~---   83 (314)
                      .+..+..+.+.||+|.||.||++.+.  |+.||+|++.....  .   ...+  |+.....++|+||+.+++.--.+   
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--R---SWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--h---hhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            45788999999999999999999655  88999999975432  1   2334  44555556999999999874222   


Q ss_pred             -CeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCceEEecCCcEEEe
Q 021299           84 -GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK--------KWVLHRDMKPNNLLIGSHGQLKLA  153 (314)
Q Consensus        84 -~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~i~H~di~~~nil~~~~~~~~l~  153 (314)
                       ...++|++|.+ |+|.+++....  ++-+....++..++.||+|||.        -.|+|||||..||+|..++..-|+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence             26799999998 89999998854  8999999999999999999994        249999999999999999999999


Q ss_pred             eccceeeeCCCC----CcccccccCccccCcccccCccCC----C-CcchHhhHHHHHHHHH
Q 021299          154 DFGLARIFGSPD----RRFTHQVFARWYRAPELLFGAKQY----G-AGVDVWAAGCIFAELL  206 (314)
Q Consensus       154 df~~~~~~~~~~----~~~~~~~~~~~y~sPE~~~~~~~~----~-~~~Di~slG~ll~~ll  206 (314)
                      |+|+|.......    ......+||.+|||||++......    + ..+||||+|+++||+.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            999998765442    234456899999999999653322    2 5689999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=230.44  Aligned_cols=190  Identities=28%  Similarity=0.375  Sum_probs=154.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHh--hcCCCCeeeeeceeccCC----e
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK--ELKSPHIIELIDAFPHKG----N   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~   85 (314)
                      +.....+++|+|.||.||+|+  -+++.||||++.....     ..+.+|-++.+  .+.|+||++++++-....    .
T Consensus       210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            345677899999999999995  4568999999975432     24445555554  457999999998754433    7


Q ss_pred             EEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccCCCCCCceEEecCCcEEEeec
Q 021299           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK---------KWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      +++|++|.+ |+|.+++....  +++.....++..+++||+|||+         ..|+|||||..||||..|+...|+||
T Consensus       283 ywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            899999998 79999998776  8999999999999999999995         45999999999999999999999999


Q ss_pred             cceeeeCCC--CCcccccccCccccCcccccCccCCC-----CcchHhhHHHHHHHHHhCCC
Q 021299          156 GLARIFGSP--DRRFTHQVFARWYRAPELLFGAKQYG-----AGVDVWAAGCIFAELLNRRP  210 (314)
Q Consensus       156 ~~~~~~~~~--~~~~~~~~~~~~y~sPE~~~~~~~~~-----~~~Di~slG~ll~~ll~g~~  210 (314)
                      |+|..+...  ....-..+||.+|||||++.+...+.     .+.||||+|++||||++...
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            999887432  22333478999999999998744443     56899999999999997653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.2e-29  Score=210.75  Aligned_cols=211  Identities=37%  Similarity=0.556  Sum_probs=176.3

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecc
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      |.+.+.||+|++|.||++....+++.+++|.+...... .....+.+|++.++.++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            67889999999999999999888899999999865443 12346668999999999999999999998889999999999


Q ss_pred             cc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Cccccc
Q 021299           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQ  171 (314)
Q Consensus        94 ~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~  171 (314)
                      ++ +|.+.+......+++..++.++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            97 8888887655448899999999999999999999999999999999999999999999999998765432 122334


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC--CCcHHHHHHHH
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG--SSDIDQLGKIF  225 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~--~~~~~~~~~~~  225 (314)
                      .++..|++||.+.+...++.++|+|+||+++++|++|..||..  .+.......+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            5667799999884336677899999999999999999999976  33334444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=5.3e-31  Score=256.38  Aligned_cols=201  Identities=14%  Similarity=0.197  Sum_probs=146.6

Q ss_pred             hcCC-CCeeeeecee-------ccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 021299           67 ELKS-PHIIELIDAF-------PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK  138 (314)
Q Consensus        67 ~l~~-~~i~~~~~~~-------~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~  138 (314)
                      .++| .||+.+.+++       .....++.++|+++++|.+++......+++..+..++.||+.||.|||++||+|+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            4455 5777777776       2234677889999999999998766679999999999999999999999999999999


Q ss_pred             CCceEEecCCc-------------------EEEeeccceeeeCCCC----------------CcccccccCccccCcccc
Q 021299          139 PNNLLIGSHGQ-------------------LKLADFGLARIFGSPD----------------RRFTHQVFARWYRAPELL  183 (314)
Q Consensus       139 ~~nil~~~~~~-------------------~~l~df~~~~~~~~~~----------------~~~~~~~~~~~y~sPE~~  183 (314)
                      |+|||++..+.                   +|++|||++.......                .......+|++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999965444                   4555555554211000                000113478889999998


Q ss_pred             cCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCC
Q 021299          184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSA  263 (314)
Q Consensus       184 ~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (314)
                      .+ ..++.++|||||||+||||++|.+|+....  .....+....   .+..                        ....
T Consensus       188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~---~~~~------------------------~~~~  237 (793)
T PLN00181        188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV---LPPQ------------------------ILLN  237 (793)
T ss_pred             cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh---cChh------------------------hhhc
Confidence            77 567999999999999999999988765322  1122221111   0000                        0011


Q ss_pred             CHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          264 SDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       264 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      .+...+++.+||..+|.+||++.|+++||||...
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            4456789999999999999999999999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-30  Score=216.48  Aligned_cols=251  Identities=18%  Similarity=0.251  Sum_probs=200.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC-----cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~   84 (314)
                      .+|++....+.+|.||.||.+++...+     +.+.+|..+.+....+ ...+.+|.-.+..+.|||++++.++. ++..
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ-v~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ-VNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH-HHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            477888899999999999999766433     2456666544332222 22455788888889999999999976 5566


Q ss_pred             eEEEEEeccc-ccHHHHHHh-----CC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecc
Q 021299           85 NLHLVFEFME-TDLETVIRN-----TN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~-----~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                      ..+.++++.+ |+|..++..     ..  ..++.-+...++.|++.|++|||++|++|.||-..|.++++.-+|||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            7889999998 799888872     21  246677889999999999999999999999999999999999999999999


Q ss_pred             ceeeeCCCCCccc--ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          157 LARIFGSPDRRFT--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       157 ~~~~~~~~~~~~~--~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      +++.........-  ....+..|+|||.+.. ..++.++|+||||++||||+| |+.|+...++.+....+..+..-..|
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            9987644332211  1122445999999977 779999999999999999985 66999999999998888877554444


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .                           ++++++..++.-||..+|++||+.+|+..
T Consensus       521 ~---------------------------NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 F---------------------------NCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             C---------------------------CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            4                           45889999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=6.5e-29  Score=199.02  Aligned_cols=167  Identities=20%  Similarity=0.257  Sum_probs=130.4

Q ss_pred             ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        95 g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                      |+|.+.+...+..+++..++.++.|++.||.|||+++      ||+||+++.++.+++  ||.+.......     ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            6788888877777999999999999999999999998      999999999999999  99998764422     2578


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      +.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .....+........+...+                
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------  130 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRS----------------  130 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccc----------------
Confidence            89999999977 66889999999999999999999999765432 2233332221111111000                


Q ss_pred             CCCCccCCCCCH--HHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          254 PPLRSLFPSASD--DALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       254 ~~~~~~~~~~~~--~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                           ....++.  ++.++|.+||..+|.+||++.|+++|+|+..
T Consensus       131 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 -----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                 0011233  6999999999999999999999999999863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5.1e-29  Score=231.60  Aligned_cols=267  Identities=26%  Similarity=0.373  Sum_probs=202.5

Q ss_pred             hhc-cceeeeCccccceEEEEEECCCCcEEEEEEeecC----CcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           12 DRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        12 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      +.| .....+|.|++|.|+.+......+.+..|.+...    .........+..|+-+-..+.|+|++.......+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            345 5678899999998888877776666777766522    11111111233566667778999998888877666655


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-  165 (314)
                      .-.||||+++|...+... +.+....+-.++.|++.|+.|||+.|+.|+|+|++|+++..+|.+||+|||.+..+..+. 
T Consensus       397 ~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            555999999888877765 358888999999999999999999999999999999999999999999999998764432 


Q ss_pred             ---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHH-HHHHhhCCCCCCCCCCcCc
Q 021299          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLG-KIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  241 (314)
                         ....+..|+..|+|||.+.+..+.....||||.|++++-|.+|+.||......+... ....          ...  
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----------~~~--  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----------SDQ--  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc----------ccc--
Confidence               334566788889999999886677889999999999999999999997655443321 0000          000  


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                              .........++..++.+.+.+|.+||+.||.+|.|+++|++.+||+++..
T Consensus       544 --------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  544 --------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                    00011112234457889999999999999999999999999999998764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-25  Score=195.76  Aligned_cols=253  Identities=22%  Similarity=0.232  Sum_probs=193.9

Q ss_pred             hccceeeeCccccceEEEEEECCCC-cEEEEEEeecCCcccCcchhhHHHHHHHhhcC----CCCeeeeecee-ccCCeE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELK----SPHIIELIDAF-PHKGNL   86 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~   86 (314)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|...........  .+..|..+++.+.    .+++..+++.. ..+.+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999987764 57888887665333221  3446788888876    36899999988 578899


Q ss_pred             EEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-----CcEEEeecccee-
Q 021299           87 HLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----GQLKLADFGLAR-  159 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-----~~~~l~df~~~~-  159 (314)
                      ++||+.++.+|.++..... +.++...+..++.|++.+|.+||+.|++||||||+|+++...     ..+.|.|||+++ 
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            9999999999999886654 789999999999999999999999999999999999999765     369999999998 


Q ss_pred             -eeC-CCC------Cc-ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCC
Q 021299          160 -IFG-SPD------RR-FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT  230 (314)
Q Consensus       160 -~~~-~~~------~~-~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~  230 (314)
                       ... ...      .. .....||..|+|+....+ ...+++.|+||++.++.+++.|..||...........+......
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence             321 111      11 223458999999998877 66799999999999999999999999776654444443332211


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .....                       .....+.++.++...+-..+...+|.-..+...
T Consensus       256 ~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11110                       111235677777777777888889988776443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-26  Score=182.47  Aligned_cols=216  Identities=22%  Similarity=0.310  Sum_probs=179.4

Q ss_pred             cccccHHH-HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC-CCeeeeecee
Q 021299            3 EVDLSKKV-ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAF   80 (314)
Q Consensus         3 ~~~~~~~~-~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~   80 (314)
                      ..++++.| ++.|++++.||+|+||.+|++....+|+.||+|.-......++.    ..|..+.+.+++ .+|..+..+.
T Consensus         5 ~~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL----~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen    5 SGSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQL----LYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             ccchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcch----hHHHHHHHHhccCCCCchhhhhc
Confidence            34556666 79999999999999999999999999999999998776655543    368888888875 7787777788


Q ss_pred             ccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           81 PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      .+..+..+||+..+.+|.+++.--...++...+..++.|++.-++|+|.++++|+||||+|+++.-   ..++.++|||+
T Consensus        81 ~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   81 TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            888899999999999999988766667999999999999999999999999999999999999954   46899999999


Q ss_pred             eeeeCC-------CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHH
Q 021299          158 ARIFGS-------PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK  223 (314)
Q Consensus       158 ~~~~~~-------~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~  223 (314)
                      ++..-+       +........||.+|.|-....+ ..-+...|+-|+|.+|.++.-|..||.+.........
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            986532       2223345678888999876655 3448899999999999999999999988665554443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.9e-23  Score=182.67  Aligned_cols=262  Identities=32%  Similarity=0.504  Sum_probs=205.9

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCC-CeeeeeceeccCCeEEEEEe
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSP-HIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~iv~e   91 (314)
                      |.+.+.||.|+++.||.+.+.   ..+++|.+........ ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999876   7889999887765543 455677899999999988 79999999977777899999


Q ss_pred             cccc-cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCCC-
Q 021299           92 FMET-DLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~-  166 (314)
                      ++.| .+...+....  ..++...+..++.|++.++.++|+.+++|+|+||+||+++..+ .++++|||.+........ 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9997 5664444433  2689999999999999999999999999999999999999988 799999999986544332 


Q ss_pred             -----cccccccCccccCcccccCc--cCCCCcchHhhHHHHHHHHHhCCCccCCCCc---HHHHHHHHHhhCCC-CCCC
Q 021299          167 -----RFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTA-TPSQ  235 (314)
Q Consensus       167 -----~~~~~~~~~~y~sPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~-~~~~  235 (314)
                           ......++..|.+||.+.+.  .......|+||+|++++++++|..||.....   .............. ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 23566789999999999774  5789999999999999999999999877764   33333333332222 1111


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ......                   ......+.+++..++..+|..|.+..+...++|....
T Consensus       239 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNP-------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCcccc-------------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            100000                   1124679999999999999999999999988666644

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.7e-24  Score=189.56  Aligned_cols=167  Identities=23%  Similarity=0.318  Sum_probs=126.3

Q ss_pred             HHHhhccceeeeCccccceEEEEEECC-CCcEEEEEEeecCCc---ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      .+.++|.+.+.||+|+||+||+|.+.. ++..+++|++.....   .......+.+|+++++.++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            457899999999999999999998876 677789998753311   112234567999999999999998533222   4


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM-KPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di-~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++||||+.|..+.... .   ..   ...++.+++.+|.+||++|++|+|| ||+||+++.++.++|+|||++.....
T Consensus        92 ~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             CcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            579999999974443321 1   11   1467899999999999999999999 99999999999999999999987654


Q ss_pred             CCCcc--------cccccCccccCcccccC
Q 021299          164 PDRRF--------THQVFARWYRAPELLFG  185 (314)
Q Consensus       164 ~~~~~--------~~~~~~~~y~sPE~~~~  185 (314)
                      .....        ....+++.|.+||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            33221        12345667899998753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.3e-24  Score=182.82  Aligned_cols=235  Identities=20%  Similarity=0.260  Sum_probs=149.8

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchhhHHHHHHHhhcC----------CCCeeeeecee-
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELK----------SPHIIELIDAF-   80 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~----------~~~i~~~~~~~-   80 (314)
                      ..+..+.||.|+++.||.+.+..+|+.+++|++........ ....+.+|.-....+.          |-.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678899999999999999999999999999877663222 2223333332332221          11222222221 


Q ss_pred             --------c---cCC-----eEEEEEecccccHHHHHHh---CCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 021299           81 --------P---HKG-----NLHLVFEFMETDLETVIRN---TNI---FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK  138 (314)
Q Consensus        81 --------~---~~~-----~~~iv~e~~~g~l~~~~~~---~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~  138 (314)
                              .   ...     ..+++|+.+.++|...+..   ...   .+.......+-.|+++.+++||+.|++|+||+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                    1   111     2478899999988777642   211   12233345566899999999999999999999


Q ss_pred             CCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCc-------cCCCCcchHhhHHHHHHHHHhCCCc
Q 021299          139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLNRRPF  211 (314)
Q Consensus       139 ~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~-------~~~~~~~Di~slG~ll~~ll~g~~p  211 (314)
                      |+|++++.+|.++|+||+.....+.....   ...+..|.|||.....       ..++.+.|.|+||+++|.|+++..|
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            99999999999999999988765443221   3445669999976432       2468899999999999999999999


Q ss_pred             cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC
Q 021299          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      |...........                               .+.... ++++.++.||..+|+.+|++|
T Consensus       250 f~~~~~~~~~~~-------------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW-------------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG-------------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc-------------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            976432221110                               112222 569999999999999999988

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-24  Score=173.32  Aligned_cols=245  Identities=15%  Similarity=0.192  Sum_probs=194.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .+......|.+.-.|..|++++.  |..+++|++.........-+.|.+|.-.++-+.||||+++++.+....+..++..
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            34456667888889999999654  6678999998888777777788899999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           92 FME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |++ |+|...+.+.. --++..++..++.++++|++|||+..  |....|+...++++++.+.+|. .+..++...    
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq----  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ----  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee----
Confidence            999 78888888764 35788899999999999999999964  4455689999999999877764 222222111    


Q ss_pred             ccccccCccccCcccccCccC--CCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FTHQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~--~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ..+....|.|+|||.+.....  ...++|+||+++++|++.|...||....+-+..-.+.-.                  
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------------  404 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------------  404 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------------
Confidence            123445788999999865222  247899999999999999999999988877765554221                  


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                              +....+.++++..+..|++-|+..||.+||....++
T Consensus       405 --------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 --------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             --------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                    122334567899999999999999999999987754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=7.9e-24  Score=172.95  Aligned_cols=174  Identities=12%  Similarity=0.086  Sum_probs=131.2

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc-hh------hHHHHHHHhhcCCCCeeeeecee
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FT------ALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-~~------~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      +.|.++|+++++||.|+||.||++.+  ++..+|+|.+.......... ..      +.+|++.+.++.|++|..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            45689999999999999999999754  46689999997654332211 11      45788899999999999998886


Q ss_pred             ccC--------CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           81 PHK--------GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        81 ~~~--------~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                      ...        +..+++|||++| +|.+..     .+++    ....+++.++..||+.|++|+|++|+||+++++| ++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence            432        357899999998 565542     1333    3456999999999999999999999999999988 99


Q ss_pred             EeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH
Q 021299          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (314)
Q Consensus       152 l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll  206 (314)
                      |+|||..........             -+.+.....+..++|+|+||+.+..+.
T Consensus       175 liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            999998864421111             111222245668999999999877665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.4e-23  Score=168.03  Aligned_cols=141  Identities=22%  Similarity=0.215  Sum_probs=107.7

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-------ch-----------------hhHHHHHHHhhcCCCC
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-------NF-----------------TALREIKLLKELKSPH   72 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~~~~   72 (314)
                      .+.||+|++|.||+|.+. +|+.||+|+++........       ..                 ....|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999986 8999999999876432211       00                 1124889999998777


Q ss_pred             eeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCceEEecCCcEE
Q 021299           73 IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        73 i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~i~H~di~~~nil~~~~~~~~  151 (314)
                      +.....+...  ..++||||++|+.+.......+.+++..+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            6443322222  2389999999853322222234689999999999999999999 799999999999999998 57899


Q ss_pred             Eeeccceeee
Q 021299          152 LADFGLARIF  161 (314)
Q Consensus       152 l~df~~~~~~  161 (314)
                      |+|||++...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=194.21  Aligned_cols=240  Identities=28%  Similarity=0.409  Sum_probs=192.7

Q ss_pred             eeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEeccc
Q 021299           19 VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      .+|.|++|.|++++..   ..|..|++|+..+.............|..++...+ ||.++.++..++.++..+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            4799999999998532   34677999998776544443334446778888886 9999999999999999999999999


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccccc
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  173 (314)
                      | .+..-+.... ...+.....+...++-++.++|+.+++|+|+|++||+++.+|.+++.|||.++..-.....    .|
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG  155 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence            7 5555554443 4667777778888888999999999999999999999999999999999999865332222    78


Q ss_pred             CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccC
Q 021299          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (314)
Q Consensus       174 ~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
                      +..|+|||++.   ......|.||+|+++++|++|..||..    ++...+...-..                       
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~-----------------------  205 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE-----------------------  205 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-----------------------
Confidence            88999999996   347899999999999999999999987    455554432111                       


Q ss_pred             CCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       254 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                           ....++.++.+++..++..+|.+|.-.     .++++|+||++++
T Consensus       206 -----~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  206 -----MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             -----CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence                 112458899999999999999999865     7899999999985

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-22  Score=168.15  Aligned_cols=210  Identities=22%  Similarity=0.289  Sum_probs=177.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+-.|++.+.||.|+||.++.+...-+++.||||.-......++.    ..|.+..+.|. .++|..++-+-+++.+..+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQL----rdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQL----RDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchH----HHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            356799999999999999999998889999999998776655543    35777777774 7999999877788889999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-----CcEEEeeccceeeeCC
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----GQLKLADFGLARIFGS  163 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-----~~~~l~df~~~~~~~~  163 (314)
                      |+|..+.+|.+++.--+..++...+..++.|++.-++++|++.++++||||+|+||...     ..+.++|||.++..-.
T Consensus       102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            99999999999988777789999999999999999999999999999999999999644     3699999999986533


Q ss_pred             C-------CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHH
Q 021299          164 P-------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI  224 (314)
Q Consensus       164 ~-------~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~  224 (314)
                      +       ........||.+|||-....+ ..-+...|+-|||=++++.+-|..||.+........+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY  248 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY  248 (449)
T ss_pred             ccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence            2       234456778999999888777 55689999999999999999999999887665555444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=7.3e-24  Score=198.98  Aligned_cols=248  Identities=27%  Similarity=0.341  Sum_probs=181.1

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc--hhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      +|...+.||++.|=+|.++++.. | .+++|++-++.......  ....++++ ...+++||.+++......++-.|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            67889999999999999997543 3 59999998776433322  12224444 55568999999998888888889999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      +|...+|.+.+..+. .+.+.....|+.|++.|+.-+|..|++|||||.+|||++.=+.+.|+||..-+..--+.++...
T Consensus       101 qyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            999999999887554 5788888999999999999999999999999999999999999999999876533222222211


Q ss_pred             -------cccCccccCcccccCc---------cC-CCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCC
Q 021299          171 -------QVFARWYRAPELLFGA---------KQ-YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       171 -------~~~~~~y~sPE~~~~~---------~~-~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                             .....+|+|||.+...         .. .+++-||||+||+++|++ .|.+||.-.+    +-....+. ...
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~-~~~  254 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGN-ADD  254 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccC-ccC
Confidence                   1123459999998541         12 578899999999999997 4578885321    11111110 000


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ++.           .        +.   .--+..++.||..|++.||++|.++++.|+.
T Consensus       255 ~e~-----------~--------Le---~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQ-----------L--------LE---KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHH-----------H--------HH---hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            000           0        00   0014479999999999999999999999976

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=5.7e-23  Score=192.62  Aligned_cols=240  Identities=26%  Similarity=0.380  Sum_probs=183.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|..++.+..|++|.||+++|+.+.+++++ ++.++..-.       +.  ++....+|.++               
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lil-------Rn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLIL-------RN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhh-cccccchhh-------hc--cccccCCccee---------------
Confidence            357899999999999999999999999999999 443322110       00  22222334433               


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC-----
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-----  164 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~-----  164 (314)
                           |+....++..+ .++.+.        +.+++|||+.||+|+|+||+|.+|..-|..|++|||+++.....     
T Consensus       136 -----gDc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 66555555443 344444        67999999999999999999999999999999999999653211     


Q ss_pred             ----------CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          165 ----------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       165 ----------~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                                ........|||.|.|||++.. .-|....|.|+||+|+|+.+.|..||.+..+++.+...+......+..
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                      111234578999999999877 668999999999999999999999999999999999988765555444


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC---HHHHhcCccccccCcc---eeecccce
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRFAKSFNGV---FVFVDFCS  308 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~~~---~~~~~~~~  308 (314)
                      ++                         .++++++++|.++|+.+|..|.-   +-++..|+||+.++-.   +-...+.+
T Consensus       281 de-------------------------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvp  335 (1205)
T KOG0606|consen  281 DE-------------------------ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVP  335 (1205)
T ss_pred             Cc-------------------------CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccc
Confidence            32                         34899999999999999999965   5778899999999755   55555555


Q ss_pred             ecccCC
Q 021299          309 YLYSSN  314 (314)
Q Consensus       309 ~~~~~~  314 (314)
                      .+.++|
T Consensus       336 ql~~ed  341 (1205)
T KOG0606|consen  336 QLESED  341 (1205)
T ss_pred             cccccc
Confidence            555443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=5.1e-22  Score=160.81  Aligned_cols=142  Identities=18%  Similarity=0.173  Sum_probs=110.4

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc------------------------chhhHHHHHHHhhcCCC
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------------------------NFTALREIKLLKELKSP   71 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~   71 (314)
                      +.+.||+|++|.||+|.+. +|+.||+|+++........                        ......|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999876 8999999999876422110                        01123688889999988


Q ss_pred             CeeeeeceeccCCeEEEEEeccccc-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCc
Q 021299           72 HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        72 ~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~  149 (314)
                      ++.....+....  .++||||++|. +...... ...++...+..++.|++.++.+||+ .|++|+||||+||+++ ++.
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            875444333222  47999999984 3333222 3457888999999999999999999 9999999999999998 889


Q ss_pred             EEEeeccceeeeC
Q 021299          150 LKLADFGLARIFG  162 (314)
Q Consensus       150 ~~l~df~~~~~~~  162 (314)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=7.9e-22  Score=167.52  Aligned_cols=202  Identities=24%  Similarity=0.284  Sum_probs=148.0

Q ss_pred             CCCCeeeeeceecc---------------------------CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHH
Q 021299           69 KSPHIIELIDAFPH---------------------------KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL  121 (314)
Q Consensus        69 ~~~~i~~~~~~~~~---------------------------~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~  121 (314)
                      +||||+.+.++|.+                           +...|+||..++.+|..++..+.  .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence            58999999887733                           34679999999999999998776  67778889999999


Q ss_pred             HHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccceeeeCC------CCCcccccccCccccCcccccCccCC--
Q 021299          122 KGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGS------PDRRFTHQVFARWYRAPELLFGAKQY--  189 (314)
Q Consensus       122 ~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~~~~~~~------~~~~~~~~~~~~~y~sPE~~~~~~~~--  189 (314)
                      .|+.|||++|+.|+|+|.+||++.-+.    .++|.|||+|-.-..      ..+......|.-.-+|||+...-..+  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999995432    589999999853221      12233345566678999988541111  


Q ss_pred             ---CCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHH
Q 021299          190 ---GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD  266 (314)
Q Consensus       190 ---~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (314)
                         =.++|.|+.|.+.||+++...||=.....                       +.+..+++..   .++.....+++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------------------~L~~r~Yqe~---qLPalp~~vpp~  485 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------------------LLDTRTYQES---QLPALPSRVPPV  485 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchh-----------------------eechhhhhhh---hCCCCcccCChH
Confidence               25899999999999999999888442111                       1111111111   123334567999


Q ss_pred             HHHHHhhhcccCCCCCCCHH---HHh------cCccccccC
Q 021299          267 ALDLLSKMFTYDPKARITAQ---QAL------EHRFAKSFN  298 (314)
Q Consensus       267 ~~~li~~~l~~dp~~Rps~~---ell------~h~~~~~~~  298 (314)
                      +++++..+|+.||+||+++.   .+|      .|.|++++.
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~  526 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMM  526 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhc
Confidence            99999999999999999963   333      466666554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.7e-20  Score=149.15  Aligned_cols=185  Identities=18%  Similarity=0.139  Sum_probs=135.9

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC--cchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEe
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--VNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .+...|++|+||+||++..  .+.+++.+.+........  ....+.+|+++++++. ++++..++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3678999999999998854  677888888766554322  2224668999999995 5788888875    44689999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCceEEecCCcEEEeeccceeeeCCCCCc---
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM-KPNNLLIGSHGQLKLADFGLARIFGSPDRR---  167 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di-~~~nil~~~~~~~~l~df~~~~~~~~~~~~---  167 (314)
                      |+.|..+.....      .. ...++.|++.+|.++|++|++|+|| ||.||+++.++.++|+|||.+.........   
T Consensus        79 yI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            999854332211      11 1357889999999999999999999 799999999999999999999865433311   


Q ss_pred             -c-c--------ccccCccccCcccccCccCCC-CcchHhhHHHHHHHHHhCCCcc
Q 021299          168 -F-T--------HQVFARWYRAPELLFGAKQYG-AGVDVWAAGCIFAELLNRRPFL  212 (314)
Q Consensus       168 -~-~--------~~~~~~~y~sPE~~~~~~~~~-~~~Di~slG~ll~~ll~g~~pf  212 (314)
                       . .        ....++.+++|+...--...+ ...+.++.|.-+|.++|+..++
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence             0 0        112356677777653322233 6778899999999999999665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=4.5e-20  Score=175.90  Aligned_cols=192  Identities=22%  Similarity=0.328  Sum_probs=157.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC---CCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   87 (314)
                      ++.|-|.+.||.|++|.||+|.+.. |+.+|+|+-.....++.-.     -.+++.+|+   -+.|..+...+...+..+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            5789999999999999999998777 9999999988777665322     223344444   345666666666677778


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-------CCcEEEeecccee
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-------HGQLKLADFGLAR  159 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-------~~~~~l~df~~~~  159 (314)
                      +|++|.+ |+|++++. ..+.+++..+..+..|++..+.+||..+|+|+||||+|+++-.       +--++|+|||.+.
T Consensus       771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            9999998 79999988 4446999999999999999999999999999999999999942       2359999999997


Q ss_pred             eeC--CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCC
Q 021299          160 IFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP  210 (314)
Q Consensus       160 ~~~--~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~  210 (314)
                      .+.  .+........+|-.+-.+|...+ .+++++.|.|.|+.+++-|+.|..
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            662  34456667778888999998877 899999999999999999999884

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.9e-20  Score=154.31  Aligned_cols=151  Identities=20%  Similarity=0.193  Sum_probs=112.8

Q ss_pred             ccHHHHhh--ccceeeeCccccceEEEEE-ECCCCcEEEEEEeecCCcccC----------------------cchhhHH
Q 021299            6 LSKKVADR--YLKREVLGEGTYGVVYKAI-DTKTGQTVAIKKIRLGKQKEG----------------------VNFTALR   60 (314)
Q Consensus         6 ~~~~~~~~--y~~~~~lg~g~~g~vy~~~-~~~~~~~~~iK~~~~~~~~~~----------------------~~~~~~~   60 (314)
                      +...+...  |.+.+.||+|++|.||+|. +..+|..|++|.++.......                      .......
T Consensus        20 ~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       20 LYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             HHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            33444444  8899999999999999998 667899999999986542110                      0012347


Q ss_pred             HHHHHhhcCCCC--eeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCC
Q 021299           61 EIKLLKELKSPH--IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDM  137 (314)
Q Consensus        61 e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-i~H~di  137 (314)
                      |++.++.+.+.+  +.++++.    ...++|||+++|..+..............+..++.|++.++.+||+.| ++|+||
T Consensus       100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence            999999987533  3344432    234799999998433322222334666778899999999999999999 999999


Q ss_pred             CCCceEEecCCcEEEeeccceeee
Q 021299          138 KPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       138 ~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ||+||+++ +++++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999998754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=9.2e-20  Score=162.96  Aligned_cols=207  Identities=24%  Similarity=0.325  Sum_probs=156.3

Q ss_pred             HhhcCCCCeeeeeceeccCCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCce
Q 021299           65 LKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV-LHRDMKPNNL  142 (314)
Q Consensus        65 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i-~H~di~~~ni  142 (314)
                      ++.+.|.|+.++++.+.++...++|.+||. |+|.+.+......++......++++|+.||+|||...+ .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356889999999999988899999999998 79999998888889999999999999999999999866 9999999999


Q ss_pred             EEecCCcEEEeeccceeeeCCC--CCcccccccCccccCcccccCcc------CCCCcchHhhHHHHHHHHHhCCCccCC
Q 021299          143 LIGSHGQLKLADFGLARIFGSP--DRRFTHQVFARWYRAPELLFGAK------QYGAGVDVWAAGCIFAELLNRRPFLQG  214 (314)
Q Consensus       143 l~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~sPE~~~~~~------~~~~~~Di~slG~ll~~ll~g~~pf~~  214 (314)
                      +++....+||+|||+.......  ............|.|||.+....      ..+.+.|+||+|++++++++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999999776321  01111112234599999986621      147789999999999999999999976


Q ss_pred             CCcHHHHHHHHHhhCC-CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          215 SSDIDQLGKIFAAFGT-ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       215 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      ........+++..... ......|....                  .....+++..++++||..+|.+||+++++-
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIEL------------------LNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhh------------------hhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            3322222222222111 11111111100                  013466899999999999999999999873

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=8.5e-19  Score=142.90  Aligned_cols=135  Identities=16%  Similarity=0.152  Sum_probs=103.6

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-----CCCCeeeeeceeccCC---eE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-----KSPHIIELIDAFPHKG---NL   86 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~   86 (314)
                      .-.+.||+|++|.||.  +..++.. ++|++......  ....+.+|+..++.+     +||||++++++++++.   ..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            4567899999999995  5666555 69988764322  234567999999999     5799999999997763   43


Q ss_pred             E-EEEeccc---ccHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCceEEecC----CcEEEeeccc
Q 021299           87 H-LVFEFME---TDLETVIRNTNIFLSPADIKSYMQMTLKGL-AFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGL  157 (314)
Q Consensus        87 ~-iv~e~~~---g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~i~H~di~~~nil~~~~----~~~~l~df~~  157 (314)
                      + +|+||.+   |+|.+++.+.  .+++.  ..++.+++.++ +|||+++|+|+||||+||+++.+    .+++|+|++.
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            3 7899955   5888888653  36655  35577777777 99999999999999999999743    3799999543


Q ss_pred             e
Q 021299          158 A  158 (314)
Q Consensus       158 ~  158 (314)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.7e-18  Score=139.58  Aligned_cols=136  Identities=18%  Similarity=0.260  Sum_probs=109.6

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC------cchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++.||+|++|.||++.+  .|..+++|..........      ......+|++++..+.|+++.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999976  577899998765432211      1123557899999999998887776766677789999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ||++| +|.+.+....    . ....++.+++.+|.+||+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99987 7776665432    2 7789999999999999999999999999999999 78999999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=3.5e-19  Score=156.75  Aligned_cols=177  Identities=27%  Similarity=0.402  Sum_probs=134.6

Q ss_pred             eEEEEEeccc-ccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           85 NLHLVFEFME-TDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      +.||.|++|. .+|.+++..+  ....+......++.|++.++.|   ++.+|+|+||.||+...+..++|+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5789999998 5899998644  3356778889999999999999   99999999999999999999999999999876


Q ss_pred             CCCC------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          162 GSPD------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       162 ~~~~------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ....      .......||.+|++||.+.+ ..++.++|||+||++|++++.. ...+...   .+...+..+  ..++.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g--~ip~~  480 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDG--IIPPE  480 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcC--CCChH
Confidence            4433      23445688999999999988 7799999999999999999972 2222111   111111111  11111


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      .                         ..-.++-..|+.+||...|.+||++.+.-.|+|.+
T Consensus       481 ~-------------------------~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  481 F-------------------------LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             H-------------------------hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            1                         11145567999999999999999888888888763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=1.6e-19  Score=168.44  Aligned_cols=263  Identities=25%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC-cEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...|.+.+.||+|+++.|-++....+. ..++.|.+............+..|..+-+.+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            457889999999999999888654433 34566655544333333333445777777776 9999999999999999999


Q ss_pred             EEecccc-cHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCceEEecCC-cEEEeeccceeeeCC-
Q 021299           89 VFEFMET-DLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGS-  163 (314)
Q Consensus        89 v~e~~~g-~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~-  163 (314)
                      ..++..| ++...+ .......+...+..++.|+..++.|+| ..+++|+||+|+|.+++.++ ..++.|||++..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9999886 666666 333326778888999999999999999 99999999999999999999 999999999987644 


Q ss_pred             C--CCccccccc-CccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          164 P--DRRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       164 ~--~~~~~~~~~-~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .  ........| ++.|.+||.+.+.....+..|+||+|+++..+++|..|+...........-           |... 
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-----------~~~~-  246 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-----------WKSN-  246 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-----------eccc-
Confidence            2  223334566 889999999988667789999999999999999999888665443311110           0000 


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                 ....-...+..++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus       247 -----------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  247 -----------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       000012234567889999999999999999999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=2.1e-17  Score=134.78  Aligned_cols=138  Identities=22%  Similarity=0.273  Sum_probs=104.4

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC--------------------cchhhHHHHHHHhhcCCCC-
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--------------------VNFTALREIKLLKELKSPH-   72 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~~~-   72 (314)
                      |.+.+.||+|++|.||++... +|+.+++|.++.......                    .......|...+..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999764 789999999875431110                    0012346788888887764 


Q ss_pred             -eeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           73 -IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        73 -i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                       +...++    ....+++|||++|..+..+..      ......++.+++.++.++|+.|++|+||+|.||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             333433    234589999999843332221      134567889999999999999999999999999999999999


Q ss_pred             EeeccceeeeC
Q 021299          152 LADFGLARIFG  162 (314)
Q Consensus       152 l~df~~~~~~~  162 (314)
                      |+|||.+....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2.8e-17  Score=134.20  Aligned_cols=131  Identities=21%  Similarity=0.288  Sum_probs=101.0

Q ss_pred             eeCccccceEEEEEECCCCcEEEEEEeecCCcccCc------chhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------NFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      .||+|++|.||++.  ..|..+++|...........      ...+.+|+++++.+.++++.....++......+++||+
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999997  45678999987654322111      12345799999999887755544444455667899999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ++| ++.+.+.... .       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            987 6655544321 1       8899999999999999999999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.7e-17  Score=148.66  Aligned_cols=261  Identities=21%  Similarity=0.233  Sum_probs=205.0

Q ss_pred             HHHhhccceeeeCc--cccceEEEEEE--CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccC
Q 021299            9 KVADRYLKREVLGE--GTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~--g~~g~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   83 (314)
                      .....+.+.+.+|.  |.+|.||.+.-  ..++..+++|+-+.....+.....-.+++...+.++ |++.++....|++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            44567888999999  99999999987  678889999986555443333333446666666664 88999988899999


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccce
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK----GLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLA  158 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~  158 (314)
                      +..++-.|.++.++..+.......++...++....+...    |+.++|+.+++|.|++|+||+...+ ...+++|||..
T Consensus       191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            999999999999999999988888999999999999999    9999999999999999999999999 88999999999


Q ss_pred             eeeCCCCCccccc-----ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          159 RIFGSPDRRFTHQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       159 ~~~~~~~~~~~~~-----~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      ...+.........     .+...|++||...+  .++..+|+|+||.++.+..++..++....                -
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~----------------~  332 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK----------------N  332 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC----------------C
Confidence            8887665443333     66777999999865  67999999999999999988875543220                0


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..|-+....         .  .-..+..+.+.++...+..|++.+|..|+++..+..|+++....
T Consensus       333 ~~W~~~r~~---------~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  333 SSWSQLRQG---------Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             CCccccccc---------c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            011100000         0  00111224467777899999999999999999999999998653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=9.7e-17  Score=149.86  Aligned_cols=139  Identities=19%  Similarity=0.236  Sum_probs=107.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc------CcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      ...|...+.||+|++|+||++....  ..+++|+........      .....+.+|+++++.++|+++.....+.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455678999999999999997543  344555433221111      01124568999999999999888776666666


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ..++||||++| +|.+.+.         ....++.+++.+|.+||+.|++|+||||+||++ .++.++|+|||++...
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            77899999987 6666554         346789999999999999999999999999999 6789999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=1.5e-16  Score=128.53  Aligned_cols=136  Identities=24%  Similarity=0.310  Sum_probs=96.9

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhh----------------------HHHHHHHhhcCCCC--
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----------------------LREIKLLKELKSPH--   72 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~~~--   72 (314)
                      .+.||+|++|+||++.+. +|+.|++|++.............                      ..|.+.+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999876 78999999987654322111111                      24555555554432  


Q ss_pred             eeeeeceeccCCeEEEEEecccc-cHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCc
Q 021299           73 IIELIDAFPHKGNLHLVFEFMET-DLE-TVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        73 i~~~~~~~~~~~~~~iv~e~~~g-~l~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~  149 (314)
                      +.++++.    ...+++|||++| ++. ..+....  . ...+..++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            3334332    235899999997 221 1111111  1 16678999999999999999 9999999999999999 899


Q ss_pred             EEEeeccceeee
Q 021299          150 LKLADFGLARIF  161 (314)
Q Consensus       150 ~~l~df~~~~~~  161 (314)
                      ++|+|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1.4e-15  Score=127.08  Aligned_cols=135  Identities=24%  Similarity=0.315  Sum_probs=101.0

Q ss_pred             eeeC-ccccceEEEEEECCCCcEEEEEEeecCCc------c-----cCcchhhHHHHHHHhhcCCCCe--eeeeceecc-
Q 021299           18 EVLG-EGTYGVVYKAIDTKTGQTVAIKKIRLGKQ------K-----EGVNFTALREIKLLKELKSPHI--IELIDAFPH-   82 (314)
Q Consensus        18 ~~lg-~g~~g~vy~~~~~~~~~~~~iK~~~~~~~------~-----~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-   82 (314)
                      ..|| .|+.|+||.+...  +..+++|.+.....      .     ........+|++++..+.|+++  +..+++... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8999999999654  77899998864221      0     1122345689999999998775  556655322 


Q ss_pred             CC---eEEEEEecccc--cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           83 KG---NLHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        83 ~~---~~~iv~e~~~g--~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      .+   ..++|+|+++|  +|...+...  .+++..    +.+++.++.+||+.|++|+||||.||+++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            22   23599999996  676666542  355443    56899999999999999999999999999999999999998


Q ss_pred             eee
Q 021299          158 ARI  160 (314)
Q Consensus       158 ~~~  160 (314)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            865

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.65  E-value=3.5e-15  Score=135.34  Aligned_cols=170  Identities=23%  Similarity=0.358  Sum_probs=128.1

Q ss_pred             EEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCC
Q 021299           30 KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLS  109 (314)
Q Consensus        30 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~  109 (314)
                      .+..+.++.++.+.++.....  .......+.++.++.++||+|+++++.++.++..|+|+|.+.. +..++.+    +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH----hH
Confidence            355577888999998877655  2333566899999999999999999999999999999999873 2222222    22


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccC
Q 021299          110 PADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ  188 (314)
Q Consensus       110 ~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~  188 (314)
                      ...+..-+.||+.||.+|| +.+++|++|+.+.|+|+..|.+||++|..+...............--.|..|+.+..   
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---
Confidence            5666778899999999997 678999999999999999999999999988654332211112222223677765522   


Q ss_pred             CCCcchHhhHHHHHHHHHhCC
Q 021299          189 YGAGVDVWAAGCIFAELLNRR  209 (314)
Q Consensus       189 ~~~~~Di~slG~ll~~ll~g~  209 (314)
                      -.-..|.|.||+++++++.|.
T Consensus       180 s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  180 SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cccchhhhhHHHHHHHHhCcc
Confidence            124579999999999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.3e-15  Score=116.90  Aligned_cols=132  Identities=19%  Similarity=0.219  Sum_probs=108.7

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC--CCeeeeeceeccCCeEEEEEecc
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      +++.||+|.++.||++...  +..+++|.......    ...+.+|+..++.+.+  ..+.+++.+....+..++++|++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            5688999999999999864  37899999865432    3356689999999976  58888888887778899999999


Q ss_pred             cccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        94 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .|.....+       +......++.+++.+++.||..   +++|+|++|.||++++.+.++++||+.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            97433322       4566678899999999999985   799999999999999989999999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.54  E-value=1.1e-13  Score=106.90  Aligned_cols=144  Identities=19%  Similarity=0.214  Sum_probs=111.8

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc------hhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN------FTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+..+.+|+.+.|+++  ...|+.++||.-..........      ..-.+|++.+.++.--+|....-++.+.....++
T Consensus        11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            6789999999999999  5668899998765544322211      2234788988888766666666666677777899


Q ss_pred             Eecccc--cHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeeccceeee
Q 021299           90 FEFMET--DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF  161 (314)
Q Consensus        90 ~e~~~g--~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~~~~~~  161 (314)
                      |||++|  ++.+++...... ........++.+|-..+.-||.++++|+||+.+||++..++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999999  888888766433 33334489999999999999999999999999999997665   4589999999764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=7.7e-15  Score=122.51  Aligned_cols=213  Identities=15%  Similarity=0.206  Sum_probs=146.8

Q ss_pred             HHHHhhcCCCCeeeeeceeccCC-----eEEEEEeccc-ccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 021299           62 IKLLKELKSPHIIELIDAFPHKG-----NLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKK--  130 (314)
Q Consensus        62 ~~~l~~l~~~~i~~~~~~~~~~~-----~~~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~--  130 (314)
                      ...+..+-|.|+++++.||.+..     ...++.||+. |++...+++.   ...+......+|+.||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34556667999999999995543     5788999998 6777777643   34688888999999999999999987  


Q ss_pred             CcccCCCCCCceEEecCCcEEEeeccceeeeCC----CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH
Q 021299          131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS----PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (314)
Q Consensus       131 ~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll  206 (314)
                      -++|++++.+.|++..+|-+|++--........    .........+-+.|.+||.=.. ...+-++|||++|....+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHH
Confidence            499999999999999999888863322211100    0111112234566889986543 34577899999999999998


Q ss_pred             hCCCc-cCCCC---cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC
Q 021299          207 NRRPF-LQGSS---DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       207 ~g~~p-f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      .+..- -....   ..+..+....+                                  .-...-+.++.+|++..|..|
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~----------------------------------len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIG----------------------------------LENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheee----------------------------------ccCccccCcCcccccCCCCCC
Confidence            76521 11111   11111111110                                  012234578899999999999


Q ss_pred             CCHHHHhcCccccccCcceeeccccee
Q 021299          283 ITAQQALEHRFAKSFNGVFVFVDFCSY  309 (314)
Q Consensus       283 ps~~ell~h~~~~~~~~~~~~~~~~~~  309 (314)
                      |++.+++.||-+-.+...-....+|=.
T Consensus       323 p~ar~llfHpllfeVhslkll~ahclv  349 (458)
T KOG1266|consen  323 PDARLLLFHPLLFEVHSLKLLMAHCLV  349 (458)
T ss_pred             cchhhhhcCceeeecchHHHHhhHhee
Confidence            999999999998877655555555543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.53  E-value=1.1e-13  Score=111.06  Aligned_cols=140  Identities=17%  Similarity=0.155  Sum_probs=100.1

Q ss_pred             eeeeCccccceEEEEEECC------CCcEEEEEEeecCCcc-----------cC---------cchhhH----HHHHHHh
Q 021299           17 REVLGEGTYGVVYKAIDTK------TGQTVAIKKIRLGKQK-----------EG---------VNFTAL----REIKLLK   66 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~------~~~~~~iK~~~~~~~~-----------~~---------~~~~~~----~e~~~l~   66 (314)
                      ...||.|-.+.||.|....      .+..+|+|+++.....           ..         ....+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999997543      3578999998764311           00         011122    6888888


Q ss_pred             hcCC--CCeeeeeceeccCCeEEEEEeccccc-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCce
Q 021299           67 ELKS--PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHRDMKPNNL  142 (314)
Q Consensus        67 ~l~~--~~i~~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~i~H~di~~~ni  142 (314)
                      ++..  -.+..++++    ...++||||++|+ +...... ...++...+..+..+++.+|..| |+.|++|+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8864  345555543    4557999999873 2211111 22355667778889999999998 899999999999999


Q ss_pred             EEecCCcEEEeeccceeeeC
Q 021299          143 LIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus       143 l~~~~~~~~l~df~~~~~~~  162 (314)
                      ++. ++.+.|+|||.+...+
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            996 5789999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.6e-13  Score=123.11  Aligned_cols=152  Identities=20%  Similarity=0.288  Sum_probs=99.6

Q ss_pred             ccHHHHhhccc--eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-----------------------------
Q 021299            6 LSKKVADRYLK--REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-----------------------------   54 (314)
Q Consensus         6 ~~~~~~~~y~~--~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----------------------------   54 (314)
                      ++..+.+-|..  .+.||+|+.|.||+|.. .+|+.||||+.++.....-.                             
T Consensus       109 lg~~~~~~F~~fd~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~  187 (437)
T TIGR01982       109 LGGPLEELFAEFEEKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVV  187 (437)
T ss_pred             hCcCHHHHHhhCCCcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHH
Confidence            34444444432  46799999999999985 47899999998765311000                             


Q ss_pred             ---------chhhHHHHHHHhhcC-----CCCeeeeece-eccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHH
Q 021299           55 ---------NFTALREIKLLKELK-----SPHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQ  118 (314)
Q Consensus        55 ---------~~~~~~e~~~l~~l~-----~~~i~~~~~~-~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~  118 (314)
                               ...+.+|++.+.++.     ++++ .+-.. +...+..+++|||++| ++.+.........+   ...++.
T Consensus       188 ~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~  263 (437)
T TIGR01982       188 KEFEKTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAE  263 (437)
T ss_pred             HHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHH
Confidence                     012334555555552     2333 33332 3334557899999998 55444432211222   234555


Q ss_pred             HHHH-HHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299          119 MTLK-GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus       119 ~i~~-~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      .++. .+..+|..|++|+|++|.||++..+++++++|||.+...+
T Consensus       264 ~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       264 NLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5554 4688999999999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.45  E-value=7.9e-12  Score=110.72  Aligned_cols=221  Identities=14%  Similarity=0.177  Sum_probs=160.9

Q ss_pred             ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec----cCCeEEEEEecccc--cH
Q 021299           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP----HKGNLHLVFEFMET--DL   97 (314)
Q Consensus        24 ~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~iv~e~~~g--~l   97 (314)
                      ...+.|++..+.+|..|++|.+.....-  ...+...-+++++++.|+|++++.+++.    .+...++|++|+++  +|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3468899999999999999999433221  1113346788999999999999999885    34478999999996  67


Q ss_pred             HHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           98 ETVIRN--------------TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        98 ~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      .++.-.              .+..++++.+|.++.|++.||.++|+.|+..+-|.|.+|+++.+.+++|..+|+......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            766522              123478899999999999999999999999999999999999999999999998877644


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      +.       +       +-+.+    .++-|.=.||.+++.|.+|..- +..........                    
T Consensus       446 d~-------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~--------------------  487 (655)
T KOG3741|consen  446 DP-------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL--------------------  487 (655)
T ss_pred             CC-------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHH--------------------
Confidence            33       0       11222    4678999999999999999631 11111111101                    


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC---ccccccCc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH---RFAKSFNG  299 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h---~~~~~~~~  299 (314)
                                    ..+...++.+++++|.-+....+++ -++.+++.+   .||..+..
T Consensus       488 --------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes  532 (655)
T KOG3741|consen  488 --------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMES  532 (655)
T ss_pred             --------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHh
Confidence                          1112345888999999998888886 577777643   45544443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=6.1e-13  Score=105.60  Aligned_cols=128  Identities=20%  Similarity=0.123  Sum_probs=93.2

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeee-eeceeccCCeEEEEEecccc
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-LIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~iv~e~~~g   95 (314)
                      ++.|++|..+.||++...  +..+++|........   .....+|+..++.+.+.++++ ++...  ....++|||+++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            578899999999999754  778999997654321   123457888888886655443 44332  2335799999998


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCceEEecCCcEEEeeccceee
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV-----LHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i-----~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .......        .....+..+++.+++.||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        76 ~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4322110        1123456789999999999885     9999999999998 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=5.1e-14  Score=133.27  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=190.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-chhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+.+.+.+-+.+|+++.+..+....+|.....|........... ...+..+-.++-...+|.++...-.+.-....+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            46677888999999999999987777766666654433221111 11111111222222345555555444555677899


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC-----
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-----  163 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~-----  163 (314)
                      +++.+| ++.+.++..+ ..+.+.++..+..+..++++||...+.|+|++|.|.+...++..++.+|+.....+-     
T Consensus       883 ~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             hHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            999985 7888777665 477788888889999999999999999999999999999999999999874322110     


Q ss_pred             --------------------------CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc
Q 021299          164 --------------------------PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (314)
Q Consensus       164 --------------------------~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~  217 (314)
                                                +........+++.|.+||.+.+ ......+|.|+.|+++++.++|.+||....+
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                      0011223467888999999877 6668899999999999999999999999888


Q ss_pred             HHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHH---HHhcCccc
Q 021299          218 IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRFA  294 (314)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---ell~h~~~  294 (314)
                      ......+...-     ..|+.                    .....++++.+++..++..+|.+|..+.   ++-.|+||
T Consensus      1041 q~~f~ni~~~~-----~~~p~--------------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~ 1095 (1205)
T KOG0606|consen 1041 QQIFENILNRD-----IPWPE--------------------GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFF 1095 (1205)
T ss_pred             hhhhhccccCC-----CCCCC--------------------CccccChhhhhhhhhhhccCchhccCcccccccccCCcc
Confidence            87776554331     12221                    1234588999999999999999999987   89999999


Q ss_pred             cccC
Q 021299          295 KSFN  298 (314)
Q Consensus       295 ~~~~  298 (314)
                      +..+
T Consensus      1096 ~~~~ 1099 (1205)
T KOG0606|consen 1096 QDVD 1099 (1205)
T ss_pred             CCCC
Confidence            9874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=1.2e-12  Score=120.35  Aligned_cols=147  Identities=17%  Similarity=0.280  Sum_probs=95.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc--------------------C---c---------c-
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--------------------G---V---------N-   55 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--------------------~---~---------~-   55 (314)
                      ++-..|.. +.||+|+.|.||+|..+.+|+.||+|+.++.....                    .   .         . 
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34456776 89999999999999988789999999998653110                    0   0         0 


Q ss_pred             -----hhhHHHHHHHhhcC----CCCeeeeecee-ccCCeEEEEEecccc-cHHHH--HHhCCC---CCCHHHHHHHHHH
Q 021299           56 -----FTALREIKLLKELK----SPHIIELIDAF-PHKGNLHLVFEFMET-DLETV--IRNTNI---FLSPADIKSYMQM  119 (314)
Q Consensus        56 -----~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~iv~e~~~g-~l~~~--~~~~~~---~l~~~~~~~i~~~  119 (314)
                           ..+.+|+..+.++.    +...+.+-.++ +-....+++|||+.| .+.+.  +...+.   .+.+..+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                 11234554444442    33333333333 234567899999998 45432  222221   1333333444444


Q ss_pred             HHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccceeeeCC
Q 021299          120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGS  163 (314)
Q Consensus       120 i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~~~~~~~  163 (314)
                      +       ...|++|+|++|.||+++.++    +++++|||.......
T Consensus       276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4       469999999999999999888    999999999987643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=6.3e-13  Score=119.57  Aligned_cols=249  Identities=19%  Similarity=0.170  Sum_probs=178.4

Q ss_pred             HhhccceeeeCccccceEEEEEEC-CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ..+|-.+..||.|.++.|+.+... .++..|++|..............-..|+.+...+ .|.+++.....|...+..|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            467889999999999999998755 5778999998876654443332333566666666 48888888888888888889


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~  167 (314)
                      --|||.|.....-......+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++||+..+.+..   .
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---~  420 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---S  420 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce---e
Confidence            99999863333322333347888889999999999999999999999999999999876 7889999998874321   1


Q ss_pred             ccccccCcccc-CcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FTHQVFARWYR-APELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~~~~~~~~y~-sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......-++. .+|.+.....+..+.|++|||+-+.+..++... ....+.....    .+                  
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~----~~------------------  478 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR----SG------------------  478 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee----cc------------------
Confidence            12222333344 256565557788999999999999999988742 2221111110    00                  


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                .....++...++..+.+.+...++..||.+.++..|.=|
T Consensus       479 ----------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  479 ----------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ----------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                      001112335788899999999999999999998877644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=6.6e-12  Score=97.58  Aligned_cols=133  Identities=17%  Similarity=0.270  Sum_probs=95.9

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccC-cchh-----hHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFT-----ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~-----~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..+++|+.+.+|.+..  -|..+++|.-.+...... ...+     -.+|++++..+.--+|....-+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4678999999999944  455677776544432221 1112     2268999998876666655555556666789999


Q ss_pred             cccccHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           92 FMETDLET-VIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        92 ~~~g~l~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      |++|.++. .+...    .    ..++..+-.-+.-||..||+|+||+++||++...+ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99996655 55543    1    45666667777899999999999999999997654 999999999754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.34  E-value=7.3e-11  Score=102.37  Aligned_cols=253  Identities=14%  Similarity=0.083  Sum_probs=160.1

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeec-----ee--ccCCeEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID-----AF--PHKGNLH   87 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-----~~--~~~~~~~   87 (314)
                      ...+.||+|+.+.+|-.-.   -.-.+.|++.........    .+-..+.+.-.||-+-.-+.     .+  ..+...-
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            4567899999999998832   224677888654432211    12222333334554332111     11  1223377


Q ss_pred             EEEecccc--cHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           88 LVFEFMET--DLETVIR-----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        88 iv~e~~~g--~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ++|+.+.|  ....++.     ......++..+...++.++.+.+.||..|.+-+|++++|++|++++.|.|+|=..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            89999987  3333332     1233467888999999999999999999999999999999999999999998766655


Q ss_pred             eCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcH-----HHHHHHHHhhCC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDI-----DQLGKIFAAFGT  230 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~-----~~~~~~~~~~~~  230 (314)
                      . .........+|...|.+||.-.-    +..-+..+|.|.||+++++++.| .+||.+..-.     -.-..|..+...
T Consensus       167 ~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 N-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             c-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            4 44555566778888999997531    12346889999999999999876 7999763210     000011111111


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccC--CCCCCCHHH
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD--PKARITAQQ  287 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--p~~Rps~~e  287 (314)
                      ..+.            .......++...=+.-+++.+..|+.+|+...  +.-|||++.
T Consensus       246 ya~~------------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASD------------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echh------------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            0000            00001111111112346889999999999854  567999864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=4.4e-12  Score=115.94  Aligned_cols=154  Identities=19%  Similarity=0.266  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC---------cccccccCccccCcccccCccC
Q 021299          119 MTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---------RFTHQVFARWYRAPELLFGAKQ  188 (314)
Q Consensus       119 ~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---------~~~~~~~~~~y~sPE~~~~~~~  188 (314)
                      +++.|+.++|.. +++|++|.|++|.++.++.+||++|+++........         .........-|.+||.+.. ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            334899999976 899999999999999999999999999976533211         1111122344999999877 66


Q ss_pred             CCCcchHhhHHHHHHHHH-hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHH
Q 021299          189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDA  267 (314)
Q Consensus       189 ~~~~~Di~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (314)
                      .+.++|+||||+++|.+. .|+..+...........-.... ...                       .......+++++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~~~-----------------------~~~~s~~~p~el  241 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-NAG-----------------------AFGYSNNLPSEL  241 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-ccc-----------------------cccccccCcHHH
Confidence            789999999999999998 5666555543333222211110 000                       001114679999


Q ss_pred             HHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          268 LDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       268 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ++=+.++|..++..||++.+++..|||+.-
T Consensus       242 ~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  242 RESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             HHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            999999999999999999999999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.1e-10  Score=96.63  Aligned_cols=140  Identities=19%  Similarity=0.267  Sum_probs=100.2

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeeceeccC---CeEEEEEe
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHK---GNLHLVFE   91 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~---~~~~iv~e   91 (314)
                      .+.|+.|..+.||++... +|..+++|........ ........|+++++.+.+.+  +.+++.+....   +..+++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            467899999999999764 3679999998654432 23335668999999987644  56667666553   36689999


Q ss_pred             ccccc-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 021299           92 FMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-----------------------------------------  129 (314)
Q Consensus        92 ~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------  129 (314)
                      +++|. +......  ..++......++.+++.++..||+                                         
T Consensus        81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99984 3332211  235666666667777777777763                                         


Q ss_pred             ---------------CCcccCCCCCCceEEec--CCcEEEeeccceee
Q 021299          130 ---------------KWVLHRDMKPNNLLIGS--HGQLKLADFGLARI  160 (314)
Q Consensus       130 ---------------~~i~H~di~~~nil~~~--~~~~~l~df~~~~~  160 (314)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23699999999999998  56789999998853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=8.3e-11  Score=94.04  Aligned_cols=126  Identities=27%  Similarity=0.348  Sum_probs=80.7

Q ss_pred             EEEEEECCCCcEEEEEEeecCCcc-----------cC--------cc-----hhhHHHHHHHhhcCCCC--eeeeeceec
Q 021299           28 VYKAIDTKTGQTVAIKKIRLGKQK-----------EG--------VN-----FTALREIKLLKELKSPH--IIELIDAFP   81 (314)
Q Consensus        28 vy~~~~~~~~~~~~iK~~~~~~~~-----------~~--------~~-----~~~~~e~~~l~~l~~~~--i~~~~~~~~   81 (314)
                      ||.|.. .+|..+|+|..+.....           ..        .+     ....+|.+.|.++..-+  +.+++++. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            888874 56789999998664211           00        11     11236999999998764  55555442 


Q ss_pred             cCCeEEEEEeccc--ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           82 HKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF-CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        82 ~~~~~~iv~e~~~--g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                         ...+||||++  |.....+....  ++.+....++.+++..+.. +|..|++|+||++.||+++++ .+.++|||.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence               3369999999  74444444332  2244556777888874444 679999999999999999887 9999999999


Q ss_pred             eee
Q 021299          159 RIF  161 (314)
Q Consensus       159 ~~~  161 (314)
                      ...
T Consensus       154 v~~  156 (188)
T PF01163_consen  154 VDS  156 (188)
T ss_dssp             EET
T ss_pred             eec
Confidence            764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=4e-10  Score=95.40  Aligned_cols=141  Identities=17%  Similarity=0.051  Sum_probs=96.8

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCccc---------CcchhhHHHHHHHhhcCCCCee--eeeceecc----
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---------GVNFTALREIKLLKELKSPHII--ELIDAFPH----   82 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~----   82 (314)
                      +.+.......|.++.  .+|+.|.+|.........         .....+.+|++.+..+...+|.  +++++.+.    
T Consensus        28 e~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            344433444466663  457789999774433111         1111356788888777543333  23444422    


Q ss_pred             -CCeEEEEEecccc--cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-------CCcEE
Q 021299           83 -KGNLHLVFEFMET--DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-------HGQLK  151 (314)
Q Consensus        83 -~~~~~iv~e~~~g--~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-------~~~~~  151 (314)
                       ....++|+|+++|  ++.+++... ....+......++.+++..+..||+.|++|+|+++.||+++.       +..+.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence             2357899999998  677776532 234567788899999999999999999999999999999975       46899


Q ss_pred             Eeeccceee
Q 021299          152 LADFGLARI  160 (314)
Q Consensus       152 l~df~~~~~  160 (314)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.14  E-value=4.4e-10  Score=92.67  Aligned_cols=138  Identities=24%  Similarity=0.303  Sum_probs=102.9

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc--------------------CcchhhHHHHHHHhhcCCC--
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--------------------GVNFTALREIKLLKELKSP--   71 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~~~--   71 (314)
                      +.+...||-|-.+.||.+.+ ..|.++++|.-+......                    .......+|.+.|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            35678899999999999985 478899999754332110                    0112344788899988765  


Q ss_pred             CeeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        72 ~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                      .+.+.++.    +...+|||+++|..+..+.     ++.+.+..++..|+.-+..+-..|++|+|+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            66666654    6668999999994433332     24555667777777777777799999999999999999999999


Q ss_pred             Eeeccceeee
Q 021299          152 LADFGLARIF  161 (314)
Q Consensus       152 l~df~~~~~~  161 (314)
                      ++||..+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999887654

>PRK09902 hypothetical protein; Provisional

Probab=98.98  E-value=1.5e-08  Score=81.71  Aligned_cols=137  Identities=14%  Similarity=0.069  Sum_probs=100.7

Q ss_pred             CccccceEEEEEECCCCcEEEEEEeecCC----cccCcchhhHHHHHHHhhcCCCC--eeeeeceec-----cCCeEEEE
Q 021299           21 GEGTYGVVYKAIDTKTGQTVAIKKIRLGK----QKEGVNFTALREIKLLKELKSPH--IIELIDAFP-----HKGNLHLV   89 (314)
Q Consensus        21 g~g~~g~vy~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~-----~~~~~~iv   89 (314)
                      |.|+-+.|+.....  |+.+-+|.-....    ..+.....+.+|+..+..+...+  +.+++ ++.     ..-..++|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45888899998543  4578888764221    11334456778999888885422  44444 332     12246799


Q ss_pred             Eecccc--cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc--EEEeeccceee
Q 021299           90 FEFMET--DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARI  160 (314)
Q Consensus        90 ~e~~~g--~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~df~~~~~  160 (314)
                      +|-++|  +|.+.+... -.+.+......+..+++.+++-||+.|+.|+|+.+.||+++.++.  +.++||.-+..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            999996  888877553 234677888899999999999999999999999999999987776  99999987754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=7.8e-09  Score=84.64  Aligned_cols=136  Identities=18%  Similarity=0.215  Sum_probs=93.0

Q ss_pred             cceEEEEEEC---CCCcEEEEEEeecCCccc-----CcchhhHHHHHHHhhcCCCC--eeeeeceeccC----CeEEEEE
Q 021299           25 YGVVYKAIDT---KTGQTVAIKKIRLGKQKE-----GVNFTALREIKLLKELKSPH--IIELIDAFPHK----GNLHLVF   90 (314)
Q Consensus        25 ~g~vy~~~~~---~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~iv~   90 (314)
                      .+.++.+...   ..++.|.+|.+.......     -......+|++.+..+...+  ..+++++.+..    ...++|+
T Consensus        17 R~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lit   96 (206)
T PF06293_consen   17 RRGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLIT   96 (206)
T ss_pred             CceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEE
Confidence            3445555433   234566666543322111     12234567888777775332  33344443321    2458999


Q ss_pred             ecccc--cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeeccceeee
Q 021299           91 EFMET--DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF  161 (314)
Q Consensus        91 e~~~g--~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~~~~~~  161 (314)
                      |+++|  +|.+.+..... .+......++.+++..++-||..|++|+|+++.|||++.++   .+.++||+-+...
T Consensus        97 e~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen   97 EALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             EeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99997  67777765332 66777889999999999999999999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.97  E-value=4.7e-09  Score=84.89  Aligned_cols=138  Identities=17%  Similarity=0.229  Sum_probs=91.8

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhh---------HHHHHHHhhcCCCCeee---
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA---------LREIKLLKELKSPHIIE---   75 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~---------~~e~~~l~~l~~~~i~~---   75 (314)
                      +.+.++|.+.+++......-|.+..  -+|+.+++|..+.....  .++.+         .+.+..+..+...++..   
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~  102 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD  102 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence            3457899999999999988888884  55789999998764322  11111         13444444443322222   


Q ss_pred             -----eeceeccCCeEEEEEeccccc-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc
Q 021299           76 -----LIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        76 -----~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~  149 (314)
                           -...+......+++|||++|- +.+...     +++    .+...+.+++.-||+.|++|+|.+|.|+++..+ .
T Consensus       103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             ceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c
Confidence                 222233345567899999993 333321     333    344567788999999999999999999999854 5


Q ss_pred             EEEeecccee
Q 021299          150 LKLADFGLAR  159 (314)
Q Consensus       150 ~~l~df~~~~  159 (314)
                      ++++|++...
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999997554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.80  E-value=1.8e-08  Score=82.36  Aligned_cols=139  Identities=22%  Similarity=0.209  Sum_probs=95.2

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc----------------c-hhh-----HHHHHHHhhcCCC--C
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV----------------N-FTA-----LREIKLLKELKSP--H   72 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~----------------~-~~~-----~~e~~~l~~l~~~--~   72 (314)
                      ...|++|-.+.||+|.. .++..+|+|+++........                . ...     .+|...|+++...  .
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34667888899999963 56789999999765422111                0 111     1467777777543  3


Q ss_pred             eeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEE
Q 021299           73 IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        73 i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~  151 (314)
                      +.+.+++.    ...+|||+++..-.-.-.-+..++....+..+..++++.+.-|-. .+++|+||+.-|||+. ++.+.
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            44445442    346999999854110001112224444678888999999999888 8999999999999998 88999


Q ss_pred             Eeeccceeee
Q 021299          152 LADFGLARIF  161 (314)
Q Consensus       152 l~df~~~~~~  161 (314)
                      ++|++.+...
T Consensus       207 iID~~QaV~~  216 (268)
T COG1718         207 IIDVSQAVTI  216 (268)
T ss_pred             EEECcccccc
Confidence            9999998754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.72  E-value=8.2e-08  Score=88.16  Aligned_cols=144  Identities=19%  Similarity=0.270  Sum_probs=94.6

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc--------------------------------------hhh
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--------------------------------------FTA   58 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~--------------------------------------~~~   58 (314)
                      ...|+.++-|.||.|.- .+|+.||||+.++.....-..                                      ..+
T Consensus       130 ~~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         130 PEPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CCchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            36889999999999985 459999999987653210000                                      112


Q ss_pred             HHHHHHHhhcC-----CCCeeeeeceeccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021299           59 LREIKLLKELK-----SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV  132 (314)
Q Consensus        59 ~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i  132 (314)
                      .+|+..+.++.     .+++.-..=+|+-.+...++|||++| .+.+........++...+...+.++  -+..+-..|+
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            24555555552     24443333344556777899999999 3444322222346644444443333  2344456899


Q ss_pred             ccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299          133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus       133 ~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      +|+|.+|.||+++.+|++.+.|||.....+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            9999999999999999999999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.61  E-value=6.8e-07  Score=74.16  Aligned_cols=134  Identities=21%  Similarity=0.199  Sum_probs=81.5

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      ..|++|..+.||+.    .|..+++|......    ......+|.+.++.+..-+  +.+++++...++...++|++++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            67899999999984    25578899886432    1224568999998886443  35666666677778899999998


Q ss_pred             c-HHH-HH---------------------HhCC-CCCCHHH-HHHHHHH----------HHH-HHHHHH----hCCcccC
Q 021299           96 D-LET-VI---------------------RNTN-IFLSPAD-IKSYMQM----------TLK-GLAFCH----KKWVLHR  135 (314)
Q Consensus        96 ~-l~~-~~---------------------~~~~-~~l~~~~-~~~i~~~----------i~~-~l~~Lh----~~~i~H~  135 (314)
                      . ... ..                     +.-. ....... ...+..+          +.. ...+|.    ...++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            3 111 11                     0000 0011111 0011000          001 111121    1246899


Q ss_pred             CCCCCceEEecCCcEEEeeccceee
Q 021299          136 DMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       136 di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      |+.|.||++++++ +.++||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999998853

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.53  E-value=2.5e-07  Score=89.92  Aligned_cols=199  Identities=18%  Similarity=0.228  Sum_probs=134.0

Q ss_pred             HHHHHHhhcCCCCeeeeeceeccCCeEE----EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 021299           60 REIKLLKELKSPHIIELIDAFPHKGNLH----LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH  134 (314)
Q Consensus        60 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~----iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H  134 (314)
                      .|...+..+.|+|++.+..+-.+....-    +..+++.+ ++...+.. -+.++.+..+.+..++..|++++|+....|
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            4666777778999999988764433222    34567776 55555554 446899999999999999999999996666


Q ss_pred             CCCCCC---ceEEecCCcEEEe--eccceeeeCCCCCcccccccCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhC
Q 021299          135 RDMKPN---NLLIGSHGQLKLA--DFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNR  208 (314)
Q Consensus       135 ~di~~~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g  208 (314)
                      .-+...   +.-++..+.+..+  ||+.+.......... ....+..+.++|.... ........|+|++|.++..+..|
T Consensus       310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~  388 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG  388 (1351)
T ss_pred             eEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence            555555   3334455566666  888877654433322 2233445777776644 12234557999999999999988


Q ss_pred             CCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCC-HHHHHHHhhhcccCCCCCCCHHH
Q 021299          209 RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSAS-DDALDLLSKMFTYDPKARITAQQ  287 (314)
Q Consensus       209 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dp~~Rps~~e  287 (314)
                      ..+-........              .                        .+..+ .+..++..+|+..++++|+++.+
T Consensus       389 ~~i~~~~~~~~~--------------~------------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  389 EDISEKSAVPVS--------------L------------------------LDVLSTSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             Ccccccccchhh--------------h------------------------hccccchhhhhhhhhhcchhhhhccchhh
Confidence            743221110000              0                        00111 26889999999999999999999


Q ss_pred             HhcCccccccC
Q 021299          288 ALEHRFAKSFN  298 (314)
Q Consensus       288 ll~h~~~~~~~  298 (314)
                      ++.|+|.+.-.
T Consensus       431 ll~~~f~~~~~  441 (1351)
T KOG1035|consen  431 LLTHPFLRFPT  441 (1351)
T ss_pred             hhhchhccccc
Confidence            99999998654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=2.1e-06  Score=66.75  Aligned_cols=130  Identities=18%  Similarity=0.197  Sum_probs=93.3

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEeccc
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      ...+.|++|.+|.||++.+.  |..+++|+-+.+....    .+..|++++..+.-.++.+=+-.+..   .++.|||+.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~----~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRR----NLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCcchh----hHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhc
Confidence            56788999999999999654  6689999987665443    55689999998887776665444422   246699999


Q ss_pred             c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCceEEecCCcEEEeeccceeee
Q 021299           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK-PNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        95 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~-~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      | .|.......    +    .+-...++....-|-..||-|+.|+ |..+++-.++++.|+||..|+..
T Consensus        96 G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            9 555544321    1    3444556666666778899999975 55566666669999999988743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.42  E-value=5.5e-06  Score=69.74  Aligned_cols=72  Identities=22%  Similarity=0.223  Sum_probs=48.1

Q ss_pred             eeeCcccc-ceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTY-GVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~-g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      ..|..|.. ..||++..  .+..+++|......     ......|+++++.+. +--+.+++.+...++..++||++++|
T Consensus         4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            34445555 88999953  34688999886543     123457888888774 33355666666666678899999998


Q ss_pred             c
Q 021299           96 D   96 (314)
Q Consensus        96 ~   96 (314)
                      .
T Consensus        77 ~   77 (244)
T cd05150          77 V   77 (244)
T ss_pred             c
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=4.9e-06  Score=69.22  Aligned_cols=138  Identities=18%  Similarity=0.242  Sum_probs=77.1

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeecee---ccCCeEEEEEe
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAF---PHKGNLHLVFE   91 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~---~~~~~~~iv~e   91 (314)
                      ++.|+.|..+.||++....  ..+++|.....    .......+|..+++.+...+  +..++...   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            5789999999999997654  59999997544    12234557888887775333  34444422   33445789999


Q ss_pred             ccccc-HHH----------------H---HHhCC---CCCCHHH------HHHH---------------HHHHHH-HHHH
Q 021299           92 FMETD-LET----------------V---IRNTN---IFLSPAD------IKSY---------------MQMTLK-GLAF  126 (314)
Q Consensus        92 ~~~g~-l~~----------------~---~~~~~---~~l~~~~------~~~i---------------~~~i~~-~l~~  126 (314)
                      +++|. +..                .   ++...   .......      ...+               ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            99983 333                0   01110   0000000      0000               111112 2333


Q ss_pred             HH-------hCCcccCCCCCCceEEe-cCCcEEEeeccceee
Q 021299          127 CH-------KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARI  160 (314)
Q Consensus       127 Lh-------~~~i~H~di~~~nil~~-~~~~~~l~df~~~~~  160 (314)
                      ++       ...++|+|++|.||+++ .++++-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33       24599999999999999 566678999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=9.8e-06  Score=74.51  Aligned_cols=152  Identities=21%  Similarity=0.285  Sum_probs=95.1

Q ss_pred             cccHHHHhhcc--ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc----------------------------
Q 021299            5 DLSKKVADRYL--KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV----------------------------   54 (314)
Q Consensus         5 ~~~~~~~~~y~--~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~----------------------------   54 (314)
                      |++..+.+-|.  ..+.|+..+.+.||+|+-+. |+.||+|+-++.....-.                            
T Consensus       152 ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE  230 (538)
T KOG1235|consen  152 ELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE  230 (538)
T ss_pred             HhCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence            34444544443  34689999999999998554 999999997665322100                            


Q ss_pred             -------chhhHHHHHHHhhc----CCCC---eeeeec-eeccCCeEEEEEecccc---cHHHHHHhCCCCCCHHHHHHH
Q 021299           55 -------NFTALREIKLLKEL----KSPH---IIELID-AFPHKGNLHLVFEFMET---DLETVIRNTNIFLSPADIKSY  116 (314)
Q Consensus        55 -------~~~~~~e~~~l~~l----~~~~---i~~~~~-~~~~~~~~~iv~e~~~g---~l~~~~~~~~~~l~~~~~~~i  116 (314)
                             .-.+.+|++...+.    .|-+   -+.+-. ++.-.....++|||++|   +-.+.+.+.+  ++...+..-
T Consensus       231 ~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~  308 (538)
T KOG1235|consen  231 IAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNK  308 (538)
T ss_pred             HHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHH
Confidence                   01222344444443    2333   111222 33445677899999998   4445555554  555544333


Q ss_pred             HHHHHHHHHHHHhCCcccCCCCCCceEEec----CCcEEEeeccceeee
Q 021299          117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIF  161 (314)
Q Consensus       117 ~~~i~~~l~~Lh~~~i~H~di~~~nil~~~----~~~~~l~df~~~~~~  161 (314)
                      +.+..  +.-|-..|++|+|=+|.||++.+    ++.+.+-|||+....
T Consensus       309 l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  309 LVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            33322  22334678999999999999984    568999999999765

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=2.4e-05  Score=77.29  Aligned_cols=80  Identities=18%  Similarity=0.270  Sum_probs=55.6

Q ss_pred             ceeeeCccccceEEEEEECCCC--cEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCe--eeeeceeccC---CeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHI--IELIDAFPHK---GNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~   87 (314)
                      .++.++.|..+.+|++.....+  ..+++|+........ ....+.+|+++++.+. |.++  .+++.++.+.   +..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            4678899999999999765433  478888865432211 1224568999999985 5654  6666666543   4678


Q ss_pred             EEEeccccc
Q 021299           88 LVFEFMETD   96 (314)
Q Consensus        88 iv~e~~~g~   96 (314)
                      +|||+++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999984

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=5.9e-05  Score=60.95  Aligned_cols=133  Identities=20%  Similarity=0.337  Sum_probs=91.9

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCC--------------cccCcchhhHHHHHHHhhcC------CCCeeee
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--------------QKEGVNFTALREIKLLKELK------SPHIIEL   76 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~   76 (314)
                      ...||+|+.-.||.--   .+....||+.....              ..........+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4678999999998763   34567899987766              01111233445655555554      7899999


Q ss_pred             eceeccCCeEEEEEeccc---c----cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-
Q 021299           77 IDAFPHKGNLHLVFEFME---T----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-  148 (314)
Q Consensus        77 ~~~~~~~~~~~iv~e~~~---g----~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-  148 (314)
                      +|+.+.+...-+|+|.+.   |    +|.+++.+..  +++ ...   ..+-.-..+|-+++|+.+|++|.||++..+. 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999999999999999875   3    5777774433  555 333   3344556788899999999999999996543 


Q ss_pred             ---cEEEee-ccce
Q 021299          149 ---QLKLAD-FGLA  158 (314)
Q Consensus       149 ---~~~l~d-f~~~  158 (314)
                         .++|+| ||..
T Consensus       157 ~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  157 GEFRLVLIDGLGEK  170 (199)
T ss_pred             CceEEEEEeCCCCc
Confidence               466665 4544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.13  E-value=5e-05  Score=63.47  Aligned_cols=72  Identities=17%  Similarity=0.243  Sum_probs=46.3

Q ss_pred             eeeeCccccceEEEEEECC-CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeee-eeceeccCCeEEEEEeccc
Q 021299           17 REVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-LIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~iv~e~~~   94 (314)
                      ++.|..|-...+|++.... .++.|++|........ .  ....+|..+++.+...++.+ ++... .+   .++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~--~d~~~E~~~~~~l~~~gl~P~v~~~~-~~---~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-I--IDRERELRIHKLLSKHGLAPKLYATF-QN---GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-e--ecHHHHHHHHHHHHhCCCCCeEEEEe-CC---cEEEEeeC
Confidence            5778899999999996432 3568999977543221 1  12336888888886544443 33332 22   38999998


Q ss_pred             c
Q 021299           95 T   95 (314)
Q Consensus        95 g   95 (314)
                      |
T Consensus        76 G   76 (235)
T cd05157          76 G   76 (235)
T ss_pred             C
Confidence            7

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.11  E-value=1.5e-05  Score=69.06  Aligned_cols=143  Identities=22%  Similarity=0.181  Sum_probs=99.8

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-------------------chh-----hHHHHHHHhhcCC
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-------------------NFT-----ALREIKLLKELKS   70 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-------------------~~~-----~~~e~~~l~~l~~   70 (314)
                      .+-.+|..|-...||.|. ..+|..+|||+++.+..-...                   .++     ..+|++.|+++..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            356788899999999996 567888999998665321100                   011     1258888888877


Q ss_pred             CCeeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCc
Q 021299           71 PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        71 ~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~  149 (314)
                      .+|.-.--...  ....+||++++++-.-.-+-....++...+..+-.+++..+.-|.+ .++||.||+--|+++ .+|.
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            66442221111  3447999999953221112233357888899999999998888876 589999999999988 5679


Q ss_pred             EEEeeccceeee
Q 021299          150 LKLADFGLARIF  161 (314)
Q Consensus       150 ~~l~df~~~~~~  161 (314)
                      +.++|.+.+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999999887644

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.05  E-value=3.6e-05  Score=65.26  Aligned_cols=133  Identities=23%  Similarity=0.256  Sum_probs=76.4

Q ss_pred             eeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee-eeeceeccCCeEEEEEecccccH
Q 021299           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNLHLVFEFMETDL   97 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~e~~~g~l   97 (314)
                      .+..|-.+.+|++.  .++..+++|...........  ...+|.++++.+...++. +++...  .  .++|+|+++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~--~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGV--DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccC--cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence            46678889999995  45678999976543222111  235788888888654443 233322  2  258999999832


Q ss_pred             HH---------------H---HHhCC---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCC
Q 021299           98 ET---------------V---IRNTN---IFLSPA-DIKSYMQMT---------LKGLAFCHK--------KWVLHRDMK  138 (314)
Q Consensus        98 ~~---------------~---~~~~~---~~l~~~-~~~~i~~~i---------~~~l~~Lh~--------~~i~H~di~  138 (314)
                      .+               .   ++...   .+++.. .+..+..++         ...+..+..        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            11               1   11111   111211 111221111         111222221        258999999


Q ss_pred             CCceEEecCCcEEEeeccceee
Q 021299          139 PNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       139 ~~nil~~~~~~~~l~df~~~~~  160 (314)
                      |.||++++++ +.|+||+.+..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999998876 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.93  E-value=3.7e-05  Score=64.31  Aligned_cols=31  Identities=29%  Similarity=0.462  Sum_probs=26.1

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .+++|+|+.+.||+++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998766667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.92  E-value=0.00014  Score=62.94  Aligned_cols=138  Identities=15%  Similarity=0.070  Sum_probs=80.1

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeece------eccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA------FPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~   87 (314)
                      -++.+..|....+|++..  .+..+++|.....     .......|++++..+.+.+  +.+++..      ...++..+
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            366778888899999953  3457999987641     1123446777777775433  3343332      12344568


Q ss_pred             EEEecccccHHH---------------HHHhCCCCC----------CHHHH----------HHHHHHHHHHHHHHHh---
Q 021299           88 LVFEFMETDLET---------------VIRNTNIFL----------SPADI----------KSYMQMTLKGLAFCHK---  129 (314)
Q Consensus        88 iv~e~~~g~l~~---------------~~~~~~~~l----------~~~~~----------~~i~~~i~~~l~~Lh~---  129 (314)
                      +++++++|....               .++.....+          .+...          ......+..++..+.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            999999872210               011100000          00000          0011112233444443   


Q ss_pred             ----CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 ----KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ----~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                          .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                4799999999999999887788999998853

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.88  E-value=1.2e-06  Score=80.44  Aligned_cols=243  Identities=14%  Similarity=0.100  Sum_probs=153.0

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC-eeeeeceeccCCeEEEEEecc
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLHLVFEFM   93 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~~   93 (314)
                      .....+++++.+.+++.+...+.... .+.+...       ....-++++|.+.+||| .+...+-++.+...++.++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            33445678888999988765554333 3333221       23345889999999999 666666677788899999999


Q ss_pred             ccc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           94 ETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        94 ~g~--l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      .+.  ...........+.+-+...+.+.-+.+++++|+.-=+|+|    ||+.. ++.++..+|+......... .....
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-~~~t~  390 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-KPRTA  390 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc-ccccC
Confidence            864  2222222222244445566677778899999988767887    66553 3688999999887654332 44556


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .+++.++|||.... ..+...-|.|++|+=..++.-|.+|-....  .....      ......   ...+.+.      
T Consensus       391 ~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~------~g~~p~---s~~L~~~------  452 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPM------IGNGPN---SPMLTDK------  452 (829)
T ss_pred             CCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCC------CCCCCC---ccccchh------
Confidence            78888999998766 567788899999987667776666654310  00000      000000   0000000      


Q ss_pred             cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                            ..+.  +.+-.++...|+...|..|+.....+-|.+|+.=
T Consensus       453 ------~aw~--~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  453 ------SAWS--PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             ------hhcC--cccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence                  0000  1111146778889999999999998888888753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.87  E-value=0.00021  Score=57.44  Aligned_cols=127  Identities=25%  Similarity=0.267  Sum_probs=85.0

Q ss_pred             hhccceeeeCcccc-ceEEEEEECCCCcEEEEEEeec---CCcc-------c---------CcchhhHHHHHHHhhcC--
Q 021299           12 DRYLKREVLGEGTY-GVVYKAIDTKTGQTVAIKKIRL---GKQK-------E---------GVNFTALREIKLLKELK--   69 (314)
Q Consensus        12 ~~y~~~~~lg~g~~-g~vy~~~~~~~~~~~~iK~~~~---~~~~-------~---------~~~~~~~~e~~~l~~l~--   69 (314)
                      ..++.++.||.|.. |.||+++  -.|..||+|.+..   ....       .         .....+..|.+...+++  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67889999999999 9999995  4577999999322   1110       0         01123446666666664  


Q ss_pred             -CCCe--eeeeceeccC------------------CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021299           70 -SPHI--IELIDAFPHK------------------GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH  128 (314)
Q Consensus        70 -~~~i--~~~~~~~~~~------------------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh  128 (314)
                       +.++  ++++++.--.                  ....||.|+....-         .+..    .-+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence             4455  7888875100                  12356777766432         1223    33456667778999


Q ss_pred             hCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299          129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus       129 ~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      +.||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999987     5678899854

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.87  E-value=0.00014  Score=63.50  Aligned_cols=138  Identities=14%  Similarity=0.091  Sum_probs=78.6

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeecee------ccCCeEEE
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAF------PHKGNLHL   88 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~------~~~~~~~i   88 (314)
                      ++.++.|....+|++..  ++..+++|.......    ......+.+++..+...+  +.+++...      ..++..++
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            56677888889999863  244789998754321    113335666666664322  33333321      23456789


Q ss_pred             EEecccccH------H---------HHHHhCCCCC--------CHHHHH---------------HHHHHHHHHHHHHH--
Q 021299           89 VFEFMETDL------E---------TVIRNTNIFL--------SPADIK---------------SYMQMTLKGLAFCH--  128 (314)
Q Consensus        89 v~e~~~g~l------~---------~~~~~~~~~l--------~~~~~~---------------~i~~~i~~~l~~Lh--  128 (314)
                      ++++++|..      .         ..++.....+        ....-.               .....+...+.++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            999998721      1         0111111111        001000               00111233444443  


Q ss_pred             -----hCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          129 -----KKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       129 -----~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                           ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 26899999999999999888778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.80  E-value=0.0002  Score=62.27  Aligned_cols=72  Identities=18%  Similarity=0.246  Sum_probs=45.7

Q ss_pred             eeeeCccccceEEEEEECC------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee-eeeceeccCCeEEEE
Q 021299           17 REVLGEGTYGVVYKAIDTK------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNLHLV   89 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv   89 (314)
                      ++.|..|-...+|++....      .++.+++|.........   ....+|.++++.+...++. +++.++. +   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL---IDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce---echHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            4677888889999997433      25789999976543221   1334788888887654443 3344433 2   257


Q ss_pred             Eecccc
Q 021299           90 FEFMET   95 (314)
Q Consensus        90 ~e~~~g   95 (314)
                      +++++|
T Consensus        76 ~e~i~G   81 (302)
T cd05156          76 EEFIPS   81 (302)
T ss_pred             hheeCC
Confidence            888776

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.72  E-value=0.0014  Score=58.77  Aligned_cols=78  Identities=18%  Similarity=0.137  Sum_probs=51.5

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-----ccCcchhhHHHHHHHhhcC--C-CCeeeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-----KEGVNFTALREIKLLKELK--S-PHIIELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~   87 (314)
                      -.+.||.|..+.||++.....++.+++|.-.....     .+........|.+.|+.+.  . ..+.+++.+  +....+
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            35789999999999998754446899998643211     1112234456777777763  2 345666655  335568


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      +|||++++
T Consensus       108 lVME~L~~  115 (401)
T PRK09550        108 TVMEDLSD  115 (401)
T ss_pred             EEEecCCC
Confidence            99999875

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.0012  Score=57.91  Aligned_cols=31  Identities=26%  Similarity=0.312  Sum_probs=26.7

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .+++|+|++|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4899999999999998766668999998864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.72  E-value=0.00012  Score=58.75  Aligned_cols=98  Identities=20%  Similarity=0.232  Sum_probs=76.0

Q ss_pred             HHHHHHhhcCC-CCeeeeeceeccCCeEEEEEecccc-cHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 021299           60 REIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIR--NTNIFLSPADIKSYMQMTLKGLAFCHK---KWV  132 (314)
Q Consensus        60 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e~~~g-~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~---~~i  132 (314)
                      +|.-+++.+++ +++.+++|++   ++ +++.|+.+. .+.+...  ..--.-++.....++.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57778888876 6999999998   22 578899884 4432110  011136899999999999999999997   347


Q ss_pred             ccCCCCCCceEEecCCcEEEeeccceeee
Q 021299          133 LHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       133 ~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ...|++++|+-++.++++|++|.+.....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.57  E-value=0.00092  Score=58.90  Aligned_cols=139  Identities=17%  Similarity=0.249  Sum_probs=79.3

Q ss_pred             cceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee-eeeceeccCCeEEEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNLHLVF   90 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~   90 (314)
                      ..++.|..|-...+|++.....   +..|++|....... ...  ...+|..+++.+...++. ++++++ .++   +|.
T Consensus        17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~I--dR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~   89 (330)
T PLN02421         17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVI--DRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ   89 (330)
T ss_pred             eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEe--chHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence            3566777788899999964432   34899998765432 111  234788888888765554 344444 233   578


Q ss_pred             ecccccHH-----------HHH-------HhCCCC----C-CHHHHHHHHHHH----------------------HHHHH
Q 021299           91 EFMETDLE-----------TVI-------RNTNIF----L-SPADIKSYMQMT----------------------LKGLA  125 (314)
Q Consensus        91 e~~~g~l~-----------~~~-------~~~~~~----l-~~~~~~~i~~~i----------------------~~~l~  125 (314)
                      +|++|...           ..+       +....+    . ....+..+..++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            88776211           111       111100    1 122222222221                      11111


Q ss_pred             H---HH-hC----CcccCCCCCCceEEec-CCcEEEeeccceee
Q 021299          126 F---CH-KK----WVLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (314)
Q Consensus       126 ~---Lh-~~----~i~H~di~~~nil~~~-~~~~~l~df~~~~~  160 (314)
                      .   +. ..    -++|+|+.+.||++++ ++.++++||+.|..
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1   11 11    2799999999999975 47899999998854

>PLN02236 choline kinase

Probab=97.39  E-value=0.0024  Score=56.65  Aligned_cols=139  Identities=17%  Similarity=0.248  Sum_probs=79.6

Q ss_pred             cceeeeCccccceEEEEEECC----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee-eeeceeccCCeEEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTK----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNLHLV   89 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv   89 (314)
                      .-+..|..|-...+|++....    .++.+++|....... ...  ...+|..+++.+...++. ++++.+.. +   .|
T Consensus        39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~i--dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v  111 (344)
T PLN02236         39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFF--DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RV  111 (344)
T ss_pred             EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eee--chHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence            345677778889999986432    246899998865432 111  224788888888655544 34444432 2   47


Q ss_pred             Eecccc-cHH----------HH-------HHhCCC-----CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 021299           90 FEFMET-DLE----------TV-------IRNTNI-----FLSPADIKSYMQMT-----------------LKGLAFC--  127 (314)
Q Consensus        90 ~e~~~g-~l~----------~~-------~~~~~~-----~l~~~~~~~i~~~i-----------------~~~l~~L--  127 (314)
                      .+|++| ++.          ..       ++....     ......+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            888776 211          01       111110     01112222332221                 1111111  


Q ss_pred             ------HhCCcccCCCCCCceEEec-CCcEEEeeccceee
Q 021299          128 ------HKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (314)
Q Consensus       128 ------h~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~  160 (314)
                            +...++|+|+++.||++++ ++.+.++||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                  1236899999999999986 46899999998864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.34  E-value=0.0043  Score=54.67  Aligned_cols=82  Identities=17%  Similarity=0.118  Sum_probs=49.7

Q ss_pred             eeCccccceEEEEEECCCCcEEEEEEeecCC-----cccCcchhhHHHHHHHhhcC--CCCeeeeeceeccCCeEEEEEe
Q 021299           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-----QKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .||.|....||++.....++.++||.-....     ..+-...+..-|...|+...  .|..++-+-++ +.....++||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            4799999999999875434689999754321     12223334446777777764  35444433233 4455568999


Q ss_pred             cccc--cHHHHH
Q 021299           92 FMET--DLETVI  101 (314)
Q Consensus        92 ~~~g--~l~~~~  101 (314)
                      +++.  .+...+
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            8864  344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.32  E-value=0.00023  Score=61.01  Aligned_cols=136  Identities=18%  Similarity=0.239  Sum_probs=93.1

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC---------------cc-----hhhHHHHHHHhhcCCCC-
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---------------VN-----FTALREIKLLKELKSPH-   72 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~---------------~~-----~~~~~e~~~l~~l~~~~-   72 (314)
                      +.+..+||-|-.+-+|.+-+ ..|.+.++|.-+.......               .+     ....+|..-++.+.... 
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56788999999999999964 5578899986433221110               01     12235666666664332 


Q ss_pred             -eeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEE
Q 021299           73 -IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        73 -i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~  151 (314)
                       +.+.+++    +..++|||++.|-.+..+..-      ..+..+...+...+--|-.+|++|+|.+-=||++.+++.++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence             3344433    566899999998544433321      12245566667777888899999999999999999999999


Q ss_pred             Eeeccceee
Q 021299          152 LADFGLARI  160 (314)
Q Consensus       152 l~df~~~~~  160 (314)
                      ++||..+..
T Consensus       243 vIDFPQmvS  251 (465)
T KOG2268|consen  243 VIDFPQMVS  251 (465)
T ss_pred             EeechHhhc
Confidence            999987643

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.31  E-value=0.0025  Score=56.86  Aligned_cols=78  Identities=15%  Similarity=0.171  Sum_probs=49.5

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecC----CcccCcchhhHHHHHHHhhcC--CCCeeeeeceeccCCeEEEEE
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.||.|.-.-||++.+...++.++||.-...    ...+-...+..-|.+.|+...  .|..++-+-++ +.....+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence            67889999999999987433567999964332    222333344556888888774  46444433233 444556788


Q ss_pred             ecccc
Q 021299           91 EFMET   95 (314)
Q Consensus        91 e~~~g   95 (314)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            87753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.28  E-value=0.0013  Score=59.88  Aligned_cols=172  Identities=20%  Similarity=0.274  Sum_probs=106.2

Q ss_pred             hhHHHHHHHhhcCCCCeeeeeceecc-CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 021299           57 TALREIKLLKELKSPHIIELIDAFPH-KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR  135 (314)
Q Consensus        57 ~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~  135 (314)
                      .+.-..+.++++.|++....+++-.. .....+|+|+++-++.+.+....  +-.....              .+++.| 
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~~~-   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGVLH-   90 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------ccccce-
Confidence            34457788899999999998887633 34578999999999999888654  1111100              222222 


Q ss_pred             CCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC
Q 021299          136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS  215 (314)
Q Consensus       136 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~  215 (314)
                          .|+       ...+| .++.   .             |  |      ....+|+||||+|.++.++..|...+...
T Consensus        91 ----~~~-------~~~td-~~~t---~-------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   91 ----LNI-------IYITD-HFLT---K-------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             ----ehh-------hhccc-cccc---c-------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence                222       22222 0010   0             1  1      11125999999999999999998777666


Q ss_pred             CcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                      ...+...-+...+... .+.     .......          .+...++..+.++..+|+...|..||...++.+++-|.
T Consensus       135 ~~s~~l~~i~k~~~~d-~~~-----~~~a~e~----------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDD-QEL-----LSTAMEH----------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             HHHHHHHHHHHhccCc-hhH-----HHHHHHH----------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence            5555555444332111 000     0000000          11123467788999999999999999999999999887


Q ss_pred             cc
Q 021299          296 SF  297 (314)
Q Consensus       296 ~~  297 (314)
                      .+
T Consensus       199 ev  200 (725)
T KOG1093|consen  199 EV  200 (725)
T ss_pred             HH
Confidence            65

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.27  E-value=0.0036  Score=54.68  Aligned_cols=130  Identities=21%  Similarity=0.187  Sum_probs=87.1

Q ss_pred             ccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeecccee
Q 021299           81 PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .++.+.|++|++.++.+...-     ....+++..++.+.+..++-+..+ .+-|+++..+||+++ +|.+.|+||.+++
T Consensus       296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence            345567788888776644322     245678889999999888888875 789999999999999 9999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC--CccCCCCcHHHHHHHHH
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR--PFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~--~pf~~~~~~~~~~~~~~  226 (314)
                      ....+....     ....--|-.+.|  .-..+.+||-+   |-.|+.|.  ..++..+.........+
T Consensus       370 l~~~q~~is-----y~rldhp~lF~G--~dd~QFeIYrl---Mr~l~~g~wa~F~P~TNvlWL~yLs~~  428 (488)
T COG5072         370 LSYSQGIIS-----YNRLDHPDLFNG--VDDYQFEIYRL---MRRLLKGRWAQFEPITNVLWLYYLSHQ  428 (488)
T ss_pred             cccCCceee-----ccccCchhhhcC--ccceeeeHHHH---HHHHhcCcHHhcccchhhHHHHHHHHH
Confidence            543322211     122344555544  23788888886   55566665  33444555555444333

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.20  E-value=0.0086  Score=53.75  Aligned_cols=76  Identities=18%  Similarity=0.179  Sum_probs=50.9

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-----ccCcchhhHHHHHHHhhcC--C-CCeeeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-----KEGVNFTALREIKLLKELK--S-PHIIELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~   87 (314)
                      ..+.||.|....||++.+.  +..++||.-.....     .+........|++.|+.+.  . ..+.+++.+.+  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            5778899999999999753  45799998663221     1223334445677777664  2 46777777765  3457


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999976

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0069  Score=52.58  Aligned_cols=139  Identities=19%  Similarity=0.202  Sum_probs=79.8

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC--CCeeeeeceeccCC--eEEEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKG--NLHLVF   90 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~iv~   90 (314)
                      .+++.+..|....+|...+.  +++++++ ...............+|.+.++.+.-  --+...++.+.++.  ..|.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            45666666666666777544  7889999 43212111122234467777777643  22333444454443  679999


Q ss_pred             eccccc-HHHHHHhCCCCCCHHHHHHHH-HHHHHHHHHHH----------------------------------------
Q 021299           91 EFMETD-LETVIRNTNIFLSPADIKSYM-QMTLKGLAFCH----------------------------------------  128 (314)
Q Consensus        91 e~~~g~-l~~~~~~~~~~l~~~~~~~i~-~~i~~~l~~Lh----------------------------------------  128 (314)
                      +++.|. ..+....    .+..  .+.+ ..++..|+.||                                        
T Consensus       105 ~~veGe~~~~~~~~----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         105 EWVEGEVVWSALPP----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             EEecceeccCcCCc----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            999982 1111000    0000  1111 13333333333                                        


Q ss_pred             ----------h--------CCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299          129 ----------K--------KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus       129 ----------~--------~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                                .        ..++|+|+++.|+++++++-+-+.||+.+..-+
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                      2        237999999999999999889999999997643

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.06  E-value=0.0099  Score=51.85  Aligned_cols=29  Identities=21%  Similarity=0.400  Sum_probs=25.6

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeecccee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .+++|+|+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999998775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.03  E-value=0.012  Score=51.35  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=27.7

Q ss_pred             CcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          131 WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       131 ~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      +++|+|+.+.||+++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.98  E-value=5.2e-05  Score=76.41  Aligned_cols=152  Identities=13%  Similarity=0.034  Sum_probs=110.3

Q ss_pred             HHHHHhhcCCCCeeeeeceec--cCCeEEEEEeccc-ccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-C--
Q 021299           61 EIKLLKELKSPHIIELIDAFP--HKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKK-W--  131 (314)
Q Consensus        61 e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~-~--  131 (314)
                      |..-+++..|+++.....-..  ++..-+..++++. |.+.+.+.+.   ...++...+.....+.+....-+|+. |  
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            334445556777766555443  2334578888987 5788887643   33455555555555545566666643 2  


Q ss_pred             --cccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC
Q 021299          132 --VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR  209 (314)
Q Consensus       132 --i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~  209 (314)
                        -+|.++++.|.++..+-+++++++|+.++........+...+++.|++|++... ..++.++|+|.+|+.+|..-.|.
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhccc
Confidence              578999999999999999999999999966666666677778888999987755 66788899999999999998888


Q ss_pred             CccC
Q 021299          210 PFLQ  213 (314)
Q Consensus       210 ~pf~  213 (314)
                      .+|.
T Consensus      1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred             HHHH
Confidence            7663

>PTZ00384 choline kinase; Provisional

Probab=96.91  E-value=0.0097  Score=53.41  Aligned_cols=77  Identities=16%  Similarity=0.159  Sum_probs=43.9

Q ss_pred             cceeeeCccccceEEEEEECCC-CcEEEEEEe-ecC-CcccCcchhhHHHHHHHhhcCCCCeeee-eceeccCCeEEEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKT-GQTVAIKKI-RLG-KQKEGVNFTALREIKLLKELKSPHIIEL-IDAFPHKGNLHLVF   90 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~-~~~~~iK~~-~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~-~~~~~~~~~~~iv~   90 (314)
                      ..++.|..|-.+.+|++..... +..+.+|.+ ... .......-...+|.++++.+...++.+- ++.+. +   +++.
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~-~---g~l~  128 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG-D---FTIQ  128 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-C---EEEE
Confidence            4566777888999999964332 223333321 110 1111111233478999999976665554 44442 2   4889


Q ss_pred             ecccc
Q 021299           91 EFMET   95 (314)
Q Consensus        91 e~~~g   95 (314)
                      ||++|
T Consensus       129 efIeG  133 (383)
T PTZ00384        129 EWVEG  133 (383)
T ss_pred             EEecc
Confidence            99987

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.88  E-value=0.0029  Score=51.88  Aligned_cols=32  Identities=38%  Similarity=0.594  Sum_probs=22.4

Q ss_pred             CCcccCCCCCCceEE-ecCCcEEEeeccceeee
Q 021299          130 KWVLHRDMKPNNLLI-GSHGQLKLADFGLARIF  161 (314)
Q Consensus       130 ~~i~H~di~~~nil~-~~~~~~~l~df~~~~~~  161 (314)
                      ..++|+|+.+.||++ +.++.++++||..|...
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n  175 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGYN  175 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence            358999999999999 88899999999988653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.81  E-value=0.014  Score=50.12  Aligned_cols=75  Identities=19%  Similarity=0.136  Sum_probs=46.3

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC---CCCeeeeeceeccCCeEEEEE
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      -+-.+.++.|....+|.+.  .+++.+++|.-....     ..-+..|++-|+.|.   .-.+.+++++...++..++++
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            4566788999999999995  677899999986221     124456788788773   345667777766666679999


Q ss_pred             ecccc
Q 021299           91 EFMET   95 (314)
Q Consensus        91 e~~~g   95 (314)
                      |+++.
T Consensus        92 e~l~~   96 (288)
T PF03881_consen   92 EFLEM   96 (288)
T ss_dssp             E----
T ss_pred             EeecC
Confidence            99873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.70  E-value=0.0084  Score=51.38  Aligned_cols=30  Identities=27%  Similarity=0.558  Sum_probs=25.3

Q ss_pred             CcccCCCCCCceEEecCCc-EEEeeccceee
Q 021299          131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARI  160 (314)
Q Consensus       131 ~i~H~di~~~nil~~~~~~-~~l~df~~~~~  160 (314)
                      .++|+|++|.||+++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK10593 hypothetical protein; Provisional

Probab=96.64  E-value=0.012  Score=51.07  Aligned_cols=107  Identities=17%  Similarity=0.165  Sum_probs=71.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC---CCeeeeeceecc---CCe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIELIDAFPH---KGN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~   85 (314)
                      ..-.-.+.||+|..+.||.....  +.++++|..+....    ...+..|++.++.+..   -.+.++++.+..   .+.
T Consensus        14 ~~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         14 EKLSRVECISEQPYAALWALYDS--QGNPMPLMARSFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhhheeeecCCccceeEEEEEcC--CCCEEEEEeccccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            35556778999999999999532  33677787532111    1245578888888853   356677766543   366


Q ss_pred             EEEEEeccccc-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021299           86 LHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK  130 (314)
Q Consensus        86 ~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  130 (314)
                      .++|||+++|. +.+ .     ..+......+..+++++++.||+.
T Consensus        88 ~~LVmE~i~G~~~~~-~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         88 DVLLLERLRGVSVEA-P-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eEEEEeccCCEecCC-C-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999984 332 1     123444566777888888888874

>PTZ00296 choline kinase; Provisional

Probab=96.55  E-value=0.034  Score=50.96  Aligned_cols=73  Identities=11%  Similarity=0.155  Sum_probs=45.6

Q ss_pred             ceeeeCccccceEEEEEECCC--------CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeee-eeceeccCCeE
Q 021299           16 KREVLGEGTYGVVYKAIDTKT--------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-LIDAFPHKGNL   86 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~   86 (314)
                      .++.|..|-...+|++.....        ++.|++|+.-.....-.   ...+|..+++.+...++.+ +++.+. +   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI---dR~~E~~v~~~ls~~gi~P~l~~~f~-g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY---NPISEFEVYKTMSKYRIAPQLLNTFS-G---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee---CHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence            677788888889999964421        46799998865432221   2336777777776544443 344442 2   


Q ss_pred             EEEEecccc
Q 021299           87 HLVFEFMET   95 (314)
Q Consensus        87 ~iv~e~~~g   95 (314)
                      +.+.+|++|
T Consensus       182 g~I~efi~g  190 (442)
T PTZ00296        182 GRIEEWLYG  190 (442)
T ss_pred             CEEEEeeCC
Confidence            357788876

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.37  E-value=0.037  Score=48.52  Aligned_cols=135  Identities=17%  Similarity=0.169  Sum_probs=75.9

Q ss_pred             eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC------eeeeecee--ccCC--eEE
Q 021299           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH------IIELIDAF--PHKG--NLH   87 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~--~~~~--~~~   87 (314)
                      ..|.+ ....+|.+...  +.++++|..... ..   ...+..|...+..+...+      +...-+-.  .-++  +.+
T Consensus        32 ~~l~s-~eN~~f~~~~~--~g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a  104 (331)
T COG2334          32 RGLNS-EENSNFRVQTE--DGRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA  104 (331)
T ss_pred             ccccc-ccCceEEEEec--CCCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence            34445 56778999643  345599999765 22   224446777777774222      12221111  1233  778


Q ss_pred             EEEecccccHHHH----------------HHhC--CC---------CCCHH----H---------HHHHHHHHHHHHHHH
Q 021299           88 LVFEFMETDLETV----------------IRNT--NI---------FLSPA----D---------IKSYMQMTLKGLAFC  127 (314)
Q Consensus        88 iv~e~~~g~l~~~----------------~~~~--~~---------~l~~~----~---------~~~i~~~i~~~l~~L  127 (314)
                      -++++++|.....                ++..  +-         ...+.    .         ......++...+..+
T Consensus       105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~  184 (331)
T COG2334         105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL  184 (331)
T ss_pred             EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence            8999999843331                1110  00         01111    0         011223333444444


Q ss_pred             Hh--------CC--cccCCCCCCceEEecCCc-EEEeecccee
Q 021299          128 HK--------KW--VLHRDMKPNNLLIGSHGQ-LKLADFGLAR  159 (314)
Q Consensus       128 h~--------~~--i~H~di~~~nil~~~~~~-~~l~df~~~~  159 (314)
                      .+        .+  ++|+|+.|+||+++.+.. +.++||+.+.
T Consensus       185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            42        33  899999999999998875 8999999885

>PRK06148 hypothetical protein; Provisional

Probab=96.23  E-value=0.072  Score=54.12  Aligned_cols=31  Identities=32%  Similarity=0.513  Sum_probs=26.4

Q ss_pred             CCcccCCCCCCceEEecCC--cEE-Eeeccceee
Q 021299          130 KWVLHRDMKPNNLLIGSHG--QLK-LADFGLARI  160 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~--~~~-l~df~~~~~  160 (314)
                      .+++|+|+++.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999998875  554 999998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.93  E-value=0.26  Score=43.40  Aligned_cols=28  Identities=32%  Similarity=0.407  Sum_probs=24.0

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeecccee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899999885

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.79  E-value=0.06  Score=44.04  Aligned_cols=103  Identities=19%  Similarity=0.235  Sum_probs=63.8

Q ss_pred             cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHH
Q 021299           38 QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYM  117 (314)
Q Consensus        38 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~  117 (314)
                      ...++|+++...... ....+.++.+++.++.  +|+++..  .++-.+-++.|+|..-          .+..   ..++
T Consensus        86 G~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~----------~i~~---~N~i  147 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI----------KINF---SNFI  147 (308)
T ss_pred             chhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc----------ccch---hHHH
Confidence            366777776554321 1123456777777642  4555542  2333566888988621          0100   1122


Q ss_pred             HHHHHHHHHHHh--CCcccCCCCCCceEEecCCcEEEeeccce
Q 021299          118 QMTLKGLAFCHK--KWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus       118 ~~i~~~l~~Lh~--~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      .--+.+|.-.|+  .+..|+|.+|+||+.+..|.+||.|-+..
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            222467777884  47999999999999999999999998755

The function of this family is unknown.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.48  E-value=0.058  Score=46.74  Aligned_cols=137  Identities=17%  Similarity=0.191  Sum_probs=87.7

Q ss_pred             cceeeeCccccceEEEEEEC-----C-----CCcEEEEEEeecCCc----------------------ccCcchhhH--H
Q 021299           15 LKREVLGEGTYGVVYKAIDT-----K-----TGQTVAIKKIRLGKQ----------------------KEGVNFTAL--R   60 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~-----~-----~~~~~~iK~~~~~~~----------------------~~~~~~~~~--~   60 (314)
                      .|-..|..|-.+.|..+.-.     .     ....+|||+++....                      .+......+  +
T Consensus       255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            45677889999999888421     1     124588887744310                      011111111  3


Q ss_pred             HHHHHhhc-----CCCCeeeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Q 021299           61 EIKLLKEL-----KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLH  134 (314)
Q Consensus        61 e~~~l~~l-----~~~~i~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H  134 (314)
                      |...|.++     .+|.+|.+..       ..+||.|++.+=.-.-+-....++.+.....-.|+..++..|.. .-++|
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVH  407 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVH  407 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheee
Confidence            45555554     3566666653       35999999842111111122237888888888899988888865 57999


Q ss_pred             CCCCCCceEEecCCcEEEeecccee
Q 021299          135 RDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus       135 ~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      .|++-.|++...+ ++.++|...+.
T Consensus       408 ADlSEyN~Lw~~g-Kvw~IDVsQsv  431 (531)
T KOG2269|consen  408 ADLSEYNLLWTPG-KVWVIDVSQSV  431 (531)
T ss_pred             cchhhhhheecCC-ceEEEechhcc
Confidence            9999999999776 88999887664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	314
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-99
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-78
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-78
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-75
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-75
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-74
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-74
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-74
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-74
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-74
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-74
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-74
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-74
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-74
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-74
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-74
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-74
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-74
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-74
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-74
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-74
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-74
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-74
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-74
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-74
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-74
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-74
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-74
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-74
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-74
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-74
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-74
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-74
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-74
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-74
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-74
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-74
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-73
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-73
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-73
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-73
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-72
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-71
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-65
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-60
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-59
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-58
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-58
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-58
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-57
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-55
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-51
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-51
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-51
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-50
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-50
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-50
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-49
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-49
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-49
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-48
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-48
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-48
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-48
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-48
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-47
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-47
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-47
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-47
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-47
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-47
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-47
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-47
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-47
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-47
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-47
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-47
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-47
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-47
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-47
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-47
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-47
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-47
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-47
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-46
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-46
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-46
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-46
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-44
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-44
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-44
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-44
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-44
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-43
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-42
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-42
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-42
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-42
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-42
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-42
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-42
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-42
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-42
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-41
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-41
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-41
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-41
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-41
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-41
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-41
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-41
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-41
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-41
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-41
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-41
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-41
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-41
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-41
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-41
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-41
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-41
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-41
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-41
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-41
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-41
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-41
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-41
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-41
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-41
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-41
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-41
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-41
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-41
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-41
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-41
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-41
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-41
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-41
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-41
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-41
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-41
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-41
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-41
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-41
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-41
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-41
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-41
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-41
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-41
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-40
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-40
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-40
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-40
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-40
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-40
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-40
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-40
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-40
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-40
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-40
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-40
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-40
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-40
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-40
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-40
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-40
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-40
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-40
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-40
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-40
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-40
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-40
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-40
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-40
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-40
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-40
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-40
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-40
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-40
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-39
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-39
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-37
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-37
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-37
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-37
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-37
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-37
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-37
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-37
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-37
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-37
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-37
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-37
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-37
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-36
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-36
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-36
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-36
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-35
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-35
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-35
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-35
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-35
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-34
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-34
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-34
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-34
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-34
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-34
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-34
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-34
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-34
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-33
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-33
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-32
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-32
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-32
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-31
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-31
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-29
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-29
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-29
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-28
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-28
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-28
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-27
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-27
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-27
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-27
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-27
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-26
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-25
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-25
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-23
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-23
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-23
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-23
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-23
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-23
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-23
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-23
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-23
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-23
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-23
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-22
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-22
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-22
3soa_A	444	Full-Length Human Camkii Length = 444		1e-21
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-21
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-21
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-21
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-21
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-20
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-20
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-20
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-20
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-20
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-20
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-19
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-17
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-17
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-15
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-15
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-07

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  356 bits (914), Expect = 9e-99,   Method: Compositional matrix adjust.
 Identities = 169/289 (58%), Positives = 214/289 (74%), Gaps = 3/289 (1%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R + HQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ ++
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  286 bits (733), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 139/291 (47%), Positives = 190/291 (65%), Gaps = 3/291 (1%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K E +GEGTYGVVYKA D++ G+ VA+K+IRL  + EG+  TA+REI LLKEL 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A CH+
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K+Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-- 247
              VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +  
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
           +Q     P  S+ P    + +DLLS M  +DP  RI+A+ A+ H + K  +
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  286 bits (733), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 139/291 (47%), Positives = 190/291 (65%), Gaps = 3/291 (1%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K E +GEGTYGVVYKA D++ G+ VA+K+IRL  + EG+  TA+REI LLKEL 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A CH+
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K+Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-- 247
              VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +  
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
           +Q     P  S+ P    + +DLLS M  +DP  RI+A+ A+ H + K  +
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  277 bits (708), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 141/289 (48%), Positives = 183/289 (63%), Gaps = 2/289 (0%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLK
Sbjct: 5   SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLA 125
           EL  P+I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLA
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH   VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            K Y   VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 -VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              +   A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  276 bits (707), Expect = 8e-75,   Method: Compositional matrix adjust.
 Identities = 141/289 (48%), Positives = 183/289 (63%), Gaps = 2/289 (0%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLK
Sbjct: 5   SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLA 125
           EL  P+I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLA
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH   VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            K Y   VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 -VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              +   A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+T +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/284 (49%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFE +  DL+T +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  275 bits (703), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 181/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GL+FCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+ KIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+ KIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  274 bits (700), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  274 bits (700), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  273 bits (699), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 139/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  273 bits (697), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/288 (47%), Positives = 181/288 (62%), Gaps = 2/288 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH+V   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             P P  S      +  +DLLSKM   DP  RITA+QALEH + K  N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  272 bits (696), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 136/288 (47%), Positives = 181/288 (62%), Gaps = 2/288 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH+V   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             P P  S      +  +DLLSKM   DP  RITA+QALEH + K  N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  272 bits (695), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 135/288 (46%), Positives = 181/288 (62%), Gaps = 2/288 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             P P  S      +  +DLLSKM   DP  RITA+QALEH + K  N
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  271 bits (693), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 138/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFE ++ DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  266 bits (681), Expect = 9e-72,   Method: Compositional matrix adjust.
 Identities = 140/297 (47%), Positives = 183/297 (61%), Gaps = 11/297 (3%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + V
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLADFGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  Y
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFC 307
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H +         F DFC
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY---------FSDFC 290

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  264 bits (675), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 139/297 (46%), Positives = 183/297 (61%), Gaps = 11/297 (3%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + V
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 VDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  Y
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFC 307
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H +         F DFC
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY---------FSDFC 290

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  246 bits (628), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 133/289 (46%), Positives = 179/289 (61%), Gaps = 8/289 (2%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           DRY +   LGEGTYG VYKAIDT T +TVAIK+IRL  ++EGV  TA+RE+ LLKEL+  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +IIEL     H   LHL+FE+ E DL+  + + N  +S   IKS++   + G+ FCH + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 132 VLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            LHRD+KP NLL+          LK+ DFGLAR FG P R+FTH++   WYR PE+L G+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y   VD+W+  CI+AE+L + P   G S+IDQL KIF   G    + WP +  LPD+ 
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272
Query: 247 EY--QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +   ++      R L     D+ LDLL+ M   DP  RI+A+ ALEH +
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  226 bits (577), Expect = 9e-60,   Method: Compositional matrix adjust.
 Identities = 118/293 (40%), Positives = 170/293 (58%), Gaps = 14/293 (4%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + ++ + E LG GTY  VYK ++  TG  VA+K+++L  + EG   TA+REI L+KELK 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKH 62
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-----IKSYMQMTLKGLA 125
            +I+ L D    +  L LVFEFM+ DL+  + +  +  +P       +K +    L+GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH+  +LHRD+KP NLLI   GQLKL DFGLAR FG P   F+ +V   WYRAP++L G
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           ++ Y   +D+W+ GCI AE++  +P   G++D +QL  IF   GT   S WP +  LP Y
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 246 VEYQYVAAPP--LRSLFPSASDDAL-----DLLSKMFTYDPKARITAQQALEH 291
                   PP  LR +    + + L     D L  +   +P  R++A+QAL H
Sbjct: 243 -NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  224 bits (571), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 114/284 (40%), Positives = 170/284 (59%), Gaps = 3/284 (1%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GLA+CH++ 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + + ++V   WYR P++L G+  Y  
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240
Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              A  L S  P    D  DLL+K+  ++ + RI+A+ A++H F
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  221 bits (563), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 123/297 (41%), Positives = 175/297 (58%), Gaps = 16/297 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRF 293
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H F
Sbjct: 258 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  221 bits (563), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 123/297 (41%), Positives = 175/297 (58%), Gaps = 16/297 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRF 293
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H F
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  221 bits (562), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 123/297 (41%), Positives = 175/297 (58%), Gaps = 16/297 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRF 293
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H F
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 122/297 (41%), Positives = 174/297 (58%), Gaps = 16/297 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   K +++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRF 293
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H F
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 116/299 (38%), Positives = 164/299 (54%), Gaps = 13/299 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K   +GEG+YGVV+K  +  TGQ VAIKK    +    +   ALREI++LK+LK
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+++ L++ F  K  LHLVFE+ +  +   +      +    +KS    TL+ + FCHK
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
              +HRD+KP N+LI  H  +KL DFG AR+   P   +  +V  RWYR+PELL G  QY
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP--------SQWPDLAY 241
           G  VDVWA GC+FAELL+  P   G SD+DQL  I    G   P        +Q+     
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV 300
           +PD  + +     PL   FP+ S  AL LL      DP  R+T +Q L H + ++   +
Sbjct: 241 IPDPEDME-----PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 160/284 (56%), Gaps = 13/284 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +A P+        +   DLL K  T++P  RI+A  AL H +
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  197 bits (502), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 160/284 (56%), Gaps = 13/284 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +A P+        +   DLL K  T++P  RI+A  AL H +
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 160/284 (56%), Gaps = 13/284 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +A P+        +   DLL K  T++P  RI+A  AL H +
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 164/296 (55%), Gaps = 12/296 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S        V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALAPVVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H +     G
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 164/296 (55%), Gaps = 12/296 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S        V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H +     G
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 164/296 (55%), Gaps = 12/296 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+      F   V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-VVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H +     G
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  192 bits (489), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 106/293 (36%), Positives = 156/293 (53%), Gaps = 19/293 (6%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    ++GEG+YG+V K  +  TG+ VAIKK       + V   A+REIKLLK+L+  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCH 128
           +++ L++    K   +LVFEF++    T++ +  +F +  D   ++ Y+   + G+ FCH
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVD---HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
              ++HRD+KP N+L+   G +KL DFG AR   +P   +  +V  RWYRAPELL G  +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP------SQWPDLA-- 240
           YG  VDVWA GC+  E+    P   G SDIDQL  I    G   P      ++ P  A  
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            LP+  E +     PL   +P  S+  +DL  K    DP  R    + L H F
Sbjct: 262 RLPEIKERE-----PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  191 bits (484), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 116/303 (38%), Positives = 162/303 (53%), Gaps = 26/303 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K  +II +
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 77  I-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
                 D+F +   ++++ E M+TDL  VI  +   LS   I+ ++  TL+ +   H   
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF-------GSPDRR---FTHQVFARWYRAPE 181
           V+HRD+KP+NLLI S+  LK+ DFGLARI          P  +    T  V  RWYRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP    DL  
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPHSDNDLRC 250
Query: 242 LPDYVEYQYV------AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++ALEH + +
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 296 SFN 298
           +++
Sbjct: 311 TYH 313

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 116/303 (38%), Positives = 162/303 (53%), Gaps = 26/303 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K  +II +
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 77  I-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
                 D+F +   ++++ E M+TDL  VI  +   LS   I+ ++  TL+ +   H   
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF-------GSPDRR---FTHQVFARWYRAPE 181
           V+HRD+KP+NLLI S+  LK+ DFGLARI          P  +    T  V  RWYRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP    DL  
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPHSDNDLRC 250
Query: 242 LPDYVEYQYV------AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++ALEH + +
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 296 SFN 298
           +++
Sbjct: 311 TYH 313

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 116/303 (38%), Positives = 163/303 (53%), Gaps = 26/303 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K  +II +
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 77  I-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
                 D+F +   ++++ E M+TDL  VI  +   LS   I+ ++  TL+ +   H   
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQ-------VFARWYRAPE 181
           V+HRD+KP+NLLI S+  LK+ DFGLARI     + +   T Q       V  RWYRAPE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP    DL  
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPHSDNDLRC 250
Query: 242 LPDYVEYQYV------AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++ALEH + +
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 296 SFN 298
           +++
Sbjct: 311 TYH 313

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  187 bits (475), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 113/306 (36%), Positives = 164/306 (53%), Gaps = 15/306 (4%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREI 62
           L      RY     +G G YG VYKA D  +G  VA+K +R+     G   +  + +RE+
Sbjct: 3   LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 63  KLLKELKS---PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-I 113
            LL+ L++   P+++ L+D         +  + LVFE ++ DL T +        PA+ I
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF 173
           K  M+  L+GL F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S     T  V 
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVV 181
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             WYRAPE+L  +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G    
Sbjct: 182 TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             WP    LP    +      P++S+ P   +    LL +M T++P  RI+A +AL+H +
Sbjct: 241 DDWPRDVSLPRGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 294 AKSFNG 299
                G
Sbjct: 300 LHKDEG 305

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  187 bits (474), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 256 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 KSF 297
           + +
Sbjct: 316 EQY 318

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  187 bits (474), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 29  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 87
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 145
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 146 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 204
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 261
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 262 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321
Query: 295 KSF 297
           + +
Sbjct: 322 EQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  187 bits (474), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 KSF 297
           + +
Sbjct: 314 EQY 316

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 KSF 297
           + +
Sbjct: 314 EQY 316

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 99
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 157
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 216
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 273
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 274 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 295 KSF 297
           + +
Sbjct: 334 EQY 336

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 84
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 201
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 258
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 259 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 295 KSF 297
           + +
Sbjct: 319 EQY 321

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 27  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 85
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 144 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 202
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 259
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 260 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319
Query: 295 KSF 297
           + +
Sbjct: 320 EQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 18  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 76
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 134
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 135 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 193
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 250
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 251 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310
Query: 295 KSF 297
           + +
Sbjct: 311 EQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 254 XIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 KSF 297
           + +
Sbjct: 314 EQY 316

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 77
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 194
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 251
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 252 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 295 KSF 297
           + +
Sbjct: 312 EQY 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 KSF 297
           + +
Sbjct: 314 EQY 316

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD   T      V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 84
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD   T      V  RWYRAP
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAP 201
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 258
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 259 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 295 KSF 297
           + +
Sbjct: 319 EQY 321

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 254 XIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 KSF 297
           + +
Sbjct: 314 EQY 316

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 162/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 256 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 KSF 297
             +
Sbjct: 316 AQY 318

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 112/303 (36%), Positives = 163/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAI+KI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 KSF 297
           + +
Sbjct: 318 EQY 320

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 112/303 (36%), Positives = 162/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 77
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 194
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +P Q  DL 
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPEQ-EDLN 251
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 252 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 295 KSF 297
           + +
Sbjct: 312 EQY 314

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  184 bits (466), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 161/303 (53%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
              +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 256 CGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 KSF 297
             +
Sbjct: 316 AQY 318

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 113/315 (35%), Positives = 170/315 (53%), Gaps = 26/315 (8%)
Query: 2   AEVDLSK----KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT 57
            EV++ K     V  RY + + +GEG YG+V  A D      VAIKKI   + +     T
Sbjct: 29  GEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRT 88
Query: 58  ALREIKLLKELKSPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
            LREI++L   +  ++I + D           ++++V + METDL  ++++    LS   
Sbjct: 89  -LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ--LSNDH 145
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----F 168
           I  ++   L+GL + H   VLHRD+KP+NLLI +   LK+ DFGLARI   P+       
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARI-ADPEHDHTGFL 204
Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           T  V  RWYRAPE++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    
Sbjct: 205 TEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKAR 282
           G  +PSQ  DL  + +     Y+ + P ++      LFP +   ALDLL +M T++P  R
Sbjct: 265 G--SPSQ-EDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKR 321
Query: 283 ITAQQALEHRFAKSF 297
           IT ++AL H + + +
Sbjct: 322 ITVEEALAHPYLEQY 336

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 112/303 (36%), Positives = 160/303 (52%), Gaps = 22/303 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 99
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           +++LV   M  DL  +++  +  LS   I  ++   L+GL
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGL 157
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 216
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 273
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H + 
Sbjct: 274 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 295 KSF 297
           + +
Sbjct: 334 EQY 336

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  181 bits (458), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 109/307 (35%), Positives = 164/307 (53%), Gaps = 14/307 (4%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D++  V D Y   E +G G YGVV  A    TGQ VAIKKI             LRE+K+
Sbjct: 47  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 65  LKELKSPHIIELID----AFPHK--GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK  K  +II + D      P+    ++++V + ME+DL  +I ++   L+   ++ ++ 
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-LTLEHVRYFLY 165
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR---FTHQVFA 174
             L+GL + H   V+HRD+KP+NLL+  + +LK+ DFG+AR +  SP       T  V  
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPEL+    +Y   +D+W+ GCIF E+L RR    G + + QL  I    GT +P+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 235 --QWPDLAYLPDYVEYQYVAAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             Q      +  Y++      P P  +++P A   AL LL +M  ++P ARI+A  AL H
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345
Query: 292 RFAKSFN 298
            F   ++
Sbjct: 346 PFLAKYH 352

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 164/310 (52%), Gaps = 20/310 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D++  V D Y   E +G G YGVV  A    TGQ VAIKKI             LRE+K+
Sbjct: 48  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 65  LKELKSPHIIELID----AFPHK--GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK  K  +II + D      P+    ++++V + ME+DL  +I ++   L+   ++ ++ 
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-LTLEHVRYFLY 166
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR---FTHQVFA 174
             L+GL + H   V+HRD+KP+NLL+  + +LK+ DFG+AR +  SP       T  V  
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPEL+    +Y   +D+W+ GCIF E+L RR    G + + QL  I    GT +P+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 235 QWPDL------AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
               +      AY+      Q V   P  +++P A   AL LL +M  ++P ARI+A  A
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPV---PWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 289 LEHRFAKSFN 298
           L H F   ++
Sbjct: 344 LRHPFLAKYH 353

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/296 (36%), Positives = 150/296 (50%), Gaps = 21/296 (7%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y+    +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++  ++
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 74  IELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           I L+D F    +L      +LV  FM+TDL+ ++    +  S   I+  +   LKGL + 
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   V+HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++    
Sbjct: 161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWM 217
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G         +  L D   
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAA 274
Query: 248 YQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
             Y+ + P         LFP AS  A DLL KM   D   R+TA QAL H F + F
Sbjct: 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 115/345 (33%), Positives = 164/345 (47%), Gaps = 61/345 (17%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y+ + ++G G+YG VY A D  T + VAIKK+    +        LREI +L  LK
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 70  SPHIIELID-AFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           S +II L D   P        L++V E  ++DL+ + + T IFL+   IK+ +   L G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGE 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------- 165
            F H+  ++HRD+KP N L+     +K+ DFGLAR   S                     
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-----------NRRPF 211
              ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELL           NR P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 212 LQGS-----------------SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY----QY 250
             GS                 S+ DQL  IF   GT T     ++   P+ ++Y     +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-PEVIKYIKLFPH 321
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                L+  +PS SDD ++LL  M  ++P  RIT  QAL+H + K
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/296 (36%), Positives = 150/296 (50%), Gaps = 21/296 (7%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y+    +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++  ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 74  IELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           I L+D F    +L      +LV  FM+TDL+ ++    +  S   I+  +   LKGL + 
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   V+HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++    
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWM 199
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G         +  L D   
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAA 256
Query: 248 YQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
             Y+ + P         LFP AS  A DLL KM   D   R+TA QAL H F + F
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 160/309 (51%), Gaps = 34/309 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTA--------LREIKL 64
           Y  +  +  G+YG V   +D++ G  VAIK++         VN  +        LREI+L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 65  LKELKSPHIIELIDAFPH-----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           L     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ +M  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  RWYRA
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVTHRWYRA 201
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT--------- 230
           PEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT         
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 231 ATPSQWPDLAYLPDYV--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
           ++PS         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +QA
Sbjct: 262 SSPSAR-------DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 289 LEHRFAKSF 297
           L H + +S 
Sbjct: 315 LRHPYFESL 323

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  173 bits (439), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 160/309 (51%), Gaps = 34/309 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTA--------LREIKL 64
           Y  +  +  G+YG V   +D++ G  VAIK++         VN  +        LREI+L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 65  LKELKSPHIIELIDAFPH-----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           L     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ +M  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  RWYRA
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVTHRWYRA 201
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT--------- 230
           PEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT         
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 231 ATPSQWPDLAYLPDYV--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
           ++PS         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +QA
Sbjct: 262 SSPSAR-------DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 289 LEHRFAKSF 297
           L H + +S 
Sbjct: 315 LRHPYFESL 323

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 112/338 (33%), Positives = 174/338 (51%), Gaps = 47/338 (13%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           + + V  +Y   + LG+G YG+V+K+ID +TG+ VA+KKI    Q         REI +L
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 66  KELKS-PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            EL    +I+ L++     +  +++LVF++METDL  VIR  NI L P   +  +   +K
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-ANI-LEPVHKQYVVYQLIK 120
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ----------- 171
            + + H   +LHRDMKP+N+L+ +   +K+ADFGL+R F +  RR T+            
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI-RRVTNNIPLSINENTEN 179
Query: 172 -----------VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ 220
                      V  RWYRAPE+L G+ +Y  G+D+W+ GCI  E+L  +P   GSS ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 221 LGKIFAAF---------GTATPSQWPDLAYLPDYVEYQYVAAPP--------LRSLFPSA 263
           L +I                +P     +  L + VE +              L  + P A
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 264 --SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
             +++ALDLL K+  ++P  RI+A  AL+H F   F+ 
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/298 (35%), Positives = 168/298 (56%), Gaps = 33/298 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVV++A   ++ + VAIKK+   K+ +       RE+++++ +K P++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPNV 94
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRNTNIF------LSPADIKSYMQMTL 121
           ++L   F   G+      L+LV E++    ETV R +  +      +    IK YM   L
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIF--GSPDRRFTHQVFARWYR 178
           + LA+ H   + HRD+KP NLL+    G LKL DFG A+I   G P+      + +R+YR
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXICSRYYR 208
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APEL+FGA  Y   +D+W+ GC+ AEL+  +P   G S IDQL +I    GT +  Q   
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 239 LAYLPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +   P+Y+E+++  +   P   +F P    DA+DL+S++  Y P AR+TA +AL H F
Sbjct: 269 MN--PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 149/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +  A  Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 149/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 151/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 151/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 151/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 151/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 260 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 151/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 155
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 212
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 273 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 149/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 146
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 203
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 263
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 264 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 317

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGXVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 30/312 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +  RY+  + LG G  G+V+ A+D    + VAIKKI L   +   +  ALREIK+++ L 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRLD 66
Query: 70  SPHIIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
             +I+++ +     G+              +++V E+METDL  V+    +    A  + 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA--RL 124
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ--- 171
           +M   L+GL + H   VLHRD+KP NL I +    LK+ DFGLARI    D  ++H+   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHL 181
Query: 172 ---VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
              +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +    G+ +++Q+  I  + 
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 229 GTATPSQWPD-LAYLPDYVEYQYVAA-PPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                    + L+ +P Y+         PL  L P  S +A+D L ++ T+ P  R+TA+
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 287 QALEHRFAKSFN 298
           +AL H +   ++
Sbjct: 302 EALSHPYMSIYS 313

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  ++++    L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGL R     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 274 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 147
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 204
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 135
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 192
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 252
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 253 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 306

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 190
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 190
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 147
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 204
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 134
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 191
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 251
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 252 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 159
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 216
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 148/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 155
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 212
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 273 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 155/297 (52%), Gaps = 20/297 (6%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK ++  ++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 74  IELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           I L+D F     L      +LV  FM TDL  ++++    L    I+  +   LKGL + 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 144
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   ++HRD+KP NL +    +LK+ DFGLAR     D      V  RWYRAPE++    
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVVTRWYRAPEVILNWM 201
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +Y   VD+W+ GCI AE++  +   +GS  +DQL +I    GT  P+++  +  L     
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP-PAEF--VQRLQSDEA 258
Query: 248 YQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             Y+   P        S+  +AS  A++LL KM   D + R+TA +AL H + +S +
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 152/302 (50%), Gaps = 20/302 (6%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  + D K+G  +A+KK+    Q         RE++LLK +
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L      +LV   M  DL  +++     L+   ++  +   L+
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 165
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 222
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  I+QL +I    GT   S    ++ +
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASV---ISRM 279
Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           P +    Y+ + P         +F  A+  A+DLL KM   D   RITA +AL H +   
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 297 FN 298
           ++
Sbjct: 340 YH 341

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 149/291 (51%), Gaps = 20/291 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  ++++    LS   ++  +   L+GL + H   ++
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQA--LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 267
Query: 254 -PP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
            PP     L S+F  A+  A+DLL +M   D   R++A +AL H +   ++
Sbjct: 268 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D+GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+ +  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 159
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGYVATRWYRAPEI 216
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 330

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 159/295 (53%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+ +  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 149/299 (49%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DF LAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 148/291 (50%), Gaps = 20/291 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  +++     LS   ++  +   L+GL + H   ++
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 267
Query: 254 -PP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
            PP     L S+F  A+  A+DLL +M   D   R++A +AL H +   ++
Sbjct: 268 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 80
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 141 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 197
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 256
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 257 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 310

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 148/291 (50%), Gaps = 20/291 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  +++     LS   ++  +   L+GL + H   ++
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 203 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 259
Query: 254 -PP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
            PP     L S+F  A+  A+DLL +M   D   R++A +AL H +   ++
Sbjct: 260 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 310

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 149/299 (49%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+  FGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 103
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 164 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 220
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 279
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 280 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 333

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 88
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 149 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 205
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 264
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 265 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 318

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 149/299 (49%), Gaps = 14/299 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 76
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 137 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 193
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 252
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 253 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 306

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 79
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 140 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 196
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 255
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 256 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 226
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 285
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 286 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 83
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 144 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 200
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 259
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 260 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 204
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 263
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 264 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 94
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 155 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 211
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 270
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 271 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 324

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 204
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 263
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 264 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 154
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 215 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 271
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 330
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 331 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 384

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 111
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 172 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 228
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 287
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 288 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 341

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 161/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 113
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 174 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 230
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 289
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 290 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 343

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 160/295 (54%), Gaps = 26/295 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 125 AFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 226
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 285
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 286 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 113/357 (31%), Positives = 163/357 (45%), Gaps = 73/357 (20%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ DRY  R ++G G+YG V +A D    + VAIKKI    +        LREI +L  L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 69  KSPHIIELIDAFPHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
              H+++++D    K       L++V E  ++D + + R T ++L+   IK+ +   L G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVG 168
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------ 165
           + + H   +LHRD+KP N L+     +K+ DFGLAR    P+                  
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 166 ---------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--------- 207
                    R+ T  V  RWYRAPEL+   + Y   +DVW+ GCIFAELLN         
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 208 --RRPFLQGSS--------------------DIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
             R P   GSS                    + DQL  IF   G  TPS+  D+  L   
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG--TPSE-EDIEALEKE 345
Query: 246 VEYQYVAAPPLR------SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
              +Y+   P R        FP++S DA+ LL +M  ++P  RIT  + L H F K 
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 107/309 (34%), Positives = 152/309 (49%), Gaps = 42/309 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTV--AIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA           A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L    +KS +   L G+ + 
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAP 180
           H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +        V   WYRAP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF   G  
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 232 TPSQWPDLAYLP-------DYVEYQYVAAPPLRSLFP---SASDDALDLLSKMFTYDPKA 281
               W D+  +P       D+    Y     ++ +          A  LL K+ T DP  
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 282 RITAQQALE 290
           RIT++QA++
Sbjct: 325 RITSEQAMQ 333

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 112/351 (31%), Positives = 159/351 (45%), Gaps = 68/351 (19%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           KV D Y  + ++G G+YG VY A D    + VAIKK+    +        LREI +L  L
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 69  KSPHIIELID-AFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           KS +II L D   P        L++V E  ++DL+ + + T IFL+   +K+ +   L G
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEQHVKTILYNLLLG 143
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------ 165
             F H+  ++HRD+KP N L+     +K+ DFGLAR   S                    
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 166 -------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-----------N 207
                  ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELL           N
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTN 263
Query: 208 RRPFLQGS-----------------SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
           R P   GS                 S+ DQL  IF   GT  P +  DL  +      +Y
Sbjct: 264 RFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTP-PEE--DLKCITKQEVIKY 320
Query: 251 VAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           +   P R        + S S + +DLL  M  ++ + RIT  +AL H + K
Sbjct: 321 IKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLK 371

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 151/304 (49%), Gaps = 25/304 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      +++LV E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLXG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA--- 240
            G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 241 --YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARITAQQAL 289
             Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+   AL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 290 EHRF 293
           +H +
Sbjct: 317 QHPY 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 312 VDDALQHPY 320

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 110/311 (35%), Positives = 157/311 (50%), Gaps = 29/311 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 15  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 74
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 131
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR   S +   T  V  R+YR
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ASTNFMMTPYVVTRYYR 190
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  EL+      QG+  IDQ  K+    G  TPS    
Sbjct: 191 APEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG--TPSAEFM 247
Query: 239 LAYLP---DYVE----YQYVAAPPLRS--LFPSASD-------DALDLLSKMFTYDPKAR 282
            A  P   +YVE    Y  +A   L    +FPS S+        A DLLSKM   DP  R
Sbjct: 248 AALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR 307
Query: 283 ITAQQALEHRF 293
           I+  +AL H +
Sbjct: 308 ISVDEALRHPY 318

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 126
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 305 VDDALQHPY 313

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 151/304 (49%), Gaps = 25/304 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      +++LV E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLXG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA--- 240
            G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 241 --YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARITAQQAL 289
             Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+   AL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 290 EHRF 293
           +H +
Sbjct: 317 QHPY 320

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 312 VDDALQHPY 320

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 171
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 230
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 231 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 350 VDDALQHPY 358

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 171
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 230
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 231 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 350 VDDALQHPY 358

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  150 bits (379), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 312 VDDALQHPY 320

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 313 VDDALQHPY 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 312 VDDALQHPY 320

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 104/310 (33%), Positives = 154/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR     +   T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT------ 232
           APE++ G   Y A VD+W+ GCI  EL+      QG+  IDQ  K+    GT +      
Sbjct: 193 APEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 251
Query: 233 --PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
             P+    +   P Y   ++    P   +FPS S+        A DLLSKM   DP  RI
Sbjct: 252 LQPTVRNYVENRPKYPGIKFEELFP-DWIFPSESERDKIKTSQARDLLSKMLVIDPDKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL H +
Sbjct: 311 SVDEALRHPY 320

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 313 VDDALQHPY 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 16  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 75
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 132
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 191
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 192 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 310
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 311 VDDALQHPY 319

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 126
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 305 VDDALQHPY 313

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 306 VDDALQHPY 314

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 153/309 (49%), Gaps = 25/309 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 285 AQQALEHRF 293
              AL+H +
Sbjct: 306 VDDALQHPY 314

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 100/305 (32%), Positives = 150/305 (49%), Gaps = 27/305 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      ++++V E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---- 239
            G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 240 -AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARITAQQA 288
             Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI+  +A
Sbjct: 257 RTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 LEHRF 293
           L+H +
Sbjct: 316 LQHPY 320

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 100/305 (32%), Positives = 150/305 (49%), Gaps = 27/305 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      ++++V E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLCG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---- 239
            G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 240 -AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARITAQQA 288
             Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI+  +A
Sbjct: 257 RTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 LEHRF 293
           L+H +
Sbjct: 316 LQHPY 320

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T +V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPEVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNALKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 312 SVDEALQHPY 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/310 (32%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+       +V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P+    
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKK 251
Query: 239 LA-----YL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRNYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 311 SVDEALQHPY 320

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 246 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 304
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 305 SVDEALQHPY 314

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 101/310 (32%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 22  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 81
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 138
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 197
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 198 APEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 256
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 257 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 315
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 316 SVDEALQHPY 325

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 99/305 (32%), Positives = 149/305 (48%), Gaps = 27/305 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      ++++V E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---- 239
            G   Y   VD+W+ G I  E++       G+  IDQ  K+    GT +P     L    
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 240 -AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARITAQQA 288
             Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI+  +A
Sbjct: 257 RTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 LEHRF 293
           L+H +
Sbjct: 316 LQHPY 320

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 99/305 (32%), Positives = 149/305 (48%), Gaps = 27/305 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      ++++V E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---- 239
            G   Y   VD+W+ G I  E++       G+  IDQ  K+    GT +P     L    
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 240 -AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARITAQQA 288
             Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI+  +A
Sbjct: 257 RTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 LEHRF 293
           L+H +
Sbjct: 316 LQHPY 320

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 99/305 (32%), Positives = 149/305 (48%), Gaps = 27/305 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  SPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F P K      ++++V E M+ +L  VI+   + L    +   +   L G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCG 138
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+       +V  R+YRAPE++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYRAPEVI 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---- 239
            G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     L    
Sbjct: 198 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 240 -AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARITAQQA 288
             Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI+  +A
Sbjct: 257 RTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 289 LEHRF 293
           L+H +
Sbjct: 316 LQHPY 320

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/310 (32%), Positives = 150/310 (48%), Gaps = 27/310 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 19  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 78
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 135
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+        V  R+YR
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMVPFVVTRYYR 194
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 195 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 253
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 254 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 312
Query: 284 TAQQALEHRF 293
           +  +AL+H +
Sbjct: 313 SVDEALQHPY 322

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/298 (31%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+ +       REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNK-----IKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/331 (28%), Positives = 157/331 (47%), Gaps = 60/331 (18%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + +Y   + LG G++G+V +  D ++G+  A+KK+    + +       RE+ ++K L  
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------RELDIMKVLDH 59
Query: 71  PHIIELIDAFPHKGN--------------------------------------LHLVFEF 92
            +II+L+D F   G+                                      L+++ E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 93  METDLETVIRNTNIFLS-----PADIKS-YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS 146
           +   L  V+++   F+      P ++ S Y+    + + F H   + HRD+KP NLL+ S
Sbjct: 120 VPDTLHKVLKS---FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 147 H-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
               LKL DFG A+    P       + +R+YRAPEL+ GA +Y   +D+W+ GC+F EL
Sbjct: 177 KDNTLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 206 LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSA 263
           +  +P   G + IDQL +I    GT T  Q   +   P Y E ++  + A   R + P  
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQM--IRMNPHYTEVRFPTLKAKDWRKILPEG 293
Query: 264 SDD-ALDLLSKMFTYDPKARITAQQALEHRF 293
           +   A+DLL ++  Y+P  RI   +A+ H F
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 99/304 (32%), Positives = 153/304 (50%), Gaps = 35/304 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 142
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F +  ++   ++   +Y APE+L 
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLH 201
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW        
Sbjct: 202 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 251
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
                              S+ A DL+ KM TY P  RI+A+ AL+H + +++    + V
Sbjct: 252 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295
Query: 305 DFCS 308
           D  S
Sbjct: 296 DVPS 299

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/304 (32%), Positives = 153/304 (50%), Gaps = 35/304 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 106
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 165
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 224
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW  +     
Sbjct: 225 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----- 277
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
                              S+ A DL+ KM TY P  RI+A+ AL+H + +++    + V
Sbjct: 278 -------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 318
Query: 305 DFCS 308
           D  S
Sbjct: 319 DVPS 322

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/304 (32%), Positives = 153/304 (50%), Gaps = 35/304 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 107
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 166
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 167 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 225
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW  +     
Sbjct: 226 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----- 278
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
                              S+ A DL+ KM TY P  RI+A+ AL+H + +++    + V
Sbjct: 279 -------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 319
Query: 305 DFCS 308
           D  S
Sbjct: 320 DVPS 323

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/294 (32%), Positives = 149/294 (50%), Gaps = 35/294 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 89
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 148
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 207
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW  +     
Sbjct: 208 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----- 260
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                              S+ A DL+ KM TY P  RI+A+ AL+H + +++ 
Sbjct: 261 -------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 295

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 146/304 (48%), Gaps = 21/304 (6%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S+K  DR+    + G+GT+G V    +  TG +VAIKK+    Q        L+ ++ L 
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLA 74
Query: 67  ELKSPHIIELIDAFPHKGN-------LHLVFEFMETDLETVIRN---TNIFLSPADIKSY 116
            L  P+I++L   F   G        L++V E++   L    RN     +   P  IK +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 117 MQMTLKGLAFCH--KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVF 173
           +   ++ +   H     V HRD+KP+N+L+  + G LKL DFG A+   SP       + 
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYIC 193
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           +R+YRAPEL+FG + Y   VD+W+ GCIFAE++   P  +G +   QL +I    G  + 
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSAS----DDALDLLSKMFTYDPKARITAQQAL 289
                L      V+       P  ++F   S     +A DLLS +  Y P+ R+   +AL
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313
Query: 290 EHRF 293
            H +
Sbjct: 314 CHPY 317

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 98/304 (32%), Positives = 152/304 (50%), Gaps = 35/304 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I +L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYX 142
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F +  ++   ++   +Y APE+L 
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKDKIGTAYYIAPEVLH 201
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW  +     
Sbjct: 202 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----- 254
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
                              S+ A DL+ K  TY P  RI+A+ AL+H + +++    + V
Sbjct: 255 -------------------SESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISV 295
Query: 305 DFCS 308
           D  S
Sbjct: 296 DVPS 299

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 139/294 (47%), Gaps = 34/294 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                           + SDDA DL+ KM T+ P  RITA Q LEH + + ++ 
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 139/294 (47%), Gaps = 34/294 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                           + SDDA DL+ KM T+ P  RITA Q LEH + + ++ 
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 139/294 (47%), Gaps = 34/294 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                           + SDDA DL+ KM T+ P  RITA Q LEH + + ++ 
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 96/295 (32%), Positives = 141/295 (47%), Gaps = 36/295 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIRNTNIFL-SPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R    F+ S A    YM+  L+ L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP N+L+ S      +KL DFG+A   G        +V    + APE
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 259
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                                 S+ A DL+ +M   DP  RIT  +AL H + K 
Sbjct: 260 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 154/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + VA+K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVAVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N+LI   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVLIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 149/310 (48%), Gaps = 33/310 (10%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           + E  L+K+  + +   E LGEG+YG VYKAI  +TGQ VAIK++ +    + +    ++
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IK 73
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM 119
           EI ++++  SPH+++   ++    +L +V E+     +  +IR  N  L+  +I + +Q 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           TLKGL + H    +HRD+K  N+L+ + G  KLADFG+A        +    +   ++ A
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS-QWPD 238
           PE++     Y    D+W+ G    E+   +P     +DI  +  IF       P+ + P+
Sbjct: 194 PEVIQEIG-YNCVADIWSLGITAIEMAEGKP---PYADIHPMRAIFMIPTNPPPTFRKPE 249
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
           L                        SD+  D + +     P+ R TA Q L+H F +S  
Sbjct: 250 L-----------------------WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286
Query: 299 GVFVFVDFCS 308
           GV +  D  +
Sbjct: 287 GVSILRDLIN 296

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 96/324 (29%), Positives = 154/324 (47%), Gaps = 51/324 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ----- 235
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G   PSQ     
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG--MPSQKLLDA 325
Query: 236 ---WPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA-- 267
                +      Y  Y  V                      PP    + +A    DD   
Sbjct: 326 SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 268 LDLLSKMFTYDPKARITAQQALEH 291
           LD L +   +DP  R+T  QAL H
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRH 409

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 96/324 (29%), Positives = 154/324 (47%), Gaps = 51/324 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ----- 235
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G   PSQ     
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG--MPSQKLLDA 325
Query: 236 ---WPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA-- 267
                +      Y  Y  V                      PP    + +A    DD   
Sbjct: 326 SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 268 LDLLSKMFTYDPKARITAQQALEH 291
           LD L +   +DP  R+T  QAL H
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRH 409

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 151/289 (52%), Gaps = 25/289 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    +     ++ +   K        RE+K+L+ L+   +II+LID
Sbjct: 46  LGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLID 100
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE++  TD + + +     L+  DI+ YM   LK L +CH K ++HR
Sbjct: 101 TVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELLKALDYCHSKGIMHR 156
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 157 DVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLD 215
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           +W+ GC+ A ++ RR PF  G  + DQL +I    GT     +    ++     +  +  
Sbjct: 216 MWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILG 275
Query: 254 PPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              R  + +          S +ALDLL K+  YD + R+TA++A+EH +
Sbjct: 276 QHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 151/289 (52%), Gaps = 25/289 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    +     ++ +   K        RE+K+L+ L+   +II+LID
Sbjct: 51  LGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLID 105
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE++  TD + + +     L+  DI+ YM   LK L +CH K ++HR
Sbjct: 106 TVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELLKALDYCHSKGIMHR 161
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 162 DVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLD 220
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           +W+ GC+ A ++ RR PF  G  + DQL +I    GT     +    ++     +  +  
Sbjct: 221 MWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILG 280
Query: 254 PPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              R  + +          S +ALDLL K+  YD + R+TA++A+EH +
Sbjct: 281 QHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 151/297 (50%), Gaps = 41/297 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
               P      LVFE +       +R T   L+  DI+ YM   LK L +CH   ++HRD
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLRQT---LTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 137 MKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D+
Sbjct: 157 VKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 196 WAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVAA 253
           W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y     
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIELD 266
Query: 254 PPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 140/306 (45%), Gaps = 46/306 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           ++DRY + + LG G YG V    D  TG   AIK I+        N  AL  E+ +LK+L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+I++L + F  K N +LV E     E   E ++R      S  D    M+  L G  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTT 135
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S  +   +K+ DFGL+  F     +   ++   +Y APE+
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEV 194
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L ++     +  P  W  +   
Sbjct: 195 L--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV--- 249
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV 302
                                SD+A  L+  M TY+P  RI+A++AL H +         
Sbjct: 250 ---------------------SDEAKQLVKLMLTYEPSKRISAEEALNHPW--------- 279
Query: 303 FVDFCS 308
            V FCS
Sbjct: 280 IVKFCS 285

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 151/322 (46%), Gaps = 47/322 (14%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G +G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA------TPS 234
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G           
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASK 327
Query: 235 QWPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA--LD 269
           +  +      Y  Y  V                      PP    + +A    DD   LD
Sbjct: 328 RAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 270 LLSKMFTYDPKARITAQQALEH 291
            L +   +DP  R+T  QAL H
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRH 409

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 98
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 264
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 98
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 264
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 139/304 (45%), Gaps = 43/304 (14%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-----------GKQKEGVNFT 57
           K+ + Y K   LG G YG V    +       AIK I+             K  E  +  
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSY 116
              EI LLK L  P+II+L D F  K   +LV EF E  +L   I N + F    D  + 
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANI 151
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVF 173
           M+  L G+ + HK  ++HRD+KP N+L+ +   L   K+ DFGL+  F S D +   ++ 
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDRLG 210
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             +Y APE+L   K+Y    DVW+ G I   LL   P   G +D D + K+         
Sbjct: 211 TAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG------ 262
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                  Y  D+ +++ +            SD+A +L+  M TYD   R TA++AL  R+
Sbjct: 263 ------KYYFDFNDWKNI------------SDEAKELIKLMLTYDYNKRCTAEEALNSRW 304
Query: 294 AKSF 297
            K +
Sbjct: 305 IKKY 308

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 97
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 212
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 263
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 153/298 (51%), Gaps = 43/298 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 50  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 104
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 105 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 160
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 161 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 219
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 220 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 270
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            P    +                     S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 271 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 94/294 (31%), Positives = 140/294 (47%), Gaps = 36/294 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIRNTNIFL-SPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R    F+ S A    YM+  L+ L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    + APE
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 205
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 261
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 S+ A DL+ +M   DP  RIT  +AL H + K
Sbjct: 262 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 140/295 (47%), Gaps = 36/295 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIRNTNIFL-SPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R    F+ S A    YM+  L+ L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 259
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                                 S+ A DL+ +M   DP  RIT  +AL H + K 
Sbjct: 260 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 139/306 (45%), Gaps = 46/306 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           ++DRY + + LG G YG V    D  TG   AIK I+        N  AL  E+ +LK+L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+I++L + F  K N +LV E     E   E ++R      S  D    M+  L G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTT 118
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S  +   +K+ DFGL+  F     +   ++   +Y APE+
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEV 177
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L ++     +  P  W      
Sbjct: 178 L--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDW------ 229
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV 302
                                SD+A  L+  M TY+P  RI+A++AL H +         
Sbjct: 230 ------------------TQVSDEAKQLVKLMLTYEPSKRISAEEALNHPW--------- 262
Query: 303 FVDFCS 308
            V FCS
Sbjct: 263 IVKFCS 268

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +++ Y + + LG G YG V    D  T    AIK IR        N   L E+ +LK L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+I++L D F  K N +LV E  +     + +I       +  D    ++  L G+ + 
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYL 152
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +K+ DFGL+ +F +  ++   ++   +Y APE+L 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL- 210
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             K+Y    DVW+ G I   LL   P   G +D + L K+     T    +W ++     
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----- 264
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                              S+ A DL+ +M  +D + RI+AQQALEH + K  
Sbjct: 265 -------------------SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 134/299 (44%), Gaps = 37/299 (12%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG------KQKEGVNFTALR 60
           +K+   +Y  ++V+G G   VV + +   TG   A+K + +       +Q E V     R
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 61  EIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           E  +L+++   PHII LID++     + LVF+ M            + LS  + +S M+ 
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+ ++F H   ++HRD+KP N+L+  + Q++L+DFG +     P  +         Y A
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLA 267
Query: 180 PELLFGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           PE+L  +       YG  VD+WA G I   LL   P       I  L  I       +  
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +W D                         S    DL+S++   DP+AR+TA+QAL+H F
Sbjct: 328 EWDD------------------------RSSTVKDLISRLLQVDPEARLTAEQALQHPF 362

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 130/244 (53%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 163
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +     AYL    
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----AYLN--- 274
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 275 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 334
Query: 290 EHRF 293
            H +
Sbjct: 335 THPY 338

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 144/295 (48%), Gaps = 37/295 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G Y  V++ I+    +    K I    +             L   +  P+I++L+D 
Sbjct: 39  VGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLMGGPNIVKLLDI 94
Query: 80  F--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
               H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH + ++HRD+
Sbjct: 95  VRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDV 151
Query: 138 KPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D+W
Sbjct: 152 KPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMW 210
Query: 197 AAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           + GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    +Y+    P 
Sbjct: 211 SLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN---KYRIELDPQ 262
Query: 256 LRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQALEHRF 293
           L +L           F +A      S +A+D L K+  YD + R+TA +A+ H +
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 138/294 (46%), Gaps = 53/294 (18%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKL 64
           +SK+    Y+ RE LGEG++G V  A   KT Q VA+K I R   +K  ++    REI  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           LK L+ PHII+L D      ++ +V E+   +L   I      ++  + + + Q  +  +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFA 174
            +CH+  ++HRD+KP NLL+  +  +K+ADFGL+ I           GSP+         
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------- 172
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             Y APE++ G    G  VDVW+ G + +  L+ R PF     D + +  +F    +   
Sbjct: 173 --YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-----DDEFIPNLFKKVNSC-- 223
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                +  +PD++                 S  A  L+ +M   DP  RIT Q+
Sbjct: 224 -----VYVMPDFL-----------------SPGAQSLIRRMIVADPMQRITIQE 255

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRF 293
            H +
Sbjct: 314 THPY 317

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRF 293
            H +
Sbjct: 314 THPY 317

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRF 293
            H +
Sbjct: 314 THPY 317

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 144
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 255
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 256 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 315
Query: 290 EHRF 293
            H +
Sbjct: 316 THPY 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRF 293
            H +
Sbjct: 314 THPY 317

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 254
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 290 EHRF 293
            H +
Sbjct: 315 THPY 318

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 254
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 290 EHRF 293
            H +
Sbjct: 315 THPY 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 33/244 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSA------SDDALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A      S +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRF 293
            H +
Sbjct: 314 THPY 317

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 101/341 (29%), Positives = 155/341 (45%), Gaps = 58/341 (17%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           V   +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVR 102
Query: 64  LLKELKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKS 115
           LL EL + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + 
Sbjct: 103 LL-ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 116 YMQMTLKGLAF--CHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQ 171
           + Q     L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQX 218
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           + +R+YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G  
Sbjct: 219 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 232 TPSQWPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD------- 265
            P+   D A         LPD             EY+      L ++    +        
Sbjct: 278 -PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336
Query: 266 --------DAL---DLLSKMFTYDPKARITAQQALEHRFAK 295
                   D L   DL+ +M  YDPK RI    AL+H F K
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 101/341 (29%), Positives = 155/341 (45%), Gaps = 58/341 (17%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           V   +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++
Sbjct: 27  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVR 83
Query: 64  LLKELKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKS 115
           LL EL + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + 
Sbjct: 84  LL-ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 142
Query: 116 YMQMTLKGLAF--CHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQ 171
           + Q     L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    
Sbjct: 143 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQX 199
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           + +R+YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G  
Sbjct: 200 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258
Query: 232 TPSQWPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD------- 265
            P+   D A         LPD             EY+      L ++    +        
Sbjct: 259 -PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 317
Query: 266 --------DAL---DLLSKMFTYDPKARITAQQALEHRFAK 295
                   D L   DL+ +M  YDPK RI    AL+H F K
Sbjct: 318 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 358

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 101/341 (29%), Positives = 155/341 (45%), Gaps = 58/341 (17%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           V   +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVR 102
Query: 64  LLKELKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKS 115
           LL EL + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + 
Sbjct: 103 LL-ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 116 YMQMTLKGLAF--CHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQ 171
           + Q     L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQX 218
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           + +R+YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G  
Sbjct: 219 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 232 TPSQWPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD------- 265
            P+   D A         LPD             EY+      L ++    +        
Sbjct: 278 -PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336
Query: 266 --------DAL---DLLSKMFTYDPKARITAQQALEHRFAK 295
                   D L   DL+ +M  YDPK RI    AL+H F K
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            D    K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRD 138
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGA 186
           +KP NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G 
Sbjct: 139 LKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGK 187
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PF 211
              G  VDVW+ G I   +L RR PF
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            D    K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGA 186
           +KP NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G 
Sbjct: 138 LKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGK 186
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PF 211
              G  VDVW+ G I   +L RR PF
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 142/286 (49%), Gaps = 35/286 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVT-RKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 240
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ L+H+F K
Sbjct: 241 -----KLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            D    K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRD 132
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGA 186
           +KP NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G 
Sbjct: 133 LKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGK 181
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PF 211
              G  VDVW+ G I   +L RR PF
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            D    K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRD 128
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGA 186
           +KP NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G 
Sbjct: 129 LKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGK 177
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PF 211
              G  VDVW+ G I   +L RR PF
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 142/286 (49%), Gaps = 35/286 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT-RKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 240
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ L+H+F K
Sbjct: 241 -----KLSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 142/286 (49%), Gaps = 35/286 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 240
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ L+H+F K
Sbjct: 241 -----KLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 142/286 (49%), Gaps = 35/286 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 77
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 135
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT-RKAY 194
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ ++H+F K
Sbjct: 242 -----KLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 142/286 (49%), Gaps = 35/286 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 77
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 135
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HR++K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAY 194
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E++   P     + +  L  + A  GT      P+L   P+     
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT------PELQN-PE----- 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                 L ++F        D L++    D + R +A++ ++H+F K
Sbjct: 242 -----KLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 121
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 180
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 240
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 241 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 274

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 275

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 275

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 294 AKSFNGVFVFVDFCS 308
            +  +    F D  S
Sbjct: 278 LQDEDMKRKFQDLLS 292

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 140/315 (44%), Gaps = 42/315 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 128
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 187
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 247
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 248 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 283
Query: 294 AKSFNGVFVFVDFCS 308
            +  +    F D  S
Sbjct: 284 LQDEDMKRKFQDLLS 298

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E         E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 261
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 320
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 381 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 414

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E LG+G + VV + +   TGQ  A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVNH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH   ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKDPYGKPVDMWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      P   ++ P A     DL++KM T +P  RITA +AL+H
Sbjct: 228 -----------PEWDTVTPEAK----DLINKMLTINPAKRITASEALKH 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E LG+G + VV + +   TGQ  A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVNH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH   ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKDPYGKPVDMWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      P   ++ P A     DL++KM T +P  RITA +AL+H
Sbjct: 228 -----------PEWDTVTPEAK----DLINKMLTINPAKRITASEALKH 261

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARIC 59
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILE 116
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYR 178
            +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y 
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A           
Sbjct: 175 SPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA----- 223
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                     Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 224 ----------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 261

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEG-VNFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E         E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 247
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 306
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 367 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 400

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 142/296 (47%), Gaps = 41/296 (13%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REI 62
           ++ S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREA 79
Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQM 119
           ++ ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQ 136
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR- 175
            L+ +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H      
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTP 194
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
            Y +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A        
Sbjct: 195 GYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAG--- 245
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                AY  DY   ++    P          +A  L+  M T +PK RITA QAL+
Sbjct: 246 -----AY--DYPSPEWDTVTP----------EAKSLIDSMLTVNPKKRITADQALK 284

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARIC 59
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILE 116
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYR 178
            +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y 
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A           
Sbjct: 175 SPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA----- 223
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                     Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 224 ----------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 261

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 34/298 (11%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTAL 59
           +AE+   K   D +     LG+G +G VY A + +    +A+K + +   +KEGV     
Sbjct: 3   LAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQ 118
           REI++   L+ P+I+ + + F  +  ++L+ EF    +L   ++    F       ++M+
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFME 121
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
                L +CH++ V+HRD+KP NLL+G  G+LK+ADFG +    +P  R         Y 
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYL 179
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PE++ G K +   VD+W AG +  E L   P     S  +   +I             D
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------D 228
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           L +            PP        SD + DL+SK+  Y P  R+  +  +EH + K+
Sbjct: 229 LKF------------PPF------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 34/298 (11%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTAL 59
           +AE+   K   D +     LG+G +G VY A + +    +A+K + +   +KEGV     
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 63
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQ 118
           REI++   L+ P+I+ + + F  +  ++L+ EF    +L   ++    F       ++M+
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFME 122
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
                L +CH++ V+HRD+KP NLL+G  G+LK+ADFG +    +P  R         Y 
Sbjct: 123 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYL 180
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PE++ G K +   VD+W AG +  E L   P     S  +   +I             D
Sbjct: 181 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------D 229
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           L +            PP        SD + DL+SK+  Y P  R+  +  +EH + K+
Sbjct: 230 LKF------------PPF------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LG+G + VV + +    GQ  A K I   K     +    RE ++ + LK P+I+ L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 78  DAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           D+   +G+ +L+F+ +   E   + V R    + S AD    +Q  L+ +  CH+  V+H
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMGVVH 144
Query: 135 RDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           RD+KP NLL+ S      +KLADFGLA       + +        Y +PE+L     YG 
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGK 203
Query: 192 GVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
            VD+WA G I +  L+   PF     D  +L +   A     PS                
Sbjct: 204 PVDLWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS---------------- 245
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              P   ++ P A     DL++KM T +P  RITA +AL+H
Sbjct: 246 ---PEWDTVTPEAK----DLINKMLTINPSKRITAAEALKH 279

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 138/291 (47%), Gaps = 41/291 (14%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKE 67
           K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ ++
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRK 60
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+ +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESI 117
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYRAP 180
           A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y +P
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSP 175
Query: 181 ELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L     Y   VD+WA G I +  L+   PF     D DQ  +++A             
Sbjct: 176 EVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA------- 222
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                   Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 223 --------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 260

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 134/310 (43%), Gaps = 56/310 (18%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPH 72
           Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + PH
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           II+L        ++ +V E++      + + +N    L   + +   Q  L G+ +CH+ 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH 135
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAP 180
            V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+           Y AP
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPN-----------YAAP 184
Query: 181 ELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E++ G    G  VD+W++G I +A L    PF     D D +  +F             +
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICDG-------I 232
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
            Y P Y             L PS     + LL  M   DP  R T +   EH + K    
Sbjct: 233 FYTPQY-------------LNPS----VISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275
Query: 300 VFVFVDFCSY 309
            ++F +  SY
Sbjct: 276 KYLFPEDPSY 285

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 75  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 131
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 132 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 188
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 228
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 229 --------TEGARDLISRLLKHNPSQRPMLREVLEH 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK---SYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D +   +Y+      L++CH K V+HR
Sbjct: 93  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 149
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 150 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 206
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 246
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 247 --------TEGARDLISRLLKHNPSQRPMLREVLEH 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 137 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 193
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 233
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 234 --------TEGARDLISRLLKHNPSQRPMLREVLEH 261

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 102 YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 158
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 215
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 255
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 256 --------TEGARDLISRLLKHNPSQRPMLREVLEH 283

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 139/309 (44%), Gaps = 37/309 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y++ + +GEG++G       T+ G+   IK+I + +        + RE+ +L  +K P
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCH 128
           +I++  ++F   G+L++V ++ E  DL   I      L   D  +  ++Q+ L  L   H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL-ALKHVH 142
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
            + +LHRD+K  N+ +   G ++L DFG+AR+  S        +   +Y +PE+    K 
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KP 201
Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y    D+WA GC+  EL   +   +  S  + + KI +             ++ P  + Y
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG------------SFPPVSLHY 249
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-----HRFAKSFNGVFVF 303
            Y               D   L+S++F  +P+ R +    LE      R  K  +   + 
Sbjct: 250 SY---------------DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294
Query: 304 VDFCSYLYS 312
            +FC   +S
Sbjct: 295 EEFCLKTFS 303

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A +  +   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDSTRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKKVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  D   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 36/280 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            F     ++L+ E+    L TV R              +Y+      L++CH K V+HRD
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP NLL+GS+G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+W
Sbjct: 138 IKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLW 194
Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + G +  E L   P  +  +  +   +I     T            PD+V          
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----------FPDFV---------- 233
Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                  ++ A DL+S++  ++   R+T  + LEH + K+
Sbjct: 234 -------TEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + +    +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 73  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 129
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 130 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 186
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 226
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 227 --------TEGARDLISRLLKHNPSQRPMLREVLEH 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +LG+G++  VY+A    TG  VAIK I +    K G+      E+K+  +LK P I+EL 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           + F     ++LV E     ++   ++N     S  + + +M   + G+ + H   +LHRD
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +  +NLL+  +  +K+ADFGLA     P  +         Y +PE+   +  +G   DVW
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVW 196
Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + GC+F  LL  RP                 F T T     +   L DY        P  
Sbjct: 197 SLGCMFYTLLIGRP----------------PFDTDTVKNTLNKVVLADY------EMPSF 234
Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            S+      +A DL+ ++   +P  R++    L+H F
Sbjct: 235 LSI------EAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE + G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIEG-RXHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPXLREVLEH 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 78  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+A+FG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 135 DIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 191
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 231
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 232 --------TEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+A+FG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 78  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 135 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 191
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 231
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 232 --------TEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK---SYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D +   +Y+      L++CH K V+HR
Sbjct: 102 YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 158
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDL 215
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 255
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 256 --------TEGARDLISRLLKHNPSQRPMLREVLEH 283

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 131/284 (46%), Gaps = 34/284 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y     +G G++G V  A+   T    A KKI     ++   F   +EI+++K L  P+I
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNI 85
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L + F    +++LV E     +L   + +  +F   +D    M+  L  +A+CHK  V
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCHKLNV 144
Query: 133 LHRDMKPNNLLI---GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            HRD+KP N L         LKL DFGLA  F  P +    +V   +Y +P++L G   Y
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL--Y 201
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G   D W+AG +   LL   P     +D + + KI    GT T   +P+  +L       
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GTFT---FPEKDWL------- 249
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                       + S  A  L+ ++ T  PK RIT+ QALEH +
Sbjct: 250 ------------NVSPQAESLIRRLLTKSPKQRITSLQALEHEW 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 131/284 (46%), Gaps = 34/284 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y     +G G++G V  A+   T    A KKI     ++   F   +EI+++K L  P+I
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNI 68
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L + F    +++LV E     +L   + +  +F   +D    M+  L  +A+CHK  V
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCHKLNV 127
Query: 133 LHRDMKPNNLLI---GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            HRD+KP N L         LKL DFGLA  F  P +    +V   +Y +P++L G   Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL--Y 184
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G   D W+AG +   LL   P     +D + + KI    GT T   +P+  +L       
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GTFT---FPEKDWL------- 232
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                       + S  A  L+ ++ T  PK RIT+ QALEH +
Sbjct: 233 ------------NVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            F     ++L+ E+    L TV R              +Y+      L++CH K V+HRD
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP NLL+GS+G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+W
Sbjct: 138 IKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDLW 194
Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + G +  E L   P  +  +  +   +I     T            PD+V          
Sbjct: 195 SLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----------FPDFV---------- 233
Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                  ++ A DL+S++  ++   R+T  + LEH + K+
Sbjct: 234 -------TEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 136/298 (45%), Gaps = 37/298 (12%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA +  ++   + Y   E LG+G + VV + +    GQ  A   I   K     +    R
Sbjct: 1   MATITCTR-FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER 59
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYM 117
           E ++ + LK P+I+ L D+   +G+ +L+F+ +   E   + V R    + S AD    +
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCI 116
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFA 174
           Q  L+ +  CH+  V+HR++KP NLL+ S      +KLADFGLA       + +      
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             Y +PE+L     YG  VD+WA G I +  L+   PF     D  +L +   A     P
Sbjct: 177 PGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFP 233
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           S                   P   ++ P A     DL++KM T +P  RITA +AL+H
Sbjct: 234 S-------------------PEWDTVTPEAK----DLINKMLTINPSKRITAAEALKH 268

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E +G+G + VV + +   TG   A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
             +I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH+  V+HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKEAYGKPVDIWACGVILYILLVGYPPFW--DEDQHKLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      P   ++ P A     +L+++M T +P  RITA +AL+H
Sbjct: 228 -----------PEWDTVTPEAK----NLINQMLTINPAKRITAHEALKH 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 34/274 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F     ++L+ E+    ++   ++  + F       +Y+      L++CH K V+HRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+W+
Sbjct: 140 KPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWS 196
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  E L  +P  + ++  +   +I     T            PD+V           
Sbjct: 197 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV----------- 234
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 235 ------TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 91/309 (29%), Positives = 143/309 (46%), Gaps = 41/309 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 141
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 197
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y    D+W+ G    E+ + R P   GS  +     IF                L DY+
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSM----AIFE---------------LLDYI 238
Query: 247 EYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
               V  PP +   PS   S +  D ++K    +P  R   +Q + H F K  +     V
Sbjct: 239 ----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA--EEV 290
Query: 305 DFCSYLYSS 313
           DF  +L S+
Sbjct: 291 DFAGWLCST 299

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 138/307 (44%), Gaps = 56/307 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 176
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 177 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 225
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+T  Q+LE
Sbjct: 226 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 291 HRFAKSF 297
           H + K+ 
Sbjct: 266 HSWIKAI 272

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 133/295 (45%), Gaps = 40/295 (13%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           + D ++ +  LG G +G V+   +  +G    IK I   K +  V    +  EI++LK L
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSL 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETD--LETVI--RNTNIFLSPADIKSYMQMTLKGL 124
             P+II++ + F    N+++V E  E    LE ++  +     LS   +   M+  +  L
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+ H + V+H+D+KP N+L      H  +K+ DFGLA +F S D   T+      Y APE
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGTALYMAPE 196
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +    +      D+W+AG +   LL    PF                    T +   ++ 
Sbjct: 197 VF--KRDVTFKCDIWSAGVVMYFLLTGCLPF--------------------TGTSLEEVQ 234
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
               Y E  Y  A   R L P     A+DLL +M T DP+ R +A Q L H + K
Sbjct: 235 QKATYKEPNY--AVECRPLTPQ----AVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F     ++L+ E+    ++   ++  + F       +Y+      L++CH K V+HRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+W+
Sbjct: 140 KPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEG-RMHDEKVDLWS 196
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  E L  +P  + ++  +   +I     T            PD+V           
Sbjct: 197 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV----------- 234
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 ++ A DL+S++  ++P  R   ++ LEH
Sbjct: 235 ------TEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   VDVW
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 197 AAGCIFAELLNRRPFL 212
           + G    EL  R+P L
Sbjct: 238 SLGITCIELAERKPPL 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   VDVW
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 197 AAGCIFAELLNRRPFL 212
           + G    EL  R+P L
Sbjct: 199 SLGITCIELAERKPPL 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 31/285 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +    T  +EI+ +  L+
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLR 212
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 330
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +         W     + D  
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------DW----NMDD-- 377
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      S F   S+D  D + K+   DP  R+T  QALEH
Sbjct: 378 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   K  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-AKKALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 SD A D +  +   DP+ R T +QAL+H
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 31/285 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +    T  +EI+ +  L+
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLR 106
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 224
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +         W     + D  
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------DW----NMDD-- 271
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      S F   S+D  D + K+   DP  R+T  QALEH
Sbjct: 272 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 305

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 SD A D +  +   DP+ R T +QAL+H
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 140/282 (49%), Gaps = 37/282 (13%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           K E+LG G +G V+K  +T TG  +A K  K R  K KE V      EI ++ +L   ++
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK----NEISVMNQLDHANL 148
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+L DAF  K ++ LV E+++  +L   I + +  L+  D   +M+   +G+   H+ ++
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208
Query: 133 LHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           LH D+KP N+L  +    Q+K+ DFGLAR +  P  +         + APE++       
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVV-NYDFVS 266
Query: 191 AGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D+W+ G I   LL+   PFL G +D + L  I A        +W     L D  E+Q
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILAC-------RWD----LEDE-EFQ 313
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            +            S++A + +SK+   +   RI+A +AL+H
Sbjct: 314 DI------------SEEAKEFISKLLIKEKSWRISASEALKH 343

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 SD A D +  +   DP+ R T +QAL+H
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 31/289 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++ ++  TG+    K I      +   +T   EI ++ +L 
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLH 106
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +GL   H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +  ++H D+KP N++  +     +K+ DFGLA    +PD           + APE++   
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIV-DR 224
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           +  G   D+WA G +   LL+      G  D++ L  +           W          
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDW---------- 267
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
           E+   A       F S S +A D +  +   +P+ R+T   ALEH + K
Sbjct: 268 EFDEDA-------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 SD A D +  +   DP+ R T +QAL+H
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQH 273

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 139/286 (48%), Gaps = 40/286 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y+K   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 48  DSYVK---IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHF 102
Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ + +R     L+   I +  +  L+ LA+ 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+   G++KL+DFG          +    V   ++ APE++    
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRS 216
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y   VD+W+ G +  E+++  P     S +  + ++       +P         P  ++
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDSP---------PPKLK 262
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +  +P LR           D L +M   DP+ R TAQ+ L+H F
Sbjct: 263 NSHKVSPVLR-----------DFLERMLVRDPQERATAQELLDHPF 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           +D Y+ +E +G G+Y    + +   T    A+K I   K+          EI+ LL+  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQ 79
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II L D +    +++LV E M     L+ ++R    F S  +    +    K + + 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL 137
Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           H + V+HRD+KP+N+L     G+   L++ DFG A+   + +       +   + APE+L
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQ--LGKIFAAFGTATPSQWPDLA 240
              + Y  G D+W+ G +   +L    PF  G SD  +  L +I +   T +   W    
Sbjct: 198 -KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN--- 253
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                + S+ A DL+SKM   DP  R+TA+Q L+H
Sbjct: 254 ---------------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQH 283

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 183
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 184 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 232
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+   Q+LE
Sbjct: 233 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272
Query: 291 HRFAKS 296
           H + K+
Sbjct: 273 HSWIKA 278

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 139/309 (44%), Gaps = 57/309 (18%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK---------------------- 49
           ++Y  ++ +G+G+YGVV  A +       A+K +   K                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 50  --QKEGVNFTALREIKLLKELKSPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTN 105
             Q  G      +EI +LK+L  P++++L++    P++ +L++VFE +       +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD 165
             LS    + Y Q  +KG+ + H + ++HRD+KP+NLL+G  G +K+ADFG++  F   D
Sbjct: 133 P-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 166 RRFTHQVFARWYRAPELLFGAKQY--GAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLG 222
              ++ V    + APE L   ++   G  +DVWA G  ++  +  + PF+      D+  
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DERI 245
Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
               +   +   ++PD                      P  ++D  DL+++M   +P++R
Sbjct: 246 MCLHSKIKSQALEFPDQ---------------------PDIAEDLKDLITRMLDKNPESR 284
Query: 283 ITAQQALEH 291
           I   +   H
Sbjct: 285 IVVPEIKLH 293

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           +D Y+ +E +G G+Y    + +   T    A+K I   K+          EI+ LL+  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQ 79
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II L D +    +++LV E M     L+ ++R    F S  +    +    K + + 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL 137
Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           H + V+HRD+KP+N+L     G+   L++ DFG A+   + +       +   + APE+L
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQ--LGKIFAAFGTATPSQWPDLA 240
              + Y  G D+W+ G +   +L    PF  G SD  +  L +I +   T +   W    
Sbjct: 198 -KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN--- 253
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                + S+ A DL+SKM   DP  R+TA+Q L+H
Sbjct: 254 ---------------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQH 283

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++    EI++L     P+I++L+ A
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHPYIVKLLGA 76
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + H G L ++ EF     ++ ++   +  L+   I+   +  L+ L F H K ++HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGV 193
             N+L+   G ++LADFG+ A+   +  +R +  +   ++ APE++         Y    
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA--TPSQWPDLAYLPDYVEYQYV 251
           D+W+ G    E+    P     + +  L KI  +      TPS+W         VE++  
Sbjct: 196 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW--------SVEFR-- 245
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                            D L      +P+ R +A Q LEH F  S   
Sbjct: 246 -----------------DFLKIALDKNPETRPSAAQLLEHPFVSSITS 276

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 142/310 (45%), Gaps = 37/310 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--LPDY 245
            Y    D+W+ G    E+               +G+       A     P +A   L DY
Sbjct: 179 HYSVQSDIWSMGLSLVEM--------------AVGRYPIPPPDAKEDSRPPMAIFELLDY 224
Query: 246 VEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVF 303
           +    V  PP +   PS   S +  D ++K    +P  R   +Q + H F K  +     
Sbjct: 225 I----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA--EE 276
Query: 304 VDFCSYLYSS 313
           VDF  +L S+
Sbjct: 277 VDFAGWLCST 286

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++    EI++L     P+I++L+ A
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHPYIVKLLGA 84
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + H G L ++ EF     ++ ++   +  L+   I+   +  L+ L F H K ++HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGV 193
             N+L+   G ++LADFG+ A+   +  +R +  +   ++ APE++         Y    
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA--TPSQWPDLAYLPDYVEYQYV 251
           D+W+ G    E+    P     + +  L KI  +      TPS+W         VE++  
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW--------SVEFR-- 253
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                            D L      +P+ R +A Q LEH F  S   
Sbjct: 254 -----------------DFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 137/307 (44%), Gaps = 56/307 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 197
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 198 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 246
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+   Q+LE
Sbjct: 247 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286
Query: 291 HRFAKSF 297
           H + K+ 
Sbjct: 287 HSWIKAI 293

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 130/297 (43%), Gaps = 48/297 (16%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G   +VY+     T +  A+K ++    K+ V      EI +L  L  P+II+L + 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEI 116
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F     + LV E + T  E   R     + S  D    ++  L+ +A+ H+  ++HRD+K
Sbjct: 117 FETPTEISLVLELV-TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 139 PNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQY 189
           P NLL  +      LK+ADFGL++I         HQV  +       Y APE+L G   Y
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKI-------VEHQVLMKTVCGTPGYCAPEILRGC-AY 227
Query: 190 GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           G  VD+W+ G I +  L    PF     D     +I                      EY
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-------------------EY 268
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVD 305
            +++       +   S +A DL+ K+   DPK R+T  QAL+H +       FV +D
Sbjct: 269 YFIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 182
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                                    SD   DL+S+     P+ R TA++AL H F + +
Sbjct: 243 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +GEG+ G+V  A +  TG+ VA+KK+ L KQ+         E+ ++++    +++++  +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKP 139
           +     L +V EF+E    T I  T+  ++   I +     L+ L++ H + V+HRD+K 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 140 NNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAG 199
           +++L+ S G++KL+DFG          +    V   ++ APE++     YG  VD+W+ G
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI-SRLPYGTEVDIWSLG 228
Query: 200 CIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL 259
            +  E+++  P       +  + +I  +              LP  V+  +  +  LR  
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRDS--------------LPPRVKDLHKVSSVLRGF 274
Query: 260 FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                   LDL   M   +P  R TAQ+ L H F K
Sbjct: 275 --------LDL---MLVREPSQRATAQELLGHPFLK 299

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 195
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                                    SD   DL+S+     P+ R TA++AL H F + +
Sbjct: 256 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEII 195
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                                    SD   DL+S+     P+ R TA++AL H F + +
Sbjct: 256 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +  D Y   E LG+G + VV + +     Q  A K I   K     +    RE ++ + L
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           K P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +   L+ + 
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIHQILESVN 144
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
             H+  ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 183 LFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD+WA G I +  L+   PF     D  +L +   A     PS       
Sbjct: 205 L-RKDPYGKPVDIWACGVILYILLVGYPPFW--DEDQHKLYQQIKAGAYDFPS------- 254
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       P   ++ P A     +L+++M T +P  RITA QAL+H
Sbjct: 255 ------------PEWDTVTPEAK----NLINQMLTINPAKRITADQALKH 288

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 139/310 (44%), Gaps = 47/310 (15%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 67
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 125
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  ++HRD+KP+N+L+ S G++KL DFG++      D      V  R Y +PE L G   
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDEMANEFVGTRSYMSPERLQGT-H 182
Query: 189 YGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--LPDY 245
           Y    D+W+ G    E+ + R P                          P +A   L DY
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYP-------------------------RPPMAIFELLDY 217
Query: 246 VEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVF 303
           +    V  PP +   PSA  S +  D ++K    +P  R   +Q + H F K  +     
Sbjct: 218 I----VNEPPPK--LPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA--EE 269
Query: 304 VDFCSYLYSS 313
           VDF  +L S+
Sbjct: 270 VDFAGWLCST 279

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
            +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 79  AFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK- 130
               + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRS 131
Query: 131 ----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
                VLHRD+KP N+ +     +KL DFGLARI    +      V   +Y +PE +   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM-NR 190
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 93/330 (28%), Positives = 149/330 (45%), Gaps = 45/330 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 126
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 184
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 240
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQW---------- 236
            Y    D+W+ G    E+ + R P      D  +L  +F        ++           
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 298
Query: 237 ---------PDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARI 283
                    P +A   L DY+    V  PP +   PSA  S +  D ++K    +P  R 
Sbjct: 299 LSSYGMDSRPPMAIFELLDYI----VNEPPPK--LPSAVFSLEFQDFVNKCLIKNPAERA 352
Query: 284 TAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
             +Q + H F K  +     VDF  +L S+
Sbjct: 353 DLKQLMVHAFIKRSDA--EEVDFAGWLCST 380

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      S +  D L K    +  AR T  Q L+H F
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 44/302 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPH 72
           Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + PH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           II+L        +  +V E++      + + ++  +     + +   Q  L  + +CH+ 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILSAVDYCHRH 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+KP N+L+ +H   K+ADFGL+ +  S          +  Y APE++ G    G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 191 AGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD+W+ G I +A L    PF     D + +  +F             + Y+P+Y+   
Sbjct: 190 PEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGG-------VFYIPEYLN-- 235
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSY 309
                  RS+          LL  M   DP  R T +   EH + K         D  SY
Sbjct: 236 -------RSV--------ATLLMHMLQVDPLKRATIKDIREHEWFKQ--------DLPSY 272
Query: 310 LY 311
           L+
Sbjct: 273 LF 274

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 44/302 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPH 72
           Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + PH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           II+L        +  +V E++      + + ++  +     + +   Q  L  + +CH+ 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILSAVDYCHRH 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+KP N+L+ +H   K+ADFGL+ +    +   T    +  Y APE++ G    G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAG 189
Query: 191 AGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD+W+ G I +A L    PF     D + +  +F             + Y+P+Y+   
Sbjct: 190 PEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGG-------VFYIPEYLN-- 235
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFVDFCSY 309
                  RS+          LL  M   DP  R T +   EH + K         D  SY
Sbjct: 236 -------RSV--------ATLLMHMLQVDPLKRATIKDIREHEWFKQ--------DLPSY 272
Query: 310 LY 311
           L+
Sbjct: 273 LF 274

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      S +  D L K    +  AR T  Q L+H F
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 105/233 (45%), Gaps = 16/233 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
            +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 79  AFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK- 130
               + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRS 131
Query: 131 ----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFG 185
                VLHRD+KP N+ +     +KL DFGLARI    D  F    V   +Y +PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYYMSPEQM-N 189
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
              Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      S +  D L K    +  AR T  Q L+H F
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 105/233 (45%), Gaps = 16/233 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
            +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 79  AFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK- 130
               + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++ 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRS 131
Query: 131 ----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFG 185
                VLHRD+KP N+ +     +KL DFGLARI    D  F    V   +Y +PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQM-N 189
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
              Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 92/330 (27%), Positives = 147/330 (44%), Gaps = 45/330 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAA------------------- 227
            Y    D+W+ G    E+ + R P      D  +L  +F                     
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 228 FGTATPSQWPDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARI 283
             +      P +A   L DY+    V  PP +   PS   S +  D ++K    +P  R 
Sbjct: 237 LSSYGMDSRPPMAIFELLDYI----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 284 TAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
             +Q + H F K  +     VDF  +L S+
Sbjct: 291 DLKQLMVHAFIKRSDA--EEVDFAGWLCST 318

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 92/330 (27%), Positives = 147/330 (44%), Gaps = 45/330 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAA------------------- 227
            Y    D+W+ G    E+ + R P      D  +L  +F                     
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 228 FGTATPSQWPDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARI 283
             +      P +A   L DY+    V  PP +   PS   S +  D ++K    +P  R 
Sbjct: 237 LSSYGMDSRPPMAIFELLDYI----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 284 TAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
             +Q + H F K  +     VDF  +L S+
Sbjct: 291 DLKQLMVHAFIKRSDA--EEVDFAGWLCST 318

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 94/333 (28%), Positives = 149/333 (44%), Gaps = 51/333 (15%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 91
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 149
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 205
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAA------------------- 227
            Y    D+W+ G    E+ + R P      D  +L  +F                     
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 228 ---FGTATPSQWPDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPK 280
              FG  +    P +A   L DY+    V  PP +   PS   S +  D ++K    +P 
Sbjct: 264 LNKFGMDS---RPPMAIFELLDYI----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPA 314
Query: 281 ARITAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
            R   +Q + H F K  +     VDF  +L S+
Sbjct: 315 ERADLKQLMVHAFIKRSDA--EEVDFAGWLCST 345

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 92/330 (27%), Positives = 147/330 (44%), Gaps = 45/330 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAA------------------- 227
            Y    D+W+ G    E+ + R P      D  +L  +F                     
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 228 FGTATPSQWPDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARI 283
             +      P +A   L DY+    V  PP +   PS   S +  D ++K    +P  R 
Sbjct: 237 LSSYGMDSRPPMAIFELLDYI----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 284 TAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
             +Q + H F K  +     VDF  +L S+
Sbjct: 291 DLKQLMVHAFIKRSDA--EEVDFAGWLCST 318

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 92/330 (27%), Positives = 147/330 (44%), Gaps = 45/330 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAA------------------- 227
            Y    D+W+ G    E+ + R P      D  +L  +F                     
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 228 FGTATPSQWPDLAY--LPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARI 283
             +      P +A   L DY+    V  PP +   PS   S +  D ++K    +P  R 
Sbjct: 237 LSSYGMDSRPPMAIFELLDYI----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 284 TAQQALEHRFAKSFNGVFVFVDFCSYLYSS 313
             +Q + H F K  +     VDF  +L S+
Sbjct: 291 DLKQLMVHAFIKRSDA--EEVDFAGWLCST 318

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 14/220 (6%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + +   LG G  GVV K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 74
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P +I   + +  L+GLA+  +
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLRE 132
Query: 130 K-WVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y APE L G  
Sbjct: 133 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMAPERLQGT- 188
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFA 226
            Y    D+W+ G    EL + R P      D  +L  IF 
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPI--PPPDAKELEAIFG 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 195
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 241
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 242 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 272

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 199
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 245
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 246 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 276

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 88
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 206
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 252
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 253 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 283

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 86
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 204
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 250
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 251 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 281

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 37/292 (12%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K+    + T   EI LL+
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEI-LLR 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
             + P+II L D +     +++V E M+    L+ ++R    F S  +  + +    K +
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 125 AFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L     G+   +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G +   +L    PF  G  D  +  +I A  G+   S     
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKFS----- 241
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +   Y         + S SD A DL+SKM   DP  R+TA   L H
Sbjct: 242 ------LSGGY---------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 131
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 249
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 295
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 296 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 326

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLK 66
           K+  +YL  ++LGEG+YG V + +D++T    A+K ++  K +   N  A   +EI+LL+
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67  ELKSPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSP-ADIKSYMQMTLKG 123
            L+  ++I+L+D      K  +++V E+    ++ ++ +      P      Y    + G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI---FGSPDRRFTHQVFARWYRAP 180
           L + H + ++H+D+KP NLL+ + G LK++  G+A     F + D   T Q  +  ++ P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPP 180
Query: 181 ELLFGAKQY-GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+  G   + G  VD+W+AG     +       +G    D + K+F   G  + +   D 
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGKGSYAIPGD- 235
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                         PPL            DLL  M  Y+P  R + +Q  +H +
Sbjct: 236 ------------CGPPLS-----------DLLKGMLEYEPAKRFSIRQIRQHSW 266

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +E LG G +  V  A +  TG+  A+K I   K  +G   +   EI +L+++K  +I+ L
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIP-KKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
            D +    +L+LV + +      + ++     F +  D  + ++  L  + + H+  ++H
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 135 RDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           RD+KP NLL  S     ++ ++DFGL+++ G  D   T       Y APE+L   K Y  
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST-ACGTPGYVAPEVL-AQKPYSK 201
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD W+ G I   LL   P     +D     +I  A        W D+            
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDI------------ 249
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       SD A D +  +   DP  R T +QA  H
Sbjct: 250 ------------SDSAKDFIRNLMEKDPNKRYTCEQAARH 277

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 208
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 326
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--------------DNLPPRLKNLHK 372
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P L+             L ++   DP  R TA + L+H F
Sbjct: 373 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPF 403

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELK 69
           D    R VLG+GTYG+VY   D      +AIK+I  R  +  + ++     EI L K LK
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH----EEIALHKHLK 63
Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAF 126
             +I++ + +F   G + +  E +    L  ++R+    L   +  I  Y +  L+GL +
Sbjct: 64  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 127 CHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-F 184
            H   ++HRD+K +N+LI ++ G LK++DFG ++     +           Y APE++  
Sbjct: 124 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
           G + YG   D+W+ GC   E+   +P
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKP 209

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELK 69
           D    R VLG+GTYG+VY   D      +AIK+I  R  +  + ++     EI L K LK
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH----EEIALHKHLK 77
Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAF 126
             +I++ + +F   G + +  E +    L  ++R+    L   +  I  Y +  L+GL +
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 127 CHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-F 184
            H   ++HRD+K +N+LI ++ G LK++DFG ++     +           Y APE++  
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
           G + YG   D+W+ GC   E+   +P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKP 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 181
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 182 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 230
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 231 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 269 LQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 181
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 182 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 230
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 231 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 269 LQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELK 69
           Y  ++ +G+G +  V  A    TG+ VA+K I     K  +N T+L    RE++++K L 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKII----DKTQLNPTSLQKLFREVRIMKILN 72
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K+++HRD+K  NLL+     +K+ADFG +  F   ++  T    +  Y APEL  G K  
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPELFQGKKYD 191
Query: 190 GAGVDVWAAGCIFAELLN 207
           G  VDVW+ G I   L++
Sbjct: 192 GPEVDVWSLGVILYTLVS 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 6/191 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A     G  VA+KK+++    +       ++EI LLK+L  P++I+   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 79  AFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I++       +    +  Y       L   H + V+H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH 159
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 218
Query: 195 VWAAGCIFAEL 205
           +W+ GC+  E+
Sbjct: 219 IWSLGCLLYEM 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            + ++   + ++  +  +  + +CH+K+++
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 187
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 188 DVWSLGVILYTLVS 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 87
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 146
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 205
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 206 DIWSLGITAIELARGEP 222

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     A  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 135/307 (43%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P     
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP----- 181
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A  
Sbjct: 182 ------AFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-- 231
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y++         F + S  A D + ++   DPK R+T Q +
Sbjct: 232 -----------------VNYEFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEHRFAK 295
           L+H + K
Sbjct: 270 LQHPWIK 276

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 91/332 (27%), Positives = 147/332 (44%), Gaps = 52/332 (15%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDAD 76
Query: 70  --------SPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSPAD-IKSY 116
                   + HI++L+D F HKG    ++ +VFE +  +L  +I+       P   +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIG------SHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A  +   D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYT 193
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL----QGSS---DIDQLG 222
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+    FL    +G S   D D + 
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELIT-GDFLFEPDEGHSYTKDDDHIA 251
Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP-------PLRSLFPS----ASDDA---L 268
           +I    G        +  Y   +   + +          PL  +       + D+A    
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 269 DLLSKMFTYDPKARITAQQALEHRFAKSFNGV 300
           D LS M   DP+ R  A   + H + K   G+
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 132/324 (40%), Gaps = 50/324 (15%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           RY   + LGEG +G V + ID K  G+ VA+K +   K  +     A  EI++L+ L + 
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTT 71
Query: 72  ------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGL 124
                   +++++ F H G++ +VFE +       I+         D I+       K +
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 125 AFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIFGSPD 165
            F H   + H D+KP N+L                      +  +K+ DFG A      D
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDD 188
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL---LNRRPFLQGSSDIDQLG 222
              +  V  R YRAPE++  A  +    DVW+ GCI  E        P       +  + 
Sbjct: 189 EHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 223 KIFAAFGTATPSQWPDLAYLP----DYVEY----QYV--AAPPLRSLFPSAS---DDALD 269
           +I          +     Y      D+ E+    +YV  A  PL+    S     +   D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 270 LLSKMFTYDPKARITAQQALEHRF 293
           L+ KM  YDP  RIT ++AL+H F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPF 331

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 132/324 (40%), Gaps = 50/324 (15%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           RY   + LGEG +G V + ID K  G+ VA+K +   K  +     A  EI++L+ L + 
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTT 71
Query: 72  ------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGL 124
                   +++++ F H G++ +VFE +       I+         D I+       K +
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 125 AFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIFGSPD 165
            F H   + H D+KP N+L                      +  +K+ DFG A      D
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDD 188
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL---LNRRPFLQGSSDIDQLG 222
              +  V  R YRAPE++  A  +    DVW+ GCI  E        P       +  + 
Sbjct: 189 EHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 223 KIFAAFGTATPSQWPDLAYLP----DYVEY----QYV--AAPPLRSLFPSAS---DDALD 269
           +I          +     Y      D+ E+    +YV  A  PL+    S     +   D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 270 LLSKMFTYDPKARITAQQALEHRF 293
           L+ KM  YDP  RIT ++AL+H F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPF 331

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 82
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 141
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKA 200
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 201 DIWSLGITAIELARGEP 217

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 91/332 (27%), Positives = 147/332 (44%), Gaps = 52/332 (15%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDAD 76
Query: 70  --------SPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSPAD-IKSY 116
                   + HI++L+D F HKG    ++ +VFE +  +L  +I+       P   +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIG------SHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A  +   D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYT 193
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL----QGSS---DIDQLG 222
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+    FL    +G S   D D + 
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELIT-GDFLFEPDEGHSYTKDDDHIA 251
Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP-------PLRSLFPS----ASDDA---L 268
           +I    G        +  Y   +   + +          PL  +       + D+A    
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 269 DLLSKMFTYDPKARITAQQALEHRFAKSFNGV 300
           D LS M   DP+ R  A   + H + K   G+
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 67
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 126
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKA 185
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 67
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 126
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 185
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VAIK I     K  +N T+L    RE++++K L  P+I
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+L+ E+            +  +   + +S  +  +  + +CH+K ++
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F +   +      A  Y APEL  G K  G  V
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEV 195
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 196 DVWSLGVILYTLVS 209

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 34/279 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + K+   VA+K + +   +KEGV     REI++   L  P+I+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F  +  ++L+ E+    +L   ++ +  F       + M+     L +CH K V+HRD+
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+G  G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+W 
Sbjct: 150 KPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWC 206
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  ELL   P  + +S  +   +I                     V+ ++ A+ P  
Sbjct: 207 IGVLCYELLVGNPPFESASHNETYRRIVK-------------------VDLKFPASVP-- 245
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                    A DL+SK+  ++P  R+   Q   H + ++
Sbjct: 246 -------TGAQDLISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VAIK I     K  +N T+L    RE++++K L  P+I
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+L+ E+            +  +   + +S  +  +  + +CH+K ++
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F    +  T    +  Y APEL  G K  G  V
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYAAPELFQGKKYDGPEV 192
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 193 DVWSLGVILYTLVS 206

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA++ I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     +  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---SPPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF+         ++++  L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM-ALGHLHQK 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+KP N+++   G +KL DFGL +     D   TH       Y APE+L  +   
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
            A VD W+ G +  ++L   P   G +    + KI 
Sbjct: 200 RA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF+         ++++  L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM-ALGHLHQK 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+KP N+++   G +KL DFGL +     D   TH       Y APE+L  +   
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
            A VD W+ G +  ++L   P   G +    + KI 
Sbjct: 200 RA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA++ I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 107/206 (51%), Gaps = 18/206 (8%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EVLG+G +G   K    +TG+ + +K+  L +  E    T L+E+K+++ L+ P++++ I
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L+ + E+++   L  +I++ +     +   S+ +    G+A+ H   ++HRD
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 137 MKPNNLLIGSHGQLKLADFGLARI-------------FGSPDRRFTHQVFAR-WYRAPEL 182
           +  +N L+  +  + +ADFGLAR+                PDR+  + V    ++ APE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNR 208
           + G + Y   VDV++ G +  E++ R
Sbjct: 194 ING-RSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 37/292 (12%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K+    + T   EI LL+
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKR----DPTEEIEI-LLR 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
             + P+II L D +     +++V E  +    L+ ++R    F S  +  + +    K +
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 125 AFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L     G+   +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAP 189
Query: 181 ELLFGAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G  ++  L    PF  G  D  +  +I A  G+   S     
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGKFSL---- 242
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                               + S SD A DL+SK    DP  R+TA   L H
Sbjct: 243 ----------------SGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRH 278

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 131/291 (45%), Gaps = 30/291 (10%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K + +G+G++G VYK ID  T + VAIK I L + ++ +     +EI +L +  SP+I
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYI 79
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
                ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERKI 138
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y    
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDFKA 197
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F     + P+           +E Q+  +
Sbjct: 198 DIWSLGITAIELAKGEP---PNSDLHPMRVLFLIPKNSPPT-----------LEGQH--S 241
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
            P +           + +      DP+ R TA++ L+H+F   +     F+
Sbjct: 242 KPFK-----------EFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFL 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV    + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++  P+II L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                     ++Y  D+ E            F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 ----------VSY--DFDE----------EFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 50/304 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y  +EV+G G   VV  A      + VAIK+I L K +  ++   L+EI+ + +   P
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 73
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-------NIFLSPADIKSYMQMTLKG 123
           +I+    +F  K  L LV + +    +  +I++        +  L  + I + ++  L+G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVF--ARWYR 178
           L + HK   +HRD+K  N+L+G  G +++ADFG++      G   R    + F     + 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++   + Y    D+W+ G    EL                     A G A   ++P 
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIEL---------------------ATGAAPYHKYPP 232
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDAL---------DLLSKMFTYDPKARITAQQAL 289
           +  L   ++      PP  SL     D  +          ++S     DP+ R TA + L
Sbjct: 233 MKVLMLTLQND----PP--SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 290 EHRF 293
            H+F
Sbjct: 287 RHKF 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 50/304 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y  +EV+G G   VV  A      + VAIK+I L K +  ++   L+EI+ + +   P
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-------NIFLSPADIKSYMQMTLKG 123
           +I+    +F  K  L LV + +    +  +I++        +  L  + I + ++  L+G
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVFAR--WYR 178
           L + HK   +HRD+K  N+L+G  G +++ADFG++      G   R    + F     + 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++   + Y    D+W+ G    EL                     A G A   ++P 
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIEL---------------------ATGAAPYHKYPP 227
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDAL---------DLLSKMFTYDPKARITAQQAL 289
           +  L   ++      PP  SL     D  +          ++S     DP+ R TA + L
Sbjct: 228 MKVLMLTLQND----PP--SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
Query: 290 EHRF 293
            H+F
Sbjct: 282 RHKF 285

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE+++ K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +      + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     A  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T Q VAIK I L + ++ +     +EI +L +  S ++
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSSYV 83
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +     F     I + ++  LKGL + H +  +
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKI 142
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F       P   P                
Sbjct: 202 DIWSLGITAIELAKGEP---PNSDMHPMRVLF-----LIPKNNP---------------- 237
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P L   F  +  + +D        DP  R TA++ L+H+F
Sbjct: 238 PTLVGDFTKSFKEFID---ACLNKDPSFRPTAKELLKHKF 274

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 253
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 312
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 193 VDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL-- 76
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69
Query: 77  -----------IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
                      + A   K  L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HRD+KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D+++ G IF E++   PF  G   ++ L K+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL-- 76
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69
Query: 77  -----------IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
                      + A   K  L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HRD+KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D+++ G IF E++   PF  G   ++ L K+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 36/282 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLK 66
           K+ D ++  ++LG+G++G V+ A   KT Q  AIK ++  +    + V  T + +  L  
Sbjct: 15  KIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGL 124
             + P +  +   F  K NL  V E++   DL   I++ + F LS A    Y    + GL
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 131
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            F H K +++RD+K +N+L+   G +K+ADFG+ +     D +         Y APE+L 
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G K Y   VD W+ G +  E+L  +    G  +     ++F +     P       + P 
Sbjct: 192 GQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNP-------FYPR 239
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           ++E                  +A DLL K+F  +P+ R+  +
Sbjct: 240 WLE-----------------KEAKDLLVKLFVREPEKRLGVR 264

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLK 66
           K+ D  L + +LG+G++G V+ A   KT Q  AIK ++  +    + V  T + +  L  
Sbjct: 16  KIEDFELHK-MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGL 124
             + P +  +   F  K NL  V E++   DL   I++ + F LS A    Y    + GL
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 132
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            F H K +++RD+K +N+L+   G +K+ADFG+ +     D +         Y APE+L 
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G K Y   VD W+ G +  E+L  +    G  +     ++F +     P       + P 
Sbjct: 193 GQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNP-------FYPR 240
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           ++E                  +A DLL K+F  +P+ R+  +
Sbjct: 241 WLE-----------------KEAKDLLVKLFVREPEKRLGVR 265

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 73
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 132
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLL 188
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 240
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           DYV                 S +   L+S++F  DP  RI+  +   H +
Sbjct: 241 DYVHI---------------SPECRHLISRIFVADPAKRISIPEIRNHEW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 135/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                     ++Y  D+ E            F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 ----------VSY--DFDE----------EFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T     G+ V    +    QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T     G+ V    +    QKE ++
Sbjct: 15  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 74
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 75  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 191 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSC 230

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T     G+ V    +    QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E +     REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIAANVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           DYV                 S +   L+S++F  DP  RI+  +   H +
Sbjct: 242 DYVHI---------------SPECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T     G+ V    +    QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 5/192 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL 206
           VW+ G +   +L
Sbjct: 191 VWSCGIVLTAML 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 70  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 227
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 228 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL 206
           VW+ G +   +L
Sbjct: 190 VWSCGIVLTAML 201

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 12/221 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L    K P + +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++++ GL F HK+ +++R
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI-GLFFLHKRGIIYR 144
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           D+K +N+++ S G +K+ADFG+ +   + G   R F        Y APE++   + YG  
Sbjct: 145 DLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCG---TPDYIAPEII-AYQPYGKS 200
Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           VD WA G +  E+L  +P   G  D D+L +       + P
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYP 240

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITS-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITS-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 124/303 (40%), Gaps = 43/303 (14%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
              G     A  DV++ GC+  E+L   P   G S                         
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDS------------------------- 223
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALD-----LLSKMFTYDPKARITAQQALEHRFAKS 296
            PD V YQ+V   P+    PSA  + L      ++ K    +P+ R      +     + 
Sbjct: 224 -PDSVAYQHVREDPIP---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
Query: 297 FNG 299
            NG
Sbjct: 280 HNG 282

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITS-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++   K        +EI +L  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNI 57
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIR-NTNIF-LSPADIKSYMQMTLKGLA 125
            +  +I+ L ++F     L ++FEF+ + L+   R NT+ F L+  +I SY+    + L 
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFI-SGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 126 FCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           F H   + H D++P N++  +     +K+ +FG AR    P   F     A  Y APE +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPE-V 174
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     D+W+ G +   LL+   PFL  ++      +I      A           
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNA----------- 218
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
               EY +         F   S +A+D + ++   + K+R+TA +AL+H
Sbjct: 219 ----EYTFDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 85/337 (25%), Positives = 137/337 (40%), Gaps = 70/337 (20%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D + G   VA+K I+ + K KE        EI +L++
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARL----EINVLEK 86
Query: 68  L--KSPH----IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +  K P      +++ D F + G++ + FE +       +++ N    P     +M   L
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQL 146
Query: 122 -KGLAFCHKKWVLHRDMKPNNLL-IGSHGQL------------------KLADFGLARIF 161
            + + F H   + H D+KP N+L + S  +L                  ++ DFG A   
Sbjct: 147 CQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT-- 204
Query: 162 GSPDRRFTHQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
                 F H+     V  R YRAPE++     +    DVW+ GCI  E        Q   
Sbjct: 205 ------FDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHD 257
Query: 217 DIDQLGKIFAAFGTATPSQ-----------------WPDLAYLPDYVEYQYVAAPPLRSL 259
           + + L  +    G   PS+                 W +      YV        PLR  
Sbjct: 258 NREHLAMMERILG-PIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVREN---CKPLRRY 313
Query: 260 FPSASDDA---LDLLSKMFTYDPKARITAQQALEHRF 293
             S +++     DL+  M  Y+P  R+T  +AL+H F
Sbjct: 314 LTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPF 350

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K     +G   A+K ++    K         E  +L ++  P ++
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T + +  +  +  D+K Y+     GL   H   ++
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLHSLGII 152
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 153 YRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-NRQGHSHSA 211
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 212 DWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA 245

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 119/293 (40%), Gaps = 36/293 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G GT G V+K    KTG  +A+K++R    KE      +    +LK    P+I++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKK-WVLHRDM 137
           F    ++ +  E M T  E + +     + P  I   M + + K L +  +K  V+HRD+
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPI-PERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 138 KPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLF----GAKQYGAG 192
           KP+N+L+   GQ+KL DFG++ R+    D+          Y APE +         Y   
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 193 VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            DVW+ G    EL   + P+    +D + L K+                           
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ------------------------- 244
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVFV 304
             PPL       S D    +    T D + R    + LEH F K +  + V V
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDV 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D  LK + LGEG++ +  K +  K+ Q  A+K I   K+ E      +  +KL +    P
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCE--GHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L + F  + +  LV E +   +L   I+    F S  +    M+  +  ++  H  
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF-SETEASYIMRKLVSAVSHMHDV 125
Query: 131 WVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            V+HRD+KP NLL        ++K+ DFG AR+    ++      F   Y APELL    
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQN 184
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PF------LQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            Y    D+W+ G I   +L+ + PF      L  +S ++ + KI     +     W ++ 
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV- 243
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
                                  S +A DL+  + T DP  R+
Sbjct: 244 -----------------------SQEAKDLIQGLLTVDPNKRL 263

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 135/329 (41%), Gaps = 54/329 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E        EI +LK+
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKK 104
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 105 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 164
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 165 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 223
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 224 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280
Query: 222 GKIFAAFGTATPSQW------------PDLAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 281 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 339
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRF 293
           +   DL+ +M  +DP  RIT  +AL H F
Sbjct: 340 VQLFDLMRRMLEFDPAQRITLAEALLHPF 368

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 13/225 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YGVV K     +GQ +A+K+IR     +      +     ++ +  P  +    A
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 80  FPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKW-VL 133
              +G++ +  E M+T L+     VI        P DI   + +++ K L   H K  V+
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL---FGAKQYG 190
           HRD+KP+N+LI + GQ+K+ DFG++        + T     + Y APE +      K Y 
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYS 235
Query: 191 AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
              D+W+ G    EL + R P+    +   QL ++        P+
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 280

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELID 78
           LG G+YG V+K    + G+  A+K+     +        L E+   +++ + P  + L  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           A+   G L+L  E     L+         L  A +  Y++ TL  LA  H + ++H D+K
Sbjct: 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK 184
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAA 198
           P N+ +G  G+ KL DFGL    G+       +   R Y APELL G+  YG   DV++ 
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS--YGTAADVFSL 241
Query: 199 GCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS 258
           G    E+        G     QL +                 YLP   E+    +  LRS
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQ----------------GYLPP--EFTAGLSSELRS 283
Query: 259 LFPSASDDALDLLSKMFTYDPKARITAQQAL 289
                      +L  M   DPK R TA+  L
Sbjct: 284 -----------VLVMMLEPDPKLRATAEALL 303

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 8/223 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-TALREIKLLKELKSPHIIELID 78
           +G+G++G V       T +  A+K +   K  E        +E+++++ L+ P ++ L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           +F  + ++ +V + +   DL   ++  N+      +K ++   +  L +   + ++HRDM
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDV 195
           KP+N+L+  HG + + DF +A +    + + T     + Y APE+    K   Y   VD 
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 196 WAAGCIFAELLN-RRPF-LQGSSDIDQLGKIFAAFGTATPSQW 236
           W+ G    ELL  RRP+ ++ S+   ++   F       PS W
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 135/329 (41%), Gaps = 54/329 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E        EI +LK+
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKK 81
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 82  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 141
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 142 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 200
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 201 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257
Query: 222 GKIFAAFGTATPSQWPD------------LAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 258 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 316
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRF 293
           +   DL+ +M  +DP  RIT  +AL H F
Sbjct: 317 VQLFDLMRRMLEFDPAQRITLAEALLHPF 345

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 13/225 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YGVV K     +GQ +A+K+IR     +      +     ++ +  P  +    A
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 80  FPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKW-VL 133
              +G++ +  E M+T L+     VI        P DI   + +++ K L   H K  V+
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL---FGAKQYG 190
           HRD+KP+N+LI + GQ+K+ DFG++  +   D         + Y APE +      K Y 
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 191 AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
              D+W+ G    EL + R P+    +   QL ++        P+
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+  FG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP----KSTVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           DYV                 S +   L+S++F  DP  RI+  +   H +
Sbjct: 242 DYVHI---------------SPECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 135/329 (41%), Gaps = 54/329 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E        EI +LK+
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKK 72
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 192 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 222 GKIFAAFGTATPSQWPD------------LAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 249 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRF 293
           +   DL+ +M  +DP  RIT  +AL H F
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPF 336

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVXLLASLNHQYVVRYYA 69
Query: 79  AFPHKGN-------------LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           A+  + N             L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HR++KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D ++ G IF E +   PF  G   ++ L K+
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXERVNILKKL 241

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI +   L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 72  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 229
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 230 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 56/302 (18%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHI 73
           L  + LG G + VV + I   TGQ  A K ++  ++ +      L EI +L+  KS P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 74  IELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I L + + +   + L+ E+          +      +S  D+   ++  L+G+ + H+  
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 132 VLHRDMKPNNLLIGS---HGQLKLADFGLAR----------IFGSPDRRFTHQVFARWYR 178
           ++H D+KP N+L+ S    G +K+ DFG++R          I G+P+           Y 
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE-----------YL 200
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L          D+W  G I +  L +  PF+                G      + 
Sbjct: 201 APEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFV----------------GEDNQETYL 243
Query: 238 DLAYLP-DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
           +++ +  DY E            F S S  A D +  +   +P+ R TA+  L H + + 
Sbjct: 244 NISQVNVDYSE----------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
Query: 297 FN 298
           ++
Sbjct: 294 WD 295

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+  FG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP----KDTVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           DYV                 S +   L+S++F  DP  RI+  +   H +
Sbjct: 242 DYVHI---------------SPECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 12/215 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V K +   +GQ +A+K+IR    ++      +    +++    P+I++   A
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLS---PADIKSYMQM-TLKGLAFCHKKW-VLH 134
              +G+  +  E M T  +   +     L    P +I   + + T+K L    +   ++H
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149
Query: 135 RDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL--FGAKQ-YG 190
           RD+KP+N+L+   G +KL DFG++ ++  S  +  T     R Y APE +    ++Q Y 
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQGYD 207
Query: 191 AGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKI 224
              DVW+ G    EL   R P+ + +S  DQL ++
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 3/213 (1%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKL 64
           + K + +RY   + LG G    VY A DT     VAIK I +  ++KE       RE+  
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +L   +I+ +ID        +LV E++E    +    ++  LS     ++    L G+
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR-WYRAPELL 183
              H   ++HRD+KP N+LI S+  LK+ DFG+A+         T+ V     Y +PE  
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            G +      D+++ G +  E+L   P   G +
Sbjct: 185 KG-EATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 194
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 195 AFGVLLWEI 203

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+M   D+ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EVLG G +  V+      TG+  A+K I+  K     + +   EI +LK++K  +I+ L 
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           D +    + +LV + +   +L   I    ++ +  D    +Q  L  + + H+  ++HRD
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVY-TEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 137 MKPNNLLI---GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +KP NLL      + ++ + DFGL+++    +   +       Y APE+L   K Y   V
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVL-AQKPYSKAV 188
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D W+ G I   LL   P     ++     KI   +       W D+              
Sbjct: 189 DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI-------------- 234
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                     S+ A D +  +   DP  R T ++AL H
Sbjct: 235 ----------SESAKDFICHLLEKDPNERYTCEKALSH 262

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+M   D+ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 78
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 197
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 198 AFGVLLWEI 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       FT    A++   + APE L    ++    D
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPESL-AYNKFSIKSD 192
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 193 VWAFGVLLWEI 203

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 32/280 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG  G V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 78  DAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +GN+  +F    +  E   R   +I +   D + +    + G+ + H   + HRD
Sbjct: 71  -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           +KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +   VD
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           VW+ G +   +L    P+ Q S    +                       D+ E +    
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTYLN 228
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           P     +       L LL K+   +P ARIT     + R+
Sbjct: 229 P-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 27  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 86
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 207 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 47/294 (15%)
Query: 14  YLKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           +  ++VLG G  G +VY+ +     + VA+K+I      E  +F A RE++LL+E  + P
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRI----LPECFSF-ADREVQLLRESDEHP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++I        +   ++  E     L+  +   +      +  + +Q T  GLA  H   
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 132 VLHRDMKPNNLLI---GSHGQLK--LADFGLARIFGSPDRRFTHQV---FARWYRAPELL 183
           ++HRD+KP+N+LI    +HG++K  ++DFGL +        F+ +        + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 184 FGAKQYGA--GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
               +      VD+++AGC+F  +++     +GS            FG +   Q   L  
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVIS-----EGSH----------PFGKSLQRQANIL-- 241
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRF 293
                    + A  L  L P   +D  A +L+ KM   DP+ R +A+  L+H F
Sbjct: 242 ---------LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVFARWYRAPE 181
            F H+  ++HRD+KP N+LI +   +K+ DFG+AR     G+   +    +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 201
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 202 AFGVLLWEI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 201
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 202 AFGVLLWEI 210

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T + +  +  +  D+K Y+      L   H   ++
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 207
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 196
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 197 AFGVLLWEI 205

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 114/249 (45%), Gaps = 32/249 (12%)
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--------LETVIRNTNIFLSPAD 112
           E++++ ++K+ + +       +   +++++E+ME D           + +N   F+    
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 113 IKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ 171
           IK  ++  L   ++ H +K + HRD+KP+N+L+  +G++KL+DFG +      D++    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGS 210
Query: 172 VFARWYRAPELLFGAKQY-GAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
                +  PE       Y GA VD+W+ G C++    N  PF    S ++    I     
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI----- 265
Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDAL-----DLLSKMFTYDPKARIT 284
                +  ++ Y  D   + Y    PL +   + S++ L     D L      +P  RIT
Sbjct: 266 -----RTKNIEYPLDRNHFLY----PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 285 AQQALEHRF 293
           ++ AL+H +
Sbjct: 317 SEDALKHEW 325

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D +  + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++ H 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYAHA 133
Query: 130 KWVLHRDMKP-NNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ADFG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP----KSAVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           DYV                 S +   L+S++F  DP  RI+  +   H +
Sbjct: 242 DYVHI---------------SPECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           R+LKR   LGEG +G V    Y      TG+ VA+K +   K + G N  A   +EI++L
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEIL 65
Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTL 121
           + L   +I++        G   + L+ EF+ +    E + +N N       +K  +Q+  
Sbjct: 66  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC- 124
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFAR 175
           KG+ +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +     T +      VF  
Sbjct: 125 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 182
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WY APE L  +K Y A  DVW+ G    ELL         SD   +       G  T  Q
Sbjct: 183 WY-APECLMQSKFYIAS-DVWSFGVTLHELLT-----YCDSDSSPMALFLKMIG-PTHGQ 234
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                 +    E + +  P      P+  D+   L+ K + + P  R + Q  +E
Sbjct: 235 MTVTRLVNTLKEGKRLPCP------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 196
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 197 AFGVLLWEI 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 196
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 197 AFGVLLWEI 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           R+LKR   LGEG +G V    Y      TG+ VA+K +   K + G N  A   +EI++L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEIL 77
Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTL 121
           + L   +I++        G   + L+ EF+ +    E + +N N       +K  +Q+  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC- 136
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFAR 175
           KG+ +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +     T +      VF  
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 194
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WY APE L  +K Y A  DVW+ G    ELL         SD   +       G  T  Q
Sbjct: 195 WY-APECLMQSKFYIAS-DVWSFGVTLHELLT-----YCDSDSSPMALFLKMIG-PTHGQ 246
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                 +    E + +  P      P+  D+   L+ K + + P  R + Q  +E
Sbjct: 247 MTVTRLVNTLKEGKRLPCP------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 196
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 81
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 198
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 199 VWAFGVLLWEI 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T + +  +  +  D+K Y+      L   H   ++
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 207
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T + +  +  +  D+K Y+      L   H   ++
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGII 149
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 150 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 208
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 209 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 242

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 90
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 150
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 209
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 210 AFGVLLWEI 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 198
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 199 AFGVLLWEI 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 78
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPESL-AYNKFSIKSD 195
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 196 VWAFGVLLWEI 206

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELI---DAFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ +    +A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 194
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 195 AFGVLLWEI 203

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAPAGAKFPIKWTAPESL-AYNKFSIKSD 196
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 119/288 (41%), Gaps = 38/288 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D  T + VA+K I  G     ++    REI   + L+ 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRH 75
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L ++ E+    +L   I N   F S  + + + Q  L G+++CH 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF-SEDEARFFFQQLLSGVSYCHS 134
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             + HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLL 190
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF       D    I                 +P
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------YSIP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           D +                 S +   L+S++F  DP  RI+  +   H
Sbjct: 243 DDIRI---------------SPECCHLISRIFVADPATRISIPEIKTH 275

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/341 (22%), Positives = 135/341 (39%), Gaps = 78/341 (22%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKL 64
           ++  +Y  +  +G+G+YGVV  AI+ +T    AIK +   K ++ +N   +     E++L
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRL 81
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFM------------------------------- 93
           +K+L  P+I  L + +  +  + LV E                                 
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 94  --ETDLETVIRNTNIFLSPAD-------IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI 144
             E + E +  + + F    D       I + M+     L + H + + HRD+KP N L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 145 GSHG--QLKLADFGLARIFGSPDR----RFTHQVFARWYRAPELLFGAKQ-YGAGVDVWA 197
            ++   ++KL DFGL++ F   +       T +    ++ APE+L    + YG   D W+
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIF-AAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           AG +   LL       G +D D + ++         P+               Y    PL
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN---------------YNVLSPL 306
Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                     A DLLS +   +   R  A +AL+H +   F
Sbjct: 307 ----------ARDLLSNLLNRNVDERFDAMRALQHPWISQF 337

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEF--LKEAAVMKEIKHPNLVQLLGV 284
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HR++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 401
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 402 VWAFGVLLWEI 412

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           D++ + + LG G++G V      +TG   A+K   K ++ K KE +  T L E ++L+ +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAV 98
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRA 179
           H   +++RD+KP NL+I   G +K+ DFGLA+        + G+P+           Y A
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE-----------YLA 206
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAEL 205
           PE++  +K Y   VD WA G +  E+
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-------THQVFARW 176
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++    D+ F          +F  W
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIF--W 183
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           Y APE L  +K +    DVW+ G +  EL 
Sbjct: 184 Y-APESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 78
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 198
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 199 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 118/238 (49%), Gaps = 17/238 (7%)
Query: 16  KREVLGEGTYGVVYKA-IDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLKELKS 70
           +++V+G G +G VYK  + T +G+    VAIK ++ G  +K+ V+F  L E  ++ +   
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMGQFSH 105
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            +II L         + ++ E+ME   L+  +R  +   S   +   ++    G+ +   
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFG 185
              +HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TAPEAI-S 223
Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +++ +  DVW+ G +  E++    RP+ + S+  + +  I   F   TP   P   Y
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPSAIY 280

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 88
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 208
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 209 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 236

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 132
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIK-SYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 248
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 249 AKVDIWSSCCMMLHMLN 265

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 20  LGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK L+  +I++
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDNIVK 78
Query: 76  LIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
                   G  NL L+ EF+    L   ++     +    +  Y     KG+ +   K  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPELLFGA 186
           +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY APE L  +
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 187 KQYGAGVDVWAAGCIFAEL 205
           K +    DVW+ G +  EL
Sbjct: 196 K-FSVASDVWSFGVVLYEL 213

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 97
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 215
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 216 -APESLTESK-FSVASDVWSFGVVLYEL 241

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 14  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 71
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 189
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 190 -APESLTESK-FSVASDVWSFGVVLYEL 215

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 13  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 70
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 188
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 189 -APESLTESK-FSVASDVWSFGVVLYEL 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 8   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 65
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 183
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 184 -APESLTESK-FSVASDVWSFGVVLYEL 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 69
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 187
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 188 -APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEF--LKEAAVMKEIKHPNLVQLLGV 323
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HR++
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNL 383
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 440
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 441 VWAFGVLLWEI 451

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 16  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 73
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 191
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 192 -APESLTESK-FSVASDVWSFGVVLYEL 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 7   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 64
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 182
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 183 -APESLTESK-FSVASDVWSFGVVLYEL 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 15  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 72
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 190
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 191 -APESLTESK-FSVASDVWSFGVVLYEL 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 184
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 185 -APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 184
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 185 -APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 9   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 66
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----RFTHQVFARWYR 178
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++    D+     R   Q    WY 
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWY- 184
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L     +    DVW+ G +  EL  
Sbjct: 185 APESL-SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 84
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 202
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 203 -APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 33/203 (16%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLLKELKSPH 72
            LG G++G V+       G+  A+K       +RL KQ E  N   L    +L  +  P 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERL----MLSIVTHPF 67
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           II +   F     + ++ +++E  +L +++R +  F +P   K Y       L + H K 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-AKFYAAEVCLALEYLHSKD 126
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELL 183
           +++RD+KP N+L+  +G +K+ DFG A+        + G+PD           Y APE++
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD-----------YIAPEVV 175
Query: 184 FGAKQYGAGVDVWAAGCIFAELL 206
              K Y   +D W+ G +  E+L
Sbjct: 176 -STKPYNKSIDWWSFGILIYEML 197

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 84
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 202
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 203 -APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 34/274 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 159
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 160 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 218
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+WA GCI  +L+   P  +  ++     KI                     +EY + AA
Sbjct: 219 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------------LEYDFPAA 259
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                 FP A     DL+ K+   D   R+  ++
Sbjct: 260 -----FFPKAR----DLVEKLLVLDATKRLGCEE 284

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E ME   DL   I      L     +S+    L+ +  CH  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 133
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 192 GRSAAVWSLGILLYDMV 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           D++ + + LG G++G V      +TG   A+K   K ++ K KE +  T L E ++L+ +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAV 98
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRA 179
           H   +++RD+KP NL+I   G +++ DFGLA+        + G+P+           Y A
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE-----------YLA 206
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAEL 205
           PE++  +K Y   VD WA G +  E+
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 79
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----RFTHQVFARWYR 178
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++    D+     R   Q    WY 
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWY- 197
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L     +    DVW+ G +  EL  
Sbjct: 198 APESL-SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDKQKVVKLKQIEHT-LNEKRILQA 90
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 149
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 198
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 199 APEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 10  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 67
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----RFTHQVFARWYR 178
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++    D+     R   Q    WY 
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWY- 185
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L     +    DVW+ G +  EL  
Sbjct: 186 APESL-SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY  +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 96
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   ++V E+M   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDL 156
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L     +    D
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNTFSIKSD 213
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 214 VWAFGVLLWEI 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 118
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIK-SYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 234
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 235 AKVDIWSSCCMMLHMLN 251

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 134
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIK-SYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 250
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 251 AKVDIWSSCCMMLHMLN 267

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL             E+     L SP I+ L  A
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGA 153
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIK-SYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +++       P D    Y+   L+GL + H + +LH D+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCL--PEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G    L DFG A     PD      +   +      + APE++ G +   
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCL-QPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCD 269
Query: 191 AGVDVWAAGCIFAELLN 207
           A VDVW++ C+   +LN
Sbjct: 270 AKVDVWSSCCMMLHMLN 286

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 225
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 226 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 6   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 63
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P +  L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----RFTHQVFARWYR 178
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++    D+     R   Q    WY 
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWY- 181
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L     +    DVW+ G +  EL  
Sbjct: 182 APESL-SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 90
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 149
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 198
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 199 APEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  +    T +  A+K ++  +  Q + V  T + +  L    K P + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F   K +++R
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-GLFFLQSKGIIYR 145
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD-----------YIAPEII- 193
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             + YG  VD WA G +  E+L  +   +G  D D+L +       A P
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYP 241

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 225
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 226 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHT-LNEKRILQA 83
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 142
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------YL 191
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 192 APEIIL-SKGYNKAVDWWALGVLIYEM 217

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 14  YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 70
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 129
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 188
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 230
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 231 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 273

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 225
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 226 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 69
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 187
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            APE L  +K +    DVW+ G +  EL
Sbjct: 188 -APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 1   MAEVDLS--KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFT 57
           + E+DLS  +  A  +   E++G GTYG VYK    KTGQ  AIK + + G ++E +   
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK-- 68
Query: 58  ALREIKLLKELKS-PHIIELIDAFPHKG------NLHLVFEFMET-DLETVIRNTNIFLS 109
             +EI +LK+     +I     AF  K        L LV EF     +  +I+NT     
Sbjct: 69  --QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 110 PADIKSYM-QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRR 167
             +  +Y+ +  L+GL+  H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 168 FTHQVFARWYRAPELLFGAKQ----YGAGVDVWAAGCIFAELLNRRPFL 212
            T  +   ++ APE++   +     Y    D+W+ G    E+    P L
Sbjct: 187 NTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL             E+     L SP I+ L  A
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGA 134
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIK-SYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +++       P D    Y+   L+GL + H + +LH D+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCL--PEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G    L DFG A     PD      +   +      + APE++ G +   
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCL-QPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCD 250
Query: 191 AGVDVWAAGCIFAELLN 207
           A VDVW++ C+   +LN
Sbjct: 251 AKVDVWSSCCMMLHMLN 267

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA 226
           D+WA GCI  +L+   P  +  ++    G IFA
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE----GLIFA 244

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSAXKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA 226
           D+WA GCI  +L+   P  +  ++    G IFA
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE----GLIFA 244

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 10  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 67
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WY 177
           + +   K  +HR++   N+L+ +  ++K+ DFGL ++   P  +  ++V         WY
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVL--PQDKEYYKVKEPGESPIFWY 185
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 186 -APESLTESK-FSVASDVWSFGVVLYELF 212

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 85
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HR++   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 205
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 206 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 225
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 226 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A   +TG   A+K ++  +  Q + V  T   +  L      P + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L  V EF+   DL   I+ +  F   A  + Y    +  L F H K +++R
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DMKPNNLLIGSHGQLKLADFGL-----------ARIFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+L+   G  KLADFG+           A   G+PD           Y APE+L 
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-----------YIAPEIL- 196
Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSD 217
               YG  VD WA G +  E+L    PF   + D
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 45/295 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV A  Y  PE    +  +++ G 
Sbjct: 182 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 128/308 (41%), Gaps = 39/308 (12%)
Query: 6   LSKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           L  K  D Y L  E+LGEG Y  V  A+  + G+  A+K I   KQ         RE++ 
Sbjct: 6   LPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE--KQAGHSRSRVFREVET 63
Query: 65  LKELK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L + + + +I+ELI+ F      +LVFE ++              +  +    ++     
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLAR---------IFGSPDRRFTHQ 171
           L F H K + HRD+KP N+L  S  +   +K+ DF L              +P+   T  
Sbjct: 124 LDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE--LTTP 181
Query: 172 VFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID---QLGKI 224
             +  Y APE++      A  Y    D+W+ G +   +L+  P   G    D     G++
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEV 241
Query: 225 FAAFGTATPSQWPDLAY-LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
                        +  Y  PD  ++ ++            S +A DL+SK+   D K R+
Sbjct: 242 CRVCQNKLFESIQEGKYEFPDK-DWAHI------------SSEAKDLISKLLVRDAKQRL 288
Query: 284 TAQQALEH 291
           +A Q L+H
Sbjct: 289 SAAQVLQH 296

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 12  YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 127
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 186
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L ++        P                
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFP---------------- 228
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                  R+L P A      LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 229 -------RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 271

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 154 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSACKSS 212
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 213 DLWALGCIIYQLVAGLP 229

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKE 67
           A+ Y   +V+G G +G V       + +  A+K   K  + K+ +   F   R+I     
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA- 132
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
             SP +++L  AF     L++V E+M   DL  ++ N ++    A  K Y    +  L  
Sbjct: 133 -NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALDA 189
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA------------RIFGSPDRRFTHQVFA 174
            H   ++HRD+KP+N+L+  HG LKLADFG                 G+PD         
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD--------- 240
Query: 175 RWYRAPELL---FGAKQYGAGVDVWAAGC-IFAELLNRRPFLQGS 215
             Y +PE+L    G   YG   D W+ G  +F  L+   PF   S
Sbjct: 241 --YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 70
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 130
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 187
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 188 WSFGVLMWEVFSE 200

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 154 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 212
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 213 DLWALGCIIYQLVAGLP 229

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 68
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 185
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 186 WSFGVLMWEVFSE 198

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  +    T +  A+K ++  +  Q + V  T + +  L    K P + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F   K +++R
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-GLFFLQSKGIIYR 466
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD-----------YIAPEII- 514
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             + YG  VD WA G +  E+L  +   +G  D D+L +       A P
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYP 562

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 34/306 (11%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
            EV+G G +GVV KA      + VAIK+I    +++      + E++ L  +  P+I++L
Sbjct: 14  EEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKL 67
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---K 130
             A      + LV E+ E   L  V+       + + A   S+     +G+A+ H    K
Sbjct: 68  YGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            ++HRD+KP NLL+ + G  LK+ DFG A    +     T+   +  + APE+  G+  Y
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGS-NY 181
Query: 190 GAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLG----KIFAAFGTATPSQWPDLAYLPD 244
               DV++ G I  E++ RR PF       D++G    +I  A    T  + P +  LP 
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPF-------DEIGGPAFRIMWAVHNGT--RPPLIKNLPK 232
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG-VFVF 303
            +E               + ++ + +++ +  Y P A    Q   +H      +G V  +
Sbjct: 233 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 292
Query: 304 VDFCSY 309
           VDF  +
Sbjct: 293 VDFAEF 298

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 27/232 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-------SPH 72
           LG G YGVV K     +GQ  A+K+IR           +  + +LL +L         P 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIR-------ATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFC 127
            +    A   +G++ +  E  +T L+     VI        P DI   + +++ K L   
Sbjct: 95  TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHL 152
Query: 128 HKKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL--- 183
           H K  V+HRD+KP+N+LI + GQ+K  DFG++      D         + Y APE +   
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD-DVAKDIDAGCKPYXAPERINPE 211
Query: 184 FGAKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
              K Y    D+W+ G    EL + R P+    +   QL ++        P+
Sbjct: 212 LNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 263

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 34/306 (11%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
            EV+G G +GVV KA      + VAIK+I    +++      + E++ L  +  P+I++L
Sbjct: 13  EEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKL 66
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---K 130
             A      + LV E+ E   L  V+       + + A   S+     +G+A+ H    K
Sbjct: 67  YGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            ++HRD+KP NLL+ + G  LK+ DFG A    +     T+   +  + APE+  G+  Y
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGS-NY 180
Query: 190 GAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLG----KIFAAFGTATPSQWPDLAYLPD 244
               DV++ G I  E++ RR PF       D++G    +I  A    T  + P +  LP 
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPF-------DEIGGPAFRIMWAVHNGT--RPPLIKNLPK 231
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG-VFVF 303
            +E               + ++ + +++ +  Y P A    Q   +H      +G V  +
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291
Query: 304 VDFCSY 309
           VDF  +
Sbjct: 292 VDFAEF 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 161
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 162 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 220
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 221 DLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 131
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 132 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 190
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 191 DLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 73
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 133
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 190
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 191 WSFGVLMWEVFSE 203

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 191
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 192 DLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ +   LG G++G V      +TG   A+K   L KQK    + +  T L E ++ + 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKI--LDKQKVVKLKQIEHT-LNEKRIQQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 138
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 139 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 197
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 198 DLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 135 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 193
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 194 DLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 134 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 192
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 193 DLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 36  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQM-QPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 264
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 265 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 70
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLA 130
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 187
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 188 WSFGVLMWEVFSE 200

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 158 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 216
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 36  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 264
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 265 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 158 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSACKSS 216
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 20  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 138 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 195
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 196 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 248
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 249 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 92
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 151
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 200
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 201 APEIIL-SKGYNKAVDWWALGVLIYEM 226

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-- 75
           E++G G +G V+KA     G+T  IK+++   +K      A RE+K L +L   +I+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYN 70
Query: 76  -LIDAFPHKGN-------------LHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQ 118
              D F +                L +  EF +   LE  I  R          ++ + Q
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           +T KG+ + H K +++RD+KP+N+ +    Q+K+ DFGL     +  +R   +   R Y 
Sbjct: 131 IT-KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLR-YM 188
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +PE +  ++ YG  VD++A G I AELL+
Sbjct: 189 SPEQI-SSQDYGKEVDLYALGLILAELLH 216

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           APE++  +K Y   VD WA G +  E+    P
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 182 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 16  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 133
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 134 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 191
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 192 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 244
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 245 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV++A +       AIK+IRL   +E      +RE+K L +L+ P I+   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 78  DAF----------PHKGNLHLVFEFMETDLETVI--RNTNIFLSPADIKSYMQMTLK--- 122
           +A+          P    ++L  +      E +    N    +   +    + + L+   
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR------------RFTH 170
            + F H K ++HRD+KP+N+       +K+ DFGL       +             R T 
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           QV  + Y +PE + G   Y   VD+++ G I  ELL
Sbjct: 190 QVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 30/231 (12%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-P 71
           R   R VL EG +  VY+A D  +G+  A+K  RL   +E  N   ++E+  +K+L   P
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 72  HIIELIDAFP--------HKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTL 121
           +I++   A           +    L+ E  +  L   ++       LS   +      T 
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 122 KGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-PD-------RRFTHQ 171
           + +   H++   ++HRD+K  NLL+ + G +KL DFG A      PD       R    +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 172 VFAR----WYRAPEL--LFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGS 215
              R     YR PE+  L+     G   D+WA GCI   L  R+ PF  G+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 17  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 135 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 245
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 246 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 84
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 143
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 193 APEIIL-SKGYNKAVDWWALGVLIYEM 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGLAR+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK I+ G   E  +F  + E +++ +L  P +++L   
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSED-DF--IEEAEVMMKLSHPKLVQLYGV 90
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 150
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 207
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 208 WSFGVLMWEVFSE 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +   L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSASKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           APE++  +K Y   VD WA G +  E+    P
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 182 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 D  D+L      DPK RI+  + L H + +
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNX 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 27/305 (8%)
Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I   KQ   +     RE+++L
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEML 64
Query: 66  KELKSP-HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
            + +   +++ELI+ F  +   +LVFE M         +     +  +    +Q     L
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA---RIFGSPDRRFTHQVF----A 174
            F H K + HRD+KP N+L     Q   +K+ DFGL    ++ G      T ++     +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 175 RWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT 230
             Y APE++      A  Y    D+W+ G I   LL+  P   G    D         G 
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----CGWDRGE 240
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
           A P+    L       +Y++    P +  +   S  A DL+SK+   D K R++A Q L+
Sbjct: 241 ACPACQNMLFESIQEGKYEF----PDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 291 HRFAK 295
           H + +
Sbjct: 296 HPWVQ 300

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 79
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 197
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 65  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 123
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 181
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 134
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 193 GRSAAVWSLGILLYDMV 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 133
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 192 GRSAAVWSLGILLYDMV 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 96
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 214
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 244

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 137
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 195
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 134
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 193 GRSAAVWSLGILLYDMV 209

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 138
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 6/204 (2%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++     A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRPFLQGSSD 217
           D+WA GCI  +L+   P  +  ++
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 106
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 224
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 254

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 165
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 223
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 79  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 137
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 195
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 132
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 133 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 191 GRSAAVWSLGILLYDMV 207

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 161
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 220 GRSAAVWSLGILLYDMV 236

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 68  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 127 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 182
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRA 179
           +  L   H    +HRD+KP+N+L+   G LKLADFG           R    V    Y +
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 180 PELL---FGAKQYGAGVDVWAAGCIFAELL 206
           PE+L    G   YG   D W+ G    E+L
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 209
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 138
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 80  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 138
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 139 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 208
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 209
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 209
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 208
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 63  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 122 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 177
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRA 179
           +  L   H    +HRD+KP+N+L+   G LKLADFG           R    V    Y +
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 180 PELL---FGAKQYGAGVDVWAAGCIFAELL 206
           PE+L    G   YG   D W+ G    E+L
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 68  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 127 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 182
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRA 179
           +  L   H    +HRD+KP+N+L+   G LKLADFG           R    V    Y +
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 180 PELL---FGAKQYGAGVDVWAAGCIFAELL 206
           PE+L    G   YG   D W+ G    E+L
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 93  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 151
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 209
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIII-SKGYNKAVDWWALGVLIYEM 231

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 165
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 223
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 157
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 215
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 92  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 150
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 208
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 108/234 (46%), Gaps = 37/234 (15%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIR------LGKQKEGVNFTALREIKLLKELKS 70
            E++G G +G VY+A     G  VA+K  R      + +  E V     +E KL   LK 
Sbjct: 12  EEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR----QEAKLFAMLKH 65
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADI-KSYMQMTLKGLAFCH 128
           P+II L      + NL LV EF     L  V+    I   P DI  ++     +G+ + H
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI---PPDILVNWAVQIARGMNYLH 122
Query: 129 KKW---VLHRDMKPNNLLI--------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            +    ++HRD+K +N+LI         S+  LK+ DFGLAR +    +      +A  +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA--W 180
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
            APE++  A  +  G DVW+ G +  ELL      +G   ID L     A+G A
Sbjct: 181 MAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRG---IDGLA---VAYGVA 227

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 27  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 87  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 145
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 203
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 204 PPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII--- 74
           E++G G +G V+KA     G+T  I++++   +K      A RE+K L +L   +I+   
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEK------AEREVKALAKLDHVNIVHYN 71
Query: 75  -----------------ELIDAFPHKGN---------LHLVFEFMET-DLETVI--RNTN 105
                            E  D  P             L +  EF +   LE  I  R   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD 165
                  ++ + Q+T KG+ + H K ++HRD+KP+N+ +    Q+K+ DFGL     +  
Sbjct: 132 KLDKVLALELFEQIT-KGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +R   +   R Y +PE +  ++ YG  VD++A G I AELL+
Sbjct: 191 KRTRSKGTLR-YMSPEQI-SSQDYGKEVDLYALGLILAELLH 230

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK +   R+    E  N T +  E+ 
Sbjct: 52  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 170
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 171 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYS 228
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL 206
            PE +   + +G    VW+ G +  +++
Sbjct: 229 PPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  ++
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYQM 231

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 141/313 (45%), Gaps = 80/313 (25%)
Query: 18  EVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS-PHI 73
           ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    P++
Sbjct: 39  KILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNV 89
Query: 74  I-----ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYMQMT 120
           I     E  D F     L++  E    +L+ ++ + N+  S  ++K        S ++  
Sbjct: 90  IRYYCSETTDRF-----LYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLLRQI 142
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK-------------LADFGLARIFGSPDRR 167
             G+A  H   ++HRD+KP N+L+ +  +               ++DFGL +   S    
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 168 FTHQVF----ARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLN--RRPFLQG-SSDI 218
           F   +        +RAPELL  +  ++    +D+++ GC+F  +L+  + PF    S + 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
           + +  IF+           ++  L D            RSL   A+    DL+S+M  +D
Sbjct: 263 NIIRGIFS---------LDEMKCLHD------------RSLIAEAT----DLISQMIDHD 297
Query: 279 PKARITAQQALEH 291
           P  R TA + L H
Sbjct: 298 PLKRPTAMKVLRH 310

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 23  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 79
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 200 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 256
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 257 DNCPDMLFELMRMCWQY--NPKMRPSF 281

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 141/313 (45%), Gaps = 80/313 (25%)
Query: 18  EVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS-PHI 73
           ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    P++
Sbjct: 39  KILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNV 89
Query: 74  I-----ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYMQMT 120
           I     E  D F     L++  E    +L+ ++ + N+  S  ++K        S ++  
Sbjct: 90  IRYYCSETTDRF-----LYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLLRQI 142
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK-------------LADFGLARIFGSPDRR 167
             G+A  H   ++HRD+KP N+L+ +  +               ++DFGL +   S    
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 168 FTHQVF----ARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLN--RRPFLQG-SSDI 218
           F   +        +RAPELL  +  ++    +D+++ GC+F  +L+  + PF    S + 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
           + +  IF+           ++  L D            RSL   A+    DL+S+M  +D
Sbjct: 263 NIIRGIFS---------LDEMKCLHD------------RSLIAEAT----DLISQMIDHD 297
Query: 279 PKARITAQQALEH 291
           P  R TA + L H
Sbjct: 298 PLKRPTAMKVLRH 310

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LV EFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 188
Query: 196 WAAGCIFAELLNR 208
           W+ G +  E+ + 
Sbjct: 189 WSFGVLMWEVFSE 201

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 131
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWW 190
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 191 ALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT-SPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 79
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 197
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 22  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 199 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 256
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 257 NCPDMLFELMRMCWQY--NPKMRPSF 280

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWW 194
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 195 ALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 51  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 107
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 108 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 167
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 228 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 285
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 286 NCPDMLFELMRMCWQY--NPKMRPSF 309

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 23  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 79
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 200 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 257
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 258 NCPDMLFELMRMCWQY--NPKMRPSF 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 22  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 199 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 256
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 257 NCPDMLFELMRMCWQY--NPKMRPSF 280

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 29  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 145
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 206 WMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 263
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 264 NCPDMLFELMRMCWQY--NPKMRPSF 287

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 29  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 206 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 263
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 264 NCPDMLFELMRMCWQY--NPKMRPSF 287

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 146
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 147 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWW 205
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 206 ALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           AP ++  +K Y   VD WA G +  E+
Sbjct: 206 APAIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 16  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 72
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 193 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 249
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 250 DNCPDMLFELMRMCWQY--NPKMRPSF 274

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 20  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 76
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 77  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 136
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 197 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 253
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 254 DNCPDMLFELMRMCWQY--NPKMRPSF 278

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 19  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 75
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 76  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 196 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 253
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+ +    + +QY   P +R  F
Sbjct: 254 NCPDMLFELMRMCWQY--NPKMRPSF 277

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELI 77
           VLG+G +G V       TG+  A KK+   + K+      AL E ++L+++ S  ++ L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHR 135
            A+  K  L LV   M   DL+  I +      P A    Y      GL   H++ +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDW 368
Query: 196 WAAGCIFAELL-NRRPFLQGSSDI--DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           WA GC+  E++  + PF Q    I  +++ ++              +  +P+  EY    
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------------VKEVPE--EYSERF 412
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
           +P  RS           L S++   DP  R+     +A++  EH   K  N
Sbjct: 413 SPQARS-----------LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 142/320 (44%), Gaps = 84/320 (26%)
Query: 15  LKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS- 70
           +  ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    
Sbjct: 18  VSEKILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDH 68
Query: 71  PHII-----ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYM 117
           P++I     E  D F     L++  E    +L+ ++ + N+  S  ++K        S +
Sbjct: 69  PNVIRYYCSETTDRF-----LYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLL 121
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK-------------LADFGLARIFGSP 164
           +    G+A  H   ++HRD+KP N+L+ +  +               ++DFGL +   S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 165 DRRFTHQVF----ARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN--RRPFL 212
              F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  + PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 213 QG-SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
              S + + +  IF+           ++  L D            RSL   A+    DL+
Sbjct: 242 DKYSRESNIIRGIFS---------LDEMKCLHD------------RSLIAEAT----DLI 276
Query: 272 SKMFTYDPKARITAQQALEH 291
           S+M  +DP  R TA + L H
Sbjct: 277 SQMIDHDPLKRPTAMKVLRH 296

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 142/320 (44%), Gaps = 84/320 (26%)
Query: 15  LKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS- 70
           +  ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    
Sbjct: 18  VSEKILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDH 68
Query: 71  PHII-----ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYM 117
           P++I     E  D F     L++  E    +L+ ++ + N+  S  ++K        S +
Sbjct: 69  PNVIRYYCSETTDRF-----LYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLL 121
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK-------------LADFGLARIFGSP 164
           +    G+A  H   ++HRD+KP N+L+ +  +               ++DFGL +   S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 165 DRRFTHQVF----ARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN--RRPFL 212
              F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  + PF 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 213 QG-SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
              S + + +  IF+           ++  L D            RSL   A+    DL+
Sbjct: 242 DKYSRESNIIRGIFS---------LDEMKCLHD------------RSLIAEAT----DLI 276
Query: 272 SKMFTYDPKARITAQQALEH 291
           S+M  +DP  R TA + L H
Sbjct: 277 SQMIDHDPLKRPTAMKVLRH 296

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLG---KQKEGVNFTALREIKL 64
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++     + + G      +EI +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----QEIDI 86
Query: 65  LKELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           L+ L   HII+        G  +L LV E++    L   +   +I L  A +  + Q   
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQIC 144
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------ 175
           +G+A+ H +  +HRD+   N+L+ +   +K+ DFGLA+    P+    ++V         
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEXYRVREDGDSPVF 202
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           WY APE L   K Y A  DVW+ G    ELL 
Sbjct: 203 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 119/298 (39%), Gaps = 51/298 (17%)
Query: 10  VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKE 67
           V D Y L ++VLG G  G V +    +TGQ  A+K +    K ++ V+          + 
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH-------WQA 78
Query: 68  LKSPHIIELIDAFP--HKGN--LHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTL 121
              PHI+ ++D +   H G   L ++ E ME       +    +   +  +    M+   
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYR 178
             + F H   + HRD+KP NLL  S  +   LKL DFG A+   +         +  +Y 
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYV 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI----FAAFGTATP 233
           APE+L G ++Y    D+W+ G I   LL    PF   +      G         +G   P
Sbjct: 197 APEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            +W ++                        S+DA  L+  +   DP  R+T  Q + H
Sbjct: 256 -EWSEV------------------------SEDAKQLIRLLLKTDPTERLTITQFMNH 288

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +V+G+G++G V    +KA +      V  KK  L K+KE  +  + R + LLK +K P +
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNV-LLKNVKHPFL 101
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   +
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASALGYLHSLNI 160
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+ S G + L DFGL +     +   +       Y APE+L   + Y   
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH-KQPYDRT 219
Query: 193 VDVWAAGCIFAELL 206
           VD W  G +  E+L
Sbjct: 220 VDWWCLGAVLYEML 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELI 77
           VLG+G +G V       TG+  A KK+   + K+      AL E ++L+++ S  ++ L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHR 135
            A+  K  L LV   M   DL+  I +      P A    Y      GL   H++ +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDW 368
Query: 196 WAAGCIFAELL-NRRPFLQGSSDI--DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           WA GC+  E++  + PF Q    I  +++ ++              +  +P+  EY    
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------------VKEVPE--EYSERF 412
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
           +P  RS           L S++   DP  R+     +A++  EH   K  N
Sbjct: 413 SPQARS-----------LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 27/305 (8%)
Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I   KQ   +     RE+++L
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEML 64
Query: 66  KELKSP-HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
            + +   +++ELI+ F  +   +LVFE M         +     +  +    +Q     L
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA---RIFGSPDRRFTHQVF----A 174
            F H K + HRD+KP N+L     Q   +K+ DF L    ++ G      T ++     +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 175 RWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT 230
             Y APE++      A  Y    D+W+ G I   LL+  P   G    D         G 
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----CGWDRGE 240
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
           A P+    L       +Y++    P +  +   S  A DL+SK+   D K R++A Q L+
Sbjct: 241 ACPACQNMLFESIQEGKYEF----PDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 291 HRFAK 295
           H + +
Sbjct: 296 HPWVQ 300

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK +++G  +K+  +F  L E  ++ +   P+II
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNII 86
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V E+ME   L+T ++  +   +   +   ++    G+ +      +
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQY 189
           HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAI-AFRKF 204
Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +  DVW+ G +  E+++   RP+ + ++  D +  +   +   +P   P   Y
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYWEMTNQ-DVIKAVEEGYRLPSPMDCPAALY 257

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+             
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----------L 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 14  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 70
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 71  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 130
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 191 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 247
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+      + +QY   P +R  F
Sbjct: 248 DNCPDMLLELMRMCWQY--NPKMRPSF 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 119/298 (39%), Gaps = 51/298 (17%)
Query: 10  VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKE 67
           V D Y L ++VLG G  G V +    +TGQ  A+K +    K ++ V+          + 
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH-------WQA 59
Query: 68  LKSPHIIELIDAFP--HKGN--LHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTL 121
              PHI+ ++D +   H G   L ++ E ME       +    +   +  +    M+   
Sbjct: 60  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYR 178
             + F H   + HRD+KP NLL  S  +   LKL DFG A+   +         +  +Y 
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYV 177
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI----FAAFGTATP 233
           APE+L G ++Y    D+W+ G I   LL    PF   +      G         +G   P
Sbjct: 178 APEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 236
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            +W ++                        S+DA  L+  +   DP  R+T  Q + H
Sbjct: 237 -EWSEV------------------------SEDAKQLIRLLLKTDPTERLTITQFMNH 269

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++ G   + +     REI++L+ 
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILRT 67
Query: 68  LKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L   HI++       +G  ++ LV E++    L   +    + L  A +  + Q   +G+
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGM 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYR 178
           A+ H +  +HR +   N+L+ +   +K+ DFGLA+    P+    ++V         WY 
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY- 182
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L   K Y A  DVW+ G    ELL 
Sbjct: 183 APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 20  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 79  HVCRLL-GICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 195
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-- 74
           +E LG G +G V + I   TG+ VAIK+ R     +      L EI+++K+L  P+++  
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSA 77
Query: 75  -ELIDAF----PHKGNLHLVFEFMET-DLETVIRN--TNIFLSPADIKSYMQMTLKGLAF 126
            E+ D      P+   L L  E+ E  DL   +        L    I++ +      L +
Sbjct: 78  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
            H+  ++HRD+KP N+++    Q    K+ D G A+     +   T  V    Y APELL
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELL 195
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKI 224
              K+Y   VD W+ G +  E +   RPFL     +   GK+
Sbjct: 196 -EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 408

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 128/295 (43%), Gaps = 39/295 (13%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK-SP 71
           +VLG G YG V+   K     TG+  A+K ++     QK         E ++L+ ++ SP
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF  +  LHL+ +++   +L T +     F +  +++ Y+   +  L   HK 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGEIVLALEHLHKL 178
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S+G + L DFGL++ F + +    +       Y AP+++ G    
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           +   VD W+ G +  ELL          + +   +I      + P    +++ L      
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL------ 292
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                             A DL+ ++   DPK R+      A +  EH F +  N
Sbjct: 293 ------------------AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++ G   + +     REI++L+ 
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILRT 66
Query: 68  LKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L   HI++       +G  ++ LV E++    L   +    + L  A +  + Q   +G+
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGM 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYR 178
           A+ H +  +HR +   N+L+ +   +K+ DFGLA+    P+    ++V         WY 
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY- 181
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L   K Y A  DVW+ G    ELL 
Sbjct: 182 APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-- 74
           +E LG G +G V + I   TG+ VAIK+ R     +      L EI+++K+L  P+++  
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSA 78
Query: 75  -ELIDAF----PHKGNLHLVFEFMET-DLETVIRN--TNIFLSPADIKSYMQMTLKGLAF 126
            E+ D      P+   L L  E+ E  DL   +        L    I++ +      L +
Sbjct: 79  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
            H+  ++HRD+KP N+++    Q    K+ D G A+     +   T  V    Y APELL
Sbjct: 138 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELL 196
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKI 224
              K+Y   VD W+ G +  E +   RPFL     +   GK+
Sbjct: 197 -EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 237

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 408

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A++ ++  L    E +++    +    +    P ++ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWW 237
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 13  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 67
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 68  LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 183
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 184 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 235

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 89/348 (25%), Positives = 142/348 (40%), Gaps = 85/348 (24%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHIIE 75
           +GEGT+  VY          +A  ++++G + E +    L      I++  EL+   +  
Sbjct: 29  IGEGTFSSVY----------LATAQLQVGPE-EKIALKHLIPTSHPIRIAAELQCLTVAG 77
Query: 76  LID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             D      +  + N H+V      + E+ +   N  LS  +++ YM    K L   H+ 
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-SLSFQEVREYMLNLFKALKRIHQF 136
Query: 131 WVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFT-------------------- 169
            ++HRD+KP+N L      +  L DFGLA+  G+ D +                      
Sbjct: 137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ--GTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 170 ------HQVFAR----WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI 218
                  QV  R     +RAPE+L         +D+W+AG IF  LL+ R PF + S D+
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254
Query: 219 DQLGKIFAAFGT------------------ATPSQWPDLAYLPDYVEYQYVAAPPLRSLF 260
             L +I    G+                    P+Q  DL  L + +     + P L S  
Sbjct: 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQ--DLRKLCERLRGMDSSTPKLTSDI 312
Query: 261 PSAS----------DDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
              +          D+A DLL K+   +P +RITA++AL H F K  +
Sbjct: 313 QGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 66
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTEPCYTPYYVA 185
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 186 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L +P+I+ LI
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 76
Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  L LV E      L   +      +  +++   +     G+ +  +K  +HRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +T +   +W   + APE +   +++ +  
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRS 194
Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G    E L+  ++P+
Sbjct: 195 DVWSYGVTMWEALSYGQKPY 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 17/196 (8%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 178
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHKKWVL 133
                K  +++V E ++  D  T +R     L    +K+ +QM      G+ +   K  +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR---VKTLLQMVGDAAAGMEYLESKCCI 235
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           HRD+   N L+     LK++DFG++R     ++ +       QV  +W     L +G  +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG--LRQVPVKWTAPEALNYG--R 291
Query: 189 YGAGVDVWAAGCIFAE 204
           Y +  DVW+ G +  E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 20  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 79  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 195
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R     +  +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 13  RYLKREV-LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK ++ +G G++  VYK +DT+T   VA  +++  K  +        E + LK L+ P
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHP 85
Query: 72  HIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +I+   D++      K  + LV E   +  L+T ++   +      ++S+ +  LKGL F
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV-LRSWCRQILKGLQF 144
Query: 127 CHKKW--VLHRDMKPNNLLI-GSHGQLKLADFGLAR---------IFGSPDRRFTHQVFA 174
            H +   ++HRD+K +N+ I G  G +K+ D GLA          + G+P+         
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE--------- 195
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             + APE     ++Y   VDV+A G C      +  P+    S+     +I+    +   
Sbjct: 196 --FXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPY----SECQNAAQIYRRVTSGVK 247
Query: 234 SQWPDLAYLPDYVE 247
               D   +P+  E
Sbjct: 248 PASFDKVAIPEVKE 261

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 23  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 82  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 198
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLL 65
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++   G Q         +EI +L
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS---GWKQEIDIL 70
Query: 66  KELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           + L   HII+       +G  +L LV E++    L   +   +I L  A +  + Q   +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------W 176
           G+A+ H +  +HR++   N+L+ +   +K+ DFGLA+    P+    ++V         W
Sbjct: 129 GMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFW 186
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           Y APE L   K Y A  DVW+ G    ELL 
Sbjct: 187 Y-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 269 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 323
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 324 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 439
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 440 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 491

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 72
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 73  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 191
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 192 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 408

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 73
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 74  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 192
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 193 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 17  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 71
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 72  LVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 187
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 188 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 239

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 74
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 75  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 193
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 194 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 120/250 (48%), Gaps = 19/250 (7%)
Query: 2   AEVDLSKKVADRYLK-REVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLG-KQKEGVNF 56
             ++ +K++   Y+K  EV+G G +G V +      G+    VAIK ++ G  +++   F
Sbjct: 3   GSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREF 62
Query: 57  TALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKS 115
             L E  ++ + + P+II L     +   + ++ EFME   L++ +R  +   +   +  
Sbjct: 63  --LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 120
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH--- 170
            ++    G+ +  +   +HRD+   N+L+ S+   K++DFGL+R     S D  +T    
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 171 -QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAA 227
            ++  RW  APE +   +++ +  D W+ G +  E+++   RP+   S+  D +  I   
Sbjct: 181 GKIPIRWT-APEAI-AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ-DVINAIEQD 237
Query: 228 FGTATPSQWP 237
           +    P   P
Sbjct: 238 YRLPPPPDCP 247

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLL 65
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++   G Q         +EI +L
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS---GWKQEIDIL 70
Query: 66  KELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           + L   HII+       +G  +L LV E++    L   +   +I L  A +  + Q   +
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------W 176
           G+A+ H +  +HR++   N+L+ +   +K+ DFGLA+    P+    ++V         W
Sbjct: 129 GMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFW 186
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           Y APE L   K Y A  DVW+ G    ELL 
Sbjct: 187 Y-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 67
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 68  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 186
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 187 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     LE V  + +   S   +   +Q+  KG+ +  
Sbjct: 77  PHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 134
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 193
Query: 186 AKQYGAGVDVWAAGCIFAELLN 207
            +++    DVW+ G    EL+ 
Sbjct: 194 -RKFTHQSDVWSYGVTIWELMT 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 68
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 187
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 188 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 178
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHKKWVL 133
                K  +++V E ++  D  T +R     L    +K+ +QM      G+ +   K  +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR---VKTLLQMVGDAAAGMEYLESKCCI 235
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPELLFGAKQYG 190
           HRD+   N L+     LK++DFG++R         +    QV  +W     L +G  +Y 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG--RYS 293
Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 294 SESDVWSFGILLWE 307

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 66
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 185
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 186 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 112
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 231
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 232 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 82
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 83  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 201
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 202 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK I    G+ V    AIK +R     +  N   L E  ++  + SP
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++  L+        + LV + M    L   +R     L   D+ ++     KG+++    
Sbjct: 80  YVSRLL-GICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAPELLFGAK 187
            ++HRD+   N+L+ S   +K+ DFGLAR+    +  +     +V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--RR 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
           ++    DVW+ G    EL+ 
Sbjct: 197 RFTHQSDVWSYGVTVWELMT 216

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 68
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 187
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 188 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 44  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 102
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 103 HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 219
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 220 IYTHQSDVWSYGVTVWELMT 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 71
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 72  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 188
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 189 IYTHQSDVWSYGVTVWELMT 208

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 118
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 119 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 237
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 238 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKK-IRLGKQKEG-VNFTALREIKL-LKELKSPH 72
           K +VLG G +G V+K +    G+++ I   I++ + K G  +F A+ +  L +  L   H
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+   P   +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 95  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +   +   +W     + FG  +
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--K 211
Query: 189 YGAGVDVWAAGCIFAELLN 207
           Y    DVW+ G    EL+ 
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     LE V  + +   S   +   +Q+  KG+ +  
Sbjct: 100 PHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 157
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 216
Query: 186 AKQYGAGVDVWAAGCIFAELLN 207
            +++    DVW+ G    EL+ 
Sbjct: 217 -RKFTHQSDVWSYGVTIWELMT 237

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 25  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 84  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 200
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 201 IYTHQSDVWSYGVTVWELMT 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 120/240 (50%), Gaps = 21/240 (8%)
Query: 9   KVADRYLKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++    L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 65
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +L+   +++L  A   +  +++V E+M     L+ +   T  +L    +         G+
Sbjct: 66  KLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE 181
           A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE
Sbjct: 125 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPE 182
Query: 182 -LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 183 AALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 29  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 87
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 88  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 204
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 205 IYTHQSDVWSYGVTVWELMT 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKK-IRLGKQKEG-VNFTALREIKL-LKELKSPH 72
           K +VLG G +G V+K +    G+++ I   I++ + K G  +F A+ +  L +  L   H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+   P   +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 77  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +   +   +W     + FG  +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--K 193
Query: 189 YGAGVDVWAAGCIFAELLN 207
           Y    DVW+ G    EL+ 
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 15  LKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           LKRE LGEG +G V     Y     +    VA+K ++        +F   RE +LL  L+
Sbjct: 17  LKRE-LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQ 73
Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR------------NTNIFLSPADIKSY 116
             HI++          L +VFE+M+  DL   +R            N    L+ + +   
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA 174
            Q    G+ +   +  +HRD+   N L+G +  +K+ DFG++R   S D  R   H +  
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 175 -RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSD 217
            RW     +++  +++    DVW+ G +  E+    ++P+ Q S++
Sbjct: 194 IRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 572
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 573 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 622

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE 
Sbjct: 16  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 72
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
               G+A+ +    +HRD+   N  +     +K+ DFG+ R     D  R+    +    
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + +PE L     +    DVW+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 193 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKPD 250
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             PD+      + +QY   P +R  F
Sbjct: 251 NCPDMLLELMRMCWQY--NPKMRPSF 274

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 242

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR------EIKL 64
           + +Y     LG G +G V+ A+D +  + V +K I+  K  E       +      EI +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYM-QMTL 121
           L  ++  +II+++D F ++G   LV E   +  DL   I        P  + SY+ +  +
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP--LASYIFRQLV 140
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
             + +   K ++HRD+K  N++I     +KL DFG A  +    + F        Y APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYTFCGTIEYCAPE 199
Query: 182 LLFGAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDID 219
           +L G    G  +++W+ G  ++  +    PF +    ++
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 109/230 (47%), Gaps = 16/230 (6%)
Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK +++G  +K+  +F  L E  ++ +   P+++
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDF--LCEASIMGQFDHPNVV 107
Query: 75  ELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V EFME   L+  +R  +   +   +   ++    G+ +      +
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQY 189
           HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW-TAPEAI-QYRKF 225
Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            +  DVW+ G +  E+++   RP+   S+  D +  I   +    P   P
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGYRLPAPMDCP 274

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 242

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 120/243 (49%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 11  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 65
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 66  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 116
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 117 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 173
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 174 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 230
Query: 236 WPD 238
            P+
Sbjct: 231 CPE 233

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 120/243 (49%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 9   LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 63
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 64  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 114
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 115 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 171
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 172 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 228
Query: 236 WPD 238
            P+
Sbjct: 229 CPE 231

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 6   LSKKVADRYLKRE------VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNF 56
            + KV    L RE      V+G G +G V         +  A+K   K  + K+ E   F
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 57  TALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKS 115
              R++  L    S  I  L  AF    NL+LV ++ +  DL T++      L     + 
Sbjct: 122 REERDV--LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFA 174
           Y+   +  +   H+   +HRD+KP+N+L+  +G ++LADFG   ++      + +  V  
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 175 RWYRAPELL----FGAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
             Y +PE+L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 294

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 84
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 145 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 203
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 204 VWSIGCIMYTLLVGKPPFETSC 225

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 120/243 (49%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 239
Query: 236 WPD 238
            P+
Sbjct: 240 CPE 242

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSC 221

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSC 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 19  VLGEGTYGVVYKA--IDTKTGQT-VAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHII 74
           V+G+G +GVVY    ID    +   AIK + R+ + ++   F  LRE  L++ L  P+++
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--LREGLLMRGLNHPNVL 85
Query: 75  ELID-AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            LI    P +G  H++  +M   DL   IR+     +  D+ S+     +G+ +  ++  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK----- 187
           +HRD+   N ++     +K+ADFGLAR     DR +      R  R P      +     
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 188 QYGAGVDVWAAGCIFAELLNR 208
           ++    DVW+ G +  ELL R
Sbjct: 204 RFTTKSDVWSFGVLLWELLTR 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 242

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L +P+I+ LI
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 402
Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  L LV E      L   +      +  +++   +     G+ +  +K  +HR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +T +   +W   + APE +   +++ +  
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRS 520
Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G    E L+  ++P+
Sbjct: 521 DVWSYGVTMWEALSYGQKPY 540

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 20  LGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPH 72
           +GEG +G V++A     +  +    VA+K +   K++   +  A   RE  L+ E  +P+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111
Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVIRN----TNIFLSPADIKSYMQMT------- 120
           I++L+        + L+FE+M   DL   +R+    T   LS +D+ +  +++       
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 121 ------------LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--- 165
                         G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D   
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
                 +  RW   PE +F   +Y    DVWA G +  E+ +
Sbjct: 232 ADGNDAIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 78
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 197
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 198 VWSIGCIMYTLLVGKPPFETSC 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 16  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 74
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     +G+ +   +
Sbjct: 75  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 191
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 192 IYTHQSDVWSYGVTVWELMT 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 102
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 163 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 221
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 222 VWSIGCIMYTLLVGKPPFETSC 243

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 104 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 162
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 220
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 221 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 270

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 189
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 190 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 239

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 78  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 136
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 137 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 194
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 195 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 244

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 23  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 82  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 198
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 81  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 197
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 198 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 247

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 104
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 223
Query: 195 VWAAGCIFAELLNRRPFLQGSS 216
           VW+ GCI   LL  +P  + S 
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSC 245

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 79  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 137
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 138 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 195
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 196 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 245

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSEL 81
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNTNI-----------FL 108
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+              FL
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD-- 165
           +   +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  
Sbjct: 142 TLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 201
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 202 RKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 118/240 (49%), Gaps = 21/240 (8%)
Query: 9   KVADRYLKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++    L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 58
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +L+   +++L  A   +  + +V E+M     L+ +   T  +L    +         G+
Sbjct: 59  KLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 117
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE 181
           A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D   T +  A++   + APE
Sbjct: 118 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPE 175
Query: 182 -LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 176 AALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 232

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+++   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKIRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 239
Query: 236 WPD 238
            P+
Sbjct: 240 CPE 242

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD+   N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 239
Query: 236 WPD 238
            P+
Sbjct: 240 CPE 242

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 115/245 (46%), Gaps = 17/245 (6%)
Query: 5   DLSKKVADRYLKRE-VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTAL 59
           + +K++    +K E V+G G +G V      +  K    VAIK ++ G   K+  +F  L
Sbjct: 21  EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--L 78
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQ 118
            E  ++ +   P+II L         + ++ E+ME   L+  +R  +   +   +   ++
Sbjct: 79  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 138
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFA 174
               G+ +      +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  
Sbjct: 139 GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTAT 232
           RW  APE +   +++ +  DVW+ G +  E+++   RP+   S+  D +  I   +    
Sbjct: 199 RWT-APEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGYRLPP 255
Query: 233 PSQWP 237
           P   P
Sbjct: 256 PMDCP 260

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-----TALREIKLLKEL 68
           +L  ++LG+G    V++    KTG   AIK          ++F       +RE ++LK+L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKL 64
Query: 69  KSPHIIELIDAFPHKGNLH--LVFEFMET-DLETVIRN-TNIF-LSPADIKSYMQMTLKG 123
              +I++L          H  L+ EF     L TV+   +N + L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 124 LAFCHKKWVLHRDMKPNNLL--IGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +    +  ++HR++KP N++  IG  GQ   KL DFG AR     D +F        Y  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLH 183
Query: 180 PELLFGA-------KQYGAGVDVWAAGCIF 202
           P++   A       K+YGA VD+W+ G  F
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 81
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 202 PDXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 39/243 (16%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 187 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEK 241
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 242 LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 292
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGL R+    D  +T +  A++   + 
Sbjct: 293 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWT 349
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P +
Sbjct: 350 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPE 406
Query: 236 WPD 238
            P+
Sbjct: 407 CPE 409

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 13  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 69
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 128
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE-----------YL 177
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L ++        P    
Sbjct: 178 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP---- 230
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                              R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 231 -------------------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 267
Query: 293 F 293
           F
Sbjct: 268 F 268

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 81
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 202 PDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 14  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 70
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 129
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K V++RD+K  NL++   G +K+ DFGL +                 Y APE+L     Y
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL-EDNDY 188
Query: 190 GAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           G  VD W  G +  E++  R PF   + D ++L ++        P               
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP--------------- 231
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRF 293
                   R+L P A      LLS +   DPK R+      A++ ++HRF
Sbjct: 232 --------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 269

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-----TALREIKLLKEL 68
           +L  ++LG+G    V++    KTG   AIK          ++F       +RE ++LK+L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKL 64
Query: 69  KSPHIIELIDAFPHKGNLH--LVFEFMET-DLETVIRN-TNIF-LSPADIKSYMQMTLKG 123
              +I++L          H  L+ EF     L TV+   +N + L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 124 LAFCHKKWVLHRDMKPNNLL--IGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +    +  ++HR++KP N++  IG  GQ   KL DFG AR     D +F        Y  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVXLYGTEEYLH 183
Query: 180 PELLFGA-------KQYGAGVDVWAAGCIF 202
           P++   A       K+YGA VD+W+ G  F
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 12  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE-----------YL 176
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L ++        P    
Sbjct: 177 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP---- 229
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                              R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 230 -------------------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 266
Query: 293 F 293
           F
Sbjct: 267 F 267

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ +   +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 118
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 239 PDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 83
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLY 143
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 144 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 204 PDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 118/247 (47%), Gaps = 19/247 (7%)
Query: 5   DLSKKVADRYLK-REVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLG-KQKEGVNFTAL 59
           + +K++   Y+K  EV+G G +G V +      G+    VAIK ++ G  +++   F  L
Sbjct: 8   EFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREF--L 65
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQ 118
            E  ++ + + P+II L     +   + ++ EFME   L++ +R  +   +   +   ++
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QV 172
               G+ +  +   +HRD+   N+L+ S+   K++DFGL+R     S D   T     ++
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGT 230
             RW  APE +   +++ +  D W+ G +  E+++   RP+   S+  D +  I   +  
Sbjct: 186 PIRWT-APEAI-AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ-DVINAIEQDYRL 242
Query: 231 ATPSQWP 237
             P   P
Sbjct: 243 PPPPDCP 249

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLK 66
           A R    +++G G  G V        GQ    VAIK ++ G  +++  +F  L E  ++ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMG 105
Query: 67  ELKSPHIIELIDAFPHKGNLHL-VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +   P+II L +    +G L + V E+ME   L+T +R  +   +   +   ++    G+
Sbjct: 106 QFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAP 180
            +      +HRD+   N+L+ S+   K++DFGL+R+    PD  +T    ++  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-AP 223
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELL--NRRPF 211
           E +   + + +  DVW+ G +  E+L    RP+
Sbjct: 224 EAI-AFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSEL 81
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNTNI-----------FL 108
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+              FL
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD-- 165
           +   +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  
Sbjct: 142 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYV 201
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 202 RKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 21/240 (8%)
Query: 9   KVADRYLKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++    L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 68
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +L+   +++L  A   +  +++V E+M     L+ +      +L    +         G+
Sbjct: 69  KLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE 181
           A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D   T +  A++   + APE
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPE 185
Query: 182 -LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             L+G  ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 186 AALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 242

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSXVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 13/231 (5%)
Query: 19  VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ +   +KL DFGL+R        +    ++  +W  APE +   +++ + 
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 572
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW  G    E+L    +PF QG  + D +G+I        P   P   Y
Sbjct: 573 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTLY 622

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 155 YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 211
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 270
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YL 319
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L ++        P    
Sbjct: 320 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP---- 372
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                              R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 373 -------------------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 409
Query: 293 F 293
           F
Sbjct: 410 F 410

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 72
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 193 PDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AI ++R     +  N   L E  ++  + +P
Sbjct: 53  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA-NKEILDEAYVMASVDNP 111
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 112 HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 228
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 229 IYTHQSDVWSYGVTVWELMT 248

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 66/301 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 152 YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 208
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 267
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YL 316
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF     +     K+F            
Sbjct: 317 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF------------ 358
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                 + +  + +  P  R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 359 ------ELILMEEIRFP--RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406
Query: 293 F 293
           F
Sbjct: 407 F 407

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 72
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNTNI------------- 106
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+                
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 107 --FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
             FL+   +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 193 PDYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSYVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 115/245 (46%), Gaps = 17/245 (6%)
Query: 5   DLSKKVADRYLKRE-VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTAL 59
           + +K++    +K E V+G G +G V      +  K    VAIK ++ G   K+  +F  L
Sbjct: 6   EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--L 63
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQ 118
            E  ++ +   P+II L         + ++ E+ME   L+  +R  +   +   +   ++
Sbjct: 64  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 123
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFA 174
               G+ +      +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTAT 232
           RW  APE +   +++ +  DVW+ G +  E+++   RP+   S+  D +  I   +    
Sbjct: 184 RWT-APEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGYRLPP 240
Query: 233 PSQWP 237
           P   P
Sbjct: 241 PMDCP 245

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 18  EVLGEGTYGVVYKAID---TKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKS-PH 72
           +VLG G +G V  A     +KTG ++ +    L ++ +     AL  E+K++ +L S  +
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 73  IIELIDAFPHKGNLHLVFEFM-------------------ETDLETVIR-----NTNIFL 108
           I+ L+ A    G ++L+FE+                    E + E   R     + N+ L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV-L 169
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDR- 166
           +  D+  +     KG+ F   K  +HRD+   N+L+ +HG++ K+ DFGLAR   S    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLARDIMSDSNY 228
Query: 167 --RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             R   ++  +W  APE LF    Y    DVW+ G +  E+ +
Sbjct: 229 VVRGNARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSXVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    +E ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 108/231 (46%), Gaps = 16/231 (6%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      +  K    VAIK ++ G   K+  +F  L E  ++ +   P+I
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--LSEASIMGQFDHPNI 71
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ E+ME   L+  +R  +   +   +   ++    G+ +      
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 131
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  RW  APE +   ++
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT-APEAI-AYRK 189
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           + +  DVW+ G +  E+++   RP+   S+  D +  I   +    P   P
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGYRLPPPMDCP 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 31/234 (13%)
Query: 9   KVADRYLKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LKRE LGEG +G V     Y    TK    VA+K ++        +F   RE +
Sbjct: 13  KRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--REAE 69
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFL--SPADIKSY 116
           LL  L+  HI++          L +VFE+M+  DL   +R    +  I +   P   K  
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 117 MQMT---------LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           + ++           G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 166 RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           R   H +   RW     +++  +++    DVW+ G I  E+    ++P+ Q S+
Sbjct: 190 RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 8   KKVADRYLKREV------LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTAL 59
           K V + + +R +      +GEG +GVVYK     T  TVA+KK+   +    E +     
Sbjct: 15  KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD 72
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +EIK++ + +  +++EL+       +L LV+ +M     +++   +       +  +M+ 
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRC 130
Query: 120 TL-----KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF- 173
            +      G+ F H+   +HRD+K  N+L+      K++DFGLAR       +F   V  
Sbjct: 131 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQXVMX 186
Query: 174 -----ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
                   Y APE L G  +     D+++ G +  E++   P
Sbjct: 187 XRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 8   KKVADRYLKREV------LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTAL 59
           K V + + +R +      +GEG +GVVYK     T  TVA+KK+   +    E +     
Sbjct: 21  KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD 78
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +EIK++ + +  +++EL+       +L LV+ +M     +++   +       +  +M+ 
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRC 136
Query: 120 TL-----KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF- 173
            +      G+ F H+   +HRD+K  N+L+      K++DFGLAR       +F   V  
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVMX 192
Query: 174 -----ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
                   Y APE L G  +     D+++ G +  E++   P
Sbjct: 193 SRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 36/225 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 82
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL---SPADI-K 114
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+   +P D+ K
Sbjct: 83  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYK 142
Query: 115 SYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSP 164
            ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   P
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 165 D--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 203 DXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 14  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 68
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 69  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 122
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 176
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 8   KKVADRYLKREV------LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTAL 59
           K V + + +R +      +GEG +GVVYK     T  TVA+KK+   +    E +     
Sbjct: 21  KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFD 78
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +EIK++ + +  +++EL+       +L LV+ +M     +++   +       +  +M+ 
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRC 136
Query: 120 TL-----KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF- 173
            +      G+ F H+   +HRD+K  N+L+      K++DFGLAR       +F   V  
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVMX 192
Query: 174 -----ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
                   Y APE L G  +     D+++ G +  E++   P
Sbjct: 193 XRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 81
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 202 PDXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPK-------ARREVELHWRAS 112
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +     +   +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 231
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELL 206
           PE+L G ++Y    D W+ G I   LL
Sbjct: 232 PEVL-GPEKYDKSCDXWSLGVIXYILL 257

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIE 75
           +E +G G++G V++A     G  VA+K +       E VN   LRE+ ++K L+ P+I+ 
Sbjct: 42  KEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVL 98
Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKK-- 130
            + A     NL +V E++       + + +      D +  + M     KG+ + H +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+K  NLL+     +K+ DFGL+R+  S             + APE+L   +   
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD-EPSN 217
Query: 191 AGVDVWAAGCIFAEL 205
              DV++ G I  EL
Sbjct: 218 EKSDVYSFGVILWEL 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSEL 83
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIR---NTNIFLSPADI-KS 115
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R   N  +   P D+ K 
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 116 YMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD 165
           ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 204 XVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEF----------------METDLETVIRNTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+                +ETD    I N+   LS  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST--LSTRDLLHF 169
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 228
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 229 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 151
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 269
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTR 292

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 72
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 193 PDXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 17  REVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPH 72
            +V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E  ++ +   P+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSEASIMGQFDHPN 95
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I L         + ++ EFME   L++ +R  +   +   +   ++    G+ +     
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFARWYRAPELLFG 185
            +HRD+   N+L+ S+   K++DFGL+R     + D  +T     ++  RW  APE +  
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEAI-Q 213
Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPF 211
            +++ +  DVW+ G +  E+++   RP+
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 92
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 210
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    K    VA+K I+ G   E   F   +E + + +L  P +++    
Sbjct: 16  LGSGQFGVV-KLGKWKGQYDVAVKMIKEGSMSEDEFF---QEAQTMMKLSHPKLVKFYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  +++V E++    L   +R+    L P+ +        +G+AF      +HRD+ 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+     +K++DFG+ R     D ++   V  ++   + APE +F   +Y +  DV
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDV 188
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 189 WAFGILMWEVFSLGKMPY 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLK 66
           A R    +++G G  G V        GQ    VAIK ++ G  +++  +F  L E  ++ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMG 105
Query: 67  ELKSPHIIELIDAFPHKGNLHL-VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +   P+II L +    +G L + V E+ME   L+T +R  +   +   +   ++    G+
Sbjct: 106 QFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAP 180
            +      +HRD+   N+L+ S+   K++DFGL+R+    PD   T    ++  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-AP 223
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELL--NRRPF 211
           E +   + + +  DVW+ G +  E+L    RP+
Sbjct: 224 EAI-AFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 25  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 79
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 80  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 133
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 134 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 187
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 246

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 92
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 210
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 24  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 78
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 79  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 132
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 133 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 186
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 245

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 93
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 211
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------MET--DLETVIRNTNIFLSPAD 112
           +II L+ A    G L+++ E+                 ME   D+  V      F    D
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF---KD 158
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
           + S      +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
                 + APE LF  + Y    DVW+ G +  E+
Sbjct: 219 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 90
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 208
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTR 231

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 37/226 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EI 62
           DR    + LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 72
Query: 63  KLLKELKSP-HIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-NIFL----SPADI- 113
           K+L  +    +++ L+ A    G  L ++ EF +  +L T +R+  N F+    +P D+ 
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 114 KSYMQM---------TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS 163
           K ++ +           KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 164 PD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PD  R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 193 PDXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 97
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 215
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTR 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 93
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL--Q 211
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 20/227 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG G +G V+  + T  G T VAIK ++ G        + L E +++K+LK   +++L  
Sbjct: 17  LGNGQFGEVW--MGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIMKKLKHDKLVQLY- 70
Query: 79  AFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   +  +++V E+M     L+ +       L   ++         G+A+  +   +HRD
Sbjct: 71  AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAKQYGAG 192
           ++  N+L+G+    K+ADFGLAR+    D   T +  A++   + APE  L+G  ++   
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYG--RFTIK 186
Query: 193 VDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            DVW+ G +  EL+   R P+  G ++ + L ++   +    P   P
Sbjct: 187 SDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGYRMPCPQDCP 232

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 24/235 (10%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 29  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 83
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A   +  ++++ E+ME    ++ +   + I L+   +        +G+AF  ++  +H
Sbjct: 84  Y-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 142
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA 191
           RD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A  YG 
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----AINYGT 196
Query: 192 ---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 250

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 147
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 268 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 298

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 88
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 149 CTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 209 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 239

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 93
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 154 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 214 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 90
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 151 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 211 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 241

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 17  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 189
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 190 WAFGVLMWEIYSLGKMPY 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 32  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 204
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 205 WAFGVLMWEIYSLGKMPY 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 16  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 188
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 189 WAFGVLMWEIYSLGKMPY 206

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 79
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE 181
           +A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    + APE
Sbjct: 140 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 199
Query: 182 LLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+ 
Sbjct: 200 SLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE- 256
Query: 240 AYLPDYVEYQYVAAPPLRSLF 260
             + D +   +   P +R  F
Sbjct: 257 -RVTDLMRMCWQFNPKMRPTF 276

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 12  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 67
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 184
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 185 WAFGVLMWEIYSLGKMPY 202

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHIIELID 78
           LG G +G V+ A   K  + VA+K ++ G     ++  A L E  ++K L+   +++L  
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKL-H 76
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD
Sbjct: 77  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 136
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAG 192
           ++  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE + FG+  +   
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS--FTIK 192
Query: 193 VDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW+ G +  E++   R P+  G S+ + +  +   +    P   P+  Y
Sbjct: 193 SDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELY 242

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 15  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 69
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 70  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 123
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HR+++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 177
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 236

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 23  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 78
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 138
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 195
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 196 WAFGVLMWEIYSLGKMPY 213

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 208 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 201 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIE 75
           +E +G G++G V++A     G  VA+K +       E VN   LRE+ ++K L+ P+I+ 
Sbjct: 42  KEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVL 98
Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKK-- 130
            + A     NL +V E++       + + +      D +  + M     KG+ + H +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HR++K  NLL+     +K+ DFGL+R+  S             + APE+L   +   
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSN 217
Query: 191 AGVDVWAAGCIFAEL 205
              DV++ G I  EL
Sbjct: 218 EKSDVYSFGVILWEL 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 82
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE 181
           +A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    + APE
Sbjct: 143 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 182 LLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+ 
Sbjct: 203 SLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE- 259
Query: 240 AYLPDYVEYQYVAAPPLRSLF 260
             + D +   +   P +R  F
Sbjct: 260 -RVTDLMRMCWQFNPKMRPTF 279

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 200 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 197 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 234

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 208 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 82
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE 181
           +A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    + APE
Sbjct: 143 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 182 LLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+ 
Sbjct: 203 SLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE- 259
Query: 240 AYLPDYVEYQYVAAPPLRSLF 260
             + D +   +   P +R  F
Sbjct: 260 -RVTDLMRMCWQFNPNMRPTF 279

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 208 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHIIELID 78
           LG G +G V+ A   K  + VA+K ++ G     ++  A L E  ++K L+   +++L  
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKL-H 249
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD
Sbjct: 250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAG 192
           ++  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE + FG+  +   
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGS--FTIK 365
Query: 193 VDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            DVW+ G +  E++   R P+  G S+ + +  +   +    P   P+  Y
Sbjct: 366 SDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELY 415

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 208 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 245

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 70/256 (27%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+ + D +  + VA+K +   K  E    TAL EI+LLK +++  
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSD 78
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++L+D F   G    ++ +VFE +   L + +I++    L    +K  +Q 
Sbjct: 79  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLIGSHGQ----------------------------- 149
            L+GL + H K  ++H D+KP N+L+  + Q                             
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 150 --------------------LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
                               +K+AD G A       + FT  +  R YR+ E+L G+  Y
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQTRQYRSLEVLIGSG-Y 254
Query: 190 GAGVDVWAAGCIFAEL 205
               D+W+  C+  EL
Sbjct: 255 NTPADIWSTACMAFEL 270

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 193 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 230

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 70/256 (27%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+ + D +  + VA+K +   K  E    TAL EI+LLK +++  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSD 94
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++L+D F   G    ++ +VFE +   L + +I++    L    +K  +Q 
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLIGSHGQ----------------------------- 149
            L+GL + H K  ++H D+KP N+L+  + Q                             
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 150 --------------------LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
                               +K+AD G A       + FT  +  R YR+ E+L G+  Y
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQTRQYRSLEVLIGSG-Y 270
Query: 190 GAGVDVWAAGCIFAEL 205
               D+W+  C+  EL
Sbjct: 271 NTPADIWSTACMAFEL 286

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLL 65
           DR +  + LGEG +G  V+ +AI     +   + K+ +   K       L     E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66  KEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFL 108
           K + K  +II L+ A    G L+++ E+  + +L   ++               N    L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R 166
           S  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           + T+      + APE LF  + Y    DVW+ G +  E+
Sbjct: 249 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 286

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  +  T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +++ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEF----------------METDLETVIRNTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+                +ETD    I N+    S  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA--STRDLLHF 169
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 228
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 229 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 91
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL--Q 209
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTR 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 81
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE 181
           +A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    + APE
Sbjct: 142 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 201
Query: 182 LLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+ 
Sbjct: 202 SLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE- 258
Query: 240 AYLPDYVEYQYVAAPPLRSLF 260
             + D +   +   P +R  F
Sbjct: 259 -RVTDLMRMCWQFNPKMRPTF 278

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 20  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 74
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 75  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 128
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 129 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 182
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 241

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 25  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 79
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A   +  ++++ E+ME    ++ +   + I L+   +        +G+AF  ++  +H
Sbjct: 80  Y-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 138
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA 191
           RD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A  YG 
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----AINYGT 192
Query: 192 ---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 246

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 21  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 75
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 76  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 129
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 130 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 183
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 242

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 82
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE 181
           +A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    + APE
Sbjct: 143 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 182 LLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+ 
Sbjct: 203 SLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE- 259
Query: 240 AYLPDYVEYQYVAAPPLRSLF 260
             + D +   +   P +R  F
Sbjct: 260 -RVTDLMRMCWQFNPKMRPTF 279

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 28  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 82
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 83  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 136
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 137 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 190
Query: 187 KQYGA---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 249

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 75
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +  K  L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 76  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 139 PNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA +    S   +F     +  + APE+  +  +  Y    D
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 196 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 236

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 112/285 (39%), Gaps = 74/285 (25%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+   D +  + VA+K +   K  +    TAL EIKLLK ++   
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVV---KSAQHYTETALDEIKLLKCVRESD 88
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++LID F   G    ++ +VFE +   L + +I++    L    +KS ++ 
Sbjct: 89  PSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQ 148
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLI---------------------------------- 144
            L+GL + H K  ++H D+KP N+L+                                  
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 145 -------------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
                            ++K+AD G A       + FT  +  R YR+ E+L GA  Y  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWV---HKHFTEDIQTRQYRSIEVLIGAG-YST 264
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGT 230
             D+W+  C+  EL       +  S      D D +  I    G+
Sbjct: 265 PADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGS 309

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA +    E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 2   MQRTVAHQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 59
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 116
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 117 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 27  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 81
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A   +  ++++ E+ME    ++ +   + I L+   +        +G+AF  ++  +H
Sbjct: 82  Y-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 140
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA 191
           RD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A  YG 
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----AINYGT 194
Query: 192 ---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 248

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWIT 137
Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + +L+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 197
Query: 134 HRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +PE
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD-----------YISPE 246
Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 294

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWIT 153
Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + +L+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 213
Query: 134 HRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +PE
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD-----------YISPE 262
Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 310

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 32  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 139 PNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
             N L+   G +K++DFGL+R +    +       F   +  PE+L  +K + +  D+WA
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWA 206
Query: 198 AGCIFAEL--LNRRPF 211
            G +  E+  L + P+
Sbjct: 207 FGVLMWEIYSLGKMPY 222

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 39/292 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-- 75
           EV   G +G V+KA      + VA+K   +  ++   N     E+  L  +K  +I++  
Sbjct: 30  EVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEY---EVYSLPGMKHENILQFI 84
Query: 76  --------------LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
                         LI AF  KG+L    +F++ ++ +     +I  + A   +Y+   +
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLS---DFLKANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRA 179
            GL   HK  + HRD+K  N+L+ ++    +ADFGLA  F  G        QV  R Y A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 180 PELLFGAKQYGAG----VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           PE+L GA  +       +D++A G +  EL +R     G  D     +    F      Q
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-----EYMLPFEEEI-GQ 255
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDAL--DLLSKMFTYDPKARITA 285
            P L  + + V ++    P LR  +   +  A+  + + + + +D +AR++A
Sbjct: 256 HPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 46/283 (16%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           YL  + LGEG +  V        G   A+K+I   +Q++     A RE  + +    P+I
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNI 88
Query: 74  IELID-AFPHKGNLH---LVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           + L+      +G  H   L+  F +      ++E  +++   FL+   I   +    +GL
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER-LKDKGNFLTEDQILWLLLGICRGL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG-----LARIFGSPD----RRFTHQVFAR 175
              H K   HRD+KP N+L+G  GQ  L D G        + GS      + +  Q    
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 176 WYRAPELLFGAKQYGA---GVDVWAAGCI-FAELLNRRPF-------------LQGSSDI 218
            YRAPE LF  + +       DVW+ GC+ +A +    P+             +Q    I
Sbjct: 208 SYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 219 DQ-------LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
            Q       L ++  +  T  P Q P +  L   +E     AP
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA +    E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 31  VQRTVARQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 88
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 145
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 146 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 203
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 111
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 229
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMTR 252

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 92
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 210
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 85
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 203
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTR 225

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 91
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 209
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTR 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 88
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 206
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 110
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 228
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTR 251

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 92
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 210
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 90
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--Q 208
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTR 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 90
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 208
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTR 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E  ++ +   P++
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSEASIMGQFDHPNV 70
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ EFME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFARWYRAPELLFGA 186
           +HR +   N+L+ S+   K++DFGL+R     + D  +T     ++  RW  APE +   
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEAI-QY 188
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++ +  DVW+ G +  E+++   RP+
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++  +  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA      E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 2   MQRTVARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 59
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 116
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 117 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 108/233 (46%), Gaps = 23/233 (9%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHIIELID 78
           LG G +G V+      + + VA+K ++ G     ++  A L E  L+K L+   ++ L  
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 79  AFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
               +  ++++ E+M      D         + L P  I    Q+  +G+A+  +K  +H
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA-EGMAYIERKNYIH 133
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYG 190
           RD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG   + 
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC--FT 189
Query: 191 AGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
              DVW+ G +  E++   + P+  G ++ D +  +   +        PD  Y
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPY-PGRTNADVMTALSQGYRMPRVENCPDELY 241

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 22  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 79  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HR++   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 199 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 256
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 257 NCPE--RVTDLMRMCWQFNPNMRPTF 280

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HR++   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 255
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 256 NCPE--RVTDLMRMCWQFNPNMRPTF 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +  K  L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 139 PNNLLIGSHGQLKLADFGLA--RIFGSPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA  +   S   +F     +  + APE+  +  +  Y    D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 208 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 248

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 17  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T    +++   +  PE+L  +K + +  D+
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSK-FSSKSDI 189
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 190 WAFGVLMWEIYSLGKMPY 207

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 108/233 (46%), Gaps = 23/233 (9%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHIIELID 78
           LG G +G V+      + + VA+K ++ G     ++  A L E  L+K L+   ++ L  
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 79  AFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
               +  ++++ EFM      D         + L P  I    Q+  +G+A+  +K  +H
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA-EGMAYIERKNYIH 132
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYG 190
           RD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG   + 
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC--FT 188
Query: 191 AGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
              +VW+ G +  E++   + P+  G ++ D +  +   +        PD  Y
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPY-PGRTNADVMSALSQGYRMPRMENCPDELY 240

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++  +  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
              + APE LF  + Y    DVW+ G +  E+
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 252

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 112 DIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRF 168
           D+ SY     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+ +PD  R+ 
Sbjct: 200 DLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             ++  +W  APE +F  K Y    DVW+ G +  E+ +
Sbjct: 260 DTRLPLKWM-APESIFD-KIYSTKSDVWSYGVLLWEIFS 296

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 13/211 (6%)
Query: 28  VYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKSPHIIELIDAFPHKGNL 86
           VY+A DT   + VA+K        + V  T   RE +    L+ PH++ + D     G L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 87  HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG 145
           ++    +   DL   +R       P  +    Q+    L   H     HRD+KP N+L+ 
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIG-SALDAAHAAGATHRDVKPENILVS 168
Query: 146 SHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF 202
           +     L DFG+A    + D + T   + V   +Y APE  F         D++A  C+ 
Sbjct: 169 ADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVL 225
Query: 203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            E L   P  QG    DQL    A    A P
Sbjct: 226 YECLTGSPPYQG----DQLSVXGAHINQAIP 252

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 28/262 (10%)
Query: 20  LGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K     H+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGFTCHHV 82
Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTLK---G 123
           + L+          +V E M   DL++ +R+       N    P  ++  +QM  +   G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF--ARWYRAP 180
           +A+ + K  +HRD+   N ++     +K+ DFG+ R I+ +   R   +     RW  AP
Sbjct: 143 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM-AP 201
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           E L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P   P+
Sbjct: 202 ESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPDNCPE 259
Query: 239 LAYLPDYVEYQYVAAPPLRSLF 260
              + D +   +   P +R  F
Sbjct: 260 --RVTDLMRMCWQFNPKMRPTF 279

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G  G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQAGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A   +  ++++ E+ME    ++ +   + I L+   +        +G+AF  ++  +H
Sbjct: 74  Y-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA 191
           RD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A  YG 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPE----AINYGT 186
Query: 192 ---GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+    DL   +R               N    LS  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 172 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 230
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 231 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 25  DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 83  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 200
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++    DVW       E+L+  ++PF
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 9   DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 67  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 184
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++    DVW       E+L+  ++PF
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 13  DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 188
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++    DVW       E+L+  ++PF
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           +  +V +++     +G G++G +Y   + +T + VAIK   +  +   +    L E K+ 
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKIY 56
Query: 66  KELKSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           + L+    I  +  F  +G+ + LV + +   LE +    +  LS   +       +  +
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 125 AFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            F H K  LHRD+KP+N L+G      Q+ + DFGLA+ +       THQ     YR  +
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS---THQHIP--YRENK 171
Query: 182 LLFGAKQYGA 191
            L G  +Y +
Sbjct: 172 NLTGTARYAS 181

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHIIELID 78
           LG G +G V+ A   K  + VA+K ++ G     ++  A L E  ++K L+   +++L  
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKL-H 243
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD
Sbjct: 244 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-FGAKQYGAGVDV 195
           ++  N+L+ +    K+ADFGLAR+            F   + APE + FG+  +    DV
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAK---------FPIKWTAPEAINFGS--FTIKSDV 352
Query: 196 WAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           W+ G +  E++   R P+  G S+ + +  +   +    P   P+  Y
Sbjct: 353 WSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELY 399

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 12/176 (6%)
Query: 40  VAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PHIIELIDAFPHKGNLHLVFEFM 93
           VAIK +   R+    E  N T +  E+ LLK++ S    +I L+D F    +  L+ E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 94  E--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQL 150
           E   DL   I      L     +S+    L+ +  CH   VLHRD+K  N+LI  + G+L
Sbjct: 139 EPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 197
Query: 151 KLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           KL DFG   +    D  +T     R Y  PE +   + +G    VW+ G +  +++
Sbjct: 198 KLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 21  GEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           GEG +GVVYK     T  TVA+KK+   +    E +     +EIK+  + +  +++EL+ 
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 79  AFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 +L LV+ +       D  + +  T   LS        Q    G+ F H+   +H
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP-LSWHXRCKIAQGAANGINFLHENHHIH 147
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYRAPELLFGAKQ 188
           RD+K  N+L+      K++DFGLAR       +F   V          Y APE L G  +
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLAR----ASEKFAQXVXXSRIVGTTAYXAPEALRG--E 201
Query: 189 YGAGVDVWAAGCIFAELLNRRP 210
                D+++ G +  E++   P
Sbjct: 202 ITPKSDIYSFGVVLLEIITGLP 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E+   G +G V+KA        VA+K   L  ++   ++ + REI     +K  ++++ I
Sbjct: 21  EIKARGRFGCVWKA--QLMNDFVAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFI 75
Query: 78  DAFPHKGNLH----LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF------- 126
            A     NL     L+  F +    T     NI ++  ++    +   +GL++       
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-ITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 127 C----HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAP 180
           C    HK  + HRD K  N+L+ S     LADFGLA  F  G P      QV  R Y AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 181 ELLFGAKQYGAG----VDVWAAGCIFAELLNRRPFLQGSSD 217
           E+L GA  +       +D++A G +  EL++R     G  D
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G G++G VYK    K    VA+K +++        F A R E+ +L++ +  +I+ L  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNIL-LFM 98
Query: 79  AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            +  K NL +V ++ E + L   +           +    + T +G+ + H K ++HRDM
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 138 KPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAGV 193
           K NN+ +     +K+ DFGLA +    S  ++      +  + APE++       +    
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 194 DVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           DV++ G +  EL+    P+    S I+   +I    G    S  PDL+ L
Sbjct: 219 DVYSYGIVLYELMTGELPY----SHINNRDQIIFMVGRGYAS--PDLSKL 262

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +     L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 139 PNNLLIGSHGQLKLADFGLA--RIFGSPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA  +   S   +F     +  + APE+  +  +  Y    D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 208 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 248

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +
Sbjct: 16  KRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAE 72
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN-----------TNIFLSPA 111
           LL  L+  HI+           L +VFE+M   DL   +R+            ++   P 
Sbjct: 73  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 112 DIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR 167
            +   + +  +   G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R
Sbjct: 133 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
              +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 193 VGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 243

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEFM-------------ETDLETVIRNTNIFLSPADIKSYMQM 119
           I+ L+ A  H G + ++ E+              E DL+   +     L   D+  +   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQ 168
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--- 176
             +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR    
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVK 227
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           + APE +F    Y    DVW+ G +  E+ +
Sbjct: 228 WMAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 73  IIELIDAFPHKGNLHLVFEFM-------------ETDLETVIRNTNIFLSPADIKSYMQM 119
           I+ L+ A  H G + ++ E+              E DL+   +     L   D+  +   
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQ 160
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--- 176
             +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR    
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVK 219
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           + APE +F    Y    DVW+ G +  E+ +
Sbjct: 220 WMAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKS---- 70
           +LG+G +G V+          VAIK I     LG      + T   E+ LL ++ +    
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 71  PHIIELIDAFPHKGNLHLVFE--FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P +I L+D F  +    LV E      DL   I      L     + +    +  +  CH
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH 156
Query: 129 KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + V+HRD+K  N+LI    G  KL DFG   +    D  +T     R Y  PE +   +
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEWISRHQ 214
Query: 188 QYGAGVDVWAAGCIFAELL 206
            +     VW+ G +  +++
Sbjct: 215 YHALPATVWSLGILLYDMV 233

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +
Sbjct: 10  KRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAE 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN-----------TNIFLSPA 111
           LL  L+  HI+           L +VFE+M   DL   +R+            ++   P 
Sbjct: 67  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 112 DIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR 167
            +   + +  +   G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R
Sbjct: 127 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
              +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 187 VGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 237

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           VDL ++  + +  + ++G G +G VYK +  + G  VA+K+ R  +  +G+        +
Sbjct: 32  VDL-EEATNNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-RTPESSQGIEEFETEI-E 87
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL- 121
            L   + PH++ LI     +  + L++++ME  +L+  +  +++       +  +++ + 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 122 --KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWY 177
             +GL + H + ++HRD+K  N+L+  +   K+ DFG+++     D+     V      Y
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRR 209
             PE  F   +     DV++ G +  E+L  R
Sbjct: 208 IDPE-YFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +
Sbjct: 39  KRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAE 95
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN-----------TNIFLSPA 111
           LL  L+  HI+           L +VFE+M   DL   +R+            ++   P 
Sbjct: 96  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 112 DIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR 167
            +   + +  +   G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSS 216
              +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 216 VGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++G+G +G VY     +    VAI+ I + +  E       RE+   ++ +  +++  +
Sbjct: 39  ELIGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 78  DAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            A     +L ++    +   L +V+R+  I L     +   Q  +KG+ + H K +LH+D
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG---SPDRRFTHQVFARW--YRAPELLFGAK---- 187
           +K  N+    +G++ + DFGL  I G   +  R    ++   W  + APE++        
Sbjct: 156 LKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 188 ----QYGAGVDVWAAGCIFAELLNRR-PF 211
                +    DV+A G I+ EL  R  PF
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/326 (22%), Positives = 125/326 (38%), Gaps = 62/326 (19%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-----I 74
           +G+GT+G V         +  A+K +R  K+      +A  E  +LK++++  I     +
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAKIEADILKKIQNDDINNNNIV 99
Query: 75  ELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +    F +  ++ L+FE +   L E + RN        DIK Y    LK L +  K  + 
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLT 159
Query: 134 HRDMKPNNLLI-----------------GSHGQ--------LKLADFGLARIFGSPDRRF 168
           H D+KP N+L+                 G   Q        +KL DFG A          
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSI 219
Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
              +  R YRAPE++     +    D+W+ GC+ AEL       +    ++ L  + +  
Sbjct: 220 ---INTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESII 275
Query: 229 G--------TATPSQ-------------WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDA 267
                     AT +              WP+ A   + +++     P  + +     +  
Sbjct: 276 QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII---KHELF 332
Query: 268 LDLLSKMFTYDPKARITAQQALEHRF 293
            D L  +   DP  R +  + L+H+F
Sbjct: 333 CDFLYSILQIDPTLRPSPAELLKHKF 358

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 71
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 72  YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 193 VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 190 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 77  YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 193 VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 195 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 237
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	314
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-180
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-173
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-172
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-171
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-171
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-170
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-170
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-167
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-163
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-163
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-158
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-156
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-156
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-136
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-127
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-122
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-111
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-111
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-108
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-107
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-101
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-101
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-99
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-90
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-68
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-68
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-65
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-64
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-64
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-63
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-63
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-62
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-62
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-62
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-62
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-62
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-61
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-61
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-61
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-61
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-60
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-60
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-60
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-60
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-60
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-60
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-60
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-60
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-59
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-59
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-59
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-59
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-59
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-59
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-59
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-59
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-59
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-59
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-59
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-58
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-58
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-58
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-58
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-58
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-56
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-56
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-55
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-54
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-54
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-54
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-54
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-53
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-53
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-52
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-51
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-51
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-51
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-51
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-50
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-50
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-49
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-48
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-48
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-47
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-47
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-47
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-46
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-46
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-46
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-45
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-44
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-44
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-44
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-44
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-42
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-39
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-36
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-13
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-30
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-25
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  499 bits (1287), Expect = e-180
 Identities = 171/296 (57%), Positives = 219/296 (73%), Gaps = 5/296 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG---KQKEGVNFT 57
           MA +D+  +   RY K + LGEG +  VYKA D  T Q VAIKKI+LG   + K+G+N T
Sbjct: 1   MA-LDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT 58

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           ALREIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM
Sbjct: 59  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            MTL+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWY
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 178

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWP
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           D+  LPDYV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ ++
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  481 bits (1240), Expect = e-173
 Identities = 113/285 (39%), Positives = 154/285 (54%), Gaps = 3/285 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y K   +GEG+YGVV+K  +  TGQ VAIKK    +    +   ALREI++LK+LK P
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++ L++ F  K  LHLVFE+ +  +   +      +    +KS    TL+ + FCHK  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
            +HRD+KP N+LI  H  +KL DFG AR+   P   +  +V  RWYR+PELL G  QYG 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY--- 248
            VDVWA GC+FAELL+  P   G SD+DQL  I    G   P      +    +      
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 PL   FP+ S  AL LL      DP  R+T +Q L H +
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  477 bits (1230), Expect = e-172
 Identities = 135/284 (47%), Positives = 179/284 (63%), Gaps = 2/284 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 192 GVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q 249
            +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           Y A   L ++ P  +    DLL  +   +P  RI+A++AL+H +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  476 bits (1228), Expect = e-171
 Identities = 137/288 (47%), Positives = 186/288 (64%), Gaps = 3/288 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           + + ++Y K E +GEGTYGVVYKA D   G+ VA+K+IRL  + EG+  TA+REI LLKE
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L  P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A C
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H+  +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +Y   VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 248 YQY--VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +      P  S+ P    + +DLLS M  +DP  RI+A+ A+ H +
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  473 bits (1221), Expect = e-170
 Identities = 131/283 (46%), Positives = 179/283 (63%), Gaps = 2/283 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA +   G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQY 250
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y   +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
               P  S      +  +DLLSKM   DP  RITA+QALEH +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  474 bits (1223), Expect = e-170
 Identities = 101/296 (34%), Positives = 149/296 (50%), Gaps = 3/296 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           +   +L  +  ++Y    ++GEG+YG+V K  +  TG+ VAIKK       + V   A+R
Sbjct: 14  LGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLK+L+  +++ L++    K   +LVFEF++  +   +      L    ++ Y+   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI 133

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           + G+ FCH   ++HRD+KP N+L+   G +KL DFG AR   +P   +  +V  RWYRAP
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G  +YG  VDVWA GC+  E+    P   G SDIDQL  I    G   P       
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 241 YLPDYVEY---QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             P +      +     PL   +P  S+  +DL  K    DP  R    + L H F
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  465 bits (1199), Expect = e-167
 Identities = 113/284 (39%), Positives = 169/284 (59%), Gaps = 3/284 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GLA+CH++ 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + + ++V   WYR P++L G+  Y  
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240

Query: 252 AAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 L S  P    D  DLL+K+  ++ + RI+A+ A++H F
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  456 bits (1176), Expect = e-163
 Identities = 133/289 (46%), Positives = 179/289 (61%), Gaps = 8/289 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           DRY +   LGEGTYG VYKAIDT T +TVAIK+IRL  ++EGV  TA+RE+ LLKEL+  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +IIEL     H   LHL+FE+ E DL+  + + N  +S   IKS++   + G+ FCH + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR 152

Query: 132 VLHRDMKPNNLLI-----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            LHRD+KP NLL+          LK+ DFGLAR FG P R+FTH++   WYR PE+L G+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y   VD+W+  CI+AE+L + P   G S+IDQL KIF   G    + WP +  LPD+ 
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272

Query: 247 EY--QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +   ++      R L     D+ LDLL+ M   DP  RI+A+ ALEH +
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  455 bits (1172), Expect = e-163
 Identities = 116/294 (39%), Positives = 168/294 (57%), Gaps = 12/294 (4%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + ++ + E LG GTY  VYK ++  TG  VA+K+++L   +EG   TA+REI L+KELK 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPSTAIREISLMKELKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-----LSPADIKSYMQMTLKGLA 125
            +I+ L D    +  L LVFEFM+ DL+  + +  +      L    +K +    L+GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH+  +LHRD+KP NLLI   GQLKL DFGLAR FG P   F+ +V   WYRAP++L G
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           ++ Y   +D+W+ GCI AE++  +P   G++D +QL  IF   GT   S WP +  LP Y
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 246 -VEYQYVAAPPLRSLFPSA-----SDDALDLLSKMFTYDPKARITAQQALEHRF 293
               Q      LR +           + +D L  +   +P  R++A+QAL H +
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  443 bits (1142), Expect = e-158
 Identities = 114/301 (37%), Positives = 163/301 (54%), Gaps = 13/301 (4%)

Query: 3   EVDLSKKVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALRE 61
           E D   +   +Y     +GEG YG V+KA D K  G+ VA+K++R+   +EG+  + +RE
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 62  IKLLKELKS---PHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNT-NIFLSPAD 112
           + +L+ L++   P+++ L D         +  L LVFE ++ DL T +       +    
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           IK  M   L+GL F H   V+HRD+KP N+L+ S GQ+KLADFGLARI+       T  V
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVV 180

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
              WYRAPE+L  +  Y   VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G   
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR 292
              WP    LP    +   +A P+        +   DLL K  T++P  RI+A  AL H 
Sbjct: 240 EEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 293 F 293
           +
Sbjct: 299 Y 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  439 bits (1131), Expect = e-156
 Identities = 109/294 (37%), Positives = 158/294 (53%), Gaps = 15/294 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKEL 68
            RY     +G G YG VYKA D  +G  VA+K +R+     G   +  + +RE+ LL+ L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 69  KS---PHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQM 119
           ++   P+++ L+D         +  + LVFE ++ DL T +       L    IK  M+ 
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+GL F H   ++HRD+KP N+L+ S G +KLADFGLARI+       T  V   WYRA
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRA 187

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE+L  +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP  
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             LP           P++S+ P   +    LL +M T++P  RI+A +AL+H +
Sbjct: 247 VSLPRGAFPPR-GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  440 bits (1134), Expect = e-156
 Identities = 120/299 (40%), Positives = 171/299 (57%), Gaps = 16/299 (5%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75

Query: 71  PHIIELID--------AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            +++ LI+            KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RFTHQVFARWYR 178
           GL + H+  +LHRDMK  N+LI   G LKLADFGLAR F         R+T++V   WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP+
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 239 LAYLPDYVEYQYVAAPP--LRSLFPS--ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           +     Y + + V      ++    +      ALDL+ K+   DP  RI +  AL H F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  392 bits (1008), Expect = e-136
 Identities = 107/325 (32%), Positives = 156/325 (48%), Gaps = 43/325 (13%)

Query: 8   KKVADRYLK-REVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           ++V D +      +G GTYG VYKA   D K  +  A+K+I       G++ +A REI L
Sbjct: 16  ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIAL 71

Query: 65  LKELKSPHIIELIDAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIK 114
           L+ELK P++I L   F    +  + L+F++ E DL  +I+           + L    +K
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIFGSPDRRFTH 170
           S +   L G+ + H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +    
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 171 ---QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--------- 218
               V   WYRAPELL GA+ Y   +D+WA GCIFAELL   P      +          
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEY----------QYVAAPPLRSLFPSASDDAL 268
           DQL +IF   G      W D+  +P++                    +          A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 269 DLLSKMFTYDPKARITAQQALEHRF 293
            LL K+ T DP  RIT++QA++  +
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPY 336

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  369 bits (948), Expect = e-127
 Identities = 100/300 (33%), Positives = 153/300 (51%), Gaps = 22/300 (7%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            +     Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE+++++
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMR 102

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIR---NTNIFLSPADIKSYM 117
           +L   +I+ L   F   G       L+LV +++   +  V R        L    +K YM
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARW 176
               + LA+ H   + HRD+KP NLL+      LKL DFG A+            + +R+
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRY 221

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q 
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281

Query: 237 PDLAYLPDYVEY---QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            ++   P+Y E+   Q  A P  +   P    +A+ L S++  Y P AR+T  +A  H F
Sbjct: 282 REM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  355 bits (913), Expect = e-122
 Identities = 101/300 (33%), Positives = 163/300 (54%), Gaps = 23/300 (7%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            ++    Y   +V+G G++GVV++A   ++ + VAIKK+   K+ +       RE+++++
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMR 87

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIR---NTNIFLSPADIKSYM 117
            +K P++++L   F   G+      L+LV E++   +    R        +    IK YM
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
              L+ LA+ H   + HRD+KP NLL+    G LKL DFG A+I           + +R+
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRY 206

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y   +D+W+ GC+ AEL+  +P   G S IDQL +I    GT +  Q 
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266

Query: 237 PDLAYLPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             +   P+Y+E+++  +   P   +F P    DA+DL+S++  Y P AR+TA +AL H F
Sbjct: 267 KTM--NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  325 bits (835), Expect = e-111
 Identities = 96/299 (32%), Positives = 155/299 (51%), Gaps = 25/299 (8%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
             D Y     LG G Y  V++AI+    + V +K ++  K+K+       REIK+L+ L+
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLR 88

Query: 70  S-PHIIELIDAF--PHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+II L D    P      LVFE    TD + + +     L+  DI+ YM   LK L 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALD 144

Query: 126 FCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           +CH   ++HRD+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL 
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLV 203

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPD---LA 240
             + Y   +D+W+ GC+ A ++ R+ PF  G  + DQL +I    GT     + D   + 
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 241 YLPDYVE-YQYVAAPPLRSLFPS-----ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             P + +     +         S      S +ALD L K+  YD ++R+TA++A+EH +
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  326 bits (838), Expect = e-111
 Identities = 91/309 (29%), Positives = 149/309 (48%), Gaps = 31/309 (10%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S+K  DR+    + G+GT+G V    +  TG +VAIKK+    +         RE+++++
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQ 71

Query: 67  ELKS---PHIIELIDAFPHKGN-------LHLVFEFMETDLETVIR---NTNIFLSPADI 113
           +L     P+I++L   F   G        L++V E++   L    R      +   P  I
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 114 KSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTH 170
           K ++   ++ +   H     V HRD+KP+N+L+  + G LKL DFG A+   SP      
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVA 190

Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT 230
            + +R+YRAPEL+FG + Y   VD+W+ GCIFAE++   P  +G +   QL +I    G 
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250

Query: 231 ATPSQWPDLAYLPDYVEYQY--VAAPPLRSLF----PSASDDALDLLSKMFTYDPKARIT 284
            +      L   P + +         P  ++F       + +A DLLS +  Y P+ R+ 
Sbjct: 251 PSREVLRKLN--PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308

Query: 285 AQQALEHRF 293
             +AL H +
Sbjct: 309 PYEALCHPY 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  320 bits (821), Expect = e-108
 Identities = 91/330 (27%), Positives = 152/330 (46%), Gaps = 54/330 (16%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
             + +Y   + LG G++G+V +  D ++G+  A+KK+    +         RE+ ++K L
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVL 57

Query: 69  KSPHIIELIDAFPHKGN--------------------------------------LHLVF 90
              +II+L+D F   G+                                      L+++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 91  EFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH 147
           E++   L  V++    +   +    I  Y+    + + F H   + HRD+KP NLL+ S 
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177

Query: 148 -GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              LKL DFG A+    P       + +R+YRAPEL+ GA +Y   +D+W+ GC+F EL+
Sbjct: 178 DNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSAS 264
             +P   G + IDQL +I    GT T  Q   +   P Y E ++  + A   R + P  +
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGT 294

Query: 265 D-DALDLLSKMFTYDPKARITAQQALEHRF 293
              A+DLL ++  Y+P  RI   +A+ H F
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  319 bits (820), Expect = e-107
 Identities = 109/354 (30%), Positives = 157/354 (44%), Gaps = 67/354 (18%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + DRY  R ++G G+YG V +A D    + VAIKKI    +        LREI +L  L 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110

Query: 70  SPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             H+++++D    K       L++V E  ++D + + R T ++L+   IK+ +   L G+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGV 169

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------- 165
            + H   +LHRD+KP N L+     +K+ DFGLAR    P+                   
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 166 --------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---------- 207
                   R+ T  V  RWYRAPEL+   + Y   +DVW+ GCIFAELLN          
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289

Query: 208 -RRPFLQGSS--------------------DIDQLGKIFAAFGTATPSQWPDLA--YLPD 244
            R P   GSS                    + DQL  IF   GT +      L       
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349

Query: 245 YVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           Y+  +       L   FP++S DA+ LL +M  ++P  RIT  + L H F K  
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  301 bits (773), Expect = e-101
 Identities = 106/309 (34%), Positives = 156/309 (50%), Gaps = 26/309 (8%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FT-------ALR 60
           +   Y  +  +  G+YG V   +D+  G  VAIK++             +        LR
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 61  EIKLLKELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
           EI+LL     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M   L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  R
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED-TADANKTHYVTHR 197

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WYRAPEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT     
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE- 256

Query: 236 WPDLAYLP-----DYVEYQ--YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
             D+         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +QA
Sbjct: 257 --DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 289 LEHRFAKSF 297
           L H + +S 
Sbjct: 315 LRHPYFESL 323

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  299 bits (768), Expect = e-101
 Identities = 113/316 (35%), Positives = 159/316 (50%), Gaps = 40/316 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-------ALREI 62
           ++  +  + +LGEG YGVV  A    TG+ VAIKKI          F         LREI
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--------PFDKPLFALRTLREI 60

Query: 63  KLLKELKSPHIIELIDAF--PHKGNLH---LVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           K+LK  K  +II + +        N +   ++ E M+TDL  VI      LS   I+ ++
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFI 118

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------ 171
             TL+ +   H   V+HRD+KP+NLLI S+  LK+ DFGLARI        +        
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 172 ----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
               V  RWYRAPE++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF  
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

Query: 228 FGTATPSQWPDLAYLP-----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA 281
            G  TP    DL  +      +Y++      A PL  +FP  +   +DLL +M  +DP  
Sbjct: 239 IG--TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296

Query: 282 RITAQQALEHRFAKSF 297
           RITA++ALEH + +++
Sbjct: 297 RITAKEALEHPYLQTY 312

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  294 bits (755), Expect = 2e-99
 Identities = 98/311 (31%), Positives = 153/311 (49%), Gaps = 30/311 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +  RY+  + LG G  G+V+ A+D    + VAIKKI L   +      ALREIK+++ L 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALREIKIIRRLD 66

Query: 70  SPHIIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
             +I+++ +     G+              +++V E+METDL  V+      L     + 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--LLEEHARL 124

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRR---FTHQ 171
           +M   L+GL + H   VLHRD+KP NL I +    LK+ DFGLARI           +  
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +    G+ +++Q+  I  +    
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP-- 242

Query: 232 TPSQWPDLAYLP----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
              +  D   L      Y+         PL  L P  S +A+D L ++ T+ P  R+TA+
Sbjct: 243 VVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301

Query: 287 QALEHRFAKSF 297
           +AL H +   +
Sbjct: 302 EALSHPYMSIY 312

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  293 bits (753), Expect = 1e-98
 Identities = 111/309 (35%), Positives = 156/309 (50%), Gaps = 34/309 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-------ALREI 62
           V  RY     +GEG YG+V  A D      VAIKKI          F         LREI
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREI 76

Query: 63  KLLKELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           K+L   +  +II + D            +++V + METDL  +++  +  LS   I  ++
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFL 134

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFA 174
              L+GL + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+           T  V  
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PS
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPS 252

Query: 235 QWPDLAYLPDYVEYQYVAA------PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
           Q  DL  + +     Y+ +       P   LFP+A   ALDLL KM T++P  RI  +QA
Sbjct: 253 Q-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311

Query: 289 LEHRFAKSF 297
           L H + + +
Sbjct: 312 LAHPYLEQY 320

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  289 bits (743), Expect = 3e-97
 Identities = 107/300 (35%), Positives = 147/300 (49%), Gaps = 21/300 (7%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +   Y+    +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F    +L       LV  FM+TDL+ ++       S   I+  +   LKG
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKG 138

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   V+HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVI 195

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G         +  L 
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE---FVQKLN 252

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                 Y++            LFP AS  A DLL KM   D   R+TA QAL H F + F
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  289 bits (742), Expect = 6e-97
 Identities = 104/300 (34%), Positives = 154/300 (51%), Gaps = 20/300 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   Y   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK ++
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F     L       LV  FM TDL  ++++    L    I+  +   LKG
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKG 140

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVI 197

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
               +Y   VD+W+ GCI AE++  +   +GS  +DQL +I    G  TP     +  L 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG--TPPA-EFVQRLQ 254

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                +Y++    +      S+  +AS  A++LL KM   D + R+TA +AL H + +S 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  286 bits (734), Expect = 1e-95
 Identities = 104/300 (34%), Positives = 147/300 (49%), Gaps = 20/300 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +K
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F    +L       LV   M  DL  +++     L+   ++  +   L+G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRG 144

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM 201

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y   VD+W+ GCI AELL  R    G+  IDQL  I    G  TP     L  + 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG--TPGA-ELLKKIS 258

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
                +Y++    +      ++F  A+  A+DLL KM   D   RITA QAL H +   +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  283 bits (727), Expect = 7e-94
 Identities = 115/349 (32%), Positives = 164/349 (46%), Gaps = 65/349 (18%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y+ + ++G G+YG VY A D  T + VAIKK+    +        LREI +L  LK
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83

Query: 70  SPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           S +II L D            L++V E  ++DL+ + + T IFL+   IK+ +   L G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGE 142

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-------------------- 164
            F H+  ++HRD+KP N L+     +K+ DFGLAR   S                     
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 165 --DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-----------RRPF 211
              ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELLN           R P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 212 LQGSSD-----------------IDQLGKIFAAFGTATPSQWPDLAYLP-----DYVE-Y 248
             GSS                   DQL  IF   G  TP++  DL  +       Y++ +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG--TPTE-DDLKNINKPEVIKYIKLF 319

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
            +     L+  +PS SDD ++LL  M  ++P  RIT  QAL+H + K  
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  276 bits (708), Expect = 2e-91
 Identities = 109/334 (32%), Positives = 167/334 (50%), Gaps = 51/334 (15%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  +Y   + LG+G YG+V+K+ID +TG+ VA+KKI    Q         REI +L EL 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 70  S-PHIIELIDAFPHKGN--LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
              +I+ L++      +  ++LVF++METDL  VIR  NI L P   +  +   +K + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-ANI-LEPVHKQYVVYQLIKVIKY 124

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------------ 174
            H   +LHRDMKP+N+L+ +   +K+ADFGL+R F +  R   +   +            
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 175 ---------RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
                    RWYRAPE+L G+ +Y  G+D+W+ GCI  E+L  +P   GSS ++QL +I 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244

Query: 226 AAFGTATPSQWPDLAYLP-----DYVE---------------YQYVAAPPLRSLFPSA-- 263
                  PS   D+  +        +E                       L  + P A  
Sbjct: 245 GVID--FPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 264 SDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           +++ALDLL K+  ++P  RI+A  AL+H F   F
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  277 bits (709), Expect = 1e-90
 Identities = 98/311 (31%), Positives = 141/311 (45%), Gaps = 31/311 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F  +  L       LV E M+ +L  VI+     L    +   +   L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCG 176

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G      T  V  R+YRAPE++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVI 235

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL- 242
            G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     +  L 
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE---FMKKLQ 291

Query: 243 PDYVEY----QYVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARITAQ 286
           P    Y       A      LFP +            +  A DLLSKM   DP  RI+  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 287 QALEHRFAKSF 297
            AL+H +   +
Sbjct: 352 DALQHPYINVW 362

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  268 bits (687), Expect = 1e-88
 Identities = 96/311 (30%), Positives = 141/311 (45%), Gaps = 31/311 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F  + +L       +V E M+ +L  VI+     L    +   +   L G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCG 139

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR         T  V  R+YRAPE++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVI 198

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            G   Y   VD+W+ GCI  E++       G+  IDQ  K+    G  TP     +  L 
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG--TPCP-EFMKKLQ 254

Query: 244 D----YVE-YQYVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARITAQ 286
                YVE     A      LFP              +  A DLLSKM   D   RI+  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 287 QALEHRFAKSF 297
           +AL+H +   +
Sbjct: 315 EALQHPYINVW 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  214 bits (548), Expect = 2e-68
 Identities = 69/315 (21%), Positives = 120/315 (38%), Gaps = 57/315 (18%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S + A  + +  VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL 
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLA 57

Query: 67  ELKSPHIIELIDAFPHKGN-------------LHLVFEFMET-DLETVIRNTNIFLSPAD 112
            L   +++    A+  + N             L +  E+ E   L  +I + N+     +
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
                +  L+ L++ H + ++HRD+KP N+ I     +K+ DFGLA+             
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 173 FARW--------------YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
                             Y A E+L G   Y   +D+++ G IF E++   PF  G   +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
           + L K+ +      P    +                               ++  +  +D
Sbjct: 236 NILKKLRSVSIEFPPDFDDNK------------------------MKVEKKIIRLLIDHD 271

Query: 279 PKARITAQQALEHRF 293
           P  R  A+  L   +
Sbjct: 272 PNKRPGARTLLNSGW 286

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  213 bits (545), Expect = 5e-68
 Identities = 72/307 (23%), Positives = 113/307 (36%), Gaps = 66/307 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 146

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQVFARWY 177
            ++H D+KP N LI   G LKL DFG+A                G+             Y
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV-----------NY 194

Query: 178 RAPELLFGA----------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA 226
             PE +              +     DVW+ GCI   +   + PF Q  + I +L  I  
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-- 252

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                 P+   +    PD                     D  D+L      DPK RI+  
Sbjct: 253 ----IDPNHEIE---FPDIP-----------------EKDLQDVLKCCLKRDPKQRISIP 288

Query: 287 QALEHRF 293
           + L H +
Sbjct: 289 ELLAHPY 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  208 bits (532), Expect = 1e-65
 Identities = 71/307 (23%), Positives = 114/307 (37%), Gaps = 66/307 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 127

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQVFARWY 177
            ++H D+KP N LI   G LKL DFG+A                G+ +           Y
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN-----------Y 175

Query: 178 RAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFA 226
             PE +              +     DVW+ GCI   +   + PF      I+Q+ K+ A
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHA 232

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                   ++PD                           D  D+L      DPK RI+  
Sbjct: 233 IIDPNHEIEFPD-----------------------IPEKDLQDVLKCCLKRDPKQRISIP 269

Query: 287 QALEHRF 293
           + L H +
Sbjct: 270 ELLAHPY 276

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  207 bits (528), Expect = 2e-64
 Identities = 72/307 (23%), Positives = 114/307 (37%), Gaps = 66/307 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 174

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQVFARWY 177
            ++H D+KP N LI   G LKL DFG+A                G+ +           Y
Sbjct: 175 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN-----------Y 222

Query: 178 RAPELLFGA----------KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFA 226
             PE +              +     DVW+ GCI   +   + PF Q  + I +L  I  
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-- 280

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                 P+   +    PD                     D  D+L      DPK RI+  
Sbjct: 281 ----IDPNHEIE---FPDIP-----------------EKDLQDVLKCCLKRDPKQRISIP 316

Query: 287 QALEHRF 293
           + L H +
Sbjct: 317 ELLAHPY 323

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  204 bits (521), Expect = 7e-64
 Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 44/302 (14%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           +   +L  +  ++Y++ + +GEG++G       T+ G+   IK+I + +        + R
Sbjct: 13  LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVI-RNTNIFLSPADIKSYMQ 118
           E+ +L  +K P+I++  ++F   G+L++V ++ E  DL   I     +      I  +  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR--- 175
                L   H + +LHRD+K  N+ +   G ++L DFG+AR+  S          AR   
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS------TVELARACI 186

Query: 176 ---WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA 231
              +Y +PE+    K Y    D+WA GC+  EL   +  F +  S  + + KI       
Sbjct: 187 GTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKI------- 237

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                         +   +   PP+   +   S D   L+S++F  +P+ R +    LE 
Sbjct: 238 --------------ISGSF---PPVSLHY---SYDLRSLVSQLFKRNPRDRPSVNSILEK 277

Query: 292 RF 293
            F
Sbjct: 278 GF 279

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  209 bits (534), Expect = 1e-63
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 33/289 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              V D Y   E LG G +GVV++  +  TG   A K +    + +       +EI+ + 
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMS 209

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L+ P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 126 FCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
             H+   +H D+KP N++  +    +LKL DFGL      P +          + APE+ 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVA 328

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G K  G   D+W+ G +   LL+   PF  G +D + L  + +                
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSC--------------- 371

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
               ++    +      F   S+D  D + K+   DP  R+T  QALEH
Sbjct: 372 ----DWNMDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  202 bits (515), Expect = 2e-63
 Identities = 70/283 (24%), Positives = 107/283 (37%), Gaps = 33/283 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KS 70
             + +   LG G+YG V+K    + G+  A+K+     +        L E+   +++ + 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P  + L  A+   G L+L  E     L+         L  A +  Y++ TL  LA  H +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++H D+KP N+ +G  G+ KL DFGL    G+       Q     Y APELL     YG
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELL--QGSYG 233

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
              DV++ G    E+        G     QL + +                         
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------------------------- 268

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              PP        S +   +L  M   DPK R TA+  L    
Sbjct: 269 --LPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  200 bits (512), Expect = 1e-62
 Identities = 86/298 (28%), Positives = 133/298 (44%), Gaps = 38/298 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTAL-REIK 63
                D Y   EV+G+G + VV + I+ +TGQ  A+K +         G++   L RE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIR--NTNIFLSPADIKSYMQM 119
           +   LK PHI+EL++ +   G L++VFEFM+  DL   +++  +     S A    YM+ 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARW 176
            L+ L +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           + APE++   + YG  VDVW  G I   LL    PF      +     I           
Sbjct: 199 FMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--FEGIIKG-------- 247

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      +Y+          +   S+ A DL+ +M   DP  RIT  +AL H +
Sbjct: 248 -----------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  199 bits (508), Expect = 2e-62
 Identities = 63/324 (19%), Positives = 113/324 (34%), Gaps = 48/324 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
             +L  ++LG+G    V++    KTG   AIK    I   +  +      +RE ++LK+L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 69  KSPHIIELIDAF--PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQMTLKG 123
              +I++L          +  L+ EF     L TV+   +    L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIF----------GSPDRRFT 169
           +    +  ++HR++KP N++           KL DFG AR            G+ +    
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---- 180

Query: 170 HQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL 221
                  Y  P++   A       K+YGA VD+W+ G  F        PF +      + 
Sbjct: 181 -------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRN 232

Query: 222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR-SLFPSASDDALDLLSKMFTYDPK 280
            ++     T  PS         +     +    P+  SL          +L+ +   D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292

Query: 281 ARITAQQALEHR-FAKSFNGVFVF 303
                 Q                 
Sbjct: 293 KCWGFDQFFAETSDILHRGNSHHH 316

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  199 bits (508), Expect = 3e-62
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 36/289 (12%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLK 66
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++ G  +  V     +EI +L 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILN 56

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             +  +I+ L ++F     L ++FEF+   D+   I  +   L+  +I SY+    + L 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 126 FCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           F H   + H D++P N++  +     +K+ +FG AR    P   F     A  Y APE+ 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVH 175

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     D+W+ G +   LL+   PFL   ++   +  I  A               
Sbjct: 176 QH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNA--------------- 218

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
               EY +         F   S +A+D + ++   + K+R+TA +AL+H
Sbjct: 219 ----EYTFDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  197 bits (502), Expect = 6e-62
 Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 60/311 (19%)

Query: 2   AEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE 61
               + K+    + + E++G G +G V+KA     G+T  IK+++   +K      A RE
Sbjct: 1   GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AERE 54

Query: 62  IKLLKELKSPHIIELIDAF----------------PHKGNLHLVFEFMET-DLETVI-RN 103
           +K L +L   +I+     +                     L +  EF +   LE  I + 
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 104 TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS 163
               L         +   KG+ + H K +++RD+KP+N+ +    Q+K+ DFGL     +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG 222
             +R T       Y +PE +   + YG  VD++A G I AELL+      + S     L 
Sbjct: 175 DGKR-TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
                              + D                         LL K+ +  P+ R
Sbjct: 233 DG----------------IISDIF-----------------DKKEKTLLQKLLSKKPEDR 259

Query: 283 ITAQQALEHRF 293
               + L    
Sbjct: 260 PNTSEILRTLT 270

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  200 bits (510), Expect = 7e-62
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 37/291 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKL 64
              V D Y   E LG G +GVV++ ++  TG+    K I       K  V      EI +
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISI 101

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           + +L  P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           L   H+  ++H D+KP N++  +     +K+ DFGLA     PD           + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPE 220

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ++   +  G   D+WA G +   LL+   PF  G  D++ L  +                
Sbjct: 221 IVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRC------------- 265

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 ++++         F S S +A D +  +   +P+ R+T   ALEH
Sbjct: 266 ------DWEFDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  195 bits (499), Expect = 2e-61
 Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 53/300 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y     +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 72  HIIELIDAFPHKGN--LHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTLKGLA 125
           +I+   D    + N  L++V E+ E  DL +VI        +L    +   M      L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 126 FCHKK-----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR----- 175
            CH++      VLHRD+KP N+ +     +KL DFGLARI            FA+     
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKTFVGT 179

Query: 176 -WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP 233
            +Y +PE +     Y    D+W+ GC+  EL     PF    S  +  GKI         
Sbjct: 180 PYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKI--------- 228

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                        E ++     +   +   SD+  +++++M       R + ++ LE+  
Sbjct: 229 ------------REGKF---RRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILENPL 270

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  196 bits (501), Expect = 2e-61
 Identities = 73/306 (23%), Positives = 122/306 (39%), Gaps = 54/306 (17%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG---KQKEGVNFTALRE 61
           D+       +   + +G G +  VY+A     G  VA+KK+++      K   +   ++E
Sbjct: 25  DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKE 82

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYM 117
           I LLK+L  P++I+   +F     L++V E  +  DL  +I++       +    +  Y 
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR-- 175
                 L   H + V+HRD+KP N+ I + G +KL D GL R F S          A   
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSL 196

Query: 176 ----WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL-GKIFAAFG 229
               +Y +PE +     Y    D+W+ GC+  E+   + PF     ++  L  KI     
Sbjct: 197 VGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----- 250

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQ 287
                            +  Y   PPL    PS   S++   L++     DP+ R     
Sbjct: 251 ----------------EQCDY---PPL----PSDHYSEELRQLVNMCINPDPEKRPDVTY 287

Query: 288 ALEHRF 293
             +   
Sbjct: 288 VYDVAK 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  199 bits (509), Expect = 3e-61
 Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 45/294 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-P 71
            +  ++VLG G  G +         + VA+K+I      E  +F A RE++LL+E    P
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI----LPECFSF-ADREVQLLRESDEHP 78

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++I        +   ++  E     L+  +   +      +  + +Q T  GLA  H   
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 132 VLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPDRRFTHQVFA---RWYRAPELL 183
           ++HRD+KP+N+LI            ++DFGL +        F+ +        + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 184 FGA--KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
                +     VD+++AGC+F  +++    PF  G S   Q   +  A            
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANILLGACSLDCLHPEKHE 256

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                                      A +L+ KM   DP+ R +A+  L+H F
Sbjct: 257 ------------------------DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  194 bits (496), Expect = 8e-61
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 42/294 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREI 62
               A+RY    +LG+G++G V K  D  T Q  A+K I       K    +    LRE+
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREV 72

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           +LLK+L  P+I++L +      + ++V E     +L   I     F S  D    ++   
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVF 131

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            G+ + HK  ++HRD+KP N+L+ S      +K+ DFGL+  F   + +   ++   +Y 
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYI 190

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     Y    DVW+AG I   LL    PF  G ++ D L ++             
Sbjct: 191 APEVL--RGTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETG---------- 237

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +Y +         + + SDDA DL+ KM T+ P  RITA Q LEH
Sbjct: 238 ---------KYAFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (509), Expect = 1e-60
 Identities = 91/291 (31%), Positives = 143/291 (49%), Gaps = 35/291 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           +   +DRY  + VLG+G++G V    D  TGQ  A+K I   + K+  +  +L RE++LL
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           K+L  P+I++L + F  KG  +LV E     +L   I +   F S  D    ++  L G+
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGI 139

Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + HK  ++HRD+KP NLL+ S      +++ DFGL+  F    ++   ++   +Y APE
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPE 198

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     Y    DVW+ G I   LL    PF  G+++ D L K+                
Sbjct: 199 VL--HGTYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKG------------- 242

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +Y +         +   S+ A DL+ KM TY P  RI+A+ AL+H
Sbjct: 243 ------KYTFELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  194 bits (496), Expect = 1e-60
 Identities = 76/303 (25%), Positives = 126/303 (41%), Gaps = 44/303 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-------EGVNFTAL 59
           +    + Y  +E+LG G   VV + I   T +  A+K I +           + +    L
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71

Query: 60  REIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSY 116
           +E+ +L+++   P+II+L D +       LVF+ M+  +L + +       LS  + +  
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKI 129

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
           M+  L+ +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPS 188

Query: 177 YRAPELLFGA-----KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGT 230
           Y APE++  +       YG  VD+W+ G I   LL    PF      +  L  I +    
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQ 247

Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
               +W D                         SD   DL+S+     P+ R TA++AL 
Sbjct: 248 FGSPEWDDY------------------------SDTVKDLVSRFLVVQPQKRYTAEEALA 283

Query: 291 HRF 293
           H F
Sbjct: 284 HPF 286

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  198 bits (506), Expect = 1e-60
 Identities = 67/321 (20%), Positives = 129/321 (40%), Gaps = 62/321 (19%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           +  + + +  +  ++LG G+ G V     +  G+ VA+K++ +          AL EIKL
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALMEIKL 61

Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF------LSPADIKSYM 117
           L E    P++I    +      L++  E    +L+ ++ + N+           +  S +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGS-------------HGQLKLADFGLARIFGSP 164
           +    G+A  H   ++HRD+KP N+L+ +             + ++ ++DFGL +   S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 165 DRRFTHQVFAR----WYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN--RRPFL 212
              F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  + PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF- 240

Query: 213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLS 272
                  +   I     +    +                          S   +A DL+S
Sbjct: 241 --GDKYSRESNIIRGIFSLDEMKCLHD---------------------RSLIAEATDLIS 277

Query: 273 KMFTYDPKARITAQQALEHRF 293
           +M  +DP  R TA + L H  
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPL 298

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  199 bits (509), Expect = 1e-60
 Identities = 89/289 (30%), Positives = 136/289 (47%), Gaps = 32/289 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              +++ Y + + LG G YG V    D  T    AIK IR        N   L E+ +LK
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L  P+I++L D F  K N +LV E  +  +L   I +   F +  D    ++  L G+ 
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-NEVDAAVIIKQVLSGVT 150

Query: 126 FCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S      +K+ DFGL+ +F    ++   ++   +Y APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEV 209

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L K+     T    +W ++   
Sbjct: 210 L--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV--- 264

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                S+ A DL+ +M  +D + RI+AQQALEH
Sbjct: 265 ---------------------SEGAKDLIKQMLQFDSQRRISAQQALEH 292

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  193 bits (494), Expect = 1e-60
 Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 43/295 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREI 62
           S K +D Y  +E LG+G + VV + +   TG   A K I       +  + +     RE 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREA 56

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMT 120
           ++ ++L+ P+I+ L D+   +   +LVF+ +   +L E ++     F S AD    +Q  
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWY 177
           L+ +A+CH   ++HR++KP NLL+ S      +KLADFGLA         +        Y
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 173

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            +PE+L     Y   VD+WA G I   LL    PF           +I A          
Sbjct: 174 LSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAG--------- 222

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      Y Y +       + + + +A  L+  M T +PK RITA QAL+ 
Sbjct: 223 ----------AYDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  195 bits (497), Expect = 3e-60
 Identities = 82/300 (27%), Positives = 139/300 (46%), Gaps = 43/300 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALR 60
           +K+   +Y  ++V+G G   VV + +   TG   A+K + +  ++      E V     R
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148

Query: 61  EIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
           E  +L+++   PHII LID++     + LVF+ M   +L + +       LS  + +S M
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIM 206

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           +  L+ ++F H   ++HRD+KP N+L+  + Q++L+DFG +     P  +         Y
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGY 265

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTA 231
            APE+L  +       YG  VD+WA G I   LL    PF        Q+  +       
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF----WHRRQIL-MLRMIMEG 320

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                          +YQ+ +       +   S    DL+S++   DP+AR+TA+QAL+H
Sbjct: 321 ---------------QYQFSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  195 bits (496), Expect = 5e-60
 Identities = 52/318 (16%), Positives = 85/318 (26%), Gaps = 59/318 (18%)

Query: 12  DRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELK 69
           +R LK  E L  G   VV+   D +  +  A+K   +G +        L         L 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120

Query: 70  SPHIIELIDAF--------------------------PHKGNLHLVFEFMETDLETVIR- 102
                E  D                                N  L+      DLE +   
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 103 -----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL 157
                          +       ++  A    K ++H    P+NL I   G+L L D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 158 ARIFGSPDRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELL-NRRPFLQGS 215
               G+   R         Y   E L  +   +   ++ W  G     +     PF   +
Sbjct: 241 LWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
             I    K                  +P      + +  PL        D    L+ +  
Sbjct: 298 PGIKGSWKR-------------PSLRVPGTDSLAFGSCTPL-------PDFVKTLIGRFL 337

Query: 276 TYDPKARITAQQALEHRF 293
            +D + R+   +A+E   
Sbjct: 338 NFDRRRRLLPLEAMETPE 355

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  197 bits (504), Expect = 6e-60
 Identities = 89/290 (30%), Positives = 135/290 (46%), Gaps = 34/290 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
               A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +L  P+I++L +      + ++V E     +L   I     F S  D    ++    G+ 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVFSGIT 135

Query: 126 FCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP N+L+ S      +K+ DFGL+  F   + +   ++   +Y APE+
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEV 194

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     Y    DVW+AG I   LL    PF  G ++ D L ++                 
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETG-------------- 237

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                +Y +         + + SDDA DL+ KM T+ P  RITA Q LEH
Sbjct: 238 -----KYAFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  192 bits (491), Expect = 1e-59
 Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 42/300 (14%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL- 59
             K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E      + 
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
            EI++LK+L  P II++ + F  + + ++V E ME  +L + V+ N    L  A  K Y 
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYF 120

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFA 174
              L  + + H+  ++HRD+KP N+L+ S      +K+ DFG ++I G            
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGT 179

Query: 175 RWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTA 231
             Y APE+L       Y   VD W+ G I    L+   PF +  + +    +I +     
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P  W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 240 IPEVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 275

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  192 bits (490), Expect = 2e-59
 Identities = 69/336 (20%), Positives = 127/336 (37%), Gaps = 76/336 (22%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIK 63
             ++  +Y  +  +G+G+YGVV  AI+ +T    AIK +   ++ +           E++
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME----------------------------- 94
           L+K+L  P+I  L + +  +  + LV E                                
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 95  -----------TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL 143
                        +     + +       I + M+     L + H + + HRD+KP N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 144 IGSHG--QLKLADFGLARIFGSPDRRFTHQVFAR----WYRAPELLFGA-KQYGAGVDVW 196
             ++   ++KL DFGL++ F   +    + +  +    ++ APE+L    + YG   D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 197 AAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           +AG +   LL    PF  G +D D + ++                      +  +     
Sbjct: 261 SAGVLLHLLLMGAVPF-PGVNDADTISQVLNK-------------------KLCFENPN- 299

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
               +   S  A DLLS +   +   R  A +AL+H
Sbjct: 300 ----YNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  193 bits (492), Expect = 2e-59
 Identities = 85/291 (29%), Positives = 129/291 (44%), Gaps = 35/291 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S K +D Y  +E LG+G + VV + +   TG   A K I   K          RE ++ +
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +L+ P+I+ L D+   +   +LVF+ +   +L E ++     F S AD    +Q  L+ +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESI 141

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+CH   ++HR++KP NLL+ S      +KLADFGLA         +        Y +PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 200

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     Y   VD+WA G I   LL    PF           +I A              
Sbjct: 201 VLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAG------------- 245

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  Y Y +       + + + +A  L+  M T +PK RITA QAL+ 
Sbjct: 246 ------AYDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  192 bits (489), Expect = 2e-59
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 40/295 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +L+++   ++I L D + ++ ++ L+ E +   +L + + +     LS  +  S+++  L
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQIL 125

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H K + H D+KP N+++         +KL DFGLA         F +      +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +          
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV--------- 233

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      Y +         F   S+ A D + K+   + + R+T Q+AL H
Sbjct: 234 ----------SYDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  192 bits (489), Expect = 2e-59
 Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 35/292 (11%)

Query: 8   KKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +   + Y L  + LG G + VV + I   TGQ  A K ++  ++ +      L EI +L+
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKG 123
             KS P +I L + + +   + L+ E+    ++    +      +S  D+   ++  L+G
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           + + H+  ++H D+KP N+L+ S    G +K+ DFG++R  G         +    Y AP
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAP 202

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L          D+W  G I   LL    PF+ G  + +    I               
Sbjct: 203 EILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQV------------ 248

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                     Y         F S S  A D +  +   +P+ R TA+  L H
Sbjct: 249 -------NVDYSEET-----FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  194 bits (496), Expect = 2e-59
 Identities = 87/324 (26%), Positives = 145/324 (44%), Gaps = 47/324 (14%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R    ++  +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLR 151

Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L  +I+       S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G   +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRFYRAP 268

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG----------- 229
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G           
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 230 ----------------TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP---SASDDAL-D 269
                             T S    +         +    P  R          D    D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 270 LLSKMFTYDPKARITAQQALEHRF 293
            L +   +DP  R+T  QAL H +
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPW 411

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  195 bits (497), Expect = 3e-59
 Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 35/297 (11%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA +    +  + Y   E LG+G + VV + +    GQ  A   I   K     +    R
Sbjct: 1   MATIT-CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER 59

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIRNTNIFLSPADIKSYMQ 118
           E ++ + LK P+I+ L D+   +G+ +L+F+ +   +L E ++     + S AD    +Q
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQ 117

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFAR 175
             L+ +  CH+  V+HR++KP NLL+ S      +KLADFGLA       + +       
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPS 234
            Y +PE+L     YG  VD+WA G I   LL    PF           +I A        
Sbjct: 178 GYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAG------- 228

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                        Y + +       + + + +A DL++KM T +P  RITA +AL+H
Sbjct: 229 ------------AYDFPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  190 bits (484), Expect = 3e-59
 Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 40/293 (13%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKG 123
           +E++ P+II L D F +K ++ L+ E +   +L + +       L+  +   +++  L G
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDG 120

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           + + H K + H D+KP N+++        ++KL DFG+A         F +      + A
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVA 179

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A            
Sbjct: 180 PEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV----------- 226

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y +         F + S+ A D + ++   DPK R+T  Q+LEH
Sbjct: 227 --------NYDFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  190 bits (484), Expect = 3e-59
 Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 44/296 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              + D ++ +  LG G +G V+   +  +G    IK I   + +  +      EI++LK
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLK 75

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLK 122
            L  P+II++ + F    N+++V E  E     +     +     LS   +   M+  + 
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            LA+ H + V+H+D+KP N+L      H  +K+ DFGLA +F   D   T+      Y A
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMA 194

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA---FGTATPSQ 235
           PE+    +      D+W+AG +   LL    PF  G+S  +   K       +      +
Sbjct: 195 PEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNY----AVE 247

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              L                        +  A+DLL +M T DP+ R +A Q L H
Sbjct: 248 CRPL------------------------TPQAVDLLKQMLTKDPERRPSAAQVLHH 279

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  192 bits (491), Expect = 4e-59
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 39/293 (13%)

Query: 7   SKKVADRY--LKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREI 62
              V   Y   K E+LG G +G V+K  +T TG  +A K I  R  K KE V      EI
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV----KNEI 137

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
            ++ +L   ++I+L DAF  K ++ LV E+++  +L   I + +  L+  D   +M+   
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +G+   H+ ++LH D+KP N+L  +    Q+K+ DFGLAR +  P  +         + A
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLA 256

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++          D+W+ G I   LL+   PFL G +D + L  I A            
Sbjct: 257 PEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILAC----------- 303

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +           F   S++A + +SK+   +   RI+A +AL+H
Sbjct: 304 --------RWDLEDEE-----FQDISEEAKEFISKLLIKEKSWRISASEALKH 343

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  193 bits (493), Expect = 6e-59
 Identities = 86/300 (28%), Positives = 135/300 (45%), Gaps = 42/300 (14%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL- 59
             K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E      + 
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
            EI++LK+L  P II++ + F  + + ++V E ME  +L + V+ N    L  A  K Y 
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYF 245

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFA 174
              L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G            
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGT 304

Query: 175 RWYRAPELLFGA--KQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
             Y APE+L       Y   VD W+ G I F  L    PF +  + +    +I +     
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P  W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 365 IPEVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 400

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  190 bits (486), Expect = 7e-59
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 40/295 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +LKE++ P++I L + + +K ++ L+ E +   +L + +       L+  +   +++  L
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQIL 124

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H   + H D+KP N+++        ++K+ DFGLA         F +      +
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEF 183

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A          
Sbjct: 184 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV--------- 232

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      Y++         F + S  A D + ++   DPK R+T Q +L+H
Sbjct: 233 ----------NYEFEDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  194 bits (495), Expect = 2e-58
 Identities = 91/301 (30%), Positives = 133/301 (44%), Gaps = 45/301 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-------- 58
             K+ + Y K   LG G YG V    +       AIK I+  +  +G             
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 59  ---LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIK 114
                EI LLK L  P+II+L D F  K   +LV EF E  +L   I N + F    D  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAA 149

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQ 171
           + M+  L G+ + HK  ++HRD+KP N+L+ +      +K+ DFGL+  F S D +   +
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDR 208

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGT 230
           +   +Y APE+L   K+Y    DVW+ G I   LL    PF  G +D D + K+      
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYY 265

Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
              + W ++                        SD+A +L+  M TYD   R TA++AL 
Sbjct: 266 FDFNDWKNI------------------------SDEAKELIKLMLTYDYNKRCTAEEALN 301

Query: 291 H 291
            
Sbjct: 302 S 302

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  190 bits (485), Expect = 2e-58
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 40/295 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV    + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +L+++  P+II L D + ++ ++ L+ E +   +L + + +     LS  +  S+++  L
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQIL 125

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H K + H D+KP N+++         +KL DFGLA         F +      +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A          
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV--------- 233

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      Y +         F   S+ A D + K+   + + R+T Q+AL H
Sbjct: 234 ----------SYDFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  187 bits (478), Expect = 4e-58
 Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 58/314 (18%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             +   + LG G +GVV++A +       AIK+IRL  ++       +RE+K L +L+ P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHP 63

Query: 72  HIIELIDAF------------PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSY 116
            I+   +A+              K  L++  +     +L+  +  R T      +     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR- 175
                + + F H K ++HRD+KP+N+       +K+ DFGL       +   T       
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 176 -----------WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
                       Y +PE + G   Y   VD+++ G I  ELL   PF      +  L  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV 240

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                                   ++   PP   LF         ++  M +  P  R  
Sbjct: 241 ---------------------RNLKF---PP---LFTQKYPCEYVMVQDMLSPSPMERPE 273

Query: 285 AQQALEHRFAKSFN 298
           A   +E+   +  +
Sbjct: 274 AINIIENAVFEDLD 287

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  186 bits (475), Expect = 8e-58
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 42/291 (14%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLK 66
            +   Y     +G G++G V  A+   T    A KKI     +  +       +EI+++K
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF----KQEIEIMK 61

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
            L  P+II L + F    +++LV E     +L E V+         +D    M+  L  +
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+CHK  V HRD+KP N L  +      LKL DFGLA  F  P +    +V   +Y +P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQ 178

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     YG   D W+AG +   LL    PF    +D + + KI                
Sbjct: 179 VL--EGLYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREG------------- 222

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  + +         + + S  A  L+ ++ T  PK RIT+ QALEH
Sbjct: 223 ------TFTFPEKD-----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  190 bits (483), Expect = 9e-58
 Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 47/311 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
             +L  ++LG+G    V++    KTG   AIK    I   +  +      +RE ++LK+L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 69  KSPHIIELIDAF--PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQMTLKG 123
              +I++L          +  L+ EF     L TV+   +    L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIF----------GSPDRRFT 169
           +    +  ++HR++KP N++           KL DFG AR            G+ +    
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---- 180

Query: 170 HQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL 221
                  Y  P++   A       K+YGA VD+W+ G  F        PF +      + 
Sbjct: 181 -------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRN 232

Query: 222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL-RSLFPSASDDALDLLSKMFTYDPK 280
            ++     T  PS         +     +    P+  SL          +L+ +   D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292

Query: 281 ARITAQQALEH 291
                 Q    
Sbjct: 293 KCWGFDQFFAE 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  185 bits (473), Expect = 3e-57
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 56/300 (18%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +  +   ++  EVLG G +  V+      TG+  A+K I+  K     + +   EI +LK
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLK 61

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K  +I+ L D +    + +LV + +   +L + ++       +  D    +Q  L  +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF---------GSPDRRFTHQV 172
            + H+  ++HRD+KP NLL  +     ++ + DFGL+++          G+P        
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP-------- 171

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTA 231
               Y APE+L   K Y   VD W+ G I   LL    PF    ++     KI       
Sbjct: 172 ---GYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPF-YEETESKLFEKIKEG---- 222

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +   +              +   S+ A D +  +   DP  R T ++AL H
Sbjct: 223 ------YYEFESPF--------------WDDISESAKDFICHLLEKDPNERYTCEKALSH 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  184 bits (470), Expect = 2e-56
 Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 37/292 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LL 65
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K K         EI+ LL
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDP----TEEIEILL 70

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +  + P+II L D +     +++V E M+  +L   I     F S  +  + +    K +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-SEREASAVLFTITKTV 129

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ----LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L          +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G +   +L    PF  G  D  +  +I A  G+         
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSG-------- 238

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  ++           + S SD A DL+SKM   DP  R+TA   L H
Sbjct: 239 -------KFSLSGGY-----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  185 bits (472), Expect = 3e-56
 Identities = 86/332 (25%), Positives = 142/332 (42%), Gaps = 56/332 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
             DRY    ++G+G++G V KA D    + VAIK I+    K+     A  E++LL+ + 
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMN 108

Query: 70  SP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTL 121
                   +I+ L   F  + +L LVFE +  +L  ++RNTN F  +S    + + Q   
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFAQQMC 167

Query: 122 KGLAFCH--KKWVLHRDMKPNNLLI--GSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
             L F    +  ++H D+KP N+L+       +K+ DFG +       +R    + +R+Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFY 224

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS--- 234
           R+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G        
Sbjct: 225 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283

Query: 235 -----------------------------QWPDLAYLPDYVEYQYVAAPPLRSLFPSASD 265
                                        + P    L + +  +       R+     + 
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343

Query: 266 DA----LDLLSKMFTYDPKARITAQQALEHRF 293
                  DL+ +M  YDPK RI    AL+H F
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  183 bits (467), Expect = 3e-56
 Identities = 67/299 (22%), Positives = 97/299 (32%), Gaps = 48/299 (16%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            YL  + LGEG +  V        G   A+K+I   +Q++     A RE  + +    P+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE--AQREADMHRLFNHPN 87

Query: 73  IIELIDAF----PHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           I+ L+         K    L+  F +   L   I        FL+   I   +    +GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-PDRRFTHQVFARW------- 176
              H K   HRD+KP N+L+G  GQ  L D G         +          W       
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 177 -YRAPELLFGAKQYGAG--VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTAT 232
            YRAPEL             DVW+ GC+   ++    P+       D +           
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ---- 263

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +P    +               S     LL+ M T DP  R      L  
Sbjct: 264 -------LSIPQSPRH---------------SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  182 bits (463), Expect = 2e-55
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 38/288 (13%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           ++D +     LG G   +VY+     T +  A+K ++    K+ V      EI +L  L 
Sbjct: 51  LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLS 106

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II+L + F     + LV E +   +L + ++     + S  D    ++  L+ +A+ 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYL 164

Query: 128 HKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           H+  ++HRD+KP NLL  +      LK+ADFGL++I                Y APE+L 
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILR 223

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           G   YG  VD+W+ G I   LL    PF     D     +I                   
Sbjct: 224 G-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC---------------- 266

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              EY +++       +   S +A DL+ K+   DPK R+T  QAL+H
Sbjct: 267 ---EYYFISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  181 bits (461), Expect = 3e-55
 Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 57/316 (18%)

Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIK 63
           S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I  + G  +  V     RE++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV----FREVE 62

Query: 64  LLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           +L + +   +++ELI+ F  +   +LVFE M    + + I     F +  +    +Q   
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-NELEASVVVQDVA 121

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW-- 176
             L F H K + HRD+KP N+L     Q   +K+ DF L       +   +         
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLT 180

Query: 177 ------YRAPELL----FGAKQYGAGVDVWAAGCI-----------FAELLNRRPFLQGS 215
                 Y APE++      A  Y    D+W+ G I                +   + +G 
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
           +       +F +                   +Y++         +   S  A DL+SK+ 
Sbjct: 241 ACPACQNMLFESIQEG---------------KYEFPDKD-----WAHISCAAKDLISKLL 280

Query: 276 TYDPKARITAQQALEH 291
             D K R++A Q L+H
Sbjct: 281 VRDAKQRLSAAQVLQH 296

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  180 bits (458), Expect = 1e-54
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 43/297 (14%)

Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
              V D Y L ++VLG G  G V +    +TGQ  A+K +      +     A +E+   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPK-----ARQEVDHH 75

Query: 66  KELKS-PHIIELIDAF----PHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQ 118
            +    PHI+ ++D +      K  L ++ E ME       +    +   +  +    M+
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR 175
                + F H   + HRD+KP NLL  S  +   LKL DFG A+             +  
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTP 193

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           +Y APE+L G ++Y    D+W+ G I   LL    PF   ++       +          
Sbjct: 194 YYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPF-YSNTGQAISPGMKRRIRLG--- 248

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       +Y +         +   S+DA  L+  +   DP  R+T  Q + H
Sbjct: 249 ------------QYGFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  179 bits (455), Expect = 2e-54
 Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 35/288 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  LK + LGEG++ +  K +  K+ Q  A+K I   K+ E       +EI  LK  +  
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEA---NTQKEITALKLCEGH 65

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I++L + F  + +  LV E +   +L   I+    F S  +    M+  +  ++  H 
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF-SETEASYIMRKLVSAVSHMHD 124

Query: 130 KWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
             V+HRD+KP NLL         +K+ DFG AR+    ++      F   Y APELL   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQ 183

Query: 187 KQYGAGVDVWAAGCIFAELL-NRRPFL--QGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             Y    D+W+ G I   +L  + PF     S       +I                   
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------------ 231

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              ++ +         + + S +A DL+  + T DP  R+       +
Sbjct: 232 ---DFSFEGEA-----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  179 bits (457), Expect = 3e-54
 Identities = 82/324 (25%), Positives = 138/324 (42%), Gaps = 50/324 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP- 71
           RY+    LG G +  V+ A D      VA+K +R     +     A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDAD 76

Query: 72  ----------HIIELIDAFPHKGN--LH--LVFEFMETDLETVI-RNTNIFLSPADIKSY 116
                     HI++L+D F HKG   +H  +VFE +  +L  +I +  +  +    +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLI------GSHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A      D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYT 193

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG------SSDIDQLGK 223
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+      +       + D D + +
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 224 IFAAFGTATP-----SQWPDLAYLPDYVEYQYVAAPP------LRSLFPSASDDA---LD 269
           I    G          ++    +    +               L   +  + D+A    D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 270 LLSKMFTYDPKARITAQQALEHRF 293
            LS M   DP+ R  A   + H +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPW 336

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  180 bits (458), Expect = 5e-54
 Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 41/291 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  +  +VLG G  G V +  + +T +  A+K ++     +     A RE++L       
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPK-----ARREVELHWRASQC 114

Query: 71  PHIIELIDAF----PHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           PHI+ ++D +      +  L +V E ++       +    +   +  +    M+   + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   + HRD+KP NLL  S      LKL DFG A+   +     T   +  +Y APE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPE 233

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L G ++Y    D+W+ G I   LL    PF   +  +     +                
Sbjct: 234 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMG--------- 282

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +Y++         +   S++   L+  +   +P  R+T  + + H
Sbjct: 283 ------QYEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  178 bits (452), Expect = 9e-54
 Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 43/297 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            ++       +  +G G++G V++  D +TG   A+KK+RL   +         E+    
Sbjct: 53  YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACA 105

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L SP I+ L  A      +++  E +E   L  +I+             Y+   L+GL 
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQALEGLE 164

Query: 126 FCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFAR-----WYRA 179
           + H + +LH D+K +N+L+ S G +  L DFG A          +            + A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++ G K   A VD+W++ C+   +LN   P+    +   +                  
Sbjct: 225 PEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW----TQYFRGPLCL------------- 266

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
              +           PP+R + PS +      + +    +P  R +A +        
Sbjct: 267 --KIAS-------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  177 bits (451), Expect = 2e-53
 Identities = 62/322 (19%), Positives = 124/322 (38%), Gaps = 59/322 (18%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL----- 59
            K  + Y     L +G +  +      K  +  A+K   K  L K+++            
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84

Query: 60  -------REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME--------TDLETVIRNT 104
                   E++++ ++K+ + +       +   +++++E+ME             + +N 
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 105 NIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-- 161
             F+    IK  ++  L   ++ H +K + HRD+KP+N+L+  +G++KL+DFG +     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 162 -------GSPDRRFTHQVFARWYRAPELLFGAKQY-GAGVDVWAAGCIFAELLNRR-PFL 212
                  G+ +           +  PE       Y GA VD+W+ G     +     PF 
Sbjct: 205 KKIKGSRGTYE-----------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF- 252

Query: 213 QGSSDIDQL-GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
                + +L   I          ++P       Y      +      L    S++ +D L
Sbjct: 253 SLKISLVELFNNIRTK-----NIEYPLDRNHFLYPLTNKKSTCSNNFL----SNEDIDFL 303

Query: 272 SKMFTYDPKARITAQQALEHRF 293
                 +P  RIT++ AL+H +
Sbjct: 304 KLFLRKNPAERITSEDALKHEW 325

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  174 bits (443), Expect = 5e-53
 Identities = 54/316 (17%), Positives = 103/316 (32%), Gaps = 62/316 (19%)

Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           + +  +    + + E +G G +G V+K +    G   AIK+ +           ALRE+ 
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 64  LLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR---NTNIFLSPADIKSYMQ 118
               L +  H++    A+    ++ +  E+     L   I        +   A++K  + 
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL-------------------KLADFGLAR 159
              +GL + H   ++H D+KP+N+ I                         K+ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 160 IFGSPDRRFTHQVFA--RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD 217
              SP      QV      + A E+L     +    D++A            P  +    
Sbjct: 183 RISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 218 IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTY 277
             ++ +                              P +  +    S +  +LL  M   
Sbjct: 237 WHEIRQG---------------------------RLPRIPQVL---SQEFTELLKVMIHP 266

Query: 278 DPKARITAQQALEHRF 293
           DP+ R +A   ++H  
Sbjct: 267 DPERRPSAMALVKHSV 282

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  171 bits (436), Expect = 6e-52
 Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 51/294 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +    +LG+G++  VY+A    TG  VAIK   K  +   K G+      E+K+  +L
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQL 68

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           K P I+EL + F     ++LV E     ++   ++N     S  + + +M   + G+ + 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFT-----HQVFARWYRAPE 181
           H   +LHRD+  +NLL+  +  +K+ADFGLA     P  + +T     +      Y +PE
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN------YISPE 182

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +      +G   DVW+ GC+F  LL  R PF    +  + L K+  A             
Sbjct: 183 IATR-SAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLA------------- 227

Query: 241 YLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 +Y+           PS  S +A DL+ ++   +P  R++    L+H F
Sbjct: 228 ------DYE----------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  172 bits (438), Expect = 1e-51
 Identities = 75/329 (22%), Positives = 125/329 (37%), Gaps = 54/329 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFT--ALREIKLLK 66
           ++ RY   + LGEG +G V + ID K G + VA+K ++    +    +   A  EI++L+
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDR----YCEAARSEIQVLE 66

Query: 67  ELKSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQM 119
            L +         +++++ F H G++ +VFE +       I+           I+     
Sbjct: 67  HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-----------F 168
             K + F H   + H D+KP N+L       +  +  + R   +               +
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 169 THQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
             +     V  R YRAPE++     +    DVW+ GCI  E              + L  
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 224 IFAAFGTATPS----------------QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD- 266
           +    G                      W + +    YV     A  PL+    S   + 
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR---ACKPLKEFMLSQDVEH 302

Query: 267 --ALDLLSKMFTYDPKARITAQQALEHRF 293
               DL+ KM  YDP  RIT ++AL+H F
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  179 bits (455), Expect = 1e-51
 Identities = 65/309 (21%), Positives = 108/309 (34%), Gaps = 41/309 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLK 66
            +    +  +E LG G +G V + I   TG+ VAIK+ R  ++    N      EI+++K
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--QELSPKNRERWCLEIQIMK 67

Query: 67  ELKSPHIIELIDAFPHKGNLH------LVFEFMET-DLETVI--RNTNIFLSPADIKSYM 117
           +L  P+++   +       L       L  E+ E  DL   +        L    I++ +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIF----------GSP 164
                 L + H+  ++HRD+KP N+++    Q    K+ D G A+            G+ 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
                       Y APELL   K+Y   VD W+ G +  E +        +    Q    
Sbjct: 188 Q-----------YLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                      + DL     +        P    L    +      L  M  +  + R T
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVL----PTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291

Query: 285 AQQALEHRF 293
             Q      
Sbjct: 292 DPQNPNVGC 300

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  170 bits (432), Expect = 3e-51
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 46/297 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKS 70
           D    R VLG+GTYG+VY   D      +AIK+I     +       L  EI L K LK 
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKH 78

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPAD--IKSYMQMTLKGLAFC 127
            +I++ + +F   G + +  E +    L  ++R+    L   +  I  Y +  L+GL + 
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLA-RIFGSPDRRFTHQ--VFARWYRAPELL 183
           H   ++HRD+K +N+LI ++ G LK++DFG + R+ G      T    +    Y APE++
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEII 195

Query: 184 FGAKQ-YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ-LGKIFA-AFGTATPSQWPDL 239
               + YG   D+W+ GC   E+   + PF     ++ +    +F        P      
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF----YELGEPQAAMFKVGMFKVHPE----- 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
             +P+                 S S +A   + K F  DP  R  A   L   F K 
Sbjct: 247 --IPE-----------------SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  171 bits (436), Expect = 3e-51
 Identities = 77/328 (23%), Positives = 125/328 (38%), Gaps = 52/328 (15%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFT--ALREIKLLK 66
           + +RY     LGEGT+G V + +D   G++ VA+K IR    K    +   A  EI +LK
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGK----YREAARLEINVLK 71

Query: 67  ELKSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQM 119
           ++K          + + D F   G++ + FE +  +    ++  N        ++     
Sbjct: 72  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-----------F 168
               L F H+  + H D+KP N+L  +     L +   +    S               F
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 169 THQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
            H+     V  R YR PE++     +    DVW+ GCI  E        Q   + + L  
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 224 IFAAFGTATPSQW-------------PDLAYLPDYVEYQYVAAP--PLRSLFPSASDD-- 266
           +    G                      L +  +  + +YV     PL+S     S +  
Sbjct: 251 MEKILGP--IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308

Query: 267 -ALDLLSKMFTYDPKARITAQQALEHRF 293
              DL+ +M  +DP  RIT  +AL H F
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPF 336

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  169 bits (430), Expect = 4e-51
 Identities = 72/287 (25%), Positives = 133/287 (46%), Gaps = 54/287 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
            LG+G +G VY A + ++   +A+K +   + +K GV     RE+++   L+ P+I+ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
             F     ++L+ E+     +   ++  + F       +Y+      L++CH K V+HRD
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRD 134

Query: 137 MKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELLFGAK 187
           +KP NLL+GS G+LK+ADFG +            G+ D           Y  PE++ G +
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD-----------YLPPEMIEG-R 182

Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            +   VD+W+ G +  E L  + PF + ++  +   +I             +  + PD+V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV----------EFTF-PDFV 230

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                            ++ A DL+S++  ++P  R   ++ LEH +
Sbjct: 231 -----------------TEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  170 bits (434), Expect = 8e-51
 Identities = 69/337 (20%), Positives = 124/337 (36%), Gaps = 60/337 (17%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKE 67
           + + +L    +G+GT+G V         +  A+K +R   +K    +T  A  E  +LK+
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKK----YTRSAKIEADILKK 87

Query: 68  LKS-----PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTL 121
           +++      +I++    F +  ++ L+FE +   L  +I   N       DIK Y    L
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG-------------------------QLKLADFG 156
           K L +  K  + H D+KP N+L+                              +KL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            A  F          +  R YRAPE++     +    D+W+ GC+ AEL       +   
Sbjct: 208 CA-TFK--SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263

Query: 217 DIDQLGKIFAAFGTATPS----------------QWPDLAYLPDYVEYQYV-AAPPLRSL 259
            ++ L  + +       +                    LA+  +      +        L
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 260 FPSASDDAL-DLLSKMFTYDPKARITAQQALEHRFAK 295
           +     +   D L  +   DP  R +  + L+H+F +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  169 bits (429), Expect = 2e-50
 Identities = 71/305 (23%), Positives = 112/305 (36%), Gaps = 74/305 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
            RY++   LG+G +   ++  D  T +  A K   K  L   K         EI + + L
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSL 98

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              H++     F     + +V E          R  ++         L+  + + Y++  
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLEL--------CRRRSLLELHKRRKALTEPEARYYLRQI 150

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFT 169
           + G  + H+  V+HRD+K  NL +    ++K+ DFGLA              G+P+    
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
                  Y APE+L   K +   VDVW+ GCI   LL  +P  + S   +   +I     
Sbjct: 207 -------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-- 256

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQA 288
                            EY            P   +  A  L+ KM   DP AR T  + 
Sbjct: 257 -----------------EYS----------IPKHINPVAASLIQKMLQTDPTARPTINEL 289

Query: 289 LEHRF 293
           L   F
Sbjct: 290 LNDEF 294

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  167 bits (426), Expect = 3e-50
 Identities = 71/305 (23%), Positives = 112/305 (36%), Gaps = 74/305 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
            RY++   LG+G +   ++  D  T +  A K   K  L   K         EI + + L
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSL 72

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              H++     F     + +V E          R  ++         L+  + + Y++  
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLEL--------CRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFT 169
           + G  + H+  V+HRD+K  NL +    ++K+ DFGLA              G+P+    
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
                  Y APE+L   K +   VDVW+ GCI   LL  +P  + S   +   +I     
Sbjct: 181 -------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-- 230

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQA 288
                            EY            P   +  A  L+ KM   DP AR T  + 
Sbjct: 231 -----------------EYS----------IPKHINPVAASLIQKMLQTDPTARPTINEL 263

Query: 289 LEHRF 293
           L   F
Sbjct: 264 LNDEF 268

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  166 bits (423), Expect = 6e-50
 Identities = 56/291 (19%), Positives = 105/291 (36%), Gaps = 62/291 (21%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  +  +VLG G  G V +  + +T +  A+K ++     +     A RE++L       
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPK-----ARREVELHWRASQC 70

Query: 71  PHIIELIDAF----PHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           PHI+ ++D +      +  L +V E ++       +    +   +  +    M+   + +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   + HRD+KP NLL  S      LKL DFG A                      E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------KE 169

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
                ++Y    D+W+ G I   LL    PF   +  +     +                
Sbjct: 170 TT--GEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMG--------- 217

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +Y++         +   S++   L+  +   +P  R+T  + + H
Sbjct: 218 ------QYEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 8e-50
 Identities = 71/310 (22%), Positives = 117/310 (37%), Gaps = 61/310 (19%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-P 71
           R   R VL EG +  VY+A D  +G+  A+K++ L  ++E      ++E+  +K+L   P
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNR-AIIQEVCFMKKLSGHP 86

Query: 72  HIIELIDAFPHK-----GNLHLVFEFME----TDLETVI-RNTNIFLSPADIKSYMQMTL 121
           +I++   A                   E      +E +    +   LS   +      T 
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 122 KGLAFCH--KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARW-- 176
           + +   H  K  ++HRD+K  NLL+ + G +KL DFG A      PD  ++ Q  A    
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 177 ---------YRAPEL--LFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKI 224
                    YR PE+  L+     G   D+WA GCI   L  R+ PF  G+       +I
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA-----KLRI 261

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                                 +Y     PP      +       L+  M   +P+ R++
Sbjct: 262 VNG-------------------KYSI---PP----HDTQYTVFHSLIRAMLQVNPEERLS 295

Query: 285 AQQALEHRFA 294
             + +     
Sbjct: 296 IAEVVHQLQE 305

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  164 bits (418), Expect = 3e-49
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 45/295 (15%)

Query: 13  RYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK    +G G++  VYK +DT+T   VA  +++  K  +        E ++LK L+ P
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 72  HIIELIDAF----PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +I+   D++      K  + LV E M +  L+T ++   +      ++S+ +  LKGL F
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV-LRSWCRQILKGLQF 144

Query: 127 CH--KKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAP 180
            H     ++HRD+K +N+ I G  G +K+ D GLA +  +   +    T +    +  AP
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-AP 199

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E+    ++Y   VDV+A G    E+          S+     +I+    +       D  
Sbjct: 200 EM--YEEKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFD-- 252

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                                 A  +  +++      +   R + +  L H F +
Sbjct: 253 --------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  163 bits (415), Expect = 1e-48
 Identities = 76/320 (23%), Positives = 136/320 (42%), Gaps = 81/320 (25%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL---------- 59
           +Y  ++ +G+G+YGVV  A +       A+K   K +L +Q                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 60  -----------REIKLLKELKSPHIIELID--AFPHKGNLHLVFEFMET-DLETVIRNTN 105
                      +EI +LK+L  P++++L++    P++ +L++VFE +    +  V     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---- 161
             LS    + Y Q  +KG+ + H + ++HRD+KP+NLL+G  G +K+ADFG++  F    
Sbjct: 134 --LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 162 -------GSPDRRFTHQVFARWYRAPELLFGA-KQY-GAGVDVWAAGCI-FAELLNRRPF 211
                  G+P            + APE L    K + G  +DVWA G   +  +  + PF
Sbjct: 192 ALLSNTVGTPA-----------FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
                 +    KI +                      ++   P      P  ++D  DL+
Sbjct: 241 -MDERIMCLHSKIKSQ-------------------ALEF---PD----QPDIAEDLKDLI 273

Query: 272 SKMFTYDPKARITAQQALEH 291
           ++M   +P++RI   +   H
Sbjct: 274 TRMLDKNPESRIVVPEIKLH 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  163 bits (414), Expect = 1e-48
 Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 54/287 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
            LG+G +G VY A + +    +A+K +   + +KEGV     REI++   L+ P+I+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           + F  +  ++L+ EF    +L   ++    F       ++M+     L +CH++ V+HRD
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHERKVIHRD 139

Query: 137 MKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELLFGAK 187
           +KP NLL+G  G+LK+ADFG +            G+ D           Y  PE++ G K
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD-----------YLPPEMIEG-K 187

Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            +   VD+W AG +  E L    PF    S  +   +I             DL + P ++
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNV----------DLKF-PPFL 235

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                            SD + DL+SK+  Y P  R+  +  +EH +
Sbjct: 236 -----------------SDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  161 bits (410), Expect = 2e-47
 Identities = 62/312 (19%), Positives = 117/312 (37%), Gaps = 69/312 (22%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL-RE 61
            + + +Y     LG G +G V+ A+D +  + V +K     K+      E      +  E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLET---VIRNTNIFLSPADIKSYMQ 118
           I +L  ++  +II+++D F ++G   LV E   + L+    + R+    L         +
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFR 137

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRF 168
             +  + +   K ++HRD+K  N++I     +KL DFG A             G+ +   
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE--- 194

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA 227
                   Y APE+L G    G  +++W+ G   +  +    PF        +L +   A
Sbjct: 195 --------YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVEA 239

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                        + P  V                 S + + L+S +    P+ R T ++
Sbjct: 240 -----------AIHPPYLV-----------------SKELMSLVSGLLQPVPERRTTLEK 271

Query: 288 ALEHR-FAKSFN 298
            +      +  N
Sbjct: 272 LVTDPWVTQPVN 283

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  158 bits (403), Expect = 4e-47
 Identities = 69/312 (22%), Positives = 112/312 (35%), Gaps = 75/312 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +   + LGEG YG V  A++  T + VA+K     R     E +     +EI + K L
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKML 62

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              ++++           +L  E+             +F        +   D + +    
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--------CSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRR 167
           + G+ + H   + HRD+KP NLL+     LK++DFGLA +F             G+    
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-- 172

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFA 226
                    Y APELL   + +   VDVW+ G +  A L    P+ Q S    +      
Sbjct: 173 ---------YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                               +       P + +        L LL K+   +P ARIT  
Sbjct: 224 K-------------------KTYL---NPWKKI----DSAPLALLHKILVENPSARITIP 257

Query: 287 QALEHR-FAKSF 297
              + R + K  
Sbjct: 258 DIKKDRWYNKPL 269

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  160 bits (406), Expect = 6e-47
 Identities = 68/315 (21%), Positives = 120/315 (38%), Gaps = 65/315 (20%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL- 59
           +AE+         +     +G G++G VY A D +  + VAIKK+    ++    +  + 
Sbjct: 43  VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +E++ L++L+ P+ I+    +  +    LV E+       ++      L   +I +    
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA---RW 176
            L+GLA+ H   ++HRD+K  N+L+   G +KL DFG A          +   F     W
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANS---FVGTPYW 216

Query: 177 YRAPELLFGAKQ--YGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             APE++    +  Y   VDVW+ G I   EL  R+P                      P
Sbjct: 217 M-APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP----------------------P 252

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF------------PSASDDALDLLSKMFTYDPKA 281
                                 + +L+               S+   + +       P+ 
Sbjct: 253 ----------------LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296

Query: 282 RITAQQALEHRFAKS 296
           R T++  L+HRF   
Sbjct: 297 RPTSEVLLKHRFVLR 311

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  157 bits (399), Expect = 3e-46
 Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 68/305 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELK 69
           +YL  ++LGEG+YG V + +D++T    A+K   K +L ++         +EI+LL+ L+
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLR 64

Query: 70  SPHIIELIDAFPH--KGNLHLVFEFME---TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             ++I+L+D   +  K  +++V E+      ++   +              Y    + GL
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGL 122

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQ 171
            + H + ++H+D+KP NLL+ + G LK++  G+A                GSP       
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA------ 176

Query: 172 VFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-F 228
                ++ PE+  G   + G  VD+W+AG   +       PF +G +       I    +
Sbjct: 177 -----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSY 230

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                        +P                         DLL  M  Y+P  R + +Q 
Sbjct: 231 ------------AIPGDC-----------------GPPLSDLLKGMLEYEPAKRFSIRQI 261

Query: 289 LEHRF 293
            +H +
Sbjct: 262 RQHSW 266

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  159 bits (403), Expect = 3e-46
 Identities = 44/326 (13%), Positives = 94/326 (28%), Gaps = 82/326 (25%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE----IKLLKEL 68
             ++  VLG+       +A D +TG++  +      ++        ++E    ++LL+ +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 69  KSPHIIEL-------IDAFPHKG-----------------NLHLVFEFMETDLETVIR-- 102
           K+    ++        D                       +   ++  M+++L+T     
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 103 ----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
               +T+  L            ++ LA  H   ++H  ++P ++++   G + L  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 159 RIFGSPDRRFTHQVFARWYRAPELL----------FGAKQYGAGVDVWAAGCIFAELL-N 207
              G           +R +  PEL                     D WA G +   +   
Sbjct: 254 VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 208 RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDA 267
             P     + +     IF            ++                            
Sbjct: 310 DLPI-TKDAALGGSEWIF--------RSCKNI------------------------PQPV 336

Query: 268 LDLLSKMFTYDPKARITAQQALEHRF 293
             LL     Y  + R+   QA+E   
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPE 362

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  157 bits (400), Expect = 3e-46
 Identities = 69/313 (22%), Positives = 113/313 (36%), Gaps = 77/313 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +   + LGEG YG V  A++  T + VA+K     R     E +     +EI + K L
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKML 62

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              ++++           +L  E+             +F        +   D + +    
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--------CSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRR 167
           + G+ + H   + HRD+KP NLL+     LK++DFGLA +F             G+    
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-- 172

Query: 168 FTHQVFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIF 225
                    Y APELL   +++    VDVW+ G +  A L    P+ Q S    +     
Sbjct: 173 ---------YVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                +       P + +        L LL K+   +P ARIT 
Sbjct: 223 EK-------------------KTYL---NPWKKI----DSAPLALLHKILVENPSARITI 256

Query: 286 QQALEHR-FAKSF 297
               + R + K  
Sbjct: 257 PDIKKDRWYNKPL 269

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  157 bits (398), Expect = 6e-46
 Identities = 73/301 (24%), Positives = 113/301 (37%), Gaps = 48/301 (15%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK   K R+    E  N T +  E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98

Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQ 157

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYS 215

Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            PE +   + +G    VW+ G + +  +    PF       +   +I             
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-------EHDEEIIRG---------- 258

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
              +    V                 S +   L+       P  R T ++   H + +  
Sbjct: 259 -QVFFRQRV-----------------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

Query: 298 N 298
            
Sbjct: 301 L 301

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  158 bits (402), Expect = 6e-46
 Identities = 62/321 (19%), Positives = 107/321 (33%), Gaps = 40/321 (12%)

Query: 11  ADRYLKREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
              Y    V+G+G      V  A    TG+ V +++I L      +      E+ + K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P+I+     F     L +V  FM      DL  +  +    ++   I   +Q  LK L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKAL 141

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG-LARIFGSPDRRFTHQVFAR-------W 176
            + H    +HR +K +++LI   G++ L+       +     R+     F +       W
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 177 YRAPELLF-GAKQYGAGVDVWAAGC--------------------IFAELLNRRPFLQGS 215
             +PE+L    + Y A  D+++ G                     +  +L    P L  +
Sbjct: 202 L-SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
           S I       +   +   S   D                P      + S      + +  
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTP--RPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 276 TYDPKARITAQQALEHRFAKS 296
             +P AR +A   L H F K 
Sbjct: 319 QRNPDARPSASTLLNHSFFKQ 339

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  155 bits (395), Expect = 8e-46
 Identities = 87/306 (28%), Positives = 143/306 (46%), Gaps = 71/306 (23%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELK 69
            +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENK 75

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +P+I+  +D++     L +V E++     TD+   +  T   +    I +  +  L+ L 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETC--MDEGQIAAVCRECLQALE 130

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLF 184
           F H   V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++ 
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT 189

Query: 185 GAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             K YG  VD+W+ G I A E++   P                      P          
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEP----------------------P---------- 215

Query: 244 DYVEYQYVAAPPLRSLF-------PS------ASDDALDLLSKMFTYDPKARITAQQALE 290
                 Y+   PLR+L+       P        S    D L++    D + R +A++ L+
Sbjct: 216 ------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269

Query: 291 HRFAKS 296
           H+F K 
Sbjct: 270 HQFLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  156 bits (396), Expect = 1e-45
 Identities = 70/304 (23%), Positives = 134/304 (44%), Gaps = 67/304 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ + +R     L+   I +  +  L+ LA+ 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H + V+HRD+K +++L+   G++KL+DFG  A+I     +R +  V   ++ APE++   
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISR- 215

Query: 187 KQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
             Y   VD+W+ G I   E+++  P                      P            
Sbjct: 216 SLYATEVDIWSLG-IMVIEMVDGEP----------------------P------------ 240

Query: 246 VEYQYVAAPPLRSLF------------PSA-SDDALDLLSKMFTYDPKARITAQQALEHR 292
               Y +  P++++                 S    D L +M   DP+ R TAQ+ L+H 
Sbjct: 241 ----YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296

Query: 293 FAKS 296
           F   
Sbjct: 297 FLLQ 300

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (395), Expect = 3e-45
 Identities = 79/319 (24%), Positives = 131/319 (41%), Gaps = 27/319 (8%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  S
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNS 90

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYM-QMTLKGLAFCH 128
           P+I+    AF   G + +  E M+   L+ V++       P  I   +    +KGL +  
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLR 148

Query: 129 KKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           +K  ++HRD+KP+N+L+ S G++KL DFG++          +  V  R Y +PE L G  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SF-VGTRSYMSPERLQG-T 205

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y    D+W+ G    E+   R  +      +                 P        + 
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 248 YQYVAAPPLRSLF-----------PSA-----SDDALDLLSKMFTYDPKARITAQQALEH 291
              + + P  ++F           P       S +  D ++K    +P  R   +Q + H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

Query: 292 RFAKSFNGVFVFVDFCSYL 310
            F K  +     VDF  +L
Sbjct: 326 AFIKRSDA--EEVDFAGWL 342

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  157 bits (398), Expect = 4e-45
 Identities = 45/323 (13%), Positives = 94/323 (29%), Gaps = 73/323 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE----IKLLKEL 68
             ++  VLG+       +A D +TG++  +      ++        ++E    ++LL+ +
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 69  KSP-------HIIELIDAFPHKG-----------------NLHLVFEFMETDLETVIR-- 102
           K+          I   D                       +   ++  M+++L+T     
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 103 ----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
               +T+  L            ++ LA  H   ++H  ++P ++++   G + L  F   
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 159 RIFGSPDRRFTHQVF-ARWYRAPELLFGAKQ----YGAGVDVWAAGCIFAELL-NRRPFL 212
              G+       + F      A  +L   +          D W  G     +     P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN- 317

Query: 213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLS 272
              + +     IF                +P  V                       LL 
Sbjct: 318 TDDAALGGSEWIF-----------RSCKNIPQPVR---------------------ALLE 345

Query: 273 KMFTYDPKARITAQQALEHRFAK 295
               Y  + R+   QA+E    +
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYE 368

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  153 bits (390), Expect = 2e-44
 Identities = 82/298 (27%), Positives = 130/298 (43%), Gaps = 63/298 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKE 67
            Y+ RE LGEG++G V  A   KT Q VA+K      ++       V     REI  LK 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----REISYLKL 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L+ PHII+L D      ++ +V E+   +L   I      ++  + + + Q  +  + +C
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYC 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWY 177
           H+  ++HRD+KP NLL+  +  +K+ADFGL+ I           GSP+           Y
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------Y 173

Query: 178 RAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTATPSQ 235
            APE++ G    G  VDVW+ G + +  L+ R PF       +   K+ +  +       
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCVY------- 225

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                 +PD++                 S  A  L+ +M   DP  RIT Q+     +
Sbjct: 226 -----VMPDFL-----------------SPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  151 bits (384), Expect = 2e-44
 Identities = 79/302 (26%), Positives = 119/302 (39%), Gaps = 70/302 (23%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSP 71
            Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + P
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLKG 123
           HII+L        +  +V E+        +    +F        +   + +   Q  L  
Sbjct: 72  HIIKLYQVISTPTDFFMVMEY--------VSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVF 173
           + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+        
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 175

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTA 231
              Y APE++ G    G  VD+W+ G I +A L    PF           KI    F   
Sbjct: 176 ---YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGGVF--- 228

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y+P+Y+                 +     LL  M   DP  R T +   EH
Sbjct: 229 ---------YIPEYL-----------------NRSVATLLMHMLQVDPLKRATIKDIREH 262

Query: 292 RF 293
            +
Sbjct: 263 EW 264

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  152 bits (386), Expect = 3e-44
 Identities = 87/315 (27%), Positives = 148/315 (46%), Gaps = 67/315 (21%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           + E  L+K+  + +   E LGEG+YG VYKAI  +TGQ VAIK++ +    + +    ++
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IK 73

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSY 116
           EI ++++  SPH+++   ++    +L +V E+      +D+   IR  N  L+  +I + 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATI 130

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFAR 175
           +Q TLKGL + H    +HRD+K  N+L+ + G  KLADFG+  ++  +  +R T  +   
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTP 189

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           ++ APE++     Y    D+W+ G I A E+   +P                      P 
Sbjct: 190 FWMAPEVIQE-IGYNCVADIWSLG-ITAIEMAEGKP----------------------P- 224

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF------------PSA-SDDALDLLSKMFTYDPKA 281
                          Y    P+R++F            P   SD+  D + +     P+ 
Sbjct: 225 ---------------YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQ 269

Query: 282 RITAQQALEHRFAKS 296
           R TA Q L+H F +S
Sbjct: 270 RATATQLLQHPFVRS 284

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  152 bits (386), Expect = 3e-44
 Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 50/297 (16%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL-REIK 63
           +     Y    +LG+G +G V+          VAIK   + R+       +      E+ 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86

Query: 64  LLKELKS----PHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYM 117
           LL ++ +    P +I L+D F  +    LV E      DL   I      L     + + 
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFF 145

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
              +  +  CH + V+HRD+K  N+LI    G  KL DFG   +    D  +T     R 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRV 203

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           Y  PE +   + +     VW+ G + +  +    PF       ++  +I  A        
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-------ERDQEILEA-------- 248

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR 292
             +L + P +V                 S D   L+ +     P +R + ++ L   
Sbjct: 249 --EL-HFPAHV-----------------SPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  152 bits (385), Expect = 4e-44
 Identities = 78/322 (24%), Positives = 128/322 (39%), Gaps = 74/322 (22%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
              V       + +     LG+G +G VYKA + +TG   A K I    ++E  ++  + 
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IV 65

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSY 116
           EI++L     P+I++L+ A+ H G L ++ EF        +   +   +  L+   I+  
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVV 122

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFA- 174
            +  L+ L F H K ++HRD+K  N+L+   G ++LADFG+ A+   +  +R +   F  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIG 179

Query: 175 --RWYRAPELLFGA----KQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAA 227
              W  APE++         Y    D+W+ G I   E+    P                 
Sbjct: 180 TPYWM-APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP----------------- 220

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF------------PSA-SDDALDLLSKM 274
                P                +    P+R L             PS  S +  D L   
Sbjct: 221 -----P----------------HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 259

Query: 275 FTYDPKARITAQQALEHRFAKS 296
              +P+ R +A Q LEH F  S
Sbjct: 260 LDKNPETRPSAAQLLEHPFVSS 281

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  152 bits (386), Expect = 4e-44
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 53/293 (18%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            Y   + +G+G +  V  A    TG+ VAIK I   +          RE++++K L  P+
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I++L +    +  L+L+ E+    ++   +      +   + +S  +  +  + +CH+K 
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPE 181
           ++HRD+K  NLL+ +   +K+ADFG +  F          G+P            Y APE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP-----------PYAAPE 183

Query: 182 LLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           L  G K  G  VDVW+ G I +  +    PF  G +  +   ++                
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRG-----------KY 231

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
            +P Y+                 S D  +LL +    +P  R T +Q ++ R+
Sbjct: 232 RIPFYM-----------------STDCENLLKRFLVLNPIKRGTLEQIMKDRW 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  151 bits (383), Expect = 7e-44
 Identities = 75/312 (24%), Positives = 125/312 (40%), Gaps = 37/312 (11%)

Query: 1   MAEVDLSKK---VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT 57
           M+E   +       D Y  +EV+G G   VV  A      + VAIK+I L K +  ++  
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-E 59

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIF----LS 109
            L+EI+ + +   P+I+    +F  K  L LV + +      D+   I          L 
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPD--R 166
            + I + ++  L+GL + HK   +HRD+K  N+L+G  G +++ADFG+ A +    D  R
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 167 RFTHQVFA---RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
               + F     W  APE++   + Y    D+W+ G    EL               +  
Sbjct: 180 NKVRKTFVGTPCWM-APEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKV 235

Query: 224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
           +        PS    +       +Y                     ++S     DP+ R 
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKY---------------GKSFRKMISLCLQKDPEKRP 280

Query: 284 TAQQALEHRFAK 295
           TA + L H+F +
Sbjct: 281 TAAELLRHKFFQ 292

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  148 bits (375), Expect = 1e-42
 Identities = 76/295 (25%), Positives = 135/295 (45%), Gaps = 48/295 (16%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            + + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  S
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDS 79

Query: 71  PHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           P++ +   ++     L ++ E++      DL   +      L    I + ++  LKGL +
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGP--LDETQIATILREILKGLDY 134

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFA---RWYRAPEL 182
            H +  +HRD+K  N+L+  HG++KLADFG+  ++  +  +R T   F     W  APE+
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWM-APEV 190

Query: 183 LFGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +     Y +  D+W+ G I A EL    P     S++  +  +F       P   P    
Sbjct: 191 IKQ-SAYDSKADIWSLG-ITAIELARGEPPH---SELHPMKVLF-----LIPKNNP---- 236

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                       P L   +   S    + +      +P  R TA++ L+H+F   
Sbjct: 237 ------------PTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  151 bits (384), Expect = 1e-42
 Identities = 81/302 (26%), Positives = 121/302 (40%), Gaps = 70/302 (23%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSP 71
            Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + P
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLKG 123
           HII+L        ++ +V E+        +    +F        L   + +   Q  L G
Sbjct: 77  HIIKLYQVISTPSDIFMVMEY--------VSGGELFDYICKNGRLDEKESRRLFQQILSG 128

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVF 173
           + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+        
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 180

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTA 231
              Y APE++ G    G  VD+W++G I +A L    PF           KI    F   
Sbjct: 181 ---YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGIF--- 233

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y P Y+                 +   + LL  M   DP  R T +   EH
Sbjct: 234 ---------YTPQYL-----------------NPSVISLLKHMLQVDPMKRATIKDIREH 267

Query: 292 RF 293
            +
Sbjct: 268 EW 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  148 bits (376), Expect = 3e-42
 Identities = 69/305 (22%), Positives = 116/305 (38%), Gaps = 70/305 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKS 70
           DRY   + +G G +GV     D  T + VA+K I R     E V     REI   + L+ 
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLK 122
           P+I+   +      +L ++ E+             ++         S  + + + Q  L 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEY--------ASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIF----------GSPDRRFTH 170
           G+++CH   + HRD+K  N L+      +LK+ DFG ++            G+P      
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA----- 182

Query: 171 QVFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAF 228
                 Y APE+L   ++Y G   DVW+ G   +  L+   PF +   +     K     
Sbjct: 183 ------YIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRI 234

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +      PD   +                     S +   L+S++F  DP  RI+  + 
Sbjct: 235 LSVKY-SIPDDIRI---------------------SPECCHLISRIFVADPATRISIPEI 272

Query: 289 LEHRF 293
             H +
Sbjct: 273 KTHSW 277

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  140 bits (354), Expect = 1e-39
 Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 41/294 (13%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           AD       LG G YGVV K     +GQ +A+K+IR            L ++   ++ + 
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLS--PADIKSYM-QMTLKGLAF 126
            P  +    A   +G++ +  E M+T L+   +         P DI   +    +K L  
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 127 CHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRAPELL 183
            H K  V+HRD+KP+N+LI + GQ+K+ DFG++        +      A  + Y APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERI 181

Query: 184 FGAKQ---YGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
                   Y    D+W+ G    EL + R P+    +   QL ++               
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--------------- 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                      V  P  +      S + +D  S+    + K R T  + ++H F
Sbjct: 227 -----------VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  140 bits (355), Expect = 1e-39
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 37/299 (12%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           A+       +G G YG V K +   +GQ +A+K+IR     E      L ++  +++   
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSD 79

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLS---PADIKSYM-QMTLKGLA 125
            P+I++   A   +G+  +  E M T  +   +     L    P +I   +   T+K L 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 126 FCHKKW-VLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELL 183
              +   ++HRD+KP+N+L+   G +KL DFG+  ++  S  +        R Y APE +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERI 197

Query: 184 FGAKQ---YGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
             +     Y    DVW+ G    EL   R P+ + +S  DQL ++            P  
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--------VKGDPPQ 249

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             L +  E ++             S   ++ ++   T D   R   ++ L+H F   + 
Sbjct: 250 --LSNSEEREF-------------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (351), Expect = 4e-39
 Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 36/295 (12%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
            +       +G GT G V+K    KTG  +A+K++R    KE      L ++  +LK   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHD 82

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH- 128
            P+I++    F    ++ +  E M T  E + +     +    +       +K L +   
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  V+HRD+KP+N+L+   GQ+KL DFG+  R+     +          Y APE +    
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPD 200

Query: 188 QYGAG----VDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     DVW+ G    EL   + P+    +D + L K+          + P L  L
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--------LQEEPPL--L 250

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           P ++ +               S D    +    T D + R    + LEH F K +
Sbjct: 251 PGHMGF---------------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  138 bits (348), Expect = 5e-38
 Identities = 79/366 (21%), Positives = 131/366 (35%), Gaps = 90/366 (24%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             RY     LG G +  V+ + D +  + VA+K   + K  E    TAL EI+LLK +++
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRN 92

Query: 71  --------PHIIELIDAFPHKGN--LH--LVFEFMETDLETVI-RNTNIFLSPADIKSYM 117
                     +++L+D F   G    H  +VFE +   L   I ++    L    +K  +
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 118 QMTLKGLAFCHKKW-VLHRDMKPNNLLIG------------------------------- 145
           Q  L+GL + H K  ++H D+KP N+L+                                
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 146 ------------------SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
                                ++K+AD G A       + FT  +  R YR+ E+L G+ 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSG 269

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQG------SSDIDQLGKIFAAFGTATPSQWPDLAY 241
            Y    D+W+  C+  EL       +       + D D +  I    G           Y
Sbjct: 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328

Query: 242 LPDYV----EYQYVAAPPLRSLFPSA----------SDDALDLLSKMFTYDPKARITAQQ 287
             ++     + +++       LF             +    D L  M    P+ R TA +
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388

Query: 288 ALEHRF 293
            L H +
Sbjct: 389 CLRHPW 394

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  134 bits (338), Expect = 5e-37
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 58/318 (18%)

Query: 1   MAEVDLSKKV--ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           + E+DLS     A  +   E++G GTYG VYK    KTGQ  AIK + +   +E      
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EI 67

Query: 59  LREIKLLKEL-KSPHIIELIDAF------PHKGNLHLVFEFME----TDLETVIRNTNIF 107
            +EI +LK+     +I     AF           L LV EF      TDL    +     
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-- 125

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDR 166
           L    I    +  L+GL+  H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  R
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 167 RFTHQVFA---RWYRAPELL----FGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDI 218
           R T   F     W  APE++         Y    D+W+ G I A E+    P L    D+
Sbjct: 186 RNT---FIGTPYWM-APEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL---CDM 237

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
             +  +F       P                    P L+S     S      +      +
Sbjct: 238 HPMRALF-----LIPRNPA----------------PRLKS--KKWSKKFQSFIESCLVKN 274

Query: 279 PKARITAQQALEHRFAKS 296
              R   +Q ++H F + 
Sbjct: 275 HSQRPATEQLMKHPFIRD 292

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  131 bits (331), Expect = 4e-36
 Identities = 50/212 (23%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EVLG+G +G   K    +TG+ + +K++    ++    F  L+E+K+++ L+ P++++ I
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVLKFI 73

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWVL 133
                   L+ + E+++   L  +I++ +     +     +        G+A+ H   ++
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR---VSFAKDIASGMAYLHSMNII 130

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARI---------------FGSPDRRFTHQVFARWYR 178
           HRD+  +N L+  +  + +ADFGLAR+                    +R+T      W  
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM- 189

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           APE++ G + Y   VDV++ G +  E++ R  
Sbjct: 190 APEMING-RSYDEKVDVFSFGIVLCEIIGRVN 220

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (332), Expect = 5e-36
 Identities = 51/310 (16%), Positives = 88/310 (28%), Gaps = 58/310 (18%)

Query: 12  DRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
                  +LGEG +  VY+A      D K  Q   +K  +     E   +   + ++ LK
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLK 122

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVI----RNTNIFLSPADIKSYMQMTL 121
                  ++   A   +    LV E      L   I          +    + S+    L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGS-----------HGQLKLADFGLARIFGS--PDRRF 168
             +   H   ++H D+KP+N ++G+              L L D G +           F
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           T +     ++  E+L   K +   +D +        +L                     F
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML---------------------F 280

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
           GT    +       P             R L     D   +    M        + +   
Sbjct: 281 GTYMKVKNEGGECKP---------EGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDL 329

Query: 289 LEHRFAKSFN 298
           L  +  K F 
Sbjct: 330 LRQKLKKVFQ 339

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  126 bits (319), Expect = 3e-34
 Identities = 43/252 (17%), Positives = 85/252 (33%), Gaps = 45/252 (17%)

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVI--RNTNIFLSPADIKSYM 117
           +I+ +    + + +  +     K  L++  +     +L+  +  R +             
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------ 165
               + + F H K ++HRD+KP+N+       +K+ DFGL       +            
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
              T QV  + Y +PE + G   Y   VD+++ G I  ELL    F      +  +  + 
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV- 286

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                  ++   P    LF         ++  M +  P  R  A
Sbjct: 287 --------------------RNLKF---PL---LFTQKYPQEHMMVQDMLSPSPTERPEA 320

Query: 286 QQALEHRFAKSF 297
              +E+   ++ 
Sbjct: 321 TDIIENAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 67.6 bits (165), Expect = 6e-13
 Identities = 27/139 (19%), Positives = 54/139 (38%), Gaps = 2/139 (1%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           + +    +   + +G G +GVV++A +       AIK+IRL   +E      +RE+K L 
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALA 59

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT-LKGLA 125
           +L+ P I+   +A+          E  E  L+    +  +          +++  +   +
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 126 FCHKKWVLHRDMKPNNLLI 144
             +    L        L I
Sbjct: 120 TKNTVGQLQPSSPKVYLYI 138

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  123 bits (312), Expect = 1e-33
 Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 42/220 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-----REIKLLKELKSPH 72
           + +G+G +G+V+K    K    VAIK + LG  +             RE+ ++  L  P+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
           I++L           +V EF+   DL   + +    +  +     +++ L    G+ +  
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK---LRLMLDIALGIEYMQ 139

Query: 129 --KKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIF--------GSPDRRFTHQVF 173
                ++HRD++  N+ + S  +      K+ADFGL++          G+          
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNF--------- 190

Query: 174 ARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELL-NRRPF 211
            +W  APE +    + Y    D ++   I   +L    PF
Sbjct: 191 -QW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  123 bits (312), Expect = 2e-33
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G++G V++A     G  VA+K +             LRE+ ++K L+ P+I+  +
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKK--W 131
            A     NL +V E++    L  ++  +       D +  + M     KG+ + H +   
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV-FARWYRAPELLFGAKQYG 190
           ++HR++K  NLL+     +K+ DFGL+R+  S             W  APE+L   +   
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW-MAPEVLRD-EPSN 217

Query: 191 AGVDVWAAGCIFAELLNRR-PF 211
              DV++ G I  EL   + P+
Sbjct: 218 EKSDVYSFGVILWELATLQQPW 239

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  123 bits (310), Expect = 4e-33
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV+G G +GVV KA      + VAIK+I    +++   F  + E++ L  +  P+I++L 
Sbjct: 14  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK--AF--IVELRQLSRVNHPNIVKLY 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHK---K 130
            A  +   + LV E+ E   L  V+      L        M   L   +G+A+ H    K
Sbjct: 68  GACLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVF-ARWYRAPELLFGAKQ 188
            ++HRD+KP NLL+ + G  LK+ DFG A    +     T+    A W  APE+  G   
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAW-MAPEVFEG-SN 179

Query: 189 YGAGVDVWAAGCIFAELLNRR-PF 211
           Y    DV++ G I  E++ RR PF
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF 203

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  121 bits (305), Expect = 1e-32
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 14/218 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+  +
Sbjct: 30  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L +V ++ E   L   +  +        +    + T +G+ + H K ++HRD
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR--APELLFG--AKQYGAG 192
           +K NN+ +     +K+ DFGLA            +  +      APE++    +  Y   
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 193 VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFG 229
            DV+A G +  EL+  + P+    S+I+   +I    G
Sbjct: 206 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIEMVG 239

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 2e-32
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 55/305 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G YG V+       G+ VA+K     ++     +    EI     ++  +I+  I
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFI 97

Query: 78  DA----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            A          L+L+ ++ E   L   +++T +     D KS +++      GL   H 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL-----DAKSMLKLAYSSVSGLCHLHT 152

Query: 129 -------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
                  K  + HRD+K  N+L+  +G   +AD GLA  F       D     +V  + Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
             PE+L  +      Q     D+++ G I  E+  RR    G  +  QL      +    
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSGGIVEEYQL-----PYHDLV 266

Query: 233 PSQWPDLAYLPDYVEYQYVAA-----PPLRSLFPSASDDAL--DLLSKMFTYDPKARITA 285
           PS        P Y + + +       P   + + S         L+++ + ++P +R+TA
Sbjct: 267 PSD-------PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 286 QQALE 290
            +  +
Sbjct: 320 LRVKK 324

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (303), Expect = 4e-32
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++G+G +G VY     +    VAI+ I + +  E       RE+   ++ +  +++  +
Sbjct: 39  ELIGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            A     +L ++    +   L +V+R+  I L     +   Q  +KG+ + H K +LH+D
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG---SPDRRFTHQVFARWYR--APELL-------- 183
           +K  N+    +G++ + DFGL  I G   +  R    ++   W    APE++        
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
                +    DV+A G I+ EL  R  PF
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPF 243

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (299), Expect = 7e-32
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPHIIE 75
           E++G G +G VY+A     G  VA+K  R    ++         +E KL   LK P+II 
Sbjct: 13  EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKK- 130
           L      + NL LV EF     L  V+    I          +   +   +G+ + H + 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-----PPDILVNWAVQIARGMNYLHDEA 125

Query: 131 --WVLHRDMKPNNLLIG--------SHGQLKLADFGLARIFGSPDRRFTHQVF-ARWYRA 179
              ++HRD+K +N+LI         S+  LK+ DFGLAR +    +          W  A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAW-MA 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
           PE++     +  G DVW+ G +  ELL    PF
Sbjct: 183 PEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (298), Expect = 1e-31
 Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 24/207 (11%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             L E   G ++K      G  + +K +++       +     E   L+    P+++ ++
Sbjct: 16  TKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 78  DAF--PHKGNLHLVFEFMET-DLETVIR-NTNIFLSPADIKSYMQMTL---KGLAFCH-- 128
            A   P   +  L+  +M    L  V+   TN  +  +     ++  L   +G+AF H  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA---VKFALDMARGMAFLHTL 130

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +  +    +   +++I      +++   +   F SP R +       W  APE L   K 
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV-APEALQK-KP 184

Query: 189 YGAG---VDVWAAGCIFAELLNRR-PF 211
                   D+W+   +  EL+ R  PF
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPF 211

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (298), Expect = 2e-31
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 59/307 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G YG V++   +  G+ VA+K      +K    +    E+     L+  +I+  I
Sbjct: 14  ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGFI 68

Query: 78  DA----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            +          L L+  + E   L   ++ T +     D  S +++ L    GLA  H 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL-----DTVSCLRIVLSIASGLAHLHI 123

Query: 129 -------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
                  K  + HRD+K  N+L+  +GQ  +AD GLA +        D     +V  + Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 178 RAPELL-----FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
            APE+L              VD+WA G +  E+  RR    G  +  +       F    
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNGIVEDYKP-----PFYDVV 237

Query: 233 PSQWPDLAYLPDYVEYQYVAA-----PPLRSLFPSASDDALDLLSKMFT----YDPKARI 283
           P+        P + + + V       P + + +   SD  L  L+K+       +P AR+
Sbjct: 238 PND-------PSFEDMRKVVCVDQQRPNIPNRWF--SDPTLTSLAKLMKECWYQNPSARL 288

Query: 284 TAQQALE 290
           TA +  +
Sbjct: 289 TALRIKK 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  119 bits (301), Expect = 2e-31
 Identities = 62/298 (20%), Positives = 117/298 (39%), Gaps = 58/298 (19%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIEL 76
            +G+G++G V       T +  A+K +   K  ++  V     +E+++++ L+ P ++ L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQGLEHPFLVNL 80

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVLH 134
             +F  + ++ +V + +   DL   ++    F     +K ++ ++ +  L +   + ++H
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF-KEETVKLFICELVM-ALDYLQNQRIIH 138

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLF 184
           RDMKP+N+L+  HG + + DF +A +           G+             Y APE+  
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP-----------YMAPEMFS 187

Query: 185 --GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                 Y   VD W+ G    ELL  RRP+   SS      +I   F T   +       
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEIVHTFETTVVT------- 238

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALEHRFAKSFN 298
            P                    S + + LL K+   +P  R           +    N
Sbjct: 239 YPSAW-----------------SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (295), Expect = 8e-31
 Identities = 66/308 (21%), Positives = 119/308 (38%), Gaps = 61/308 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G +G V++      G+ VA+K     +++    +    EI     L+  +I+  I
Sbjct: 48  ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFI 102

Query: 78  DAFPHKGNLH----LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHK 129
            A            LV ++ E   L   +    +      ++  +++ L    GLA  H 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHLHM 157

Query: 130 KW--------VLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
           +         + HRD+K  N+L+  +G   +AD GLA        + D    H+V  + Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
            APE+L  +      +     D++A G +F E+  R                 +  G   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----------------CSIGGIHE 261

Query: 233 PSQWPDLAYLPDYVE----YQYVAAPPLRSLFPSA--SDDALDLLSKMFT----YDPKAR 282
             Q P    +P         + V    LR   P+   S +AL +++K+       +  AR
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

Query: 283 ITAQQALE 290
           +TA +  +
Sbjct: 322 LTALRIKK 329

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 2e-30
 Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 8/208 (3%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLK 66
                Y  R ++G G  G VY+A DT   + VA+K +      +   F     RE +   
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAG 89

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L+ PH++ + D     G L++    +   DL  ++R     L+P    + ++     L 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALD 148

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLF 184
             H     HRD+KP N+L+ +     L DFG+A                   Y APE   
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPF 211
                    D++A  C+  E L    P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (291), Expect = 3e-30
 Identities = 71/312 (22%), Positives = 115/312 (36%), Gaps = 58/312 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++G G YG VYK   +   + VA+K      ++    F   + I  +  ++  +I   I
Sbjct: 19  ELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFI 73

Query: 78  DA-----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
                     +    LV E+     L   +          D  S  ++     +GLA+ H
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLH 128

Query: 129 ---------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQ 171
                    K  + HRD+   N+L+ + G   ++DFGL+           G  D     +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 172 VFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
           V    Y APE+L GA      +     VD++A G I+ E+  R   L     + +     
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ--- 245

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT-------YD 278
            AF T   +  P    +   V  +       R  FP A  +    +  +          D
Sbjct: 246 MAFQTEVGNH-PTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 279 PKARITAQQALE 290
            +AR+TAQ A E
Sbjct: 300 AEARLTAQXAEE 311

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  114 bits (287), Expect = 5e-30
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           K + +RY   + LG G    VY A DT     VAIK I +  +++         RE+   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNS 65

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
            +L   +I+ +ID        +LV E++E   L   I +    LS     ++    L G+
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGI 124

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPEL 182
              H   ++HRD+KP N+LI S+  LK+ DFG+A+         T+ V    + Y +PE 
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ-YFSPEQ 183

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
             G +      D+++ G +  E+L    PF
Sbjct: 184 AKG-EATDECTDIYSIGIVLYEMLVGEPPF 212

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  114 bits (287), Expect = 9e-30
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV   G +G V+KA      + VA+K   +  ++    +    E+  L  +K  +I++ I
Sbjct: 30  EVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFI 84

Query: 78  DAFPHKGNLH----LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            A     ++     L+  F E   L   ++   +            +     +GLA+ H 
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV-----SWNELCHIAETMARGLAYLHE 139

Query: 129 ---------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWY 177
                    K  + HRD+K  N+L+ ++    +ADFGLA  F  G        QV  R Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 178 RAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            APE+L GA    +     +D++A G +  EL +R     G  D   L      F     
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML-----PFEEEIG 254

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT----YDPKARITAQQAL 289
              P L  + + V ++    P LR  +       + +L +       +D +AR++A    
Sbjct: 255 QH-PSLEDMQEVVVHK-KKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 290 E 290
           E
Sbjct: 311 E 311

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (295), Expect = 1e-29
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           VA +Y  +  +  G  G +Y A+D    G+ V +K +      E     A+ E + L E+
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA-MAMAERQFLAEV 136

Query: 69  KSPHIIELIDAFPHKGN-----LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK 122
             P I+++ +   H         ++V E++    L+         L  A+  +Y+   L 
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILP 193

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFAR 175
            L++ H   +++ D+KP N+++ +  QLKL D G          ++G+P           
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLYGTPG---------- 242

Query: 176 WYRAPELLFGAKQYGAGV--DVWAAGCIFAELLNRRPFLQGSS 216
            ++APE++      G  V  D++  G   A L    P   G  
Sbjct: 243 -FQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRNGRY 280

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (280), Expect = 7e-29
 Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 55/298 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +LGEG++  V  A +  T +  AIK   K  + K+ + V +   RE  ++  L  P  ++
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYV-TRERDVMSRLDHPFFVK 94

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVL 133
           L   F     L+    + +  +L   IR    F      + Y  ++    L + H K ++
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVS-ALEYLHGKGII 152

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF---ARWYRAPELLFGAKQYG 190
           HRD+KP N+L+     +++ DFG A++     ++     F   A+ Y +PELL   K   
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ-YVSPELLTE-KSAC 210

Query: 191 AGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D+WA GCI  +L+    PF   + +   +                          +Q
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFR--AGNEYLI--------------------------FQ 242

Query: 250 YVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARIT------AQQALEHRFAKSFNGV 300
            +        FP      A DL+ K+   D   R+             H F   F  V
Sbjct: 243 KIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF---FESV 295

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  114 bits (286), Expect = 2e-28
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 64/303 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKS---PHI 73
           ++G G +G VY      TG+  A+K +     K K+G     L E  +L  + +   P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 254

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELL 183
           ++RD+KP N+L+  HG ++++D GLA  F         G+             Y APE+L
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG-----------YMAPEVL 362

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                Y +  D ++ GC+  +LL    PF Q  + D  ++                    
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------------- 402

Query: 242 LPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRFAK 295
                  +      +    P + S +   LL  +   D   R+      AQ+  E  F +
Sbjct: 403 ------DRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 296 SFN 298
           S +
Sbjct: 455 SLD 457

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  109 bits (274), Expect = 6e-28
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 24/220 (10%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
             ++DRY   E+LG G    V+ A D +  + VA+K +R    ++  +F     RE +  
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNA 66

Query: 66  KELKSPHIIELID---AFPHKGNLH-LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMT 120
             L  P I+ + D   A    G L  +V E+++   L  ++      ++P      +   
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADA 125

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH--------QV 172
            + L F H+  ++HRD+KP N++I +   +K+ DFG+AR         T         Q 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ- 184

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPF 211
               Y +PE   G     A  DV++ GC+  E+L    PF
Sbjct: 185 ----YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (264), Expect = 8e-27
 Identities = 38/283 (13%), Positives = 68/283 (24%), Gaps = 58/283 (20%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKE 67
              RY      G       ++A+DT   + VA+  +         +     L     L  
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ-GVLPDDVLQETLSRTLRLSR 87

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +  ++D    +    +V E++    L+ V   +    SP      MQ        
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADA 144

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            H+  V      P+ + +   G + LA                                 
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA----- 179

Query: 187 KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
                  D+   G     LL NR P  +                +       D A  P  
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVR------------SGLAPAERDTAGQP-- 222

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                        +          + ++    D   R  +   
Sbjct: 223 --------IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  108 bits (272), Expect = 1e-26
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G +G V       TG+  A KK+     K+++G     L E ++L+++ S  ++ L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSL 249

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A+  K  L LV   M   DL+  I +        A    Y      GL   H++ +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRF--THQVFARWYRAPELLFGAKQYG 190
           RD+KP N+L+  HG ++++D GLA     G   +    T       Y APE++   ++Y 
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG-----YMAPEVVKN-ERYT 363

Query: 191 AGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D WA GC+  E++  + PF Q      +  ++                   +     
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEE-------YSERF--- 412

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                         S  A  L S++   DP  R+     +A++  EH   K  N
Sbjct: 413 --------------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  107 bits (268), Expect = 4e-26
 Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 57/301 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG G +G V+      TG+  A KK+     K+++G     + E K+L ++ S  I+ L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSL 250

Query: 77  IDAFPHKGNLHLVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
             AF  K +L LV   M        +  V  +   F        Y    + GL   H++ 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFYTAQIVSGLEHLHQRN 309

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---F--THQVFARWYRAPELLFGA 186
           +++RD+KP N+L+   G ++++D GLA    +   +   +  T       + APELL G 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG-----FMAPELLLG- 363

Query: 187 KQYGAGVDVWAAGCIFAELLN-RRPFLQ--GSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           ++Y   VD +A G    E++  R PF       +  +L                      
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---------------------- 401

Query: 244 DYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSF 297
                Q V    +   +P   S  + D    +   DP+ R+     +      H   +  
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

Query: 298 N 298
           +
Sbjct: 456 S 456

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/305 (22%), Positives = 116/305 (38%), Gaps = 63/305 (20%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G G +G V         +  A+K +    + K+ E   F   R++  L    S  I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITT 138

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF    NL+LV ++    DL T++      L     + Y+   +  +   H+   +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWYRAPEL 182
           RD+KP+N+L+  +G ++LADFG                 G+PD           Y +PE+
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-----------YISPEI 247

Query: 183 L----FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           L     G  +YG   D W+ G    E+L         S ++  GKI             +
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------NHKE 298

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRFAK 295
               P  V                 S++A DL+ ++     + R+      +   H F  
Sbjct: 299 RFQFPTQV--------------TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF-- 341

Query: 296 SFNGV 300
            F+G+
Sbjct: 342 -FSGI 345

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 2e-25
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK  + LG+G +G V       +   TG+ VA+KK++   ++   +F   REI++LK 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIEILKS 98

Query: 68  LKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+  +I++         + NL L+ E++    L   ++     +    +  Y     KG+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   K  +HRD+   N+L+ +  ++K+ DFGL ++       +  +        WY AP
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-AP 217

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKI 224
           E L     ++    DVW+ G +  EL     +     +  +  +G  
Sbjct: 218 ESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (255), Expect = 2e-25
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK  + LG+G +G V       +   TG+ VA+KK++   ++   +F   REI++LK 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIEILKS 67

Query: 68  LKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+  +I++         + NL L+ E++    L   ++     +    +  Y     KG+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   K  +HRD+   N+L+ +  ++K+ DFGL ++       F  +        WY AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-AP 186

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKI 224
           E L     ++    DVW+ G +  EL     +     +  +  +G  
Sbjct: 187 ESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  102 bits (256), Expect = 3e-25
 Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 64/299 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            LG G++G V      ++G   A+K   K ++ K K+ +  T L E ++L+ +  P +++
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLVK 105

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F    NL++V E++   ++ + +R    F S    + Y    +    + H   +++
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIY 164

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQVFARWYRAPELLFGA 186
           RD+KP NLLI   G +++ DFG A+          G+P+             APE++   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------ALAPEIILS- 212

Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           K Y   VD WA G +  E+     PF   +    Q+                        
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI------------------------ 246

Query: 246 VEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQA-----LEHRFAKSFN 298
             Y+ + +  +R  FPS  S D  DLL  +   D   R    +        H++  + +
Sbjct: 247 --YEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (254), Expect = 5e-25
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 66/300 (22%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            LG G++G V+       G+  A+K   K  + + K+ V  T   E  +L  +  P II 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHT-NDERLMLSIVTHPFIIR 70

Query: 76  LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVL 133
           +   F     + ++ +++E  +L +++R +  F      K Y  ++ L  L + H K ++
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCL-ALEYLHSKDII 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQVFARWYRAPELLFG 185
           +RD+KP N+L+  +G +K+ DFG A+          G+PD           Y APE++  
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-----------YIAPEVVST 177

Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            K Y   +D W+ G +  E+L    PF    S+  +                        
Sbjct: 178 -KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT----------------------- 211

Query: 245 YVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
              Y+ +    LR  FP   ++D  DLLS++ T D   R+       +    H + K   
Sbjct: 212 ---YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  101 bits (251), Expect = 8e-25
 Identities = 60/340 (17%), Positives = 91/340 (26%), Gaps = 84/340 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN------FTALREIKLL 65
           ++  + E +GEG +G V++ I   T   VAIK I +                 L EI + 
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 66  KEL---------KSPHIIELIDAFPHKG------------------------------NL 86
           KEL         ++   I L      +G                               L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 87  HLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDMKPNNLL 143
            +V EF     DLE +        S A  KS +      LA         HRD+   N+L
Sbjct: 138 FIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 144 IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFA 203
           +      KL      +    P      QV    Y    L                  +F 
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPS--CGLQVSIIDYTLSRLE------------RDGIVVFC 240

Query: 204 ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD---------LAYLPDY-VEYQYVAA 253
           ++        G  D D    I+        ++W +         L YL D  ++      
Sbjct: 241 DVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT 298

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                          +    M  +      +A   L    
Sbjct: 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  101 bits (254), Expect = 1e-24
 Identities = 69/307 (22%), Positives = 115/307 (37%), Gaps = 66/307 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G G +  V      +TGQ  A+K +    + K+ E   F   R++  L       I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQ 125

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF  +  L+LV E+    DL T++      +     + Y+   +  +   H+   +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWYRAPEL 182
           RD+KP+N+L+   G ++LADFG                 G+PD           Y +PE+
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD-----------YLSPEI 234

Query: 183 L------FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL-GKIFAAFGTATPS 234
           L       G   YG   D WA G    E+   + PF   +    +  GKI          
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY--ADSTAETYGKIV--------- 283

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---H 291
            + +   LP                     ++A D + ++    P+ R+    A +   H
Sbjct: 284 HYKEHLSLPLVD--------------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328

Query: 292 RFAKSFN 298
            F    +
Sbjct: 329 PFFFGLD 335

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 98.2 bits (245), Expect = 9e-24
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK    LG+G +G V           TG  VA+K+++     +  +F   REI++LK 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--QREIQILKA 80

Query: 68  LKSPHIIELID--AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L S  I++       P + +L LV E++ +  L   ++     L  + +  Y     KG+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   +  +HRD+   N+L+ S   +K+ADFGLA++       +  +        WY AP
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-AP 199

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL 206
           E L      +    DVW+ G +  EL 
Sbjct: 200 ESLSDN--IFSRQSDVWSFGVVLYELF 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 11/188 (5%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPHIIEL 76
           E +G G +G V+          VA+K  R     +    F  L+E ++LK+   P+I+ L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF--LQEARILKQYSHPNIVRL 177

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
           I     K  +++V E ++  D  T +R     L    +   +     G+ +   K  +HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPD---RRFTHQVFARWYRAPE-LLFGAKQYGA 191
           D+   N L+     LK++DFG++R              QV  +W  APE L +G  +Y +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYG--RYSS 294

Query: 192 GVDVWAAG 199
             DVW+ G
Sbjct: 295 ESDVWSFG 302

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 76/308 (24%), Positives = 129/308 (41%), Gaps = 67/308 (21%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG G YG V+   K     TG+  A+K ++    + K K   +    R++ L    +SP
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSP 119

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHK 129
            ++ L  AF  +  LHL+ +++   +L T +     F +  +++ Y+ ++ L  L   HK
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGEIVL-ALEHLHK 177

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWY 177
             +++RD+K  N+L+ S+G + L DFGL++ F            G+ +           Y
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE-----------Y 226

Query: 178 RAPELLFGAKQ-YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
            AP+++ G    +   VD W+ G +  ELL    PF        Q  +I      + P  
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSEPP- 284

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALE 290
                  P  +                 S  A DL+ ++   DPK R+      A +  E
Sbjct: 285 ------YPQEM-----------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321

Query: 291 HRFAKSFN 298
           H F +  N
Sbjct: 322 HLFFQKIN 329

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 66/302 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELKSPHIIE 75
           VLG+G++G V  +    T +  A+K ++     Q + V  T   + + L    K P + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQ 406

Query: 76  LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F     L+ V E++   DL   I+    F  P     Y      GL F   K +++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIGLFFLQSKGIIY 465

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+++ S G +K+ADFG+           + F G+PD           Y APE++
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----------YIAPEII 514

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + YG  VD WA G +  E+L  + PF     D D+L                     
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL--------------------- 550

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKS 296
                +Q +    +   +P S S +A+ +   + T  P  R+       +   EH F + 
Sbjct: 551 -----FQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

Query: 297 FN 298
            +
Sbjct: 604 ID 605

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.1 bits (237), Expect = 7e-23
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLK 66
           R+LK    LGEG +G V           TG+ VA+K ++       +      +EI++L+
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--KKEIEILR 78

Query: 67  ELKSPHIIELIDAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   +I++        G   + L+ EF+ +  L+  +      ++      Y     KG
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRA 179
           + +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +    +T +        WY A
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-A 197

Query: 180 PE-LLFGAKQYGAGVDVWAAG 199
           PE L+    ++    DVW+ G
Sbjct: 198 PECLMQS--KFYIASDVWSFG 216

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G YG VY+ +  K   TVA+K ++    +    F  L+E  ++KE+K P++++L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF--LKEAAVMKEIKHPNLVQLL 282

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +   +++ EFM   +L   +R  N   +S   +          + +  KK  +HR
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGV 193
           ++   N L+G +  +K+ADFGL+R+            +   +W  APE L    ++    
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-APESLA-YNKFSIKS 400

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVWA G +  E+      P+
Sbjct: 401 DVWAFGVLLWEIATYGMSPY 420

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.9 bits (237), Expect = 1e-22
 Identities = 71/304 (23%), Positives = 123/304 (40%), Gaps = 69/304 (22%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHI 73
           VLG+G++G V+   K   +   Q  A+K ++    K ++ V     R+I  L E+  P I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFI 88

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   +
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGI 147

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRAPE 181
           ++RD+KP N+L+   G +KL DFGL++             G+ +           Y APE
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-----------YMAPE 196

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ++   + +    D W+ G +  E+L    PF     D  +                    
Sbjct: 197 VVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ--GKDRKET------------------- 234

Query: 241 YLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRFA 294
                     +    L    P   S +A  LL  +F  +P  R+       ++   H F 
Sbjct: 235 -------MTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

Query: 295 KSFN 298
            + +
Sbjct: 286 STID 289

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 74/321 (23%), Positives = 118/321 (36%), Gaps = 65/321 (20%)

Query: 5   DLSKKVADRYLKRE------VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVN 55
           D   K+ D  +K E      V+G G +G V       T +  A+K +    + K+ +   
Sbjct: 56  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115

Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIK 114
           F   R+I  +    SP +++L  AF     L++V E+M   DL  ++ N ++       +
Sbjct: 116 FWEERDI--MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWAR 171

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA 174
            Y    +  L   H    +HRD+KP+N+L+   G LKLADFG                  
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC----- 226

Query: 175 RW-------YRAPELLF---GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQL-G 222
                    Y +PE+L    G   YG   D W+ G  ++  L+   PF   +  +     
Sbjct: 227 -DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYS 283

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
           KI           +PD   +                     S +A +L+    T D + R
Sbjct: 284 KIMNH---KNSLTFPDDNDI---------------------SKEAKNLICAFLT-DREVR 318

Query: 283 ITAQQALE---HRFAKSFNGV 300
           +      E   H F   F   
Sbjct: 319 LGRNGVEEIKRHLF---FKND 336

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 73/306 (23%), Positives = 122/306 (39%), Gaps = 71/306 (23%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF        Y+      L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF-MEDTACFYLAEISMALGHLHQK 140

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRA 179
            +++RD+KP N+++   G +KL DFGL +             G+ +           Y A
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE-----------YMA 189

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE+L     +   VD W+ G +  ++L    PF     +  +                  
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT--GENRKKT----------------- 229

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                       +    L    P   + +A DLL K+   +  +R+      A +   H 
Sbjct: 230 ---------IDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278

Query: 293 FAKSFN 298
           F +  N
Sbjct: 279 FFRHIN 284

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 93.5 bits (233), Expect = 2e-22
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           +    LG G +G V + +     +   VAIK ++ G ++ +      +RE +++ +L +P
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM--MREAQIMHQLDNP 70

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+ LI        L LV E      L   +      +  +++   +     G+ +  +K
Sbjct: 71  YIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFG 185
             +HRD+   N+L+ +    K++DFGL++  G+ D  +T +       +WY APE + F 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 188

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPF 211
             ++ +  DVW+ G    E L+  ++P+
Sbjct: 189 --KFSSRSDVWSYGVTMWEALSYGQKPY 214

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 64/304 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELK 69
              K  +LG+G++G V+ A   KT Q  AIK ++       + V  T   + + L    +
Sbjct: 20  ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWE 76

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +  +   F  K NL  V E++   DL   I++ + F        Y    + GL F H
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-RATFYAAEIILGLQFLH 135

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWY 177
            K +++RD+K +N+L+   G +K+ADFG+ +             G+PD           Y
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-----------Y 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE+L G ++Y   VD W+ G +  E+L  + PF     D ++L               
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH--GQDEEEL--------------- 226

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQAL-EHRFA 294
                      +  +        +P     +A DLL K+F  +P+ R+  +  + +H   
Sbjct: 227 -----------FHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

Query: 295 KSFN 298
           +  N
Sbjct: 274 REIN 277

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 67/307 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKS 70
            YLK  +LG+GT+G V    +  TG+  A+K +R      K+ V  T + E ++L+  + 
Sbjct: 8   DYLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRH 64

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHS 123

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYR 178
           + V++RD+K  NL++   G +K+ DFGL           + F G+P+           Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----------YL 172

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L                
Sbjct: 173 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERL---------------- 213

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEH 291
                     ++ +    +R  FP + S +A  LL+ +   DPK R+      A++ +EH
Sbjct: 214 ----------FELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 292 RFAKSFN 298
           RF  S N
Sbjct: 262 RFFLSIN 268

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 78/308 (25%), Positives = 129/308 (41%), Gaps = 68/308 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKS 70
            YLK  +LG+GT+G V    +  TG+  A+K ++      K+ V  T L E ++L+  + 
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH- 128
           P +  L  +F     L  V E+    +L   +    +F      + Y    +  L + H 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHS 266

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWY 177
           +K V++RD+K  NL++   G +K+ DFGL           + F G+P+           Y
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------Y 315

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE+L     YG  VD W  G +  E++  R PF   + D ++L               
Sbjct: 316 LAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL--------------- 357

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALE 290
                      ++ +    +R  FP     +A  LLS +   DPK R+      A++ ++
Sbjct: 358 -----------FELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404

Query: 291 HRFAKSFN 298
           HRF     
Sbjct: 405 HRFFAGIV 412

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.3 bits (230), Expect = 6e-22
 Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 14/192 (7%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHI 73
           E LG+G++GVV +      +    +VA+K ++     +       +RE+  +  L   ++
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E      L   +R          +  Y     +G+ +   K  
Sbjct: 84  IRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   NLL+ +   +K+ DFGL R     D  +  Q        W  APE L     
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLKTR-- 199

Query: 188 QYGAGVDVWAAG 199
            +    D W  G
Sbjct: 200 TFSHASDTWMFG 211

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 15/189 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G YG VY+ +  K   TVA+K ++    +    F  L+E  ++KE+K P++++L+
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF--LKEAAVMKEIKHPNLVQLL 75

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +   +++ EFM   +L   +R  N   +S   +          + +  KK  +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D+   N L+G +  +K+ADFGL+R+       +T    A    +W  APE L +   ++ 
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWT-APESLAYN--KFS 190

Query: 191 AGVDVWAAG 199
              DVWA G
Sbjct: 191 IKSDVWAFG 199

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G VYK +      K    VAIK++R     K       L E  ++  + +PH
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNPH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +  L+        + L+ + M    L   +R     +    + ++     KG+ +   + 
Sbjct: 79  VCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA-RWYRAPE-LLFGAK 187
           ++HRD+   N+L+ +   +K+ DFGLA++ G+ +            +W  A E +L    
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHR-- 194

Query: 188 QYGAGVDVWAAG 199
            Y    DVW+ G
Sbjct: 195 IYTHQSDVWSYG 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 13/193 (6%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ + LG G +G V K      K  +TVA+K ++       +    L E  ++++L +P+
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ +I       +  LV E  E   L   ++  N  +   +I   +     G+ +  +  
Sbjct: 80  IVRMI-GICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGA 186
            +HRD+   N+L+ +    K++DFGL++   + +  +  Q       +WY APE + +  
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYY- 195

Query: 187 KQYGAGVDVWAAG 199
            ++ +  DVW+ G
Sbjct: 196 -KFSSKSDVWSFG 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.0 bits (229), Expect = 1e-21
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLK 66
           RYLK    LGEG +G V        +  TG+ VA+K ++     +  + +   +EI +L+
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW--KQEIDILR 88

Query: 67  ELKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   HII+           +L LV E++    L   +   +  +  A +  + Q   +G
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEG 146

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRA 179
           +A+ H +  +HRD+   N+L+ +   +K+ DFGLA+        +  +        WY A
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 205

Query: 180 PE-LLFGAKQYGAGVDVWAAG 199
           PE L     ++    DVW+ G
Sbjct: 206 PECLKEY--KFYYASDVWSFG 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 50/208 (24%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 15  LKREVLGEGTYGVVYKAI-DTKTGQT-VAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           +    LG G +G V + +   +  Q  VAIK ++ G ++ +      +RE +++ +L +P
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM--MREAQIMHQLDNP 396

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+ LI        L LV E      L   +      +  +++   +     G+ +  +K
Sbjct: 397 YIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFG 185
             +HR++   N+L+ +    K++DFGL++  G+ D  +T +       +WY APE + F 
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 514

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPF 211
             ++ +  DVW+ G    E L+  ++P+
Sbjct: 515 --KFSSRSDVWSYGVTMWEALSYGQKPY 540

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 90.4 bits (225), Expect = 4e-21
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 17/194 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY      +       A+K +       E   F  L E  ++K+   P++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 88

Query: 74  IELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA---RWYRAPE-LLFG 185
            +HRD+   N ++     +K+ADFGLAR     +              +W  A E L   
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQ 207

Query: 186 AKQYGAGVDVWAAG 199
             ++    DVW+ G
Sbjct: 208 --KFTTKSDVWSFG 219

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 68/308 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELK 69
            +L   VLG+G++G V  +    T +  A+K ++     Q + V  T   + + L    K
Sbjct: 23  NFLM--VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGK 79

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P + +L   F     L+ V E++   DL   I+    F  P     Y      GL F  
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIGLFFLQ 138

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWY 177
            K +++RD+K +N+++ S G +K+ADFG+           + F G+PD           Y
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----------Y 187

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   + YG  VD WA G +  E+L  + PF     D D+L               
Sbjct: 188 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL--------------- 229

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALE 290
                      +Q +    +   +P S S +A+ +   + T  P  R+       +   E
Sbjct: 230 -----------FQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276

Query: 291 HRFAKSFN 298
           H F +  +
Sbjct: 277 HAFFRYID 284

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.9 bits (228), Expect = 6e-21
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG+G +G V+      T + VAIK ++ G       F  L+E +++K+L+   +++L 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE-AF--LQEAQVMKKLRHEKLVQLY 328

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +  +++V E+M    L   ++  T  +L    +         G+A+  +   +HR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFA-RWYRAPELLFGAKQYGAGV 193
           D++  N+L+G +   K+ADFGLAR I  +         F  +W  APE      ++    
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAAL-YGRFTIKS 445

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  EL    R P+
Sbjct: 446 DVWSFGILLTELTTKGRVPY 465

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 90.0 bits (224), Expect = 9e-21
 Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 52/281 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFT-ALREIKLLKELKSPHIIE 75
           V+G G+Y  V      KT +  A+K ++       E +++    + +   +    P ++ 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG 74

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  +  L  V E++   DL   ++           + Y       L + H++ +++
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLALNYLHERGIIY 133

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ S G +KL D+G+             F G+P+           Y APE+L
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----------YIAPEIL 182

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G + YG  VD WA G +  E++  R PF    S  +                     YL
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------------TEDYL 227

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKAR 282
                +Q +    +R   P S S  A  +L      DPK R
Sbjct: 228 -----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      K    VA+K I+ G   E   F   +E + + +L  P +++  
Sbjct: 14  KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSE-DEF--FQEAQTMMKLSHPKLVKFY 69

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  +++V E++    L   +R+    L P+ +        +G+AF      +HRD
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYGA 191
           +   N L+     +K++DFG+ R     D ++   V      +W  APE   +   +Y +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWS-APEVFHYF--KYSS 184

Query: 192 GVDVWAAGCIFAELLN--RRPF 211
             DVWA G +  E+ +  + P+
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPY 206

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 5   DLSKKVADRYLKRE--------VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKE 52
            L  +V D  +  E        V+G+G +GVVY        +     AIK +    + ++
Sbjct: 6   ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ 65

Query: 53  GVNFTALREIKLLKELKSPHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSP 110
              F  LRE  L++ L  P+++ LI    P +G  H++  +M   DL   IR+     + 
Sbjct: 66  VEAF--LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----R 166
            D+ S+     +G+ +  ++  +HRD+   N ++     +K+ADFGLAR     +    +
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183

Query: 167 RFTHQVF-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
           +  H     +W  A E L     ++    DVW+ G
Sbjct: 184 QHRHARLPVKWT-ALESLQTY--RFTTKSDVWSFG 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G VYK +      K    VAIK++R     K       L E  ++  + +PH
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNPH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +  L+        + L+ + M    L   +R     +    + ++     KG+ +   + 
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE-LLFGAK 187
           ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W  A E +L    
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHR-- 194

Query: 188 QYGAGVDVWAAG 199
            Y    DVW+ G
Sbjct: 195 IYTHQSDVWSYG 206

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 65/301 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G+G++G V  A         A+K ++   + K+KE  +  + R + LLK +K P ++ 
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 103

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   +++
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAAEIASALGYLHSLNIVY 162

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+KP N+L+ S G + L DFGL             F G+P+           Y APE+L
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-----------YLAPEVL 211

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + Y   VD W  G +  E+L    PF   S +  ++                     
Sbjct: 212 HK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM--------------------- 247

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQALE----HRFAKSF 297
                Y  +   PL+     + ++ A  LL  +   D   R+ A+        H F    
Sbjct: 248 -----YDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

Query: 298 N 298
           N
Sbjct: 301 N 301

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 19/188 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V        G  VA+K I+     +   F  L E  ++ +L+  ++++L+
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ--AF--LAEASVMTQLRHSNLVQLL 252

Query: 78  DA-FPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 KG L++V E+M    L   +R+     L    +  +     + + +      +H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE-LLFGAKQYGA 191
           RD+   N+L+      K++DFGL +         +       +W  APE L     ++  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP----VKWT-APEALREK--KFST 365

Query: 192 GVDVWAAG 199
             DVW+ G
Sbjct: 366 KSDVWSFG 373

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           +V+G G +G VYK +      K    VAIK ++ G  +K+ V+F  L E  ++ +    +
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMGQFSHHN 107

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           II L         + ++ E+ME   L+  +R  +   S   +   ++    G+ +     
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGA 186
            +HRD+   N+L+ S+   K++DFGL+R+                  RW  APE + +  
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-APEAISYR- 225

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
            ++ +  DVW+ G +  E++    RP+    S+ + +  I
Sbjct: 226 -KFTSASDVWSFGIVMWEVMTYGERPY-WELSNHEVMKAI 263

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPH 72
           ++LGEG +G V +     +  T   VA+K  K+    Q+E   F  L E   +K+   P+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF--LSEAACMKDFSHPN 97

Query: 73  IIELI-----DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTL--- 121
           +I L+      +        ++  FM+  DL T +  + +   P  I  ++ ++  +   
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYR 178
            G+ +   +  LHRD+   N ++     + +ADFGL++   S D  R+        +W  
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI- 216

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
           A E L      Y +  DVWA G
Sbjct: 217 AIESLADR--VYTSKSDVWAFG 236

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG+G +G V+      T + VAIK ++ G       F  L+E +++K+L+   +++L 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE-AF--LQEAQVMKKLRHEKLVQLY 245

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +  +++V E+M    L   ++  T  +L    +         G+A+  +   +HR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFA-RWYRAPELLFGAKQYGAGV 193
           D++  N+L+G +   K+ADFGLAR I  +         F  +W  APE      ++    
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAAL-YGRFTIKS 362

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  EL    R P+
Sbjct: 363 DVWSFGILLTELTTKGRVPY 382

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V        +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+LI S+   K++DFGL R+                  RW  +PE + +   
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPEAIAYR-- 225

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPF 211
           ++ +  DVW+ G +  E+++   RP+
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPY 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 78/305 (25%), Positives = 119/305 (39%), Gaps = 71/305 (23%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK----QKEGVNFT-ALREIKLLKELKSPHI 73
           VLG+G++G V  A   +TG   A+K ++  K    Q + V  T   + I L      P +
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--KDVILQDDDVECTMTEKRI-LSLARNHPFL 86

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            +L   F     L  V EF+   DL   I+ +  F   A  + Y    +  L F H K +
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEIISALMFLHDKGI 145

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRAPE 181
           ++RD+K +N+L+   G  KLADFG+ +             G+PD           Y APE
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-----------YIAPE 194

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     YG  VD WA G +  E+L    PF   + + D L                   
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE--AENEDDL------------------- 232

Query: 241 YLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI------TAQQALEHRF 293
                  ++ +    +   +P    +DA  +L    T +P  R+           L H F
Sbjct: 233 -------FEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

Query: 294 AKSFN 298
            K  +
Sbjct: 284 FKEID 288

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 52/281 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFT-ALREIKLLKELKSPHIIE 75
           V+G G+Y  V      KT +  A++ ++       E +++    + +   +    P ++ 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG 117

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  +  L  V E++   DL   ++           + Y       L + H++ +++
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLALNYLHERGIIY 176

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ S G +KL D+G+             F G+P+           Y APE+L
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----------YIAPEIL 225

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G + YG  VD WA G +  E++  R PF    S  +                     YL
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------------TEDYL 270

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKAR 282
                +Q +    +R   P S S  A  +L      DPK R
Sbjct: 271 -----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 47/192 (24%), Positives = 87/192 (45%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G V+K +    G+     V IK I     ++          +  +  L   H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV--TDHMLAIGSLDHAH 76

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+       +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 77  IVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE-LLFGAK 187
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +       +W  A E + FG  
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIHFG-- 192

Query: 188 QYGAGVDVWAAG 199
           +Y    DVW+ G
Sbjct: 193 KYTHQSDVWSYG 204

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G G +G+V+          VAIK IR G   E  +F  + E +++ +L  P +++L 
Sbjct: 14  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE-EDF--IEEAEVMMKLSHPKLVQLY 69

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + LV EFME   L   +R      +   +        +G+A+  +  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFA-RWYRAPE-LLFGAKQYGAGV 193
           +   N L+G +  +K++DFG+ R          T   F  +W  +PE   F   +Y +  
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-SPEVFSFS--RYSSKS 186

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  E+ +  + P+
Sbjct: 187 DVWSFGVLMWEVFSEGKIPY 206

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 45/202 (22%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V        G  VA+K I+     +   F  L E  ++ +L+  ++++L+
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ--AF--LAEASVMTQLRHSNLVQLL 80

Query: 78  DA-FPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 KG L++V E+M    L   +R+     L    +  +     + + +      +H
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE-LLFGAKQYGA 191
           RD+   N+L+      K++DFGL +         +       +W  APE L     ++  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP----VKWT-APEALREK--KFST 193

Query: 192 GVDVWAAGCIFAEL--LNRRPF 211
             DVW+ G +  E+    R P+
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPY 215

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.6 bits (218), Expect = 3e-20
 Identities = 46/192 (23%), Positives = 77/192 (40%), Gaps = 18/192 (9%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
            +LGEG +G VY+ +          VA+K  +          F  + E  ++K L  PHI
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF--MSEAVIMKNLDHPHI 75

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +    ++ E     +L   +      L    +  Y     K +A+      
Sbjct: 76  VKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+L+ S   +KL DFGL+R     D  +          +W  +PE + F   
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDED--YYKASVTRLPIKWM-SPESINFR-- 189

Query: 188 QYGAGVDVWAAG 199
           ++    DVW   
Sbjct: 190 RFTTASDVWMFA 201

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.7 bits (220), Expect = 3e-20
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 17/194 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY      +       A+K +       E   F  L E  ++K+   P++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 152

Query: 74  IELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA-----RWYRAPE-LLFG 185
            +HRD+   N ++     +K+ADFGLAR     +    H         +W  A E L   
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQ 271

Query: 186 AKQYGAGVDVWAAG 199
             ++    DVW+ G
Sbjct: 272 --KFTTKSDVWSFG 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.9 bits (216), Expect = 5e-20
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G V++ I          VAIK  +          F  L+E   +++   PHI
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF--LQEALTMRQFDHPHI 78

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  
Sbjct: 79  VKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+L+ S+  +KL DFGL+R        +          +W  APE + F   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWM-APESINFR-- 192

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
           ++ +  DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 87.8 bits (218), Expect = 5e-20
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 26/203 (12%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPH 72
            +LG+G +G V +A    +  +   VA+K  K  +    +   F  LRE   +KE   PH
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF--LREAACMKEFDHPH 86

Query: 73  IIELI------DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTL-- 121
           + +L+       A        ++  FM+  DL   +  + I  +P ++  ++ ++  +  
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWY 177
             G+ +   +  +HRD+   N ++     + +ADFGL+R   S D  R+        +W 
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 178 RAPE-LLFGAKQYGAGVDVWAAG 199
            A E L      Y    DVWA G
Sbjct: 207 -ALESLADN--LYTVHSDVWAFG 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.4 bits (217), Expect = 6e-20
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
           +++G G  G V         +    VAIK ++ G  +++  +F  L E  ++ +   P+I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMGQFDHPNI 112

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L           +V E+ME   L+T +R  +   +   +   ++    G+ +      
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF---ARWYRAPE-LLFGAK 187
           +HRD+   N+L+ S+   K++DFGL+R +   PD  +T        RW  APE + F   
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIAFR-- 229

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPF 211
            + +  DVW+ G +  E+L    RP+
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPY 255

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.0 bits (216), Expect = 9e-20
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEFNCH 88

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN------TNIFLSPADIKSYMQMTL--- 121
           H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM     
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYR 178
            G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   RW  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
           +PE L  G   +    DVW+ G
Sbjct: 208 SPESLKDG--VFTTYSDVWSFG 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G V++ I          VAIK  +          F  L+E   +++   PHI
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF--LQEALTMRQFDHPHI 453

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  
Sbjct: 454 VKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE-LLFGAKQY 189
           +HRD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE + F   ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESINFR--RF 569

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW  G    E+L    +PF
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPF 593

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 40/159 (25%), Positives = 83/159 (52%), Gaps = 15/159 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQ--KEGVNFTALREIKLLKELKSPHIIE 75
           ++G G +G VYK +  + G  VA+K+      Q  +E   F    EI+ L   + PH++ 
Sbjct: 46  LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE---FET--EIETLSFCRHPHLVS 99

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW 131
           LI     +  + L++++ME  +L+  +  +++       +  +++ +   +GL + H + 
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
           ++HRD+K  N+L+  +   K+ DFG+++     D+  TH
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--TH 196

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 15/188 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      +    VAIK I+ G   E   F  + E K++  L    +++L 
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE-DEF--IEEAKVMMNLSHEKLVQLY 85

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + ++ E+M    L   +R          +    +   + + +   K  LHRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYGA 191
           +   N L+   G +K++DFGL+R     D  +T  V +    RW   PE L++   ++ +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWS-PPEVLMYS--KFSS 200

Query: 192 GVDVWAAG 199
             D+WA G
Sbjct: 201 KSDIWAFG 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
             LGEG +G V+ A        +    VA+K ++   +    +F   RE +LL  L+  H
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF--QREAELLTMLQHQH 104

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIR-----------NTNIFLSPADIKSYMQMT 120
           I+           L +VFE+M   DL   +R             ++   P  +   + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 121 L---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-A 174
                G+ +      +HRD+   N L+G    +K+ DFG++R   S D  R     +   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224

Query: 175 RWYRAPE-LLFGAKQYGAGVDVWAAG 199
           RW   PE +L+   ++    DVW+ G
Sbjct: 225 RWM-PPESILYR--KFTTESDVWSFG 247

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
             LGEG +G V+ A       TK    VA+K ++        +F   RE +LL  L+  H
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF--QREAELLTNLQHEH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIR------------NTNIFLSPADIKSYMQM 119
           I++          L +VFE+M+  DL   +R                      +   + +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 120 TL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF- 173
                 G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  R   H +  
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 174 ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
            RW   PE +++   ++    DVW+ G
Sbjct: 199 IRWM-PPESIMYR--KFTTESDVWSFG 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 35/198 (17%), Positives = 71/198 (35%), Gaps = 22/198 (11%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT-------VAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           E LG+GT+  ++K +  + G         V +K +    +    +F       ++ +L  
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF--FEAASMMSKLSH 71

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            H++             LV EF++   L+T ++     ++        +     + F  +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 130 KWVLHRDMKPNNLLIGSHGQL--------KLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
             ++H ++   N+L+              KL+D G++      D     Q    W   PE
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWV-PPE 187

Query: 182 LLFGAKQYGAGVDVWAAG 199
            +   K      D W+ G
Sbjct: 188 CIENPKNLNLATDKWSFG 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 17/189 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LG G +G V+          VA+K ++ G       F  L E  L+K+L+   ++ L 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD-AF--LAEANLMKQLQHQRLVRLY 74

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   +  ++++ E+ME   L   ++  + I L+   +        +G+AF  ++  +HR
Sbjct: 75  -AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D++  N+L+      K+ADFGLAR+    D  +T +  A    +W  APE + +G   + 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT-APEAINYG--TFT 188

Query: 191 AGVDVWAAG 199
              DVW+ G
Sbjct: 189 IKSDVWSFG 197

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 17/189 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +G V+ A   K  + VA+K ++ G       F  L E  ++K L+   +++L 
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV-EAF--LAEANVMKTLQHDKLVKLH 249

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   K  ++++ EFM    L   ++ +         +  +     +G+AF  ++  +HR
Sbjct: 250 -AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D++  N+L+ +    K+ADFGLAR+    D  +T +  A    +W  APE + FG   + 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT-APEAINFG--SFT 363

Query: 191 AGVDVWAAG 199
              DVW+ G
Sbjct: 364 IKSDVWSFG 372

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 19  VLGEGTYGVVYK-AIDTKTGQTVAIKKIRLGKQKEGVN----FTALREIKLLKELKSPHI 73
            +GEG +GVVYK  ++     TVA+KK+              F    EIK++ + +  ++
Sbjct: 38  KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQ--EIKVMAKCQHENL 92

Query: 74  IELIDAFPHKGN-LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
           +EL+  F   G+ L LV+ +M    L   +   +    P       ++      G+ F H
Sbjct: 93  VELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH 150

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPELL 183
           +   +HRD+K  N+L+      K++DFGLAR         T  + +R      Y APE L
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQTV-MTSRIVGTTAYMAPEAL 207

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
            G  +     D+++ G +  E++      
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLPAV 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 18/166 (10%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   +   + +G G +G +    +  T + VAIK   L   K         E +  K+L 
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAP-QLHLEYRFYKQLG 62

Query: 70  -SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLKGL 124
               I ++    P      +V E +   LE +    +   S   +K+     +Q+ +  +
Sbjct: 63  SGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFS---LKTVLMIAIQL-ISRM 118

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLK-----LADFGLARIFGSPD 165
            + H K +++RD+KP N LIG  G        + DF LA+ +  P+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.1 bits (201), Expect = 9e-18
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A     I +    TVA+K ++      E      + E+K+L  L + 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 86

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRN-----------------TNIFLSPAD 112
            +I+ L+ A    G   ++ E+    DL   +R                    + L   D
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
           + S+     KG+AF   K  +HRD+   N+L+      K+ DFGLAR   +        +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE +F    Y    DVW+ G
Sbjct: 207 ARLPVKWM-APESIFNCV-YTFESDVWSYG 234

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.7 bits (197), Expect = 3e-17
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 18/162 (11%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKE 67
           +V +RY     +G G++G +Y   D   G+ VAIK      +        L  E K+ K 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKM 60

Query: 68  LK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLK 122
           ++    I  +           +V E +   LE +    +   S   +K+      QM + 
Sbjct: 61  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS---LKTVLLLADQM-IS 116

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF 161
            + + H K  +HRD+KP+N L+G       + + DFGLA+ +
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 16/165 (9%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
            +V +++     +G G++G +Y   + +T + VAIK   +  +        L E K+ + 
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRI 58

Query: 68  LK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLK 122
           L+    I  +           LV + +   LE +    +  LS   +K+      QM + 
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS---LKTVLMLADQM-IN 114

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSP 164
            + F H K  LHRD+KP+N L+G      Q+ + DFGLA+ +   
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 28/206 (13%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A             VA+K ++      E      + E+K++  L   
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL-------- 121
            +I+ L+ A  H G + ++ E+    DL   +R  +  L      +    T         
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 122 -----KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF- 173
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   +        +    
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAG 199
            +W  APE +F    Y    DVW+ G
Sbjct: 230 VKWM-APESIFDCV-YTVQSDVWSYG 253

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 20/176 (11%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHIIELI 77
           +LG G +G VYK      G  VA+K+++    Q   + F    E++++      +++ L 
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 93

Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW-- 131
                     LV+ +M    + + +R       P D     ++ L   +GLA+ H     
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 132 -VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPE 181
            ++HRD+K  N+L+    +  + DFGLA++    D + TH V         + APE
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH-VTTAVRGTIGHIAPE 205

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 47/220 (21%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           + LGEG +G V KA            TVA+K ++      E  +   L E  +LK++  P
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL--LSEFNVLKQVNHP 86

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN-----------------------TNIF 107
           H+I+L  A    G L L+ E+ +   L   +R                            
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGV-----DVWAAG 199
            + +      +W  A E LF        +     DVW+ G
Sbjct: 207 VKRSQGRIPVKWM-AIESLF------DHIYTTQSDVWSFG 239

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A          K   TVA+K ++    +K+  +   + E++++K + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKS 115
              +II L+ A    G L+++ E+                 +E       +       K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 116 YMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
            +  T    +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 219 GRLPVKWM-APEALFDRV-YTHQSDVWSFG 246

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 20/167 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           V   Y     +GEG++GV+++  +    Q VAIK      +    +   L  E +  K L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLL 62

Query: 69  K-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLKG 123
                I  +        +  LV + +   LE ++       S   +K+      QM L  
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS---VKTVAMAAKQM-LAR 118

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG-----QLKLADFGLARIFGSPD 165
           +   H+K +++RD+KP+N LIG         + + DFG+ + +  P 
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A               VA+K ++    +K+  +   + E++++K + 
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 132

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKS 115
              +II L+ A    G L+++ E+                 LE     ++        K 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 116 YMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
            +       +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  ++ T+
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 253 GRLPVKWM-APEALFDRI-YTHQSDVWSFG 280

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A       T T +TVA+K ++ G    E      + E+K+L  +   
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 90

Query: 71  PHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRN---------------TNIFLSPADI 113
            +++ L+ A     G L ++ EF +  +L T +R+                  FL+   +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQ 171
             Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR         R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 172 VF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
               +W  APE +F    Y    DVW+ G
Sbjct: 211 RLPLKWM-APETIFDRV-YTIQSDVWSFG 237

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS-PHI 73
           +V+GEG +G V KA   K G     AIK+++    + +  +F    E+++L +L   P+I
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF--AGELEVLCKLGHHPNI 88

Query: 74  IELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKSYMQMT 120
           I L+ A  H+G L+L  E+                + +      N   S    +  +   
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 121 L---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR 159
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.5 bits (194), Expect = 8e-17
 Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG G +G VY+       +  +   VA+K +     +++ ++F  L E  ++ +    
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF--LMEALIISKFNHQ 93

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTL---KGL 124
           +I+  I          ++ E M   DL++ +R         S   +   + +      G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPD--RRFTHQVFA-RWYR 178
            +  +   +HRD+   N L+   G     K+ DFG+AR        R+    +   +W  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM- 212

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
            PE  + G   + +  D W+ G
Sbjct: 213 PPEAFMEG--IFTSKTDTWSFG 232

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 38/194 (19%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           L     ++++  + +G G +G++Y A  T   +  A   +++  Q+ G  F    E+K  
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFY 87

Query: 66  KELKSPHIIELIDAFPHKGNL-------------------HLVFEFMETDLETVIRNTNI 106
           + +     I+          L                    +V E +  DL+ +      
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT 147

Query: 107 F-----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGLAR 159
           F     L         +M L  L + H+   +H D+K  NLL+G  +  Q+ LAD+GL+ 
Sbjct: 148 FKKSTVLQLGI-----RM-LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Query: 160 IFGSPDRRFTHQVF 173
            +        H+ +
Sbjct: 202 RYCPNG---NHKQY 212

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 1e-16
 Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 33/209 (15%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           E LGE  +G VYK         +  Q VAIK ++   +      F    E  L   L+ P
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF--RHEAMLRARLQHP 72

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN----TNIFLSPADIKSYMQMTLKGL-A 125
           +++ L+        L ++F +    DL   +      +++  +  D      +       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 126 FCH-----------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
                            V H+D+   N+L+     +K++D GL R   + D  +   + +
Sbjct: 133 LVAQIAAGMEYLSSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 173 F-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
              RW  APE +++G  ++    D+W+ G
Sbjct: 192 LPIRWM-APEAIMYG--KFSIDSDIWSYG 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 40/201 (19%), Positives = 77/201 (38%), Gaps = 23/201 (11%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG G +G VY+       +  +   VA+K +     +++ ++F  L E  ++ +    
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF--LMEALIISKFNHQ 134

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTL---KGL 124
           +I+  I          ++ E M   DL++ +R         S   +   + +      G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPD--RRFTHQVFA-RWYR 178
            +  +   +HRD+   N L+   G     K+ DFG+AR        R+    +   +W  
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM- 253

Query: 179 APELLFGAKQYGAGVDVWAAG 199
            PE       + +  D W+ G
Sbjct: 254 PPEAFMEGI-FTSKTDTWSFG 273

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A          K   TVA+K ++    +K+  +   + E++++K + 
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 144

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN----TNIFLSPADIKSYMQMTLK- 122
              +II L+ A    G L+++ E+    +L   +R        +    +     QMT K 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 123 ----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
                     G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 265 GRLPVKWM-APEALFDRV-YTHQSDVWSFG 292

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 39/216 (18%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             +GEG +G V++A        +    VA+K ++         +F   RE  L+ E  +P
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF--QREAALMAEFDNP 110

Query: 72  HIIELIDAFPHKGNLHLVFEFME---------------------TDLETVIRNTNIFLSP 110
           +I++L+        + L+FE+M                      +DL T  R ++    P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 111 ADIKSYMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
                 + +      G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 166 RRFTHQVF-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
           +   +     RW   PE + +   +Y    DVWA G
Sbjct: 231 KADGNDAIPIRWM-PPESIFYN--RYTTESDVWAYG 263

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 37/215 (17%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           +VLG G +G V  A       T     VA+K ++      E      + E+K++ +L S 
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL--MSELKMMTQLGSH 108

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN-----------TNIFLSPADIKSYMQ 118
            +I+ L+ A    G ++L+FE+    DL   +R+                   + +    
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 119 MTLK-----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           +T +           G+ F   K  +HRD+   N+L+     +K+ DFGLAR   S    
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
               +     +W  APE LF    Y    DVW+ G
Sbjct: 229 VVRGNARLPVKWM-APESLF-EGIYTIKSDVWSYG 261

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.4 bits (157), Expect = 8e-12
 Identities = 35/194 (18%), Positives = 71/194 (36%), Gaps = 39/194 (20%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKK---IRLGKQKEGVNFTALREI 62
           ++   A  +     +G+G +G +Y A D  + ++V       +++     G  F    E+
Sbjct: 29  ITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLF---TEL 84

Query: 63  KLLKELKSPHIIELIDAFPHKGNL-------------------HLVFEFMETDLETVIRN 103
           K  +    P  I+          L                    ++ +   +DL+ +   
Sbjct: 85  KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144

Query: 104 TNIFLSPADIKS-YM---QMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGL 157
                S    K+      ++ L  L + H+   +H D+K +NLL+   +  Q+ L D+GL
Sbjct: 145 NAKRFS---RKTVLQLSLRI-LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 158 ARIFGSPDRRFTHQ 171
           A  +        H+
Sbjct: 201 AYRYCPEG---VHK 211

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 31/188 (16%), Positives = 62/188 (32%), Gaps = 44/188 (23%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTG--------QTVAIK-------------- 43
           L+ K   ++  +        G++Y+A  T T         Q  ++K              
Sbjct: 36  LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95

Query: 44  KIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIR 102
             R  K  +      + + K L       I   +    H+     LV   +   L++ + 
Sbjct: 96  FQRAAKPLQ------VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD 149

Query: 103 NTN--IF-----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLA 153
            +   +      L  A      ++ L  L F H+   +H ++   N+ +      Q+ LA
Sbjct: 150 VSPKHVLSERSVLQVAC-----RL-LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLA 203

Query: 154 DFGLARIF 161
            +G A  +
Sbjct: 204 GYGFAFRY 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 9e-08
 Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 5/95 (5%)

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           L+   +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR        
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
            R        +W  APE +F  + Y    DVW+ G
Sbjct: 250 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFG 282

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 41/195 (21%), Positives = 74/195 (37%), Gaps = 18/195 (9%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A       T T +TVA+K ++ G    E      + E+K+L  +   
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 85

Query: 71  PHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            +++ L+ A     G L ++ EF +  +L T +R+      P   K       K      
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE-LLFGAK 187
                  D+K     I S      + F   +     +     +   + +   E L+  + 
Sbjct: 146 -----PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 188 QYGAGVDVWAA-GCI 201
           Q   G++  A+  CI
Sbjct: 201 QVAKGMEFLASRKCI 215

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 1e-04
 Identities = 45/319 (14%), Positives = 86/319 (26%), Gaps = 76/319 (23%)

Query: 28  VYKAIDTKTGQTVAIKKIRLG---KQKEGV--NFTALREIKLLKELK--SPHIIELIDAF 80
           V   +   T   +++    +     + + +   +   R   L +E+   +P  + +I   
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336

Query: 81  PHKGNLHL-VFEFMETD-LETVIRNTNIFLSPADIKSYMQM-------------TLKGL- 124
              G      ++ +  D L T+I ++   L PA+ +                   L  + 
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396

Query: 125 ------------AFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ 171
                          HK  ++ +   P    I      L+L            +    H+
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQ--PKESTISIPSIYLELK-------VKLENEYALHR 447

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIF------------AELLN--RRPFLQGSSD 217
                Y  P+           +  +     +             E +   R  FL    D
Sbjct: 448 SIVDHYNIPK----TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL----D 499

Query: 218 IDQLG-KIFAAFGTATPSQWPDLAYLPDYVEY-QYVAAPPLRSLFPSASDDALDLLSKMF 275
              L  KI     TA  +    L  L     Y  Y+        +    +  LD L K+ 
Sbjct: 500 FRFLEQKIRHD-STAWNASGSILNTLQQLKFYKPYIC--DNDPKYERLVNAILDFLPKIE 556

Query: 276 TY---DPKARITAQQALEH 291
                     +  + AL  
Sbjct: 557 ENLICSKYTDLL-RIALMA 574

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	314
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.98
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.61
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.6
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.6
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.36
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.03
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.82
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.5
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.28
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.71

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-62  Score=415.94  Aligned_cols=255  Identities=31%  Similarity=0.475  Sum_probs=210.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++....... .....+.+|+++++.++||||+++++++++++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            78999999999999999999999999999999998765433 33446779999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      ||++|+|.+.+.+.+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+..... .....
T Consensus        93 Ey~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~  170 (275)
T 3hyh_A           93 EYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT  170 (275)
T ss_dssp             ECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCC
Confidence            999999999987654 6999999999999999999999999999999999999999999999999999876432 23345


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..||+.|+|||++.+..+++.++|||||||++|+|++|.+||...+.......+......                    
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~--------------------  230 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT--------------------  230 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------------
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            679999999999988555678999999999999999999999988777776666543211                    


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                              ....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       231 --------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 --------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             --------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             --------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                    11246999999999999999999999999999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4e-63  Score=432.68  Aligned_cols=260  Identities=25%  Similarity=0.459  Sum_probs=223.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+++++.++||||+++++++++++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            79999999999999999999999999999999998776555455577899999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        92 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||+| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..........
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  183 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR  183 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence            9985 999999765 44679999999999999999999999999999999999999999999999999987644333344


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.......                  
T Consensus       184 ~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------  244 (350)
T 4b9d_A          184 ACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP------------------  244 (350)
T ss_dssp             HHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------------------
T ss_pred             ccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC------------------
Confidence            5679999999999977 678999999999999999999999999988888887776642211                  


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                               ....+++++.+||.+||+.||++|||++|+|+||||++-.+
T Consensus       245 ---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          245 ---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             ---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence                     12346999999999999999999999999999999986443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-61  Score=423.06  Aligned_cols=258  Identities=25%  Similarity=0.422  Sum_probs=226.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.|++++.||+|+||+||+|.++.+|+.||+|++.....  .....+.+|+++++.++||||+++++++++++.+|+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3679999999999999999999999999999999976543  23346779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||+| +|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...........
T Consensus       151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99985 788877653  499999999999999999999999999999999999999999999999999998766655666


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+........                 
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-----------------  290 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----------------  290 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-----------------
Confidence            7789999999999876 6789999999999999999999999999888887777655321111                 


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              ..+..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       291 --------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          291 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             --------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                    11234699999999999999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7e-62  Score=418.21  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=226.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+++++.++||||+++++++++++.+|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3689999999999999999999999999999999986542 223344677999999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--C
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R  166 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~  166 (314)
                      ||||+| +|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......  .
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999985 8999887654 69999999999999999999999999999999999999999999999999999874332  2


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+......     +          
T Consensus       190 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----~----------  253 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD-----F----------  253 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----C----------
T ss_pred             cccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----C----------
Confidence            3445689999999999977 67899999999999999999999999998888888877654211     1          


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHH------HhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ------ALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------ll~h~~~~~~~  298 (314)
                                   ...+++++++||.+||+.||++|||++|      |++||||++++
T Consensus       254 -------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          254 -------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             -------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             -------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence                         1246999999999999999999999987      68999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-60  Score=424.06  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=226.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.|++++.||+|+||+||+|+++.+|+.||+|++......  ....+.+|+.+++.++||||++++++|++++.+|+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            36799999999999999999999999999999999865432  3346779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||+| +|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...........
T Consensus       228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            99986 788877654  499999999999999999999999999999999999999999999999999998766655666


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+........                 
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-----------------  367 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-----------------  367 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-----------------
Confidence            7789999999999876 6789999999999999999999999999888887777655321111                 


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              .....+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       368 --------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          368 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             --------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                    11235699999999999999999999999999999999754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-61  Score=428.54  Aligned_cols=290  Identities=35%  Similarity=0.613  Sum_probs=241.4

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec------c
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP------H   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~   82 (314)
                      .+.++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+++++.++||||+++++++.      +
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            3567999999999999999999999999999999999766544444456678999999999999999999864      3


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      .+..|+|||||+|+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          131 FKSVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             CCCEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             CCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            4678999999999999888754 469999999999999999999999999999999999999999999999999998653


Q ss_pred             CC----CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          163 SP----DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       163 ~~----~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ..    .......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+......+..
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            32    22334568999999999998867789999999999999999999999999999999999999988877666554


Q ss_pred             cCcccchh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          239 LAYLPDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       239 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ........   ........++...++.+++++.+||.+||+.||++|||++|+|+||||+.+.+
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            32222111   11112223334456778999999999999999999999999999999998743

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-61  Score=415.66  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=217.6

Q ss_pred             hhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++............+.+|+++++.++||||+++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            68999999999999999999874   467899999998765444444466789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |||||+| +|.+.+.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            9999985 8888887644 6999999999999999999999999999999999999999999999999999876554555


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......                 
T Consensus       183 ~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------  244 (304)
T 3ubd_A          183 AYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-----------------  244 (304)
T ss_dssp             CCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred             ccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----------------
Confidence            556789999999999977 67899999999999999999999999998888888777654211                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                 .+..+|+++.+||.+||+.||++|||     ++|+++||||+.++
T Consensus       245 -----------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          245 -----------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                       11246999999999999999999998     58999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9e-60  Score=403.04  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=213.0

Q ss_pred             Hhhc-cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc----CCe
Q 021299           11 ADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGN   85 (314)
Q Consensus        11 ~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~   85 (314)
                      .++| ++.+.||+|+||+||+|.++.++..||+|++............+.+|+++++.++||||++++++|++    ++.
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            4566 67788999999999999999999999999998765554445567899999999999999999999854    456


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEe-cCCcEEEeeccceeee
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIG-SHGQLKLADFGLARIF  161 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~-~~~~~~l~df~~~~~~  161 (314)
                      +|+|||||+| +|.+++.+. +.+++..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+..
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            8999999985 888888754 46999999999999999999999998  99999999999997 4789999999999754


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .  ........||+.|+|||++.+  .++.++|||||||++|+|++|.+||................  ..+.       
T Consensus       183 ~--~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--~~~~-------  249 (290)
T 3fpq_A          183 R--ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPA-------  249 (290)
T ss_dssp             C--TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCG-------
T ss_pred             C--CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--CCCC-------
Confidence            2  233445689999999999865  58999999999999999999999998766555444332211  1111       


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                      .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       250 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            112245889999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.5e-59  Score=403.93  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=216.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +.|++.+.||+|+||+||+|+++.+|+.||+|+++....       ..+|+.+++.++||||+++++++++++..|+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            568899999999999999999999999999999976432       2379999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCCCc--
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRR--  167 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~--  167 (314)
                      ||+| +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+........  
T Consensus       131 y~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9985 8888887654 699999999999999999999999999999999999999987 6999999999876443221  


Q ss_pred             ---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                         .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....                
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----------------  272 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP----------------  272 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC----------------
T ss_pred             eecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC----------------
Confidence               223469999999999987 678999999999999999999999998877766666654431                


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH-------------hcCccccccCc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA-------------LEHRFAKSFNG  299 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el-------------l~h~~~~~~~~  299 (314)
                               .+.....+.+++++.+||.+||+.||.+|||+.|+             |+|||++.+.+
T Consensus       273 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          273 ---------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             ---------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ---------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence                     11122345679999999999999999999999998             57999987754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.4e-57  Score=398.36  Aligned_cols=282  Identities=24%  Similarity=0.400  Sum_probs=216.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .+.++|++.+.||+|+||+||+|.++   .+++.||+|.+....    ....+.+|+++++.+ +||||+++++++++++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            46789999999999999999999875   457889999986543    223566899999988 6999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeeeC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFG  162 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~~  162 (314)
                      +.|+||||++| +|.+.+.    .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        94 ~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999985 8888773    48999999999999999999999999999999999999877 799999999998654


Q ss_pred             CCCC----------------------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCcc-C
Q 021299          163 SPDR----------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL-Q  213 (314)
Q Consensus       163 ~~~~----------------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~  213 (314)
                      ....                            .....+||+.|+|||++.+...++.++||||+||++|+|++|.+|| .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            3211                            1123469999999999987667899999999999999999999888 5


Q ss_pred             CCCcHHHHHHHHHhhCCCCCC--------------CCCCcCccc------------chhhhccccCCCCCccCCCCCHHH
Q 021299          214 GSSDIDQLGKIFAAFGTATPS--------------QWPDLAYLP------------DYVEYQYVAAPPLRSLFPSASDDA  267 (314)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~  267 (314)
                      ..+..+.+..+....++....              ..+......            ................+..+++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            566667777766654431100              000000000            000000001111122356789999


Q ss_pred             HHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          268 LDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       268 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .+||.+||+.||++|||++|+|+||||+.++
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-56  Score=386.71  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=197.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   84 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+++++.++||||++++++|.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            4569999999999999999999999999999999976542 223346779999999999999999999985433      


Q ss_pred             ------eEEEEEecccc-cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           85 ------NLHLVFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        85 ------~~~iv~e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                            +.|++||||.| +|.+++.....  ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence                  47999999985 88888876542  3556778999999999999999999999999999999999999999999


Q ss_pred             cceeeeCCCCC------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHH
Q 021299          156 GLARIFGSPDR------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK  223 (314)
Q Consensus       156 ~~~~~~~~~~~------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~  223 (314)
                      |+|+.......            .....+||+.|+|||++.+ ..++.++|||||||++|+|++   ||...  .+....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence            99987643322            1223579999999999987 678999999999999999995   66532  222222


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      +........|                        +.+...++.+.+||.+||+.||.+|||+.|+|+||||+.++
T Consensus       237 ~~~~~~~~~p------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          237 LTDVRNLKFP------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHTTCCC------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHhcCCCC------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            2221111111                        11122367789999999999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.8e-56  Score=386.54  Aligned_cols=294  Identities=47%  Similarity=0.861  Sum_probs=250.5

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ..+.+.++|++++.||+|+||+||++.+. +|+.+|+|++............+.+|+++++.++||||+++++++.+++.
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            45667899999999999999999999985 58899999998765555555567799999999999999999999999999


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .++||||++|++.+.+......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...+...
T Consensus        94 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99999999999999999887789999999999999999999999999999999999999999999999999999876555


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+...+..++........
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            55566778999999999977667899999999999999999999999999999999999999998888887765544433


Q ss_pred             hhhc--cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          246 VEYQ--YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       246 ~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ....  .....+.....+.+++++.+||.+||+.||++|||++|+|+||||++++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence            2211  112222334456789999999999999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-55  Score=375.97  Aligned_cols=286  Identities=47%  Similarity=0.805  Sum_probs=249.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|++|+||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            68999999999999999999999999999999998776655555677799999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++|++.+.+....+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...+.........
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  161 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence            99999999998877889999999999999999999999999999999999999999999999999999876666666667


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .+++.|+|||.+.+...++.++||||||+++|+|++|..| |......+....+....+......|+.............
T Consensus       162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T 3o0g_A          162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM  241 (292)
T ss_dssp             CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred             ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence            8899999999998756689999999999999999977654 788888888899999988888888876655443322111


Q ss_pred             c-cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          251 V-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      . .........+.+++++.+||.+||+.||++|||++|+++||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            1 1222334456789999999999999999999999999999999965

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-55  Score=379.16  Aligned_cols=254  Identities=20%  Similarity=0.292  Sum_probs=207.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      +++++.+.||+|+||+||+|++.   ..+|+|+++...........+.+|++++++++||||+++++++.+ +..++|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            67889999999999999999754   358999997665555555678899999999999999999998754 56899999


Q ss_pred             ccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC--CCcc
Q 021299           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP--DRRF  168 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~--~~~~  168 (314)
                      ||+ |+|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....  ....
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            998 5999999887778999999999999999999999999999999999999999999999999999865432  2233


Q ss_pred             cccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          169 THQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ....||+.|+|||++.+  ...++.++|||||||++|+|++|..||...+.......+.......               
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------  256 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS---------------  256 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC---------------
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence            45679999999999864  2458999999999999999999999998877766665554431111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                             +........+++++.+|+.+||+.||++|||+.||+++
T Consensus       257 -------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          257 -------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             -------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             -------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                   11122334679999999999999999999999987543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-54  Score=374.27  Aligned_cols=285  Identities=46%  Similarity=0.848  Sum_probs=241.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|+||+||+|.+ .+|+.+++|++............+.+|+++++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999998 678999999998776555555677799999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      +++|+|.+.+....+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            99999999998877789999999999999999999999999999999999999999999999999998765444444556


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh-hhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  250 (314)
                      .+++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+......|+......... ....
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            789999999999775678999999999999999999999999999999999998888888777777554333221 1111


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ....+.......+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            22233344556789999999999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-56  Score=381.46  Aligned_cols=256  Identities=21%  Similarity=0.358  Sum_probs=214.6

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|+||+||+|++.     .++..||+|.+....  ......+.+|++++++++||||+++++++.+++.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            478999999999999999999864     357789999997542  2234567899999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           86 LHLVFEFME-TDLETVIRNTN------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      .++|||||+ |+|.+++...+            ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence            999999998 59999987542            46999999999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhC
Q 021299          153 ADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (314)
Q Consensus       153 ~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~  229 (314)
                      +|||+++.......  ......||+.|+|||.+.+ ..++.++|||||||++|||+| |..||......+....+..+..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~  248 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  248 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999976533222  1223458999999999987 678999999999999999998 8999999888887777765422


Q ss_pred             CCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ...                           ...+++++.+|+.+||+.||++|||++||  ++|++++.
T Consensus       249 ~~~---------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          249 LQR---------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             CCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             CCC---------------------------CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            111                           12468999999999999999999999999  56887664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.9e-55  Score=409.54  Aligned_cols=262  Identities=29%  Similarity=0.455  Sum_probs=229.0

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++++.||+|+||+||+|.++.+|+.||+|.+......  ....+.+|+++++.++||||++++++|++++..|+
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            3568999999999999999999999999999999999764322  23456789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC--CcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~~~l~df~~~~~~~~~~  165 (314)
                      +||||.| +|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.+  +.+||+|||+++..... 
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999985 8999998777789999999999999999999999999999999999999854  89999999999987443 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+..........           
T Consensus       311 ~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------  378 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-----------  378 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG-----------
T ss_pred             CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc-----------
Confidence            33345679999999999987 678999999999999999999999999998888888776553322221           


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   .+..+++++.+||.+||+.||.+|||++|+|+||||+..+
T Consensus       379 -------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          379 -------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             -------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence                         2245799999999999999999999999999999999764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-54  Score=376.86  Aligned_cols=251  Identities=21%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|.+.+.||+|+||+||+|++.     .++..||+|.+....  ......+.+|++++++++||||+++++++.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            367889999999999999999864     357899999997532  2334567899999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcE
Q 021299           86 LHLVFEFME-TDLETVIRNT--------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~  150 (314)
                      .++|||||+ |+|.+++...              .+++++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence            999999998 5899988653              2469999999999999999999999999999999999999999999


Q ss_pred             EEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      ||+|||+++......  .......||+.|+|||.+.+ ..++.++|||||||++|||+| |..||......+....+..+
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998653332  22334578999999999977 678999999999999999998 89999998888877777654


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .....                           ...+++++.+|+.+||+.||++|||++||+++
T Consensus       277 ~~~~~---------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          277 RELER---------------------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCCCC---------------------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCC---------------------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            22111                           12468999999999999999999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.6e-55  Score=405.38  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=214.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-chhh---HHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTA---LREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+....... ....   ..++.+++.++||||++++++|++.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            57899999999999999999999999999999999765422211 1122   2346677778999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |+|||||.| +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            999999985 888888764 469999999999999999999999999999999999999999999999999998764432


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH---HHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ---LGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                        ....+||+.|+|||++..+..++.++|+|||||++|+|++|.+||......+.   ...+...    ..         
T Consensus       347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----~~---------  411 (689)
T 3v5w_A          347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AV---------  411 (689)
T ss_dssp             --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----CC---------
T ss_pred             --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----CC---------
Confidence              34568999999999997656789999999999999999999999976433222   2222111    11         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                     .++..+|+++.+||.+||+.||.+|++     ++||++||||++++
T Consensus       412 ---------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          412 ---------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             ---------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                           112356999999999999999999998     79999999999985

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-54  Score=374.94  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=211.3

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .+++++.+.||+|+||+||+|...     .+++.||+|.+.... .......+.+|+.++++++||||+++++++.+++.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            367889999999999999999853     356789999997543 33344578899999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc
Q 021299           86 LHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~  149 (314)
                      .++|||||+ |+|.+++....               ..+++..+..++.||+.||+|||+++++||||||+|||++.++.
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence            999999998 59999986532               35899999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHH
Q 021299          150 LKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       150 ~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~  226 (314)
                      +||+|||+++......  .......||+.|+|||.+.+ ..++.++|||||||++|||+| |..||......+....+..
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999997653221  22334578999999999977 678999999999999999998 8999999888777766654


Q ss_pred             hhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +....                           ....+++++.+|+.+||+.||++|||+.||+++
T Consensus       263 ~~~~~---------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          263 RQVLP---------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            32111                           123468999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.5e-53  Score=368.76  Aligned_cols=289  Identities=39%  Similarity=0.725  Sum_probs=227.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++++.||+|+||+||+|.++.+|+.|++|.+..... ......+.+|+++++.++||||+++++++..++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            5789999999999999999999999999999999976543 233346778999999999999999999999999999999


Q ss_pred             ecccccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           91 EFMETDLETVIRNTN-----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        91 e~~~g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ||++|+|.+++....     ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            999999999886542     458999999999999999999999999999999999999999999999999998876554


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+......|+........
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence            45556678999999999977567899999999999999999999999999999999999888887776666654333222


Q ss_pred             hhhcc-ccCCC-----CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          246 VEYQY-VAAPP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       246 ~~~~~-~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ..... .....     .......+++++.+||.+||+.||++|||++|+|+||||+.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            11000 00000     011123578999999999999999999999999999999987543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-54  Score=374.58  Aligned_cols=291  Identities=39%  Similarity=0.726  Sum_probs=239.7

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|+||+||++.+..+++.||+|++........ ...+.+|+++++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            689999999999999999999999999999999976543222 2234479999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      |++|++.+.+...+..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  160 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE  160 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence            99999999999887789999999999999999999999999999999999999999999999999998765555555566


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
                      .+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+...+..|+..............
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
T 3mtl_A          161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP  240 (324)
T ss_dssp             --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred             cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence            78999999999987677899999999999999999999999999999999999999998888888765433322222111


Q ss_pred             --cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceee
Q 021299          252 --AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVF  303 (314)
Q Consensus       252 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~  303 (314)
                        .........+.+++++.+||.+||+.||++|||++|+|+||||+++..+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence              1112223345689999999999999999999999999999999998765443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-53  Score=374.08  Aligned_cols=290  Identities=58%  Similarity=1.023  Sum_probs=245.1

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc---CcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ...++|++.+.||+|++|.||++.+..+|+.|++|.+.......   .....+.+|+++++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            35689999999999999999999999999999999997643322   223466789999999999999999999999999


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .++||||++|++...+......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            99999999999999998877789999999999999999999999999999999999999999999999999998765555


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+......|+........
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            55556778999999999977566899999999999999999999999999999999999999998888888877665554


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .........+.......+++++.+||.+||..||++|||++|+|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            44333333334445567899999999999999999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=364.37  Aligned_cols=290  Identities=38%  Similarity=0.711  Sum_probs=235.3

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhc---CCCCeeeeece
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKEL---KSPHIIELIDA   79 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l---~~~~i~~~~~~   79 (314)
                      +++.+.++|++.+.||+|+||+||+|.+..+|+.||+|.+......   ........+|+++++.+   +||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            4667889999999999999999999999999999999999754422   22233455677776666   49999999999


Q ss_pred             eccCC-----eEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEe
Q 021299           80 FPHKG-----NLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLA  153 (314)
Q Consensus        80 ~~~~~-----~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~  153 (314)
                      +....     ..+++||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            86544     589999999999999998764 349999999999999999999999999999999999999999999999


Q ss_pred             eccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       154 df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      |||.+...... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+....+....
T Consensus       163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCCC-cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999765332 23345678999999999977 66899999999999999999999999999999999999999988888


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..|+....... ..+......+.....+.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       241 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          241 DDWPRDVSLPR-GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTSCSSCSSCG-GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhccchhhccc-cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            88776544432 22223333444455677899999999999999999999999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-53  Score=367.11  Aligned_cols=293  Identities=39%  Similarity=0.649  Sum_probs=228.3

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +.++|++++.||+|++|+||+|.+..+|+.|++|++............+.+|+++++.++||||+++++++...+..++|
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            35799999999999999999999999999999999977655444445667899999999999999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||++|+++..+....+.+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+...........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999877766666666799999999999999999999999999999999999999999999999999988765555555


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc---ccchh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY---LPDYV  246 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  246 (314)
                      ...+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+...+........   .....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            667899999999998767789999999999999999999999999988888887776655443211100000   00000


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                      ..............+.+++++.+||.+||+.||++|||++|+++||||+++.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            00000111122223568999999999999999999999999999999999865543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.5e-53  Score=369.41  Aligned_cols=290  Identities=46%  Similarity=0.790  Sum_probs=230.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ....++|++.+.||+|++|+||++.+..+++.||+|++............+.+|+++++.++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34468999999999999999999999999999999999876655555556779999999999999999999999999999


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe-----cCCcEEEeeccceeeeC
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-----SHGQLKLADFGLARIFG  162 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~-----~~~~~~l~df~~~~~~~  162 (314)
                      +||||++|+|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++     .++.++|+|||.+....
T Consensus       110 lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            999999999999987664 499999999999999999999999999999999999995     44569999999998765


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..........+++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+......++.....
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            55555556678999999999987666899999999999999999999999999999999999988887777776654433


Q ss_pred             cchhhhccc-cCCCCC-ccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYV-AAPPLR-SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~-~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ......... ....+. .....+++++.+||.+||+.||.+|||++|+|+||||++.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            322111000 000000 01122689999999999999999999999999999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-52  Score=365.44  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=225.5

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            45889999999999999999999999999999999987655544455677999999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| +|.+.+...+ .+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  170 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKL  170 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGG
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccc
Confidence            999975 8888886554 5999999999999999999999999999999999999999999999999999765432 334


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....|++.|+|||.+.+....+.++||||||+++|+|++|..||...........+.......                 
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------------  233 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI-----------------  233 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------------
Confidence            556789999999999885555689999999999999999999999988777777765542111                 


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                 ...+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       234 -----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          234 -----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                       113589999999999999999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.4e-52  Score=376.27  Aligned_cols=265  Identities=30%  Similarity=0.461  Sum_probs=230.3

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.+++|.+............+.+|+++++.++||||+++++++.+.+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            34678999999999999999999999999999999999987765544455677999999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe---cCCcEEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~df~~~~~~~  162 (314)
                      ++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999986 8888887654 599999999999999999999999999999999999998   45789999999998776


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..........|++.|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.......+...+      
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------  237 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW------  237 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT------
T ss_pred             CCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc------
Confidence            55555556789999999999976 56899999999999999999999999998888888877766444333322      


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                        +.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       238 ------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          238 ------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                              3469999999999999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-51  Score=364.63  Aligned_cols=289  Identities=42%  Similarity=0.709  Sum_probs=241.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   82 (314)
                      .++|++++.||+|++|+||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            589999999999999999999999999999999998776666556677799999999999999999998865        


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      .+..++||||++|++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            45789999999999999998887789999999999999999999999999999999999999999999999999998764


Q ss_pred             CC----CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          163 SP----DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       163 ~~----~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ..    ........+++.|+|||.+.+...++.++||||||+++|+|++|.+||...........+....+...+..++.
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            32    22234456799999999997766789999999999999999999999999999999999999988888877776


Q ss_pred             cCcccchhhhccccCCCC--Ccc--CCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          239 LAYLPDYVEYQYVAAPPL--RSL--FPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..................  ...  ....++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            543322211111100000  000  0013778999999999999999999999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-52  Score=367.66  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC-CCeeeeeceecc-C
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPH-K   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~   83 (314)
                      .++|++.+.||+|+||+||+|.+...     ++.||+|.+...... .....+.+|+++++++.| |||+++++++.+ +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            47899999999999999999987653     357999998754332 223467789999999976 899999998855 5


Q ss_pred             CeEEEEEeccc-ccHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC
Q 021299           84 GNLHLVFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (314)
Q Consensus        84 ~~~~iv~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~  147 (314)
                      +..++|||||+ |+|.+++...               ...+++..+..++.||+.||+|||+++++||||||+|||++.+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            67899999998 5999998753               2358999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHH
Q 021299          148 GQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKI  224 (314)
Q Consensus       148 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~  224 (314)
                      +.+||+|||+|+.......  ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||......+.+...
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999986543322  2334568899999999987 678999999999999999998 89999887655444443


Q ss_pred             H-HhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          225 F-AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      . .+.....                           ...+++++.+|+.+||+.||++|||+.||++|
T Consensus       301 i~~g~~~~~---------------------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEGTRMRA---------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTCCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCC---------------------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            3 3211111                           12458999999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-51  Score=365.81  Aligned_cols=265  Identities=27%  Similarity=0.435  Sum_probs=226.9

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceecc
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPH   82 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   82 (314)
                      ...+.++|++.+.||+|+||+||+|.++.+|+.||+|.+........    ....+.+|+.+++.++||||+++++++++
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            35678999999999999999999999999999999999987654322    23456799999999999999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccc
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~  157 (314)
                      .+..++||||+. |+|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++    .++|+|||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999997 5888887654 4699999999999999999999999999999999999998776    799999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +...... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||......+....+........+    
T Consensus       166 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  239 (361)
T 2yab_A          166 AHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE----  239 (361)
T ss_dssp             CEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH----
T ss_pred             ceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc----
Confidence            9876443 23345678999999999876 67899999999999999999999999988877777776554221111    


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                          ..+..+++++.+||.+||..||.+|||++|+++||||+..+
T Consensus       240 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 --------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             --------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             --------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                                11235699999999999999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-52  Score=373.46  Aligned_cols=293  Identities=35%  Similarity=0.629  Sum_probs=225.4

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccC-
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK-   83 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~-   83 (314)
                      +...+.++|++++.||+|+||+||+|.+..+|+.||+|++..............+|+.+++.+. ||||+++++++... 
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            4567899999999999999999999999999999999999765444444456668999999997 99999999998543 


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ...|+||||++|+|...+...  .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence             478999999999999988764  58999999999999999999999999999999999999999999999999998653


Q ss_pred             CC---------------------CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHH
Q 021299          163 SP---------------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL  221 (314)
Q Consensus       163 ~~---------------------~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~  221 (314)
                      ..                     ........||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                     112234578999999999987677899999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccch------hhhccccCCCCCcc-------------CCCCCHHHHHHHhhhcccCCCCC
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDY------VEYQYVAAPPLRSL-------------FPSASDDALDLLSKMFTYDPKAR  282 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~R  282 (314)
                      ..+....+.+....+.....-...      ..............             ...+++++.+||.+||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            999887766554332211100000      00000000001111             12679999999999999999999


Q ss_pred             CCHHHHhcCccccccCcc
Q 021299          283 ITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       283 ps~~ell~h~~~~~~~~~  300 (314)
                      ||++|+|+||||+.+.+.
T Consensus       321 ~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCG
T ss_pred             CCHHHHhCCHHHHHhcCC
Confidence            999999999999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.3e-51  Score=352.99  Aligned_cols=262  Identities=28%  Similarity=0.475  Sum_probs=226.4

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...++|++.+.||+|+||+||++.+..+|+.||+|.+......  ....+.+|+.+++.++||||+++++++..++..++
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3568999999999999999999999999999999999765432  23456789999999999999999999999999999


Q ss_pred             EEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+. |+|.+.+...  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999997 4888888765  4899999999999999999999999999999999999999999999999999887666555


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.........              
T Consensus       173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  237 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ--------------  237 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS--------------
T ss_pred             cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--------------
Confidence            666789999999999977 66899999999999999999999999888777766665543211110              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                 ....+++.+.+||.+||+.||++|||++|+++||||+.....
T Consensus       238 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          238 -----------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             -----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             -----------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence                       112468999999999999999999999999999999976543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.1e-51  Score=359.24  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=222.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|.+..... .......+.+|+++++.++||||++++++++..+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            4789999999999999999999999999999999976532 222334567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| +|...+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus        84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            999986 787777654 469999999999999999999999999999999999999999999999999998654444445


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                  
T Consensus       163 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------  223 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------------  223 (337)
T ss_dssp             CCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred             cccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            56678999999999876 66899999999999999999999999888777766666543111                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                ....+++++.+||.+||+.||.+||     +++|+++||||+.++
T Consensus       224 ----------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          224 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                      1124689999999999999999999     999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.5e-52  Score=363.33  Aligned_cols=289  Identities=35%  Similarity=0.616  Sum_probs=230.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|++|.||++.+..+|+.|++|++............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            36899999999999999999999999999999999976655444445567899999999999999999999999999999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |||++|+++..+......+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...........
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            99999987777766666799999999999999999999999999999999999999999999999999987655555555


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc---chh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP---DYV  246 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  246 (314)
                      ...+++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+...+.........+   ...
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            66789999999999876678999999999999999999999999998888888877765544322110000000   000


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ........+.....+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            0000111122223456799999999999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-51  Score=377.44  Aligned_cols=289  Identities=37%  Similarity=0.623  Sum_probs=217.6

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-----ccCC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-----PHKG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~   84 (314)
                      +.++|++.+.||+|+||+||+|.++.+|+.||+|++............+.+|+++++.++||||+++++++     +...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            45899999999999999999999999999999999976544444445677999999999999999999998     3346


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..|+|||+++|+|...+... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            79999999999999988754 46999999999999999999999999999999999999999999999999999865422


Q ss_pred             C---------------------------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh----------
Q 021299          165 D---------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN----------  207 (314)
Q Consensus       165 ~---------------------------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~----------  207 (314)
                      .                           .......||++|+|||++.....++.++|||||||++|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           122345679999999987665779999999999999999998          


Q ss_pred             -CCCccCCCCc--------------------HHHHHHHHHhhCCCCCCCCCCcCcccch---hhhccccCCCCCccCCCC
Q 021299          208 -RRPFLQGSSD--------------------IDQLGKIFAAFGTATPSQWPDLAYLPDY---VEYQYVAAPPLRSLFPSA  263 (314)
Q Consensus       208 -g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  263 (314)
                       |.++|.+...                    .+.+..+....+....+.+.........   ..........+...++.+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777766542                    4555666666665554333222111100   011111223344456778


Q ss_pred             CHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          264 SDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       264 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ++++.+||.+||..||.+|||++|+|+||||+.+..
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            999999999999999999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-51  Score=366.09  Aligned_cols=287  Identities=35%  Similarity=0.573  Sum_probs=231.2

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   83 (314)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...     
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            346899999999999999999999999999999999976544443445667899999999999999999998655     


Q ss_pred             -CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 -~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                       ..+|+|||+++++|.+.+...  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          102 FTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence             346999999988999888763  59999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   .....+|++|+|||.+.+...++.++||||||+++++|++|.+||...+..+....+....+..+.+.+......
T Consensus       180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            32   345578999999999987667899999999999999999999999999999999999888776654332222111


Q ss_pred             cch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          243 PDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       243 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...   ..........+....+.+++++.+||.+||+.||++|||++|+|+||||+.+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            000   0111112233445567789999999999999999999999999999999988643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-52  Score=361.50  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=225.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++.+.||+|+||+||++.+..+++.+++|.+.....   ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            457899999999999999999999999999999999875422   23356689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec--CCcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~df~~~~~~~~~~  165 (314)
                      ||||++| +|.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.++|+|||.+...... 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            9999985 899988777667999999999999999999999999999999999999987  789999999999876433 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+..........           
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----------  225 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-----------  225 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-----------
T ss_pred             CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh-----------
Confidence            33345678999999999977 567899999999999999999999999888887777776543222111           


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   .++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       226 -------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          226 -------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             -------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             -------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                         1235699999999999999999999999999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.7e-51  Score=362.04  Aligned_cols=265  Identities=31%  Similarity=0.447  Sum_probs=226.5

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .+..+.++|++.+.||+|+||.||++.++.+|..|++|.+............+.+|+++++.++||||+++++++.+.+.
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            34567899999999999999999999999999999999998765544444567789999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeeccceeee
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF  161 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~~~~~~  161 (314)
                      .++||||+.| +|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++   .++|+|||++...
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999986 888877654 4699999999999999999999999999999999999997654   5999999999876


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ... .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+.......+.......+...      
T Consensus       182 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------  253 (362)
T 2bdw_A          182 NDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------  253 (362)
T ss_dssp             TTC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG------
T ss_pred             cCC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence            433 23345678999999999876 6789999999999999999999999998887777777665533222211      


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                        +..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       254 ------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          254 ------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                              23468999999999999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-51  Score=376.38  Aligned_cols=283  Identities=34%  Similarity=0.557  Sum_probs=226.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   83 (314)
                      +.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46899999999999999999999999999999999986644444445677899999999999999999998544      


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ...|+||||++|++...+..   .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++...+.
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            46799999999998887753   389999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+....+....+...++.+...... 
T Consensus       217 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~-  293 (464)
T 3ttj_A          217 S-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-  293 (464)
T ss_dssp             C-CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH-
T ss_pred             C-cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh-
Confidence            2 23345678999999999987 67899999999999999999999999999999999999998887766544432110 


Q ss_pred             chhhhcccc----CCCCCccCC------------CCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          244 DYVEYQYVA----APPLRSLFP------------SASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       244 ~~~~~~~~~----~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                       ........    .......++            ..++++.+||.+||+.||++|||++|+|+||||+.+.+
T Consensus       294 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          294 -VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             -HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             -hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence             00000000    000000000            11567999999999999999999999999999997643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.6e-51  Score=372.57  Aligned_cols=290  Identities=38%  Similarity=0.638  Sum_probs=229.0

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----C
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   84 (314)
                      +.++|++.+.||+|++|+||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            46899999999999999999999999999999999976544444445677999999999999999999998665     5


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..|+|||+++|+|.+.+... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus       104 ~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            78999999999999988754 46999999999999999999999999999999999999999999999999999876443


Q ss_pred             CC----------------------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-----------CCCc
Q 021299          165 DR----------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-----------RRPF  211 (314)
Q Consensus       165 ~~----------------------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-----------g~~p  211 (314)
                      ..                      ......||++|+|||++.....++.++|||||||++|+|++           |.++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            21                      12456789999999997665779999999999999999998           4455


Q ss_pred             cCCCC-----------------cHHHHHHHHHhhCCCCCCCCCCcCcccch---hhhccccCCCCCccCCCCCHHHHHHH
Q 021299          212 LQGSS-----------------DIDQLGKIFAAFGTATPSQWPDLAYLPDY---VEYQYVAAPPLRSLFPSASDDALDLL  271 (314)
Q Consensus       212 f~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li  271 (314)
                      |.+..                 ....+..+....+.+..+.+.........   ..............++.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            55443                 24566667776666554433222111100   01111112223334567899999999


Q ss_pred             hhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          272 SKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       272 ~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .+||+.||.+|||++|+|+||||+.+...
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            99999999999999999999999998543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-51  Score=362.74  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=217.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..... .........+|.++++.+ +||||+++++++++.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            5789999999999999999999999999999999976532 222333456899999988 69999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|...+... +.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus       102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            9999986 888777654 35999999999999999999999999999999999999999999999999999865444444


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+..+....+.......                
T Consensus       181 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------  243 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----------------  243 (353)
T ss_dssp             -----CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred             ccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence            556679999999999876 668999999999999999999999999988888887776542111                


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH------HHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~h~~~~~~~  298 (314)
                                  ...+++++.+||.+||+.||.+||++      +|+++||||+.++
T Consensus       244 ------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          244 ------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             ------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             ------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence                        12358999999999999999999999      8999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=353.71  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=225.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      ..+.++|++.+.||+|+||.||++.++.+|..+++|.+........    ....+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4678999999999999999999999999999999999987653321    234577999999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccce
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA  158 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~~  158 (314)
                      +..++||||+.| +|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++    .++|+|||.+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999975 888887654 4699999999999999999999999999999999999998887    8999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+.........     
T Consensus       166 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  238 (326)
T 2y0a_A          166 HKIDFGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-----  238 (326)
T ss_dssp             EECCTTS-CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-----
T ss_pred             eECCCCC-ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-----
Confidence            8764332 2344578999999999876 66899999999999999999999999888777777666543221111     


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                         ..+..+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       239 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          239 -------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             -------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             -------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence                               11235689999999999999999999999999999998765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.9e-50  Score=347.04  Aligned_cols=270  Identities=31%  Similarity=0.442  Sum_probs=231.0

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ++.+.++|++.+.||+|++|+||++.+..+|..+++|++............+.+|+.+++.++||||+++++++...+..
T Consensus         1 s~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             CCTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CchhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            35678999999999999999999999999999999999987665544445677899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc---EEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~df~~~~~~~  162 (314)
                      +++||++.| +|.+.+... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999986 787777655 35999999999999999999999999999999999999987655   9999999998764


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...........       
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  230 (284)
T 3kk8_A          160 DSE-AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-------  230 (284)
T ss_dssp             SSC-BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT-------
T ss_pred             cCc-cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh-------
Confidence            332 3344678999999999977 5679999999999999999999999998888777777665533322222       


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcceee
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFVF  303 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~  303 (314)
                                       ...+++++.+||.+||+.||++|||++|+++||||+........
T Consensus       231 -----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          231 -----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             -----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             -----------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence                             23468999999999999999999999999999999987655543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.1e-51  Score=359.49  Aligned_cols=264  Identities=33%  Similarity=0.508  Sum_probs=219.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc---cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .+.++|++.+.||+|+||+||++.++.+|+.||+|.+......   ......+.+|+.+++.++||||+++++++.+++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4678999999999999999999999999999999999754321   1233467799999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc---EEEeeccce
Q 021299           86 LHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA  158 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~df~~~  158 (314)
                      .++||||++| +|.+.+...   +..+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999985 887777543   345899999999999999999999999999999999999987654   999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ..............||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.... ......+........+     
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~-----  253 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP-----  253 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH-----
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc-----
Confidence            887665544556679999999999977 567999999999999999999999998743 3333344332111111     


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                         ..+..+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus       254 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          254 -------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                               11235689999999999999999999999999999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8e-51  Score=364.08  Aligned_cols=284  Identities=30%  Similarity=0.560  Sum_probs=225.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec-------
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-------   81 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------   81 (314)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++......      ..+|+++++.++||||+++++++.       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3468999999999999999999999999999999998754322      227999999999999999999883       


Q ss_pred             -------------------------------cCCeEEEEEecccccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHH
Q 021299           82 -------------------------------HKGNLHLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFC  127 (314)
Q Consensus        82 -------------------------------~~~~~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~L  127 (314)
                                                     .+...++||||++|+|.+.+.   ..+..+++..++.++.||+.||+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           344588999999998777765   3456799999999999999999999


Q ss_pred             HhCCcccCCCCCCceEEe-cCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHH
Q 021299          128 HKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (314)
Q Consensus       128 h~~~i~H~di~~~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll  206 (314)
                      |++|++|+||||+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+...++.++||||||+++|+|+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            999999999999999998 6789999999999876433 33345577899999999987667899999999999999999


Q ss_pred             hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC-CCccCCCCCHHHHHHHhhhcccCCCCCCCH
Q 021299          207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP-LRSLFPSASDDALDLLSKMFTYDPKARITA  285 (314)
Q Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  285 (314)
                      +|.+||......+....+....+....+.+......-....+....... .......+++++.+||.+||+.||.+|||+
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999999999999999988877765443221110000000000000000 111234579999999999999999999999


Q ss_pred             HHHhcCccccccCc
Q 021299          286 QQALEHRFAKSFNG  299 (314)
Q Consensus       286 ~ell~h~~~~~~~~  299 (314)
                      .|+++||||+.+..
T Consensus       317 ~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          317 YEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHTSGGGHHHHH
T ss_pred             HHHhcCHHHHHHHh
Confidence            99999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-51  Score=362.21  Aligned_cols=261  Identities=30%  Similarity=0.446  Sum_probs=218.5

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      +....++|++.+.||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            445568999999999999999999999999999999999765322 2334467789999999999999999999999999


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .++||||++|++.+.+...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        84 ~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             EEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            99999999999999887654 5999999999999999999999999999999999999999999999999999765332 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......|++.|+|||.+.+....+.++||||||+++|+|++|..||...........+                     
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------------  220 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------------  220 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------------
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------------
Confidence            23345578999999999987555588999999999999999999999764322211100                     


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                             ..........+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus       221 -------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          221 -------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             -------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             -------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                   000111223569999999999999999999999999999999854

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-49  Score=348.43  Aligned_cols=290  Identities=38%  Similarity=0.705  Sum_probs=240.2

Q ss_pred             HHhhccceeeeCccccceEEEEEEC-CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc---CCCCeeeeeceec----
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDT-KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP----   81 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----   81 (314)
                      ..++|++.+.||+|++|+||++.+. .+|+.|++|.+............+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4689999999999999999999985 6788999999987655444444566777777766   8999999999886    


Q ss_pred             -cCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           82 -HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        82 -~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                       .....++|||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence             566889999999999999997653 459999999999999999999999999999999999999999999999999997


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      ..... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....+......|+..
T Consensus       169 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          169 IYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             cccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            65322 23344567899999999877 56899999999999999999999999999999999998888777766666644


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                      ..... ..+......+.......+++.+.+||.+||+.||.+|||++|+++||||+.+.....
T Consensus       247 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          247 VALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             CSSCG-GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             cccch-hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            33222 111222233445556778999999999999999999999999999999998875544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-51  Score=363.67  Aligned_cols=285  Identities=35%  Similarity=0.573  Sum_probs=219.1

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   83 (314)
                      +.++|++++.||+|++|.||+|.+..+|+.||+|++............+.+|+++++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            46899999999999999999999999999999999976544333445667899999999999999999988543      


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ...++++|+++++|.+.+..  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            56899999998888888765  3599999999999999999999999999999999999999999999999999986533


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .   .....++++|+|||.+.+...++.++||||||+++|+|++|.+||...+..+.+..+....+....+.++......
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            2   3445789999999999776778999999999999999999999999999999999998888776554443322111


Q ss_pred             ch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          244 DY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       244 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..   ..........+....+.+++++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            10   000111122233445678999999999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.6e-50  Score=358.39  Aligned_cols=259  Identities=23%  Similarity=0.346  Sum_probs=215.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....... .....+..|..+++.+ +||||+++++++++.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            478999999999999999999999999999999998754332 2233466888888877 89999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|...+... +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++........
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            9999986 787777654 45999999999999999999999999999999999999999999999999999865444555


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc--------HHHHHHHHHhhCCCCCCCCCCc
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--------IDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .....||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||.....        .............         
T Consensus       210 ~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------  279 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------  279 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---------
T ss_pred             cccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---------
Confidence            566789999999999977 6789999999999999999999999964321        1112222111110         


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH------HHHhcCccccccC
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRFAKSFN  298 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~h~~~~~~~  298 (314)
                                        .....+++++.+||++||+.||.+||++      +|+++||||+.++
T Consensus       280 ------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          280 ------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             ------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence                              1123469999999999999999999995      8999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-50  Score=356.28  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=221.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|.+...... .........|..+++.+ +||||+++++++++.+..|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            58999999999999999999999999999999999765321 22233456788888877 89999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        96 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            9999975 8888876543 5999999999999999999999999999999999999999999999999999865444444


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+......     +           
T Consensus       175 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~-----------  237 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-----Y-----------  237 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----C-----------
T ss_pred             ccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC-----C-----------
Confidence            556678999999999977 56899999999999999999999999988877777766543111     1           


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHH-HHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~h~~~~~~~  298 (314)
                                  ...+++++.+||.+||+.||++||++. ++++||||+.++
T Consensus       238 ------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          238 ------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             ------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             ------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                        123589999999999999999999998 999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-50  Score=359.13  Aligned_cols=286  Identities=36%  Similarity=0.630  Sum_probs=233.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----Ce
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----GN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   85 (314)
                      .++|++++.||+|+||.||++.+..++..||+|++..... ......+.+|+++++.++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            5899999999999999999999999999999999975332 22234567899999999999999999988544     47


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      .+++||+++|+|.+.+...  .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus       105 ~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999999999988764  49999999999999999999999999999999999999999999999999998764332


Q ss_pred             C---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 R---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .   ......|++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+......+......
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2   1234578999999999877677899999999999999999999999999999999998887776654433222111


Q ss_pred             cchh---hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ....   ........+.....+.+++++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            1100   00011111223334667999999999999999999999999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=351.98  Aligned_cols=260  Identities=26%  Similarity=0.361  Sum_probs=212.6

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   83 (314)
                      ..++.+.++|++.+.||+|+||+||+|.+..+|+.||+|++...............|+..+..+ .||||+++++++.++
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            3456778999999999999999999999999999999999876544333333444555555555 899999999999999


Q ss_pred             CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      +..++|||+++|+|.+.+...+..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+.....
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            99999999999999999988777899999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .. ......||+.|+|||.+.+  .++.++||||||+++|+|++|..|+....   ....+...   ..+          
T Consensus       210 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~---~~~----------  270 (311)
T 3p1a_A          210 AG-AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQG---YLP----------  270 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTT---CCC----------
T ss_pred             CC-CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhcc---CCC----------
Confidence            32 3344568999999999876  57999999999999999999976654422   22222111   000          


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                   ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       271 -------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 -------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                         0112346899999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=347.06  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=211.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc------------------------CcchhhHHHHHHHh
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------------------------GVNFTALREIKLLK   66 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~------------------------~~~~~~~~e~~~l~   66 (314)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.......                        .....+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            489999999999999999999999999999999997654221                        11245678999999


Q ss_pred             hcCCCCeeeeeceecc--CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceE
Q 021299           67 ELKSPHIIELIDAFPH--KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (314)
Q Consensus        67 ~l~~~~i~~~~~~~~~--~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil  143 (314)
                      .++||||+++++++.+  .+..++||||++| +|.+..  ....+++..++.++.||+.||+|||++|++|+||||+||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            9999999999999875  6689999999986 554432  2346999999999999999999999999999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccC--CCCcchHhhHHHHHHHHHhCCCccCCCCcHHHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL  221 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~--~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~  221 (314)
                      ++.++.++|+|||++..............|++.|+|||.+.+...  .+.++||||||+++|+|++|..||.........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  249 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH  249 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence            999999999999999887655444556678999999999876332  478899999999999999999999887666555


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      ..+.......     +                     ..+.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       250 ~~~~~~~~~~-----~---------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          250 SKIKSQALEF-----P---------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHCCCCC-----C---------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHhcccCCC-----C---------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            5444321110     0                     01346899999999999999999999999999999963

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-50  Score=348.61  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=221.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||+||+++++.+|+.||+|++....... .....+.+|..+++.++||||+++++++++.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            578999999999999999999999999999999997653221 2233556899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......   .
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---c
Confidence            999985 8888887543 5999999999999999999999999999999999999999999999999999875432   2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                  
T Consensus       161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------  221 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------------  221 (318)
T ss_dssp             CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------------
T ss_pred             ccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence            34578999999999876 66899999999999999999999999988877777776653211                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                ....+++++.+||.+||+.||.+||     +++++++||||+.++
T Consensus       222 ----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          222 ----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ----------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence                      1124589999999999999999999     899999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.2e-50  Score=360.41  Aligned_cols=261  Identities=26%  Similarity=0.330  Sum_probs=222.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|..+++.++||||+++++++++.+..|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999976432 222233567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||++| +|.+.+...  .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus       148 ~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             ECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             EeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            999974 888888654  489999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccccccCccccCcccccCcc---CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVFARWYRAPELLFGAK---QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~---~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....||+.|+|||++.+..   .++.++|+||||+++|+|++|.+||...+.......+...........         
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~---------  296 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD---------  296 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT---------
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC---------
Confidence            33567999999999997632   268999999999999999999999999888888888765421111110         


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCcccccc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSF  297 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~  297 (314)
                                     ...+++++.+||++||+.+|.+  ||+++||++||||+.+
T Consensus       297 ---------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          297 ---------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             ---------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ---------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                           1246999999999999999988  9999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-49  Score=355.97  Aligned_cols=262  Identities=28%  Similarity=0.454  Sum_probs=224.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++.+.||+|+||+||+|.++.+|+.+++|.+......  ....+.+|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            4568999999999999999999999999999999999754322  22356689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec--CCcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~df~~~~~~~~~~  165 (314)
                      ||||+.| +|.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.  ++.++|+|||++.......
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999985 888888877667999999999999999999999999999999999999974  4689999999998764432


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+........+.           
T Consensus       206 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------  272 (387)
T 1kob_A          206 -IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-----------  272 (387)
T ss_dssp             -CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-----------
T ss_pred             -ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence             2334578999999999876 668999999999999999999999999888777777765542222211           


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   .+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       273 -------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          273 -------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                         2235699999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-49  Score=357.55  Aligned_cols=289  Identities=20%  Similarity=0.221  Sum_probs=218.9

Q ss_pred             HhhccceeeeCcc--ccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g--~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|  ++|+||++.++.+|+.||+|.+............+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            6899999999999  99999999999999999999998765544444566789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC--
Q 021299           89 VFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP--  164 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~--  164 (314)
                      ||||+.| +|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......  
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            9999985 888888764 356999999999999999999999999999999999999999999999999988654221  


Q ss_pred             -----CCcccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCC--C
Q 021299          165 -----DRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ--W  236 (314)
Q Consensus       165 -----~~~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  236 (314)
                           ........|++.|+|||.+.+. ..++.++||||||+++|+|++|..||.......................  .
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI  263 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence                 1122334678889999999764 4689999999999999999999999988776665554433211100000  0


Q ss_pred             CCcC----------------cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          237 PDLA----------------YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       237 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      +...                ..............+.......+++++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            0000                00000000001111122344567999999999999999999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.5e-50  Score=353.62  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=222.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..... ..........|..++..+ .||+|+++++++++.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            5899999999999999999999999999999999976532 122333556889999887 79999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|.+.+...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            9999985 8888877543 5999999999999999999999999999999999999999999999999999865444444


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+....+......                 
T Consensus       178 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----------------  239 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----------------  239 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred             cccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence            556678999999999976 66799999999999999999999999988887777776653211                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                 ....+++++.+||.+||+.||.+||+     ++++++||||+.++
T Consensus       240 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          240 -----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             -----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence                       11246899999999999999999994     69999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-50  Score=357.22  Aligned_cols=285  Identities=37%  Similarity=0.603  Sum_probs=230.4

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE--
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL--   86 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--   86 (314)
                      ++.++|.+.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..  
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            356899999999999999999999999999999999986654444445677899999999999999999999776654  


Q ss_pred             ----EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           87 ----HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ----~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                          ++|||+++|+|...+.   ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       119 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          119 FYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             ceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence                9999999999887763   349999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   .....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+......+......
T Consensus       196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            32   334567899999999977677899999999999999999999999999999988888887665544332222111


Q ss_pred             cch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...   ...............+.+++++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence            100   000111112223334567999999999999999999999999999999998753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-50  Score=351.95  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   87 (314)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|.+.....      ...+|++++.++ +||||+++++++++.+..|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            468999999999999999999999999999999999976532      234688888888 7999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC----CcEEEeeccceeeeC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFG  162 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----~~~~l~df~~~~~~~  162 (314)
                      +||||+.| +|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||++..+    +.++|+|||++....
T Consensus        93 lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999985 888888755 469999999999999999999999999999999999998543    359999999998876


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC---CcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS---SDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      ..........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...   ...+....+.........      
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------  244 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG------  244 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS------
T ss_pred             CCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc------
Confidence            55555556678999999999876 55788999999999999999999999753   333344444332211111      


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                        ..+..+++++.+||.+||..||++|||++++++||||..+..
T Consensus       245 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          245 ------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             ------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             ------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence                              123457999999999999999999999999999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.5e-50  Score=362.00  Aligned_cols=265  Identities=23%  Similarity=0.322  Sum_probs=225.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||+||+++++.+++.||+|++...... ......+.+|..++..++||||+++++++++.+..|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999999764321 22223467899999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||+. |+|.+.+....+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            99996 589999987667799999999999999999999999999999999999999999999999999987644332 2


Q ss_pred             ccccccCccccCccccc----CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          168 FTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .....||+.|+|||++.    +...++.++|+||||+++|+|++|.+||...+..+....+........           
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  301 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-----------  301 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-----------
Confidence            33457999999999986    235689999999999999999999999999888888877764321111           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCC--CCCHHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~ell~h~~~~~~~  298 (314)
                                  .+.....+++++.+||++||+.+|++  ||+++|+++||||++++
T Consensus       302 ------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          302 ------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             ------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence                        11112346999999999999988888  99999999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-49  Score=347.76  Aligned_cols=267  Identities=25%  Similarity=0.415  Sum_probs=226.7

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceecc
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPH   82 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   82 (314)
                      .+.+.++|++.+.||+|++|.||++.+..+|+.+++|.+........    ....+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            35678999999999999999999999999999999999987654322    23457789999999999999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccc
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~  157 (314)
                      .+..++||||+.| +|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++    .++|+|||.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999975 888888654 4689999999999999999999999999999999999999887    799999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+........     
T Consensus       166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----  238 (321)
T 2a2a_A          166 AHEIEDGV-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-----  238 (321)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----
T ss_pred             ceecCccc-cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-----
Confidence            98764432 2345568999999999876 6789999999999999999999999988877777666654321111     


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                         ......+++.+.+||.+||..||++|||++|+++||||+....+
T Consensus       239 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          239 -------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             -------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             -------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence                               11123568999999999999999999999999999999987643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.7e-50  Score=359.60  Aligned_cols=284  Identities=34%  Similarity=0.589  Sum_probs=224.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC----
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK----   83 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   83 (314)
                      +....+|++.+.||+|+||+||+|++..++. +++|++......      ..+|+++++.++||||+++++++...    
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3446789999999999999999999877665 888887644321      12799999999999999999988432    


Q ss_pred             --CeEEEEEecccccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe-cCCcEEEeeccc
Q 021299           84 --GNLHLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGL  157 (314)
Q Consensus        84 --~~~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~df~~  157 (314)
                        ...++||||+++++...+.   .....+++..++.++.||+.||+|||++|++|+||||+||+++ .++.+||+|||.
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence              3488999999998776654   2356799999999999999999999999999999999999999 789999999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +....... ......+++.|+|||.+.+...++.++||||||+++|+|++|.+||......+....+....+......+.
T Consensus       189 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98764332 33456789999999999876678999999999999999999999999999999999888877765543322


Q ss_pred             CcCcccchhhhccccCCCC-CccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          238 DLAYLPDYVEYQYVAAPPL-RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..........+......+. ....+.+++++.+||.+||+.||.+|||+.|+++||||+.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            1110000000000111111 1123357999999999999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-49  Score=347.69  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=211.3

Q ss_pred             HhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcc--cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|+||.||++++.   .+|+.+|+|++......  ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            589999999999999999999875   67899999999765321  1223345689999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      .++||||+.| +|.+.+...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            9999999985 8888776543 5899999999999999999999999999999999999999999999999999765444


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......              
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--------------  239 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN--------------  239 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------------
T ss_pred             CccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence            444445678999999999876 66799999999999999999999999988877777776654211              


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                    ..+.+++++.+||.+||..||.+||     +++|+++||||+.++
T Consensus       240 --------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          240 --------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             --------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             --------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                          1124589999999999999999999     899999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-49  Score=367.33  Aligned_cols=263  Identities=33%  Similarity=0.517  Sum_probs=222.0

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ..+.++|++++.||+|+||+||+|.++.++..+|+|++............+.+|+.+++.++||||+++++++.+.+..+
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            35788999999999999999999999999999999999877655555667789999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcEEEeeccceeeeCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGS  163 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~df~~~~~~~~  163 (314)
                      +||||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++..   +.++|+|||++.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999985 8888776553 59999999999999999999999999999999999999764   4599999999987644


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . .......|++.|+|||++.+  .++.++||||||+++|+|++|.+||......+....+...........        
T Consensus       192 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------  260 (494)
T 3lij_A          192 Q-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------  260 (494)
T ss_dssp             T-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG--------
T ss_pred             C-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh--------
Confidence            3 23345678999999999854  589999999999999999999999999888888877766533322222        


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                      +..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       261 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          261 ----------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             ----------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             ----------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                            235699999999999999999999999999999998763

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-49  Score=339.68  Aligned_cols=260  Identities=29%  Similarity=0.418  Sum_probs=214.8

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      -++.++|++.+.||+|+||+||++.+..++..+++|.+...... .....+.+|+++++.++||||+++++++.+.+..+
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            45789999999999999999999999999999999999865432 23346778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceee
Q 021299           88 LVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARI  160 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~  160 (314)
                      +||||++| +|.+.+...   ...+++..++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999985 888887543   4679999999999999999999999999999999999999   4457899999999976


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .... .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||......+..............       
T Consensus       177 ~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  246 (285)
T 3is5_A          177 FKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-------  246 (285)
T ss_dssp             -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-------
T ss_pred             cCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-------
Confidence            5432 22345568899999999854  5789999999999999999999999887766665554432211111       


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                        ....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       247 ------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          247 ------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                              11235899999999999999999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-49  Score=349.08  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=215.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....... .....+.+|..+++.+ +||||+++++++++.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999998654322 2223456799999887 89999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|...+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            9999975 888877654 35999999999999999999999999999999999999999999999999999865444444


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---------HHHHHHHHHhhCCCCCCCCCC
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....         ......+... ..        
T Consensus       167 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~--------  236 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI--------  236 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CC--------
T ss_pred             ccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CC--------
Confidence            556678999999999977 6679999999999999999999999965321         1122222211 00        


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH------HHHhcCccccccC
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~ell~h~~~~~~~  298 (314)
                                         .....+++++.+||.+||+.||.+||++      +|+++||||+.++
T Consensus       237 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          237 -------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                               1123469999999999999999999995      8999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-49  Score=347.66  Aligned_cols=268  Identities=24%  Similarity=0.421  Sum_probs=226.5

Q ss_pred             cccHHHHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceecc
Q 021299            5 DLSKKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPH   82 (314)
Q Consensus         5 ~~~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   82 (314)
                      .-.+.+.++|.+. +.||+|+||+||++.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3457789999998 8999999999999999999999999999876655555567779999999995 6999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      .+..++||||+.| +|.+.+... ...+++..++.++.||+.||++||++|++|+||||+||+++.   ++.++|+|||.
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            9999999999986 777777543 457999999999999999999999999999999999999987   78999999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+...........  
T Consensus       181 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--  256 (327)
T 3lm5_A          181 SRKIGHAC-ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET--  256 (327)
T ss_dssp             CEEC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT--
T ss_pred             ccccCCcc-ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh--
Confidence            98764332 2344578999999999876 6789999999999999999999999998888777777665533332222  


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                            ...+++.+.+||.+||+.||++|||++++|+||||+.++
T Consensus       257 ----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          257 ----------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             ----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             ----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence                                  235689999999999999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.2e-50  Score=349.81  Aligned_cols=263  Identities=25%  Similarity=0.360  Sum_probs=215.3

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++.+.||+|+||+||++.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+++..++
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            45789999999999999999999999999999999997654322 22456789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--  165 (314)
                      ||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......  
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999986 77776654 3459999999999999999999999999999999999999999999999999998653222  


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......|++.|+|||.+.+....+.++||||||+++|+|++|..||....................             
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  228 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------------  228 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------------
Confidence            2233567899999999998755568899999999999999999999977655433222222111100             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  .....+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus       229 ------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          229 ------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             ------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                        01134689999999999999999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.9e-50  Score=357.44  Aligned_cols=286  Identities=32%  Similarity=0.513  Sum_probs=218.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   84 (314)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            3568999999999999999999999999999999999865444444456678999999999999999999986554    


Q ss_pred             --eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        85 --~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                        ..++||||++|++.+.+..   .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              7899999999999888863   48999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+....+...+..+......
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            32 22334578899999999977 66899999999999999999999999999988888888776665544322221100


Q ss_pred             cch--------------hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDY--------------VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...              ........+.........++++.+||.+||+.||++|||++|+|+||||+.+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence            000              000000000000000112568999999999999999999999999999997654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=351.86  Aligned_cols=259  Identities=22%  Similarity=0.409  Sum_probs=216.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            5899999999999999999999999999999999976542 223334667899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| +|...+.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCB
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-Cce
Confidence            999976 77777765 446999999999999999999999999999999999999999999999999999876433 334


Q ss_pred             cccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHH--HHHHhhCCCCCCCCCCcCcccc
Q 021299          169 THQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLG--KIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ....||+.|+|||++..  +..++.++|+||||+++|+|++|..||..........  ........              
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------  237 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--------------  237 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--------------
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--------------
Confidence            55678999999999864  2457899999999999999999999997543322221  11111111              


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-HHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~ell~h~~~~~~~  298 (314)
                                   .....+++++.+||.+||+.||.+||+ ++++++||||+.++
T Consensus       238 -------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          238 -------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             -------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence                         112245899999999999999999999 89999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.5e-50  Score=368.03  Aligned_cols=264  Identities=33%  Similarity=0.532  Sum_probs=225.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+++++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            57899999999999999999999999999999999997665444455577799999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe---cCCcEEEeeccceeeeCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~df~~~~~~~~~  164 (314)
                      ||||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++......
T Consensus        99 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999985 8888776554 599999999999999999999999999999999999995   4567999999999765332


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .......|++.|+|||++.+  .++.++||||||+++|+|++|.+||......+....+..........          
T Consensus       178 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------  244 (486)
T 3mwu_A          178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----------  244 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG----------
T ss_pred             -CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc----------
Confidence             23345578999999999976  48999999999999999999999999988888877776543222211          


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                    .+..+++++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus       245 --------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          245 --------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             --------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             --------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence                          123469999999999999999999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-49  Score=350.53  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=222.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||.||+++++.+|+.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            5899999999999999999999999999999999976542 222334567899999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+. |+|.+.+...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......   .
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---c
Confidence            99997 58888887644 5999999999999999999999999999999999999999999999999999876432   2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......                  
T Consensus       196 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------  256 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------------  256 (350)
T ss_dssp             CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred             ccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            34578999999999977 56899999999999999999999999988887777776654211                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                ....+++++.+||.+||+.||.+||+     ++++++||||+.++
T Consensus       257 ----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          257 ----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             ----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             ----------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence                      11245899999999999999999999     99999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-49  Score=353.54  Aligned_cols=293  Identities=35%  Similarity=0.577  Sum_probs=226.7

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc---------chhhHHHHHHHhhcCCCCeeeee
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV---------NFTALREIKLLKELKSPHIIELI   77 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~   77 (314)
                      ...+.++|++.+.||+|++|.||++.+.. |..||+|.+.........         ...+.+|+++++.++||||++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            34567999999999999999999998755 899999998765433221         14567899999999999999999


Q ss_pred             cee-----ccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           78 DAF-----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        78 ~~~-----~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      +++     ......++|||+++|++.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence            988     344578999999999999999988778999999999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCC
Q 021299          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       153 ~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      +|||.+...... .......+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+...
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999754332 2334557889999999987766789999999999999999999999999998888888887766544


Q ss_pred             CCCCCCcCcccch----hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          233 PSQWPDLAYLPDY----VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       233 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                      ...+.........    ...............+.+++.+.+||.+||..||.+|||++|+++||||+.+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            3211100000000    00000011112223456789999999999999999999999999999999885443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=358.32  Aligned_cols=264  Identities=24%  Similarity=0.321  Sum_probs=222.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+++++.+|+.||+|++..... .......+.+|..++..++||||+++++++++.+..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            4789999999999999999999999999999999975432 112223466899999999999999999999999999999


Q ss_pred             Eeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        90 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |||+. |+|.+.+...+..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            99996 599999887666799999999999999999999999999999999999999999999999999987654433 2


Q ss_pred             ccccccCccccCcccccC------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          168 FTHQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .....||+.|+|||++..      ...++.++|+||||+++|+|++|..||...+..+....+.........        
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------  291 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL--------  291 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC--------
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC--------
Confidence            234578999999999863      246799999999999999999999999998888877777643211110        


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCC---CCHHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR---ITAQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~ell~h~~~~~~~  298 (314)
                                     +.....+++++.+||++||+ +|.+|   |+++|+++||||+.++
T Consensus       292 ---------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          292 ---------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ---------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             ---------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence                           01113469999999999999 99998   5999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-50  Score=346.79  Aligned_cols=256  Identities=23%  Similarity=0.301  Sum_probs=190.1

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----e
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----N   85 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   85 (314)
                      |..+|.+.+.||+|+||+||+|++  +|+.||+|++......   ......|+..+..++||||+++++++.+++    .
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            357899999999999999999976  5889999998643221   112224666667889999999999986543    5


Q ss_pred             EEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCceEEecCCcEEEeecc
Q 021299           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--------WVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                      .++|||||+ |+|.+++...  .++++.+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            799999998 5899988765  489999999999999999999987        99999999999999999999999999


Q ss_pred             ceeeeCCCCCc----ccccccCccccCcccccCcc-----CCCCcchHhhHHHHHHHHHhCCCccCCCCcHH--------
Q 021299          157 LARIFGSPDRR----FTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDID--------  219 (314)
Q Consensus       157 ~~~~~~~~~~~----~~~~~~~~~y~sPE~~~~~~-----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~--------  219 (314)
                      +++........    .....||+.|+|||++.+..     .++.++|||||||++|||+||.+||.......        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876543322    22457999999999986532     35779999999999999999988775432111        


Q ss_pred             ---HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccC--CCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          220 ---QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       220 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                         ....+......                   ....+.++...  ...++.+.+|+.+||+.||++|||+.||++.
T Consensus       234 ~~~~~~~~~~~~~~-------------------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCE-------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTT-------------------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhc-------------------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               00011110000                   00001111111  1134578899999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-49  Score=352.65  Aligned_cols=289  Identities=30%  Similarity=0.535  Sum_probs=218.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC---
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   84 (314)
                      ....++|++.+.||+|+||+||++.+..+|+.||+|++.....   ......++++.++.++||||+++++++...+   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3457899999999999999999999999999999999865432   2235567888888999999999999885432   


Q ss_pred             ----eEEEEEecccccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCceEEec-CCcEEEee
Q 021299           85 ----NLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCH--KKWVLHRDMKPNNLLIGS-HGQLKLAD  154 (314)
Q Consensus        85 ----~~~iv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~i~H~di~~~nil~~~-~~~~~l~d  154 (314)
                          ..++||||++|++...+..   ....+++..++.++.|++.||.+||  ++|++|+||||+||+++. ++.++|+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                3789999999988776653   4567899999999999999999999  999999999999999997 89999999


Q ss_pred             ccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       155 f~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ||++....... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||...........+....+.....
T Consensus       176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            99998764332 33455679999999999776678999999999999999999999999999999888888776655433


Q ss_pred             CCCCcCcccchhhhccccCCC----CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPP----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      .+..................+    +.......++++.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence            221111000000000000000    111223367899999999999999999999999999999988643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-49  Score=353.18  Aligned_cols=260  Identities=25%  Similarity=0.370  Sum_probs=203.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++++.||+|+||+||++++..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            5899999999999999999999999999999999975432   2345678999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc--EEEeeccceeeeCCCCCc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRR  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~df~~~~~~~~~~~~  167 (314)
                      ||+.| +|.+.+...+ .+++..++.++.||+.||+|||++|++|+||||+||+++.++.  ++|+|||.+..... ...
T Consensus        96 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-~~~  173 (361)
T 3uc3_A           96 EYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  173 (361)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-cCC
Confidence            99975 8888876544 5999999999999999999999999999999999999987765  99999999974322 223


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....|++.|+|||.+.+....+.++||||||+++|+|++|..||..................... ..+          
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~----------  242 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SIP----------  242 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-CCC----------
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-CCC----------
Confidence            344578999999999987444456699999999999999999999875543333333222111110 011          


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                 ....+++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus       243 -----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          243 -----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                       012468999999999999999999999999999999654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-49  Score=338.70  Aligned_cols=260  Identities=31%  Similarity=0.451  Sum_probs=222.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ..+.++|++.+.||+|++|+||++.+..++..+++|++......  ....+.+|+++++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            45789999999999999999999999999999999999765332  2346778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeeeCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~~~  163 (314)
                      +||||+.| +|.+.+.... .+++..++.++.|++.||.+||++|++|+||||+||++   +.++.++|+|||.+.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999986 8878776543 58999999999999999999999999999999999999   7788999999999987643


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||......+....+.......+..         
T Consensus       162 ~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  229 (277)
T 3f3z_A          162 G-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK---------  229 (277)
T ss_dssp             T-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---------
T ss_pred             c-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---------
Confidence            3 33345578999999999866  47999999999999999999999999888777777765542222111         


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                     ....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       230 ---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          230 ---------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             ---------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             ---------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                           112458999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.3e-49  Score=348.94  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=223.1

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      +...++|.+++.||+|+||+||+|.+..+|+.|++|++...... ......+.+|+++++.++||||+++++++..++..
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            34567899999999999999999999999999999999765432 22234567899999999999999999999999999


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++||||+.|++.+.+......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....   
T Consensus       130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            99999999999999887777899999999999999999999999999999999999999999999999999976533   


Q ss_pred             cccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .....|++.|+|||.+.+  ...++.++||||||+++|+|++|..||...........+........            
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------  273 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------  273 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------------
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Confidence             234568999999999853  35678999999999999999999999988777666665544311110            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                    ....+++.+.+||.+||+.||++|||++++++||||....
T Consensus       274 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          274 --------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             --------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                          0124588999999999999999999999999999998654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-49  Score=358.31  Aligned_cols=280  Identities=34%  Similarity=0.582  Sum_probs=221.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc------CCe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------KGN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   85 (314)
                      .+|++.+.||+|+||+||++.+..+|+.||+|++.....      ...+|+++++.++||||+++++++..      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            479999999999999999999999999999999865432      12379999999999999999998732      234


Q ss_pred             EEEEEecccccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceeee
Q 021299           86 LHLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIF  161 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~~  161 (314)
                      .++||||+++++.+.+.   .....+++..++.++.||+.||+|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus       128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            67999999998877665   345679999999999999999999999999999999999999965 57899999999876


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||......+.+..+....+....+.+.....
T Consensus       208 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          208 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             ccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            4332 234457899999999997756789999999999999999999999999998888888887766554332211100


Q ss_pred             ccchhhhccccCCC-CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPP-LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .-....+......+ ...+.+.+++++.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            00000000000000 0112345789999999999999999999999999999998874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-49  Score=366.86  Aligned_cols=265  Identities=34%  Similarity=0.564  Sum_probs=227.4

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+++++.++||||+++++++.+.+.
T Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            345789999999999999999999999999999999999776543 3344567799999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeee
Q 021299           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIF  161 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~  161 (314)
                      .++|||++.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            9999999985 8888777554 59999999999999999999999999999999999999   46789999999999766


Q ss_pred             CCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .... ......|++.|+|||++.+  .++.++||||||+++|+|++|.+||......+....+..........       
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------  249 (484)
T 3nyv_A          180 EASK-KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-------  249 (484)
T ss_dssp             CCCC-SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-------
T ss_pred             cccc-ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-------
Confidence            4332 3345578999999999866  58999999999999999999999999988888877776543222211       


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                       .+..+++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       250 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          250 -----------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             -----------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             -----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                             12346999999999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-48  Score=341.02  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=219.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ..|...+.||+|++|.||+|.+..+|+.||+|.+.....  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            358888999999999999999999999999999976532  233456799999999999999999999999999999999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |++| +|.+.+..  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus       123 ~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          123 FLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             cCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            9986 77776654  35999999999999999999999999999999999999999999999999999877655445556


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      ..|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......    +.             
T Consensus       201 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~-------------  262 (321)
T 2c30_A          201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK----LK-------------  262 (321)
T ss_dssp             CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC----CT-------------
T ss_pred             ccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----cC-------------
Confidence            778999999999876 668999999999999999999999998887777666654431111    00             


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              ....+++++.++|.+||+.||++|||++|+++||||....
T Consensus       263 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          263 --------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             --------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             --------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                    0124588999999999999999999999999999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-49  Score=350.00  Aligned_cols=270  Identities=26%  Similarity=0.425  Sum_probs=221.9

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc---ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      ..+.++|++.+.||+|+||+||++.+..++..+++|++.....   .......+.+|+++++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            4678999999999999999999999999999999999976532   2334456778999999999999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 021299           85 NLHLVFEFMET-DLETVIRNT---------------------------------------NIFLSPADIKSYMQMTLKGL  124 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l  124 (314)
                      ..++||||++| +|.+.+...                                       ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999975 888877421                                       11246778899999999999


Q ss_pred             HHHHhCCcccCCCCCCceEEecCC--cEEEeeccceeeeCCCCC----cccccccCccccCcccccC-ccCCCCcchHhh
Q 021299          125 AFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDR----RFTHQVFARWYRAPELLFG-AKQYGAGVDVWA  197 (314)
Q Consensus       125 ~~Lh~~~i~H~di~~~nil~~~~~--~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~s  197 (314)
                      +|||++|++|+||||+||+++.++  .++|+|||.+........    ......+++.|+|||.+.+ ...++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998776  899999999987533221    2345568999999999864 256789999999


Q ss_pred             HHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhccc
Q 021299          198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTY  277 (314)
Q Consensus       198 lG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  277 (314)
                      ||+++|+|++|..||......+....+..........                        ....+++++.+||.+||+.
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------------------------NYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG------------------------GGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc------------------------ccccCCHHHHHHHHHHcCC
Confidence            9999999999999999888888777766542221111                        1124589999999999999


Q ss_pred             CCCCCCCHHHHhcCccccccCcce
Q 021299          278 DPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       278 dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                      ||.+|||+.|+++||||+.+.++.
T Consensus       318 ~p~~Rps~~~~l~hp~~~~~~~~~  341 (345)
T 3hko_A          318 NVDERFDAMRALQHPWISQFSDKI  341 (345)
T ss_dssp             CTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred             ChhHCCCHHHHhcChhhccChHhh
Confidence            999999999999999999887654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.5e-49  Score=348.84  Aligned_cols=289  Identities=38%  Similarity=0.649  Sum_probs=230.8

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC---
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK---   83 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   83 (314)
                      ...+.++|.+.+.||+|++|+||++.+..+|+.|++|.+..... ......+.+|+++++.++||||+++++++...   
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            34567999999999999999999999999999999999964322 22233566899999999999999999886543   


Q ss_pred             --CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           84 --GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        84 --~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                        ...+++||+++|+|.+.+...  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        85 ~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           85 NFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence              678999999999999988764  5999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCc----------ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCC
Q 021299          162 GSPDRR----------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       162 ~~~~~~----------~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      ......          .....|++.|+|||.+.+...++.++||||||+++|+|++|.+||...+.......+....+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            432211          1234678999999998766778999999999999999999999999998888888887776655


Q ss_pred             CCCCCCCcCcccchhhh----ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          232 TPSQWPDLAYLPDYVEY----QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .................    ............+.+++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            43222111100000000    01111222333457899999999999999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-49  Score=362.86  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||.||++.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            4789999999999999999999999999999999976432 222233456899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |||++| +|...+... +.+++..+..++.||+.||+|||+ +|++|+||||+||+++.++.++|+|||++.........
T Consensus       227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            999986 777777654 469999999999999999999998 99999999999999999999999999999764444444


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+......                 
T Consensus       306 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----------------  367 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-----------------  367 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred             cccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence            556778999999999977 67899999999999999999999999888877777666543111                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                 ....+++++.+||.+||+.||.+||     +++|+++||||++++
T Consensus       368 -----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          368 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                       1124589999999999999999999     999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=355.72  Aligned_cols=286  Identities=37%  Similarity=0.655  Sum_probs=218.5

Q ss_pred             HHHhhccce-eeeCccccceEEEEEEC--CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee--ccC
Q 021299            9 KVADRYLKR-EVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF--PHK   83 (314)
Q Consensus         9 ~~~~~y~~~-~~lg~g~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~   83 (314)
                      .+.+.|.+. +.||+|+||+||+|.++  .++..||+|.+....    ....+.+|+.+++.++||||+++++++  ...
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            456888874 47999999999999965  568899999996442    233567899999999999999999998  557


Q ss_pred             CeEEEEEecccccHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE----ecCCcEE
Q 021299           84 GNLHLVFEFMETDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLK  151 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~  151 (314)
                      ...++||||++|+|.+.+...        ...+++..++.++.||+.||+|||++|++|+||||+||++    +.++.++
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            889999999999998888632        2249999999999999999999999999999999999999    6678999


Q ss_pred             EeeccceeeeCCCC---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---------HH
Q 021299          152 LADFGLARIFGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------ID  219 (314)
Q Consensus       152 l~df~~~~~~~~~~---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---------~~  219 (314)
                      |+|||++.......   .......||+.|+|||++.+...++.++||||||+++|+|++|.+||.....         .+
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999998764322   2233457899999999998766789999999999999999999999976554         57


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC----------CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP----------LRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      .+..++...+......|+.....+............          ........++.+.+||.+||+.||.+|||++|+|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            888888888888888777665444332221111000          0011123478899999999999999999999999


Q ss_pred             cCccccccC
Q 021299          290 EHRFAKSFN  298 (314)
Q Consensus       290 ~h~~~~~~~  298 (314)
                      +||||+...
T Consensus       333 ~hp~f~~~~  341 (405)
T 3rgf_A          333 QDPYFLEDP  341 (405)
T ss_dssp             TSGGGTSSS
T ss_pred             cChhhccCC
Confidence            999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.1e-49  Score=347.07  Aligned_cols=264  Identities=29%  Similarity=0.419  Sum_probs=206.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +.+.++|++.+.||+|+||+||+|.+..+++.|++|++.....    ...+.+|+++++.++||||+++++++...+..+
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            4567899999999999999999999999999999999976532    234568999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccceeeeCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGS  163 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~~~~~~~  163 (314)
                      +||||+.| +|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.   ++.++|+|||++.....
T Consensus       125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999985 888877654 45999999999999999999999999999999999999975   78999999999986543


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH-HHHHHHHhhCCCCCCCCCCcCcc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      . .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... ....+........          
T Consensus       204 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~----------  271 (349)
T 2w4o_A          204 Q-VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI----------  271 (349)
T ss_dssp             ----------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC----------
T ss_pred             c-cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC----------
Confidence            2 22334568999999999977 568999999999999999999999997766555 3333333211111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                    .+....++.++.+||.+||+.||++|||++|+++||||++......
T Consensus       272 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  317 (349)
T 2w4o_A          272 --------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV  317 (349)
T ss_dssp             --------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS
T ss_pred             --------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh
Confidence                          1123456999999999999999999999999999999998765443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.1e-49  Score=340.36  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+..+|+.||+|.+..............++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            58999999999999999999999999999999999765443333333445556688889999999999999999999999


Q ss_pred             ecccccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           91 EFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        91 e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ||++|++.+.+..   ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||.+....... 
T Consensus        86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  164 (290)
T 3fme_A           86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-  164 (290)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence            9999988777654   566799999999999999999999998 99999999999999999999999999998664332 


Q ss_pred             cccccccCccccCccccc---CccCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 RFTHQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ......+++.|+|||.+.   ....++.++||||||+++|+|++|..||.... ................+         
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  235 (290)
T 3fme_A          165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---------  235 (290)
T ss_dssp             -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---------
T ss_pred             cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---------
Confidence            223346889999999973   34568899999999999999999999997633 33333333332111110         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                       ...+++++.+||.+||+.||++|||++|+++||||+.....
T Consensus       236 -----------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~  276 (290)
T 3fme_A          236 -----------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK  276 (290)
T ss_dssp             -----------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             -----------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence                             12458999999999999999999999999999999876533

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-49  Score=365.84  Aligned_cols=266  Identities=32%  Similarity=0.510  Sum_probs=223.4

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-----------CcchhhHHHHHHHhhcCCCCeee
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-----------GVNFTALREIKLLKELKSPHIIE   75 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~   75 (314)
                      ...+.++|++++.||+|+||+||+|.++.++..+|+|++.......           .....+.+|+.+++.++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3457899999999999999999999999999999999998654321           23345678999999999999999


Q ss_pred             eeceeccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEE
Q 021299           76 LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLK  151 (314)
Q Consensus        76 ~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~  151 (314)
                      +++++.+.+..++||||+.| +|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++   .++
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999985 8888886553 599999999999999999999999999999999999998776   699


Q ss_pred             EeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCC
Q 021299          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       152 l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      |+|||++...... .......|++.|+|||.+.+  .++.++||||||+++|+|++|.+||......+....+.......
T Consensus       190 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          190 IVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             ECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999999876443 23345678999999999864  57999999999999999999999999988888887776642221


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...                        .+..+++++.+||.+||+.||.+|||++|+|+||||+.....
T Consensus       267 ~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          267 DFN------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CHH------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             Ccc------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            111                        123569999999999999999999999999999999977543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=338.45  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=195.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|++|.||++.+..+|+.+++|.+...... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            47899999999999999999999999999999999754322 22334667899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++++ +|.+.+......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            999975 8888888777789999999999999999999999999999999999999999999999999998775544444


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...     .               
T Consensus       170 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~---------------  228 (278)
T 3cok_A          170 YTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-----D---------------  228 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-----C---------------
T ss_pred             eeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-----c---------------
Confidence            45678899999999876 56789999999999999999999999765543332221000     0               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              ......++.++.+||.+||+.||++|||++++++||||+...
T Consensus       229 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          229 --------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             --------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                    011234689999999999999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-49  Score=359.88  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=223.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3468999999999999999999999999999999999765322 223346778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||+.| +|.+++.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus        93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~  170 (476)
T 2y94_A           93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E  170 (476)
T ss_dssp             EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-C
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-c
Confidence            99999974 88888764 446999999999999999999999999999999999999999999999999999876443 2


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......|++.|+|||.+.+....+.++||||||+++|+|++|..||...........+.......               
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------  235 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT---------------  235 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC---------------
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC---------------
Confidence            33455789999999999875556889999999999999999999999888887777765542111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                   ...+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       236 -------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          236 -------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                         12358899999999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=351.45  Aligned_cols=285  Identities=36%  Similarity=0.602  Sum_probs=228.2

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe---
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN---   85 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---   85 (314)
                      .+.++|.+.+.||+|++|+||+|.+..+|+.|++|.+............+.+|+.+++.++||||+++++++...+.   
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            35689999999999999999999999999999999997654444444566789999999999999999999876653   


Q ss_pred             ---EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           86 ---LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        86 ---~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                         .+++||+++|+|.+.+.   ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          101 FYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             ceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence               49999999998776653   348999999999999999999999999999999999999999999999999997643


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   .....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+......+......
T Consensus       178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            22   234567899999999877667899999999999999999999999999988888888777665443222211111


Q ss_pred             cch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...   ...............+.+++++.+||.+||+.||++|||++|+++||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence            000   000111122233445678999999999999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.6e-49  Score=351.20  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=215.1

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHH-HhhcCCCCeeeeeceeccCCeEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKL-LKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      -.++|++++.||+|+||+||+++++.+++.||+|++....... .....+..|..+ ++.++||||+++++++++.+..|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3589999999999999999999999999999999998764322 222234456665 56789999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||+.| +|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       116 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            99999986 787777654 3589999999999999999999999999999999999999999999999999976444444


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......                
T Consensus       195 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------------  257 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----------------  257 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC----------------
T ss_pred             ccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC----------------
Confidence            4556678999999999976 67899999999999999999999999988877777776653111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH----HHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~ell~h~~~~~~~  298 (314)
                                  ..+.+++++.+||.+||+.||.+||++    +++++||||+.++
T Consensus       258 ------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          258 ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             ------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             ------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence                        113468999999999999999999997    6999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-49  Score=338.68  Aligned_cols=266  Identities=27%  Similarity=0.448  Sum_probs=221.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      .+.++|++.+.||+|++|+||++.+..+|+.+++|.+........    ....+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            478999999999999999999999999999999999987653322    2345778999999999999999999999999


Q ss_pred             eEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeecccee
Q 021299           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR  159 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~~~  159 (314)
                      ..++|||++. ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++    .++|+|||.+.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999997 5888888654 3599999999999999999999999999999999999998877    89999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      ...... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+........       
T Consensus       161 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  231 (283)
T 3bhy_A          161 KIEAGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------  231 (283)
T ss_dssp             ECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------
T ss_pred             eccCCC-cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------
Confidence            764332 2334568899999999876 6689999999999999999999999988877766666543311111       


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                       ......+++.+.+||.+||..||++|||+.|+++||||+.+..+.
T Consensus       232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          232 -----------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             -----------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             -----------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                             111235689999999999999999999999999999999886543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.9e-49  Score=337.19  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=214.8

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++...+.++|++.+.||+|++|+||++.+..+++.|++|.+............+.+|+..+..+ +||||+++++++.+
T Consensus         3 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             --CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            35677889999999999999999999999999999999999987655554555677899999999 89999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-----------
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----------  147 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-----------  147 (314)
                      .+..++||||++| +|.+.+...   ...+++..++.++.||+.||.|||++|++|+||||+||+++.+           
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            9999999999975 999888754   2568999999999999999999999999999999999999844           


Q ss_pred             --------CcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH
Q 021299          148 --------GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID  219 (314)
Q Consensus       148 --------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~  219 (314)
                              ..++|+|||.+.......    ...+++.|+|||.+.+...++.++||||||+++|+|++|.+++.....  
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             cccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                    479999999998765432    345889999999998755677899999999999999999987654322  


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                       ...+.....                           ......+++++.+||.+||+.||++|||+.|+++||||++..
T Consensus       237 -~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 -WHEIRQGRL---------------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -HHHHHTTCC---------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -HHHHHcCCC---------------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             222222111                           112235689999999999999999999999999999998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-49  Score=347.28  Aligned_cols=262  Identities=25%  Similarity=0.408  Sum_probs=197.0

Q ss_pred             HHHHhhccce---eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccC
Q 021299            8 KKVADRYLKR---EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK   83 (314)
Q Consensus         8 ~~~~~~y~~~---~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   83 (314)
                      +.+.++|.+.   +.||+|+||+||++.++.+|+.||+|.+...     ......+|+.+++.+. ||||+++++++.+.
T Consensus         4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             CHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            4567888876   8899999999999999999999999999643     2235568999999997 99999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeecccee
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLAR  159 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df~~~~  159 (314)
                      ...++||||++| +|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++   .++|+|||++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999986 888888765 4699999999999999999999999999999999999998765   89999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-------HHHHHHHHhhCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-------DQLGKIFAAFGTAT  232 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~  232 (314)
                      .............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......       +....+....... 
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-  235 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-  235 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-
Confidence            77655555556678999999999876 66899999999999999999999999765432       2222222111000 


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                             ....+..+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus       236 -----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          236 -----------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             -----------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             -----------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence                                   011123469999999999999999999999999999999976543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-49  Score=349.42  Aligned_cols=284  Identities=23%  Similarity=0.334  Sum_probs=224.2

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-----CCCeeeeece
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----SPHIIELIDA   79 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~   79 (314)
                      .-+..+.++|++++.||+|+||+||+|.+..+++.||+|++....   ........|+.+++.+.     ||||++++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            334556799999999999999999999999999999999996422   12234557889999886     9999999999


Q ss_pred             eccCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec------------
Q 021299           80 FPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS------------  146 (314)
Q Consensus        80 ~~~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~------------  146 (314)
                      +...+..++|||+++++|.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.            
T Consensus       105 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          105 FMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            99999999999999889999998654 46999999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccC
Q 021299          147 -------------HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ  213 (314)
Q Consensus       147 -------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~  213 (314)
                                   ++.++|+|||.+......   .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                         789999999999875432   235578999999999977 668999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh-----c-------------cccCCCCCccCCCCCHHHHHHHhhhc
Q 021299          214 GSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-----Q-------------YVAAPPLRSLFPSASDDALDLLSKMF  275 (314)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-------------~~~~~~~~~~~~~~~~~~~~li~~~l  275 (314)
                      .....+....+.......+...+............     .             .......+......++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            98888888887776554432211100000000000     0             00000001111123578899999999


Q ss_pred             ccCCCCCCCHHHHhcCcccc
Q 021299          276 TYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       276 ~~dp~~Rps~~ell~h~~~~  295 (314)
                      +.||++|||++|+|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=350.90  Aligned_cols=261  Identities=28%  Similarity=0.437  Sum_probs=217.0

Q ss_pred             HHhhccc--eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           10 VADRYLK--REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        10 ~~~~y~~--~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +.+.|.+  .+.||+|+||.||++.+..+|..|++|++.....  .....+.+|+++++.++||||+++++++.+.+..+
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  162 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV  162 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3445555  6789999999999999999999999999986532  22345678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE--ecCCcEEEeeccceeeeCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI--GSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~--~~~~~~~l~df~~~~~~~~~  164 (314)
                      +||||++| +|.+.+......+++..++.++.||+.||.|||++|++|+||||+||++  +.++.++|+|||++......
T Consensus       163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            99999985 8888887776679999999999999999999999999999999999999  45678999999999876443


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      . ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+.........           
T Consensus       243 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------  309 (373)
T 2x4f_A          243 E-KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-----------  309 (373)
T ss_dssp             C-BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-----------
T ss_pred             c-ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-----------
Confidence            3 2334568999999999876 67899999999999999999999999998888887777665322111           


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ..+..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                         11235699999999999999999999999999999999763

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=337.92  Aligned_cols=269  Identities=29%  Similarity=0.466  Sum_probs=219.4

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      -++.+...++|++.+.||+|++|.||++.+..+|+.|++|.+....    ....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            3456667899999999999999999999999999999999997643    234677899999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      +..++||||++| +|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999986 8888887666779999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....    ..+      
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~------  245 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP----PTF------  245 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----CCC------
T ss_pred             hhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC----ccc------
Confidence            55444556678999999999876 5688999999999999999999999988776655544333211    000      


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                     .....+++.+.+||.+||..||.+|||++++++||||+.......
T Consensus       246 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~  290 (314)
T 3com_A          246 ---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI  290 (314)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGG
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchH
Confidence                           011235889999999999999999999999999999998765443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=342.80  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=215.0

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC------cchhhHHHHHHHhhcCCCCeeeeeceec
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKELKSPHIIELIDAFP   81 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   81 (314)
                      ..+.++|++.+.||+|+||+||++.+..+++.|++|.+........      ....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4578999999999999999999999999999999999987653322      2234568999999999999999999999


Q ss_pred             cCCeEEEEEeccc-c-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           82 HKGNLHLVFEFME-T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        82 ~~~~~~iv~e~~~-g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      +.+..++|||++. | +|.+.+... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999986 4 777777654 359999999999999999999999999999999999999999999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      ...... ......|++.|+|||.+.+....+.++||||||+++|+|++|..||.......      .   .         
T Consensus       179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~---~---------  239 (335)
T 3dls_A          179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E---A---------  239 (335)
T ss_dssp             ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T---T---------
T ss_pred             ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h---h---------
Confidence            764433 33445689999999999875555889999999999999999999996522100      0   0         


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                      .......+++++.+||.+||+.||.+|||++++++||||+...
T Consensus       240 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          240 ----------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ----------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                            0001123689999999999999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.6e-49  Score=337.16  Aligned_cols=259  Identities=26%  Similarity=0.442  Sum_probs=218.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ..++|++.+.||+|++|+||++.+..++..+++|++...... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            468999999999999999999999999999999999764322 2233456789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||++| +|.+.+.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....  ..
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--~~  163 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SR  163 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--cc
Confidence            9999985 7888776543 599999999999999999999999999999999999999999999999998865432  22


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+......                 
T Consensus       164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  225 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------------  225 (279)
T ss_dssp             ----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----------------
T ss_pred             ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-----------------
Confidence            344568899999999876 67789999999999999999999999988877777666543211                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                 ....+++.+.+||.+||+.||.+|||++|+++||||+.....
T Consensus       226 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          226 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             -----------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             -----------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence                       112358899999999999999999999999999999976544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-48  Score=337.97  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=221.3

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ...+.++|++.+.||+|++|+||++.+..+|+.+++|.+......  ....+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            456889999999999999999999999999999999999865322  223567899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~~  162 (314)
                      +++||+++| +|.+.+...+ .+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999975 8888876544 58999999999999999999999999999999999999   678899999999987543


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.........         
T Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---------  228 (304)
T 2jam_A          161 N--GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES---------  228 (304)
T ss_dssp             C--BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT---------
T ss_pred             C--CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---------
Confidence            2  22334568899999999876 67899999999999999999999999988877777766654322211         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                     .....+++++.+||.+||..||++|||++|+++||||+....
T Consensus       229 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          229 ---------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             ---------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             ---------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence                           122356899999999999999999999999999999987643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=345.14  Aligned_cols=287  Identities=34%  Similarity=0.628  Sum_probs=219.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec------
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP------   81 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------   81 (314)
                      ..+.++|++.+.||+|++|.||++.+..+|+.|++|.+....  ......+.+|+++++.++||||+++++++.      
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            356799999999999999999999999999999999987543  223345678999999999999999998863      


Q ss_pred             --------cCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe-cCCcEEE
Q 021299           82 --------HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKL  152 (314)
Q Consensus        82 --------~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l  152 (314)
                              +....++||||++|+|.+.+..  +.+++..++.++.|++.||++||++|++|+||||+||+++ .++.++|
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence                    4467899999999999988864  4589999999999999999999999999999999999997 4679999


Q ss_pred             eeccceeeeCCCC---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhC
Q 021299          153 ADFGLARIFGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG  229 (314)
Q Consensus       153 ~df~~~~~~~~~~---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~  229 (314)
                      +|||.+.......   .......+++.|+|||.+.+...++.++||||||+++|+|++|..||......+....+.....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998654321   1223445688899999987766789999999999999999999999999888887777766543


Q ss_pred             CCCCCCCCCcCc-ccchh-hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          230 TATPSQWPDLAY-LPDYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       230 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ............ ..... ........+.....+.+++++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            322111110000 00000 0000111222333456899999999999999999999999999999999654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.2e-49  Score=356.04  Aligned_cols=285  Identities=30%  Similarity=0.531  Sum_probs=224.4

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc------CCCCeeeeeceecc
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL------KSPHIIELIDAFPH   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~   82 (314)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|.+.....   ....+.+|+++++.+      +|+||+.+++++..
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            456889999999999999999999999999999999975321   223445677777776      56799999999999


Q ss_pred             CCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc--EEEeecccee
Q 021299           83 KGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLAR  159 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--~~l~df~~~~  159 (314)
                      .+..+++||+++|+|.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.  ++|+|||++.
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999999999999999998654 45999999999999999999999999999999999999999887  9999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .....   .....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+.+..+....+......+...
T Consensus       251 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          251 YEHQR---VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             ETTCC---CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             ecCCc---ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            65432   234578999999999987 66899999999999999999999999999999999888887665543321111


Q ss_pred             Ccccchhh--------------------------hccccCCC-----CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH
Q 021299          240 AYLPDYVE--------------------------YQYVAAPP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (314)
Q Consensus       240 ~~~~~~~~--------------------------~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  288 (314)
                      ........                          ......++     ........++++.+||.+||+.||++|||++|+
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~  406 (429)
T 3kvw_A          327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA  406 (429)
T ss_dssp             TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence            00000000                          00000000     001122358889999999999999999999999


Q ss_pred             hcCccccccCcc
Q 021299          289 LEHRFAKSFNGV  300 (314)
Q Consensus       289 l~h~~~~~~~~~  300 (314)
                      |+||||+....+
T Consensus       407 L~Hpw~~~~~~~  418 (429)
T 3kvw_A          407 LRHPWLRRRLPK  418 (429)
T ss_dssp             HTSTTTC-----
T ss_pred             hCChhhccCCCC
Confidence            999999976543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.3e-48  Score=344.77  Aligned_cols=263  Identities=30%  Similarity=0.517  Sum_probs=220.8

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC------cchhhHHHHHHHhhc-CCCCeeeeecee
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKEL-KSPHIIELIDAF   80 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l-~~~~i~~~~~~~   80 (314)
                      ..+.++|++.+.||+|++|.||+|.+..+|+.||+|++........      ....+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            4567899999999999999999999998999999999986543211      123456899999999 799999999999


Q ss_pred             ccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        81 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      ...+..++||||+.| +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            999999999999986 888877654 459999999999999999999999999999999999999999999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccC-----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ..... .......|++.|+|||.+.+     ...++.++||||||+++|+|++|..||...........+......... 
T Consensus       249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  326 (365)
T 2y7j_A          249 HLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS-  326 (365)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH-
T ss_pred             ccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-
Confidence            76443 23345678999999999863     235788999999999999999999999887777666665543221111 


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                             +.+..+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus       327 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 -----------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             -----------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                                   112345889999999999999999999999999999973

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-48  Score=341.53  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC---
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   84 (314)
                      +.+.++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+++++.++||||+++++++.+..   
T Consensus         2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            457899999999999999999999999999999999997654 2334456779999999999999999999874432   


Q ss_pred             ------------------------------------------------------eEEEEEecccc-cHHHHHHhCC--CC
Q 021299           85 ------------------------------------------------------NLHLVFEFMET-DLETVIRNTN--IF  107 (314)
Q Consensus        85 ------------------------------------------------------~~~iv~e~~~g-~l~~~~~~~~--~~  107 (314)
                                                                            ..+++|||+.| +|.+.+....  ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999986 8888887643  23


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC------------CcccccccCc
Q 021299          108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------RRFTHQVFAR  175 (314)
Q Consensus       108 l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~------------~~~~~~~~~~  175 (314)
                      .++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......            .......|++
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5667789999999999999999999999999999999999999999999998875442            1223456899


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (314)
                      .|+|||.+.+ ..++.++||||||+++|+|++|..|+...     ............+                      
T Consensus       241 ~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~~~----------------------  292 (332)
T 3qd2_B          241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLKFP----------------------  292 (332)
T ss_dssp             GGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTCCC----------------------
T ss_pred             CccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccCCC----------------------
Confidence            9999999977 67899999999999999999987664221     1111111111110                      


Q ss_pred             CCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       256 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                        ......++++.+||.+||+.||.+|||++|+++||||+++
T Consensus       293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             --cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence              1112337788999999999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-48  Score=336.85  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=224.0

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      ......++|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A            9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            34456789999999999999999999999999999999997654322 23345668999999999999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..+++||+++| +|.+.+... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999985 777766544 4699999999999999999999999999999999999999999999999999988755


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.....              
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  232 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------  232 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------------
T ss_pred             CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--------------
Confidence            5545556678999999999876 5678999999999999999999999988776666555433211              


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                    .....+++.+.++|.+||+.||++|||++|+++||||+...
T Consensus       233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          233 --------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             --------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence                          01124588999999999999999999999999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-48  Score=338.51  Aligned_cols=267  Identities=26%  Similarity=0.382  Sum_probs=218.1

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .-...++|++.+.||+|++|.||++.+..+|..+++|.+....  ......+.+|+++++.++||||+++++++...+..
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            3456799999999999999999999999999999999987543  22344677899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++|||+++| +|..++......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999986 7877777666679999999999999999999999999999999999999999999999999875432221


Q ss_pred             CcccccccCccccCccccc----CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RRFTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .......+++.|+|||.+.    ....++.++|+||||+++|+|++|..||...........+........         
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  242 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---------  242 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc---------
Confidence            2223456788999999984    335678999999999999999999999988877766655544311100         


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                      .....++.++.++|.+||..||++|||++++++||||+.....
T Consensus       243 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          243 ----------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             ----------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             ----------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence                            0112458899999999999999999999999999999987643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-48  Score=331.22  Aligned_cols=265  Identities=25%  Similarity=0.357  Sum_probs=217.9

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      -.+.++|++.+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus         3 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            45789999999999999999999999999999999999755432 23346678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-  165 (314)
                      +|||+++| +|.+.+.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999986 77776654 3469999999999999999999999999999999999999999999999999998653322 


Q ss_pred             -CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH-HHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 -~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                       .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||........ ....... .. .   .       
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-~---~-------  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT-Y---L-------  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT-T---S-------
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc-c---c-------
Confidence             2233456889999999997755557899999999999999999999977554322 2222111 00 0   0       


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                    .....+++.+.+||.+||+.||++|||++|+++||||+.....
T Consensus       229 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          229 --------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             --------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             --------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence                          0112468999999999999999999999999999999976544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-48  Score=334.43  Aligned_cols=262  Identities=29%  Similarity=0.473  Sum_probs=223.3

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ....++|++.+.||+|++|.||++.+..++..+++|.+...... ......+.+|+++++.++||||+++++++.+++..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            34468999999999999999999999999999999999765322 22334677899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++||++.| +|.+.+...+ .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999975 8888887654 5899999999999999999999999999999999999999999999999999765432 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+......               
T Consensus       168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  230 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK---------------  230 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------------
T ss_pred             -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC---------------
Confidence             2334568899999999877 56789999999999999999999999887776666555432110               


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                   ....+++++.++|.+||..||++|||++++++||||+....+.
T Consensus       231 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          231 -------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             -------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             -------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence                         1124689999999999999999999999999999999766543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-49  Score=354.69  Aligned_cols=286  Identities=27%  Similarity=0.433  Sum_probs=220.1

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC--------CCCeee
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--------SPHIIE   75 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~   75 (314)
                      +.+++.+.++|++.+.||+|+||+||+|++..+++.||+|++....   .....+.+|+++++.+.        |+||++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            4566777899999999999999999999999999999999996432   22345668999998885        788999


Q ss_pred             eeceec----cCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCC-
Q 021299           76 LIDAFP----HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHG-  148 (314)
Q Consensus        76 ~~~~~~----~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~-  148 (314)
                      +++++.    .....++|||+++|++++.+.... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.++ 
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             eecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            999886    566899999999999998887653 5799999999999999999999998 999999999999998775 


Q ss_pred             ------------------------------------------------cEEEeeccceeeeCCCCCcccccccCccccCc
Q 021299          149 ------------------------------------------------QLKLADFGLARIFGSPDRRFTHQVFARWYRAP  180 (314)
Q Consensus       149 ------------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sP  180 (314)
                                                                      .++|+|||.+......   .....+|+.|+||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aP  262 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCC
Confidence                                                            7999999999876432   3445789999999


Q ss_pred             ccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC------cHHHHHHHHHhhCCCCCCCCCCcCcccchhhh----cc
Q 021299          181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY----QY  250 (314)
Q Consensus       181 E~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  250 (314)
                      |.+.+ ..++.++||||||+++|+|++|..||....      .......+....+..+...+............    ..
T Consensus       263 E~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          263 EVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99987 568999999999999999999999997655      34455555555544322110000000000000    00


Q ss_pred             ccC-C---------CCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          251 VAA-P---------PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       251 ~~~-~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      ... .         .........++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000 0         000111234567899999999999999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-48  Score=361.50  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=217.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+++++.++||||+++++++++.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            57899999999999999999999999999999999765322 22334566899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |||+.| +|.+.+...+ ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~  341 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T  341 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-C
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-c
Confidence            999975 8888887653 359999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH---HHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---DQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .....||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||......   ............    .         
T Consensus       342 ~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~---------  407 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----E---------  407 (576)
T ss_dssp             EECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----C---------
T ss_pred             ccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----c---------
Confidence            344578999999999977 56899999999999999999999999875432   222222222111    1         


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                    +...+++++.+||.+||+.||.+||     +++|+++||||+.++
T Consensus       408 --------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          408 --------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             --------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence                          1134699999999999999999999     899999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.7e-48  Score=334.33  Aligned_cols=264  Identities=33%  Similarity=0.536  Sum_probs=223.9

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ...+.++|++.+.||+|++|+||++.+..+++.|++|.+............+.+|+++++.++||||+++++++...+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            45678999999999999999999999999999999999987665555556778999999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcEEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~df~~~~~~~  162 (314)
                      ++++|++.| +|.+.+.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+   +.++|+|||.+....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999975 8888776544 59999999999999999999999999999999999999764   469999999997654


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ... ......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||......+....+.........         
T Consensus       176 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  243 (287)
T 2wei_A          176 QNT-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---------  243 (287)
T ss_dssp             CCS-SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---------
T ss_pred             CCC-ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---------
Confidence            332 2234457888999999866  4799999999999999999999999988777766666543211111         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                     +....+++++.++|.+||..||++|||++|+++||||+++.
T Consensus       244 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          244 ---------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             ---------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             ---------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence                           11235689999999999999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-48  Score=359.78  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=219.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|.+.+.||+|+||+||+|+++.+|+.||+|++....... .....+.+|+++++.++||||++++++++..+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999999999999999997654322 2334567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           90 FEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |||+.| +|...+...   ...+++..++.++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++.......
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ  343 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence            999985 888887654   3469999999999999999999999999999999999999999999999999998875554


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc----HHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD----IDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .......||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||.....    ......+.....            
T Consensus       344 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------------  410 (543)
T 3c4z_A          344 TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------------  410 (543)
T ss_dssp             CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC------------
T ss_pred             cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc------------
Confidence            44455689999999999977 6789999999999999999999999977542    223333322110            


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                      .....+++++.+||.+||+.||.+||+     ++++++||||+.++
T Consensus       411 ----------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          411 ----------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             ----------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence                            112346999999999999999999996     58999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.5e-48  Score=334.53  Aligned_cols=266  Identities=27%  Similarity=0.455  Sum_probs=222.2

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-------CcchhhHHHHHHHhhcC-CCCeeeeece
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-------GVNFTALREIKLLKELK-SPHIIELIDA   79 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-~~~i~~~~~~   79 (314)
                      ..+.++|++.+.||+|++|.||++.++.+|+.|++|.+.......       .....+.+|+++++.+. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            445799999999999999999999999999999999997654221       11234568999999995 9999999999


Q ss_pred             eccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           80 FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        80 ~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      +..++..++|||+++| +|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            9999999999999985 888888754 46999999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCCcccccccCccccCccccc-----CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLF-----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~-----~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      ...... .......+++.|+|||.+.     ....++.++||||||+++|+|++|..||...........+.........
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            876433 2334556889999999985     2345789999999999999999999999888777766666554222211


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ..                        ...+++.+.+||.+||..||.+|||++|+++||||++...
T Consensus       251 ~~------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          251 PE------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             TT------------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             cc------------------------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            11                        1245899999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.1e-48  Score=333.48  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=223.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ....++|++.+.||+|++|.||++.+..+++.|++|.+...... .....+.+|+.+++.++||||+++++++..++..+
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            34568899999999999999999999999999999999766433 23446778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||++| +|.+++..  +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        97 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999986 78777754  4599999999999999999999999999999999999999999999999999988765544


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......                
T Consensus       175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------  237 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP----------------  237 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------------
T ss_pred             ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC----------------
Confidence            4556678999999999976 56789999999999999999999999887766655554332111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                 .....++..+.+||.+||+.||++|||++++++||||.....
T Consensus       238 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          238 -----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             -----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             -----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence                       112346899999999999999999999999999999976543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-48  Score=341.03  Aligned_cols=279  Identities=31%  Similarity=0.548  Sum_probs=213.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceecc--CCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPH--KGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~   87 (314)
                      .++|++.+.||+|++|+||+|.+..+++.||+|.+....     ...+.+|+.+++.+. ||||+++++++.+  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            589999999999999999999999999999999986432     346778999999997 9999999999876  67889


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPD  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~  165 (314)
                      ++||++.| ++...+.    .+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||.+.......
T Consensus       110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999986 6666664    388999999999999999999999999999999999999777 89999999998764332


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC-CCcHHHHHHHHHhhCCCCCCCCCC---cCc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDIDQLGKIFAAFGTATPSQWPD---LAY  241 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~  241 (314)
                       ......+++.|+|||.+.+...++.++||||||+++|+|++|..||.. ....+....+....+......+..   ...
T Consensus       186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence             334557888999999997767789999999999999999999988844 344444444333322110000000   000


Q ss_pred             ccchhhh------ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVEY------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      .+.....      ..............+++++.+||.+||+.||.+|||++|+|+||||+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            0000000      000000000111236999999999999999999999999999999998764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4e-48  Score=340.51  Aligned_cols=261  Identities=25%  Similarity=0.348  Sum_probs=223.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ....++|.+.+.||+|+||.||++.+..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++.+.+..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            345689999999999999999999999999999999997654322 2334566899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++|||+.| +|.+.+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       117 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999985 777776654 469999999999999999999999999999999999999999999999999998875555


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+......               
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  259 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS---------------  259 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------
T ss_pred             ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC---------------
Confidence            45556678999999999977 56789999999999999999999999887766665555433111               


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       260 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          260 -------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             -------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                         1124588999999999999999999999999999998764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-48  Score=342.10  Aligned_cols=288  Identities=26%  Similarity=0.431  Sum_probs=225.2

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEE-CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCC------Ceeeee
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAID-TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP------HIIELI   77 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~   77 (314)
                      ..++.+.++|++.+.||+|++|+||++.+ ..+++.||+|++....   .....+.+|+++++.++|+      ++++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            45667789999999999999999999998 5678899999986432   1223456788888888654      599999


Q ss_pred             ceeccCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec----------
Q 021299           78 DAFPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----------  146 (314)
Q Consensus        78 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~----------  146 (314)
                      +++...+..++|||+++++|.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.          
T Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999999999889999997664 46899999999999999999999999999999999999987          


Q ss_pred             ---------CCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc
Q 021299          147 ---------HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (314)
Q Consensus       147 ---------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~  217 (314)
                               ++.++|+|||.+......   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     668999999999875332   234578999999999976 6689999999999999999999999999888


Q ss_pred             HHHHHHHHHhhCCCCCCCCCCc-------------CcccchhhhccccCCCCC---ccCCCCCHHHHHHHhhhcccCCCC
Q 021299          218 IDQLGKIFAAFGTATPSQWPDL-------------AYLPDYVEYQYVAAPPLR---SLFPSASDDALDLLSKMFTYDPKA  281 (314)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~  281 (314)
                      .+....+....+..+...+...             ..................   ......++++.+||.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            8877777666554332111000             000000000000001111   111223678999999999999999


Q ss_pred             CCCHHHHhcCccccccCc
Q 021299          282 RITAQQALEHRFAKSFNG  299 (314)
Q Consensus       282 Rps~~ell~h~~~~~~~~  299 (314)
                      |||++|+++||||+.+.+
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-48  Score=340.29  Aligned_cols=268  Identities=28%  Similarity=0.393  Sum_probs=209.2

Q ss_pred             cccHHHHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299            5 DLSKKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus         5 ~~~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++..+.++|.+. +.||+|++|+||++.+..+++.||+|++....  ......+.+|+++++++ +||||+++++++.+
T Consensus         5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A            5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             SSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4556678899995 78999999999999999999999999997653  23344677899999885 79999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc---EEEeeccce
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA  158 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~df~~~  158 (314)
                      ++..++||||+. |+|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.   ++|+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            999999999998 58888887653 5899999999999999999999999999999999999988765   999999998


Q ss_pred             eeeCCCC-------CcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH---------
Q 021299          159 RIFGSPD-------RRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---------  218 (314)
Q Consensus       159 ~~~~~~~-------~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---------  218 (314)
                      .......       .......|++.|+|||.+.+    ...++.++||||||+++|+|++|..||......         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            7553211       11223458999999999864    234789999999999999999999999765432         


Q ss_pred             ------HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          219 ------DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       219 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                            .....+......     ++                   ......+++++.+||.+||+.||++|||++|+++||
T Consensus       242 ~~~~~~~~~~~i~~~~~~-----~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYE-----FP-------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCC-----CC-------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             chhHHHHHHHHHhccCcc-----cC-------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence                  112222211000     00                   011134689999999999999999999999999999


Q ss_pred             cccccCc
Q 021299          293 FAKSFNG  299 (314)
Q Consensus       293 ~~~~~~~  299 (314)
                      ||++...
T Consensus       298 ~~~~~~~  304 (316)
T 2ac3_A          298 WVQGCAP  304 (316)
T ss_dssp             TCC----
T ss_pred             hhcCCCC
Confidence            9997643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-48  Score=333.09  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=218.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee--ccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF--PHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~i   88 (314)
                      .++|++.+.||+|++|+||++.+..+|+.+++|.+............+.+|+.+++.++||||+++++++  ..++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            5799999999999999999999999999999999987655444455677899999999999999999977  45678999


Q ss_pred             EEecccc-cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCceEEecCCcEEEeecccee
Q 021299           89 VFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKW-----VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      ||||++| +|.+++...   ...+++..++.++.|++.||++||+.|     ++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            9999985 898888643   345999999999999999999999999     9999999999999999999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....+.......        
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------  235 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--------  235 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------
T ss_pred             eeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc--------
Confidence            76544433344568899999999977 568899999999999999999999999887776666665442211        


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                         ....+++++.++|.+||+.||.+|||++|+++|+|+..-
T Consensus       236 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          236 -------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             -------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                               112458999999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.1e-48  Score=367.23  Aligned_cols=258  Identities=24%  Similarity=0.340  Sum_probs=224.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++++.||+|+||+||++.++.+++.||+|++..... ..........|..++..+ .||+|+.+++++++.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999986532 222334566788888887 69999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|...+...+ .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus       420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            9999985 8888877554 5999999999999999999999999999999999999999999999999999875555555


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....||+.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+..+....+......                 
T Consensus       499 ~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  560 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----------------  560 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC-----------------
T ss_pred             cccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence            566789999999999976 67899999999999999999999999998888887777653211                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCH-----HHHhcCccccccC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRFAKSFN  298 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~ell~h~~~~~~~  298 (314)
                                 +...+++++.+||.+||+.||++||++     +||++||||+.++
T Consensus       561 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          561 -----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             -----------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             -----------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence                       112469999999999999999999997     9999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=334.46  Aligned_cols=263  Identities=24%  Similarity=0.421  Sum_probs=217.4

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc--cCcchhhHHHHHHHhhcCCCCeeeeecee--ccCC
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAF--PHKG   84 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~   84 (314)
                      .+.++|++.+.||+|++|.||++.+..++..+++|.+......  ......+.+|+++++.++||||+++++++  .+..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            4678999999999999999999999999999999999765322  22344677999999999999999999988  5566


Q ss_pred             eEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++||||+.+++.+.+... ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            89999999999888877654 45699999999999999999999999999999999999999999999999999987643


Q ss_pred             C--CCcccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          164 P--DRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       164 ~--~~~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .  ........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||...........+......          
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----------  231 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA----------  231 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC----------
Confidence            2  2223345688999999998752 23478999999999999999999999987776666655443110          


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                        ....+++.+.+||.+||+.||++|||++|+++||||++...
T Consensus       232 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          232 ------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             ------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                              11245889999999999999999999999999999997654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-48  Score=337.32  Aligned_cols=271  Identities=24%  Similarity=0.375  Sum_probs=198.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+..+++.|++|.+...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            57999999999999999999999889999999998654322 22335668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           91 EFMET-DLETVIRN-------TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        91 e~~~g-~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ||+.| +|.+++..       ..+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            99975 88888764       34569999999999999999999999999999999999999999999999999987553


Q ss_pred             CCC-----CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          163 SPD-----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       163 ~~~-----~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ...     .......+++.|+|||.+.+...++.++||||||+++|+|++|..||........................ 
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  251 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV-  251 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc-
Confidence            221     11234468889999999876456899999999999999999999999887766655444332211111100 


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                       ........+++++.+||.+||+.||++|||++++++||||++....
T Consensus       252 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          252 -----------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             --------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             -----------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence                             0112234578999999999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-48  Score=330.50  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=212.7

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ...++|++.+.||+|++|.||++.+..+|+.+++|.+..... .......+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            345899999999999999999999999999999999976532 2233446678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +|||++.| +|.+.+.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            99999975 8888887543 58999999999999999999999999999999999999999999999999997654322 


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+......                
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------  229 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY----------------  229 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc----------------
Confidence            2234567889999999987444578999999999999999999999887766666555443111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                  ....+++++.++|.+||+.||++|||++|+++||||++..
T Consensus       230 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          230 ------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             ------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence                        1123588999999999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-47  Score=344.43  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             HHHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHh-hcCCCCeeeeeceecc----
Q 021299            9 KVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK-ELKSPHIIELIDAFPH----   82 (314)
Q Consensus         9 ~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----   82 (314)
                      .+.++|.+. +.||+|+||+||++.++.+|+.||+|++...       ....+|+.++. ..+||||+++++++..    
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            345677776 7899999999999999999999999998632       24557888774 4479999999998864    


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      ....|+||||+.| +|.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            6678999999985 8999988653 46999999999999999999999999999999999999987   78899999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH----HHHHHHHhhCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID----QLGKIFAAFGTATP  233 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~~  233 (314)
                      +...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......    ....+.........
T Consensus       211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          211 AKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             CEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            9876432 22345678999999999866 678999999999999999999999997654322    22222222111111


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                              ..+..+++++.+||.+||+.||++|||++|+++||||....
T Consensus       289 ------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          289 ------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             ------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                                    11235699999999999999999999999999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.7e-48  Score=336.85  Aligned_cols=266  Identities=31%  Similarity=0.486  Sum_probs=213.1

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc------cCcchhhHHHHHHHhhcCCCCeeeeece
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELKSPHIIELIDA   79 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   79 (314)
                      .+..+.++|++.+.||+|+||.||++.+..+++.|++|.+......      ......+.+|+++++.++||||++++++
T Consensus         4 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   83 (322)
T 2ycf_A            4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF   83 (322)
T ss_dssp             CCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence            4678999999999999999999999999999999999999764321      1222346689999999999999999999


Q ss_pred             eccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc---EEEeec
Q 021299           80 FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADF  155 (314)
Q Consensus        80 ~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~df  155 (314)
                      +..+. .++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+||
T Consensus        84 ~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           84 FDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             EESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             EcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            87655 8999999985 88777764 346999999999999999999999999999999999999987664   999999


Q ss_pred             cceeeeCCCCCcccccccCccccCccccc--CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHH-HHHHHhhCCCC
Q 021299          156 GLARIFGSPDRRFTHQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL-GKIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~sPE~~~--~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~  232 (314)
                      |.+...... .......+++.|+|||.+.  +...++.++||||||+++|+|++|..||......... ..+....... 
T Consensus       162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  239 (322)
T 2ycf_A          162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-  239 (322)
T ss_dssp             TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-
T ss_pred             ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-
Confidence            999876432 2223456889999999974  3456789999999999999999999999765543222 2222221110 


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                             .+.....+++++.+||.+||+.||++|||++++++||||+...
T Consensus       240 -----------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          240 -----------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             -----------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             -----------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence                                   1111235689999999999999999999999999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=338.57  Aligned_cols=259  Identities=26%  Similarity=0.372  Sum_probs=208.6

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC--CCeeeeeceeccCCeEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKGNLH   87 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~   87 (314)
                      .+++|++.+.||+|+||+||++.+ .+++.||+|.+............+.+|+.+++.++|  +||+++++++...+..+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            367899999999999999999987 468899999998766554444567789999999986  99999999999999999


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      +|||+.+|+|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++........ 
T Consensus        86 lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           86 MVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEECCCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             EEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            999988889999998754 699999999999999999999999999999999999996 67899999999986643322 


Q ss_pred             -cccccccCccccCcccccC----------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhCCCCCC
Q 021299          167 -RFTHQVFARWYRAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPS  234 (314)
Q Consensus       167 -~~~~~~~~~~y~sPE~~~~----------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  234 (314)
                       ......|++.|+|||.+.+          ...++.++||||||+++|+|++|..||...... .....+.   ......
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHEI  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCCccc
Confidence             2234578999999999853          246788999999999999999999999764433 2222222   111111


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      .++                       ...++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       241 ~~~-----------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          241 EFP-----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCC-----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCc-----------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            111                       2347889999999999999999999999999999854

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.7e-48  Score=351.32  Aligned_cols=268  Identities=30%  Similarity=0.463  Sum_probs=208.3

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc------cCcchhhHHHHHHHhhcCCCCeeeeece
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELKSPHIIELIDA   79 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   79 (314)
                      .+..+.++|.+.+.||+|+||+||+|.+..+++.||+|.+......      ......+.+|+++++.++||||++++++
T Consensus       129 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             SCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             cchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4677899999999999999999999999999999999999765321      1122346689999999999999999999


Q ss_pred             eccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEEeec
Q 021299           80 FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADF  155 (314)
Q Consensus        80 ~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l~df  155 (314)
                      +.. +..++||||+.| +|.+.+.. .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++   .++|+||
T Consensus       209 ~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          209 FDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             EES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             Eec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence            854 457899999986 77666654 44699999999999999999999999999999999999997554   5999999


Q ss_pred             cceeeeCCCCCcccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHH-HHHHhhCCCC
Q 021299          156 GLARIFGSPDRRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLG-KIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~  232 (314)
                      |.+...+.. .......|++.|+|||.+.+  ...++.++||||||+++|+|++|.+||.......... .+....... 
T Consensus       287 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~-  364 (419)
T 3i6u_A          287 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF-  364 (419)
T ss_dssp             STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC-
T ss_pred             ccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC-
Confidence            999876432 22334568999999999853  3567889999999999999999999997654433222 222211111 


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                             ....+..+++.+.+||.+||+.||++|||++|+|+||||+...-.
T Consensus       365 -----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  409 (419)
T 3i6u_A          365 -----------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK  409 (419)
T ss_dssp             -----------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred             -----------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence                                   111223569999999999999999999999999999999876533

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.3e-48  Score=342.38  Aligned_cols=290  Identities=26%  Similarity=0.393  Sum_probs=227.0

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEEECCCC-cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC------eeee
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH------IIEL   76 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~   76 (314)
                      +.+++.+.++|++.+.||+|++|+||+|.+..++ ..||+|.+....   .....+.+|+.+++.+.|++      ++.+
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            4567778899999999999999999999998776 689999986432   12234567888888887654      8899


Q ss_pred             eceeccCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE-----------
Q 021299           77 IDAFPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-----------  144 (314)
Q Consensus        77 ~~~~~~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~-----------  144 (314)
                      .+++...+..++|||+++|++.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||++           
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999999999999999887654 569999999999999999999999999999999999999           


Q ss_pred             --------ecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC
Q 021299          145 --------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (314)
Q Consensus       145 --------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~  216 (314)
                              +.++.++|+|||.+......   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                    66789999999999875332   234578999999999976 668999999999999999999999999988


Q ss_pred             cHHHHHHHHHhhCCCCCCCCCCcC-------------cccchhhhccccCCCCCcc---CCCCCHHHHHHHhhhcccCCC
Q 021299          217 DIDQLGKIFAAFGTATPSQWPDLA-------------YLPDYVEYQYVAAPPLRSL---FPSASDDALDLLSKMFTYDPK  280 (314)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~  280 (314)
                      ..+....+....+..+...+....             ..............+....   ....++++.+||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            888777777666544322110000             0000000000011111111   112356899999999999999


Q ss_pred             CCCCHHHHhcCccccccCcc
Q 021299          281 ARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       281 ~Rps~~ell~h~~~~~~~~~  300 (314)
                      +|||++|+++||||+++...
T Consensus       324 ~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCCHH
T ss_pred             hCcCHHHHhcChhhcCCChh
Confidence            99999999999999988654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5e-48  Score=345.80  Aligned_cols=287  Identities=30%  Similarity=0.495  Sum_probs=222.2

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CC-----Ceeeeec
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SP-----HIIELID   78 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~   78 (314)
                      ..++.+.++|++.+.||+|+||+||+|.+..+++.||+|++....   ........|+++++.+. |+     +++.+.+
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            344566799999999999999999999999999999999997432   12234456778887775 44     4999999


Q ss_pred             eeccCCeEEEEEecccccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCceEEe--cCCcEEEe
Q 021299           79 AFPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCH--KKWVLHRDMKPNNLLIG--SHGQLKLA  153 (314)
Q Consensus        79 ~~~~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh--~~~i~H~di~~~nil~~--~~~~~~l~  153 (314)
                      ++...+..++|||+++|+|.+.+.... ..+++..++.++.|++.||.|||  +.|++|+||||+||+++  .++.+||+
T Consensus       124 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999999999999998764 56999999999999999999999  57999999999999995  46789999


Q ss_pred             eccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       154 df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      |||.+...+..   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+....+..+.
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999876432   234678899999999977 56899999999999999999999999999999999888887665543


Q ss_pred             CCCCCcCcccchhhh----c-----------cccCCCCCc---------------------cCCCCCHHHHHHHhhhccc
Q 021299          234 SQWPDLAYLPDYVEY----Q-----------YVAAPPLRS---------------------LFPSASDDALDLLSKMFTY  277 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~----~-----------~~~~~~~~~---------------------~~~~~~~~~~~li~~~l~~  277 (314)
                      ..++...........    .           ....+....                     .....++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence            222211100000000    0           000000000                     0000114789999999999


Q ss_pred             CCCCCCCHHHHhcCccccccC
Q 021299          278 DPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       278 dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ||++|||++|+|+||||+...
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC--
T ss_pred             ChhhCCCHHHHhcCcccccCC
Confidence            999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-47  Score=330.74  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=212.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc----CCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~   86 (314)
                      +..|++.+.||+|++|+||+|.+..++..+++|.+............+.+|+.+++.++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            456899999999999999999999999999999998766555555567799999999999999999998754    4568


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEe-cCCcEEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIG-SHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~-~~~~~~l~df~~~~~~~  162 (314)
                      ++||||++| +|.+++... +.+++..++.++.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||.+....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999975 888888654 45899999999999999999999999  99999999999997 78899999999996543


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.................  .+.        
T Consensus       184 ~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~--------  249 (290)
T 1t4h_A          184 A--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPA--------  249 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCG--------
T ss_pred             c--cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--Ccc--------
Confidence            2  23344568999999998865  489999999999999999999999987665555444332210  110        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                     ......++++.+||.+||+.||++|||++|+++||||+.
T Consensus       250 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          250 ---------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                           112245789999999999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-47  Score=342.76  Aligned_cols=258  Identities=27%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC--CCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++.+.||+|+||+||++.+.. ++.||+|.+............+.+|+.+++.+.  ||||+++++++..++..++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            3569999999999999999998765 889999999876555444556779999999997  5999999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--  166 (314)
                      |||+.+|+|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........  
T Consensus       134 v~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            99977789999988654 689999999999999999999999999999999999995 68999999999986643322  


Q ss_pred             cccccccCccccCcccccC----------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhCCCCCCC
Q 021299          167 RFTHQVFARWYRAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~----------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  235 (314)
                      ......||+.|+|||++.+          ...++.++||||||+++|+|++|..||...... .....+...   .....
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---~~~~~  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIE  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT---TSCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc---cccCC
Confidence            2334578999999999864          135789999999999999999999999765432 333333221   11111


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ++                       ...++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       289 ~~-----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          289 FP-----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CC-----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CC-----------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            11                       1237889999999999999999999999999999854

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-48  Score=337.06  Aligned_cols=281  Identities=21%  Similarity=0.254  Sum_probs=215.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC--e
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--N   85 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~   85 (314)
                      +.+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+++++.++||||+++++++....  .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            345789999999999999999999999999999999997544322 2345668999999999999999999886554  7


Q ss_pred             EEEEEeccc-ccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE----ecCCcEEEeeccce
Q 021299           86 LHLVFEFME-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLA  158 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~df~~~  158 (314)
                      .++||||+. |+|.+++.....  .+++..++.++.||+.||+|||++|++|+||||+||++    +.++.++|+|||.+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            899999997 588888876432  39999999999999999999999999999999999999    67778999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccC-------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCc----HHHHHHHHHh
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFG-------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD----IDQLGKIFAA  227 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~-------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~----~~~~~~~~~~  227 (314)
                      ....... ......+++.|+|||.+..       ...++.++||||||+++|+|++|..||.....    ......+...
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8764433 3344568999999999852       35678999999999999999999999975443    3344444433


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                      ..   +..+.................+........+++.+.+||.+||+.||++|||++|+|+||=
T Consensus       243 ~p---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KP---SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CC---TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CC---cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            22   2222211111111000011111122233445778999999999999999999999999983

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-49  Score=353.70  Aligned_cols=255  Identities=17%  Similarity=0.196  Sum_probs=201.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHH---HHHhhcCCCCeeeee-------ce
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREI---KLLKELKSPHIIELI-------DA   79 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~~   79 (314)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4789999999999999999999989999999999986533 223344666888   555556899999988       44


Q ss_pred             eccCC-----------------eEEEEEecccccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 021299           80 FPHKG-----------------NLHLVFEFMETDLETVIRNTNI------FLSPADIKSYMQMTLKGLAFCHKKWVLHRD  136 (314)
Q Consensus        80 ~~~~~-----------------~~~iv~e~~~g~l~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~d  136 (314)
                      ++..+                 ..+++|||++|+|.+++...+.      .+++..++.++.||+.||+|||++|++|+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            44332                 3789999999999999976432      233488889999999999999999999999


Q ss_pred             CCCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCc----------cCCCCcchHhhHHHHHHHHH
Q 021299          137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----------KQYGAGVDVWAAGCIFAELL  206 (314)
Q Consensus       137 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~----------~~~~~~~Di~slG~ll~~ll  206 (314)
                      |||+||+++.++.+||+|||++...+.   ......| +.|+|||.+.+.          ..++.++||||||+++|+|+
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            999999999999999999999986433   3334556 889999999773          26899999999999999999


Q ss_pred             hCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHH
Q 021299          207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ  286 (314)
Q Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  286 (314)
                      +|..||...........+                                ......+++++.+||.+||+.||++|||+.
T Consensus       308 tg~~Pf~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          308 CADLPITKDAALGGSEWI--------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             HSSCCC------CCSGGG--------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             HCCCCCcccccccchhhh--------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence            999999654322211111                                011235699999999999999999999999


Q ss_pred             HHhcCccccccCcce
Q 021299          287 QALEHRFAKSFNGVF  301 (314)
Q Consensus       287 ell~h~~~~~~~~~~  301 (314)
                      |+++||||+.+....
T Consensus       356 e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          356 QAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHHTSHHHHHHHHHH
T ss_pred             HHhhChHHHHHHHHH
Confidence            999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=332.15  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=211.6

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc------
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH------   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------   82 (314)
                      ..++|++.+.||+|++|.||++.+..+|+.+++|.+.....   ....+.+|+.+++.+ .||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            46899999999999999999999999999999999975432   334677899999999 79999999999865      


Q ss_pred             CCeEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           83 KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .+..++||||++| +|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  178 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  178 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence            5688999999986 899888765 35699999999999999999999999999999999999999999999999999987


Q ss_pred             eCCCCCcccccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      ............+++.|+|||.+..    ...++.++||||||+++|+|++|..||...........+.....   +.  
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~--  253 (326)
T 2x7f_A          179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---PR--  253 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CC--
T ss_pred             cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---cc--
Confidence            6544334445678999999999863    35678999999999999999999999988776665554433211   00  


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                           .....+++.+.+||.+||..||.+||+++++++||||+....
T Consensus       254 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          254 ---------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             ---------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ---------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence                                 011346899999999999999999999999999999997653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=331.77  Aligned_cols=266  Identities=25%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+..+|+.|++|.+............+.++..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            57899999999999999999999999999999999876543333333445556788889999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      |++++.+..........+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus       104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~  182 (318)
T 2dyl_A          104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKD  182 (318)
T ss_dssp             CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-ccc
Confidence            9997777776666567799999999999999999999995 99999999999999999999999999997653322 233


Q ss_pred             ccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      ...+++.|+|||.+..    ...++.++||||||+++|+|++|..||.... .......+.......    .+       
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~-------  251 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL----LP-------  251 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC----CC-------
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC----CC-------
Confidence            4568889999999852    3567899999999999999999999998743 344444443321111    11       


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCccee
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVFV  302 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  302 (314)
                                    ....+++++.+||.+||+.||.+||+++++++||||+.+....+
T Consensus       252 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (318)
T 2dyl_A          252 --------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV  295 (318)
T ss_dssp             --------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCC
T ss_pred             --------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccc
Confidence                          11246899999999999999999999999999999998765443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.9e-47  Score=329.34  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=206.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||++.+  +|..+++|++............+.+|+++++.++||||+++++++...+..++||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            57999999999999999999976  5789999999876554444456778999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           91 EFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ||+.| +|.+.+.....  .+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.++|+|||.+.......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            99985 88888876532  4899999999999999999999999  9999999999999999999999999998665544


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......              
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------------  258 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--------------  258 (309)
T ss_dssp             --------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred             cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence            44556678999999999977 667999999999999999999999999887776665553321111              


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc--Cccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKS  296 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~  296 (314)
                                  .....+++++.+||.+||+.||.+|||++++++  +++++.
T Consensus       259 ------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          259 ------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                        112356899999999999999999999999987  555554

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5e-47  Score=328.25  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc------
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------   82 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   82 (314)
                      .+.++|++.+.||+|++|+||++.+..+|+.|++|.+....   .....+.+|+.+++.++||||+++++++.+      
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            57899999999999999999999999999999999996432   223456789999999999999999998743      


Q ss_pred             -------CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEee
Q 021299           83 -------KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (314)
Q Consensus        83 -------~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d  154 (314)
                             .+..++||||++| +|.+.+......+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   4578999999975 99999987777789999999999999999999999999999999999999999999999


Q ss_pred             ccceeeeCCC--------------CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHH
Q 021299          155 FGLARIFGSP--------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDID  219 (314)
Q Consensus       155 f~~~~~~~~~--------------~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~  219 (314)
                      ||.+......              ........+++.|+|||.+.+...++.++||||||+++|+|++   ||... ....
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9999765322              1222345678899999999875678999999999999999998   44322 2222


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ....+.... ...+.                       ......++.+.++|.+||+.||.+|||++++++||||+..
T Consensus       237 ~~~~~~~~~-~~~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVS-IEFPP-----------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTT-CCCCT-----------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhccccc-cccCc-----------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            222222211 11111                       1223457889999999999999999999999999999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.9e-48  Score=342.92  Aligned_cols=268  Identities=16%  Similarity=0.142  Sum_probs=196.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHH---HHHhhcCCCCeeeeec-------ee
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREI---KLLKELKSPHIIELID-------AF   80 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~---~~l~~l~~~~i~~~~~-------~~   80 (314)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+   +.++. +||||++++.       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            35999999999999999999999999999999998765422 2233445664   45555 6999887553       22


Q ss_pred             ccC-----------------CeEEEEEecccccHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccCCC
Q 021299           81 PHK-----------------GNLHLVFEFMETDLETVIRNTNIFLSPADI------KSYMQMTLKGLAFCHKKWVLHRDM  137 (314)
Q Consensus        81 ~~~-----------------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~i~H~di  137 (314)
                      ...                 ...++||||++|+|.+++...+..+++...      ..++.||+.||+|||++|++|+||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            211                 348999999999999999876555655666      678899999999999999999999


Q ss_pred             CCCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhCCCccCCCC
Q 021299          138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (314)
Q Consensus       138 ~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~  216 (314)
                      ||+||+++.++.+||+|||++...+..   .....+++.|+|||.+.+ ...++.++||||||+++|+|++|..||....
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999876432   224456689999999964 2467999999999999999999999997653


Q ss_pred             cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      ....             ..+.....      ..........+..+.+++.+.+||.+||+.||++|||++++++||||+.
T Consensus       298 ~~~~-------------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          298 PGIK-------------GSWKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TTCT-------------TCCCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cccc-------------cchhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            2210             00000000      0000011111223467999999999999999999999999999999998


Q ss_pred             cCccee
Q 021299          297 FNGVFV  302 (314)
Q Consensus       297 ~~~~~~  302 (314)
                      +.....
T Consensus       359 ~~~~~~  364 (371)
T 3q60_A          359 LQNEIS  364 (371)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            865543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-48  Score=339.14  Aligned_cols=268  Identities=22%  Similarity=0.360  Sum_probs=215.3

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      ..++.+.++|++.+.||+|++|+||++.+..+++.|++|++....... .....+.+|+++++.++||||+++++++...
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A            5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            346678899999999999999999999999999999999997654322 2233566899999999999999999988654


Q ss_pred             C----eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           84 G----NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        84 ~----~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      .    ..++||||++| +|.+.+...+ .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4    34999999975 8888876544 5999999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          159 RIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       159 ~~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      ........   ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................   
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---  239 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  239 (311)
T ss_dssp             ------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred             ccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence            86543321   2233468999999999977 6789999999999999999999999988877766655544311110   


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                           ......+++++.++|.+||..||.+||++.+++.|+|++...
T Consensus       240 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          240 ---------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                                 111235699999999999999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-47  Score=338.76  Aligned_cols=263  Identities=26%  Similarity=0.420  Sum_probs=211.1

Q ss_pred             HhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCc--ccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||+||++++.   .+|+.||+|++.....  .......+.+|+++++.+ .||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            379999999999999999999984   4789999999875432  122233455799999999 6999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++||||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            99999999985 8888887544 599999999999999999999999999999999999999999999999999986533


Q ss_pred             CC-CcccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          164 PD-RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       164 ~~-~~~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .. .......||+.|+|||.+.+. ..++.++||||||+++|+|++|..||...........+........+        
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  283 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------  283 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--------
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--------
Confidence            22 223345689999999999753 44789999999999999999999999754432222222221111111        


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                      .....+++.+.+||.+||..||.+||     +++|+++||||++++
T Consensus       284 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          284 ----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence                            11234689999999999999999999     999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.2e-48  Score=332.19  Aligned_cols=270  Identities=23%  Similarity=0.333  Sum_probs=217.5

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      .+++.+.++|++.+.||+|++|+||++.+..++..+++|.+....... .....+.+|+.+++.++||||+++++++..+
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            456778899999999999999999999999999999999987654332 2334567899999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      +..++||||++| +|.+++...+ .+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999986 8888876554 69999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          163 SPD-RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       163 ~~~-~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....................         
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------  232 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV---------  232 (294)
T ss_dssp             ------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH---------
T ss_pred             cccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc---------
Confidence            332 22234568999999999987 6679999999999999999999999988776665544433211000         


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                    .....+.+++.+.++|.+||..||.+||+..+.+.+.|.+-..+
T Consensus       233 --------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          233 --------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             --------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             --------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                          01123456999999999999999999997777777777665443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-47  Score=338.32  Aligned_cols=278  Identities=19%  Similarity=0.320  Sum_probs=219.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc---------------hhhHHHHHHHhhcCCCC
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN---------------FTALREIKLLKELKSPH   72 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~~~~   72 (314)
                      +...++|++.+.||+|++|.||++.+  +|+.|++|.+..........               ..+.+|+++++.++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34468999999999999999999988  88999999997654332211               56779999999999999


Q ss_pred             eeeeeceeccCCeEEEEEecccc-cHHHH------HHhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceE
Q 021299           73 IIELIDAFPHKGNLHLVFEFMET-DLETV------IRNT-NIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLL  143 (314)
Q Consensus        73 i~~~~~~~~~~~~~~iv~e~~~g-~l~~~------~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil  143 (314)
                      |+++++++.+.+..++||||++| +|.++      +... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999986 77776      4432 5679999999999999999999999 99999999999999


Q ss_pred             EecCCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCC-cchHhhHHHHHHHHHhCCCccCCCCc-HHHH
Q 021299          144 IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA-GVDVWAAGCIFAELLNRRPFLQGSSD-IDQL  221 (314)
Q Consensus       144 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~-~~Di~slG~ll~~ll~g~~pf~~~~~-~~~~  221 (314)
                      ++.++.++|+|||.+......  ......+++.|+|||.+.+...++. ++||||||+++|+|++|..||..... .+..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            999999999999999876433  3445678999999999987435555 99999999999999999999988776 5554


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..+...... .+......  ..      .............+++++.+||.+||+.||++|||++|+++||||+..+
T Consensus       263 ~~i~~~~~~-~~~~~~~~--~~------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          263 NNIRTKNIE-YPLDRNHF--LY------PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHTSCCCC-CCCSSSSS--TT------TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHhccCcC-Cccchhhh--hc------cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            444332111 11110000  00      0000011112246799999999999999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.3e-48  Score=342.98  Aligned_cols=287  Identities=25%  Similarity=0.387  Sum_probs=217.4

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +...++|++.+.||+|++|+||++.+..++..+++|.+..... ......+.+|+.+++.++||||+++++++..++..+
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            3446899999999999999999999999999999999976532 223345678999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +||||++| +|.+.+.... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||.+...... 
T Consensus       108 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999986 8888886654 599999999999999999999996 9999999999999999999999999998654221 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC-----
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA-----  240 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  240 (314)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+............+...     
T Consensus       186 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             -cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence             2234568899999999977 678999999999999999999999998876555433321111110000000000     


Q ss_pred             ----------cccchhhhcc-ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          241 ----------YLPDYVEYQY-VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       241 ----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                .......... ............+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                      0000000000 0011111112347899999999999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=321.84  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|.....||+|++|.||++.+..++..|++|.+.....  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            445556699999999999999999999999999976532  233467789999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-CCcEEEeeccceeeeCCCCCc
Q 021299           92 FME-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-~~~~~l~df~~~~~~~~~~~~  167 (314)
                      +++ |+|.+++....+  .+++..++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            997 588888876533  4678999999999999999999999999999999999988 899999999999876554444


Q ss_pred             ccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||...................               
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  244 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH---------------  244 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC---------------
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc---------------
Confidence            4556789999999998653 237899999999999999999999997654443322211111110               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                ......+++++.+||.+||+.||++||+++++++||||+...+.
T Consensus       245 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          245 ----------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             ----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence                      11123568999999999999999999999999999999976544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.4e-47  Score=331.05  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=194.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE-
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL-   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-   86 (314)
                      .++|++.+.||+|++|+||+|.+..++.   .+++|.+............+.+|+++++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4679999999999999999999877665   899999987654444456778999999999999999999998766654 


Q ss_pred             -----EEEEecccc-cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           87 -----HLVFEFMET-DLETVIRNTN-----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        87 -----~iv~e~~~g-~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                           +++|||+.| +|.+++....     ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence                 999999986 8888886432     25899999999999999999999999999999999999999999999999


Q ss_pred             cceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCC
Q 021299          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      |.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  260 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ  260 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC
Confidence            99986543322  2223445778999999876 668999999999999999999 8999998888777776654422111


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-------HHHHhcCcccccc
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-------AQQALEHRFAKSF  297 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~ell~h~~~~~~  297 (314)
                                                 ...+++++.+||.+||+.||.+|||       ++++++|||+...
T Consensus       261 ---------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          261 ---------------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ---------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ---------------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                       2346899999999999999999999       7889999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=319.66  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=212.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+. ++..+++|++......   ...+.+|+++++.++||||+++++++.+++..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            478999999999999999999876 4678999999765432   245779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Ccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~  168 (314)
                      ||++| +|.+.+....+.+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+....... ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            99985 8998888877789999999999999999999999999999999999999999999999999997653321 122


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+........+              
T Consensus       165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  229 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--------------  229 (269)
T ss_dssp             TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC--------------
T ss_pred             cCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC--------------
Confidence            33445678999999876 568999999999999999999 89999988887777776554222111              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                   ..+++.+.+++.+||+.||++|||++++++|
T Consensus       230 -------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          230 -------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                         2358899999999999999999999999876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.6e-47  Score=332.05  Aligned_cols=266  Identities=23%  Similarity=0.360  Sum_probs=192.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHH-HHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||.||++.++.+|+.|++|.+........ ...+..|+. +++.++||||+++++++...+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            4789999999999999999999999999999999976543222 223334554 77778999999999999999999999


Q ss_pred             EecccccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           90 FEFMETDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        90 ~e~~~g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ||+++|++.+.+..    ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+|||.+......
T Consensus       100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            99999988887763    355799999999999999999999999 9999999999999999999999999999765332


Q ss_pred             CCcccccccCccccCccccc---CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 DRRFTHQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~---~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      . ......+++.|+|||.+.   ....++.++||||||+++|+|++|..||........  .+ .......+..+     
T Consensus       180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~-----  250 (327)
T 3aln_A          180 I-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL-TQVVKGDPPQL-----  250 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCC-----
T ss_pred             c-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH-HHHhcCCCCCC-----
Confidence            2 223346888999999984   235678999999999999999999999976432110  00 00000000000     


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                                    .......+++.+.+||.+||+.||++|||+.++++||||......
T Consensus       251 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          251 --------------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             --------------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             --------------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence                          011123579999999999999999999999999999999977543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=327.57  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=210.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||+||++.+..++.   .|++|.+..... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            5899999999999999999999886554   599999975432 223346778999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||+.| +|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            99999975 89999887777899999999999999999999999999999999999999999999999999987644322


Q ss_pred             c---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+........          
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  275 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----------  275 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----------
T ss_pred             ceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC----------
Confidence            2   222344677999999976 567899999999999999998 9999988887777776655422111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ...+++++.+||.+||..||.+|||+.++++
T Consensus       276 -----------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          276 -----------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             -----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             1246899999999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-47  Score=332.12  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=213.8

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc----CcchhhHHHHHHHhhcC--CCCeeeeec
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE----GVNFTALREIKLLKELK--SPHIIELID   78 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~   78 (314)
                      ...+.+.++|++.+.||+|+||.||++.+..+|+.|++|.+.......    .....+.+|+.+++.+.  |+||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344567899999999999999999999999999999999998764332    12234558999999996  599999999


Q ss_pred             eeccCCeEEEEEeccc--ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe-cCCcEEEeec
Q 021299           79 AFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADF  155 (314)
Q Consensus        79 ~~~~~~~~~iv~e~~~--g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~df  155 (314)
                      ++...+..++++|++.  ++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++ .++.++|+||
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999999999997  5888888764 4689999999999999999999999999999999999999 6789999999


Q ss_pred             cceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          156 GLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      |.+......  ......+++.|+|||.+.+....+.++||||||+++|+|++|..||....      .+...  .     
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~-----  259 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q-----  259 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C-----
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--c-----
Confidence            999876432  23345689999999998775556789999999999999999999996532      11111  0     


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                           ......+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       260 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          260 ---------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             ---------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ---------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                                 0011346899999999999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.5e-46  Score=316.64  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=211.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+. ++..+++|.+......   ...+.+|+++++.++||||+++++++.+++..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            589999999999999999999765 5678999999754432   345779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-cc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~  168 (314)
                      |+++| +|.+.+......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            99975 79998887776799999999999999999999999999999999999999999999999999987644332 22


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........+              
T Consensus       163 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  227 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP--------------  227 (268)
T ss_dssp             CSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC--------------
T ss_pred             cCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC--------------
Confidence            33445677999999876 567899999999999999998 99999888877776665543221111              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                   ...++.+.+++.+||+.||++|||+.+++++
T Consensus       228 -------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          228 -------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         2348899999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.7e-46  Score=321.23  Aligned_cols=256  Identities=20%  Similarity=0.226  Sum_probs=212.3

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCe
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGN   85 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   85 (314)
                      ++.+.++|++.+.||+|++|+||++.+..+|+.|++|.+......    ..+.+|+++++.+ .|++++++++++.....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            345678999999999999999999999999999999998654322    3466899999999 79999999999999999


Q ss_pred             EEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc-----EEEeeccceee
Q 021299           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARI  160 (314)
Q Consensus        86 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-----~~l~df~~~~~  160 (314)
                      .+++||+++|+|.+++...+..+++..++.++.||+.||+|||++|++|+||||+||+++.++.     ++|+|||.+..
T Consensus        81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999988999999887777999999999999999999999999999999999999987765     99999999987


Q ss_pred             eCCCCC-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---HHHHHHHHHhhCC
Q 021299          161 FGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGT  230 (314)
Q Consensus       161 ~~~~~~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~~~~~~~~  230 (314)
                      ......       ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....   ......+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            654322       2344568999999999877 6689999999999999999999999987543   2333333222111


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .                       +.......+++++.+|+.+||+.||++|||+++|++
T Consensus       240 ~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 T-----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             S-----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             c-----------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1                       111222356899999999999999999999999865

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=324.18  Aligned_cols=252  Identities=22%  Similarity=0.393  Sum_probs=208.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||++.+..+++.+++|.+...  .......+.+|+++++.++||||+++++++.+++..++||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            58999999999999999999999999999999998543  2233446779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc-
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-  168 (314)
                      ||+.| +|.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.......... 
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99985 9999998877789999999999999999999999999999999999999999999999999998764332221 


Q ss_pred             -------------cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH-----HHHHHHhhCC
Q 021299          169 -------------THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-----LGKIFAAFGT  230 (314)
Q Consensus       169 -------------~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~  230 (314)
                                   ....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||........     ......    
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----  241 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----  241 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred             ccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence                         14568999999999977 6789999999999999999999988754321110     000000    


Q ss_pred             CCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                                ......+++++.+++.+||+.||++|||++++++  |++.+
T Consensus       242 --------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          242 --------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             --------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence                                      0012356889999999999999999999999987  55544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.1e-46  Score=329.59  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             HhhccceeeeCccccceEEEEEEC-------CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|++.+.||+|+||+||+|.+.       .++..|++|.+..... ......+.+|+++++.+ +||||+++++++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            589999999999999999999864       3456799999975532 22334567899999999 89999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      .+..|+||||+.| +|.+++....               ..+++..++.++.||+.||.|||++|++|+||||+||+++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            9999999999985 9999887653               34889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.+||+|||++........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999987644322  2233456778999999977 678999999999999999999 9999988777766665


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +.......                           ....+++++.+||.+||+.||++|||+.|++++
T Consensus       318 ~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 LKEGHRMD---------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHTTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54432111                           112468899999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.1e-46  Score=327.05  Aligned_cols=252  Identities=20%  Similarity=0.214  Sum_probs=208.3

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +.++|++.+.||+|+||+||++.+..+|+.||+|.+......    ..+.+|+++++.+ +||||+++++++..++..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            468999999999999999999999999999999998765332    2566899999999 89999999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc-----EEEeeccceeeeCC
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGS  163 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~-----~~l~df~~~~~~~~  163 (314)
                      |||+++|+|.+++....+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.     ++|+|||++.....
T Consensus        83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           83 VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999988999999877778999999999999999999999999999999999999998887     99999999987644


Q ss_pred             CCCc-------ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH---HHHHHHhhCCCCC
Q 021299          164 PDRR-------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ---LGKIFAAFGTATP  233 (314)
Q Consensus       164 ~~~~-------~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~  233 (314)
                      ....       .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+.   ...+.........
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            3321       245678999999999977 6689999999999999999999999987543332   2222221111000


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                             .......+ ++.+++..||..||.+||++++|++
T Consensus       242 -----------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 -----------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             -----------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                   00011234 8999999999999999999988875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=333.23  Aligned_cols=261  Identities=18%  Similarity=0.244  Sum_probs=213.6

Q ss_pred             HHHHhhccceeeeCccccceEEEEE-----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   82 (314)
                      +...++|++.+.||+|+||+||+|.     +..++..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3346899999999999999999998     445677899999864322 2233356789999999999999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC---cEEE
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKL  152 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~---~~~l  152 (314)
                      ....++||||+.| +|.+++....      ..+++..++.++.||+.||+|||++|++|+||||+||+++.++   .++|
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999975 9999887643      3589999999999999999999999999999999999998555   5999


Q ss_pred             eeccceeeeCC--CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhC
Q 021299          153 ADFGLARIFGS--PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (314)
Q Consensus       153 ~df~~~~~~~~--~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~  229 (314)
                      +|||.+.....  .........+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999975422  1222334557888999999876 568999999999999999998 9999998887777766654422


Q ss_pred             CCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ...                           ...+++.+.+|+.+||+.||.+|||+++++++.++-..
T Consensus       305 ~~~---------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          305 MDP---------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC---------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            111                           12458899999999999999999999999999876543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.6e-46  Score=317.92  Aligned_cols=249  Identities=20%  Similarity=0.316  Sum_probs=209.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++++.||+|+||+||++.+. ++..+++|.+......   ...+.+|+++++.++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            579999999999999999999875 5678999999755432   245779999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Ccc
Q 021299           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRF  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~  168 (314)
                      ||+. |+|.+++......+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... ...
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            9997 58999988766679999999999999999999999999999999999999999999999999997653321 122


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........+              
T Consensus       179 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  243 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--------------  243 (283)
T ss_dssp             TSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC--------------
T ss_pred             cCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC--------------
Confidence            23445678999999876 568999999999999999998 99999988887777776554322221              


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                   ...++.+.++|.+||+.||.+|||++++++|
T Consensus       244 -------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          244 -------------HLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                         2348899999999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-46  Score=335.54  Aligned_cols=282  Identities=28%  Similarity=0.495  Sum_probs=212.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-----------CCCeeeeece
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----------SPHIIELIDA   79 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~   79 (314)
                      .++|++.+.||+|++|+||+|.+..+++.||+|.+.....   ....+.+|+.+++.+.           |+||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            5799999999999999999999999999999999974321   2234567888888876           7899999999


Q ss_pred             eccCC----eEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCceEEecC------
Q 021299           80 FPHKG----NLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSH------  147 (314)
Q Consensus        80 ~~~~~----~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~-~i~H~di~~~nil~~~~------  147 (314)
                      +...+    ..+++||+++++|.+.+... ...+++..++.++.||+.||+|||++ |++|+||||+||+++.+      
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            86543    78999999988999999864 45699999999999999999999998 99999999999999543      


Q ss_pred             CcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC------cHHHH
Q 021299          148 GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQL  221 (314)
Q Consensus       148 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~------~~~~~  221 (314)
                      +.++|+|||.+......   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....      .....
T Consensus       175 ~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            37999999999876432   234578999999999987 668999999999999999999999997654      34455


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccchhh----hcccc---C-------CCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHH
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDYVE----YQYVA---A-------PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ  287 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  287 (314)
                      ..+....+..+...+...........    .....   .       .........+++++.+||.+||+.||++|||++|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            55655555433211100000000000    00000   0       0000112234678999999999999999999999


Q ss_pred             HhcCccccccCc
Q 021299          288 ALEHRFAKSFNG  299 (314)
Q Consensus       288 ll~h~~~~~~~~  299 (314)
                      +|+||||+....
T Consensus       331 ll~hp~f~~~~~  342 (373)
T 1q8y_A          331 LVNHPWLKDTLG  342 (373)
T ss_dssp             HHTCGGGTTCTT
T ss_pred             HhhChhhhcccC
Confidence            999999998743

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-45  Score=320.43  Aligned_cols=259  Identities=26%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC--CCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++.+.||+|++|.||++.+. +++.+++|.+............+.+|+++++.++  |+||+++++++...+..++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            578999999999999999999875 5889999999876554444456778999999997  5999999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--  166 (314)
                      +||+.+++|.+.+.... .+++..++.++.|++.||.+||++|++|+||||+||+++ ++.++|+|||.+........  
T Consensus       106 v~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          106 VMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence            99987889999988654 689999999999999999999999999999999999996 58999999999986543322  


Q ss_pred             cccccccCccccCcccccC----------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH-HHHHHHHhhCCCCCCC
Q 021299          167 RFTHQVFARWYRAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATPSQ  235 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~----------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  235 (314)
                      ......+++.|+|||.+.+          ...++.++||||||+++|+|++|..||....... ....+..   ......
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~  260 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PNHEIE  260 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---TTSCCC
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh---cccccC
Confidence            2234568999999999864          1357889999999999999999999997654332 2222221   111111


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                             .....++++.++|.+||+.||++|||++|+++||||+...
T Consensus       261 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          261 -----------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             -----------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             -----------------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                                   1123478899999999999999999999999999998654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5e-46  Score=332.23  Aligned_cols=251  Identities=21%  Similarity=0.319  Sum_probs=209.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||.||++.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            4789999999999999999999998999999999875422 222335668999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc-
Q 021299           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~-  168 (314)
                      ||++ |+|.+++...+..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......... 
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            9997 59999998776679999999999999999999999999999999999999999999999999998653321111 


Q ss_pred             -cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       169 -~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+.......               
T Consensus       272 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------  335 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---------------  335 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---------------
T ss_pred             CCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence             11234567999999876 567899999999999999998 999998877766655544331111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  ....+++++.+||.+||+.||++|||++++++
T Consensus       336 ------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          336 ------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                        11245889999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.8e-45  Score=313.90  Aligned_cols=256  Identities=19%  Similarity=0.235  Sum_probs=209.6

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcc-----hhhHHHHHHHhhcCCCCeeeeecee
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-----FTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      ++....++|++.+.||+|++|+||++.+..+++.|++|.+..........     ..+.+|+++++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            44555789999999999999999999999999999999997655433221     4667899999999999999999999


Q ss_pred             ccCCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCc-----EEE
Q 021299           81 PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQ-----LKL  152 (314)
Q Consensus        81 ~~~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~-----~~l  152 (314)
                      .+..  ++||||+. |+|.+.+......+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.     ++|
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7666  69999998 5999999888778999999999999999999999999  999999999999988776     999


Q ss_pred             eeccceeeeCCCCCcccccccCccccCcccccC-ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCC
Q 021299          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       153 ~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~-~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      +|||.+.....   ......+++.|+|||.+.. ...++.++||||||+++|+|++|..||...................
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            99999975432   3345678999999999843 3456889999999999999999999997755444321111111111


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .                        ......+++++.+||.+||+.||.+|||++|+++
T Consensus       248 ~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 R------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             C------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1                        1122356899999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.8e-46  Score=326.01  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=184.3

Q ss_pred             HHHhhcccee-eeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc----C
Q 021299            9 KVADRYLKRE-VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----K   83 (314)
Q Consensus         9 ~~~~~y~~~~-~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~   83 (314)
                      .+.++|.+.+ .||+|++|+||++.++.+|+.||+|++....      ....+....++.+.||||+++++++..    .
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            4679999965 6999999999999999999999999986432      112233344666789999999999865    5


Q ss_pred             CeEEEEEecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcEEEeeccce
Q 021299           84 GNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLA  158 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~~l~df~~~  158 (314)
                      ...++||||+.| +|.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.+   +.++|+|||.+
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            568999999986 9999988664 469999999999999999999999999999999999999764   45999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ......  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................      
T Consensus       179 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  249 (336)
T 3fhr_A          179 KETTQN--ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ------  249 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc--ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc------
Confidence            875432  2334567899999999865 5678899999999999999999999976554433222111110000      


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                    .......+..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       250 --------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          250 --------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             --------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                          0001112245799999999999999999999999999999998653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=326.55  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=211.4

Q ss_pred             HhhccceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|.+.+.||+|+||+||+|.+..       .+..+|+|.+..... ......+.+|+++++.+ +||||+++++++..
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            5899999999999999999998643       335799999976532 22234567899999999 89999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      .+..++||||+.| +|.+++....               ..+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  226 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence            9999999999985 9999987654               35999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~  305 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  305 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999998664432  22333456788999999977 678999999999999999999 9999998877776666


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +........                           ...+++++.+||.+||+.||++|||++|++++
T Consensus       306 ~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          306 LKEGHRMDK---------------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHTTCCCCC---------------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCC---------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            554321111                           12458999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=321.79  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=201.0

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc----CcchhhHHHHHHHhhc----CCCCeeeeec
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE----GVNFTALREIKLLKEL----KSPHIIELID   78 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~   78 (314)
                      .+.+.++|++.+.||+|++|.||++.+..+|+.|++|.+.......    .....+.+|+.+++.+    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            4567899999999999999999999999999999999997654322    1122344789999988    8999999999


Q ss_pred             eeccCCeEEEEEec-cc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe-cCCcEEEeec
Q 021299           79 AFPHKGNLHLVFEF-ME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADF  155 (314)
Q Consensus        79 ~~~~~~~~~iv~e~-~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~-~~~~~~l~df  155 (314)
                      ++...+..++++|+ +. ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++ .++.++|+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999998 55 58888887644 599999999999999999999999999999999999999 7899999999


Q ss_pred             cceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCC
Q 021299          156 GLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      |.+......  ......+++.|+|||.+.+....+.++||||||+++|+|++|..||....      .+....       
T Consensus       185 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~-------  249 (312)
T 2iwi_A          185 GSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE-------  249 (312)
T ss_dssp             SSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC-------
T ss_pred             chhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc-------
Confidence            999876443  23455688999999998764555679999999999999999999996532      111110       


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                           ......+++.+.+||.+||+.||++|||++|+++||||+...+
T Consensus       250 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          250 ---------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                                 0112346899999999999999999999999999999997654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.7e-45  Score=314.66  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ..++|++.+.||+|+||.||++.+..+   +..+++|.+..... ......+.+|+.+++.++||||+++++++. ++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            468999999999999999999998654   45699998865432 223345678999999999999999999984 4568


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++||||+.| +|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            899999985 8999998777779999999999999999999999999999999999999999999999999998764332


Q ss_pred             C-cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          166 R-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       166 ~-~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      . ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+......             
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~-------------  236 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------------  236 (281)
T ss_dssp             --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred             ccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC-------------
Confidence            2 2223445678999999876 568899999999999999996 89999988877776665443111             


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                    .....+++++.++|.+||..||++|||+.+++++
T Consensus       237 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 --------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          1123568999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=335.14  Aligned_cols=257  Identities=24%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+|.+.+.||+|++|+|+. ....+|+.||+|++.....     ....+|+++++.+ +||||+++++++.+....++||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            4699999999999999764 3456789999999965332     2345899999999 7999999999999999999999


Q ss_pred             ecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-----CcEEEeeccceeeeCCCC
Q 021299           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----GQLKLADFGLARIFGSPD  165 (314)
Q Consensus        91 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-----~~~~l~df~~~~~~~~~~  165 (314)
                      |+++|+|.+++.......++..++.++.||+.||.|||++|++|+||||+||+++.+     .+++|+|||++.......
T Consensus        98 E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           98 ELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             ECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             ECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            999999999998877667777788999999999999999999999999999999532     368899999998764332


Q ss_pred             ---CcccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          166 ---RRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       166 ---~~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                         .......||+.|+|||.+.+  ...++.++||||||+++|+|++ |..||........... .   .......... 
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-~---~~~~~~~~~~-  252 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-L---GACSLDCLHP-  252 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-T---TCCCCTTSCT-
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-h---ccCCccccCc-
Confidence               22334568999999999874  3456889999999999999999 8899976544433221 1   1111111000 


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                          ....+..+.+||.+||+.||.+|||++|+++||||..+..
T Consensus       253 --------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          253 --------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             --------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             --------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence                                0123566899999999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.6e-45  Score=316.66  Aligned_cols=257  Identities=18%  Similarity=0.225  Sum_probs=202.3

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCC
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKG   84 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~   84 (314)
                      +.-.+.++|++.+.||+|++|+||++.+..+++.|++|.+.......    .+.+|+.+++.++|++++..+..+ ....
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC----CHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch----HHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            44567899999999999999999999999999999999876554332    466899999999988766666554 6778


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeee
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIF  161 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~  161 (314)
                      ..+++||+++|+|.+.+......+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+...
T Consensus        79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            889999999889999998777789999999999999999999999999999999999999   78899999999999876


Q ss_pred             CCCCC-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH---HHHHHHHHhhCCC
Q 021299          162 GSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---DQLGKIFAAFGTA  231 (314)
Q Consensus       162 ~~~~~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~  231 (314)
                      .....       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......   .....+...... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  236 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-  236 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-
Confidence            54332       2234578999999999877 56899999999999999999999999764322   222222111100 


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                            .+.......+++++.+||.+||+.||++|||++++++
T Consensus       237 ----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 ----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                  0111122356899999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-45  Score=311.62  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=211.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+. ++..+++|.+......   ...+.+|+++++.++||||+++++++.+.+..+++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            478999999999999999999876 5678999999765432   246778999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Ccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~  168 (314)
                      |+++| +|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            99975 8999998877789999999999999999999999999999999999999999999999999997653321 112


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+........               
T Consensus       163 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------  226 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------------  226 (267)
T ss_dssp             TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---------------
T ss_pred             ccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---------------
Confidence            23455678999999876 567899999999999999999 8999998877777666654322111               


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  ....++.+.+++.+||+.||++|||+++++++
T Consensus       227 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          227 ------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        12358899999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-45  Score=315.57  Aligned_cols=257  Identities=19%  Similarity=0.283  Sum_probs=201.0

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +...++|++.+.||+|+||+||++.+.   ..+++|++............+.+|+++++.++||||++++++. .....+
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            344689999999999999999999754   3599999987665555555677999999999999999999965 556689


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC--
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP--  164 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~--  164 (314)
                      +||||+.| +|.+.+......+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......  
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999985 888888777778999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CCcccccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 DRRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ........+++.|+|||.+..  ...++.++||||||+++|+|++|..||....................          
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  245 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----------  245 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----------
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----------
Confidence            222334568999999999862  35678899999999999999999999988777766666554422111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  ........+++++.+||.+||..||++|||++++++
T Consensus       246 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                        111223456899999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-45  Score=326.53  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=207.0

Q ss_pred             HhhccceeeeCccccceEEEEE-----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||.||++.     +..+++.||+|.+....... ....+.+|+++++.+ +||||+++++++.+.+
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-HHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            5899999999999999999998     55677899999997543222 234567899999999 7899999999987654


Q ss_pred             -eEEEEEecccc-cHHHHHHhCCC--------------------------------------------------------
Q 021299           85 -NLHLVFEFMET-DLETVIRNTNI--------------------------------------------------------  106 (314)
Q Consensus        85 -~~~iv~e~~~g-~l~~~~~~~~~--------------------------------------------------------  106 (314)
                       ..++||||+.| +|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             58999999985 89888876432                                                        


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--CcccccccCc
Q 021299          107 ---------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFAR  175 (314)
Q Consensus       107 ---------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~  175 (314)
                               .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......  .......+++
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                     28999999999999999999999999999999999999999999999999998653322  2333456788


Q ss_pred             cccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCC
Q 021299          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (314)
Q Consensus       176 ~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
                      .|+|||.+.+ ..++.++||||||+++|+|++ |..||....................                      
T Consensus       260 ~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------  316 (359)
T 3vhe_A          260 KWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------------  316 (359)
T ss_dssp             GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC----------------------
T ss_pred             eeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC----------------------
Confidence            8999999876 678999999999999999998 9999988775555544443321111                      


Q ss_pred             CCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       255 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                          ....+++++.+++.+||..||++|||++|+++|
T Consensus       317 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 ----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                112358899999999999999999999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-45  Score=318.31  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=210.5

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|+||.||++.+.     .++..+++|.+..... ......+.+|+++++.++||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            689999999999999999999873     4557899999975432 2223456789999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 021299           86 LHLVFEFME-TDLETVIRNTN-----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~n  141 (314)
                      .++||||+. |+|.+++....                       ..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N  180 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN  180 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence            999999998 58998887643                       248999999999999999999999999999999999


Q ss_pred             eEEecCCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcH
Q 021299          142 LLIGSHGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI  218 (314)
Q Consensus       142 il~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~  218 (314)
                      |+++.++.++|+|||.+.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543322  223456778999999876 567999999999999999999 99999888776


Q ss_pred             HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .....+.......                           ....+++++.++|.+||+.||++|||+++++++
T Consensus       260 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          260 RLFNLLKTGHRME---------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhcCCcCC---------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6665554332111                           123468999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8e-45  Score=315.96  Aligned_cols=259  Identities=25%  Similarity=0.439  Sum_probs=198.4

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      +++....++|++.+.||+|++|.||++.+..+|+.+++|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus        25 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           25 DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34455678999999999999999999999999999999999764322 22334567899999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecccee
Q 021299           84 GNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      +..+++||++.| +|.+++..   ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            999999999986 88887754   35569999999999999999999999999999999999999999999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH--HHHHHHHHhhCCCCCCCCC
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--DQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (314)
                      .............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......  .....+...  ...+.   
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~---  258 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPL---  258 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCC---
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCC---
Confidence            76554444445678899999999876 66899999999999999999999999654322  222222211  00000   


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                           ....+++++.+||.+||+.||++|||++++++
T Consensus       259 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          259 ---------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ---------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                 01246899999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.5e-45  Score=314.28  Aligned_cols=255  Identities=18%  Similarity=0.217  Sum_probs=207.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~   86 (314)
                      ..+.++|++.+.||+|++|+||++.+..+|+.|++|.+......    ..+.+|+.+++.++|+++++.+..+ ..++..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            34678999999999999999999999999999999998765432    3567899999999988766665544 667788


Q ss_pred             EEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeeeCC
Q 021299           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~~~  163 (314)
                      +++||+++|+|.+++......+++..++.++.|++.||+|||++|++|+||||+||++   +.++.++|+|||.+.....
T Consensus        81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            9999999889999998777789999999999999999999999999999999999999   4788999999999987654


Q ss_pred             CCC-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---HHHHHHHHHhhCCCCC
Q 021299          164 PDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTATP  233 (314)
Q Consensus       164 ~~~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~  233 (314)
                      ...       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....   ......+.......  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  237 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  237 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred             cccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC--
Confidence            432       1245578999999999877 5689999999999999999999999976432   22222222211110  


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                           +.......+++++.+++.+||+.||++|||++++++
T Consensus       238 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 ---------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ---------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ---------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                 011112356899999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-45  Score=322.04  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=205.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcE----EEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|+||+||+|.+..++..    +++|.+..... ......+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            57899999999999999999999888775    67777654332 223335568999999999999999999886 4568


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++||||+. |+|.+.+....+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            89999998 58999988777789999999999999999999999999999999999999999999999999998764332


Q ss_pred             C--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........+         
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  239 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---------  239 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---------
T ss_pred             ccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---------
Confidence            2  2334556778999999976 568999999999999999999 99999887777666655443211111         


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                        ..+++++.+++.+||..||.+|||+.+++++
T Consensus       240 ------------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 ------------------QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ------------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ------------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              2347789999999999999999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=324.03  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=209.7

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|+||.||++.+..     +++.|++|.+..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            5899999999999999999999873     457899999975432 2233456789999999999999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 021299           86 LHLVFEFMET-DLETVIRNTN-----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~n  141 (314)
                      .++||||+.| +|.+++....                       ..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  204 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  204 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence            9999999985 9999887642                       569999999999999999999999999999999999


Q ss_pred             eEEecCCcEEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcH
Q 021299          142 LLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI  218 (314)
Q Consensus       142 il~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~  218 (314)
                      |+++.++.++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            999999999999999997653221  12234456888999999876 568999999999999999999 99999888777


Q ss_pred             HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +....+.......                           ....+++++.+||.+||+.||++|||+.+++++
T Consensus       284 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          284 EVIYYVRDGNILA---------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHTTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCcCC---------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            7666654432111                           112468899999999999999999999999753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.1e-45  Score=315.00  Aligned_cols=273  Identities=21%  Similarity=0.333  Sum_probs=207.0

Q ss_pred             ccccHHHHhhccceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeece
Q 021299            4 VDLSKKVADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA   79 (314)
Q Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   79 (314)
                      ++......++|++.+.||+|++|.||++.    +..+++.|++|.+..... ......+.+|+++++.++||||++++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGI   91 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            34444456889999999999999999998    567889999999976543 2233467789999999999999999999


Q ss_pred             eccC--CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecc
Q 021299           80 FPHK--GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        80 ~~~~--~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                      +...  ...+++|||++| +|.+++......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            8766  678999999975 9999997777779999999999999999999999999999999999999999999999999


Q ss_pred             ceeeeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          157 LARIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       157 ~~~~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      .+........   ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+......  .....   .... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~---~~~~-  244 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--FLKMI---GPTH-  244 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHH---CSCC-
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhH--Hhhcc---CCcc-
Confidence            9987754432   2334557778999999876 56789999999999999999999886432110  00000   0000 


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                            .......................+++++.+||.+||..||.+|||++++++
T Consensus       245 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          245 ------GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ------GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ------cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                  000000000000111111223467999999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-45  Score=317.42  Aligned_cols=269  Identities=19%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             HHHHhhccceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--   81 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--   81 (314)
                      +...++|++++.||+|+||+||++.    +..+++.||+|++.....  .....+.+|+++++.++||||+++++++.  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3457999999999999999999998    566889999999875422  22345678999999999999999999874  


Q ss_pred             cCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           82 HKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        82 ~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      +....++||||++| +|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            34568999999974 99999988777799999999999999999999999999999999999999999999999999987


Q ss_pred             eCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          161 FGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       161 ~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ......   ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|+......  ....   ........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~---~~~~~~~~--  235 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRM---IGNDKQGQ--  235 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHH---HCTTCCTH--
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhh---hcCccccc--
Confidence            643321   2223346677999999876 56899999999999999999999887543211  1110   00000000  


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                          ................+....+++++.+||.+||+.||++|||++|+++
T Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          236 ----MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             ----HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                0000000000001111223457999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.5e-45  Score=313.18  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=213.5

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...++|++.+.||+|++|+||++.+..++..+++|.+.....   ....+.+|+++++.++||||+++++++.+.+..++
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            357899999999999999999999999999999999975332   33467789999999999999999999999999999


Q ss_pred             EEeccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-
Q 021299           89 VFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-  165 (314)
                      |||++. |+|.+.+... ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999998 5999988764 4569999999999999999999999999999999999999999999999999997654332 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+........            
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  233 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------------  233 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC------------
T ss_pred             ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC------------
Confidence            22233455778999999876 568999999999999999999 9999988877776665544322111            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     ...+++.+.+|+.+||..||.+|||++++++
T Consensus       234 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          234 ---------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                           1345899999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-45  Score=321.99  Aligned_cols=263  Identities=18%  Similarity=0.245  Sum_probs=210.6

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEE-----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      +.+...++|++.+.||+|++|+||++.     +..++..|++|.+..... ......+.+|+.+++.++||||+++++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            444567999999999999999999998     456778999999964332 22334567899999999999999999999


Q ss_pred             ccCCeEEEEEeccc-ccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC---CcE
Q 021299           81 PHKGNLHLVFEFME-TDLETVIRNTN------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQL  150 (314)
Q Consensus        81 ~~~~~~~iv~e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~---~~~  150 (314)
                      ...+..++||||++ |+|.+++....      ..+++..++.++.|++.||.|||++|++|+||||+||+++.+   ..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999996 59999987654      358999999999999999999999999999999999999844   469


Q ss_pred             EEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +|+|||.+.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            999999997543222  22234456888999999876 568999999999999999998 89999887776666555443


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      .....                           ...+++.+.++|.+||+.||.+||++.+++++.|+-..
T Consensus       262 ~~~~~---------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 GRMDP---------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCCC---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC---------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            21111                           12468899999999999999999999999999887544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3e-44  Score=308.18  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=210.8

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--   82 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   82 (314)
                      .+.+.+.++|++.+.||+|++|.||++.+..+|+.|++|.+....      ..+.+|+++++.++||||+++++++..  
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            356789999999999999999999999999999999999997543      255689999999999999999998754  


Q ss_pred             --------------CCeEEEEEecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 --------------KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 --------------~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                                    ....+++|||++| +|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence                          4468999999996 999988754 457999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA  226 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~  226 (314)
                      ++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..|+....  .....+..
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~  233 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD  233 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT
T ss_pred             CCCEEECcchhheeccccc-cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc
Confidence            9999999999998765432 2344568899999999977 668999999999999999999998774321  11111111


Q ss_pred             hhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      .   .                           ....+++.+.++|.+||+.||.+|||+.|+++|.+.-.
T Consensus       234 ~---~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 G---I---------------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             T---C---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             c---c---------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0   0                           11235889999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-45  Score=326.45  Aligned_cols=251  Identities=21%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             HhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|.+.+.||+|+||.||++.++   .++..|++|.+.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            468999999999999999999876   456789999997543 2223346778999999999999999999999999999


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||++ |+|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence            9999997 599999987777899999999999999999999999999999999999999999999999999987643322


Q ss_pred             c---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .   .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........          
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~----------  271 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----------  271 (373)
T ss_dssp             -----------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC----------
T ss_pred             cceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence            1   112234667999999876 668999999999999999997 9999988777666655543321111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ...+++++.+|+.+||+.||++||+++++++
T Consensus       272 -----------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          272 -----------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -----------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                             1245889999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=311.55  Aligned_cols=253  Identities=21%  Similarity=0.330  Sum_probs=209.7

Q ss_pred             Hhhcccee-eeCccccceEEEEEEC--CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKRE-VLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~-~lg~g~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|.+.+ .||+|++|.||++.+.  .++..+++|.+..... ......+.+|+++++.++||||+++++++ ..+..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            46787877 9999999999999754  4677899999976532 22334567899999999999999999998 456689


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +|||++.| +|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            99999986 88888877777799999999999999999999999999999999999999999999999999987754332


Q ss_pred             c---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......            
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~------------  232 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------  232 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC------------
T ss_pred             eeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC------------
Confidence            2   223345788999999875 567899999999999999998 99999988877766655443111            


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                                     .....+++++.++|.+||+.||++||++.+++++.+
T Consensus       233 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          233 ---------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                           112356899999999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-45  Score=319.99  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=207.9

Q ss_pred             HhhccceeeeCccccceEEEEEE-----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||+||+|.+     ..++..|++|.+.... .......+.+|+.+++.+ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            58999999999999999999986     3456689999997543 233345677999999999 8999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 021299           85 NLHLVFEFMET-DLETVIRNTNI----------------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~----------------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~n  141 (314)
                      ..++||||++| +|.+++.....                      .+++..++.++.||+.||.|||++|++|+||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            99999999975 99999876543                      37899999999999999999999999999999999


Q ss_pred             eEEecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcH
Q 021299          142 LLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI  218 (314)
Q Consensus       142 il~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~  218 (314)
                      |+++.++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            9999999999999999976543322  2233456778999999876 668999999999999999998 99999887665


Q ss_pred             HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                      .............                          .....+++++.+||.+||+.||++|||+.+++++..
T Consensus       282 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          282 ANFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             HHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            5555444321110                          011245899999999999999999999999998653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.9e-45  Score=312.79  Aligned_cols=247  Identities=16%  Similarity=0.241  Sum_probs=203.8

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCC-------cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTG-------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   82 (314)
                      ..++|++.+.||+|+||+||++.+..++       ..+++|.+....  ......+.+|+++++.++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4689999999999999999999988776       469999986532  2233467789999999999999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc--------EEEe
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--------LKLA  153 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~--------~~l~  153 (314)
                      .+..++||||+. |+|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.        ++|+
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999998 5999999887767999999999999999999999999999999999999998887        9999


Q ss_pred             eccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCC
Q 021299          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       154 df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      |||.+.....    .....+++.|+|||.+.+...++.++||||||+++|+|++|. +||.......... .......  
T Consensus       164 Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~--  236 (289)
T 4fvq_A          164 DPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ--  236 (289)
T ss_dssp             CCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC--
T ss_pred             cCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC--
Confidence            9999864322    233456788999999987567899999999999999999965 5555544433332 2222111  


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                .....++++.+||.+||+.||++|||+.++++|
T Consensus       237 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          237 --------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                      112347789999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-44  Score=306.79  Aligned_cols=247  Identities=15%  Similarity=0.201  Sum_probs=207.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC--CeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   88 (314)
                      .++|++.+.||+|++|+||++.+.  +..+++|++............+.+|+.+++.++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            589999999999999999999875  78999999987655555555678999999999999999999998776  78899


Q ss_pred             EEecccc-cHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           89 VFEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      +|||++| +|.+++..... .+++..++.++.|++.||.|||++|  ++|+||||+||+++.++.++|+||+++....  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            9999985 99999886543 5899999999999999999999999  9999999999999999999999998875422  


Q ss_pred             CCcccccccCccccCcccccCccC--CCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~--~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                         .....+++.|+|||.+.+...  ++.++||||||+++|+|++|..||...................           
T Consensus       165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  230 (271)
T 3kmu_A          165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----------  230 (271)
T ss_dssp             ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----------
Confidence               233567889999999976322  2348999999999999999999998887777665554331111           


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     .....+++++.+++.+||+.||++|||++++++
T Consensus       231 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ---------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           112356999999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-44  Score=314.93  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=210.1

Q ss_pred             HhhccceeeeCccccceEEEEEE-----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||.||++.+     ..++..+++|.+...... .....+.+|+.+++.+ +||||+++++++...+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            58999999999999999999984     456789999999755322 2234567899999999 8999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           85 NLHLVFEFMET-DLETVIRNTNI-----------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ..++||||+.| +|.+++.....                 .+++..++.++.|++.||.+||++|++|+||||+||+++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            99999999975 99999876543                 4899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence            99999999999987644332  1223456778999999876 668999999999999999998 9999988776555555


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .........                          ....+++++.++|.+||..||.+|||++|++++
T Consensus       260 ~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          260 MIKEGFRML--------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHTCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccCCCCC--------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            444321111                          112458999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-44  Score=308.43  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=194.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc--CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .++|++.+.||+|++|+||++.+.  |..+++|.+.......  .....+.+|+++++.++||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999875  7899999987654332  233456789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCceEEec--------CCcEEEeecc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW---VLHRDMKPNNLLIGS--------HGQLKLADFG  156 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---i~H~di~~~nil~~~--------~~~~~l~df~  156 (314)
                      ||||++| +|.+.+.  ...+++..++.++.|++.||.+||++|   ++|+||||+||+++.        ++.++|+|||
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999985 7766664  336999999999999999999999999   889999999999986        6789999999


Q ss_pred             ceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      .+.......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...................     
T Consensus       162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  233 (271)
T 3dtc_A          162 LAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-----  233 (271)
T ss_dssp             C---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC-----
T ss_pred             ccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC-----
Confidence            998654332  234568899999999876 668999999999999999999999998877666655543321111     


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                           .....+++.+.++|.+||+.||.+|||+.|++++
T Consensus       234 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          234 ---------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                 1123468999999999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=316.72  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEE----EEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|+||+||++.+..+++.+    ++|.+.... .......+.+|+.+++.++||||+++++++..+. .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            589999999999999999999998887755    666664332 2334456779999999999999999999987765 6


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++++++. |+|.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            77888877 59999998887789999999999999999999999999999999999999999999999999998764332


Q ss_pred             C--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+........          
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  240 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----------  240 (327)
T ss_dssp             --------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----------
T ss_pred             ccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence            2  2223445778999999976 678999999999999999999 9999988877776665544321111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ...+++++.++|.+||..||.+|||+.|+++
T Consensus       241 -----------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          241 -----------------PPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -----------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             1245889999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=332.62  Aligned_cols=279  Identities=21%  Similarity=0.271  Sum_probs=211.0

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC--e
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--N   85 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~   85 (314)
                      +.+.++|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+++++.++||||+++++++...+  .
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            455789999999999999999999999999999999997543322 2345668999999999999999999986554  7


Q ss_pred             EEEEEecccc-cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE----ecCCcEEEeeccce
Q 021299           86 LHLVFEFMET-DLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLA  158 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~----~~~~~~~l~df~~~  158 (314)
                      .++||||+.| +|.+.+....  ..+++..++.++.||+.||+|||++|++|+||||+||++    +.++.++|+|||.+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            8999999975 8888887543  239999999999999999999999999999999999999    66778999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCc-------cCCCCcchHhhHHHHHHHHHhCCCccCCCC----cHHHHHHHHHh
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLNRRPFLQGSS----DIDQLGKIFAA  227 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~-------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~----~~~~~~~~~~~  227 (314)
                      ...... .......|++.|+|||.+.+.       ..++.++||||||+++|+|++|..||....    ..+....+...
T Consensus       164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            876433 233456689999999988541       356789999999999999999999996533    33334343332


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                         .++..+.................+........+++.+.+++.+||+.||++||++.|++++
T Consensus       243 ---~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 ---KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             ---CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ---CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence               2222222111111110001111112222334457789999999999999999999997543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.7e-45  Score=317.89  Aligned_cols=251  Identities=22%  Similarity=0.359  Sum_probs=201.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcE----EEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|+||+||+|.+..+++.    +++|.+.... .......+.+|+.+++.++||||+++++++..+. .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            58999999999999999999998877765    4777765432 2234456779999999999999999999997765 6


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++++++. |+|.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            77888887 59999998877789999999999999999999999999999999999999999999999999998764433


Q ss_pred             Cc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 RR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 ~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+........          
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------  240 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----------  240 (327)
T ss_dssp             C-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----------
T ss_pred             ccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC----------
Confidence            22  223445778999999876 678999999999999999999 9999988777666555543321111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                       ...++.++.+++.+||+.||.+|||+.+++++
T Consensus       241 -----------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 -----------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -----------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -----------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                             12358899999999999999999999999865

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.5e-45  Score=318.21  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=206.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEE--EEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCe
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTV--AIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGN   85 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   85 (314)
                      .-.++|++.+.||+|++|.||++.+..+|..+  ++|.+..... ......+.+|+++++.+ +||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            33589999999999999999999998888765  9998875432 22334677899999999 89999999999999999


Q ss_pred             EEEEEecccc-cHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc
Q 021299           86 LHLVFEFMET-DLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (314)
Q Consensus        86 ~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~  149 (314)
                      .++|||+++| +|.+++....               ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence            9999999975 9999887643               46999999999999999999999999999999999999999999


Q ss_pred             EEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhh
Q 021299          150 LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF  228 (314)
Q Consensus       150 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~  228 (314)
                      ++|+|||.+..... ........+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+....
T Consensus       181 ~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          181 AKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             EEECCTTCEESSCE-ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEEcccCcCccccc-cccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            99999999974321 112233455778999999866 567899999999999999998 999998887766655543321


Q ss_pred             CCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ...                           ....+++++.+||.+||..||++|||+++++++
T Consensus       259 ~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 RLE---------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCC---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111                           112458999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=316.09  Aligned_cols=252  Identities=20%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC----cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|++|+||+|.+..++    ..+++|.+..... ......+.+|+++++.++||||+++++++...+..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            468899999999999999999876543    3599999975432 22233567899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++|||++.| +|.+++....+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            999999986 8999988777789999999999999999999999999999999999999999999999999998764332


Q ss_pred             C---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 R---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .   ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........         
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---------  271 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---------  271 (333)
T ss_dssp             ---------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---------
T ss_pred             ccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---------
Confidence            1   1122345678999999976 668999999999999999998 9999988777666665544321111         


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                        ...+++.+.++|.+||+.||++||++.+++++
T Consensus       272 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 ------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              12458899999999999999999999998864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-44  Score=311.24  Aligned_cols=250  Identities=20%  Similarity=0.327  Sum_probs=204.2

Q ss_pred             Hhhcccee-eeCccccceEEEEE--ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKRE-VLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~-~lg~g~~g~vy~~~--~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|.+.+ .||+|++|+||++.  ...+++.+++|.+............+.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            47899998 99999999999994  456678999999987654444455677999999999999999999998 566789


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +|||++.| +|.+++... +.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            99999985 888888764 4599999999999999999999999999999999999999999999999999987654432


Q ss_pred             cc---cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 RF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ~~---~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      ..   ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+......            
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------  239 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------  239 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred             cccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence            21   22335678999999876 557889999999999999999 99999887776665554432111            


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     .....+++++.++|.+||+.||.+|||+.++++
T Consensus       240 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 ---------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           112346899999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.4e-45  Score=329.60  Aligned_cols=265  Identities=24%  Similarity=0.360  Sum_probs=201.6

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   83 (314)
                      ++...+.+.|.+.+.||+|+||+||.+. ..+|+.||+|.+....     .....+|+++++.+ +||||+++++++.++
T Consensus         8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A            8 NFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             chhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            4556677889899999999999998753 5678999999986532     23456899999876 899999999999999


Q ss_pred             CeEEEEEecccccHHHHHHhCCCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC----------
Q 021299           84 GNLHLVFEFMETDLETVIRNTNIF------LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----------  147 (314)
Q Consensus        84 ~~~~iv~e~~~g~l~~~~~~~~~~------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~----------  147 (314)
                      +..++|||+++|+|.+.+......      .++..++.++.||+.||+|||++|++|+||||+||+++.+          
T Consensus        82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            999999999999999999765421      1233467899999999999999999999999999999754          


Q ss_pred             ---CcEEEeeccceeeeCCCCCc----ccccccCccccCcccccC------ccCCCCcchHhhHHHHHHHHHh-CCCccC
Q 021299          148 ---GQLKLADFGLARIFGSPDRR----FTHQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLN-RRPFLQ  213 (314)
Q Consensus       148 ---~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~sPE~~~~------~~~~~~~~Di~slG~ll~~ll~-g~~pf~  213 (314)
                         +.++|+|||++.........    .....||+.|+|||++.+      ...++.++||||||+++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               48999999999877543221    234578999999999865      2567999999999999999998 899997


Q ss_pred             CCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          214 GSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                      ......  ..+........  ..+.                   .....+++++.+||.+||+.||.+|||+.++++|||
T Consensus       242 ~~~~~~--~~i~~~~~~~~--~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLD--EMKC-------------------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             STTTHH--HHHHHTCCCCC--CCTT-------------------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CchhhH--HHHhcCCCCcc--cccc-------------------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence            655443  22222211111  0000                   001124678999999999999999999999999999


Q ss_pred             ccccC
Q 021299          294 AKSFN  298 (314)
Q Consensus       294 ~~~~~  298 (314)
                      |....
T Consensus       299 f~~~~  303 (434)
T 2rio_A          299 FWPKS  303 (434)
T ss_dssp             GSCHH
T ss_pred             cCCcH
Confidence            97543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-44  Score=314.55  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=200.2

Q ss_pred             HhhccceeeeCccccceEEEEEECC---CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC---
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   84 (314)
                      .++|++.+.||+|++|+||+|.+..   ++..+++|.+............+.+|+.+++.++||||+++++++.+.+   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            5899999999999999999998765   4558999999866544444456778999999999999999999986654   


Q ss_pred             --eEEEEEecccc-cHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecc
Q 021299           85 --NLHLVFEFMET-DLETVIRN-----TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        85 --~~~iv~e~~~g-~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                        ..+++||++.+ +|.+++..     ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence              45999999985 88888853     33569999999999999999999999999999999999999999999999999


Q ss_pred             ceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          157 LARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       157 ~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      .+.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+........ 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-  270 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-  270 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-
T ss_pred             cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC-
Confidence            997654332  12233456778999999977 678999999999999999999 8899988887777666554321111 


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                ...+++++.++|.+||..||.+|||+.+++++
T Consensus       271 --------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          271 --------------------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      12468899999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-44  Score=316.38  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=208.9

Q ss_pred             HhhccceeeeCccccceEEEEEEC-------CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|++.+.||+|+||+||+|.+.       .++..|++|.+..... ......+.+|+++++.+ +||||+++++++..
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            589999999999999999999875       3567899999975432 22234567899999999 89999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTNI---------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      .+..++||||+.| +|.+++.....               .+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence            9999999999985 99998876532               4899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCCc--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++|+|||.+.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence            999999999999876543321  223345778999999876 567899999999999999999 9999988877766665


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      +.......                           ....+++++.++|.+||..||++|||++|++++
T Consensus       272 ~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          272 LKEGHRMD---------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCC---------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            54432111                           112458899999999999999999999999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.9e-44  Score=309.28  Aligned_cols=251  Identities=21%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             HhhccceeeeCccccceEEEEEECC---CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|++|+||++.+..   ++..+++|.+..... ......+.+|+.+++.++||||+++++++.++ ..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            5899999999999999999998654   334699999876532 22334667899999999999999999998654 568


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++||++.| +|.+++......+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            99999985 89999887777799999999999999999999999999999999999999999999999999976543321


Q ss_pred             -cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 -RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 -~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........            
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~------------  235 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------------  235 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC------------
T ss_pred             cccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC------------
Confidence             2233456778999999876 568999999999999999998 9999987777766665544321111            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                     ...+++.+.++|.+||..||++|||+.|++++
T Consensus       236 ---------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          236 ---------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                           12458899999999999999999999999865

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.1e-45  Score=317.22  Aligned_cols=253  Identities=21%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             HHhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   84 (314)
                      ..++|++.+.||+|++|.||+|.+.     .++..+++|.+...... .....+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            4689999999999999999999876     35678999998754322 22335678999999999999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEee
Q 021299           85 NLHLVFEFMET-DLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d  154 (314)
                      ..++|||++.| +|.+++....         ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence            99999999985 8988886532         3578999999999999999999999999999999999999999999999


Q ss_pred             ccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCC
Q 021299          155 FGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       155 f~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      ||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  259 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL-  259 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC-
Confidence            999975533221  1223355788999999876 568999999999999999999 88999888776666655443111 


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                .....+++.+.+||.+||+.||.+|||+.|++++
T Consensus       260 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          260 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                      1123468999999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-44  Score=312.38  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      ....++|++.+.||+|++|.||++.+..+++.|++|.+....... .....+.+|+.+++.++||||+++++++..++..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            345689999999999999999999999999999999997654322 2234567899999999999999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++||+++| +|.+++... +.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999986 888888754 359999999999999999999999999999999999999999999999999997654332


Q ss_pred             -CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       166 -~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...    .            
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~------------  251 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----I------------  251 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC----C------------
T ss_pred             cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC----C------------
Confidence             22334568899999999876 67789999999999999999999999876554333222211    0            


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-CHHHHhc
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALE  290 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~ell~  290 (314)
                               .......+.+++++.++|.+||+.||++|| +++++++
T Consensus       252 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ---------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                     001122345789999999999999999999 7777664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=318.57  Aligned_cols=263  Identities=15%  Similarity=0.133  Sum_probs=199.5

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECC---CCcEEEEEEeecCCccc---------CcchhhHHHHHHHhhcCCCCeee
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKE---------GVNFTALREIKLLKELKSPHIIE   75 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~~iK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~   75 (314)
                      +...++|++.+.||+|+||+||+|.+..   ++..+++|.+.......         .....+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3345799999999999999999999987   77899999997653211         01123457888899999999999


Q ss_pred             eeceecc----CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC--c
Q 021299           76 LIDAFPH----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG--Q  149 (314)
Q Consensus        76 ~~~~~~~----~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~--~  149 (314)
                      +++++..    ....++|||+++++|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++.++  .
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred             eecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence            9999866    77899999999779988887655 799999999999999999999999999999999999999887  9


Q ss_pred             EEEeeccceeeeCCCC-------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHHHH
Q 021299          150 LKLADFGLARIFGSPD-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQL  221 (314)
Q Consensus       150 ~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~  221 (314)
                      ++|+|||.+.......       .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||... ......
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999998763221       11234578999999999987 57899999999999999999999999542 333333


Q ss_pred             HHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ...........+..+...                  .-...+++++.++|.+||..||++|||+++|++
T Consensus       271 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKW------------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHH------------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhcccccHHHHhh------------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            322222111111100000                  001146899999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.7e-44  Score=330.65  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=211.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||.||++.++.++..||+|.+.....   ....+.+|+++++.++||||+++++++...+..++||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            5789999999999999999999998899999999975432   3456789999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      ||+. |+|.+++... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence            9998 5999998764 45699999999999999999999999999999999999999999999999999987643322 2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+.......               
T Consensus       376 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------  439 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---------------  439 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---------------
T ss_pred             cCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence            223345678999999876 567999999999999999998 899998887766665554332111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  ....+++++.+||.+||+.||++|||+.+|++
T Consensus       440 ------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          440 ------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                        12346899999999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.1e-44  Score=309.14  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=203.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC---cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~   86 (314)
                      ..+|++.+.||+|+||+||+|.+..++   ..+++|.+..... ......+.+|+.+++.++||||+++++++ ..++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            357999999999999999999865433   3588888865332 22234567899999999999999999984 566788


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      +++|||++| +|.+.+......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            999999986 9999998777789999999999999999999999999999999999999999999999999998654322


Q ss_pred             ----CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          166 ----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       166 ----~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                          .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+....+........+       
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  254 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-------  254 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC-------
T ss_pred             hhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC-------
Confidence                12233456778999999876 668999999999999999999 66888877776666665544222111       


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                          ..+++.+.+++.+||+.||++|||+.++++
T Consensus       255 --------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 --------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             --------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                235889999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-44  Score=316.72  Aligned_cols=275  Identities=19%  Similarity=0.260  Sum_probs=209.8

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...++|++.+.||+|++|+||++.+ .+|+.||+|.+........ ...+.+|+++++.++||||+++++++...+..++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            3468999999999999999999974 4688999999976543322 2357789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           89 VFEFMET-DLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKK---WVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~---~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ||||+.| +|.+.+....   ..+++..++.++.|++.||+|||++   |++|+||||+||+++.++.++|+|||.+...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            9999986 8888887643   3499999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC-cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCC-----CCcHHHHHHHHHhhCCCCCCC
Q 021299          162 GSPDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-----SSDIDQLGKIFAAFGTATPSQ  235 (314)
Q Consensus       162 ~~~~~-~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~-----~~~~~~~~~~~~~~~~~~~~~  235 (314)
                      ..... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..     .........+...........
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            54332 2334458999999999876 5579999999999999999999999952     111111111111111100000


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ...              ...........++.+.+++.+||+.||.+|||+.|+++|-.-..+.+.
T Consensus       264 ~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~  314 (326)
T 3uim_A          264 LVD--------------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER  314 (326)
T ss_dssp             SSC--------------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred             hcC--------------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence            000              000111122335789999999999999999999999998766555443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-44  Score=314.98  Aligned_cols=266  Identities=22%  Similarity=0.298  Sum_probs=205.6

Q ss_pred             HhhccceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec--cCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~   84 (314)
                      .++|++.+.||+|++|.||++.    +..++..|++|.+.....  .....+.+|+++++.++||||+++++++.  +.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            4899999999999999999998    567889999999975432  22345678999999999999999999874  566


Q ss_pred             eEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++||||++ |+|.+++......+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            7899999996 589998887666799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          164 PDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       164 ~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ...   ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........     .  .....+.. 
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-----~--~~~~~~~~-  250 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-----G--CERDVPAL-  250 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-----C------CCHH-
T ss_pred             CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-----c--cccccccH-
Confidence            332   2223456788999999876 5678999999999999999999999865432211100     0  00000000 


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                          ..................+++++.+||.+||+.||.+|||++|++++
T Consensus       251 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 ----SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                00000000111112234679999999999999999999999999644

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-44  Score=307.98  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             hccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE-EE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL-HL   88 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~i   88 (314)
                      .|.+.+.||+|+||+||+|.+..++.   .+++|.+..... ......+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45667999999999999998655444   799999865332 22234567899999999999999999998765554 89


Q ss_pred             EEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC---
Q 021299           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP---  164 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~---  164 (314)
                      ++|++. |+|.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+......   
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999996 5999999887778999999999999999999999999999999999999999999999999999754332   


Q ss_pred             -CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          165 -DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       165 -~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                       ........+++.|+|||.+.+ ..++.++||||||+++|+|++| .+||......+....+........          
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----------  249 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ----------  249 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC----------
T ss_pred             ccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC----------
Confidence             122233456788999999976 6689999999999999999995 566776666666555544322111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                       ...+++.+.+++.+||+.||.+|||++++++
T Consensus       250 -----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          250 -----------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             1245889999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-43  Score=323.59  Aligned_cols=243  Identities=21%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-CeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-GNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv   89 (314)
                      .++|++.+.||+|+||.||++.+.  |+.||+|.+....    ....+.+|+++++.++||||+++++++... +..++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            478999999999999999999775  7799999997543    345678999999999999999999987554 479999


Q ss_pred             Eecccc-cHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      |||+.| +|.+++...+. .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......  
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            999985 99999986543 47999999999999999999999999999999999999999999999999998653322  


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+..+....               
T Consensus       344 -~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------------  406 (450)
T 1k9a_A          344 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---------------  406 (450)
T ss_dssp             ----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC---------------
T ss_pred             -cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence             22356778999999977 678999999999999999998 999998877776666654432111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                  ....+++++.+||.+||+.||++|||+.++++
T Consensus       407 ------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          407 ------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                        12346899999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=316.12  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=187.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeecee--------c
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAF--------P   81 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--------~   81 (314)
                      ..+|++.+.||+|+||.||++.+..+|+.|++|.+.....  .....+.+|+.+++.+. ||||+++++++        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3589999999999999999999999999999999865432  22345668999999996 99999999987        4


Q ss_pred             cCCeEEEEEecccccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEecCCcEEEeeccc
Q 021299           82 HKGNLHLVFEFMETDLETVIRN--TNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        82 ~~~~~~iv~e~~~g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      .....+++||+++|+|.+.+..  ..+.+++..++.++.||+.||.|||++|  ++|+||||+||+++.++.++|+|||.
T Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            4556899999999999998865  4557999999999999999999999999  99999999999999999999999999


Q ss_pred             eeeeCCCCCc------------ccccccCccccCccccc--CccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHH
Q 021299          158 ARIFGSPDRR------------FTHQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK  223 (314)
Q Consensus       158 ~~~~~~~~~~------------~~~~~~~~~y~sPE~~~--~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~  223 (314)
                      +.........            .....+++.|+|||.+.  ....++.++||||||+++|+|++|..||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9876433221            11345788899999984  335678999999999999999999999976443322111


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcc
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF  293 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  293 (314)
                      .    ..                          .......++.+.+||.+||+.||.+|||++|++++.+
T Consensus       265 ~----~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 K----YS--------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----CC--------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             c----cc--------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0    00                          0011234778999999999999999999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.1e-44  Score=311.51  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=205.5

Q ss_pred             HhhccceeeeCccccceEEEEEE-----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccC-
Q 021299           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   83 (314)
                      .++|++.+.||+|+||+||++.+     ..+++.|++|.+...... .....+.+|+.+++.+ +||||+++++++... 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            58999999999999999999984     456789999999754322 2233567899999999 689999999998664 


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIF---------------LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~---------------l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~  147 (314)
                      +..+++|||+.| +|.+++......               +++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence            458999999985 899988765432               8999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHH
Q 021299          148 GQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKI  224 (314)
Q Consensus       148 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~  224 (314)
                      +.++|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||............
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence            9999999999976543322  2234456788999999876 668999999999999999998 99999876654444333


Q ss_pred             HHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .......                          .....+++++.++|.+||+.||.+|||++++++|
T Consensus       264 ~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          264 LKEGTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCccC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3321110                          0112358899999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9e-44  Score=316.24  Aligned_cols=261  Identities=14%  Similarity=0.119  Sum_probs=199.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-----CcEEEEEEeecCCcccC---------cchhhHHHHHHHhhcCCCCeeee
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEG---------VNFTALREIKLLKELKSPHIIEL   76 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~~iK~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~   76 (314)
                      .++|++.+.||+|+||+||+|.+..+     ++.||+|.+........         .......++..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            35999999999999999999988764     57899999876542110         01122345666777889999999


Q ss_pred             eceeccC----CeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe--cCCcE
Q 021299           77 IDAFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQL  150 (314)
Q Consensus        77 ~~~~~~~----~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~--~~~~~  150 (314)
                      ++++...    ...++||||++|+|.+++....+.+++..++.++.||+.||+|||++|++|+||||+||+++  .++.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            9988553    56899999997799999988777899999999999999999999999999999999999999  88999


Q ss_pred             EEeeccceeeeCCCCC-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC-cHHHHH
Q 021299          151 KLADFGLARIFGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLG  222 (314)
Q Consensus       151 ~l~df~~~~~~~~~~~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~-~~~~~~  222 (314)
                      +|+|||++........       ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.... ......
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            9999999987643211       1123448999999999977 568999999999999999999999998533 332222


Q ss_pred             HHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      ..........+.          .....      +  ....+++++.+++..||..||.+||++.+|++
T Consensus       273 ~~~~~~~~~~~~----------~~~~~------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIAS----------LMDKC------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHH----------HHHHH------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHH----------HHHHh------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            222111000000          00000      0  01346899999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=317.60  Aligned_cols=254  Identities=13%  Similarity=0.127  Sum_probs=201.9

Q ss_pred             HhhccceeeeCccccceEEEEEECC--------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeee-------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK--------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-------   75 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-------   75 (314)
                      .++|++.+.||+|++|+||+|.+..        .++.||+|.+...       ..+.+|+++++.++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            5799999999999999999999887        4789999998754       25668999999999999887       


Q ss_pred             --------eeceecc-CCeEEEEEecccccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe
Q 021299           76 --------LIDAFPH-KGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (314)
Q Consensus        76 --------~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~  145 (314)
                              +++++.. ++..++||||++|+|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                    4455543 6789999999977999999865 45799999999999999999999999999999999999999


Q ss_pred             cCC--cEEEeeccceeeeCCCCC-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCC
Q 021299          146 SHG--QLKLADFGLARIFGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (314)
Q Consensus       146 ~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~  216 (314)
                      .++  .++|+|||++........       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            998  999999999976543211       1233478899999999877 568999999999999999999999998764


Q ss_pred             -cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          217 -DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                       ...........+....+.....                  ......+++++.+||.+||+.||++|||++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVGP------------------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEECT------------------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhhhhhh------------------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             3333333333221111110000                  0011246899999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-43  Score=303.48  Aligned_cols=255  Identities=21%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|+||++.+. ++..+++|.+.....   ....+.+|+++++.++||||+++++++.. +..+++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            579999999999999999999865 567899999875432   23467789999999999999999998864 4589999


Q ss_pred             eccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      |++. |+|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+........ .
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence            9997 58888886542 3699999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........              
T Consensus       167 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  231 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--------------  231 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------------
T ss_pred             ccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC--------------
Confidence            223445778999999875 567899999999999999999 8999988877776666544321111              


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc--CccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~  298 (314)
                                   ...+++++.+++.+||..||++|||++++++  ..++....
T Consensus       232 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          232 -------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                         1246899999999999999999999999875  44444433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6e-44  Score=313.53  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=207.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc-----EEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||+||++.+..++.     .+++|.+...... .....+.+|+.+++.+ +||||+++++++...+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            5789999999999999999999876654     7999999754322 2234567899999999 8999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcE
Q 021299           85 NLHLVFEFMET-DLETVIRNT-------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~  150 (314)
                      ..++||||++| +|.+++...             ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence            99999999985 898888653             3358999999999999999999999999999999999999999999


Q ss_pred             EEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHh
Q 021299          151 KLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       151 ~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~  227 (314)
                      +|+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...............
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  282 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD  282 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence            9999999986533222  2233456778999999876 568999999999999999998 88999887666655555443


Q ss_pred             hCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      .....                          .....++.+.+||.+||+.||.+|||+.|+++
T Consensus       283 ~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          283 GYQMA--------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             TCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC--------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            21111                          11235889999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-45  Score=343.08  Aligned_cols=288  Identities=23%  Similarity=0.287  Sum_probs=210.1

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc---
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH---   82 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   82 (314)
                      ++....++|++.+.||+|+||+||++.+..+|..||+|.+.... .......+.+|+++++.++||||+++++++..   
T Consensus         8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A            8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            45566799999999999999999999999999999999986542 22233456789999999999999999998755   


Q ss_pred             ---CCeEEEEEecccc-cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCc---EEEe
Q 021299           83 ---KGNLHLVFEFMET-DLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLA  153 (314)
Q Consensus        83 ---~~~~~iv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~---~~l~  153 (314)
                         ++..++||||+.| +|.+++....  ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.   ++|+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               6778999999964 8888887643  36899999999999999999999999999999999999997764   9999


Q ss_pred             eccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCC
Q 021299          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (314)
Q Consensus       154 df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  233 (314)
                      |||.+....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..............   ....
T Consensus       167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~  241 (676)
T 3qa8_A          167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSN  241 (676)
T ss_dssp             SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-------
T ss_pred             cccccccccccc-ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccc
Confidence            999998764332 3345678999999999876 6789999999999999999999999976543322111100   0000


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGV  300 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  300 (314)
                      ..............+. ...+........+++.+.+||.+||..||++|||++|+++||||+.+.+.
T Consensus       242 ~~~~~~~~l~g~~~~~-~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFS-SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             --CCSCCCCSSSCCCC-SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             hhhhhhhhhccccccc-cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence            0000000000000000 11111222334568899999999999999999999999999999988643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-44  Score=316.49  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=205.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      ..++|++.+.||+|+||+||++.+ .+|..|++|.+....  ......+.+|+++++.++||||+++++++...+..++|
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            458999999999999999999985 468899999886543  22344677899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           90 FEFMET-DLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |||+.| +|.+.+....   ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999985 8877775443   358999999999999999999999999999999999999999999999999998754322


Q ss_pred             --CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHH---HHhhCCCCCCCCCCcC
Q 021299          166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI---FAAFGTATPSQWPDLA  240 (314)
Q Consensus       166 --~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  240 (314)
                        .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+.+.....   .............   
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  269 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV---  269 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS---
T ss_pred             ccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc---
Confidence              22233457889999999876 56899999999999999999999999654432211110   0110000000000   


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                                 .........+..+..+.+++.+||+.||++|||+.|++++.
T Consensus       270 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          270 -----------DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             -----------SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----------ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                       00001111223467899999999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-43  Score=304.14  Aligned_cols=243  Identities=20%  Similarity=0.320  Sum_probs=195.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec-cCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv   89 (314)
                      .++|++.+.||+|++|+||++.+.  |+.+++|.+....    ....+.+|+++++.++||||+++++++. ..+..+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            589999999999999999999764  7899999986432    3346778999999999999999999864 44578999


Q ss_pred             Eecccc-cHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           90 FEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||+++| +|.+++..... .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999986 99988875532 38899999999999999999999999999999999999999999999999997653322  


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                       ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......                
T Consensus       172 -~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  233 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------------  233 (278)
T ss_dssp             -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC----------------
T ss_pred             -cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----------------
Confidence             23356778999999876 668999999999999999998 99999887766655554322110                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                 .....+++++.++|.+||..||++|||+.|+++
T Consensus       234 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          234 -----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                       112356899999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-44  Score=317.68  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=195.2

Q ss_pred             hccceeeeCccccceEEEEEECCCC---cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee-ccCCeEEE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNLHL   88 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~i   88 (314)
                      +|.+.+.||+|+||+||++.+..++   ..+++|.+.... .......+.+|+.+++.++||||+++++++ ..++..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            5778899999999999999865432   358899886432 222334677899999999999999999985 45668899


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-  166 (314)
                      ||||+.| +|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ 
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            9999985 99999988777799999999999999999999999999999999999999999999999999976533221 


Q ss_pred             ---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          167 ---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       167 ---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                         ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....+........          
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~----------  317 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----------  317 (373)
T ss_dssp             ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC----------
T ss_pred             cccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence               1233456778999999876 678999999999999999999 6788887766666555543321111          


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                       ...+++.+.++|.+||..||++|||++|++++
T Consensus       318 -----------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 -----------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             12458899999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-44  Score=312.06  Aligned_cols=254  Identities=26%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----eE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----NL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   86 (314)
                      .++|++.+.||+|+||+||++.+.  ++.||+|++.....   .......|+.+++.++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            478999999999999999999865  78999999965422   1223446888899999999999999986643    47


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCceEEecCCcEEEeec
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK----------WVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      ++||||+.| +|.+++....  +++..++.++.|++.||+|||+.          |++|+||||+||+++.++.+||+||
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999985 8999887644  99999999999999999999999          9999999999999999999999999


Q ss_pred             cceeeeCCCCC--cccccccCccccCcccccCc----cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHH---------
Q 021299          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ---------  220 (314)
Q Consensus       156 ~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~----~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~---------  220 (314)
                      |.+........  ......|++.|+|||.+.+.    ..++.++||||||+++|+|++|..||........         
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987654332  23345789999999998763    2346788999999999999999999976432110         


Q ss_pred             ---HHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccC--CCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          221 ---LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                         ...+........                   ..+.....+  ...++++.+||.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          256 HPSLEDMQEVVVHKK-------------------KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SCCHHHHHHHHTTSC-------------------CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhhhhhhhccc-------------------CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               000100000000                   000011110  112456999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-43  Score=306.02  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             HhhccceeeeCccccceEEEEEECC-CCc--EEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~--~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|++|+||++.+.. ++.  .|++|.+....... .....+.+|+++++.++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            5899999999999999999998643 333  68999987654322 23346678999999999999999999987655 7


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++++|++. |+|.+.+....+.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            89999998 59999998776779999999999999999999999999999999999999999999999999998764433


Q ss_pred             Cc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.......          
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  244 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL----------  244 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------
T ss_pred             cchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC----------
Confidence            21   223456778999999876 557899999999999999999 999998887776666554321110          


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                      +....+++++.++|.+||..||.+|||+.++++
T Consensus       245 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 ----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            112346899999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-43  Score=323.62  Aligned_cols=247  Identities=21%  Similarity=0.353  Sum_probs=206.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||++.++ ++..||+|.+.....   ....+.+|+++++.++||||+++++++. .+..++||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            578999999999999999999875 467899999975432   3456789999999999999999999986 56789999


Q ss_pred             eccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Cc
Q 021299           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~  167 (314)
                      ||+. |+|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            9997 58999987542 368999999999999999999999999999999999999999999999999997653321 11


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+........              
T Consensus       342 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--------------  406 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--------------  406 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC--------------
T ss_pred             cCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence            223345677999999976 568999999999999999999 9999998887777776655422211              


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                   ...+++++.+||.+||..||++|||+++|++
T Consensus       407 -------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 -------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                         1245899999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=310.23  Aligned_cols=252  Identities=26%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec----cCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP----HKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~   86 (314)
                      .++|++.+.||+|++|.||++.+..+|+.|++|.+.....  .....+.+|+++++.++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4789999999999999999999999999999999865422  23345678999999999999999999885    34578


Q ss_pred             EEEEecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           87 HLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ++||||+.| +|.+.+..   ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999986 88888865   45679999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCc---------ccccccCccccCcccccCcc--CCCCcchHhhHHHHHHHHHhCCCccCCCC--cHHHHHHHHHhhC
Q 021299          163 SPDRR---------FTHQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSS--DIDQLGKIFAAFG  229 (314)
Q Consensus       163 ~~~~~---------~~~~~~~~~y~sPE~~~~~~--~~~~~~Di~slG~ll~~ll~g~~pf~~~~--~~~~~~~~~~~~~  229 (314)
                      .....         .....+++.|+|||.+.+..  .++.++||||||+++|+|++|..||....  .......+...  
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--  263 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ--  263 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc--
Confidence            21110         11234688899999986532  36899999999999999999999985311  00111111110  


Q ss_pred             CCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      ..                         .+....+++++.++|.+||+.||.+|||+++++++
T Consensus       264 ~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 LS-------------------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-------------------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            00                         01113468999999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=308.95  Aligned_cols=257  Identities=21%  Similarity=0.319  Sum_probs=207.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|++|.||++.+..   .+++|++............+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            4789999999999999999998753   4999999876655555556668999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC-----C
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-----P  164 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~-----~  164 (314)
                      |++.| +|.+++...+..+++..++.++.||+.||++||++|++|+||||+||+++ ++.++|+|||++.....     .
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            99984 88888887766799999999999999999999999999999999999998 67999999999865432     1


Q ss_pred             CCcccccccCccccCcccccC--------ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          165 DRRFTHQVFARWYRAPELLFG--------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~--------~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      ........|++.|+|||.+..        ...++.++||||||+++|+|++|..||...........+.........   
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  264 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS---  264 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC---
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC---
Confidence            122234457888999999864        234788999999999999999999999888777666555433111110   


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                                             ...+++++.+++.+||..||++|||+.++++  .++.+.+
T Consensus       265 -----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          265 -----------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             -----------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             -----------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence                                   1135888999999999999999999999986  3444433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-43  Score=322.54  Aligned_cols=254  Identities=19%  Similarity=0.229  Sum_probs=207.1

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC-CCeeeeeceeccCCeEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLH   87 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~   87 (314)
                      .+.++|++.+.||+|+||.||++.+..+++.||+|++.......    .+..|+++++.+.| +++..+..++......+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            46789999999999999999999999999999999887654332    46689999999987 55555666667788899


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEE---ecCCcEEEeeccceeeeCCC
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~---~~~~~~~l~df~~~~~~~~~  164 (314)
                      +||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            999999889999998777789999999999999999999999999999999999999   58899999999999876543


Q ss_pred             CCc-------ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHH---HHHHHhhCCCCCC
Q 021299          165 DRR-------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL---GKIFAAFGTATPS  234 (314)
Q Consensus       165 ~~~-------~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~  234 (314)
                      ...       .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........   ..+......    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----  234 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA----  234 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----
T ss_pred             ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----
Confidence            321       225678999999999977 66899999999999999999999999875543222   222211100    


Q ss_pred             CCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                         .........+++++.+||..||..||++||++++|++
T Consensus       235 -------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          235 -------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             -------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                               0011112356899999999999999999999988764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.4e-43  Score=304.27  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=191.5

Q ss_pred             HHHhhccce-eeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHH-hhcCCCCeeeeeceecc----
Q 021299            9 KVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL-KELKSPHIIELIDAFPH----   82 (314)
Q Consensus         9 ~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----   82 (314)
                      .+.++|.+. +.||+|++|.||++.+..+++.||+|.+...       ....+|+.++ +..+||||+++++++..    
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            456778777 7899999999999999999999999998632       2455788887 55689999999998866    


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      ....++||||+.| +|.+.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.   ++.++|+|||.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            6788999999985 9999988754 46999999999999999999999999999999999999988   78899999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +.....                       ..++.++||||||+++|+|++|..||...........+...        ..
T Consensus       167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~--------~~  215 (299)
T 3m2w_A          167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--------IR  215 (299)
T ss_dssp             CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS--------SC
T ss_pred             cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH--------Hh
Confidence            875421                       34678999999999999999999999765433221110000        00


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                      .            ............+++++.+||.+||+.||++|||++|+++||||++..+..
T Consensus       216 ~------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          216 M------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             T------------TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             h------------ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            0            000000111235799999999999999999999999999999998775443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.4e-44  Score=310.43  Aligned_cols=263  Identities=22%  Similarity=0.312  Sum_probs=204.7

Q ss_pred             cHHHHhhc-cceeeeCccccceEEEEEE----CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec
Q 021299            7 SKKVADRY-LKREVLGEGTYGVVYKAID----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP   81 (314)
Q Consensus         7 ~~~~~~~y-~~~~~lg~g~~g~vy~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   81 (314)
                      +..+.++| ++++.||+|+||+||++..    ..+++.||+|++..... ......+.+|+++++.++||||+++++++.
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            44567788 9999999999999988753    34788999999976532 223345678999999999999999999987


Q ss_pred             c--CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccce
Q 021299           82 H--KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (314)
Q Consensus        82 ~--~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~  158 (314)
                      +  ....++||||+.| +|.+.+....  +++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            6  4678999999985 8888886654  899999999999999999999999999999999999999999999999999


Q ss_pred             eeeCCCCC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHH-----------HHHHH
Q 021299          159 RIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-----------QLGKI  224 (314)
Q Consensus       159 ~~~~~~~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~-----------~~~~~  224 (314)
                      ........   ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......           ....+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            88754332   2234456788999999876 567899999999999999999999986532211           11111


Q ss_pred             HHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .......                       ........+++++.+||.+||+.||.+|||++|+++  +++.+.
T Consensus       261 ~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~  309 (318)
T 3lxp_A          261 TELLERG-----------------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVH  309 (318)
T ss_dssp             HHHHHTT-----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             HHHHhcc-----------------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHH
Confidence            1111111                       111123456899999999999999999999999984  444443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-44  Score=324.62  Aligned_cols=252  Identities=15%  Similarity=0.152  Sum_probs=195.6

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCC-CCeee---------------
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKS-PHIIE---------------   75 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~---------------   75 (314)
                      +|+..+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.+.| ++...               
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            47888999999999999999999999999999874432 22334567789999998876 22111               


Q ss_pred             ------eeceecc-----CCeEEEEEecccccHHHHHH------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 021299           76 ------LIDAFPH-----KGNLHLVFEFMETDLETVIR------NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK  138 (314)
Q Consensus        76 ------~~~~~~~-----~~~~~iv~e~~~g~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~  138 (314)
                            +..++..     ....+++|+.+.|+|.+++.      .....+++..+..++.||+.||+|||++|++|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK  238 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  238 (413)
T ss_dssp             CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence                  1111111     23468899999999988884      224457888999999999999999999999999999


Q ss_pred             CCceEEecCCcEEEeeccceeeeCCCCCcccccccCccccCccccc---------CccCCCCcchHhhHHHHHHHHHhCC
Q 021299          139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF---------GAKQYGAGVDVWAAGCIFAELLNRR  209 (314)
Q Consensus       139 ~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~---------~~~~~~~~~Di~slG~ll~~ll~g~  209 (314)
                      |+||+++.++.+||+|||++...+..   .....| +.|+|||.+.         ....++.++||||||+++|+|++|.
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~  314 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD  314 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred             cceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999999999999875433   334456 8899999984         3355788999999999999999999


Q ss_pred             CccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh
Q 021299          210 PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (314)
Q Consensus       210 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell  289 (314)
                      .||...........+                                -.....+++++.+||.+||+.||++||++.+++
T Consensus       315 ~Pf~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          315 LPNTDDAALGGSEWI--------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             CCCCTTGGGSCSGGG--------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCCcchhhhHHHH--------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999765432211110                                001125689999999999999999999999999


Q ss_pred             cCccccccCcc
Q 021299          290 EHRFAKSFNGV  300 (314)
Q Consensus       290 ~h~~~~~~~~~  300 (314)
                      +||||+.+.+.
T Consensus       363 ~~~~~~~~~~~  373 (413)
T 3dzo_A          363 ETPEYEQLRTE  373 (413)
T ss_dssp             TSHHHHHHHHH
T ss_pred             hCHHHHHHHHH
Confidence            99999987544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=305.80  Aligned_cols=266  Identities=20%  Similarity=0.330  Sum_probs=202.6

Q ss_pred             HhhccceeeeCccccceEEEEE----ECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC--
Q 021299           11 ADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   84 (314)
                      .++|++.+.||+|++|.||++.    +..+|+.|++|.+....  ......+.+|+++++.++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            5779999999999999999998    45678999999987542  223345678999999999999999999875543  


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..++|||+++| +|.+++......+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            78999999975 99999988777799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          164 PDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       164 ~~~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ....   .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.....  .....   .+.......    
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~---~~~~~~~~~----  267 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRM---IGNDKQGQM----  267 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHH---HCTTCCTHH----
T ss_pred             cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHh---hccccchhh----
Confidence            4321   223446677999999876 5578999999999999999999988864311  11110   000000000    


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                        ...............+....+++++.+||.+||+.||++|||+.++++
T Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 --IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             --HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              000000000000011123457899999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-43  Score=306.19  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=194.1

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhh--cCCCCeeeeeceec---
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE--LKSPHIIELIDAFP---   81 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~---   81 (314)
                      ...+.++|++.+.||+|+||+||++.+  +|+.||+|++....     ......|.+++..  ++||||+++++++.   
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            455789999999999999999999976  58899999986432     2234456666665  78999999999853   


Q ss_pred             -cCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCceEEecCCcEE
Q 021299           82 -HKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH--------KKWVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        82 -~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~i~H~di~~~nil~~~~~~~~  151 (314)
                       .....++||||+.| +|.+++...  .+++..++.++.|++.||+|||        ++|++|+||||+||+++.++.++
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence             34568999999985 888888543  5999999999999999999999        99999999999999999999999


Q ss_pred             EeeccceeeeCCCCCc----ccccccCccccCcccccCcc-----CCCCcchHhhHHHHHHHHHhC----------CCcc
Q 021299          152 LADFGLARIFGSPDRR----FTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNR----------RPFL  212 (314)
Q Consensus       152 l~df~~~~~~~~~~~~----~~~~~~~~~y~sPE~~~~~~-----~~~~~~Di~slG~ll~~ll~g----------~~pf  212 (314)
                      |+|||.+.........    .....||+.|+|||.+.+..     .++.++||||||+++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999999876443322    22347899999999997633     234789999999999999999          7777


Q ss_pred             CCCC----cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH
Q 021299          213 QGSS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (314)
Q Consensus       213 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  288 (314)
                      ....    .............  .....+.                  .......++++.+|+.+||+.||.+|||++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQ--QRPNIPN------------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSC--CCCCCCG------------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccCCCCcchhhhhHHHhccC--CCCCCCh------------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            4422    2222222221111  1111110                  00011246789999999999999999999999


Q ss_pred             hc
Q 021299          289 LE  290 (314)
Q Consensus       289 l~  290 (314)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.4e-43  Score=320.22  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||.||++.+.. +..||+|.+.....   ....+.+|+++++.++||||+++++++.+ +..++||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            5789999999999999999998765 46799999976432   23467899999999999999999999866 6789999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Cc
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~  167 (314)
                      ||+.| +|.+++... +..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence            99985 899988653 3469999999999999999999999999999999999999999999999999998654322 12


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+........              
T Consensus       338 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--------------  402 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--------------  402 (452)
T ss_dssp             -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------------
T ss_pred             ccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence            233445678999999876 568999999999999999999 8999998887777666654321111              


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc--CccccccCc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKSFNG  299 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~~  299 (314)
                                   ...+++.+.+||.+||+.||++|||++++++  +.++.....
T Consensus       403 -------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          403 -------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence                         1246889999999999999999999999986  355554443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=300.04  Aligned_cols=243  Identities=28%  Similarity=0.402  Sum_probs=191.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||++.+.  ++.+++|.+...    .....+.+|+++++.++||||+++++++.+  ..++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            578999999999999999999864  688999998643    233467789999999999999999998864  378999


Q ss_pred             ecccc-cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCceEEecCCc-EEEeeccceeeeCC
Q 021299           91 EFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---KWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGS  163 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~Lh~---~~i~H~di~~~nil~~~~~~-~~l~df~~~~~~~~  163 (314)
                      ||+.| +|.+++.....  .++...++.++.|++.||+|||+   +|++|+||||+||+++.++. ++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99975 88888876543  47899999999999999999999   89999999999999998886 79999999976533


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .   .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||................+. .           
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~-----------  222 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-R-----------  222 (307)
T ss_dssp             ---------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-C-----------
T ss_pred             c---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-C-----------
Confidence            2   223458899999999976 67899999999999999999999999764433221111111111 1           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                   ......+++.+.++|.+||+.||++|||++++++
T Consensus       223 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 -------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         1112356899999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.7e-43  Score=303.37  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCc--ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      ...+.||+|++|+||++.+  ++..+++|++.....  .......+.+|+.+++.++||||+++++++.+.+..+++||+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            3449999999999999975  578999999976432  223345677899999999999999999999999999999999


Q ss_pred             cc-ccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC--c
Q 021299           93 ME-TDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--R  167 (314)
Q Consensus        93 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~--~  167 (314)
                      ++ |+|.+.+...  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            97 5888888643  34699999999999999999999999999999999999999999999999999987644322  2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      .....|++.|+|||.+.+  .++.++|+||||+++|+|++|.+||...........+.......... ++          
T Consensus       192 ~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----------  258 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-IE----------  258 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-HH----------
T ss_pred             ccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-hh----------
Confidence            234568999999998865  46899999999999999999999997755443332222221111000 00          


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                        ..............++.+.+++.+||+.||.+|||+++++++
T Consensus       259 --~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          259 --DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             --HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              000000111122346779999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=327.30  Aligned_cols=254  Identities=20%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             hhcccee-eeCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKRE-VLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~-~lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +++.+.+ .||+|+||.||++.+..  ++..||+|++.... .......+.+|+++++.++||||+++++++.. +..++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            3444555 89999999999997653  45679999997653 22334567899999999999999999999876 56899


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||+.| +|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            9999985 888888777777999999999999999999999999999999999999999999999999999765432221


Q ss_pred             ---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       168 ---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                         .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+..+....            
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------  559 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------------  559 (613)
T ss_dssp             ---------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC------------
T ss_pred             eeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence               122334578999999876 678999999999999999998 999999988887776665442111            


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHh---cCcccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL---EHRFAK  295 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell---~h~~~~  295 (314)
                                     ....+++++.+||.+||+.||++||++++++   ++.|+.
T Consensus       560 ---------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          560 ---------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ---------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                           1124689999999999999999999999974   444443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-42  Score=328.44  Aligned_cols=243  Identities=21%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             eeeCccccceEEEEEE--CCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||++.+  +.+++.||+|++............+.+|+++++.++||||+++++++.. +..++||||+.|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  4567899999998765555455678899999999999999999999864 457899999985


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC---ccccc
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---RFTHQ  171 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~  171 (314)
                       +|.+++... +.+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........   .....
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence             888888654 4699999999999999999999999999999999999999999999999999976543321   12233


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........                  
T Consensus       533 ~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------  593 (635)
T 4fl3_A          533 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC------------------  593 (635)
T ss_dssp             --CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC------------------
T ss_pred             CCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence            45678999999966 678999999999999999998 9999998888777766655422111                  


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                               ...+++++.+||.+||+.||++||++++|++
T Consensus       594 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          594 ---------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                     1246899999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-42  Score=302.66  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=191.1

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc--CCCCeeeeeceeccC-
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL--KSPHIIELIDAFPHK-   83 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~-   83 (314)
                      ...+.++|++.+.||+|+||.||++.+.  |+.||+|++.....     .....|.+++...  +||||+++++++... 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            4557899999999999999999999875  88999999864321     2333455555544  899999999998666 


Q ss_pred             ---CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCceEEecCCcEE
Q 021299           84 ---GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--------WVLHRDMKPNNLLIGSHGQLK  151 (314)
Q Consensus        84 ---~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~i~H~di~~~nil~~~~~~~~  151 (314)
                         ...++||||+.| +|.+++...  .+++..++.++.|++.||+|||++        |++|+||||+||+++.++.++
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence               789999999985 999988765  499999999999999999999998        999999999999999999999


Q ss_pred             EeeccceeeeCCCCCc----ccccccCccccCcccccCccCCCC------cchHhhHHHHHHHHHhC----------CCc
Q 021299          152 LADFGLARIFGSPDRR----FTHQVFARWYRAPELLFGAKQYGA------GVDVWAAGCIFAELLNR----------RPF  211 (314)
Q Consensus       152 l~df~~~~~~~~~~~~----~~~~~~~~~y~sPE~~~~~~~~~~------~~Di~slG~ll~~ll~g----------~~p  211 (314)
                      |+|||.+.........    .....|++.|+|||.+.+. ....      ++||||||+++|+|++|          ..|
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            9999999776433222    1245689999999999763 3333      49999999999999999          455


Q ss_pred             cCCCC----cHHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHH
Q 021299          212 LQGSS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ  287 (314)
Q Consensus       212 f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  287 (314)
                      |....    ...........  .......+.                  ......+++++.+||.+||+.||++|||+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCI--KKLRPSFPN------------------RWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT--SCCCCCCCG------------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhhcCCCCchhhhHHHHhh--hccCccccc------------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            53321    11111111111  000000000                  0001134677999999999999999999999


Q ss_pred             HhcC
Q 021299          288 ALEH  291 (314)
Q Consensus       288 ll~h  291 (314)
                      +++|
T Consensus       322 ll~~  325 (337)
T 3mdy_A          322 VKKT  325 (337)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=321.67  Aligned_cols=257  Identities=22%  Similarity=0.366  Sum_probs=210.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||.||++.+.. +..||+|++.....   ....+.+|+++++.++|+||+++++++.+ +..++||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            5789999999999999999998765 46799999976442   23467899999999999999999999866 6789999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Cc
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~  167 (314)
                      ||+.| +|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            99985 899988653 3468999999999999999999999999999999999999999999999999997653211 11


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+.......               
T Consensus       421 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------------  484 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------  484 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---------------
T ss_pred             ccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence            123345678999999876 568999999999999999999 899999887777766664432111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC--ccccccCcc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH--RFAKSFNGV  300 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h--~~~~~~~~~  300 (314)
                                  ....+++++.+||.+||+.||++|||+++|++.  .++.....+
T Consensus       485 ------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          485 ------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             ------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence                        112468899999999999999999999999863  455544443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.1e-42  Score=323.87  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=205.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCC---CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||+||+|.+..+   +..+++|.+..... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            57899999999999999999987653   45799998865322 223346778999999999999999999985 45689


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||+. |+|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            9999998 599999987777799999999999999999999999999999999999999999999999999986543221


Q ss_pred             -cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          167 -RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       167 -~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.......             
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  612 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------  612 (656)
T ss_dssp             -------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-------------
T ss_pred             eeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence             2223445678999999876 578999999999999999997 899999888777776665542111             


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                    ..+.+++.+.+||.+||..||++|||+.++++.
T Consensus       613 --------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          613 --------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                          123468999999999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-41  Score=297.65  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             ccHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhh--cCCCCeeeeeceeccC
Q 021299            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE--LKSPHIIELIDAFPHK   83 (314)
Q Consensus         6 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~   83 (314)
                      ....+.++|++.+.||+|++|+||++.+  +|+.||+|.+....     ...+.+|.++++.  ++||||+++++++...
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            4566789999999999999999999987  48899999986432     2345678888887  7899999999998766


Q ss_pred             C----eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCceEEecCCcE
Q 021299           84 G----NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH--------KKWVLHRDMKPNNLLIGSHGQL  150 (314)
Q Consensus        84 ~----~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~i~H~di~~~nil~~~~~~~  150 (314)
                      .    ..++||||+.| +|.+++...  .+++..++.++.|++.||.|||        +.|++|+||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    78999999986 999988764  4899999999999999999999        8999999999999999999999


Q ss_pred             EEeeccceeeeCCCCC----cccccccCccccCcccccCccC-----CCCcchHhhHHHHHHHHHhC----------CCc
Q 021299          151 KLADFGLARIFGSPDR----RFTHQVFARWYRAPELLFGAKQ-----YGAGVDVWAAGCIFAELLNR----------RPF  211 (314)
Q Consensus       151 ~l~df~~~~~~~~~~~----~~~~~~~~~~y~sPE~~~~~~~-----~~~~~Di~slG~ll~~ll~g----------~~p  211 (314)
                      +|+|||.+........    ......+++.|+|||.+.+...     ++.++||||||+++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999987654432    2234568999999999876322     23689999999999999999          667


Q ss_pred             cCCCCc----HHHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHH
Q 021299          212 LQGSSD----IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ  287 (314)
Q Consensus       212 f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  287 (314)
                      |.....    ..........  .......+..                  .....+++.+.+|+.+||+.||++|||+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCE--QKLRPNIPNR------------------WQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT--SCCCCCCCGG------------------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccccCcCcccHHHHHHHHHH--HHhCCCCccc------------------ccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence            754321    1222221111  0111111100                  001123567999999999999999999999


Q ss_pred             HhcC
Q 021299          288 ALEH  291 (314)
Q Consensus       288 ll~h  291 (314)
                      +++|
T Consensus       327 i~~~  330 (342)
T 1b6c_B          327 IKKT  330 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=304.86  Aligned_cols=244  Identities=18%  Similarity=0.239  Sum_probs=194.8

Q ss_pred             HhhccceeeeCccccceEEEE-----EECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC---CCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   82 (314)
                      .++|.+.+.||+|+||+||+|     .+..+++.||+|.+....     ...+..|+++++.+.   |+||+.+++++..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            478999999999999999999     467788999999986432     235567777777776   8999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-----------
Q 021299           83 KGNLHLVFEFME-TDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-----------  146 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----------  146 (314)
                      .+..++||||++ |+|.+.+..    ....+++..++.++.||+.||+|||++|++|+||||+||+++.           
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            999999999998 589888864    3456999999999999999999999999999999999999998           


Q ss_pred             CCcEEEeeccceeeeC--CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHH
Q 021299          147 HGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI  224 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~  224 (314)
                      ++.+||+|||++....  ..........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........    
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence            8999999999998653  22334455678999999999977 5689999999999999999999998854322100    


Q ss_pred             HHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                                                .....+...  ..++.+.+++..||..+|.+|++..+.+.+.
T Consensus       294 --------------------------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          294 --------------------------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             --------------------------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             --------------------------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                                      000000000  2367899999999999999997765555443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=300.67  Aligned_cols=271  Identities=22%  Similarity=0.282  Sum_probs=188.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHH--HHHHHhhcCCCCeeeeecee-----ccC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR--EIKLLKELKSPHIIELIDAF-----PHK   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~--e~~~l~~l~~~~i~~~~~~~-----~~~   83 (314)
                      .++|++.+.||+|+||+||++.+  +++.||+|++.....     ..+..  ++..+..++||||+++++.+     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            58999999999999999999965  578999999964422     12233  44445558999999998743     334


Q ss_pred             CeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCceEEecCCcEEEe
Q 021299           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---------WVLHRDMKPNNLLIGSHGQLKLA  153 (314)
Q Consensus        84 ~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------~i~H~di~~~nil~~~~~~~~l~  153 (314)
                      ..+++||||++ |+|.+++....  .++..++.++.||+.||.|||+.         |++|+||||+||+++.++.+||+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            46789999997 49999887655  58899999999999999999999         99999999999999999999999


Q ss_pred             eccceeeeCCCC--------CcccccccCccccCcccccCc------cCCCCcchHhhHHHHHHHHHhCCCccCCCCc-H
Q 021299          154 DFGLARIFGSPD--------RRFTHQVFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-I  218 (314)
Q Consensus       154 df~~~~~~~~~~--------~~~~~~~~~~~y~sPE~~~~~------~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~-~  218 (314)
                      |||.+.......        .......||+.|+|||.+.+.      ..++.++||||||+++|+|++|..||..... .
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764321        122244689999999998752      3456789999999999999999765533211 1


Q ss_pred             HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCcc---CCCCCHHHHHHHhhhcccCCCCCCCHHHH------h
Q 021299          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL---FPSASDDALDLLSKMFTYDPKARITAQQA------L  289 (314)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el------l  289 (314)
                      ..........+..+     ....... ........+.+...   ...+++++.+||.+||+.||++|||++|+      +
T Consensus       243 ~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          243 EYQMAFQTEVGNHP-----TFEDMQV-LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCTTHHHHCSSC-----CHHHHHH-HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCc-----hHHHHHh-hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            00000000000000     0000000 00000000001111   11235679999999999999999999999      4


Q ss_pred             cCccccc
Q 021299          290 EHRFAKS  296 (314)
Q Consensus       290 ~h~~~~~  296 (314)
                      .++|-++
T Consensus       317 l~~~~~~  323 (336)
T 3g2f_A          317 MMIWERN  323 (336)
T ss_dssp             HHCCCC-
T ss_pred             HHHHHhc
Confidence            4566553

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.4e-43  Score=307.04  Aligned_cols=248  Identities=21%  Similarity=0.250  Sum_probs=189.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc------cCcchhhHHHHHHHhhcC---------C-----
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELK---------S-----   70 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~---------~-----   70 (314)
                      .++|++.+.||+|+||+||+|++  +|+.||+|++......      ......+.+|+.+++.++         |     
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            58999999999999999999987  6799999999876432      222245678999988886         4     


Q ss_pred             ------------CCeeeeeceecc-------------CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 021299           71 ------------PHIIELIDAFPH-------------KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL  124 (314)
Q Consensus        71 ------------~~i~~~~~~~~~-------------~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l  124 (314)
                                  |||+++++++.+             .+..++||||+.| ++++.+..  +.+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence                        555555555543             7889999999975 56666644  4589999999999999999


Q ss_pred             HHHH-hCCcccCCCCCCceEEecCC--------------------cEEEeeccceeeeCCCCCcccccccCccccCcccc
Q 021299          125 AFCH-KKWVLHRDMKPNNLLIGSHG--------------------QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL  183 (314)
Q Consensus       125 ~~Lh-~~~i~H~di~~~nil~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~  183 (314)
                      .||| ++|++|+||||+||+++.++                    .+||+|||++......     ...||+.|+|||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999887                    8999999999876432     34789999999999


Q ss_pred             cCccCCCCcchHhhHHHH-HHHHHhCCCccCCCCcHH-HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCC
Q 021299          184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDID-QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (314)
Q Consensus       184 ~~~~~~~~~~Di~slG~l-l~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (314)
                      .+..  +.++|||||+++ .++++.|..||....... ....+.........                     ......+
T Consensus       250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~  306 (336)
T 2vuw_A          250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK---------------------CNTPAMK  306 (336)
T ss_dssp             CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC---------------------CCSHHHH
T ss_pred             cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc---------------------cchhhhh
Confidence            7733  889999998766 677888999885422111 11222211111000                     0011122


Q ss_pred             CCCHHHHHHHhhhcccCCCCCCCHHHHh-cCcccc
Q 021299          262 SASDDALDLLSKMFTYDPKARITAQQAL-EHRFAK  295 (314)
Q Consensus       262 ~~~~~~~~li~~~l~~dp~~Rps~~ell-~h~~~~  295 (314)
                      .+++++.+||.+||+.|     |++|+| +||||+
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            45889999999999976     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.4e-40  Score=283.56  Aligned_cols=232  Identities=16%  Similarity=0.094  Sum_probs=185.1

Q ss_pred             ccH-HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            6 LSK-KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         6 ~~~-~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      .++ .+.++|++.+.||+|+||.||++.+..+|+.|++|.+....... .....+.+|+..++.++||||+++++++..+
T Consensus        24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR  103 (286)
T ss_dssp             TTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence            344 56789999999999999999999999999999999998654432 2234677899999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      +..|+||||++| +|.+++.. +  .....+..++.|++.||.|||++|++|+||||+||+++.++.++|++++      
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~-~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT-S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT-C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             CcEEEEEEecCCCCHHHHHhc-C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999985 88888743 2  4566788999999999999999999999999999999999999997433      


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                                    |++        .++.++||||||+++|+|++|..||...............               
T Consensus       175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~---------------  217 (286)
T 3uqc_A          175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD---------------  217 (286)
T ss_dssp             --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC---------------
T ss_pred             --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH---------------
Confidence                          333        3588999999999999999999999765432211000000               


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                            ..............+++++.++|.+||..||++| |++|+++
T Consensus       218 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          218 ------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                  0000111122335679999999999999999999 9999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.1e-42  Score=327.00  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             cccHHHHhhccceeeeCccccceEEEEEECC-CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         5 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      ..++.+.++|++.+.||+|+||+||++.+.. +|+.|++|.+..... ......+.+|+++++.++||||+++++++...
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            3445677999999999999999999999876 789999999865322 22233566899999999999999999998765


Q ss_pred             Ce-----EEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           84 GN-----LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        84 ~~-----~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      +.     .|+||||++| +|.+.+..   .+++..++.++.||+.||.|||++||+|+||||+||+++.+ .+||+|||.
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence            54     7999999986 66655443   59999999999999999999999999999999999999875 899999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      +......    ....||+.|+|||.+.+.  ++.++||||||+++|+|++|.+||......                ..+
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~  285 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP  285 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC
T ss_pred             chhcccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc
Confidence            9876433    345689999999998662  488999999999999999999888642110                000


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      ..                  ......++.+.+||.+||+.||++||+..+.+.|+|+.-.
T Consensus       286 ~~------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ED------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             TT------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cc------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            00                  0001136789999999999999999999999999998654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.6e-33  Score=261.49  Aligned_cols=184  Identities=16%  Similarity=0.051  Sum_probs=131.1

Q ss_pred             eCccccceEEEEEECCCCcEEEEEEeecCCccc--------CcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEEEE
Q 021299           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--------GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        20 lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .+.|+.|.+..++....|+.+++|.+.......        ....++.+|+++|+++ .|+||+++++++++++..|+||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456667777776666778999999998764322        2224567899999999 6999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+.+... +++++.   .|+.||+.||+|+|++||+||||||+|||++.+|++||+|||+++..........
T Consensus       322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99997 888888754 456654   5889999999999999999999999999999999999999999987765555556


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR  209 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~  209 (314)
                      ..+||+.|+|||++.+  .+..++|+||+|++++.+.++.
T Consensus       398 t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          398 NLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             CceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            6789999999999976  4577899999999888776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.2e-26  Score=215.49  Aligned_cols=185  Identities=17%  Similarity=0.171  Sum_probs=138.3

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc------chhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------NFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ...+.||+|+||+||++  ...+..+++|...........      ...+.+|+++++.++||||+++..+....+..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            45679999999999999  445778999987654322111      1235789999999999999965555556667799


Q ss_pred             EEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||++ |+|.+.+..         +..++.|++.||.|||++|++|+||||+||+++.  .+||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            999998 588888775         5689999999999999999999999999999998  9999999999987543221


Q ss_pred             -------ccccccCccccCcccccCc-cCCCCcchHhhHHHHHHHHHhCCCcc
Q 021299          168 -------FTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFL  212 (314)
Q Consensus       168 -------~~~~~~~~~y~sPE~~~~~-~~~~~~~Di~slG~ll~~ll~g~~pf  212 (314)
                             .....||+.|+|||++... ..|+...|+||..+-..+-+-+..++
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   1345789999999998641 23577889999988777766655443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.9e-23  Score=178.49  Aligned_cols=144  Identities=17%  Similarity=0.258  Sum_probs=112.5

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----------------cchhhHHHHHHHhhcCCCCeeeee
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----------------VNFTALREIKLLKELKSPHIIELI   77 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~   77 (314)
                      |.+.+.||+|++|.||+|.+ .+|+.+|+|.+........                ....+.+|+++++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            44559999999999999998 8899999999975432211                1234668999999998  4 6666


Q ss_pred             ceeccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeecc
Q 021299           78 DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        78 ~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                      +++.. +..++||||++| +|.+ +.       ......++.|++.||.+||++|++|+||||+||+++ ++.++|+|||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            65543 556999999986 7766 32       123457999999999999999999999999999999 9999999999


Q ss_pred             ceeeeCCCCCcccccccCccccCccccc
Q 021299          157 LARIFGSPDRRFTHQVFARWYRAPELLF  184 (314)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~sPE~~~  184 (314)
                      .+....             .+.|||.+.
T Consensus       238 ~a~~~~-------------~~~a~e~l~  252 (282)
T 1zar_A          238 QSVEVG-------------EEGWREILE  252 (282)
T ss_dssp             TCEETT-------------STTHHHHHH
T ss_pred             CCeECC-------------CCCHHHHHH
Confidence            997532             267888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=6e-21  Score=161.04  Aligned_cols=138  Identities=17%  Similarity=0.200  Sum_probs=106.2

Q ss_pred             ccceeeeCccccceEEEEEECCCCcE--EEEEEeecCCcccCc----------------------chhhHHHHHHHhhcC
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGV----------------------NFTALREIKLLKELK   69 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~--~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~   69 (314)
                      |.+.+.||+|++|.||+|.+..+|+.  +|+|+++........                      ...+.+|++.++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999998678888  999998654221110                      014568999999998


Q ss_pred             CCCe--eeeeceeccCCeEEEEEecccc------cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCC
Q 021299           70 SPHI--IELIDAFPHKGNLHLVFEFMET------DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPN  140 (314)
Q Consensus        70 ~~~i--~~~~~~~~~~~~~~iv~e~~~g------~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~i~H~di~~~  140 (314)
                      |+++  ..+++.    +..++||||+++      .|.+....    .++..+..++.|++.+|.+|| +.|++|+||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            8764  333322    356899999953      55554332    235577899999999999999 999999999999


Q ss_pred             ceEEecCCcEEEeeccceeee
Q 021299          141 NLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       141 nil~~~~~~~~l~df~~~~~~  161 (314)
                      ||+++.  .++|+|||++...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=3.7e-18  Score=150.05  Aligned_cols=139  Identities=17%  Similarity=0.189  Sum_probs=97.2

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc------------chh--------hHHHHHHHhhcCCCCe
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------------NFT--------ALREIKLLKELKSPHI   73 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~------------~~~--------~~~e~~~l~~l~~~~i   73 (314)
                      |.+.+.||+|++|.||+|.+ .+|+.+|+|+++........            ...        ..+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999986 46899999998654321100            000        1235556666644443


Q ss_pred             eeeeceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-----
Q 021299           74 IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----  148 (314)
Q Consensus        74 ~~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-----  148 (314)
                      ... ..+.. ...++||||++|..+..+.      +.+.+..++.||+.+|.+||+.|++|+||||.|||+++++     
T Consensus       176 ~vp-~p~~~-~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVP-EPIAQ-SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCC-CEEEE-ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCC-eeeec-cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            211 11111 1237999999984322221      1234567889999999999999999999999999998876     


Q ss_pred             -----cEEEeeccceeee
Q 021299          149 -----QLKLADFGLARIF  161 (314)
Q Consensus       149 -----~~~l~df~~~~~~  161 (314)
                           .+.|+||+.+...
T Consensus       248 ~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECCCTTCEET
T ss_pred             cccccceEEEEeCCcccC
Confidence                 3899999988754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=1.3e-12  Score=109.94  Aligned_cols=140  Identities=12%  Similarity=0.139  Sum_probs=108.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .+.|++...++.|+.+.||++...  +..+++|.........  ...+.+|+++++.+. +..+.+++++....+..|+|
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            477999999999999999999643  6799999987532111  224668999999885 56677888888888899999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK---------------------------------------  129 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------  129 (314)
                      ||+++| ++.+...      +......++.+++.+++.||+                                       
T Consensus        89 ~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999998 5544321      123345788899999999998                                       


Q ss_pred             --------------------CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 --------------------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 --------------------~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                                          ..++|+|++|.||+++.++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                4489999999999998765667999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=1.3e-11  Score=103.47  Aligned_cols=135  Identities=13%  Similarity=0.041  Sum_probs=96.4

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeeceeccCCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHKGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv   89 (314)
                      ..|.+....+.|..+.||++. ..+|..+++|.....     ....+..|+..++.+.+.+  +.+++++...++..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            345554444567779999995 456778999997543     1124568889888886544  45577777777889999


Q ss_pred             EecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 021299           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--------------------------------------  131 (314)
Q Consensus        90 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------  131 (314)
                      ||+++|..+. ..    ..+   ...++.+++.+++.||+..                                      
T Consensus        94 ~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999984333 11    111   2356677777788888643                                      


Q ss_pred             --------------------cccCCCCCCceEEecCCcEEEeeccceee
Q 021299          132 --------------------VLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       132 --------------------i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                                          ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                99999999999998766667999998864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=9.3e-11  Score=103.27  Aligned_cols=142  Identities=18%  Similarity=0.249  Sum_probs=102.9

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEee--cCCcccCcchhhHHHHHHHhhcCC--CCeeeeeceeccC---CeEE
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHK---GNLH   87 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~   87 (314)
                      ..++.|+.|.++.||++...  +..+++|...  ...... ....+.+|+++++.+..  ..+.+++.++.+.   +..|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~-~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLP-SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCC-cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            35778999999999999643  4689999876  332111 12355689999998874  4467777777655   4589


Q ss_pred             EEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021299           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK--------------------------------------  129 (314)
Q Consensus        88 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------------------------------------  129 (314)
                      +|||+++|.....  ..-..++......++.+++.+|+.||+                                      
T Consensus       118 ~vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999999843211  112236788888999999999999997                                      


Q ss_pred             --------------------CCcccCCCCCCceEEecCCc--EEEeeccceeee
Q 021299          130 --------------------KWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIF  161 (314)
Q Consensus       130 --------------------~~i~H~di~~~nil~~~~~~--~~l~df~~~~~~  161 (314)
                                          ..++|+|+++.||+++.++.  +.|+||+.+..-
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                36899999999999987753  689999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=5.6e-10  Score=95.94  Aligned_cols=184  Identities=15%  Similarity=0.101  Sum_probs=116.7

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCC--eeeeeceeccCC---eEEEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPH--IIELIDAFPHKG---NLHLV   89 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~iv   89 (314)
                      .++.++.|..+.||++.     ..+++|.....    .....+..|++.++.+. +..  +..++......+   ..|+|
T Consensus        24 ~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eeEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            35678899999999983     56999986432    12235568999998874 322  333443332222   34789


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK---------------------------------------  129 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------  129 (314)
                      |++++| .+.....   ..++.+....++.+++..++.||+                                       
T Consensus        95 m~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999998 4433222   136777778888888888888885                                       


Q ss_pred             -------------------CCcccCCCCCCceEEec--CCcEEEeeccceeeeCCCCCcccccccCccccCcccccC--c
Q 021299          130 -------------------KWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG--A  186 (314)
Q Consensus       130 -------------------~~i~H~di~~~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~--~  186 (314)
                                         ..++|+|++|.||+++.  ++.+.|+||+.+................ .-.+|+....  .
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~  250 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHH
Confidence                               23699999999999998  4568899999987653321111000000 0022222110  0


Q ss_pred             cC-----------CCCcchHhhHHHHHHHHHhCCCcc
Q 021299          187 KQ-----------YGAGVDVWAAGCIFAELLNRRPFL  212 (314)
Q Consensus       187 ~~-----------~~~~~Di~slG~ll~~ll~g~~pf  212 (314)
                      .+           ...-.+.|+++.+++.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00           012258999999999999999765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=2.5e-07  Score=79.46  Aligned_cols=134  Identities=18%  Similarity=0.113  Sum_probs=89.0

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCC---Ceeeeecee-ccCCeEEEEEe
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP---HIIELIDAF-PHKGNLHLVFE   91 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~-~~~~~~~iv~e   91 (314)
                      .++.++.|....||++     |..+++|.....    .....+..|+++++.+.+.   .+..++.+. ...+..+++|+
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            3567888999999999     567999985321    1223566899999998652   244555554 34566789999


Q ss_pred             cccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 021299           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-----------------------------------------  129 (314)
Q Consensus        92 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------  129 (314)
                      +++| .+......   .++......++.++...|+.||+                                         
T Consensus        94 ~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           94 KVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             CCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             ccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9998 33332111   13444444455555555555543                                         


Q ss_pred             -------------------CCcccCCCCCCceEEec---CCc-EEEeeccceeee
Q 021299          130 -------------------KWVLHRDMKPNNLLIGS---HGQ-LKLADFGLARIF  161 (314)
Q Consensus       130 -------------------~~i~H~di~~~nil~~~---~~~-~~l~df~~~~~~  161 (314)
                                         ..++|+|++|.||+++.   ++. +.|+||+.+..-
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               23589999999999987   355 589999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.58  E-value=1.2e-06  Score=73.54  Aligned_cols=132  Identities=15%  Similarity=0.106  Sum_probs=91.1

Q ss_pred             eeCccccc-eEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceeccCCeEEEEEecccc-
Q 021299           19 VLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEFMET-   95 (314)
Q Consensus        19 ~lg~g~~g-~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~g-   95 (314)
                      .+..|..+ .||+......+..+++|.-....     ...+..|...++.+. +--+.+++.+..+.+..++||++++| 
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445444 69999877778899999876432     224557888888874 22356677777888899999999998 


Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---------------------------------------------  130 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------------  130 (314)
                      ++.+.....     ......+..++...|+.||+.                                             
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            444433221     122234555666666666621                                             


Q ss_pred             -------------CcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          131 -------------WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       131 -------------~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                                   .++|+|+++.||+++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         168999999999998877778999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.41  E-value=4.8e-06  Score=66.46  Aligned_cols=99  Identities=16%  Similarity=0.064  Sum_probs=68.5

Q ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccccC
Q 021299           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (314)
Q Consensus        96 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  174 (314)
                      +|.+.++..+.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|.|...+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            7999999999999999999999999999887732 1212333567899999999988863 1110            112


Q ss_pred             ccccCcccccCccCCCCcchHhhHHHHHHHHHhCC
Q 021299          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR  209 (314)
Q Consensus       175 ~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~  209 (314)
                      ..+.|||...  ...+.+.=|||||+++|..+--.
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            2377888763  24468889999999999998554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=4.3e-06  Score=74.33  Aligned_cols=78  Identities=17%  Similarity=0.144  Sum_probs=48.5

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCc--c---cCcchhhHHHHHHHhhcCC--CCe-eeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--K---EGVNFTALREIKLLKELKS--PHI-IELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~--~---~~~~~~~~~e~~~l~~l~~--~~i-~~~~~~~~~~~~~~   87 (314)
                      ..+.||.|..+.||++....++..+++|.......  .   .........|.+.++.+..  +.. .+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46789999999999997655678899998754321  0   1122344578888887742  333 344433  233457


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      +|||+++|
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            99999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=1e-06  Score=77.14  Aligned_cols=80  Identities=5%  Similarity=0.034  Sum_probs=51.3

Q ss_pred             ceeee-CccccceEEEEEEC---C---CCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCC---CCeeeeeceeccC-
Q 021299           16 KREVL-GEGTYGVVYKAIDT---K---TGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKS---PHIIELIDAFPHK-   83 (314)
Q Consensus        16 ~~~~l-g~g~~g~vy~~~~~---~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~-   83 (314)
                      ..+.| +.|..+.+|++...   .   ++..+++|....... .......+..|+..++.+..   -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35677 88999999998643   0   256899998654320 00011245578888887742   2455666665444 


Q ss_pred             --CeEEEEEecccc
Q 021299           84 --GNLHLVFEFMET   95 (314)
Q Consensus        84 --~~~~iv~e~~~g   95 (314)
                        +..++|||+++|
T Consensus       104 ~~g~~~~v~e~l~G  117 (357)
T 3ats_A          104 VLGTPFFLMDYVEG  117 (357)
T ss_dssp             TTSSCEEEEECCCC
T ss_pred             ccCCceEEEEecCC
Confidence              456899999987

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=4.4e-06  Score=72.50  Aligned_cols=31  Identities=23%  Similarity=0.361  Sum_probs=28.1

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      ..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            6799999999999998888999999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.98  E-value=0.00013  Score=62.18  Aligned_cols=71  Identities=14%  Similarity=0.183  Sum_probs=44.9

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeEEEEEec
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~   92 (314)
                      +.-++.|+.|....+|++      ..+++|.........   .....|+..++.+...++ .+++....  ...++++++
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~   88 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRY   88 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEEC
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEee
Confidence            444788999999999999      469999886542211   122367777777753333 34444433  234689999


Q ss_pred             c-cc
Q 021299           93 M-ET   95 (314)
Q Consensus        93 ~-~g   95 (314)
                      + +|
T Consensus        89 i~~g   92 (301)
T 3dxq_A           89 IAGA   92 (301)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            9 66

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=9.5e-05  Score=66.17  Aligned_cols=33  Identities=9%  Similarity=0.205  Sum_probs=28.8

Q ss_pred             HhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299          128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       128 h~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      +...++|+|++|.||+++.++ +.++||+.+..-
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            356799999999999998776 999999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.65  E-value=0.00035  Score=59.76  Aligned_cols=74  Identities=20%  Similarity=0.117  Sum_probs=55.8

Q ss_pred             cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC---CCCeeeeeceeccCCeEEEEEe
Q 021299           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      .-.+.|+.|....+|++..  ++..+++|......     ...+..|++.++.+.   ...+.+++.+....+..++|||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            3457789999999999964  46789999876431     234557888888874   2457777777777788999999


Q ss_pred             cccc
Q 021299           92 FMET   95 (314)
Q Consensus        92 ~~~g   95 (314)
                      +++|
T Consensus       112 ~l~G  115 (312)
T 3jr1_A          112 ALNK  115 (312)
T ss_dssp             CCCC
T ss_pred             eccC
Confidence            9987

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.61  E-value=0.00037  Score=60.18  Aligned_cols=32  Identities=28%  Similarity=0.376  Sum_probs=28.1

Q ss_pred             CCcccCCCCCCceEEecC----CcEEEeeccceeee
Q 021299          130 KWVLHRDMKPNNLLIGSH----GQLKLADFGLARIF  161 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~----~~~~l~df~~~~~~  161 (314)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    68999999999765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.60  E-value=0.00023  Score=61.07  Aligned_cols=138  Identities=14%  Similarity=0.075  Sum_probs=75.4

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeece------eccCCeEEE
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA------FPHKGNLHL   88 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~i   88 (314)
                      ++.|+.|....+|++...  +..+++|.......    ...+..|..+++.+...+  +.+++..      ....+..++
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            456778888999999653  33799999875311    123445777776664222  2223321      122356789


Q ss_pred             EEecccccH---------------HHHHHhC--C--CC----CCHHHHHH---------------HHHHHHHHHHHHHh-
Q 021299           89 VFEFMETDL---------------ETVIRNT--N--IF----LSPADIKS---------------YMQMTLKGLAFCHK-  129 (314)
Q Consensus        89 v~e~~~g~l---------------~~~~~~~--~--~~----l~~~~~~~---------------i~~~i~~~l~~Lh~-  129 (314)
                      ++++++|..               +..++..  .  ..    ........               +...+...+..+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998731               1111111  0  00    11110000               00113334444542 


Q ss_pred             ------CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 ------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ------~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                            .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  4689999999999998876668999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.60  E-value=0.00023  Score=63.78  Aligned_cols=72  Identities=11%  Similarity=0.135  Sum_probs=48.0

Q ss_pred             ceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   87 (314)
                      .++.|+.|....+|++....       .+..+++|+....    .....+..|..+++.+...++ .++++.+.+    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            46778899999999997542       2578999998432    111244478888888754444 445555432    2


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            88999986

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.60  E-value=0.00019  Score=63.15  Aligned_cols=138  Identities=14%  Similarity=0.187  Sum_probs=79.4

Q ss_pred             ceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   87 (314)
                      -++.|..|-...+|++....       ++..+++|......   .......+|.++++.+...++ .++++.+.+ +   
T Consensus        54 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-g---  126 (379)
T 3feg_A           54 RVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE-G---  126 (379)
T ss_dssp             CCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-E---
T ss_pred             EEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-c---
Confidence            45678888899999997532       35789999863321   122344578888888753333 445555543 2   


Q ss_pred             EEEeccccc-HH----------HH-------HHhCC----CCCC--HHHHHHHHHHHHH-------------------HH
Q 021299           88 LVFEFMETD-LE----------TV-------IRNTN----IFLS--PADIKSYMQMTLK-------------------GL  124 (314)
Q Consensus        88 iv~e~~~g~-l~----------~~-------~~~~~----~~l~--~~~~~~i~~~i~~-------------------~l  124 (314)
                      +|+||++|. +.          ..       ++...    +...  ..++..+..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            899999872 10          01       11111    1111  3445555544321                   12


Q ss_pred             HHHH----h----CCcccCCCCCCceEEecC----CcEEEeeccceee
Q 021299          125 AFCH----K----KWVLHRDMKPNNLLIGSH----GQLKLADFGLARI  160 (314)
Q Consensus       125 ~~Lh----~----~~i~H~di~~~nil~~~~----~~~~l~df~~~~~  160 (314)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2222    2    258999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.36  E-value=0.0016  Score=58.78  Aligned_cols=73  Identities=19%  Similarity=0.208  Sum_probs=47.5

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeEEEEEeccc
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEFME   94 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~   94 (314)
                      .++.|+.|-...+|++.....+..+++|+...... ...  ....|..+++.+...++ .++++.+.  +.  .|++|++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~i--dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EII--NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCS--CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhc--CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence            46788899999999997654457899998754321 111  22478888988876555 34555553  22  5999998


Q ss_pred             c
Q 021299           95 T   95 (314)
Q Consensus        95 g   95 (314)
                      |
T Consensus       185 G  185 (458)
T 2qg7_A          185 G  185 (458)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.35  E-value=0.0021  Score=54.20  Aligned_cols=78  Identities=12%  Similarity=0.040  Sum_probs=52.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCC---CeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP---HIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~   87 (314)
                      +.+..-++.+|.|..+.||++.. .+|+.+++|.........  ...+..|++.|+.+...   -+.++++.  +  ..+
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~   86 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRT   86 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cce
Confidence            45667788999999999999974 568899999876443221  22355788888888532   23334433  1  236


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      ++||++.+
T Consensus        87 lv~e~l~~   94 (288)
T 3f7w_A           87 LAMEWVDE   94 (288)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeecc
Confidence            88998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.30  E-value=0.0013  Score=57.58  Aligned_cols=73  Identities=12%  Similarity=0.210  Sum_probs=42.9

Q ss_pred             ceeeeCccccceEEEEEECC--------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeE
Q 021299           16 KREVLGEGTYGVVYKAIDTK--------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNL   86 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   86 (314)
                      .++.|+.|....+|++....        .+..+++|.........   .....|.++++.+...++ .++++..  .+  
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            46678889899999997543        12689999875432111   123467777777754343 3455443  22  


Q ss_pred             EEEEecccc
Q 021299           87 HLVFEFMET   95 (314)
Q Consensus        87 ~iv~e~~~g   95 (314)
                      ++|+++++|
T Consensus       110 ~~v~e~i~G  118 (369)
T 3c5i_A          110 GRIEEWLYG  118 (369)
T ss_dssp             EEEEECCCS
T ss_pred             cEEEEEecC
Confidence            689999987

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.20  E-value=0.0047  Score=52.93  Aligned_cols=138  Identities=15%  Similarity=0.132  Sum_probs=77.2

Q ss_pred             eeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeece-----eccCCeEEEE
Q 021299           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA-----FPHKGNLHLV   89 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~iv   89 (314)
                      +..++ |....||++.. .+|+.+++|.......   ....+..|...++.+...+  +.+++..     ...++..+++
T Consensus        31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            34566 77889999853 3466899999864321   1224456777777764322  3333332     1224566889


Q ss_pred             Eeccccc------HHH---------HHHh---CC-----CCCCHHHH----------------------HHHHHHHHHHH
Q 021299           90 FEFMETD------LET---------VIRN---TN-----IFLSPADI----------------------KSYMQMTLKGL  124 (314)
Q Consensus        90 ~e~~~g~------l~~---------~~~~---~~-----~~l~~~~~----------------------~~i~~~i~~~l  124 (314)
                      +++++|.      ...         .++.   ..     ...+....                      ...+..++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999872      110         1111   00     01121110                      11112222222


Q ss_pred             HHH----HhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299          125 AFC----HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       125 ~~L----h~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ..+    ....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            222    234589999999999998 4 8999999888643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.12  E-value=0.012  Score=50.90  Aligned_cols=32  Identities=19%  Similarity=0.390  Sum_probs=28.6

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999888764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.82  E-value=0.009  Score=53.24  Aligned_cols=73  Identities=14%  Similarity=0.157  Sum_probs=47.2

Q ss_pred             ceeeeCccccceEEEEEECCC-------CcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-eeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~   87 (314)
                      -++.+..|-...+|++.....       +..+++|........ ..  ...+|.++++.+...++ .++++.+.  +  +
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~i--dR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FY--DSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CC--CHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hc--CHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            567788899999999976521       578999997543211 11  23468888887753333 34444332  2  6


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      .|++|++|
T Consensus       147 ~I~efI~G  154 (424)
T 3mes_A          147 RIEEFIDG  154 (424)
T ss_dssp             EEEECCCS
T ss_pred             EEEEEeCC
Confidence            88999987

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.50  E-value=0.01  Score=52.53  Aligned_cols=30  Identities=27%  Similarity=0.381  Sum_probs=25.5

Q ss_pred             cccCCCCCCceEEe------cCCcEEEeeccceeee
Q 021299          132 VLHRDMKPNNLLIG------SHGQLKLADFGLARIF  161 (314)
Q Consensus       132 i~H~di~~~nil~~------~~~~~~l~df~~~~~~  161 (314)
                      ++|+|+.+.||++.      +++.+.++||.+|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            68999999999994      4567999999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.28  E-value=3.1  Score=32.97  Aligned_cols=83  Identities=12%  Similarity=0.159  Sum_probs=57.7

Q ss_pred             cCCCCeeeeeceeccCCeEEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           68 LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        68 l~~~~i~~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ..||++++. .+-++++.+.+.++.-+ +.....++.    .+....+.++.+|+....++  ..-+|--|+|+|++++.
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            368988877 45556666666665544 322232332    67888899999998766333  33457889999999999


Q ss_pred             CCcEEEeeccc
Q 021299          147 HGQLKLADFGL  157 (314)
Q Consensus       147 ~~~~~l~df~~  157 (314)
                      ++.+++.=-|.
T Consensus       115 ~~~p~i~~RGi  125 (215)
T 4ann_A          115 DGLPIAKTRGL  125 (215)
T ss_dssp             TSCEEESCCEE
T ss_pred             CCCEEEEEccC
Confidence            99999975553

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.71  E-value=0.14  Score=46.18  Aligned_cols=62  Identities=15%  Similarity=0.073  Sum_probs=15.9

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEE------EEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAI------KKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~i------K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      +.+.||   ||.||.+.......+||+      |..............+.++..+.+.++|+|+++.+++-
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            345565   999999987655557777      66554333333334566788888888999999887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	314
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-96
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-87
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-87
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-85
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-82
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-79
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-77
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-77
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-76
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-75
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-75
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-73
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-72
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-72
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-71
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-71
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-68
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-68
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-68
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-67
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-59
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-58
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-56
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-53
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-51
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-50
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-26

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  284 bits (726), Expect = 5e-96
 Identities = 165/279 (59%), Positives = 210/279 (75%), Gaps = 3/279 (1%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHII 74
           + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+EL  P+II
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
            L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + H+ W+LH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLFGA+ YG GVD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           +WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV ++     
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
           PL  +F +A DD LDL+  +F ++P ARITA QAL+ ++
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (666), Expect = 5e-87
 Identities = 139/289 (48%), Positives = 181/289 (62%), Gaps = 2/289 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  +    +    IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
             A      + P   +D   LLS+M  YDP  RI+A+ AL H F +   
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  260 bits (664), Expect = 6e-87
 Identities = 131/283 (46%), Positives = 179/283 (63%), Gaps = 2/283 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA +   G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQY 250
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y   +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
               P  S      +  +DLLSKM   DP  RITA+QALEH +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  256 bits (655), Expect = 2e-85
 Identities = 136/288 (47%), Positives = 180/288 (62%), Gaps = 2/288 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 192 GVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q 249
            +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           Y A   L ++ P  +    DLL  +   +P  RI+A++AL+H +   F
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (638), Expect = 2e-82
 Identities = 123/301 (40%), Positives = 171/301 (56%), Gaps = 16/301 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 72  HIIELIDAF--------PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LI+            KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG----SPDRRFTHQVFARWYRA 179
           L + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+T++V   WYR 
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 240 AYLPDYVEYQYVAAP----PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                Y + + V         R         ALDL+ K+   DP  RI +  AL H F  
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

Query: 296 S 296
           S
Sbjct: 310 S 310

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 2e-79
 Identities = 104/299 (34%), Positives = 150/299 (50%), Gaps = 14/299 (4%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +       LREIK+L   +
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFR 64

Query: 70  SPHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           +++LV   M  DL  +++  +  LS   I  ++   L+GL
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGL 122

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWYRAPE 181
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+           T  V  RWYRAPE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G+ +      +  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 242 LPDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           L      +   +    P   LFP+A   ALDLL KM T++P  RI  +QAL H + + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  238 bits (608), Expect = 2e-77
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 31/292 (10%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +       +EI+ +  L+
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMSVLR 81

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 199

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +       S +  +       
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI------- 252

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                            S+D  D + K+   DP  R+T  QALEH +    N
Sbjct: 253 -----------------SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 3e-77
 Identities = 81/318 (25%), Positives = 126/318 (39%), Gaps = 23/318 (7%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L  +    N   +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSP 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KK 130
           +I+    AF   G + +  E M+      +      +    +       +KGL +   K 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP+N+L+ S G++KL DFG++      D      V  R Y +PE L G   Y 
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYS 181

Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY- 248
              D+W+ G    E+   R P     +   +L       G A  +             Y 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 249 --------------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA 294
                           V  PP +      S +  D ++K    +P  R   +Q + H F 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 295 KSFNGVFVFVDFCSYLYS 312
           K  +     VDF  +L S
Sbjct: 302 KRSDA--EEVDFAGWLCS 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 5e-76
 Identities = 101/299 (33%), Positives = 151/299 (50%), Gaps = 14/299 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V   Y   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 69  KSPHIIELIDAFPHKG------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           +  ++I L+D F          + +LV  FM TDL  ++++    L    I+  +   LK
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLK 132

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEV 189

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +    +Y   VD+W+ GCI AE++  +   +GS  +DQL +I    GT        L   
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                      +      S+  +AS  A++LL KM   D + R+TA +AL H + +S +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 7e-76
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 32/287 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D +     LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHP 69

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L+DAF ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG----A 186
            ++HRD+K  N+L    G +KLADFG++       +R    +   ++ APE++       
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y    DVW+ G    E+    P     + +  L KI                      
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-------------------- 229

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                + PP  +     S +  D L K    +  AR T  Q L+H F
Sbjct: 230 -----SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 1e-75
 Identities = 97/302 (32%), Positives = 155/302 (51%), Gaps = 18/302 (5%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            +     Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE+++++
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMR 68

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYM 117
           +L   +I+ L   F   G       L+LV +++   +  V R+       L    +K YM
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW 176
               + LA+ H   + HRD+KP NLL+      LKL DFG A+     +   ++ + +R+
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY 187

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
            ++       ++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H F  
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

Query: 296 SF 297
             
Sbjct: 308 EL 309

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  233 bits (595), Expect = 1e-75
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 31/294 (10%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             V D Y   E LG G +GVV++ ++  TG+    K I      +   +T   EI ++ +
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQ 82

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           L  P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +GL  
Sbjct: 83  LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 127 CHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            H+  ++H D+KP N++  +     +K+ DFGLA    +PD           + APE++ 
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVD 201

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             +  G   D+WA G +   LL+      G  D++ L  +           +  +     
Sbjct: 202 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----- 255

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                              S +A D +  +   +P+ R+T   ALEH + K  +
Sbjct: 256 -------------------SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 3e-75
 Identities = 111/296 (37%), Positives = 160/296 (54%), Gaps = 13/296 (4%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            +Y     +GEG YG V+KA D K  G+ VA+K++R+   +EG+  + +RE+ +L+ L++
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 71  ---PHIIELIDAF-----PHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL 121
              P+++ L D         +  L LVFE ++ D    + +     +    IK  M   L
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           +GL F H   V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPE 185

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L     Y   VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           LP    +   +A P+        +   DLL K  T++P  RI+A  AL H + +  
Sbjct: 245 LPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 3e-73
 Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 28/284 (9%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + +   + LGEG YG V  A++  T + VA+K + + +  +       +EI + K L   
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHE 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++++           +L  E+            +I +   D + +    + G+ + H   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + HRD+KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VDVW+ G +   +L         SD  Q    +                        
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------------------ 219

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                   + +       L LL K+   +P ARIT     + R+
Sbjct: 220 -KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 7e-73
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 31/285 (10%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q +      + EI +++E K+P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+  +D++     L +V E++    L  V+  T +      I +  +  L+ L F H  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K YG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG 194

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ G +  E++   P     + +  L  I    GT        L           
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKL----------- 242

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK 295
                        S    D L++    D + R +A++ L+H+F K
Sbjct: 243 -------------SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 1e-72
 Identities = 59/289 (20%), Positives = 123/289 (42%), Gaps = 32/289 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++    +       +EI +L  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            +  +I+ L ++F     L ++FEF+   D+   I  +   L+  +I SY+    + L F
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 127 CHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            H   + H D++P N++  +     +K+ +FG AR     D          +Y       
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-- 175

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
                    D+W+ G +   LL+        ++   +  I  A  T     + ++     
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                              S +A+D + ++   + K+R+TA +AL+H +
Sbjct: 231 -------------------SIEAMDFVDRLLVKERKSRMTASEALQHPW 260

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 3e-72
 Identities = 104/299 (34%), Positives = 147/299 (49%), Gaps = 14/299 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 69  KSPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L       LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEI 189

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H +   ++
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (563), Expect = 3e-71
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 32/291 (10%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   K  EG   +   EI +L 
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLH 62

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           ++K P+I+ L D +   G+L+L+ + +   +L   I     F +  D    +   L  + 
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVK 121

Query: 126 FCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + H   ++HRD+KP NLL  S     ++ ++DFGL+++   P    +       Y APE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEV 180

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+   
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI--- 236

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                                SD A D +  +   DP+ R T +QAL+H +
Sbjct: 237 ---------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  220 bits (561), Expect = 9e-71
 Identities = 94/302 (31%), Positives = 156/302 (51%), Gaps = 25/302 (8%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-S 70
           D Y     LG G Y  V++AI+    + V +K ++  K+K+       REIK+L+ L+  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 89

Query: 71  PHIIELIDAF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           P+II L D    P      LVFE +  TD + + +     L+  DI+ YM   LK L +C
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 145

Query: 128 HKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H   ++HRD+KP+N++I   H +L+L D+GLA  +  P + +  +V +R+++ PELL   
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 204

Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           + Y   +D+W+ GC+ A ++ R+ PF  G  + DQL +I    GT     + D   +   
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 246 VEYQYVAAPPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
             +  +     R  +            S +ALD L K+  YD ++R+TA++A+EH +  +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

Query: 297 FN 298
             
Sbjct: 325 VV 326

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-70
 Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 32/283 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           + +     LG+G +G VY A + ++   +A+K +   + +K GV     RE+++   L+ 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P+I+ L   F     ++L+ E+                      +Y+      L++CH K
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + + 
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG-RMHD 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ G +  E L  +P  + ++  +   +I     T            PD+V    
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV---- 227

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                        ++ A DL+S++  ++P  R   ++ LEH +
Sbjct: 228 -------------TEGARDLISRLLKHNPSQRPMLREVLEHPW 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 6e-70
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 39/294 (13%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+ Y     +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK 
Sbjct: 3   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 71  PHIIELIDAF--PHKGNLHLVFEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           P+I+   D         L++V E+ E  DL +VI        +L    +   M      L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 125 AFCHKK-----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
             CH++      VLHRD+KP N+ +     +KL DFGLARI           V   +Y +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE +     Y    D+W+ GC+  EL    P     S  +  GKI               
Sbjct: 183 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------------- 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                            R +    SD+  +++++M       R + ++ LE+  
Sbjct: 227 ------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  214 bits (545), Expect = 2e-68
 Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 33/296 (11%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTAL 59
           +AE+         +     +G G++G VY A D +  + VAIKK+   GKQ        +
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +E++ L++L+ P+ I+    +  +    LV E+       ++      L   +I +    
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+GLA+ H   ++HRD+K  N+L+   G +KL DFG A I           V   ++ A
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMA 179

Query: 180 PELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           PE++      QY   VDVW+ G    EL  R+P L   + +  L  I          Q  
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNE 230

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
             A    +                  S+   + +       P+ R T++  L+HRF
Sbjct: 231 SPALQSGHW-----------------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  212 bits (540), Expect = 3e-68
 Identities = 75/300 (25%), Positives = 128/300 (42%), Gaps = 40/300 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           L+++   P+II+L D +       LVF+ M+  +L   +    + LS  + +  M+  L+
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
            +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE+
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEI 180

Query: 183 LFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +  +       YG  VD+W+ G I   LL   P       +  L  I +        +W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF 297
           D                         SD   DL+S+     P+ R TA++AL H F + +
Sbjct: 241 DY------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 5e-68
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIK 63
           + V D Y   E LG G + VV K  +  TG   A K I+  + K      +     RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           + + H   + H D+KP N+++        ++K+ DFGLA         F +      + A
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVA 184

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++   +  G   D+W+ G I   LL+      G +  + L  + A         + + 
Sbjct: 185 PEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN 298
                                   S  A D + ++   DPK R+T Q +L+H + K  +
Sbjct: 244 ------------------------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-67
 Identities = 64/299 (21%), Positives = 110/299 (36%), Gaps = 35/299 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLK 66
           KK  + +   ++LGEG++  V  A +  T +  AIK +      KE       RE  ++ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            L  P  ++L   F     L+    + +                   + Y    +  L +
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLF 184
            H K ++HRD+KP N+L+     +++ DFG A++     +  R    V    Y +PELL 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             K      D+WA GCI  +L+   P  +  ++     KI           +P+      
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EYDFPE------ 231

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS---FNGV 300
                                 A DL+ K+   D   R+  ++   +   K+   F  V
Sbjct: 232 -----------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 2e-66
 Identities = 97/313 (30%), Positives = 146/313 (46%), Gaps = 25/313 (7%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 65  LKELKSPHIIELIDAFPHKG------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F  +       +++LV E M+ +L  VI+          +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLY 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G      T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYR 185

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G       VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 239 L-AYLPDYVEYQ-YVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARIT 284
           L   + +YVE +   A      LFP +            +  A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 285 AQQALEHRFAKSF 297
              AL+H +   +
Sbjct: 305 VDDALQHPYINVW 317

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  201 bits (511), Expect = 9e-63
 Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 38/297 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKE 67
           + +    ++G G +G VY      TG+  A+K +       KQ E +       + L+  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
              P I+ +  AF     L  + + M   DL   +    +F S AD++ Y    + GL  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            H ++V++RD+KP N+L+  HG ++++D GLA  F       +       Y APE+L   
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQKG 180

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             Y +  D ++ GC+  +LL      +     D+  +I     T                
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSF------- 232

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN 298
                            S +   LL  +   D   R+      AQ+  E  F +S +
Sbjct: 233 -----------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-61
 Identities = 62/297 (20%), Positives = 119/297 (40%), Gaps = 40/297 (13%)

Query: 8   KKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LL 65
             + D Y +  +VLG G  G V +  + +T +  A+K ++   +       A RE++   
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHW 59

Query: 66  KELKSPHIIELIDAF----PHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQM 119
           +  + PHI+ ++D +      +  L +V E ++  +L + I+   +   +  +    M+ 
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARW 176
             + + + H   + HRD+KP NLL  S      LKL DFG A+   S +   T   +  +
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPY 178

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           Y APE+L   ++Y    D+W+ G I   LL   P    +  +     +            
Sbjct: 179 YVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--- 234

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRF 293
                                  +   S++   L+  +   +P  R+T  + + H +
Sbjct: 235 -----------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 1e-60
 Identities = 53/285 (18%), Positives = 109/285 (38%), Gaps = 31/285 (10%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +    + +G G++G VYK    K    VA+K + +             E+ +L++ +  
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+  +  +     L +V ++ E + L   +           +    + T +G+ + H K
Sbjct: 65  NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQ 188
            ++HRD+K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 189 --YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             Y    DV+A G +  EL+  +      ++ DQ+  +                      
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------------------- 223

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             +   +P L  +  +       L+++        R    Q L  
Sbjct: 224 --RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-60
 Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 39/290 (13%)

Query: 13  RYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK    +G G++  VYK +DT+T   VA  +++  K  +        E ++LK L+ P
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 72  HIIELIDAF----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +I+   D++      K  + LV E M +            +    ++S+ +  LKGL F 
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 128 HKK--WVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           H +   ++HRD+K +N+ I G  G +K+ D GLA +           +    + APE+  
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYE 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
              +Y   VDV+A G    E+           +  Q+                       
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------------- 221

Query: 245 YVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRF 293
              Y+ V +    + F   A  +  +++      +   R + +  L H F
Sbjct: 222 ---YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 5e-60
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 34/291 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK 69
           + ++  ++LG+G++G V+ A   KT Q  AIK ++       + V  T + +  L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +  +   F  K NL  V E++   DL   I++ + F   +    Y    + GL F H
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
            K +++RD+K +N+L+   G +K+ADFG+ +     D +         Y APE+L G ++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QK 179

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y   VD W+ G +  E+L  +    G  + +    I             D  + P ++  
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----------RMDNPFYPRWL-- 226

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRFAKSFN 298
                            +A DLL K+F  +P+ R+       +H   +  N
Sbjct: 227 ---------------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  189 bits (480), Expect = 3e-59
 Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 33/300 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLK 66
             ++DRY   E+LG G    V+ A D +  + VA+K +R    +         RE +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 67  ELKSPHIIELIDAF----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            L  P I+ + D      P     ++V E+++      I +T   ++P      +    +
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRA 179
            L F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE   G     A  DV++ GC+  E+L   P   G S +    +          ++   L
Sbjct: 183 PEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG 299
                                   S D   ++ K    +P+ R      +     +  NG
Sbjct: 242 ------------------------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-58
 Identities = 66/295 (22%), Positives = 106/295 (35%), Gaps = 46/295 (15%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT----ALREIKLLK 66
             +Y    +LG G +G VY  I       VAIK +   +  +            E+ LLK
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 67  ELKSPH--IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+    L+
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLE 121

Query: 123 GLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPE 179

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +   + +G    VW+ G +  +++      +   +I +    F                
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------------- 224

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS 296
                                 S +   L+       P  R T ++   H + + 
Sbjct: 225 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  184 bits (467), Expect = 8e-57
 Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 38/293 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
             +     LG G++G V+       G+  A+K ++     +         E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P II +   F     + ++ +++E      +   +        K Y       L + H K
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +++RD+KP N+L+  +G +K+ DFG A+                 Y APE++   K Y 
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-KPYN 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             +D W+ G +  E+L        S+ +    KI  A       ++P             
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----ELRFP------------- 221

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                     P  ++D  DLLS++ T D   R+       +    H + K   
Sbjct: 222 ----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-56
 Identities = 56/283 (19%), Positives = 107/283 (37%), Gaps = 35/283 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                 + +G G +G+V+          VAIK IR G   E      + E +++ +L  P
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +++L      +  + LVFEFME   L   +R      +   +        +G+A+  + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFGAKQY 189
            V+HRD+   N L+G +  +K++DFG+ R         +    F   + +PE+     +Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 190 GAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
            +  DVW+ G +  E+ +  +   +  S+ + +  I   F    P               
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA------------ 227

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                          S     +++  +   P+ R    + L  
Sbjct: 228 ---------------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-55
 Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 35/293 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           + +   ++LG+GT+G V    +  TG+  A+K +R      +      + E ++L+  + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P +  L  AF     L  V E+          +     +    + Y    +  L + H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 183

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD W  G +  E++  R              I          ++P             
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEIRFP------------- 225

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                      + S +A  LL+ +   DPK R+      A++ +EHRF  S N
Sbjct: 226 ----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 6e-54
 Identities = 51/284 (17%), Positives = 99/284 (34%), Gaps = 41/284 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                 + +G+G +G V        G  VA+K I+     +      L E  ++ +L+  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLRHS 60

Query: 72  HIIELIDAF-PHKGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCH 128
           ++++L+      KG L++V E+M    L   +R+     L    +  +     + + +  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
               +HRD+   N+L+      K++DFGL +   S             + APE L   K+
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE-KK 176

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  E+    R         D + ++   +    P   P          
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP---------- 226

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                +++   +  D   R +  Q  E 
Sbjct: 227 -----------------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 52/302 (17%), Positives = 100/302 (33%), Gaps = 39/302 (12%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G++G +Y   D   G+ VAIK   +  +   +      E K+ K +
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMM 59

Query: 69  KSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +    I  I     +G+ + +V E +   LE +    +   S   +       +  + + 
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 128 HKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPD-------RRFTHQVFARWY 177
           H K  +HRD+KP+N L+G       + + DFGLA+ +           R   +      Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            +     G  +     D+ + G +           QG     +  K              
Sbjct: 180 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----------- 227

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRFA 294
                      +   + P+  L      +    L+   +     +       Q   + F 
Sbjct: 228 ---------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 295 KS 296
           + 
Sbjct: 279 RQ 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 63/300 (21%), Positives = 119/300 (39%), Gaps = 37/300 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGK--QKEGVNFTALREIKLLK 66
           + +   +VLG G YG V+         TG+  A+K ++     QK         E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 67  ELK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            ++ SP ++ L  AF  +  LHL+ +++         +     +  +++ Y+   +  L 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT--HQVFARWYRAPELL 183
             HK  +++RD+K  N+L+ S+G + L DFGL++ F + +            +     + 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            G   +   VD W+ G +  ELL          + +   +I      + P    ++    
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM---- 259

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                               S  A DL+ ++   DPK R+      A +  EH F +  N
Sbjct: 260 --------------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-53
 Identities = 49/277 (17%), Positives = 97/277 (35%), Gaps = 35/277 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      +    VAIK I+ G   E      + E K++  L    +++L 
Sbjct: 10  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 65

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + ++ E+M    L   +R          +    +   + + +   K  LHRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +   N L+   G +K++DFGL+R     +        F   +  PE+L    ++ +  D+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDI 184

Query: 196 WAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           WA G +  E+ +  +   +  ++ +    I        P                     
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS----------------- 227

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                     +    ++   +      R T +  L +
Sbjct: 228 ----------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-52
 Identities = 57/292 (19%), Positives = 111/292 (38%), Gaps = 40/292 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           +     E LG G +G V+          VA+K ++ G          L E  L+K+L+  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQ 68

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            ++ L      +  ++++ E+ME     + +   + I L+   +        +G+AF  +
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +  +HRD++  N+L+      K+ADFGLAR+   +         F   + APE +     
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  E++ + R    G ++ + +  +   +    P   P          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP---------- 236

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ---ALEHRFAKS 296
                            ++   L+   +   P+ R T       LE  F  +
Sbjct: 237 -----------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (434), Expect = 3e-52
 Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 33/282 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                +  LG G YG VY+ +  K   TVA+K ++    +       L+E  ++KE+K P
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73

Query: 72  HIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           ++++L+     +   +++ EFM     L+ +       +S   +          + +  K
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  +HRD+   N L+G +  +K+ADFGL+R+  G          F   + APE L    +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           +    DVWA G +  E+           D+ Q+                          Y
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------------------Y 226

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
           + +             +   +L+   + ++P  R +  +  +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  170 bits (431), Expect = 1e-51
 Identities = 52/294 (17%), Positives = 92/294 (31%), Gaps = 38/294 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   Y     +GEG++GV+++  +    Q VAIK          +      E +  K L 
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLA 58

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
               I  +        +  LV + +   LE ++       S   +    +  L  +   H
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 129 KKWVLHRDMKPNNLLIGS-----HGQLKLADFGLARIFGSPD-------RRFTHQVFARW 176
           +K +++RD+KP+N LIG         + + DFG+ + +  P        R   +      
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           Y +     G ++     D+ A G +F   L      QG        K             
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--------- 228

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                       +   + PLR L     ++    +         A         
Sbjct: 229 -----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 61/293 (20%), Positives = 104/293 (35%), Gaps = 38/293 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           D++ + + LG G++G V      ++G   A+K +   K  K       L E ++L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P +++L  +F    NL++V E++               S    + Y    +    + H  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +++RD+KP NLLI   G +++ DFG A+                   APE++   K Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILS-KGYN 216

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD WA G +  E+    P       I    KI                  P +     
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-----------VSGKVRFPSHF---- 261

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN 298
                        S D  DLL  +   D   R             H++  + +
Sbjct: 262 -------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-51
 Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 35/303 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +A   + +E +G+G +G V++      G+ VA+K     +++    +    EI     L+
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS---WFREAEIYQTVMLR 55

Query: 70  SPHIIELIDAFPHKGN----LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +I+  I A          L LV ++ E   L   +      ++   +      T  GL
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGL 113

Query: 125 AFCH--------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP----DRRFTHQV 172
           A  H        K  + HRD+K  N+L+  +G   +AD GLA    S     D    H+V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 173 FARWYRAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
             + Y APE+L  +      +     D++A G +F E+  R        D          
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL------P 227

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
           +    PS            E +     P R     A      ++ + +  +  AR+TA +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 288 ALE 290
             +
Sbjct: 288 IKK 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 5e-51
 Identities = 57/294 (19%), Positives = 116/294 (39%), Gaps = 40/294 (13%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ + LG G +G V K      K  +TVA+K ++       +    L E  ++++L +P+
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ +I     + +  LV E  E          N  +   +I   +     G+ +  +   
Sbjct: 70  IVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQY 189
           +HRD+   N+L+ +    K++DFGL++   + +  +  Q   +W   + APE +    ++
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKF 187

Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            +  DVW+ G +  E  +  ++P+ +G    +    +        P+  P          
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCP---------- 236

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ---ALEHRFAKSFN 298
                             +  DL++  +TYD + R         L + +    N
Sbjct: 237 -----------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 8e-51
 Identities = 58/283 (20%), Positives = 113/283 (39%), Gaps = 37/283 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           +       LG+G +G V+      T + VAIK ++ G          L+E +++K+L+  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHE 72

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            +++L      +  +++V E+M     L+ +   T  +L    +         G+A+  +
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLFGAKQ 188
              +HRD++  N+L+G +   K+ADFGLAR+    +        F   + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  EL    R    G  + + L ++   +    P + P          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP---------- 240

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                            +   DL+ + +  +P+ R T +    
Sbjct: 241 -----------------ESLHDLMCQCWRKEPEERPTFEYLQA 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-50
 Identities = 58/285 (20%), Positives = 103/285 (36%), Gaps = 34/285 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +R      +GEG +G V++ I          VAIK  +     + V    L+E   +++ 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF 65

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             PHI++LI     +  + ++ E     +L + ++     L  A +  Y       LA+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             K  +HRD+   N+L+ S+  +KL DFGL+R           +               +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 188 QYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           ++ +  DVW  G    E+L       QG  + D +G+I                      
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------------- 225

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       + P+       L++K + YDP  R    +    
Sbjct: 226 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (424), Expect = 6e-50
 Identities = 76/324 (23%), Positives = 128/324 (39%), Gaps = 50/324 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDAD 70

Query: 70  --------SPHIIELIDAF----PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSY 116
                   + HI++L+D F    P+  ++ +VFE +    L  + +  +  +    +K  
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIGSHG------QLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+          Q+K+AD G A  +        
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGK 223
                R YR+PE+L G   +G G D+W+  C+  EL+      +         D D + +
Sbjct: 191 QT---REYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 224 IFAAFGTATPSQWPDLAYLPDYVE-------YQYVAAPPLRSLFPS-------ASDDALD 269
           I    G        +  Y   +            +   PL  +           + +  D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 270 LLSKMFTYDPKARITAQQALEHRF 293
            LS M   DP+ R  A   + H +
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPW 330

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-49
 Identities = 59/294 (20%), Positives = 118/294 (40%), Gaps = 43/294 (14%)

Query: 12  DRYLKREV-LGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           D  L  ++ LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQL 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            +P+I+ LI        L LV E      L   +      +  +++   +     G+ + 
Sbjct: 67  DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR---WYRAPELLF 184
            +K  +HRD+   N+L+ +    K++DFGL++  G+ D  +T +   +    + APE + 
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
             +++ +  DVW+ G    E L+  ++P+ +     + +  I        P + P     
Sbjct: 186 F-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP----- 238

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRF 293
                                  +   L+S  + Y  + R       Q +   +
Sbjct: 239 ----------------------PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-49
 Identities = 61/313 (19%), Positives = 109/313 (34%), Gaps = 62/313 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKIRLGKQKEGVNFTALREIKLLK 66
           +     +VLG G +G V  A      +T     VA+K ++            + E+K++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE-ALMSELKMMT 95

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTN------------------- 105
           +L S  +I+ L+ A    G ++L+FE+    DL   +R+                     
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 106 ---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG 162
                L+  D+  +     KG+ F   K  +HRD+   N+L+     +K+ DFGLAR   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 163 SPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDID 219
           S        +      + APE LF    Y    DVW+ G +  E+ +       G     
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYD 278
              K+                                +   P  A+++   ++   + +D
Sbjct: 275 NFYKLI---------------------------QNGFKMDQPFYATEEIYIIMQSCWAFD 307

Query: 279 PKARITAQQALEH 291
            + R +       
Sbjct: 308 SRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  162 bits (410), Expect = 2e-48
 Identities = 52/290 (17%), Positives = 105/290 (36%), Gaps = 39/290 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKEL 68
                 +V+G G +G V        G+    VAIK ++ G  ++      L E  ++ + 
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQF 84

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P++I L         + ++ EFME   L++ +R  +   +   +   ++    G+ + 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPEL 182
                +HRD+   N+L+ S+   K++DFGL+R         T+           + APE 
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +   +++ +  DVW+ G +  E+++         ++ D +  I   +    P   P    
Sbjct: 205 IQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP---- 259

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                       L+   +  D   R    Q +  
Sbjct: 260 -----------------------SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-48
 Identities = 48/288 (16%), Positives = 92/288 (31%), Gaps = 35/288 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKE 67
                 E LG+G++GVV +      +    +VA+K ++     +       +RE+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           L   ++I L         + +V E      L   +R          +  Y     +G+ +
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR--WYRAPELLF 184
              K  +HRD+   NLL+ +   +K+ DFGL R     D  +  Q   +  +        
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             + +    D W  G    E+    +    G +    L KI                   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------------- 227

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 D  +++ + + + P+ R T     + 
Sbjct: 228 -------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 7e-48
 Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 55/306 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R    + LG G +G V +A     I +    TVA+K ++            + E+K+L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MSELKVLS 81

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIR-----------------NTNIF 107
            L +  +I+ L+ A    G   ++ E+    DL   +R                 +  + 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR 167
           L   D+ S+     KG+AF   K  +HRD+   N+L+      K+ DFGLAR   +    
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 168 F--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
               +      + APE +F    Y    DVW+ G    EL +                  
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGS--------------- 245

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARIT 284
                           +P   ++  +     R L P  A  +  D++   +  DP  R T
Sbjct: 246 -----------SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294

Query: 285 AQQALE 290
            +Q ++
Sbjct: 295 FKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-47
 Identities = 50/287 (17%), Positives = 104/287 (36%), Gaps = 34/287 (11%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLK 66
              + K +VLG G +G VYK +    G+     VAIK++R     +      L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            + +PH+  L+          +        L   +R     +    + ++     KG+ +
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRAPELLF 184
              + ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +       + A E + 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             + Y    DVW+ G    EL+             ++                       
Sbjct: 187 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------------- 222

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +         P  + D   ++ K +  D  +R   ++ +  
Sbjct: 223 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-47
 Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 50/300 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +    ++V+GEG +G V KA   K G     AIK+++    K+        E+++L +L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLG 68

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------------LSPAD 112
             P+II L+ A  H+G L+L  E+    +L   +R + +                LS   
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           +  +     +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTA 231
             RW     L +    Y    DVW+ G +  E+++       G +  +   K+   +   
Sbjct: 189 PVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P                               D+  DL+ + +   P  R +  Q L  
Sbjct: 247 KPLNC---------------------------DDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 3e-47
 Identities = 59/311 (18%), Positives = 115/311 (36%), Gaps = 61/311 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +       +GEG +G V++A     +  +    VA+K ++     +       RE  L+ 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMA 71

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF------------------ 107
           E  +P+I++L+        + L+FE+M   DL   +R+ +                    
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 108 -----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG 162
                LS A+     +    G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 163 SPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDID 219
           S D  +   +      +  PE +F   +Y    DVWA G +  E+ +       G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP 279
            +                            YV    + +   +   +  +L+   ++  P
Sbjct: 251 VI---------------------------YYVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 280 KARITAQQALE 290
             R +      
Sbjct: 284 ADRPSFCSIHR 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-47
 Identities = 58/307 (18%), Positives = 115/307 (37%), Gaps = 42/307 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLG-KQKEGVNFTALREIKLLK 66
               +++V+G G +G VYK +   +       VAIK ++ G  +K+ V+F  L E  ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMG 64

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +    +II L         + ++ E+ME    +  +R  +   S   +   ++    G+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWYRAPEL 182
           +      +HRD+   N+L+ S+   K++DFGL+R+           +       + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +   K   A  DVW+ G +  E++          S+ + +  I   F   TP   P    
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP---- 239

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKSFNG 299
                                       L+ + +  +   R      +    +  ++ + 
Sbjct: 240 -----------------------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

Query: 300 VFVFVDF 306
           +    DF
Sbjct: 277 LKTLADF 283

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 6e-47
 Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 39/284 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           EV+G G +G VY              A+K +        V+   L E  ++K+   P+++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 91

Query: 75  ELIDA-FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----RRFTHQVFARWYRAPELLFGAKQ 188
           +HRD+   N ++     +K+ADFGLAR     +       T       + A E L   K 
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
                DVW+ G +  EL+    P     +  D    +        P   P          
Sbjct: 212 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP---------- 260

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                            D   +++ K +    + R +  + +  
Sbjct: 261 -----------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 4e-44
 Identities = 54/298 (18%), Positives = 105/298 (35%), Gaps = 47/298 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++      LG+G++G+VY+ +       +    VAIK +             L E  ++K
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMK 78

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------LSPADIKSY 116
           E    H++ L+          ++ E M   DL++ +R+              S + +   
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA 174
                 G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +  
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP 233
             + +PE L     +    DVW+ G +  E+        QG S+   L  +         
Sbjct: 199 VRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------- 249

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 L     +  D   +L+   + Y+PK R +  + +  
Sbjct: 250 -------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-43
 Identities = 62/306 (20%), Positives = 120/306 (39%), Gaps = 54/306 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G V  A               VA+K ++    ++ ++   + E+++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 71

Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+    +L   ++               N    
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
           ++ T+      + APE LF  + Y    DVW+ G +  E+            +++L    
Sbjct: 192 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 246

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                 ++ +          + +++   ++   +   P  R T 
Sbjct: 247 ----------------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284

Query: 286 QQALEH 291
           +Q +E 
Sbjct: 285 KQLVED 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-42
 Identities = 63/305 (20%), Positives = 109/305 (35%), Gaps = 52/305 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           DR    + LG G +G V +A       T T +TVA+K ++ G               L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 67  ELKSPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRN---------------TNIFLS 109
                +++ L+ A    G  L ++ EF +  +L T +R+                  FL+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RR 167
              +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR         R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFA 226
                    + APE +F  + Y    DVW+ G +  E+ +       G    ++  +   
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL- 250

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                   +       PDY                  + +    +   +  +P  R T  
Sbjct: 251 --------KEGTRMRAPDYT-----------------TPEMYQTMLDCWHGEPSQRPTFS 285

Query: 287 QALEH 291
           + +EH
Sbjct: 286 ELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  100 bits (250), Expect = 3e-26
 Identities = 26/202 (12%), Positives = 68/202 (33%), Gaps = 41/202 (20%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK----------------QKEGVNFTALRE 61
           +++GEG    V+     +      +K  ++G                        +A  E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
            + L++L+   + ++     +     ++ E ++             +   +    + M L
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVLDMIL 113

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF----THQVFARWY 177
           + +A  + + ++H D+   N+L+   G + + DF  +   G    R       +    ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 178 RAPELLFGAKQYGAGVDVWAAG 199
                    + Y    D+ +A 
Sbjct: 173 S--------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	314
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.86
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.14

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=410.73  Aligned_cols=283  Identities=59%  Similarity=1.036  Sum_probs=244.8

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc---CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEec
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   92 (314)
                      .+++||+|+||+||+|+++.+|+.||+|++.......   .....+.+|+++++.++||||+++++++..+++.|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4689999999999999999999999999997654322   2234677999999999999999999999999999999999


Q ss_pred             ccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccccc
Q 021299           93 METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (314)
Q Consensus        93 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  172 (314)
                      +.|++...+...+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+..............
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            99988888877777899999999999999999999999999999999999999999999999999987766555555678


Q ss_pred             cCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcccc
Q 021299          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (314)
Q Consensus       173 ~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
                      ||+.|+|||++.....++.++|||||||++|+|++|.+||......+....+....+......++...............
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            99999999999876778999999999999999999999999999999999999999988888887766555554444444


Q ss_pred             CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       253 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..+.....+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            4445555677899999999999999999999999999999998654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-60  Score=403.49  Aligned_cols=258  Identities=29%  Similarity=0.484  Sum_probs=224.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++......  ....+.+|+++++.++||||+++++++.+++..|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            35899999999999999999999999999999999765332  3346779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+++...  .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...........
T Consensus        97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            99986 777766543  499999999999999999999999999999999999999999999999999998766555666


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhc
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........                 
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------------  236 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----------------  236 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------------
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence            7789999999999977 6789999999999999999999999998887777766655421111                 


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                              .....+++++.+||.+||+.||++|||++|+|+||||+.-.
T Consensus       237 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         237 --------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             --------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence                    11234699999999999999999999999999999998543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-60  Score=406.97  Aligned_cols=288  Identities=48%  Similarity=0.852  Sum_probs=245.5

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      |+|++++.||+|+||+||+|.+..+|+.||+|++............+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            78999999999999999999999999999999997766555556678899999999999999999999999999999999


Q ss_pred             cccccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcccc
Q 021299           92 FMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (314)
Q Consensus        92 ~~~g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  170 (314)
                      |+.|++.+.+.. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+............
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            999987777754 4567999999999999999999999999999999999999999999999999999887666666667


Q ss_pred             cccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh-hhc
Q 021299          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ  249 (314)
Q Consensus       171 ~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  249 (314)
                      ..|++.|+|||.+.....++.++|+||||+++|+|++|..||...+..+....+....+......++......... ...
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP  241 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence            7899999999998876777999999999999999999999999999999999998888877776666544333221 112


Q ss_pred             cccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...........+.+++++.+||++||+.||++|||++|+|+||||+.+.+
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            22223334445678999999999999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=404.23  Aligned_cols=261  Identities=26%  Similarity=0.366  Sum_probs=216.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|.+....... ....+.+|+++++.++||||+++++++.+++..|+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            3578999999999999999999999999999999997654322 234677999999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--C
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R  166 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~  166 (314)
                      |||++| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+......  .
T Consensus        82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999985 88877754 4469999999999999999999999999999999999999999999999999998764332  2


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|.+||...................               
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------  225 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------  225 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence            33456799999999999875556789999999999999999999997655443333322221110               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                ......+++++.+||.+||+.||++|||++|+|+||||++-
T Consensus       226 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         226 ----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             ----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                      11123568999999999999999999999999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=401.02  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=221.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+++++.++||||+++++++.+++..|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            37899999999999999999999999999999999765432 33444667899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| +|.+.+...+ .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.....  ...
T Consensus        85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--CCC
T ss_pred             EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--Ccc
Confidence            999985 8888877544 599999999999999999999999999999999999999999999999999976533  233


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......                  
T Consensus       162 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------  222 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------------  222 (263)
T ss_dssp             EETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------------------
T ss_pred             cccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            45678999999999987 66899999999999999999999999988877777766543111                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                                ....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       223 ----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 ----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                      11246899999999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-60  Score=402.81  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=224.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .|.|++++.||+|+||+||+|+++.+|..||+|++.....  .....+.+|+++++.++||||+++++++.+++..++||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            3679999999999999999999999999999999976532  23446779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~  169 (314)
                      ||++| +|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99985 78888777677799999999999999999999999999999999999999999999999999987644333444


Q ss_pred             ccccCccccCcccccC----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      ...||+.|+|||++..    ...++.++|||||||++|+|++|.+||......+....+........             
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------  235 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-------------  235 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-------------
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            5679999999999842    35578999999999999999999999999888887777665421110             


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                  .....+++++.+||.+||+.||++|||++|+++||||+.-
T Consensus       236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             ------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                        1123469999999999999999999999999999999853

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-60  Score=401.02  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=209.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--CCeEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHL   88 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~i   88 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|.+............+.+|++++++++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999998776555445567799999999999999999998843  567899


Q ss_pred             EEecccc-cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCceEEecCCcEEEeecccee
Q 021299           89 VFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKW-----VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----i~H~di~~~nil~~~~~~~~l~df~~~~  159 (314)
                      |||||+| +|.+++..   .+..+++..++.++.||+.||.|||++|     |+||||||+||+++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999985 88888754   3567999999999999999999999876     9999999999999999999999999998


Q ss_pred             eeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCc
Q 021299          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (314)
Q Consensus       160 ~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
                      .............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+.......        
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--------  233 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--------  233 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred             ecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            77555555556788999999999976 678999999999999999999999999888777777665542111        


Q ss_pred             CcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccc
Q 021299          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFA  294 (314)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  294 (314)
                                         ....+++++.+||.+||+.||++|||++|+|+|||+
T Consensus       234 -------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 -------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                               123468999999999999999999999999999996

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.9e-59  Score=399.08  Aligned_cols=284  Identities=46%  Similarity=0.855  Sum_probs=245.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      |+|++++.||+|+||+||+|+++ +|+.||+|++............+.+|+.++++++||||+++++++..++..+++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            68999999999999999999985 78999999998776666666678899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++.|+++..+....+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||.+.............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            99999999888888889999999999999999999999999999999999999999999999999998776655555666


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch-hhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  250 (314)
                      .+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+...++....+......++........ .....
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            78899999999988778899999999999999999999999999999999999998888887777765444332 22222


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      ....+.......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            3333445566788999999999999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-59  Score=402.79  Aligned_cols=263  Identities=29%  Similarity=0.425  Sum_probs=211.1

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .+.+.++|++.+.||+|+||+||+|+++.+|+.||+|++........ ...+.+|+.+++.++||||+++++++++++..
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45688999999999999999999999999999999999986654332 23456899999999999999999999999999


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe---cCCcEEEeeccceeeeC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~---~~~~~~l~df~~~~~~~  162 (314)
                      |+|||||+ |+|.+++... +.+++..+..++.||+.||+|||++|++|+||||+||++.   .++.+||+|||++....
T Consensus        83 ~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999998 5888888754 4699999999999999999999999999999999999994   47899999999998664


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+..........        
T Consensus       162 ~~-~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  231 (307)
T d1a06a_         162 PG-SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------  231 (307)
T ss_dssp             ------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT--------
T ss_pred             CC-CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc--------
Confidence            33 23345679999999999977 678999999999999999999999999888888777776543222221        


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                      ..+.+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus       232 ----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ----------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ----------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                            234579999999999999999999999999999999854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-59  Score=397.81  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=220.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..... .......+.+|++++++++||||+++++++++++..|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            3789999999999999999999999999999999976542 233344677999999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--C
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R  166 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~  166 (314)
                      |||++| +|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+|+......  .
T Consensus        87 mEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999985 8888776544 69999999999999999999999999999999999999999999999999998764332  2


Q ss_pred             cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       167 ~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......                
T Consensus       166 ~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----------------  228 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD----------------  228 (288)
T ss_dssp             ----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----------------
T ss_pred             ccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence            3345679999999999987 67899999999999999999999999988887777776543111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHH------HhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ------ALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------ll~h~~~~~~~  298 (314)
                                  +...+++++.+||.+||+.||++|||++|      +++||||+.++
T Consensus       229 ------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         229 ------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             ------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence                        11246999999999999999999999987      68999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-58  Score=404.84  Aligned_cols=262  Identities=28%  Similarity=0.449  Sum_probs=228.6

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++++.||+|+||+||+|.+..+|+.||+|++......  ....+.+|++++++++||||+++++++++++..|+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3568899999999999999999999999999999999765422  23356689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEe--cCCcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~--~~~~~~l~df~~~~~~~~~~  165 (314)
                      |||||+| +|.+.+...+..+++..++.++.||+.||+|||++|++|+||||+|||++  .++.+||+|||++...... 
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            9999985 88888877777899999999999999999999999999999999999997  5689999999999887543 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+.......+..           
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------  250 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-----------  250 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-----------
T ss_pred             CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence            33445678999999999977 678999999999999999999999999988888888876654332222           


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ....+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       251 -------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         251 -------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             -------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                         2245699999999999999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-58  Score=406.17  Aligned_cols=262  Identities=29%  Similarity=0.454  Sum_probs=227.9

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      .+.++|++++.||+|+||+||+|+++.+|+.||+|++......  ....+.+|+++++.++||||+++++++++++..|+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4568999999999999999999999999999999999754322  23456789999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec--CCcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~--~~~~~l~df~~~~~~~~~~  165 (314)
                      |||||+| +|.+.+....+.+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.+||+|||++...... 
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            9999985 898988777778999999999999999999999999999999999999964  578999999999877443 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..........           
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------  247 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-----------  247 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-----------
T ss_pred             cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence            33345678999999999987 667899999999999999999999999988888888776653322221           


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ....+++++.+||.+||..||++|||++|+|+||||+..+
T Consensus       248 -------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         248 -------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             -------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                         1235699999999999999999999999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-58  Score=397.10  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=221.7

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ..+.|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+++++.++||||+++++++.+++..|+
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            3457999999999999999999999999999999998654322 233456789999999999999999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||||.|+++..+...++.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....    .
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~  168 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  168 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence            999999876666665666799999999999999999999999999999999999999999999999999976533    2


Q ss_pred             cccccCccccCcccccC--ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          169 THQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~--~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      ....||+.|+|||++.+  ...++.++|||||||++|+|++|..||......+....+.........             
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------  235 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------------  235 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------------
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------------
Confidence            34579999999999864  245789999999999999999999999988877777666554211111             


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                   ...+++++.+||.+||+.||++|||++|+|+||||..-.
T Consensus       236 -------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         236 -------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence                         124589999999999999999999999999999997643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-58  Score=395.74  Aligned_cols=267  Identities=26%  Similarity=0.428  Sum_probs=225.7

Q ss_pred             HHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcCCCCeeeeeceeccC
Q 021299            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHK   83 (314)
Q Consensus         8 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   83 (314)
                      +.+.++|++.+.||+|+||+||+|+++.+|+.||+|++........    ....+.+|++++++++||||+++++++++.
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4577899999999999999999999999999999999987643322    234577899999999999999999999999


Q ss_pred             CeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC----cEEEeeccce
Q 021299           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA  158 (314)
Q Consensus        84 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~----~~~l~df~~~  158 (314)
                      +..|+|||||+| +|.+++...+ .+++..++.++.|++.||+|||++|++|+||||+||+++.++    .+||+|||++
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999985 8888876654 699999999999999999999999999999999999998776    5999999999


Q ss_pred             eeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+........      
T Consensus       165 ~~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------  236 (293)
T d1jksa_         165 HKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE------  236 (293)
T ss_dssp             EECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC------
T ss_pred             hhcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            876433 33345678999999999977 6789999999999999999999999998888887777655422111      


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCcce
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNGVF  301 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  301 (314)
                                        ....+.+++++.+||.+||+.||++|||++|+++||||+..+.+.
T Consensus       237 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         237 ------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             ------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence                              112235699999999999999999999999999999999766443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-58  Score=398.79  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=225.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++++.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            3689999999999999999999999999999999986542 223344567899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| +|...+...+ .+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||+++.........
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            999996 7777766544 68999999999999999999999999999999999999999999999999998765555555


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+......                  
T Consensus       163 ~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~------------------  223 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------------  223 (337)
T ss_dssp             CCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred             ccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC------------------
Confidence            66789999999999987 66799999999999999999999999998887777766554211                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                ++..+++++.+||++||+.||.+|++     ++|+++||||+.++
T Consensus       224 ----------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         224 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                      12346999999999999999999995     89999999998763

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-57  Score=385.80  Aligned_cols=261  Identities=28%  Similarity=0.449  Sum_probs=224.8

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc-------chhhHHHHHHHhhcC-CCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-------NFTALREIKLLKELK-SPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   82 (314)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.........       ...+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            57999999999999999999999999999999999876543322       124568999999997 9999999999999


Q ss_pred             CCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeee
Q 021299           83 KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (314)
Q Consensus        83 ~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~  161 (314)
                      +++.|+||||++| +|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            9999999999985 9999987654 6999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccCccccCcccccC-----ccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCC
Q 021299          162 GSPDRRFTHQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (314)
Q Consensus       162 ~~~~~~~~~~~~~~~y~sPE~~~~-----~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
                      .... ......||+.|+|||.+.+     ...++.++||||+|+++|+|++|..||......+....+..........  
T Consensus       161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--  237 (277)
T d1phka_         161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP--  237 (277)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence            5433 3445678999999999853     2346889999999999999999999999988888777776653221111  


Q ss_pred             CCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                            ....+|+++.+||.+||+.||++|||++|+|+||||+.+
T Consensus       238 ----------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 ----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                  123569999999999999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=390.76  Aligned_cols=286  Identities=39%  Similarity=0.724  Sum_probs=239.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCC-CcEEEEEEeecCCcccCcchhhHHHHHHHhhc---CCCCeeeeeceec-----
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP-----   81 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----   81 (314)
                      .++|++++.||+|+||+||+|++..+ ++.||+|++..............+|+++++.+   +||||+++++++.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            58999999999999999999999765 56789999987665555455566777777666   7999999999874     


Q ss_pred             cCCeEEEEEecccccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           82 HKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        82 ~~~~~~iv~e~~~g~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .....+++||++.|++..... .....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+..
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            345789999999987665554 4556799999999999999999999999999999999999999999999999999875


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .. .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+....+......++...
T Consensus       166 ~~-~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         166 YS-FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CC-GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hc-ccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            43 2334456778999999999977 678999999999999999999999999999999999999988887777776544


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ...... .......+.......+++++.+||.+||+.||++|||++|+|+||||+.+..
T Consensus       244 ~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         244 ALPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             SSCGGG-SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cchhhh-hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            333222 2333344455666788999999999999999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-58  Score=387.32  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=212.2

Q ss_pred             HHhhc-cceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc----CC
Q 021299           10 VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KG   84 (314)
Q Consensus        10 ~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~   84 (314)
                      ..++| +..+.||+|+||+||+|.+..++..||+|.+............+.+|++++++++||||+++++++++    +.
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            34566 67778999999999999999999999999998765544444567799999999999999999998854    45


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCceEEe-cCCcEEEeeccceee
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIG-SHGQLKLADFGLARI  160 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--i~H~di~~~nil~~-~~~~~~l~df~~~~~  160 (314)
                      .+|+||||++| +|.+++.+. +.+++..++.++.||+.||+|||++|  |+||||||+||+++ +++.+||+|||+++.
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            68999999985 888887654 36999999999999999999999998  99999999999996 578999999999975


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ...  .......||+.|+|||++.+  .++.++|||||||++|+|++|..||................  ..+.      
T Consensus       165 ~~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--~~~~------  232 (270)
T d1t4ha_         165 KRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPA------  232 (270)
T ss_dssp             CCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCG------
T ss_pred             ccC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--CCCc------
Confidence            432  23345679999999999865  58999999999999999999999998766555444332210  1111      


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                       ......++++.+||.+||+.||++|||++|+|+||||+
T Consensus       233 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 -----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             11234588999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-57  Score=392.91  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=221.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcc-cCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            36799999999999999999999999999999999765432 23344677899999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||+.| ++...+. ....+++..++.++.||+.||+|||++||+|+||||+||+++.+|.+||+|||+++.....   .
T Consensus        83 mE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~  158 (316)
T d1fota_          83 MDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T  158 (316)
T ss_dssp             ECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred             eeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---c
Confidence            999997 5555544 4556899999999999999999999999999999999999999999999999999876443   2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......                  
T Consensus       159 ~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------------  219 (316)
T d1fota_         159 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------------  219 (316)
T ss_dssp             CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------------
T ss_pred             ccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC------------------
Confidence            35679999999999976 66899999999999999999999999998888887777654211                  


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                ..+.+++++.++|.+||+.||.+|+     |++++++||||++++
T Consensus       220 ----------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         220 ----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ----------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence                      1124689999999999999999996     899999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=401.25  Aligned_cols=283  Identities=26%  Similarity=0.411  Sum_probs=215.7

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .|+|++++.||+|+||+||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5899999999999999999999999999999999976532 333456779999999999999999999999999999999


Q ss_pred             ecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||+.| +|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+|.....  ...
T Consensus        84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~  160 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMA  160 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HTC
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--Ccc
Confidence            99996 7877776544 59999999999999999999997 5999999999999999999999999999986532  222


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHH-HHhhCCCCCC--C--CC------
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI-FAAFGTATPS--Q--WP------  237 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~--~--~~------  237 (314)
                      ....||+.|+|||++.+ ..++.++||||+||++|+|++|..||...+........ ....+.....  .  .+      
T Consensus       161 ~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            35689999999999987 67899999999999999999999999776544322211 1111100000  0  00      


Q ss_pred             ----CcCcccchhhhcccc-CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          238 ----DLAYLPDYVEYQYVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       238 ----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                          ............... ..+.......++.++.+||.+||+.||++|||++|+|+||||+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                000000000000000 0111111124689999999999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=397.66  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=225.9

Q ss_pred             HHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus         9 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      +|.++|++.+.||+|+||+||+|.++.+|+.||+|.+......   ...+.+|+++++.++||||+++++++++++.+|+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            4678999999999999999999999999999999999765322   2346689999999999999999999999999999


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC--CcEEEeeccceeeeCCCC
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~--~~~~l~df~~~~~~~~~~  165 (314)
                      |||||+| +|.+.+...+..+++..++.++.||+.||.|||++|++||||||+||+++.+  ..++|+|||++..... .
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~  157 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-G  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-T
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-C
Confidence            9999985 8999888777789999999999999999999999999999999999999854  4899999999987643 3


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||......+....+.......+.            
T Consensus       158 ~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------  224 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------------  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------------
T ss_pred             CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh------------
Confidence            33445678899999999877 66899999999999999999999999999888888887665322221            


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                  ..++.+++++.+||.+||+.||++|||++|+++||||++-
T Consensus       225 ------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         225 ------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                        1123569999999999999999999999999999999753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=382.02  Aligned_cols=286  Identities=47%  Similarity=0.805  Sum_probs=245.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++++.||+|+||+||+|.+..+|+.||+|+++...........+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            68999999999999999999999999999999998776555555677899999999999999999999999999999999


Q ss_pred             cccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCccccc
Q 021299           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (314)
Q Consensus        92 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  171 (314)
                      ++.|+.+..+....+.+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+.............
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~  161 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence            99987777777777789999999999999999999999999999999999999999999999999999886666666667


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCc-cCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .+++.|.|||.+.....++.++|||||||++|+|++|..| |...+..+....+....+......++.............
T Consensus       162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T d1unla_         162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM  241 (292)
T ss_dssp             CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred             ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence            7888999999988766789999999999999999999866 566777777888888877777776665544433322221


Q ss_pred             c-cCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          251 V-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       251 ~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                      . .........+.+++++.+||++||+.||.+|||++|+|+||||+.+
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence            1 1223444556789999999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-56  Score=392.65  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=222.4

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+++++.++||||+++++++......++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            3899999999999999999999999999999999976542 223334567999999999999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++.| ++...+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   .
T Consensus       120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence            999986 7777776544 6999999999999999999999999999999999999999999999999999876432   2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......                 
T Consensus       196 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------  257 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----------------  257 (350)
T ss_dssp             CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred             ccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-----------------
Confidence            34678999999999977 668999999999999999999999999988888777776542111                 


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                 ...+++++.+||++||+.||.+|+     |++++++||||++++
T Consensus       258 -----------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         258 -----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             -----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             -----------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence                       124699999999999999999995     999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-56  Score=392.75  Aligned_cols=260  Identities=26%  Similarity=0.388  Sum_probs=215.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-Ccchhh---HHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTA---LREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....... .....+   .+++++++.++||||+++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999999999999999997543221 111222   2457777888899999999999999999


Q ss_pred             EEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      |+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+|+..... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999985 888887654 45899999999999999999999999999999999999999999999999999876543 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                       ......||+.|+|||++..+..++.++|||||||++|+|++|..||......+.... ........+            
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~~------------  226 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAV------------  226 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCCC------------
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCCC------------
Confidence             234567999999999997657789999999999999999999999987654443322 222111111            


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCC-----HHHHhcCccccccC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRFAKSFN  298 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~ell~h~~~~~~~  298 (314)
                                  .....+++++.+||.+||+.||++|||     ++|+++||||++++
T Consensus       227 ------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         227 ------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             ------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence                        112356999999999999999999999     79999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=387.29  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=221.2

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-ccCcchhhHHHHHHHh-hcCCCCeeeeeceeccCCeEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLK-ELKSPHIIELIDAFPHKGNLHLV   89 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv   89 (314)
                      |+|++.+.||+|+||+||+|.++.+|+.||+|++.+... ..........|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            789999999999999999999999999999999976532 2222334456666654 68999999999999999999999


Q ss_pred             Eecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        90 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      |||++| +|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.++.........
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999985 8888776544 58999999999999999999999999999999999999999999999999998776656666


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....     .+            
T Consensus       161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~------------  222 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----FY------------  222 (320)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CC------------
T ss_pred             cccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CC------------
Confidence            66789999999999987 6789999999999999999999999999888877777654311     11            


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHH-HHhcCccccccC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRFAKSFN  298 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-ell~h~~~~~~~  298 (314)
                                 ...+++++.+||++||+.||++|||+. |+++||||++++
T Consensus       223 -----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         223 -----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                       124699999999999999999999995 899999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=391.57  Aligned_cols=284  Identities=36%  Similarity=0.578  Sum_probs=230.4

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC-----
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   84 (314)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+++++.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            678999999999999999999999999999999999765544444456779999999999999999999986544     


Q ss_pred             -eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 -NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 -~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                       .+|+||||+++++.......  .+++..++.++.||+.||+|||++||+|+||||+||+++.++.++++|||.+.....
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecccccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             57999999987887777654  499999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       164 ~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .   .....+++.|+|||.+.+...++.++|||||||++|+|++|.+||...+.......+....+..+...+.......
T Consensus       174 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         174 E---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             S---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             c---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence            3   3456789999999999876778999999999999999999999999999888888888776665543222211111


Q ss_pred             ch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          244 DY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       244 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      ..   .................+++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            11   11111222334455667899999999999999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=381.76  Aligned_cols=286  Identities=42%  Similarity=0.738  Sum_probs=232.3

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc--------
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   82 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            589999999999999999999999999999999998776666666677899999999999999999998743        


Q ss_pred             CCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeC
Q 021299           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (314)
Q Consensus        83 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~  162 (314)
                      ++..+++||++.+++..........+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            45689999999998888887777789999999999999999999999999999999999999999999999999997664


Q ss_pred             CCC----CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          163 SPD----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       163 ~~~----~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      ...    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+....+...+..+..
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            322    2223356899999999998767789999999999999999999999999999999999999888877766554


Q ss_pred             cCcccchhhhccccCCC--CCccC--CCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccc
Q 021299          239 LAYLPDYVEYQYVAAPP--LRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEHRFAKS  296 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  296 (314)
                      .................  .....  ...++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            43322222111111100  00000  123778899999999999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=385.31  Aligned_cols=280  Identities=34%  Similarity=0.572  Sum_probs=224.8

Q ss_pred             hccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec------cCCeE
Q 021299           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP------HKGNL   86 (314)
Q Consensus        13 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~   86 (314)
                      +|+.+++||+|+||+||+|+++.+|+.||+|++......      ..+|++++++++||||+++++++.      +..+.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            699999999999999999999999999999999764322      237999999999999999999873      33467


Q ss_pred             EEEEecccccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeC
Q 021299           87 HLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFG  162 (314)
Q Consensus        87 ~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~  162 (314)
                      ++||||+++++...+.   .....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            9999999987766654   3455799999999999999999999999999999999999999875 89999999998764


Q ss_pred             CCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       163 ~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                      .. .......|++.|+|||.+.+...++.++|||||||++|+|++|.+||......+....+....+....+.+......
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            33 23345678999999999887678999999999999999999999999999988888888877666543322211110


Q ss_pred             cchhhhcccc-CCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          243 PDYVEYQYVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      .......... .+......+..++++.+||.+||+.||++|||+.|+|+||||+.+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            0000000000 11112223467999999999999999999999999999999998743

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=375.11  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=211.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccC----cchhhHHHHHHHhhcC--CCCeeeeeceeccC
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELK--SPHIIELIDAFPHK   83 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   83 (314)
                      +.++|++.+.||+|+||+||+|.+..+|+.||+|++........    ....+.+|+.+++.++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            46899999999999999999999999999999999986543221    1223558999999997  89999999999999


Q ss_pred             CeEEEEEecccc--cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC-CcEEEeeccceee
Q 021299           84 GNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARI  160 (314)
Q Consensus        84 ~~~~iv~e~~~g--~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~-~~~~l~df~~~~~  160 (314)
                      +..++|||++.|  ++.+.+... +.+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||.+..
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            999999999974  666666544 469999999999999999999999999999999999999865 7999999999987


Q ss_pred             eCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       161 ~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      ...  .......||+.|+|||++.+...++.++|||||||++|+|++|..||...+      .+.....           
T Consensus       161 ~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~-----------  221 (273)
T d1xwsa_         161 LKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-----------  221 (273)
T ss_dssp             CCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC-----------
T ss_pred             ccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc-----------
Confidence            533  233456799999999999875666788999999999999999999997532      1221100           


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                       .....+|+++.+||.+||+.||++|||++|+++||||+++.
T Consensus       222 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         222 -----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                             11235699999999999999999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=381.27  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=209.8

Q ss_pred             HHHhhcccee-eeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc----
Q 021299            9 KVADRYLKRE-VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH----   82 (314)
Q Consensus         9 ~~~~~y~~~~-~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----   82 (314)
                      .+.++|.+++ .||+|+||+||+|.+..+|+.||+|++...       ....+|+.++.++ +||||++++++|++    
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            4578998875 599999999999999999999999998632       3456899886655 79999999998864    


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccc
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~  157 (314)
                      +..+|+|||||+ |+|.+++...+ ..+++..++.++.||+.||+|||++|++||||||+||+++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            567899999998 49999998653 46999999999999999999999999999999999999975   45799999999


Q ss_pred             eeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      ++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+......... .++
T Consensus       161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~  237 (335)
T d2ozaa1         161 AKETTSHN-SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFP  237 (335)
T ss_dssp             CEECCCCC-CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCC
T ss_pred             eeeccCCC-ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CCC
Confidence            98765433 3455679999999999876 67899999999999999999999999877665554444332211110 000


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                                         ......+++++.+||++||+.||++|||++|+++||||+.-.
T Consensus       238 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         238 -------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             -------------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             -------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence                               011124699999999999999999999999999999997543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=365.78  Aligned_cols=255  Identities=20%  Similarity=0.280  Sum_probs=210.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||+|+.+   ..||+|+++...........+.+|++++++++||||+++++++. ++..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            478999999999999999999753   36999999877666666667889999999999999999999875 45679999


Q ss_pred             eccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC--Cc
Q 021299           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RR  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~--~~  167 (314)
                      ||++ |+|.+++...+..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  ..
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            9998 59999998877789999999999999999999999999999999999999999999999999997654322  23


Q ss_pred             ccccccCccccCcccccCc--cCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccch
Q 021299          168 FTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~--~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
                      .....||+.|+|||++.+.  ..++.++||||||+++|+|++|..||...................              
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------------  228 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--------------  228 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC--------------
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence            3455789999999998642  357899999999999999999999998877766665554431111              


Q ss_pred             hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                              +........+++++.+||.+||+.||++|||++||+++
T Consensus       229 --------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 --------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    11122334579999999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=379.75  Aligned_cols=287  Identities=36%  Similarity=0.628  Sum_probs=227.3

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccC-----C
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   84 (314)
                      ++++|++++.||+|+||+||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++...     .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            46789999999999999999999999999999999975432 22234567899999999999999999988544     3


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..+++++.++|+|.+++...  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             eEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            46777777778999998765  4999999999999999999999999999999999999999999999999999876432


Q ss_pred             CC---cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       165 ~~---~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..   ......|++.|+|||++.....++.++||||+|+++|+|++|..||...+..+......................
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            22   234567899999999997767789999999999999999999999999888888777766655443322111111


Q ss_pred             ccch---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          242 LPDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       242 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      ....   .........+.....+.+++++++||.+||+.||.+|||++|+|+||||+...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            1110   111111222333456678999999999999999999999999999999997654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=378.62  Aligned_cols=290  Identities=32%  Similarity=0.521  Sum_probs=223.8

Q ss_pred             ccccHH---HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeecee
Q 021299            4 VDLSKK---VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (314)
Q Consensus         4 ~~~~~~---~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   80 (314)
                      +.+++.   |.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||++++++|
T Consensus         6 ~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f   85 (355)
T d2b1pa1           6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_dssp             EEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             EEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            344553   55899999999999999999999999999999999987765544445677999999999999999999998


Q ss_pred             c------cCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEee
Q 021299           81 P------HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (314)
Q Consensus        81 ~------~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~d  154 (314)
                      .      ...+.|+||||+.|++++.+.   ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++++|
T Consensus        86 ~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          86 TPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             CSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             ecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeec
Confidence            4      446899999999999887764   3589999999999999999999999999999999999999999999999


Q ss_pred             ccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCC
Q 021299          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (314)
Q Consensus       155 f~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (314)
                      ||.+..... ........+|+.|+|||.+.+ ..++.++||||+||++++|++|.+||...+.......+........++
T Consensus       163 f~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         163 FGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CCC----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhhcccc-ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            999876543 333345568899999999987 678999999999999999999999999999888888888777765554


Q ss_pred             CCCCcCcccc--------------hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          235 QWPDLAYLPD--------------YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       235 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .+........              ...................++++.+||++||..||++|||++|+|+||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            3332211100              000000111111111123477899999999999999999999999999999753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-54  Score=369.22  Aligned_cols=263  Identities=22%  Similarity=0.357  Sum_probs=211.1

Q ss_pred             cHHHHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCccc-CcchhhHHHHHHHhhcCCCCeeeeeceeccCC-
Q 021299            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG-   84 (314)
Q Consensus         7 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   84 (314)
                      |+.|.|+|++.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+++++.++||||+++++++...+ 
T Consensus         2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            5668899999999999999999999999999999999998754432 23345778999999999999999999885433 


Q ss_pred             ---eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299           85 ---NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus        85 ---~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                         ..|+||||++| +|...+... +.+++..++.++.||+.||+|||++|++|+||||+||+++.++..+|+|||.+..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence               48999999996 677666544 4699999999999999999999999999999999999999999999999999876


Q ss_pred             eCCCC---CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCC
Q 021299          161 FGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (314)
Q Consensus       161 ~~~~~---~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
                      .....   .......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||......+....+.......+     
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-----  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-----  234 (277)
T ss_dssp             CC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-----
T ss_pred             hccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-----
Confidence            53322   23344578999999999876 6789999999999999999999999998887777766654321111     


Q ss_pred             CcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccc
Q 021299          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAK  295 (314)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  295 (314)
                                         ....+.+|+++.+||.+||+.||++||+..+.+.|+|++
T Consensus       235 -------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 -------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                               122345799999999999999999999655555677765

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=360.14  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.....   ....+.+|+++++.++||||+++++++..++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            57999999999999999999875 567899999875432   33567899999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-ccc
Q 021299           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFT  169 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~  169 (314)
                      |++ |+|.+++......+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++....... ...
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            998 588888887777899999999999999999999999999999999999999999999999999987644332 233


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...||+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....+........|               
T Consensus       161 ~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---------------  224 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---------------  224 (263)
T ss_dssp             ----CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---------------
T ss_pred             ceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---------------
Confidence            4567899999999977 668999999999999999998 46777777766666666554221111               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  ...++++.+|+.+||+.||++|||++||++|
T Consensus       225 ------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         225 ------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                        2358899999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=377.78  Aligned_cols=284  Identities=35%  Similarity=0.569  Sum_probs=226.6

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceecc------CC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------KG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   84 (314)
                      .++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+++++.++|||++++++++..      ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            579999999999999999999999999999999998765544444567799999999999999999998743      33


Q ss_pred             eEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCC
Q 021299           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (314)
Q Consensus        85 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~  164 (314)
                      ..+++++..+|+|.+++...  .+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+....  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence            45666666667898887543  59999999999999999999999999999999999999999999999999997542  


Q ss_pred             CCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       165 ~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                       .......|++.|+|||.+.+...++.++||||||+++|+|++|.+||.+.+.......+....+...............
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             3344567888999999987767789999999999999999999999999999999888888776654332222111111


Q ss_pred             h---hhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccCc
Q 021299          245 Y---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFNG  299 (314)
Q Consensus       245 ~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  299 (314)
                      .   ..........+......+++++++||.+||+.||.+|||++|+|+||||+++.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            1   011111122233345678999999999999999999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=357.12  Aligned_cols=248  Identities=20%  Similarity=0.313  Sum_probs=214.8

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   91 (314)
                      ++|++.+.||+|+||+||+|+++ ++..||+|.++....   ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            58999999999999999999974 677899999986543   23478899999999999999999999999999999999


Q ss_pred             ccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-ccc
Q 021299           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFT  169 (314)
Q Consensus        92 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~  169 (314)
                      |+. |++...+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||+++....... ...
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            997 578888887777899999999999999999999999999999999999999999999999999986544322 333


Q ss_pred             ccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhh
Q 021299          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (314)
Q Consensus       170 ~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
                      ...+|+.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+........|               
T Consensus       160 ~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---------------  223 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------------  223 (258)
T ss_dssp             CSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---------------
T ss_pred             ccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---------------
Confidence            4668899999999976 668999999999999999998 79999998888777766554222111               


Q ss_pred             ccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  ...++++.+||.+||+.||++|||++++++|
T Consensus       224 ------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         224 ------------HLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                        2458899999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-53  Score=363.49  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=201.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCc---EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||+||+|.++.+|+   .+++|.+...... .....+.+|+++++.++||||+++++++..++..+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            4788999999999999999999887665   4778877644322 23346779999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      +||||++| +|.+++....+.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            99999985 78888887777899999999999999999999999999999999999999999999999999987643322


Q ss_pred             c-----ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcC
Q 021299          167 R-----FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (314)
Q Consensus       167 ~-----~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
                      .     .....+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+........        
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  254 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP--------  254 (299)
T ss_dssp             ------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC--------
T ss_pred             cceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence            1     122456888999999877 678999999999999999998 8999998888777766654322111        


Q ss_pred             cccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                         ...+++++.+|+.+||+.||++|||+.||+++
T Consensus       255 -------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         255 -------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                               12468999999999999999999999998865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-53  Score=361.71  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=209.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++.....   ....+.+|++++++++||||+++++++.+++..+++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            3689999999999999999999999999999999875432   3346789999999999999999999999999999999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      ||++ |++...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            9998 5888888654 55799999999999999999999999999999999999999999999999999986644332 2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCcc-CCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL-QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|| ...+.......+......                
T Consensus       173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~----------------  235 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------------  235 (287)
T ss_dssp             ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----------------
T ss_pred             eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC----------------
Confidence            334457888999999877 67899999999999999999976554 444444433333222111                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCcccccc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSF  297 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  297 (314)
                                 .....+++++.+||.+||+.||++|||++||++  +|+.+
T Consensus       236 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         236 -----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             -----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                       112356899999999999999999999999965  45544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=360.38  Aligned_cols=254  Identities=21%  Similarity=0.339  Sum_probs=211.8

Q ss_pred             hhccceee-eCccccceEEEEEECC--CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKREV-LGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~~-lg~g~~g~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||+|++..... ......+.+|++++++++||||+++++++.. +..++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            67888885 9999999999997654  345799999975432 2234467799999999999999999999865 45789


Q ss_pred             EEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc
Q 021299           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (314)
Q Consensus        89 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~  167 (314)
                      ||||++| +|.+++...+..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            9999995 888888777778999999999999999999999999999999999999999999999999999887543322


Q ss_pred             ---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       168 ---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                         .....||+.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+..+....            
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~------------  232 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------------  232 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC------------
T ss_pred             cccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence               223457889999999876 568999999999999999998 899999888877776665432211            


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH---hcCcccc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA---LEHRFAK  295 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~h~~~~  295 (314)
                                     ..+.+++++.+||.+||+.||++|||+.+|   |+|+|++
T Consensus       233 ---------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 ---------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                           123468999999999999999999999887   6788875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=362.01  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=202.7

Q ss_pred             eeeCccccceEEEEEEC--CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEEecccc
Q 021299           18 EVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        18 ~~lg~g~~g~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      +.||+|+||+||+|.+.  .+++.||+|++............+.+|++++++++||||++++++++. +..++||||++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999754  345789999997665544445578899999999999999999999865 457899999985


Q ss_pred             -cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCc---cccc
Q 021299           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQ  171 (314)
Q Consensus        96 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~  171 (314)
                       +|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++........   ....
T Consensus        92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence             787777654 46999999999999999999999999999999999999999999999999999876443322   2234


Q ss_pred             ccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhhhcc
Q 021299          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (314)
Q Consensus       172 ~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
                      .||+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....+..+....                   
T Consensus       171 ~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------  230 (277)
T d1xbba_         171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------------  230 (277)
T ss_dssp             CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------------
T ss_pred             CCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            67889999999976 567999999999999999997 899999887776666554431111                   


Q ss_pred             ccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHH---hcCccccccC
Q 021299          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA---LEHRFAKSFN  298 (314)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~h~~~~~~~  298 (314)
                              ....+++++.+||.+||+.||++|||+++|   |+|+|++-++
T Consensus       231 --------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         231 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             --------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence                    123468999999999999999999999998   5777766443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-52  Score=363.75  Aligned_cols=278  Identities=31%  Similarity=0.517  Sum_probs=212.2

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeeceec--cCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFP--HKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~   87 (314)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....     ...+.+|+++++.+. ||||+++++++.  .....+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            478999999999999999999999999999999986432     345678999999995 999999999985  456799


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCC-cEEEeeccceeeeCCCC
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPD  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~-~~~l~df~~~~~~~~~~  165 (314)
                      +||||+++ +|...    .+.+++..++.++.||+.||.|||++||+|+||||+|||++.++ .++|+|||.+...... 
T Consensus       109 ~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-  183 (328)
T d3bqca1         109 LVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  183 (328)
T ss_dssp             EEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred             EEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence            99999996 54332    34599999999999999999999999999999999999998755 6999999999876433 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcH-HHHHHHHHhhCCCCCC---------C
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPS---------Q  235 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~---------~  235 (314)
                      .......+|+.|+|||.+.+...++.++||||||+++++|++|..||...... .....+....+.....         .
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            33455678999999999887667899999999999999999999999765543 3333333332211100         0


Q ss_pred             CCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCccccccC
Q 021299          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRFAKSFN  298 (314)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  298 (314)
                      .+.........................+++++.+||++||+.||.+|||++|+|+||||+.+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            000000000000000000011112235789999999999999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=359.13  Aligned_cols=253  Identities=21%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||+|.++ ++..||+|++.....   ....+.+|++++++++||||+++++++.+ +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            378999999999999999999875 567899999975432   33467899999999999999999998754 5578999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC-c
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~  167 (314)
                      ||+++ +|.+.+... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            99985 777766543 33599999999999999999999999999999999999999999999999999988754332 2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhC-CCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|+|| .+|+......+....+........              
T Consensus       167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~--------------  231 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--------------  231 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------------
T ss_pred             ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Confidence            334567889999999876 5679999999999999999995 566666666666655544321111              


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc--Cccccc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKS  296 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~  296 (314)
                                   ...+++++.+|+.+||+.||++|||+++|++  |+||.+
T Consensus       232 -------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         232 -------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                         1246899999999999999999999999998  888864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=364.08  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             hhccceeeeCccccceEEEEEECCCCc-----EEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCe
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGN   85 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   85 (314)
                      ++|++.+.||+|+||+||+|.+...++     .|++|.+..... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            789999999999999999998765443     688998865433 23344677899999998 89999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCce
Q 021299           86 LHLVFEFME-TDLETVIRNTN----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNL  142 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~ni  142 (314)
                      .++|||||+ |+|.+++....                      ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            999999998 59999987653                      2488999999999999999999999999999999999


Q ss_pred             EEecCCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHH
Q 021299          143 LIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDID  219 (314)
Q Consensus       143 l~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~  219 (314)
                      +++.++.+||+|||+|+.......  ......||+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.......
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999986544332  2234567899999999876 678999999999999999997 899998877766


Q ss_pred             HHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .+..+.......                          +....+++++.+||.+||+.||++|||++||++|
T Consensus       275 ~~~~~~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         275 NFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            666655432111                          1123468999999999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=364.36  Aligned_cols=263  Identities=25%  Similarity=0.419  Sum_probs=217.2

Q ss_pred             HhhccceeeeCccccceEEEEEEC---CCCcEEEEEEeecCCc--ccCcchhhHHHHHHHhhcCC-CCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS-PHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~   84 (314)
                      .++|++++.||+|+||+||+|++.   .+|+.||+|.+.....  .......+.+|++++++++| |||+++++++++..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            388999999999999999999873   4688999999876532  22233456689999999977 89999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCC
Q 021299           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~  163 (314)
                      ..+++|||+.| +|.+.+...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            99999999985 8888876554 478999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-CcccccccCccccCcccccCcc-CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          164 PD-RRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       164 ~~-~~~~~~~~~~~y~sPE~~~~~~-~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      .. .......|++.|++||.+.+.. .++.++|||||||+||+|++|..||......+....+........+.       
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-------  254 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-------  254 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-------
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-------
Confidence            32 2334567889999999987533 46889999999999999999999998876666655555443222211       


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCC-----CHHHHhcCccccccC
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRFAKSFN  298 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~~  298 (314)
                                       ....+++++.+||.+||+.||++||     |++|+++||||+.++
T Consensus       255 -----------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         255 -----------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             -----------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                             1234699999999999999999999     589999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=352.83  Aligned_cols=250  Identities=20%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             hhccceeeeCccccceEEEEEECCCC----cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      +.|++.++||+|+||+||+|.++.++    ..||+|.+...... .....+.+|++++++++||||+++++++.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            57999999999999999999877654    36999998654332 22345779999999999999999999999999999


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-  165 (314)
                      ++|||+.+ ++...+....+.+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++...... 
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            99999986 6777777777789999999999999999999999999999999999999999999999999998754322 


Q ss_pred             --CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcc
Q 021299          166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (314)
Q Consensus       166 --~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
                        .......||+.|+|||.+.+ ..++.++||||||+++|+|+++. +|+......+....+..+....           
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-----------  233 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-----------  233 (283)
T ss_dssp             --------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------
T ss_pred             cceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-----------
Confidence              12234567889999999977 67899999999999999999865 5555555555555444332111           


Q ss_pred             cchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                      ....+++++.+||.+||+.||++|||+.||++
T Consensus       234 ----------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         234 ----------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                            12245889999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-52  Score=350.94  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=200.5

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC---cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      .++|++.+.||+|+||+||+|.+..++   ..+++|.+.... .......+.+|+++++.++||||+++++++. ++..+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            479999999999999999999876543   468888875433 2223346779999999999999999999985 46789


Q ss_pred             EEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-
Q 021299           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (314)
Q Consensus        88 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-  165 (314)
                      +||||+.+ ++..++....+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... 
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            99999984 7888887777789999999999999999999999999999999999999999999999999998764332 


Q ss_pred             CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccc
Q 021299          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (314)
Q Consensus       166 ~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
                      .......+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....+......              
T Consensus       164 ~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~--------------  228 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------------  228 (273)
T ss_dssp             -------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------------
T ss_pred             eeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence            23334567889999999976 678999999999999999997 89999998888877776543211              


Q ss_pred             hhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                   +..+.+++++.+||.+||+.||++|||++||++|
T Consensus       229 -------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         1123569999999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=357.52  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=204.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCc----EEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   87 (314)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+.... .......+.+|++++++++||||+++++++.++.. +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-Q   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-E
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-e
Confidence            469999999999999999999888776    57888776432 33344578899999999999999999999977654 5


Q ss_pred             EEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC
Q 021299           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (314)
Q Consensus        88 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~  166 (314)
                      ++++++. |+|.+.+......+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            5566665 699999988888899999999999999999999999999999999999999999999999999987644332


Q ss_pred             c--ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCccc
Q 021299          167 R--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (314)
Q Consensus       167 ~--~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
                      .  .....||+.|+|||.+.+ ..++.++||||||+++|+|+| |.+||......+....+..+.....           
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-----------  234 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-----------  234 (317)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-----------
T ss_pred             cccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence            2  233457899999999877 678999999999999999998 7899988877776666655422111           


Q ss_pred             chhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcCc
Q 021299          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (314)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  292 (314)
                                      .+.+++++.+|+.+||..||++|||+.||++|.
T Consensus       235 ----------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         235 ----------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             ----------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                            124589999999999999999999999999873

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=351.07  Aligned_cols=257  Identities=22%  Similarity=0.369  Sum_probs=206.0

Q ss_pred             HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCeEEEEE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   90 (314)
                      .++|++.+.||+|+||+||+|.++.+ ..||+|++.....   ....+.+|+.++++++||||+++++++.+ +..++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            47999999999999999999988654 5799999875433   33568899999999999999999999855 5578999


Q ss_pred             ecccc-cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC-Cc
Q 021299           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (314)
Q Consensus        91 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~  167 (314)
                      ||+.+ ++...+... .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            99995 677776543 4569999999999999999999999999999999999999999999999999998654332 23


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....+++.|+|||.+.. ..++.++||||||+++|+|++|. +|+......+....+......                
T Consensus       171 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----------------  233 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------  233 (285)
T ss_dssp             -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------
T ss_pred             eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence            334568899999999976 67899999999999999999965 555666655565555433211                


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc--CccccccCcc
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRFAKSFNGV  300 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~~~  300 (314)
                                 +....+++++.+||.+||+.||++|||+++|++  ++||+.....
T Consensus       234 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         234 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             -----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence                       112356899999999999999999999999988  8899876543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=343.80  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=199.4

Q ss_pred             HhhccceeeeCccccceEEEEEECC-CC--cEEEEEEeecCCcccC-cchhhHHHHHHHhhcCCCCeeeeeceeccCCeE
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-TG--QTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~--~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   86 (314)
                      .++|++++.||+|+||+||+|+... ++  ..||+|++........ ....+.+|+++++.++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3679999999999999999997543 33  3689999876654333 33467899999999999999999999965 467


Q ss_pred             EEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCC
Q 021299           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        87 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~  165 (314)
                      ++||||++ |++.+.+....+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            89999998 58888887777789999999999999999999999999999999999999999999999999999864433


Q ss_pred             Cc---ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCc
Q 021299          166 RR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (314)
Q Consensus       166 ~~---~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
                      ..   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+..+....+......           
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-----------  233 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-----------  233 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-----------
T ss_pred             CcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-----------
Confidence            32   223456788999999987 678999999999999999998 89999998888877776543111           


Q ss_pred             ccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                     .+....+++++.+||.+||..||++|||++||++
T Consensus       234 ---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 ---------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0112356899999999999999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=339.49  Aligned_cols=243  Identities=20%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec-cCCeEEEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLVF   90 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~   90 (314)
                      ++|++.+.||+|+||.||+|.++  |..||+|+++.+.    ....+.+|++++++++||||+++++++. +.+.+++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            67999999999999999999874  7799999996533    3346779999999999999999999874 456789999


Q ss_pred             eccc-ccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCCcc
Q 021299           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (314)
Q Consensus        91 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~  168 (314)
                      ||++ |+|.+++... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||.+......   .
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---C
Confidence            9998 5898888654 335899999999999999999999999999999999999999999999999999865332   2


Q ss_pred             cccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHHHHHhhCCCCCCCCCCcCcccchhh
Q 021299          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (314)
Q Consensus       169 ~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
                      ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....+......                 
T Consensus       158 ~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-----------------  219 (262)
T d1byga_         158 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-----------------  219 (262)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-----------------
T ss_pred             ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence            33456888999999976 678999999999999999998 68888887777776665432111                 


Q ss_pred             hccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                +....+++++.+||.+||+.||.+|||+.+++++
T Consensus       220 ----------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         220 ----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                      1223468999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-50  Score=345.93  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=208.9

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|++.+.||+|+||+||+|+++.     +++.||+|++..... ......+.+|++++++++||||+++++++...+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            5789999999999999999998653     457899999865432 2234567899999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 021299           86 LHLVFEFME-TDLETVIRNTN-----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~n  141 (314)
                      .+++||++. |+|.+++....                       ..+++..+..++.|++.||+|||+++++||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            999999998 58888886432                       248899999999999999999999999999999999


Q ss_pred             eEEecCCcEEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcH
Q 021299          142 LLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDI  218 (314)
Q Consensus       142 il~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~  218 (314)
                      |+++.++.+||+|||++.......  .......+++.|+|||.+.+ ..++.++||||||+++|+|++|. +||......
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            999999999999999997653322  22234567888999999977 67899999999999999999995 789888888


Q ss_pred             HHHHHHHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      +....+......                           .....+++++.+||.+||+.||++|||+.||++
T Consensus       250 e~~~~v~~~~~~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVIYYVRDGNIL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            877776544211                           112356899999999999999999999999954

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=344.84  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=205.0

Q ss_pred             hhccceeeeCccccceEEEEEECCCCcE--EEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCCeEEE
Q 021299           12 DRYLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        12 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   88 (314)
                      ++|++.++||+|+||+||+|.++.+|..  |++|.+...... .....+.+|+++++++ +||||+++++++.+++..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            7999999999999999999999888774  667777544332 2344678999999998 69999999999999999999


Q ss_pred             EEeccc-ccHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEE
Q 021299           89 VFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (314)
Q Consensus        89 v~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l  152 (314)
                      ||||++ |+|.+++...               ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence            999999 5898888643               356999999999999999999999999999999999999999999999


Q ss_pred             eeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCC
Q 021299          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTA  231 (314)
Q Consensus       153 ~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~  231 (314)
                      +|||++...... .......+|+.|+|||.+.. ..++.++||||||+++|+|++|. +||...+..+....+...... 
T Consensus       169 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~-  245 (309)
T d1fvra_         169 ADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-  245 (309)
T ss_dssp             CCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-
T ss_pred             cccccccccccc-ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-
Confidence            999999754322 22234567889999999976 66899999999999999999975 678877777766655433111 


Q ss_pred             CCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                                +....+++++.+||.+||+.||++|||++||+++
T Consensus       246 --------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         246 --------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             --------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                      1123468999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=342.55  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=195.1

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc-C
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~   83 (314)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|.+....... ....+.+|...+.++ +|+||+.+.+++.. +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3789999999999999999998654     34689999987543322 233556777777777 58899999988654 5


Q ss_pred             CeEEEEEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecC
Q 021299           84 GNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (314)
Q Consensus        84 ~~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~  147 (314)
                      ...+++||||+ |+|.+++....               ..+++..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            57899999998 58988886542               348999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHH
Q 021299          148 GQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKI  224 (314)
Q Consensus       148 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~  224 (314)
                      +.+||+|||+++.......  ......||+.|+|||.+.+ ..++.++||||+|+++|+|++|. +||............
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999986543322  3344578999999999977 67899999999999999999874 788776655554444


Q ss_pred             HHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                      .......                          .....+++++.+||.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRM--------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCC--------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3321111                          1123468999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-49  Score=340.79  Aligned_cols=262  Identities=19%  Similarity=0.220  Sum_probs=208.2

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC-eeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~i   88 (314)
                      ++++|++.+.||+|+||+||+|++..+|+.||+|.+......    ..+..|+++++.++|++ |+.+..++.+++..++
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            468999999999999999999999999999999998765432    24668999999998766 5555566678889999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec---CCcEEEeeccceeeeCCCC
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPD  165 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~---~~~~~l~df~~~~~~~~~~  165 (314)
                      |||+++|++...+....+.+++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||+++......
T Consensus        81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9999999999988888888999999999999999999999999999999999999864   4579999999999875432


Q ss_pred             C-------cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHhhCCCCCCCCCC
Q 021299          166 R-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (314)
Q Consensus       166 ~-------~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
                      .       ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+......        
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--------  231 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------  231 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--------
T ss_pred             cccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--------
Confidence            2       2334578999999999877 66899999999999999999999999776554443332221100        


Q ss_pred             cCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHH---HHhcCccccc
Q 021299          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRFAKS  296 (314)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---ell~h~~~~~  296 (314)
                                  ....+.+...+.+|+++.++|.+||..||++||+++   ++|+|+|.+.
T Consensus       232 ------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 ------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                        000111222346799999999999999999999986   5578887653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=339.51  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=203.1

Q ss_pred             HhhccceeeeCccccceEEEEEECCCC-------cEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceecc
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-------QTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   82 (314)
                      .++|.+.+.||+|+||.||+|++..++       ..||+|++....... ...++.+|+..+.++ +||||+++++++.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            479999999999999999999876543       479999997654322 334566788888888 79999999999999


Q ss_pred             CCeEEEEEeccc-ccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           83 KGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        83 ~~~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ++..++||||+. |++.+++....               ..+++..+..++.||+.||+|||+++++||||||+||+++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            999999999998 58888886553               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.+||+|||.+........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+....
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~  249 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  249 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            99999999999987644322  2334567888999999977 678999999999999999998 6889988777666555


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      +..+....                           ....+++++.+||.+||+.||++|||+.||++
T Consensus       250 i~~~~~~~---------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         250 LKEGHRMD---------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHTTCCCC---------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCCC---------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            44331111                           12346899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=340.56  Aligned_cols=258  Identities=20%  Similarity=0.320  Sum_probs=213.6

Q ss_pred             HhhccceeeeCccccceEEEEEECC-----CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCCe
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   85 (314)
                      .++|.+.+.||+|+||+||+|.+..     ++..||+|++..... ......+.+|++++++++||||+++++++..++.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            4899999999999999999998753     356899999875432 2233457799999999999999999999999999


Q ss_pred             EEEEEeccc-ccHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeec
Q 021299           86 LHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df  155 (314)
                      .++||||+. |++.+++....         ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            999999998 58888775321         24688999999999999999999999999999999999999999999999


Q ss_pred             cceeeeCCCCC--cccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCC-CccCCCCcHHHHHHHHHhhCCCC
Q 021299          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTAT  232 (314)
Q Consensus       156 ~~~~~~~~~~~--~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~  232 (314)
                      |++........  ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|. +||......+....+..+.... 
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~-  255 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD-  255 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC-
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            99976543322  2233467899999999977 67889999999999999999985 8898888877777665432111 


Q ss_pred             CCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc------Ccccccc
Q 021299          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE------HRFAKSF  297 (314)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~------h~~~~~~  297 (314)
                                                ....+++.+.+||.+||+.||++|||++||++      +|+|++.
T Consensus       256 --------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         256 --------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             --------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence                                      12346899999999999999999999999997      7777644

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-48  Score=330.97  Aligned_cols=253  Identities=21%  Similarity=0.232  Sum_probs=208.8

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCC-CCeeeeeceeccCCeEEE
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHL   88 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~i   88 (314)
                      ++++|++.+.||+|+||+||+|++..+|+.||+|++......    ..+.+|++.++.+.| +|++.+.+++..+...++
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            568999999999999999999999999999999998654332    245688999999975 899999999999999999


Q ss_pred             EEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec-----CCcEEEeeccceeeeCC
Q 021299           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-----HGQLKLADFGLARIFGS  163 (314)
Q Consensus        89 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~-----~~~~~l~df~~~~~~~~  163 (314)
                      |||+++|+|.+.+...+..++...+..++.|++.||++||++|++||||||+||+++.     ++.++|+|||+++....
T Consensus        79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999999999999888878999999999999999999999999999999999999964     56899999999987643


Q ss_pred             CC-------CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHH---HHHHhhCCCCC
Q 021299          164 PD-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLG---KIFAAFGTATP  233 (314)
Q Consensus       164 ~~-------~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~  233 (314)
                      ..       .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..........   .+......   
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~---  234 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS---  234 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH---
T ss_pred             CccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC---
Confidence            22       12334578999999999987 678999999999999999999999997654433322   22221100   


Q ss_pred             CCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                                          .+.......+++++.+++..|+..+|++||+.+.+.+
T Consensus       235 --------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 --------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             --------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                1111223456899999999999999999999777643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=332.94  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             HhhccceeeeCccccceEEEEEEC-----CCCcEEEEEEeecCCcccCcchhhHHHHHHHhhc-CCCCeeeeeceeccCC
Q 021299           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (314)
Q Consensus        11 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   84 (314)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|.+...... .....+.+|+.+++++ +||||+++++++.+..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            479999999999999999999753     45678999999765432 2334577899999999 6999999999999999


Q ss_pred             eEEEEEecccc-cHHHHHHhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEec
Q 021299           85 NLHLVFEFMET-DLETVIRNTN-----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        85 ~~~iv~e~~~g-~l~~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~  146 (314)
                      ..+++||||+| ++...+....                 ..+++..+..++.||+.||+|||++|++|+||||+||+++.
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence            99999999985 8888876543                 25899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccceeeeCCCC--CcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHh-CCCccCCCCcHHHHHH
Q 021299          147 HGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (314)
Q Consensus       147 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~-g~~pf~~~~~~~~~~~  223 (314)
                      ++.++++|||.++......  .......+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||......+.+..
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999998764432  22334577999999999976 678999999999999999998 6677777666666555


Q ss_pred             HHHhhCCCCCCCCCCcCcccchhhhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhc
Q 021299          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (314)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  290 (314)
                      +...-....                          ....+++++.+||.+||+.||++|||++||++
T Consensus       260 ~i~~~~~~~--------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKEGFRML--------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHTCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCC--------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            544311111                          11245899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=333.25  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=196.3

Q ss_pred             eeeeCccccceEEEEEECCCC---cEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceec-cCCeEEEEEec
Q 021299           17 REVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLVFEF   92 (314)
Q Consensus        17 ~~~lg~g~~g~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~   92 (314)
                      .++||+|+||+||+|.+..++   ..||+|.+.... .......+.+|++++++++||||+++++++. .++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            568999999999999876543   358999986432 2333456789999999999999999999875 45688999999


Q ss_pred             ccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccceeeeCCCCC----c
Q 021299           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----R  167 (314)
Q Consensus        93 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~----~  167 (314)
                      +++ ++.+++......+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++........    .
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            995 78888887777788999999999999999999999999999999999999999999999999987543322    2


Q ss_pred             ccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCC-CcHHHHHHHHHhhCCCCCCCCCCcCcccchh
Q 021299          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (314)
Q Consensus       168 ~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
                      .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||... +..+....+..+....               
T Consensus       191 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---------------  254 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---------------  254 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---------------
T ss_pred             cccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence            233567899999999876 67899999999999999999977666443 3333333333321111               


Q ss_pred             hhccccCCCCCccCCCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                                  ....+++++.+||.+||..||++|||+.||++|
T Consensus       255 ------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         255 ------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        113458899999999999999999999999988

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=325.69  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=189.3

Q ss_pred             HHhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCeeeeeceeccCC----e
Q 021299           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----N   85 (314)
Q Consensus        10 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~   85 (314)
                      |..+|++.+.||+|+||+||+|++  +|+.||+|++......   ......|+..+..++||||+++++++..++    .
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            357899999999999999999975  5889999998644221   112224556666789999999999985433    6


Q ss_pred             EEEEEeccc-ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCceEEecCCcEEEeecc
Q 021299           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK--------KWVLHRDMKPNNLLIGSHGQLKLADFG  156 (314)
Q Consensus        86 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~i~H~di~~~nil~~~~~~~~l~df~  156 (314)
                      .++||||++ |+|.+.+.+.  .+++.....++.|++.||+|||+        +||+|+||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            899999998 5898988765  48999999999999999999996        699999999999999999999999999


Q ss_pred             ceeeeCCCCC----cccccccCccccCcccccCcc-----CCCCcchHhhHHHHHHHHHhCCCccCCCCcHHHHHHHHHh
Q 021299          157 LARIFGSPDR----RFTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA  227 (314)
Q Consensus       157 ~~~~~~~~~~----~~~~~~~~~~y~sPE~~~~~~-----~~~~~~Di~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~  227 (314)
                      ++........    ......||+.|+|||.+.+..     .++.++||||||+++|+|++|.+||..........     
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-----  228 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-----  228 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-----
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-----
Confidence            9987744332    223457899999999986522     25678999999999999999998875432111000     


Q ss_pred             hCCCCCCCCCCcCcccch--hhhccccCCCCCccC--CCCCHHHHHHHhhhcccCCCCCCCHHHHhcC
Q 021299          228 FGTATPSQWPDLAYLPDY--VEYQYVAAPPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEH  291 (314)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  291 (314)
                           ....+........  ........+.+...+  ......+.+|+.+||+.||++|||+.||+++
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 -----YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             -----TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             -----hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 0000000000000  000000001111111  1123568999999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-46  Score=328.77  Aligned_cols=286  Identities=27%  Similarity=0.455  Sum_probs=204.1

Q ss_pred             cccHHHH-hhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-----------CCC
Q 021299            5 DLSKKVA-DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----------SPH   72 (314)
Q Consensus         5 ~~~~~~~-~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~   72 (314)
                      .+++.+. +||++++.||+|+||+||+|+++.+|+.||+|+++....   ......+|+.+++.+.           |+|
T Consensus         5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_           5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            4566555 579999999999999999999999999999999975432   1234557888887775           478


Q ss_pred             eeeeeceecc--CCeEEEEEeccc--ccHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCceEEec
Q 021299           73 IIELIDAFPH--KGNLHLVFEFME--TDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGS  146 (314)
Q Consensus        73 i~~~~~~~~~--~~~~~iv~e~~~--g~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~i~H~di~~~nil~~~  146 (314)
                      |+++++++..  ....+.++.++.  ++..... ......+++..++.++.||+.||.|||+ .||+|+||||+||+++.
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            9999887743  345556666554  3433333 3445678999999999999999999998 89999999999999987


Q ss_pred             CC------cEEEeeccceeeeCCCCCcccccccCccccCcccccCccCCCCcchHhhHHHHHHHHHhCCCccCCCCc---
Q 021299          147 HG------QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---  217 (314)
Q Consensus       147 ~~------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~sPE~~~~~~~~~~~~Di~slG~ll~~ll~g~~pf~~~~~---  217 (314)
                      ++      .++++|||.+.....   ......|++.|+|||.+.. ..++.++|+||+|+++++|++|..||.....   
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             cCcccccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            65      499999999986533   2345678999999999886 6679999999999999999999999975432   


Q ss_pred             ---HHHHHHHHHhhCCCCCCCCCCcCcccchhhhc----cccC----------CCCCccCCCCCHHHHHHHhhhcccCCC
Q 021299          218 ---IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ----YVAA----------PPLRSLFPSASDDALDLLSKMFTYDPK  280 (314)
Q Consensus       218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~  280 (314)
                         .+........++..+...+.............    ....          ..........++++.+||.+||+.||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence               33444445554443221111000000000000    0000          000111233577899999999999999


Q ss_pred             CCCCHHHHhcCcccccc
Q 021299          281 ARITAQQALEHRFAKSF  297 (314)
Q Consensus       281 ~Rps~~ell~h~~~~~~  297 (314)
                      +|||++|+|+||||+..
T Consensus       318 ~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TCBCHHHHHTCGGGTTC
T ss_pred             HCcCHHHHhcCcccCCC
Confidence            99999999999999955

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2.1e-24  Score=172.12  Aligned_cols=165  Identities=15%  Similarity=0.168  Sum_probs=118.8

Q ss_pred             ccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCc----------------chhhHHHHHHHhhcCCCCeeeee
Q 021299           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV----------------NFTALREIKLLKELKSPHIIELI   77 (314)
Q Consensus        14 y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~~~i~~~~   77 (314)
                      +.+.+.||+|+||+||+|.+. +|+.||+|+++........                ......|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999874 6889999987653221100                01223578888889999988877


Q ss_pred             ceeccCCeEEEEEecccccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCceEEecCCcEEEeeccc
Q 021299           78 DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (314)
Q Consensus        78 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i~H~di~~~nil~~~~~~~~l~df~~  157 (314)
                      ++..    .+++||++++...       ..++...+..++.|++.++++||++|++|+||||+||+++++ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    2799999997422       125566678899999999999999999999999999999865 589999999


Q ss_pred             eeeeCCCCCcccccccCccccC------cccccCccCCCCcchHhhHHHH
Q 021299          158 ARIFGSPDRRFTHQVFARWYRA------PELLFGAKQYGAGVDVWAAGCI  201 (314)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~y~s------PE~~~~~~~~~~~~Di~slG~l  201 (314)
                      +.....+....        |..      .+.+ . ..++.++|+||+.--
T Consensus       149 a~~~~~~~~~~--------~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         149 SVEVGEEGWRE--------ILERDVRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             CEETTSTTHHH--------HHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             cccCCCCCcHH--------HHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence            98754332111        111      1112 2 457899999998543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.86  E-value=2e-08  Score=82.17  Aligned_cols=148  Identities=12%  Similarity=0.152  Sum_probs=97.3

Q ss_pred             cccccHHH---HhhccceeeeCccccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcC-CCCeeeeec
Q 021299            3 EVDLSKKV---ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELID   78 (314)
Q Consensus         3 ~~~~~~~~---~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~   78 (314)
                      ++.++.++   .+.|++++..+.++.+.||++.  .++..+++|..........  ..+..|...++.+. +--+.+++.
T Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~--~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_           2 KMRISPELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTT--YDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             CCSSCHHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTST--TCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             CcccCHHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccch--hhHHHHHHHHHHHhccCCCCcEEE
Confidence            45666666   4677777777777778999984  5567889998865533222  23457788777764 222556677


Q ss_pred             eeccCCeEEEEEecccc-cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------
Q 021299           79 AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK----------------------------  129 (314)
Q Consensus        79 ~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~----------------------------  129 (314)
                      +..+++..++||++++| .+.......      .....++.+++..++.||+                            
T Consensus        78 ~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          78 FERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            77778889999999998 443322111      1122233444444444441                            


Q ss_pred             -------------------------------CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 -------------------------------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 -------------------------------~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                                                     ..++|+|+.|.||++++++.+-|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                           1268999999999998776677999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=5.8e-06  Score=71.30  Aligned_cols=78  Identities=17%  Similarity=0.130  Sum_probs=47.6

Q ss_pred             ceeeeCccccceEEEEEECCCCcEEEEEEeecCCc-----ccCcchhhHHHHHHHhhcC--CCC-eeeeeceeccCCeEE
Q 021299           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-----KEGVNFTALREIKLLKELK--SPH-IIELIDAFPHKGNLH   87 (314)
Q Consensus        16 ~~~~lg~g~~g~vy~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~--~~~-i~~~~~~~~~~~~~~   87 (314)
                      ..+.||.|....||++....+++.+++|.-.....     ..........|.+.++.+.  .|. +.+++.+  +....+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            35678999999999998777788899997654211     1112223446777777663  233 4445443  334457


Q ss_pred             EEEecccc
Q 021299           88 LVFEFMET   95 (314)
Q Consensus        88 iv~e~~~g   95 (314)
                      ++||++++
T Consensus       108 lvmE~L~~  115 (392)
T d2pula1         108 TVMEDLSH  115 (392)
T ss_dssp             EEECCCTT
T ss_pred             EEEeccCC
Confidence            89999986

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=1.1e-05  Score=65.00  Aligned_cols=71  Identities=14%  Similarity=0.086  Sum_probs=48.3

Q ss_pred             eeCccc-cceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCC--eeeeeceeccCCeEEEEEecccc
Q 021299           19 VLGEGT-YGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHKGNLHLVFEFMET   95 (314)
Q Consensus        19 ~lg~g~-~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~g   95 (314)
                      .+..|. ...||++. ...+..+++|.......     ..+..|...++.+...+  +.+++.+..+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            444444 46789996 35567799998654322     23457888887775433  45567666777889999999987

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.43  E-value=0.00022  Score=61.10  Aligned_cols=73  Identities=12%  Similarity=0.159  Sum_probs=48.3

Q ss_pred             cceeeeCccccceEEEEEECC-------CCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCee-eeeceeccCCeE
Q 021299           15 LKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNL   86 (314)
Q Consensus        15 ~~~~~lg~g~~g~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~   86 (314)
                      ..++.|+.|-...+|++....       ..+.+++++... ...   .....+|..+++.+...++. ++++++.+    
T Consensus        45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            346789999999999997643       235677877652 111   12344788888888644544 56655532    


Q ss_pred             EEEEecccc
Q 021299           87 HLVFEFMET   95 (314)
Q Consensus        87 ~iv~e~~~g   95 (314)
                      .+|++|++|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            488999887

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.23  E-value=0.002  Score=53.37  Aligned_cols=69  Identities=17%  Similarity=0.195  Sum_probs=42.6

Q ss_pred             cccceEEEEEECCCCcEEEEEEeecCCcccCcchhhHHHHHHHhhcCCCCe-----eeeec--eeccCCeEEEEEecccc
Q 021299           23 GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-----IELID--AFPHKGNLHLVFEFMET   95 (314)
Q Consensus        23 g~~g~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~--~~~~~~~~~iv~e~~~g   95 (314)
                      +....||++.. .+|.++++|+.+....   ....+..|...+..+...++     +..-+  .+...+..+.++++++|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33568999963 5688999999875432   22345567777777643222     11111  22445677889998876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.14  E-value=0.0001  Score=61.12  Aligned_cols=31  Identities=26%  Similarity=0.250  Sum_probs=27.9

Q ss_pred             CCcccCCCCCCceEEecCCcEEEeeccceee
Q 021299          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (314)
Q Consensus       130 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~  160 (314)
                      .|++|+|+.++||+++.+...-|.||+.++.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            5799999999999999887778999999864